section_a,section_b,paper_similarity
Medical Virology Section,Emerging Respiratory Viruses Section,1.0
Molecular Signaling Section,Immune Activation Section,1.0
Vaccine Development Unit,Pathogenesis and Immunity Section,1.0
Viral Immunology Section,Cellular Biology Section,0.430622009569378
HIV Immunovirology Section,B-Cell Immunology Section,0.3401360544217687
Pathogenesis and Immunity Section,Molecular Pathogenesis and Biomarkers Section,0.3375
Vaccine Development Unit,Molecular Pathogenesis and Biomarkers Section,0.3375
Virus Ecology Section,Molecular Pathogenesis Unit,0.31724137931034485
Viral Budding Unit,Nonhuman Primate Virology Section,0.20408163265306123
Innate Immunity and Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.19767441860465115
Immunopathogenesis Section (Laboratory of Immunoregulation),HIV Immunovirology Section,0.1724137931034483
Clinical and Molecular Retrovirology Section,Clinical Research Section,0.1721311475409836
Genetic Immunotherapy Section,Clinical Pathophysiology Section,0.167420814479638
Immunobiology and Molecular Virology Unit,Disease Modeling and Transmission Section,0.1654320987654321
T-Lymphocyte Biology Section,Inflammation & Innate Immunity Unit,0.1625
Human Eosinophil Section,Allergy and Immunology Clinical Training Program,0.15862068965517243
Immunopathogenesis Section (Laboratory of Immunoregulation),B-Cell Immunology Section,0.1544943820224719
Malaria Immunology Section,Malaria Cell Biology Section,0.15357142857142858
Viral Immunity and Pathogenesis Unit,Cellular Biology Section,0.1471861471861472
Viral Immunology Section,Viral Immunity and Pathogenesis Unit,0.12751677852348994
Vector Molecular Biology Section,Vector Biology Section,0.12291666666666666
Viral Pathogenesis and Evolution Section,LID Clinical Studies Unit,0.12060301507537688
Retroviral Immunology Section,Neuroimmunology Unit,0.11811023622047244
Vector Biology Section,Molecular Entomology Unit,0.10869565217391304
RML Microscopy Unit,Host-Parasite Interactions Section,0.10714285714285714
Retroviral Immunology Section,RML Flow Cytometry Unit,0.10476190476190476
Inflammation & Innate Immunity Unit,Immunobiology Section,0.102803738317757
Human Eosinophil Section,Helminth Immunology Section,0.10129310344827586
Infectious Disease Pathogenesis Section,Building 33,0.0967741935483871
Molecular Pathogenesis Unit,Disease Modeling and Transmission Section,0.09113924050632911
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Genetic Immunotherapy Section,0.09009009009009009
HIV Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.08934707903780069
Pathogen-Host Cell Biology Section,Pathogen Molecular Genetics Section,0.0893371757925072
TSE/Prion and Retroviral Pathogenesis Section,Neuroimmunology Unit,0.088
Twinbrook Imaging Facility,Chemotaxis Signal Section,0.088
Translational Mycology Section,Infectious Disease Fellowship Training Program,0.07608695652173914
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Clinical Pathophysiology Section,0.07557117750439367
Infectious Disease Pathogenesis Section,Epithelial Therapeutics Unit,0.06818181818181818
HIV Pathogenesis Section,Clinical Research Section,0.06741573033707865
Primary Immune Deficiency Clinic,Molecular Development of the Immune System Section,0.06542056074766354
Nonhuman Primate Virology Section,Barrier Immunity Section,0.06498194945848375
Virus Ecology Section,Disease Modeling and Transmission Section,0.06382978723404255
Malaria Genetics Section,Malaria Functional Genomics Section,0.06349206349206349
Molecular Development of the Immune System Section,Human Immunological Diseases Section,0.0625
T-Lymphocyte Biology Section,Immunobiology Section,0.06198347107438017
Plague Section,Immunity to Pulmonary Pathogens Section,0.058394160583941604
Malaria Infection Biology and Immunity Unit,Malaria Cell Biology Section,0.057692307692307696
RML Flow Cytometry Unit,Neuroimmunology Unit,0.056179775280898875
Signaling Systems Section,Functional Cellular Networks Section,0.05555555555555555
Lymphocyte Biology Section,Computational Biology Unit,0.05263157894736842
T-Lymphocyte Biology Section,Infectious Disease Pathogenesis Section,0.05128205128205128
Malaria Infection Biology and Immunity Unit,Lymphocyte Activation Section,0.05054945054945055
Building NIHAC/103,Building 33,0.05
Mucosal Immunobiology Section,Mucosal Immunity Section,0.04878048780487805
TSE/Prion and Retroviral Pathogenesis Section,TSE/Prion Biochemistry Section,0.04830917874396135
Molecular Genetics Section (Laboratory of Bacteriology),Gene Regulation Section,0.048
Pathology Core,Autoimmunity and Functional Genomics Section,0.047619047619047616
T-Lymphocyte Biology Section,Building 33,0.047619047619047616
TSE/Prion and Retroviral Pathogenesis Section,TSE/Prion Molecular Biology Section,0.047619047619047616
RML Flow Cytometry Unit,Innate Immunity and Pathogenesis Section,0.04597701149425287
Translational Mycology Section,Genomic Technologies Section,0.040229885057471264
Metaorganism Immunity Section,Intracellular Parasite Biology Section,0.04
Innate Immunity and Pathogenesis Section,Immunobiology and Molecular Virology Unit,0.0392156862745098
T-Lymphocyte Biology Section,HIV Pathogenesis Section,0.03864734299516908
Malaria Immunology Section,Malaria Functional Genomics Section,0.038461538461538464
Molecular Pathogenesis Unit,Immunobiology and Molecular Virology Unit,0.03821656050955414
Malaria Cell Biology Section,Lymphocyte Activation Section,0.03770197486535009
TSE/Prion Molecular Biology Section,TSE/Prion Biochemistry Section,0.03684210526315789
Viral Pathogenesis and Vaccine Section,Nonhuman Primate Virology Section,0.035856573705179286
Neuroimmunology Unit,Innate Immunity and Pathogenesis Section,0.035398230088495575
Signaling Systems Section,Computational Biology Unit,0.03529411764705882
HIV-Specific Immunity Section,Clinical Research Section,0.03524229074889868
Immunobiology Section,HIV Pathogenesis Section,0.03468208092485549
RML Genomics Unit,Coxiella Pathogenesis Section,0.03409090909090909
Vector Molecular Biology Section,Intracellular Parasite Biology Section,0.033210332103321034
Immunopathogenesis Section (Laboratory of Immunoregulation),Clinical Research Section,0.0330188679245283
Computational Biology Unit,Chemotaxis Signal Section,0.032520325203252036
Molecular Defenses Section,Genetic Immunotherapy Section,0.032520325203252036
Mucosal Immunobiology Section,Inflammation Biology Section,0.031746031746031744
Immune Activation Section,Fungal Pathogenesis Section,0.031578947368421054
Molecular Signaling Section,Fungal Pathogenesis Section,0.031578947368421054
Functional Cellular Networks Section,Computational Biology Unit,0.030303030303030304
Molecular Pathogenesis and Biomarkers Section,Epidemiology and Population Studies Unit,0.02976190476190476
RML Flow Cytometry Unit,Plague Section,0.0297029702970297
RML Microscopy Unit,Chlamydial Diseases Section,0.02857142857142857
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Epidemiology and Population Studies Unit,0.028428093645484948
RML Microscopy Unit,Coxiella Pathogenesis Section,0.02824858757062147
Immune Activation Section,Genetic Immunotherapy Section,0.028011204481792718
Molecular Signaling Section,Genetic Immunotherapy Section,0.028011204481792718
Physiology Unit,NIAID International Center of Excellence in Research Cambodia,0.027777777777777776
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Fungal Pathogenesis Section,0.026729559748427674
Virus Ecology Section,Immunobiology and Molecular Virology Unit,0.02654867256637168
Infectious Disease Pathogenesis Section,Hepatic Pathogenesis Section,0.02631578947368421
NIAID International Center of Excellence in Research Cambodia,LID Clinical Studies Unit,0.02631578947368421
Molecular Pathogenesis Unit,Innate Immunity and Pathogenesis Section,0.02608695652173913
Malaria Functional Genomics Section,Malaria Cell Biology Section,0.025559105431309903
Twinbrook Imaging Facility,Molecular and Cellular Immunology Section,0.02531645569620253
Transplant Infectious Diseases Consult Service,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.024955436720142603
Signaling Systems Section,Lymphocyte Biology Section,0.024630541871921183
Translational Mycology Section,B-Cell Molecular Immunology Section,0.024509803921568627
Twinbrook Imaging Facility,Malaria Cell Biology Section,0.024509803921568627
Primary Immune Deficiency Clinic,Human Immunological Diseases Section,0.02413793103448276
Salmonella-Host Cell Interactions Section,RML Flow Cytometry Unit,0.024096385542168676
Innate Immunity and Pathogenesis Section,Disease Modeling and Transmission Section,0.023980815347721823
Infectious Disease Fellowship Training Program,Genomic Technologies Section,0.023668639053254437
RML Genomics Unit,Biology of Vector-Borne Viruses Section,0.023622047244094488
RNA Viruses Section,Building NIHAC/103,0.023529411764705882
Molecular Biology Section,Cellular Immunology Section,0.023474178403755867
RML Genomics Unit,International HIV/STD Section,0.023076923076923078
RML Genomics Unit,Genetic Engineering Section,0.023017902813299233
Metaorganism Immunity Section,Barrier Immunity Section,0.02287581699346405
HIV Immunovirology Section,Clinical Research Section,0.0228310502283105
Twinbrook III,Building NIHAC/103,0.022727272727272728
Translational Mycology Section,Neuroimmunological Diseases Section,0.022598870056497175
Metaorganism Immunity Section,Cellular Immunology Section,0.02258064516129032
Pathology Core,Molecular Pathology Section,0.022556390977443608
Translational Allergic Immunopathology Unit,Mast Cell Biology Section,0.022321428571428572
Genomic Technologies Section,B-Cell Molecular Immunology Section,0.022222222222222223
Immunobiology Section,Cell Signaling and Immunity Section,0.022151898734177215
TSE/Prion Molecular Biology Section,RML Microscopy Unit,0.021897810218978103
Immunopathogenesis Section (Laboratory of Immunoregulation),Clinical and Molecular Retrovirology Section,0.021739130434782608
Lymphocyte Biology Section,Cell Signaling and Immunity Section,0.021660649819494584
Malaria Functional Genomics Section,Genomic Technologies Section,0.021367521367521368
Molecular Microbiology Section,Fungal Pathogenesis Section,0.02092050209205021
RML Genomics Unit,Pathogen-Host Cell Biology Section,0.020833333333333332
Translational Allergic Immunopathology Unit,Food Allergy Research Section,0.020833333333333332
Structural Biology Section,Malaria Immunology Section,0.02072538860103627
Pathogenesis and Immunity Section,Epidemiology and Population Studies Unit,0.02054794520547945
Vaccine Development Unit,Epidemiology and Population Studies Unit,0.02054794520547945
Genomic Technologies Section,Epithelial Therapeutics Unit,0.02040816326530612
Neuroimmunological Diseases Section,Lyme Disease Studies Unit,0.020134228187919462
Molecular Microbiology Section,Clinical Pathophysiology Section,0.020100502512562814
HIV-Specific Immunity Section,Barrier Immunity Section,0.0199203187250996
RML Microscopy Unit,Plague Section,0.019867549668874173
Infectious Disease Pathogenesis Section,Genomic Technologies Section,0.019801980198019802
RML Genomics Unit,Host-Parasite Interactions Section,0.019736842105263157
Gene Regulation Section,Bacterial Physiology and Metabolism Unit,0.0196078431372549
Molecular Parasitology Section,Metaorganism Immunity Section,0.019455252918287938
TSE/Prion and Retroviral Pathogenesis Section,Retroviral Immunology Section,0.01935483870967742
Molecular and Cellular Immunoregulation Section,Metaorganism Immunity Section,0.019230769230769232
LID Clinical Studies Unit,Clinical Research Section,0.018867924528301886
Viral Immunology Section,Mucosal Immunobiology Section,0.01875
Viral Pathogenesis and Evolution Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.018367346938775512
RML Microscopy Unit,RML Genomics Unit,0.01818181818181818
Translational Autoinflammatory Disease Studies Unit,B-Cell Immunology Section,0.01818181818181818
RML Microscopy Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.017964071856287425
Structural Immunology Section,B-Cell Immunology Section,0.01775147928994083
Plague Section,Gene Regulation Section,0.017699115044247787
Nonhuman Primate Virology Section,Genetic Engineering Section,0.017582417582417582
Viral Pathogenesis Section (Laboratory of Immunoregulation),Immunopathogenesis Section (Laboratory of Immunoregulation),0.017369727047146403
Viral Pathogenesis Section (Laboratory of Viral Diseases),Viral Immunity and Pathogenesis Unit,0.017045454545454544
Immune Deficiency Genetics Section,Genetic Immunotherapy Section,0.01694915254237288
RML Microscopy Unit,Pathogen Molecular Genetics Section,0.016891891891891893
Malaria Immunology Section,Genomic Technologies Section,0.016877637130801686
Mast Cell Biology Section,Human Eosinophil Section,0.016822429906542057
HIV Pathogenesis Section,Barrier Immunity Section,0.016611295681063124
Lung and Vascular Inflammation Section,B-Cell Molecular Immunology Section,0.016597510373443983
RML Microscopy Unit,Pathogen-Host Cell Biology Section,0.016597510373443983
Biological Imaging,B-Cell Molecular Immunology Section,0.01639344262295082
Multiscale Systems Biology Section,B-Cell Immunology Section,0.01639344262295082
Pathogenesis and Immunity Section,Malaria Cell Biology Section,0.015915119363395226
Vaccine Development Unit,Malaria Cell Biology Section,0.015915119363395226
Multiscale Systems Biology Section,Computational Biology Unit,0.015873015873015872
Vector Molecular Biology Section,Metaorganism Immunity Section,0.015873015873015872
Genomic Technologies Section,Autoimmunity and Functional Genomics Section,0.015625
Innate Immunity and Pathogenesis Section,Immunity to Pulmonary Pathogens Section,0.015384615384615385
Molecular and Cellular Immunoregulation Section,Integrative Immunobiology Section,0.015384615384615385
Twinbrook Imaging Facility,Lymphocyte Activation Section,0.015217391304347827
Molecular Microbiology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.015128593040847202
Viral Pathogenesis and Vaccine Section,Clinical and Molecular Retrovirology Section,0.014925373134328358
Malaria Infection Biology and Immunity Unit,Antibody Biology Unit,0.014705882352941176
Physiology Unit,Malaria Genetics Section,0.014705882352941176
Pathogen-Host Cell Biology Section,Genetic Immunotherapy Section,0.014619883040935672
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Human Immunological Diseases Section,0.014492753623188406
Malaria Functional Genomics Section,Autoimmunity and Functional Genomics Section,0.014285714285714285
Molecular Development of the Immune System Section,Cell Signaling and Immunity Section,0.014285714285714285
Malaria Cell Biology Section,Apicomplexan Molecular Physiology Section,0.014218009478672985
Genetic Immunotherapy Section,B-Cell Immunology Section,0.014184397163120567
Malaria Immunology Section,Autoimmunity and Functional Genomics Section,0.014150943396226415
Viral Pathogenesis and Evolution Section,Systems Genomics Section,0.014124293785310734
Signaling Systems Section,Multiscale Systems Biology Section,0.014084507042253521
RML Microscopy Unit,Molecular Pathogenesis Unit,0.013986013986013986
Inflammation Biology Section,Genomic Technologies Section,0.013888888888888888
Multiscale Systems Biology Section,Cell Signaling and Immunity Section,0.013793103448275862
Mosquito Immunity and Vector Competence Section,Malaria Cell Biology Section,0.0136986301369863
Molecular Parasitology Section,Immunobiology Section,0.013651877133105802
Molecular Entomology Unit,Infectious Disease Pathogenesis Section,0.013513513513513514
Molecular and Cellular Immunoregulation Section,Immunobiology Section,0.013513513513513514
Molecular Microbiology Section,Infectious Disease Fellowship Training Program,0.013452914798206279
RML Microscopy Unit,Emerging Respiratory Viruses Section,0.013404825737265416
RML Microscopy Unit,Medical Virology Section,0.013404825737265416
Viral Biochemistry Section,Nonhuman Primate Virology Section,0.013215859030837005
Vector Biology Section,Helminth Immunology Section,0.013029315960912053
Lymphocyte Activation Section,Autoimmunity and Functional Genomics Section,0.01293103448275862
Pathology Core,Lymphocyte Activation Section,0.01276595744680851
RML Genomics Unit,Immunity to Pulmonary Pathogens Section,0.012738853503184714
Malaria Infection Biology and Immunity Unit,B-Cell Immunology Section,0.012658227848101266
Mucosal Immunobiology Section,Biological Imaging,0.012658227848101266
RML Flow Cytometry Unit,Biology of Vector-Borne Viruses Section,0.012658227848101266
Epidemiology and Population Studies Unit,Caliciviruses Section,0.012578616352201259
Metaorganism Immunity Section,Lymphocyte Biology Section,0.012461059190031152
Immune Activation Section,DNA Tumor Virus Section,0.012448132780082987
Molecular Signaling Section,DNA Tumor Virus Section,0.012448132780082987
Molecular Defenses Section,Immune Activation Section,0.012195121951219513
Molecular Signaling Section,Molecular Defenses Section,0.012195121951219513
Translational Immunobiology Unit,HIV-Specific Immunity Section,0.012195121951219513
Vector Molecular Biology Section,Molecular Entomology Unit,0.0121580547112462
Malaria Genetics Section,Malaria Cell Biology Section,0.012121212121212121
Molecular Microbiology Section,Inflammation & Innate Immunity Unit,0.012121212121212121
RML Flow Cytometry Unit,Pathogen Molecular Genetics Section,0.012096774193548387
Molecular and Cellular Immunoregulation Section,Cellular Immunology Section,0.012048192771084338
Infectious Disease Fellowship Training Program,HIV Pathogenesis Section,0.012
Structural Immunology Section,HIV Immunovirology Section,0.011976047904191617
Infectious Disease Pathogenesis Section,Chlamydial Diseases Section,0.011904761904761904
Viral Immunity and Pathogenesis Unit,Biological Imaging,0.011904761904761904
Translational Allergic Immunopathology Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.011824324324324325
Molecular Defenses Section,Biological Imaging,0.011764705882352941
Vector Biology Section,Malaria Genetics Section,0.011764705882352941
Molecular and Cellular Immunology Section,Malaria Infection Biology and Immunity Unit,0.011695906432748537
Neuroimmunological Diseases Section,Infectious Disease Fellowship Training Program,0.011695906432748537
Lymphocyte Biology Section,B-Cell Immunology Section,0.011673151750972763
Mucosal Immunobiology Section,Cellular Biology Section,0.011673151750972763
Genomic Technologies Section,Building 33,0.011627906976744186
Viral Budding Unit,Innate Immunity and Pathogenesis Section,0.011627906976744186
Twinbrook Imaging Facility,Food Allergy Research Section,0.011494252873563218
Tuberculosis Research Section,Inflammation & Innate Immunity Unit,0.011406844106463879
Twinbrook Imaging Facility,Computational Biology Unit,0.011363636363636364
Systems Genomics Section,Helminth Immunology Section,0.011299435028248588
Lymphocyte Biology Section,Immunobiology Section,0.011235955056179775
Primary Immune Deficiency Clinic,Emerging Respiratory Viruses Section,0.011204481792717087
Primary Immune Deficiency Clinic,Medical Virology Section,0.011204481792717087
Inflammation Biology Section,Fungal Pathogenesis Section,0.0111731843575419
Molecular Development of the Immune System Section,Emerging Respiratory Viruses Section,0.011111111111111112
Molecular Development of the Immune System Section,Medical Virology Section,0.011111111111111112
Physiology Unit,Pathology Core,0.011111111111111112
Multiscale Systems Biology Section,Lymphocyte Biology Section,0.01098901098901099
Molecular Parasitology Section,Intracellular Parasite Biology Section,0.010810810810810811
Virus Ecology Section,Innate Immunity and Pathogenesis Section,0.010810810810810811
Computational Biology Unit,Barrier Immunity Section,0.010752688172043012
Epithelial Therapeutics Unit,Clinical Pathophysiology Section,0.010752688172043012
Fungal Pathogenesis Section,Epidemiology and Population Studies Unit,0.010752688172043012
Lymphocyte Biology Section,Functional Cellular Networks Section,0.010752688172043012
RML Flow Cytometry Unit,Chlamydial Diseases Section,0.010752688172043012
Molecular Genetics Section (Laboratory of Viral Diseases),DNA Tumor Virus Section,0.010638297872340425
Metaorganism Immunity Section,Cell Signaling and Immunity Section,0.010526315789473684
Translational Allergic Immunopathology Unit,Human Immunological Diseases Section,0.01048951048951049
Infectious Disease Pathogenesis Section,Clinical Pathophysiology Section,0.010416666666666666
Inflammation & Innate Immunity Unit,HIV Pathogenesis Section,0.010416666666666666
Structural Biology Section,Malaria Cell Biology Section,0.010416666666666666
Physiology Unit,Malaria Immunology Section,0.010309278350515464
Viral Immunity and Pathogenesis Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.01020408163265306
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Immune Deficiency Genetics Section,0.010169491525423728
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),HIV Pathogenesis Section,0.010130246020260492
Translational Autoinflammatory Disease Studies Unit,Neuroimmunological Diseases Section,0.01
Molecular Defenses Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.009966777408637873
Malaria Cell Biology Section,Human Eosinophil Section,0.009933774834437087
T-Cell Tolerance and Memory Section,Malaria Infection Biology and Immunity Unit,0.009900990099009901
HIV-Specific Immunity Section,HIV Immunovirology Section,0.009852216748768473
Viral Pathogenesis Section (Laboratory of Immunoregulation),B-Cell Molecular Immunology Section,0.009852216748768473
Twinbrook Imaging Facility,Apicomplexan Molecular Physiology Section,0.00980392156862745
Viral Pathogenesis Section (Laboratory of Viral Diseases),Emerging Virus Immunity Unit,0.00975609756097561
Disease Modeling and Transmission Section,Biology of Vector-Borne Viruses Section,0.009708737864077669
HIV-Specific Immunity Section,B-Cell Immunology Section,0.009708737864077669
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Emerging Respiratory Viruses Section,0.009685230024213076
Immunopathogenesis Section (Laboratory of Immunoregulation),B-Cell Molecular Immunology Section,0.009685230024213076
Medical Virology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.009685230024213076
RML Flow Cytometry Unit,Host-Parasite Interactions Section,0.009615384615384616
Viral Budding Unit,Immunity to Pulmonary Pathogens Section,0.009615384615384616
Viral Pathogenesis and Evolution Section,Clinical Research Section,0.009615384615384616
Vector Biology Section,Mosquito Immunity and Vector Competence Section,0.009523809523809525
Structural Immunology Section,LID Clinical Studies Unit,0.009433962264150943
Virus Ecology Section,RML Microscopy Unit,0.009433962264150943
RML Microscopy Unit,Molecular Microbiology Section,0.009389671361502348
Pathology Core,Malaria Cell Biology Section,0.009259259259259259
Twinbrook Imaging Facility,Malaria Infection Biology and Immunity Unit,0.009259259259259259
Molecular Genetics Section (Laboratory of Viral Diseases),Genomic Technologies Section,0.009174311926605505
Helminth Immunology Section,Epidemiology and Population Studies Unit,0.009153318077803204
Pathology Core,Malaria Immunology Section,0.0091324200913242
Viral Pathogenesis and Vaccine Section,HIV-Specific Immunity Section,0.0091324200913242
Salmonella-Host Cell Interactions Section,Chlamydial Diseases Section,0.00909090909090909
Salmonella-Host Cell Interactions Section,Neuroimmunology Unit,0.00909090909090909
Vector Molecular Biology Section,Malaria Functional Genomics Section,0.00909090909090909
Malaria Infection Biology and Immunity Unit,Malaria Immunology Section,0.00904977375565611
Viral Pathogenesis and Evolution Section,Disease Modeling and Transmission Section,0.009041591320072333
Mosquito Immunity and Vector Competence Section,Molecular Entomology Unit,0.009009009009009009
Infectious Disease Pathogenesis Section,Immunobiology Section,0.008968609865470852
Microbial Pathogenesis Section,Inflammation & Innate Immunity Unit,0.008928571428571428
Viral Budding Unit,Viral Biochemistry Section,0.008928571428571428
Immunobiology Section,Helminth Immunology Section,0.008912655971479501
RML Microscopy Unit,Disease Modeling and Transmission Section,0.008888888888888889
Inflammation & Innate Immunity Unit,Genomic Technologies Section,0.008849557522123894
Malaria Infection Biology and Immunity Unit,Apicomplexan Molecular Physiology Section,0.008849557522123894
Mosquito Immunity and Vector Competence Section,Autoimmunity and Functional Genomics Section,0.008849557522123894
T-Cell Tolerance and Memory Section,Structural Immunology Section,0.008849557522123894
Plague Section,Pathogen-Host Cell Biology Section,0.008733624454148471
Viral Biochemistry Section,Barrier Immunity Section,0.008733624454148471
Translational Allergic Immunopathology Unit,T-Lymphocyte Biology Section,0.008695652173913044
Pathogen-Host Cell Biology Section,Clinical Pathophysiology Section,0.008658008658008658
Translational Mycology Section,Molecular Microbiology Section,0.008620689655172414
Type 2 Immunity Section,Malaria Infection Biology and Immunity Unit,0.008620689655172414
Immunobiology Section,Cellular Immunology Section,0.008595988538681949
RML Genomics Unit,Cellular Immunology Section,0.008547008547008548
RML Microscopy Unit,RML Flow Cytometry Unit,0.008547008547008548
Viral Immunology Section,Biological Imaging,0.00847457627118644
T-Lymphocyte Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.008445945945945946
Immunity to Pulmonary Pathogens Section,Gene Regulation Section,0.008403361344537815
RML Flow Cytometry Unit,Caliciviruses Section,0.008403361344537815
Genomic Technologies Section,Antibacterial Host Defense Unit,0.008333333333333333
Multiscale Systems Biology Section,HIV Immunovirology Section,0.008333333333333333
Salmonella-Host Cell Interactions Section,Plague Section,0.008333333333333333
Primary Immune Deficiency Clinic,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.008305647840531562
Mucosal Immunobiology Section,Immune Activation Section,0.008298755186721992
Mucosal Immunobiology Section,Molecular Signaling Section,0.008298755186721992
Mosquito Immunity and Vector Competence Section,Malaria Infection Biology and Immunity Unit,0.008264462809917356
Lyme Disease Studies Unit,Emerging Respiratory Viruses Section,0.00821917808219178
Medical Virology Section,Lyme Disease Studies Unit,0.00821917808219178
RML Microscopy Unit,Food Allergy Research Section,0.00819672131147541
Genomic Technologies Section,Biology of Vector-Borne Viruses Section,0.008130081300813009
Genomic Technologies Section,Emerging Respiratory Viruses Section,0.008130081300813009
Medical Virology Section,Genomic Technologies Section,0.008130081300813009
Pathology Core,Molecular Biology Section,0.008130081300813009
Inflammation Biology Section,Immune Activation Section,0.008097165991902834
Molecular Signaling Section,Inflammation Biology Section,0.008097165991902834
Pathology Core,Molecular Defenses Section,0.008
Translational Allergic Immunopathology Unit,Primary Immune Deficiency Clinic,0.008
Infectious Disease Fellowship Training Program,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.007936507936507936
HIV Pathogenesis Section,B-Cell Immunology Section,0.0078125
Lymphocyte Activation Section,B-Cell Immunology Section,0.007782101167315175
Molecular and Cellular Immunoregulation Section,Lymphocyte Biology Section,0.007751937984496124
RML Microscopy Unit,Biology of Vector-Borne Viruses Section,0.007751937984496124
Translational Mycology Section,HIV Pathogenesis Section,0.007722007722007722
Host-Parasite Interactions Section,Chlamydial Diseases Section,0.007692307692307693
Mucosal Immunobiology Section,Immunobiology Section,0.007692307692307693
LID Clinical Studies Unit,HIV Immunovirology Section,0.007633587786259542
T-Lymphocyte Biology Section,Epidemiology and Population Studies Unit,0.007633587786259542
Molecular Parasitology Section,Inflammation & Innate Immunity Unit,0.007575757575757576
RML Microscopy Unit,Genetic Engineering Section,0.007556675062972292
Viral Pathogenesis Section (Laboratory of Immunoregulation),LID Clinical Studies Unit,0.007518796992481203
Fungal Pathogenesis Section,Epithelial Therapeutics Unit,0.007462686567164179
Innate Immunity and Pathogenesis Section,Genomic Technologies Section,0.007462686567164179
LID Clinical Studies Unit,B-Cell Immunology Section,0.007462686567164179
Primary Immune Deficiency Clinic,Molecular Defenses Section,0.007462686567164179
Salmonella-Host Cell Interactions Section,RML Microscopy Unit,0.007462686567164179
T-Lymphocyte Biology Section,Genomic Technologies Section,0.007462686567164179
Pathology Core,Genomic Technologies Section,0.007407407407407408
RML Flow Cytometry Unit,Immunobiology and Molecular Virology Unit,0.007407407407407408
Viral Pathogenesis Section (Laboratory of Viral Diseases),Structural Informatics Unit,0.007407407407407408
Infectious Disease Fellowship Training Program,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.007352941176470588
Viral Pathogenesis Section (Laboratory of Viral Diseases),Viral Epidemiology and Immunity Unit,0.007352941176470588
RML Microscopy Unit,Apicomplexan Molecular Physiology Section,0.0072992700729927005
TSE/Prion Molecular Biology Section,Retroviral Immunology Section,0.0072992700729927005
Chemotaxis Signal Section,Autoimmunity and Functional Genomics Section,0.007246376811594203
Immunobiology Section,Genomic Technologies Section,0.007246376811594203
Retroviral Immunology Section,Innate Immunity and Pathogenesis Section,0.007246376811594203
Immunopathogenesis Section (Laboratory of Immunoregulation),HIV-Specific Immunity Section,0.007211538461538462
Molecular Defenses Section,Clinical Pathophysiology Section,0.007194244604316547
Mucosal Immunobiology Section,Genomic Technologies Section,0.007194244604316547
Molecular Development of the Immune System Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.007183908045977011
Vector Biology Section,Metaorganism Immunity Section,0.007177033492822967
Primary Immune Deficiency Clinic,Lyme Disease Studies Unit,0.007142857142857143
Translational Mycology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.007142857142857143
Viral Biology Section,Viral Biochemistry Section,0.007142857142857143
HIV Immunovirology Section,Genetic Immunotherapy Section,0.0071174377224199285
Malaria Infection Biology and Immunity Unit,Helminth Immunology Section,0.0070921985815602835
Vector Biology Section,Systems Genomics Section,0.007075471698113208
Tuberculosis Research Section,Immunobiology Section,0.00702576112412178
Immune Activation Section,B-Cell Molecular Immunology Section,0.007017543859649123
Molecular Signaling Section,B-Cell Molecular Immunology Section,0.007017543859649123
Tuberculosis Research Section,T-Lymphocyte Biology Section,0.007017543859649123
Vector Molecular Biology Section,NIAID International Center of Excellence in Research Cambodia,0.007017543859649123
RML Genomics Unit,Chlamydial Diseases Section,0.006993006993006993
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Genetics Section (Laboratory of Viral Diseases),0.006993006993006993
Vector Biology Section,Physiology Unit,0.006968641114982578
Viral Immunity and Pathogenesis Unit,Genomic Technologies Section,0.006944444444444444
Molecular Defenses Section,Genomic Technologies Section,0.006896551724137931
RML Microscopy Unit,Mosquito Immunity and Vector Competence Section,0.006896551724137931
Inflammation & Innate Immunity Unit,Fungal Pathogenesis Section,0.006756756756756757
Lyme Disease Studies Unit,Epidemiology and Population Studies Unit,0.006756756756756757
Salmonella-Host Cell Interactions Section,Coxiella Pathogenesis Section,0.006756756756756757
Systems Genomics Section,Clinical Research Section,0.006756756756756757
Translational Mycology Section,Signaling Systems Section,0.006666666666666667
Molecular and Cellular Immunology Section,Food Allergy Research Section,0.006622516556291391
Viral Pathogenesis Section (Laboratory of Immunoregulation),Hepatic Pathogenesis Section,0.006622516556291391
RML Microscopy Unit,Pathogenesis and Immunity Section,0.006557377049180328
Vaccine Development Unit,RML Microscopy Unit,0.006557377049180328
Lymphocyte Biology Section,Barrier Immunity Section,0.006535947712418301
Signaling Systems Section,B-Cell Molecular Immunology Section,0.006535947712418301
T-Lymphocyte Biology Section,Molecular Parasitology Section,0.006535947712418301
Integrative Immunobiology Section,Cell Signaling and Immunity Section,0.006493506493506494
Viral Pathogenesis Section (Laboratory of Viral Diseases),Cellular Biology Section,0.006493506493506494
Structural Immunology Section,RML Genomics Unit,0.0064516129032258064
Immunopathogenesis Section (Laboratory of Immunoregulation),HIV Pathogenesis Section,0.006437768240343348
Mucosal Immunity Section,Molecular Development of the Immune System Section,0.00641025641025641
T-Lymphocyte Biology Section,Molecular and Cellular Immunoregulation Section,0.00641025641025641
Tuberculosis Research Section,RML Microscopy Unit,0.00641025641025641
Coxiella Pathogenesis Section,Chlamydial Diseases Section,0.006369426751592357
Vector Molecular Biology Section,Physiology Unit,0.006369426751592357
Intracellular Parasite Biology Section,Immunobiology Section,0.006329113924050633
Nonhuman Primate Virology Section,Building NIHAC/103,0.006329113924050633
RML Microscopy Unit,Immunity to Pulmonary Pathogens Section,0.006329113924050633
RNA Viruses Section,RML Genomics Unit,0.006329113924050633
RNA Viruses Section,RML Microscopy Unit,0.006329113924050633
Building NIHAC/103,Barrier Immunity Section,0.006289308176100629
Mosquito Immunity and Vector Competence Section,Lymphocyte Activation Section,0.006289308176100629
Vector Molecular Biology Section,Immunobiology Section,0.00625
Pathogen Molecular Genetics Section,B-Cell Molecular Immunology Section,0.006230529595015576
Virus Ecology Section,RML Flow Cytometry Unit,0.006134969325153374
Human Immunological Diseases Section,B-Cell Immunology Section,0.006097560975609756
Protein Chemistry Section,Pathogen-Host Cell Biology Section,0.006060606060606061
Translational Autoinflammatory Disease Studies Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.006060606060606061
Molecular and Cellular Immunology Section,Apicomplexan Molecular Physiology Section,0.006024096385542169
Vector Biology Section,Genomic Technologies Section,0.006024096385542169
Microbial Pathogenesis Section,Immunobiology Section,0.006
Mucosal Immunobiology Section,B-Cell Molecular Immunology Section,0.005988023952095809
Retroviral Immunology Section,Caliciviruses Section,0.005988023952095809
Structural Biology Section,Microbial Pathogenesis Section,0.005970149253731343
Host-Parasite Interactions Section,Coxiella Pathogenesis Section,0.005952380952380952
RML Genomics Unit,Caliciviruses Section,0.005917159763313609
T-Lymphocyte Biology Section,Fungal Pathogenesis Section,0.005917159763313609
Mucosal Immunity Section,Biological Imaging,0.0058823529411764705
Viral Pathogenesis Section (Laboratory of Immunoregulation),Structural Immunology Section,0.0058823529411764705
Translational Allergic Immunopathology Unit,Fungal Pathogenesis Section,0.005847953216374269
Vector Molecular Biology Section,Mosquito Immunity and Vector Competence Section,0.0058309037900874635
TSE/Prion and Retroviral Pathogenesis Section,HIV Immunovirology Section,0.005813953488372093
Viral Pathogenesis and Evolution Section,Pathogen-Host Cell Biology Section,0.005763688760806916
Mucosal Immunobiology Section,Fungal Pathogenesis Section,0.005747126436781609
Structural Biology Section,Genetic Engineering Section,0.005747126436781609
TSE/Prion Biochemistry Section,RML Flow Cytometry Unit,0.005747126436781609
Pathogen-Host Cell Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.005738880918220947
Molecular Parasitology and Entomology Unit,Malaria Immunology Section,0.005714285714285714
Translational Mycology Section,Lyme Disease Studies Unit,0.005681818181818182
Malaria Cell Biology Section,Biological Imaging,0.005649717514124294
NIAID International Center of Excellence in Research Cambodia,Malaria Genetics Section,0.005649717514124294
Translational Mycology Section,Epidemiology and Population Studies Unit,0.005649717514124294
Primary Immune Deficiency Clinic,Fungal Pathogenesis Section,0.00558659217877095
Molecular Development of the Immune System Section,Immunobiology Section,0.005571030640668524
Molecular Defenses Section,Fungal Pathogenesis Section,0.005555555555555556
Pathology Core,Cell Signaling and Immunity Section,0.005555555555555556
RML Microscopy Unit,HIV Immunovirology Section,0.005555555555555556
Viral Biology Section,Translational Autoinflammatory Disease Studies Unit,0.0055248618784530384
Metaorganism Immunity Section,Immunobiology Section,0.005509641873278237
Integrative Immunobiology Section,Cellular Immunology Section,0.00546448087431694
RML Genomics Unit,Molecular and Cellular Immunoregulation Section,0.00546448087431694
RML Microscopy Unit,B-Cell Immunology Section,0.00546448087431694
Structural Immunology Section,Molecular and Cellular Immunology Section,0.005434782608695652
Malaria Functional Genomics Section,Infectious Disease Pathogenesis Section,0.005405405405405406
Metaorganism Immunity Section,Epithelial Therapeutics Unit,0.005376344086021506
TSE/Prion Biochemistry Section,Biology of Vector-Borne Viruses Section,0.005376344086021506
Translational Autoinflammatory Disease Studies Unit,DNA Tumor Virus Section,0.005376344086021506
Mast Cell Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0053533190578158455
Malaria Immunology Section,Infectious Disease Pathogenesis Section,0.0053475935828877
T-Lymphocyte Biology Section,Molecular Microbiology Section,0.0053475935828877
Emerging Respiratory Viruses Section,Caliciviruses Section,0.005291005291005291
Medical Virology Section,Caliciviruses Section,0.005291005291005291
Primary Immune Deficiency Clinic,Cell Signaling and Immunity Section,0.005291005291005291
Viral Pathogenesis Section (Laboratory of Viral Diseases),Genomic Technologies Section,0.005291005291005291
Genomic Technologies Section,Fungal Pathogenesis Section,0.005263157894736842
Mast Cell Biology Section,Helminth Immunology Section,0.005256241787122208
Immunopathogenesis Section (Laboratory of Immunoregulation),Clinical Pathophysiology Section,0.005249343832020997
Malaria Genetics Section,Biological Imaging,0.005235602094240838
TSE/Prion Biochemistry Section,Salmonella-Host Cell Interactions Section,0.005235602094240838
Molecular Development of the Immune System Section,Integrative Immunobiology Section,0.005208333333333333
Mucosal Immunobiology Section,Molecular Microbiology Section,0.005208333333333333
Pathogenesis and Immunity Section,Malaria Immunology Section,0.005208333333333333
Physiology Unit,Malaria Cell Biology Section,0.005208333333333333
Vaccine Development Unit,Malaria Immunology Section,0.005208333333333333
Physiology Unit,Malaria Functional Genomics Section,0.0051813471502590676
Immune Deficiency Genetics Section,Human Immunological Diseases Section,0.0051635111876075735
RML Flow Cytometry Unit,Pathogen-Host Cell Biology Section,0.005154639175257732
Signaling Systems Section,Barrier Immunity Section,0.005128205128205128
Viral Pathogenesis Section (Laboratory of Immunoregulation),HIV Immunovirology Section,0.005128205128205128
Pathogenesis and Immunity Section,Helminth Immunology Section,0.005119453924914676
Vaccine Development Unit,Helminth Immunology Section,0.005119453924914676
Translational Allergic Immunopathology Unit,Lung and Vascular Inflammation Section,0.005076142131979695
Translational Autoinflammatory Disease Studies Unit,Lyme Disease Studies Unit,0.005076142131979695
Molecular Microbiology Section,Inflammation Biology Section,0.005050505050505051
Viral Pathogenesis Section (Laboratory of Immunoregulation),B-Cell Immunology Section,0.005050505050505051
Molecular Parasitology Section,Microbial Pathogenesis Section,0.005025125628140704
Molecular and Cellular Immunology Section,Chemotaxis Signal Section,0.005025125628140704
Translational Mycology Section,Molecular Parasitology Section,0.005025125628140704
Inflammation & Innate Immunity Unit,Helminth Immunology Section,0.005
TSE/Prion Biochemistry Section,Neuroimmunology Unit,0.005
RML Flow Cytometry Unit,Disease Modeling and Transmission Section,0.004975124378109453
Fungal Pathogenesis Section,Emerging Respiratory Viruses Section,0.0049382716049382715
Medical Virology Section,Fungal Pathogenesis Section,0.0049382716049382715
Nonhuman Primate Virology Section,Innate Immunity and Pathogenesis Section,0.0049261083743842365
Type 2 Immunity Section,Barrier Immunity Section,0.004901960784313725
Viral Pathogenesis Section (Laboratory of Immunoregulation),HIV-Specific Immunity Section,0.0048543689320388345
Infectious Disease Fellowship Training Program,Fungal Pathogenesis Section,0.004830917874396135
Vector Biology Section,Malaria Cell Biology Section,0.004830917874396135
Immunobiology Section,Building 33,0.004807692307692308
Translational Autoinflammatory Disease Studies Unit,Emerging Respiratory Viruses Section,0.004807692307692308
Translational Autoinflammatory Disease Studies Unit,Medical Virology Section,0.004807692307692308
Vector Biology Section,Malaria Immunology Section,0.004796163069544364
Primary Immune Deficiency Clinic,Immune Deficiency Genetics Section,0.00477326968973747
Lung and Vascular Inflammation Section,Clinical Pathophysiology Section,0.004761904761904762
T-Lymphocyte Biology Section,Helminth Immunology Section,0.004750593824228029
Malaria Cell Biology Section,Autoimmunity and Functional Genomics Section,0.004739336492890996
Primary Immune Deficiency Clinic,Human Eosinophil Section,0.004739336492890996
Salmonella-Host Cell Interactions Section,Pathogen-Host Cell Biology Section,0.004739336492890996
Molecular and Cellular Immunology Section,B-Cell Immunology Section,0.0047169811320754715
Signaling Systems Section,Metaorganism Immunity Section,0.0047169811320754715
Viral Pathogenesis Section (Laboratory of Viral Diseases),Immunobiology and Molecular Virology Unit,0.004694835680751174
Malaria Functional Genomics Section,Apicomplexan Molecular Physiology Section,0.004672897196261682
Structural Biology Section,Immune Activation Section,0.004672897196261682
Structural Biology Section,Molecular Signaling Section,0.004672897196261682
Viral Immunity and Pathogenesis Unit,Barrier Immunity Section,0.004672897196261682
Cellular Biology Section,Biological Imaging,0.004651162790697674
Translational Mycology Section,Fungal Pathogenesis Section,0.004651162790697674
Lung and Vascular Inflammation Section,Genomic Technologies Section,0.004629629629629629
Pathology Core,Malaria Functional Genomics Section,0.0045871559633027525
Human Eosinophil Section,Emerging Respiratory Viruses Section,0.004576659038901602
Medical Virology Section,Human Eosinophil Section,0.004576659038901602
Scientist Emerita,Mast Cell Biology Section,0.004576659038901602
Human Eosinophil Section,Epidemiology and Population Studies Unit,0.0045662100456621
Molecular Parasitology Section,Cell Signaling and Immunity Section,0.0045662100456621
HIV Pathogenesis Section,DNA Tumor Virus Section,0.004545454545454545
Helminth Immunology Section,Genomic Technologies Section,0.004524886877828055
Infectious Disease Fellowship Training Program,Clinical Research Section,0.004524886877828055
Nonhuman Primate Virology Section,Immunity to Pulmonary Pathogens Section,0.004524886877828055
Structural Informatics Unit,Cellular Biology Section,0.004524886877828055
Cell Signaling and Immunity Section,B-Cell Immunology Section,0.0045045045045045045
Human Eosinophil Section,Genomic Technologies Section,0.0045045045045045045
Mosquito Immunity and Vector Competence Section,Malaria Functional Genomics Section,0.0045045045045045045
RML Microscopy Unit,Lung and Vascular Inflammation Section,0.0045045045045045045
Twinbrook Imaging Facility,Malaria Genetics Section,0.0045045045045045045
Structural Immunology Section,Cellular Immunology Section,0.004484304932735426
TSE/Prion Biochemistry Section,RML Genomics Unit,0.004464285714285714
HIV Pathogenesis Section,Emerging Respiratory Viruses Section,0.0044444444444444444
Medical Virology Section,HIV Pathogenesis Section,0.0044444444444444444
Retroviral Immunology Section,Disease Modeling and Transmission Section,0.0044444444444444444
Clinical Research Section,B-Cell Immunology Section,0.004424778761061947
Translational Mycology Section,Translational Autoinflammatory Disease Studies Unit,0.004424778761061947
Malaria Genetics Section,Apicomplexan Molecular Physiology Section,0.004405286343612335
Molecular Defenses Section,Malaria Cell Biology Section,0.004405286343612335
Protein Chemistry Section,Pathogenesis and Immunity Section,0.004405286343612335
Vaccine Development Unit,Protein Chemistry Section,0.004405286343612335
Vector Biology Section,Immunobiology Section,0.004405286343612335
Malaria Immunology Section,Emerging Respiratory Viruses Section,0.004395604395604396
Medical Virology Section,Malaria Immunology Section,0.004395604395604396
Vector Molecular Biology Section,Malaria Genetics Section,0.004395604395604396
Molecular Genetics Section (Laboratory of Viral Diseases),Cellular Biology Section,0.004366812227074236
Mucosal Immunity Section,Genomic Technologies Section,0.004347826086956522
Neuroimmunological Diseases Section,Mucosal Immunity Section,0.004347826086956522
Integrative Immunobiology Section,Immunobiology Section,0.004329004329004329
Pathogen-Host Cell Biology Section,Host-Parasite Interactions Section,0.004329004329004329
Viral Immunity and Pathogenesis Unit,Metaorganism Immunity Section,0.004329004329004329
Primary Immune Deficiency Clinic,Mast Cell Biology Section,0.004310344827586207
RNA Viruses Section,Molecular Development of the Immune System Section,0.00425531914893617
Genomic Technologies Section,Clinical and Molecular Retrovirology Section,0.00423728813559322
Immunobiology Section,Food Allergy Research Section,0.004201680672268907
Tuberculosis Research Section,Building 33,0.004201680672268907
Viral Pathogenesis and Evolution Section,Salmonella-Host Cell Interactions Section,0.004201680672268907
RML Microscopy Unit,Mast Cell Biology Section,0.004158004158004158
RML Genomics Unit,HIV Pathogenesis Section,0.004149377593360996
RML Genomics Unit,Malaria Cell Biology Section,0.00411522633744856
RML Microscopy Unit,Malaria Cell Biology Section,0.00411522633744856
Microbial Pathogenesis Section,Genetic Immunotherapy Section,0.004106776180698152
HIV Immunovirology Section,Barrier Immunity Section,0.004098360655737705
Structural Immunology Section,Lymphocyte Activation Section,0.004098360655737705
Structural Immunology Section,Malaria Genetics Section,0.004081632653061225
Systems Genomics Section,RNA Viruses Section,0.004081632653061225
Viral Pathogenesis Section (Laboratory of Immunoregulation),Nonhuman Primate Virology Section,0.004081632653061225
Lymphocyte Biology Section,Chemotaxis Signal Section,0.0040650406504065045
Pathogen-Host Cell Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0040650406504065045
Barrier Immunity Section,B-Cell Immunology Section,0.004048582995951417
Immunopathogenesis Section (Laboratory of Immunoregulation),Genetic Immunotherapy Section,0.00404040404040404
RML Genomics Unit,Metaorganism Immunity Section,0.004032258064516129
Epidemiology and Population Studies Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.003952569169960474
Infectious Disease Fellowship Training Program,Clinical and Molecular Retrovirology Section,0.003952569169960474
HIV Pathogenesis Section,HIV Immunovirology Section,0.003937007874015748
Nonhuman Primate Virology Section,HIV-Specific Immunity Section,0.003937007874015748
Tuberculosis Research Section,Infectious Disease Pathogenesis Section,0.003937007874015748
Molecular Parasitology Section,Malaria Cell Biology Section,0.00390625
Viral Pathogenesis Section (Laboratory of Immunoregulation),HIV Pathogenesis Section,0.00390625
Lymphocyte Activation Section,HIV Immunovirology Section,0.003898635477582846
Molecular Pathogenesis and Biomarkers Section,Malaria Cell Biology Section,0.0038910505836575876
Pathology Core,Immunobiology Section,0.0038910505836575876
Pathogen-Host Cell Biology Section,Coxiella Pathogenesis Section,0.003875968992248062
Molecular Development of the Immune System Section,B-Cell Immunology Section,0.0038461538461538464
Helminth Immunology Section,HIV Pathogenesis Section,0.0038314176245210726
Human Immunological Diseases Section,Emerging Respiratory Viruses Section,0.0038314176245210726
Medical Virology Section,Human Immunological Diseases Section,0.0038314176245210726
Genomic Technologies Section,Genetic Immunotherapy Section,0.0038022813688212928
HIV Pathogenesis Section,B-Cell Molecular Immunology Section,0.0038022813688212928
Tuberculosis Research Section,Structural Biology Section,0.0038022813688212928
RML Genomics Unit,Immune Activation Section,0.003787878787878788
RML Genomics Unit,Molecular Signaling Section,0.003787878787878788
Signaling Systems Section,Pathogen Molecular Genetics Section,0.003787878787878788
Transplant Infectious Diseases Consult Service,Human Immunological Diseases Section,0.003787878787878788
Metaorganism Immunity Section,Helminth Immunology Section,0.003780718336483932
Molecular and Cellular Immunology Section,Lymphocyte Activation Section,0.003780718336483932
Pathogen-Host Cell Biology Section,Disease Modeling and Transmission Section,0.003780718336483932
HIV-Specific Immunity Section,HIV Pathogenesis Section,0.0037735849056603774
Vector Biology Section,Intracellular Parasite Biology Section,0.003766478342749529
HIV-Specific Immunity Section,Clinical and Molecular Retrovirology Section,0.0037593984962406013
Human Immunological Diseases Section,Food Allergy Research Section,0.0037313432835820895
RML Genomics Unit,Genetic Immunotherapy Section,0.0037174721189591076
Twinbrook Imaging Facility,Pathogenesis and Immunity Section,0.0036900369003690036
Vaccine Development Unit,Twinbrook Imaging Facility,0.0036900369003690036
Molecular and Cellular Immunology Section,Malaria Cell Biology Section,0.003676470588235294
Pathogenesis and Immunity Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.003663003663003663
Vaccine Development Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.003663003663003663
Human Immunological Diseases Section,Gene Regulation Section,0.0036496350364963502
Genomic Technologies Section,Cellular Biology Section,0.0036363636363636364
Translational Autoinflammatory Disease Studies Unit,Cellular Immunology Section,0.0036363636363636364
Pathogenesis and Immunity Section,Apicomplexan Molecular Physiology Section,0.0036231884057971015
Vaccine Development Unit,Apicomplexan Molecular Physiology Section,0.0036231884057971015
Metaorganism Immunity Section,Fungal Pathogenesis Section,0.0036101083032490976
Clinical Research Section,Cellular Immunology Section,0.0035971223021582736
Pathogen-Host Cell Biology Section,Mast Cell Biology Section,0.0035842293906810036
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Epithelial Therapeutics Unit,0.0035714285714285713
Pathology Core,Pathogenesis and Immunity Section,0.0035714285714285713
Vaccine Development Unit,Pathology Core,0.0035714285714285713
Vector Biology Section,Infectious Disease Pathogenesis Section,0.0035714285714285713
Pathogenesis and Immunity Section,Malaria Infection Biology and Immunity Unit,0.0035460992907801418
Vaccine Development Unit,Malaria Infection Biology and Immunity Unit,0.0035460992907801418
Pathogenesis and Immunity Section,Molecular Pathogenesis Unit,0.0035335689045936395
Translational Autoinflammatory Disease Studies Unit,Lymphocyte Biology Section,0.0035335689045936395
Vaccine Development Unit,Molecular Pathogenesis Unit,0.0035335689045936395
Pathogenesis and Immunity Section,Mosquito Immunity and Vector Competence Section,0.0035211267605633804
Vaccine Development Unit,Mosquito Immunity and Vector Competence Section,0.0035211267605633804
Immune Activation Section,HIV-Specific Immunity Section,0.003472222222222222
Molecular Signaling Section,HIV-Specific Immunity Section,0.003472222222222222
Viral Pathogenesis and Evolution Section,Immunobiology and Molecular Virology Unit,0.0034602076124567475
Malaria Immunology Section,Lymphocyte Activation Section,0.0034542314335060447
Lung and Vascular Inflammation Section,Clinical and Molecular Retrovirology Section,0.003367003367003367
RML Genomics Unit,Pathogen Molecular Genetics Section,0.0033333333333333335
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Helminth Immunology Section,0.0033222591362126247
Vector Biology Section,Biology of Vector-Borne Viruses Section,0.0033222591362126247
Mucosal Immunity Section,Cellular Immunology Section,0.003289473684210526
Tuberculosis Research Section,Epidemiology and Population Studies Unit,0.003289473684210526
Vector Biology Section,Twinbrook Imaging Facility,0.003289473684210526
Immunobiology Section,B-Cell Molecular Immunology Section,0.003278688524590164
Malaria Functional Genomics Section,Human Eosinophil Section,0.003278688524590164
Nonhuman Primate Virology Section,Clinical and Molecular Retrovirology Section,0.003278688524590164
Immune Activation Section,Clinical Research Section,0.003257328990228013
Molecular Signaling Section,Clinical Research Section,0.003257328990228013
Tuberculosis Research Section,Genomic Technologies Section,0.003257328990228013
Vector Molecular Biology Section,Infectious Disease Pathogenesis Section,0.003257328990228013
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Genomic Technologies Section,0.003246753246753247
Virus Ecology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.003246753246753247
HIV Pathogenesis Section,Cellular Immunology Section,0.003236245954692557
Vector Biology Section,Apicomplexan Molecular Physiology Section,0.003236245954692557
Clinical and Molecular Retrovirology Section,Cellular Immunology Section,0.0032258064516129032
Lymphocyte Biology Section,Cellular Immunology Section,0.003215434083601286
Nonhuman Primate Virology Section,Metaorganism Immunity Section,0.003215434083601286
Intracellular Parasite Biology Section,Inflammation & Innate Immunity Unit,0.003205128205128205
Vector Biology Section,Innate Immunity and Pathogenesis Section,0.003205128205128205
Vector Biology Section,Pathology Core,0.003194888178913738
Mucosal Immunity Section,Metaorganism Immunity Section,0.0031545741324921135
Vector Molecular Biology Section,LID Clinical Studies Unit,0.0031545741324921135
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),B-Cell Immunology Section,0.003134796238244514
Lung and Vascular Inflammation Section,Immune Activation Section,0.003134796238244514
Molecular Signaling Section,Lung and Vascular Inflammation Section,0.003134796238244514
Translational Mycology Section,Pathogen Molecular Genetics Section,0.003134796238244514
International HIV/STD Section,Chlamydial Diseases Section,0.003129890453834116
Office of the Animal Program Director,Genetic Engineering Section,0.003125
Protein Chemistry Section,Genetic Engineering Section,0.003125
Translational Mycology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0031201248049922
Metaorganism Immunity Section,HIV Pathogenesis Section,0.003105590062111801
Vector Molecular Biology Section,Helminth Immunology Section,0.0030911901081916537
Metaorganism Immunity Section,Malaria Functional Genomics Section,0.003076923076923077
Nonhuman Primate Virology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.003076923076923077
Vector Biology Section,Plague Section,0.003076923076923077
Vector Molecular Biology Section,Biology of Vector-Borne Viruses Section,0.003048780487804878
Multiscale Systems Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0029940119760479044
Pathogenesis and Immunity Section,Molecular and Cellular Immunology Section,0.0029850746268656717
Vaccine Development Unit,Molecular and Cellular Immunology Section,0.0029850746268656717
Malaria Immunology Section,Malaria Genetics Section,0.002976190476190476
Vector Biology Section,Lymphocyte Activation Section,0.002976190476190476
Immune Activation Section,HIV Pathogenesis Section,0.0029585798816568047
Molecular Signaling Section,HIV Pathogenesis Section,0.0029585798816568047
Mosquito Immunity and Vector Competence Section,Intracellular Parasite Biology Section,0.0029585798816568047
Vector Molecular Biology Section,Innate Immunity and Pathogenesis Section,0.0029498525073746312
Infectious Disease Pathogenesis Section,Genetic Engineering Section,0.0029411764705882353
Malaria Cell Biology Section,Immune Activation Section,0.0029411764705882353
Molecular Signaling Section,Malaria Cell Biology Section,0.0029411764705882353
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Human Eosinophil Section,0.0029282576866764276
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Barrier Immunity Section,0.0029154518950437317
Genetic Immunotherapy Section,Clinical and Molecular Retrovirology Section,0.0029069767441860465
Cellular Biology Section,Barrier Immunity Section,0.002898550724637681
Emerging Respiratory Viruses Section,Autoimmunity and Functional Genomics Section,0.002898550724637681
Medical Virology Section,Autoimmunity and Functional Genomics Section,0.002898550724637681
Metaorganism Immunity Section,Immune Activation Section,0.002898550724637681
Molecular Signaling Section,Metaorganism Immunity Section,0.002898550724637681
Molecular Genetics Section (Laboratory of Viral Diseases),Genetic Engineering Section,0.002881844380403458
Viral Biology Section,Emerging Respiratory Viruses Section,0.002849002849002849
Viral Biology Section,Medical Virology Section,0.002849002849002849
Immunopathogenesis Section (Laboratory of Immunoregulation),Biology of Vector-Borne Viruses Section,0.0028089887640449437
T-Lymphocyte Biology Section,Microbial Pathogenesis Section,0.002785515320334262
Malaria Functional Genomics Section,Immunobiology Section,0.002777777777777778
Vector Molecular Biology Section,Genomic Technologies Section,0.002777777777777778
Malaria Immunology Section,Immunobiology Section,0.0027624309392265192
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Immunobiology Section,0.0027100271002710027
Molecular Development of the Immune System Section,International HIV/STD Section,0.002702702702702703
Visual and Medical Arts Unit,Disease Modeling and Transmission Section,0.002702702702702703
RML Genomics Unit,Emerging Respiratory Viruses Section,0.002652519893899204
RML Genomics Unit,Medical Virology Section,0.002652519893899204
Inflammation Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0026455026455026454
Pathogenesis and Immunity Section,Lymphocyte Biology Section,0.002617801047120419
Structural Immunology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.002617801047120419
Vaccine Development Unit,Lymphocyte Biology Section,0.002617801047120419
Tuberculosis Research Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0026041666666666665
RML Genomics Unit,Microbial Pathogenesis Section,0.0025906735751295338
RML Microscopy Unit,Microbial Pathogenesis Section,0.0025906735751295338
Helminth Immunology Section,Allergy and Immunology Clinical Training Program,0.002577319587628866
Lymphocyte Biology Section,Human Immunological Diseases Section,0.002570694087403599
Genomic Technologies Section,Genetic Engineering Section,0.002544529262086514
RML Genomics Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0025380710659898475
Structural Biology Section,Helminth Immunology Section,0.002506265664160401
Viral Pathogenesis and Evolution Section,Pathogen Molecular Genetics Section,0.0024752475247524753
Viral Pathogenesis Section (Laboratory of Viral Diseases),Emerging Respiratory Viruses Section,0.0024691358024691358
Viral Pathogenesis Section (Laboratory of Viral Diseases),Medical Virology Section,0.0024691358024691358
Molecular Microbiology Section,Intracellular Parasite Biology Section,0.002457002457002457
Emerging Respiratory Viruses Section,Cell Signaling and Immunity Section,0.002403846153846154
Medical Virology Section,Cell Signaling and Immunity Section,0.002403846153846154
Vector Biology Section,Malaria Functional Genomics Section,0.002403846153846154
Mast Cell Biology Section,Epithelial Therapeutics Unit,0.002380952380952381
Salmonella-Host Cell Interactions Section,Disease Modeling and Transmission Section,0.002380952380952381
Mast Cell Biology Section,Allergy and Immunology Clinical Training Program,0.0023752969121140144
Pathogenesis and Immunity Section,Immunobiology Section,0.002369668246445498
Vaccine Development Unit,Immunobiology Section,0.002369668246445498
Viral Pathogenesis and Vaccine Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.002364066193853428
Intracellular Parasite Biology Section,Cellular Immunology Section,0.002336448598130841
Lymphocyte Biology Section,Intracellular Parasite Biology Section,0.0022935779816513763
International HIV/STD Section,Emerging Respiratory Viruses Section,0.002290950744558992
Medical Virology Section,International HIV/STD Section,0.002290950744558992
Malaria Immunology Section,Intracellular Parasite Biology Section,0.002277904328018223
Emerging Respiratory Viruses Section,Barrier Immunity Section,0.0022675736961451248
Medical Virology Section,Barrier Immunity Section,0.0022675736961451248
Vector Molecular Biology Section,Lymphocyte Biology Section,0.0022624434389140274
Immunity to Pulmonary Pathogens Section,Disease Modeling and Transmission Section,0.0022522522522522522
International HIV/STD Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0022471910112359553
Mast Cell Biology Section,Autoimmunity and Functional Genomics Section,0.0022222222222222222
Physiology Unit,Lymphocyte Activation Section,0.0022222222222222222
Immune Deficiency Genetics Section,B-Cell Immunology Section,0.002207505518763797
RML Genomics Unit,Disease Modeling and Transmission Section,0.002207505518763797
Malaria Functional Genomics Section,Emerging Respiratory Viruses Section,0.0022026431718061676
Medical Virology Section,Malaria Functional Genomics Section,0.0022026431718061676
Nonhuman Primate Virology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.002188183807439825
Immunopathogenesis Section (Laboratory of Immunoregulation),Barrier Immunity Section,0.002183406113537118
Microbial Pathogenesis Section,HIV Pathogenesis Section,0.002173913043478261
Molecular Pathogenesis and Biomarkers Section,Helminth Immunology Section,0.0021598272138228943
Lymphocyte Activation Section,Apicomplexan Molecular Physiology Section,0.0021231422505307855
Immune Activation Section,Emerging Respiratory Viruses Section,0.002109704641350211
Medical Virology Section,Immune Activation Section,0.002109704641350211
Molecular Signaling Section,Emerging Respiratory Viruses Section,0.002109704641350211
Molecular Signaling Section,Medical Virology Section,0.002109704641350211
Immune Deficiency Genetics Section,Cell Signaling and Immunity Section,0.0021008403361344537
Molecular Development of the Immune System Section,Genetic Engineering Section,0.0021008403361344537
Viral Pathogenesis Section (Laboratory of Viral Diseases),Disease Modeling and Transmission Section,0.002079002079002079
Molecular Defenses Section,Lymphocyte Activation Section,0.002061855670103093
Disease Modeling and Transmission Section,Clinical Research Section,0.0020161290322580645
Immune Deficiency Genetics Section,Human Eosinophil Section,0.002008032128514056
Mast Cell Biology Section,B-Cell Immunology Section,0.002008032128514056
Lymphocyte Activation Section,Chemotaxis Signal Section,0.001984126984126984
Molecular and Cellular Immunology Section,Mast Cell Biology Section,0.0019569471624266144
Lymphocyte Biology Section,Immune Deficiency Genetics Section,0.001949317738791423
Molecular Development of the Immune System Section,Immune Deficiency Genetics Section,0.0019455252918287938
Metaorganism Immunity Section,Immune Deficiency Genetics Section,0.0019305019305019305
Translational Autoinflammatory Disease Studies Unit,Mast Cell Biology Section,0.0019157088122605363
Malaria Functional Genomics Section,Helminth Immunology Section,0.0019011406844106464
Disease Modeling and Transmission Section,Clinical and Molecular Retrovirology Section,0.001893939393939394
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Biological Imaging,0.0017953321364452424
Multiscale Systems Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0017761989342806395
Infectious Disease Pathogenesis Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0017730496453900709
Lymphocyte Activation Section,Cellular Immunology Section,0.0017574692442882249
Twinbrook III,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0017482517482517483
Inflammation & Innate Immunity Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0017391304347826088
Pathogen Molecular Genetics Section,Disease Modeling and Transmission Section,0.0017064846416382253
Pathogenesis and Immunity Section,Disease Modeling and Transmission Section,0.0016891891891891893
Vaccine Development Unit,Disease Modeling and Transmission Section,0.0016891891891891893
Innate Immunity and Pathogenesis Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0016778523489932886
Immunopathogenesis Section (Laboratory of Immunoregulation),Emerging Respiratory Viruses Section,0.0016556291390728477
Medical Virology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0016556291390728477
Genetic Engineering Section,Emerging Respiratory Viruses Section,0.0016420361247947454
Medical Virology Section,Genetic Engineering Section,0.0016420361247947454
Neuroimmunological Diseases Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0016207455429497568
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Caliciviruses Section,0.0016
Pathogenesis and Immunity Section,Lymphocyte Activation Section,0.0015625
Vaccine Development Unit,Lymphocyte Activation Section,0.0015625
Intracellular Parasite Biology Section,Helminth Immunology Section,0.001557632398753894
Immune Deficiency Genetics Section,Emerging Respiratory Viruses Section,0.0015455950540958269
Medical Virology Section,Immune Deficiency Genetics Section,0.0015455950540958269
Molecular HIV Host Interactions Section,International HIV/STD Section,0.0015408320493066256
International HIV/STD Section,Host-Parasite Interactions Section,0.0015360983102918587
Molecular and Cellular Immunology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0015337423312883436
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Cell Signaling and Immunity Section,0.0015105740181268882
Microbial Pathogenesis Section,Helminth Immunology Section,0.0014970059880239522
Immunopathogenesis Section (Laboratory of Immunoregulation),Helminth Immunology Section,0.0014792899408284023
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Cellular Immunology Section,0.001447178002894356
Viral Pathogenesis Section (Laboratory of Viral Diseases),International HIV/STD Section,0.001445086705202312
Metaorganism Immunity Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0014204545454545455
International HIV/STD Section,Clinical Research Section,0.0014144271570014145
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.001392757660167131
Lymphocyte Activation Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0013736263736263737
Mast Cell Biology Section,Immune Deficiency Genetics Section,0.0013297872340425532
Pathogenesis and Immunity Section,International HIV/STD Section,0.0012453300124533001
Vaccine Development Unit,International HIV/STD Section,0.0012453300124533001
Microbial Pathogenesis Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0011876484560570072
Immunopathogenesis Section (Laboratory of Immunoregulation),Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.001176470588235294
Antibacterial Host Defense Unit,Allergy and Immunology Clinical Training Program,0.0
Antibody Biology Unit,Allergy and Immunology Clinical Training Program,0.0
Antibody Biology Unit,Antibacterial Host Defense Unit,0.0
Apicomplexan Molecular Physiology Section,Allergy and Immunology Clinical Training Program,0.0
Apicomplexan Molecular Physiology Section,Antibacterial Host Defense Unit,0.0
Apicomplexan Molecular Physiology Section,Antibody Biology Unit,0.0
Autoimmunity and Functional Genomics Section,Allergy and Immunology Clinical Training Program,0.0
Autoimmunity and Functional Genomics Section,Antibacterial Host Defense Unit,0.0
Autoimmunity and Functional Genomics Section,Antibody Biology Unit,0.0
Autoimmunity and Functional Genomics Section,Apicomplexan Molecular Physiology Section,0.0
B-Cell Immunology Section,Allergy and Immunology Clinical Training Program,0.0
B-Cell Immunology Section,Antibacterial Host Defense Unit,0.0
B-Cell Immunology Section,Antibody Biology Unit,0.0
B-Cell Immunology Section,Apicomplexan Molecular Physiology Section,0.0
B-Cell Immunology Section,Autoimmunity and Functional Genomics Section,0.0
B-Cell Molecular Immunology Section,Allergy and Immunology Clinical Training Program,0.0
B-Cell Molecular Immunology Section,Antibacterial Host Defense Unit,0.0
B-Cell Molecular Immunology Section,Antibody Biology Unit,0.0
B-Cell Molecular Immunology Section,Apicomplexan Molecular Physiology Section,0.0
B-Cell Molecular Immunology Section,Autoimmunity and Functional Genomics Section,0.0
B-Cell Molecular Immunology Section,B-Cell Immunology Section,0.0
Bacterial Pathogenesis and Antimicrobial Resistance Unit,Allergy and Immunology Clinical Training Program,0.0
Bacterial Pathogenesis and Antimicrobial Resistance Unit,Antibacterial Host Defense Unit,0.0
Bacterial Pathogenesis and Antimicrobial Resistance Unit,Antibody Biology Unit,0.0
Bacterial Pathogenesis and Antimicrobial Resistance Unit,Apicomplexan Molecular Physiology Section,0.0
Bacterial Pathogenesis and Antimicrobial Resistance Unit,Autoimmunity and Functional Genomics Section,0.0
Bacterial Pathogenesis and Antimicrobial Resistance Unit,B-Cell Immunology Section,0.0
Bacterial Pathogenesis and Antimicrobial Resistance Unit,B-Cell Molecular Immunology Section,0.0
Bacterial Physiology and Metabolism Unit,Allergy and Immunology Clinical Training Program,0.0
Bacterial Physiology and Metabolism Unit,Antibacterial Host Defense Unit,0.0
Bacterial Physiology and Metabolism Unit,Antibody Biology Unit,0.0
Bacterial Physiology and Metabolism Unit,Apicomplexan Molecular Physiology Section,0.0
Bacterial Physiology and Metabolism Unit,Autoimmunity and Functional Genomics Section,0.0
Bacterial Physiology and Metabolism Unit,B-Cell Immunology Section,0.0
Bacterial Physiology and Metabolism Unit,B-Cell Molecular Immunology Section,0.0
Bacterial Physiology and Metabolism Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Barrier Immunity Section,Allergy and Immunology Clinical Training Program,0.0
Barrier Immunity Section,Antibacterial Host Defense Unit,0.0
Barrier Immunity Section,Antibody Biology Unit,0.0
Barrier Immunity Section,Apicomplexan Molecular Physiology Section,0.0
Barrier Immunity Section,Autoimmunity and Functional Genomics Section,0.0
Barrier Immunity Section,B-Cell Molecular Immunology Section,0.0
Barrier Immunity Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Barrier Immunity Section,Bacterial Physiology and Metabolism Unit,0.0
Biological Imaging,Allergy and Immunology Clinical Training Program,0.0
Biological Imaging,Antibacterial Host Defense Unit,0.0
Biological Imaging,Antibody Biology Unit,0.0
Biological Imaging,Apicomplexan Molecular Physiology Section,0.0
Biological Imaging,Autoimmunity and Functional Genomics Section,0.0
Biological Imaging,B-Cell Immunology Section,0.0
Biological Imaging,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Biological Imaging,Bacterial Physiology and Metabolism Unit,0.0
Biological Imaging,Barrier Immunity Section,0.0
Biology of Vector-Borne Viruses Section,Allergy and Immunology Clinical Training Program,0.0
Biology of Vector-Borne Viruses Section,Antibacterial Host Defense Unit,0.0
Biology of Vector-Borne Viruses Section,Antibody Biology Unit,0.0
Biology of Vector-Borne Viruses Section,Apicomplexan Molecular Physiology Section,0.0
Biology of Vector-Borne Viruses Section,Autoimmunity and Functional Genomics Section,0.0
Biology of Vector-Borne Viruses Section,B-Cell Immunology Section,0.0
Biology of Vector-Borne Viruses Section,B-Cell Molecular Immunology Section,0.0
Biology of Vector-Borne Viruses Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Biology of Vector-Borne Viruses Section,Bacterial Physiology and Metabolism Unit,0.0
Biology of Vector-Borne Viruses Section,Barrier Immunity Section,0.0
Biology of Vector-Borne Viruses Section,Biological Imaging,0.0
Building 14B South,Allergy and Immunology Clinical Training Program,0.0
Building 14B South,Antibacterial Host Defense Unit,0.0
Building 14B South,Antibody Biology Unit,0.0
Building 14B South,Apicomplexan Molecular Physiology Section,0.0
Building 14B South,Autoimmunity and Functional Genomics Section,0.0
Building 14B South,B-Cell Immunology Section,0.0
Building 14B South,B-Cell Molecular Immunology Section,0.0
Building 14B South,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Building 14B South,Bacterial Physiology and Metabolism Unit,0.0
Building 14B South,Barrier Immunity Section,0.0
Building 14B South,Biological Imaging,0.0
Building 14B South,Biology of Vector-Borne Viruses Section,0.0
Building 33,Allergy and Immunology Clinical Training Program,0.0
Building 33,Antibacterial Host Defense Unit,0.0
Building 33,Antibody Biology Unit,0.0
Building 33,Apicomplexan Molecular Physiology Section,0.0
Building 33,Autoimmunity and Functional Genomics Section,0.0
Building 33,B-Cell Immunology Section,0.0
Building 33,B-Cell Molecular Immunology Section,0.0
Building 33,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Building 33,Bacterial Physiology and Metabolism Unit,0.0
Building 33,Barrier Immunity Section,0.0
Building 33,Biological Imaging,0.0
Building 33,Biology of Vector-Borne Viruses Section,0.0
Building 33,Building 14B South,0.0
Building 50,Allergy and Immunology Clinical Training Program,0.0
Building 50,Antibacterial Host Defense Unit,0.0
Building 50,Antibody Biology Unit,0.0
Building 50,Apicomplexan Molecular Physiology Section,0.0
Building 50,Autoimmunity and Functional Genomics Section,0.0
Building 50,B-Cell Immunology Section,0.0
Building 50,B-Cell Molecular Immunology Section,0.0
Building 50,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Building 50,Bacterial Physiology and Metabolism Unit,0.0
Building 50,Barrier Immunity Section,0.0
Building 50,Biological Imaging,0.0
Building 50,Biology of Vector-Borne Viruses Section,0.0
Building 50,Building 14B South,0.0
Building 50,Building 33,0.0
Building NIHAC/103,Allergy and Immunology Clinical Training Program,0.0
Building NIHAC/103,Antibacterial Host Defense Unit,0.0
Building NIHAC/103,Antibody Biology Unit,0.0
Building NIHAC/103,Apicomplexan Molecular Physiology Section,0.0
Building NIHAC/103,Autoimmunity and Functional Genomics Section,0.0
Building NIHAC/103,B-Cell Immunology Section,0.0
Building NIHAC/103,B-Cell Molecular Immunology Section,0.0
Building NIHAC/103,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Building NIHAC/103,Bacterial Physiology and Metabolism Unit,0.0
Building NIHAC/103,Biological Imaging,0.0
Building NIHAC/103,Biology of Vector-Borne Viruses Section,0.0
Building NIHAC/103,Building 14B South,0.0
Building NIHAC/103,Building 50,0.0
Buildings 4 and 10/11C127,Allergy and Immunology Clinical Training Program,0.0
Buildings 4 and 10/11C127,Antibacterial Host Defense Unit,0.0
Buildings 4 and 10/11C127,Antibody Biology Unit,0.0
Buildings 4 and 10/11C127,Apicomplexan Molecular Physiology Section,0.0
Buildings 4 and 10/11C127,Autoimmunity and Functional Genomics Section,0.0
Buildings 4 and 10/11C127,B-Cell Immunology Section,0.0
Buildings 4 and 10/11C127,B-Cell Molecular Immunology Section,0.0
Buildings 4 and 10/11C127,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Buildings 4 and 10/11C127,Bacterial Physiology and Metabolism Unit,0.0
Buildings 4 and 10/11C127,Barrier Immunity Section,0.0
Buildings 4 and 10/11C127,Biological Imaging,0.0
Buildings 4 and 10/11C127,Biology of Vector-Borne Viruses Section,0.0
Buildings 4 and 10/11C127,Building 14B South,0.0
Buildings 4 and 10/11C127,Building 33,0.0
Buildings 4 and 10/11C127,Building 50,0.0
Buildings 4 and 10/11C127,Building NIHAC/103,0.0
Caliciviruses Section,Allergy and Immunology Clinical Training Program,0.0
Caliciviruses Section,Antibacterial Host Defense Unit,0.0
Caliciviruses Section,Antibody Biology Unit,0.0
Caliciviruses Section,Apicomplexan Molecular Physiology Section,0.0
Caliciviruses Section,Autoimmunity and Functional Genomics Section,0.0
Caliciviruses Section,B-Cell Immunology Section,0.0
Caliciviruses Section,B-Cell Molecular Immunology Section,0.0
Caliciviruses Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Caliciviruses Section,Bacterial Physiology and Metabolism Unit,0.0
Caliciviruses Section,Barrier Immunity Section,0.0
Caliciviruses Section,Biological Imaging,0.0
Caliciviruses Section,Biology of Vector-Borne Viruses Section,0.0
Caliciviruses Section,Building 14B South,0.0
Caliciviruses Section,Building 33,0.0
Caliciviruses Section,Building 50,0.0
Caliciviruses Section,Building NIHAC/103,0.0
Caliciviruses Section,Buildings 4 and 10/11C127,0.0
Cell Signaling and Immunity Section,Allergy and Immunology Clinical Training Program,0.0
Cell Signaling and Immunity Section,Antibacterial Host Defense Unit,0.0
Cell Signaling and Immunity Section,Antibody Biology Unit,0.0
Cell Signaling and Immunity Section,Apicomplexan Molecular Physiology Section,0.0
Cell Signaling and Immunity Section,Autoimmunity and Functional Genomics Section,0.0
Cell Signaling and Immunity Section,B-Cell Molecular Immunology Section,0.0
Cell Signaling and Immunity Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Cell Signaling and Immunity Section,Bacterial Physiology and Metabolism Unit,0.0
Cell Signaling and Immunity Section,Barrier Immunity Section,0.0
Cell Signaling and Immunity Section,Biological Imaging,0.0
Cell Signaling and Immunity Section,Biology of Vector-Borne Viruses Section,0.0
Cell Signaling and Immunity Section,Building 14B South,0.0
Cell Signaling and Immunity Section,Building 33,0.0
Cell Signaling and Immunity Section,Building 50,0.0
Cell Signaling and Immunity Section,Building NIHAC/103,0.0
Cell Signaling and Immunity Section,Buildings 4 and 10/11C127,0.0
Cell Signaling and Immunity Section,Caliciviruses Section,0.0
Cellular Biology Section,Allergy and Immunology Clinical Training Program,0.0
Cellular Biology Section,Antibacterial Host Defense Unit,0.0
Cellular Biology Section,Antibody Biology Unit,0.0
Cellular Biology Section,Apicomplexan Molecular Physiology Section,0.0
Cellular Biology Section,Autoimmunity and Functional Genomics Section,0.0
Cellular Biology Section,B-Cell Immunology Section,0.0
Cellular Biology Section,B-Cell Molecular Immunology Section,0.0
Cellular Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Cellular Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Cellular Biology Section,Biology of Vector-Borne Viruses Section,0.0
Cellular Biology Section,Building 14B South,0.0
Cellular Biology Section,Building 33,0.0
Cellular Biology Section,Building 50,0.0
Cellular Biology Section,Building NIHAC/103,0.0
Cellular Biology Section,Buildings 4 and 10/11C127,0.0
Cellular Biology Section,Caliciviruses Section,0.0
Cellular Biology Section,Cell Signaling and Immunity Section,0.0
Cellular Immunology Section,Allergy and Immunology Clinical Training Program,0.0
Cellular Immunology Section,Antibacterial Host Defense Unit,0.0
Cellular Immunology Section,Antibody Biology Unit,0.0
Cellular Immunology Section,Apicomplexan Molecular Physiology Section,0.0
Cellular Immunology Section,Autoimmunity and Functional Genomics Section,0.0
Cellular Immunology Section,B-Cell Immunology Section,0.0
Cellular Immunology Section,B-Cell Molecular Immunology Section,0.0
Cellular Immunology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Cellular Immunology Section,Bacterial Physiology and Metabolism Unit,0.0
Cellular Immunology Section,Barrier Immunity Section,0.0
Cellular Immunology Section,Biological Imaging,0.0
Cellular Immunology Section,Biology of Vector-Borne Viruses Section,0.0
Cellular Immunology Section,Building 14B South,0.0
Cellular Immunology Section,Building 33,0.0
Cellular Immunology Section,Building 50,0.0
Cellular Immunology Section,Building NIHAC/103,0.0
Cellular Immunology Section,Buildings 4 and 10/11C127,0.0
Cellular Immunology Section,Caliciviruses Section,0.0
Cellular Immunology Section,Cell Signaling and Immunity Section,0.0
Cellular Immunology Section,Cellular Biology Section,0.0
Chemotaxis Signal Section,Allergy and Immunology Clinical Training Program,0.0
Chemotaxis Signal Section,Antibacterial Host Defense Unit,0.0
Chemotaxis Signal Section,Antibody Biology Unit,0.0
Chemotaxis Signal Section,Apicomplexan Molecular Physiology Section,0.0
Chemotaxis Signal Section,B-Cell Immunology Section,0.0
Chemotaxis Signal Section,B-Cell Molecular Immunology Section,0.0
Chemotaxis Signal Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Chemotaxis Signal Section,Bacterial Physiology and Metabolism Unit,0.0
Chemotaxis Signal Section,Barrier Immunity Section,0.0
Chemotaxis Signal Section,Biological Imaging,0.0
Chemotaxis Signal Section,Biology of Vector-Borne Viruses Section,0.0
Chemotaxis Signal Section,Building 14B South,0.0
Chemotaxis Signal Section,Building 33,0.0
Chemotaxis Signal Section,Building 50,0.0
Chemotaxis Signal Section,Building NIHAC/103,0.0
Chemotaxis Signal Section,Buildings 4 and 10/11C127,0.0
Chemotaxis Signal Section,Caliciviruses Section,0.0
Chemotaxis Signal Section,Cell Signaling and Immunity Section,0.0
Chemotaxis Signal Section,Cellular Biology Section,0.0
Chemotaxis Signal Section,Cellular Immunology Section,0.0
Chlamydial Diseases Section,Allergy and Immunology Clinical Training Program,0.0
Chlamydial Diseases Section,Antibacterial Host Defense Unit,0.0
Chlamydial Diseases Section,Antibody Biology Unit,0.0
Chlamydial Diseases Section,Apicomplexan Molecular Physiology Section,0.0
Chlamydial Diseases Section,Autoimmunity and Functional Genomics Section,0.0
Chlamydial Diseases Section,B-Cell Immunology Section,0.0
Chlamydial Diseases Section,B-Cell Molecular Immunology Section,0.0
Chlamydial Diseases Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Chlamydial Diseases Section,Bacterial Physiology and Metabolism Unit,0.0
Chlamydial Diseases Section,Barrier Immunity Section,0.0
Chlamydial Diseases Section,Biological Imaging,0.0
Chlamydial Diseases Section,Biology of Vector-Borne Viruses Section,0.0
Chlamydial Diseases Section,Building 14B South,0.0
Chlamydial Diseases Section,Building 33,0.0
Chlamydial Diseases Section,Building 50,0.0
Chlamydial Diseases Section,Building NIHAC/103,0.0
Chlamydial Diseases Section,Buildings 4 and 10/11C127,0.0
Chlamydial Diseases Section,Caliciviruses Section,0.0
Chlamydial Diseases Section,Cell Signaling and Immunity Section,0.0
Chlamydial Diseases Section,Cellular Biology Section,0.0
Chlamydial Diseases Section,Cellular Immunology Section,0.0
Chlamydial Diseases Section,Chemotaxis Signal Section,0.0
Clinical Microbiome Unit (CMU),Allergy and Immunology Clinical Training Program,0.0
Clinical Microbiome Unit (CMU),Antibacterial Host Defense Unit,0.0
Clinical Microbiome Unit (CMU),Antibody Biology Unit,0.0
Clinical Microbiome Unit (CMU),Apicomplexan Molecular Physiology Section,0.0
Clinical Microbiome Unit (CMU),Autoimmunity and Functional Genomics Section,0.0
Clinical Microbiome Unit (CMU),B-Cell Immunology Section,0.0
Clinical Microbiome Unit (CMU),B-Cell Molecular Immunology Section,0.0
Clinical Microbiome Unit (CMU),Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Clinical Microbiome Unit (CMU),Bacterial Physiology and Metabolism Unit,0.0
Clinical Microbiome Unit (CMU),Barrier Immunity Section,0.0
Clinical Microbiome Unit (CMU),Biological Imaging,0.0
Clinical Microbiome Unit (CMU),Biology of Vector-Borne Viruses Section,0.0
Clinical Microbiome Unit (CMU),Building 14B South,0.0
Clinical Microbiome Unit (CMU),Building 33,0.0
Clinical Microbiome Unit (CMU),Building 50,0.0
Clinical Microbiome Unit (CMU),Building NIHAC/103,0.0
Clinical Microbiome Unit (CMU),Buildings 4 and 10/11C127,0.0
Clinical Microbiome Unit (CMU),Caliciviruses Section,0.0
Clinical Microbiome Unit (CMU),Cell Signaling and Immunity Section,0.0
Clinical Microbiome Unit (CMU),Cellular Biology Section,0.0
Clinical Microbiome Unit (CMU),Cellular Immunology Section,0.0
Clinical Microbiome Unit (CMU),Chemotaxis Signal Section,0.0
Clinical Microbiome Unit (CMU),Chlamydial Diseases Section,0.0
Clinical Pathophysiology Section,Allergy and Immunology Clinical Training Program,0.0
Clinical Pathophysiology Section,Antibacterial Host Defense Unit,0.0
Clinical Pathophysiology Section,Antibody Biology Unit,0.0
Clinical Pathophysiology Section,Apicomplexan Molecular Physiology Section,0.0
Clinical Pathophysiology Section,Autoimmunity and Functional Genomics Section,0.0
Clinical Pathophysiology Section,B-Cell Immunology Section,0.0
Clinical Pathophysiology Section,B-Cell Molecular Immunology Section,0.0
Clinical Pathophysiology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Clinical Pathophysiology Section,Bacterial Physiology and Metabolism Unit,0.0
Clinical Pathophysiology Section,Barrier Immunity Section,0.0
Clinical Pathophysiology Section,Biological Imaging,0.0
Clinical Pathophysiology Section,Biology of Vector-Borne Viruses Section,0.0
Clinical Pathophysiology Section,Building 14B South,0.0
Clinical Pathophysiology Section,Building 33,0.0
Clinical Pathophysiology Section,Building 50,0.0
Clinical Pathophysiology Section,Building NIHAC/103,0.0
Clinical Pathophysiology Section,Buildings 4 and 10/11C127,0.0
Clinical Pathophysiology Section,Caliciviruses Section,0.0
Clinical Pathophysiology Section,Cell Signaling and Immunity Section,0.0
Clinical Pathophysiology Section,Cellular Biology Section,0.0
Clinical Pathophysiology Section,Cellular Immunology Section,0.0
Clinical Pathophysiology Section,Chemotaxis Signal Section,0.0
Clinical Pathophysiology Section,Chlamydial Diseases Section,0.0
Clinical Pathophysiology Section,Clinical Microbiome Unit (CMU),0.0
Clinical Research Section,Allergy and Immunology Clinical Training Program,0.0
Clinical Research Section,Antibacterial Host Defense Unit,0.0
Clinical Research Section,Antibody Biology Unit,0.0
Clinical Research Section,Apicomplexan Molecular Physiology Section,0.0
Clinical Research Section,Autoimmunity and Functional Genomics Section,0.0
Clinical Research Section,B-Cell Molecular Immunology Section,0.0
Clinical Research Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Clinical Research Section,Bacterial Physiology and Metabolism Unit,0.0
Clinical Research Section,Barrier Immunity Section,0.0
Clinical Research Section,Biological Imaging,0.0
Clinical Research Section,Biology of Vector-Borne Viruses Section,0.0
Clinical Research Section,Building 14B South,0.0
Clinical Research Section,Building 33,0.0
Clinical Research Section,Building 50,0.0
Clinical Research Section,Building NIHAC/103,0.0
Clinical Research Section,Buildings 4 and 10/11C127,0.0
Clinical Research Section,Caliciviruses Section,0.0
Clinical Research Section,Cell Signaling and Immunity Section,0.0
Clinical Research Section,Cellular Biology Section,0.0
Clinical Research Section,Chemotaxis Signal Section,0.0
Clinical Research Section,Chlamydial Diseases Section,0.0
Clinical Research Section,Clinical Microbiome Unit (CMU),0.0
Clinical Research Section,Clinical Pathophysiology Section,0.0
Clinical and Molecular Retrovirology Section,Allergy and Immunology Clinical Training Program,0.0
Clinical and Molecular Retrovirology Section,Antibacterial Host Defense Unit,0.0
Clinical and Molecular Retrovirology Section,Antibody Biology Unit,0.0
Clinical and Molecular Retrovirology Section,Apicomplexan Molecular Physiology Section,0.0
Clinical and Molecular Retrovirology Section,Autoimmunity and Functional Genomics Section,0.0
Clinical and Molecular Retrovirology Section,B-Cell Immunology Section,0.0
Clinical and Molecular Retrovirology Section,B-Cell Molecular Immunology Section,0.0
Clinical and Molecular Retrovirology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Clinical and Molecular Retrovirology Section,Bacterial Physiology and Metabolism Unit,0.0
Clinical and Molecular Retrovirology Section,Barrier Immunity Section,0.0
Clinical and Molecular Retrovirology Section,Biological Imaging,0.0
Clinical and Molecular Retrovirology Section,Biology of Vector-Borne Viruses Section,0.0
Clinical and Molecular Retrovirology Section,Building 14B South,0.0
Clinical and Molecular Retrovirology Section,Building 33,0.0
Clinical and Molecular Retrovirology Section,Building 50,0.0
Clinical and Molecular Retrovirology Section,Building NIHAC/103,0.0
Clinical and Molecular Retrovirology Section,Buildings 4 and 10/11C127,0.0
Clinical and Molecular Retrovirology Section,Caliciviruses Section,0.0
Clinical and Molecular Retrovirology Section,Cell Signaling and Immunity Section,0.0
Clinical and Molecular Retrovirology Section,Cellular Biology Section,0.0
Clinical and Molecular Retrovirology Section,Chemotaxis Signal Section,0.0
Clinical and Molecular Retrovirology Section,Chlamydial Diseases Section,0.0
Clinical and Molecular Retrovirology Section,Clinical Microbiome Unit (CMU),0.0
Clinical and Molecular Retrovirology Section,Clinical Pathophysiology Section,0.0
Computational Biology Unit,Allergy and Immunology Clinical Training Program,0.0
Computational Biology Unit,Antibacterial Host Defense Unit,0.0
Computational Biology Unit,Antibody Biology Unit,0.0
Computational Biology Unit,Apicomplexan Molecular Physiology Section,0.0
Computational Biology Unit,Autoimmunity and Functional Genomics Section,0.0
Computational Biology Unit,B-Cell Immunology Section,0.0
Computational Biology Unit,B-Cell Molecular Immunology Section,0.0
Computational Biology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Computational Biology Unit,Bacterial Physiology and Metabolism Unit,0.0
Computational Biology Unit,Biological Imaging,0.0
Computational Biology Unit,Biology of Vector-Borne Viruses Section,0.0
Computational Biology Unit,Building 14B South,0.0
Computational Biology Unit,Building 33,0.0
Computational Biology Unit,Building 50,0.0
Computational Biology Unit,Building NIHAC/103,0.0
Computational Biology Unit,Buildings 4 and 10/11C127,0.0
Computational Biology Unit,Caliciviruses Section,0.0
Computational Biology Unit,Cell Signaling and Immunity Section,0.0
Computational Biology Unit,Cellular Biology Section,0.0
Computational Biology Unit,Cellular Immunology Section,0.0
Computational Biology Unit,Chlamydial Diseases Section,0.0
Computational Biology Unit,Clinical Microbiome Unit (CMU),0.0
Computational Biology Unit,Clinical Pathophysiology Section,0.0
Computational Biology Unit,Clinical Research Section,0.0
Computational Biology Unit,Clinical and Molecular Retrovirology Section,0.0
Coxiella Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
Coxiella Pathogenesis Section,Antibacterial Host Defense Unit,0.0
Coxiella Pathogenesis Section,Antibody Biology Unit,0.0
Coxiella Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
Coxiella Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
Coxiella Pathogenesis Section,B-Cell Immunology Section,0.0
Coxiella Pathogenesis Section,B-Cell Molecular Immunology Section,0.0
Coxiella Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Coxiella Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
Coxiella Pathogenesis Section,Barrier Immunity Section,0.0
Coxiella Pathogenesis Section,Biological Imaging,0.0
Coxiella Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.0
Coxiella Pathogenesis Section,Building 14B South,0.0
Coxiella Pathogenesis Section,Building 33,0.0
Coxiella Pathogenesis Section,Building 50,0.0
Coxiella Pathogenesis Section,Building NIHAC/103,0.0
Coxiella Pathogenesis Section,Buildings 4 and 10/11C127,0.0
Coxiella Pathogenesis Section,Caliciviruses Section,0.0
Coxiella Pathogenesis Section,Cell Signaling and Immunity Section,0.0
Coxiella Pathogenesis Section,Cellular Biology Section,0.0
Coxiella Pathogenesis Section,Cellular Immunology Section,0.0
Coxiella Pathogenesis Section,Chemotaxis Signal Section,0.0
Coxiella Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
Coxiella Pathogenesis Section,Clinical Pathophysiology Section,0.0
Coxiella Pathogenesis Section,Clinical Research Section,0.0
Coxiella Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.0
Coxiella Pathogenesis Section,Computational Biology Unit,0.0
DNA Tumor Virus Section,Allergy and Immunology Clinical Training Program,0.0
DNA Tumor Virus Section,Antibacterial Host Defense Unit,0.0
DNA Tumor Virus Section,Antibody Biology Unit,0.0
DNA Tumor Virus Section,Apicomplexan Molecular Physiology Section,0.0
DNA Tumor Virus Section,Autoimmunity and Functional Genomics Section,0.0
DNA Tumor Virus Section,B-Cell Immunology Section,0.0
DNA Tumor Virus Section,B-Cell Molecular Immunology Section,0.0
DNA Tumor Virus Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
DNA Tumor Virus Section,Bacterial Physiology and Metabolism Unit,0.0
DNA Tumor Virus Section,Barrier Immunity Section,0.0
DNA Tumor Virus Section,Biological Imaging,0.0
DNA Tumor Virus Section,Biology of Vector-Borne Viruses Section,0.0
DNA Tumor Virus Section,Building 14B South,0.0
DNA Tumor Virus Section,Building 33,0.0
DNA Tumor Virus Section,Building 50,0.0
DNA Tumor Virus Section,Building NIHAC/103,0.0
DNA Tumor Virus Section,Buildings 4 and 10/11C127,0.0
DNA Tumor Virus Section,Caliciviruses Section,0.0
DNA Tumor Virus Section,Cell Signaling and Immunity Section,0.0
DNA Tumor Virus Section,Cellular Biology Section,0.0
DNA Tumor Virus Section,Cellular Immunology Section,0.0
DNA Tumor Virus Section,Chemotaxis Signal Section,0.0
DNA Tumor Virus Section,Chlamydial Diseases Section,0.0
DNA Tumor Virus Section,Clinical Microbiome Unit (CMU),0.0
DNA Tumor Virus Section,Clinical Pathophysiology Section,0.0
DNA Tumor Virus Section,Clinical Research Section,0.0
DNA Tumor Virus Section,Clinical and Molecular Retrovirology Section,0.0
DNA Tumor Virus Section,Computational Biology Unit,0.0
DNA Tumor Virus Section,Coxiella Pathogenesis Section,0.0
Disease Modeling and Transmission Section,Allergy and Immunology Clinical Training Program,0.0
Disease Modeling and Transmission Section,Antibacterial Host Defense Unit,0.0
Disease Modeling and Transmission Section,Antibody Biology Unit,0.0
Disease Modeling and Transmission Section,Apicomplexan Molecular Physiology Section,0.0
Disease Modeling and Transmission Section,Autoimmunity and Functional Genomics Section,0.0
Disease Modeling and Transmission Section,B-Cell Immunology Section,0.0
Disease Modeling and Transmission Section,B-Cell Molecular Immunology Section,0.0
Disease Modeling and Transmission Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Disease Modeling and Transmission Section,Bacterial Physiology and Metabolism Unit,0.0
Disease Modeling and Transmission Section,Barrier Immunity Section,0.0
Disease Modeling and Transmission Section,Biological Imaging,0.0
Disease Modeling and Transmission Section,Building 14B South,0.0
Disease Modeling and Transmission Section,Building 33,0.0
Disease Modeling and Transmission Section,Building 50,0.0
Disease Modeling and Transmission Section,Building NIHAC/103,0.0
Disease Modeling and Transmission Section,Buildings 4 and 10/11C127,0.0
Disease Modeling and Transmission Section,Caliciviruses Section,0.0
Disease Modeling and Transmission Section,Cell Signaling and Immunity Section,0.0
Disease Modeling and Transmission Section,Cellular Biology Section,0.0
Disease Modeling and Transmission Section,Cellular Immunology Section,0.0
Disease Modeling and Transmission Section,Chemotaxis Signal Section,0.0
Disease Modeling and Transmission Section,Chlamydial Diseases Section,0.0
Disease Modeling and Transmission Section,Clinical Microbiome Unit (CMU),0.0
Disease Modeling and Transmission Section,Clinical Pathophysiology Section,0.0
Disease Modeling and Transmission Section,Computational Biology Unit,0.0
Disease Modeling and Transmission Section,Coxiella Pathogenesis Section,0.0
Disease Modeling and Transmission Section,DNA Tumor Virus Section,0.0
Emerging Respiratory Viruses Section,Allergy and Immunology Clinical Training Program,0.0
Emerging Respiratory Viruses Section,Antibacterial Host Defense Unit,0.0
Emerging Respiratory Viruses Section,Antibody Biology Unit,0.0
Emerging Respiratory Viruses Section,Apicomplexan Molecular Physiology Section,0.0
Emerging Respiratory Viruses Section,B-Cell Immunology Section,0.0
Emerging Respiratory Viruses Section,B-Cell Molecular Immunology Section,0.0
Emerging Respiratory Viruses Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Emerging Respiratory Viruses Section,Bacterial Physiology and Metabolism Unit,0.0
Emerging Respiratory Viruses Section,Biological Imaging,0.0
Emerging Respiratory Viruses Section,Biology of Vector-Borne Viruses Section,0.0
Emerging Respiratory Viruses Section,Building 14B South,0.0
Emerging Respiratory Viruses Section,Building 33,0.0
Emerging Respiratory Viruses Section,Building 50,0.0
Emerging Respiratory Viruses Section,Building NIHAC/103,0.0
Emerging Respiratory Viruses Section,Buildings 4 and 10/11C127,0.0
Emerging Respiratory Viruses Section,Cellular Biology Section,0.0
Emerging Respiratory Viruses Section,Cellular Immunology Section,0.0
Emerging Respiratory Viruses Section,Chemotaxis Signal Section,0.0
Emerging Respiratory Viruses Section,Chlamydial Diseases Section,0.0
Emerging Respiratory Viruses Section,Clinical Microbiome Unit (CMU),0.0
Emerging Respiratory Viruses Section,Clinical Pathophysiology Section,0.0
Emerging Respiratory Viruses Section,Clinical Research Section,0.0
Emerging Respiratory Viruses Section,Clinical and Molecular Retrovirology Section,0.0
Emerging Respiratory Viruses Section,Computational Biology Unit,0.0
Emerging Respiratory Viruses Section,Coxiella Pathogenesis Section,0.0
Emerging Respiratory Viruses Section,DNA Tumor Virus Section,0.0
Emerging Respiratory Viruses Section,Disease Modeling and Transmission Section,0.0
Emerging Virus Immunity Unit,Allergy and Immunology Clinical Training Program,0.0
Emerging Virus Immunity Unit,Antibacterial Host Defense Unit,0.0
Emerging Virus Immunity Unit,Antibody Biology Unit,0.0
Emerging Virus Immunity Unit,Apicomplexan Molecular Physiology Section,0.0
Emerging Virus Immunity Unit,Autoimmunity and Functional Genomics Section,0.0
Emerging Virus Immunity Unit,B-Cell Immunology Section,0.0
Emerging Virus Immunity Unit,B-Cell Molecular Immunology Section,0.0
Emerging Virus Immunity Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Emerging Virus Immunity Unit,Bacterial Physiology and Metabolism Unit,0.0
Emerging Virus Immunity Unit,Barrier Immunity Section,0.0
Emerging Virus Immunity Unit,Biological Imaging,0.0
Emerging Virus Immunity Unit,Biology of Vector-Borne Viruses Section,0.0
Emerging Virus Immunity Unit,Building 14B South,0.0
Emerging Virus Immunity Unit,Building 33,0.0
Emerging Virus Immunity Unit,Building 50,0.0
Emerging Virus Immunity Unit,Building NIHAC/103,0.0
Emerging Virus Immunity Unit,Buildings 4 and 10/11C127,0.0
Emerging Virus Immunity Unit,Caliciviruses Section,0.0
Emerging Virus Immunity Unit,Cell Signaling and Immunity Section,0.0
Emerging Virus Immunity Unit,Cellular Biology Section,0.0
Emerging Virus Immunity Unit,Cellular Immunology Section,0.0
Emerging Virus Immunity Unit,Chemotaxis Signal Section,0.0
Emerging Virus Immunity Unit,Chlamydial Diseases Section,0.0
Emerging Virus Immunity Unit,Clinical Microbiome Unit (CMU),0.0
Emerging Virus Immunity Unit,Clinical Pathophysiology Section,0.0
Emerging Virus Immunity Unit,Clinical Research Section,0.0
Emerging Virus Immunity Unit,Clinical and Molecular Retrovirology Section,0.0
Emerging Virus Immunity Unit,Computational Biology Unit,0.0
Emerging Virus Immunity Unit,Coxiella Pathogenesis Section,0.0
Emerging Virus Immunity Unit,DNA Tumor Virus Section,0.0
Emerging Virus Immunity Unit,Disease Modeling and Transmission Section,0.0
Emerging Virus Immunity Unit,Emerging Respiratory Viruses Section,0.0
Epidemiology and Population Studies Unit,Allergy and Immunology Clinical Training Program,0.0
Epidemiology and Population Studies Unit,Antibacterial Host Defense Unit,0.0
Epidemiology and Population Studies Unit,Antibody Biology Unit,0.0
Epidemiology and Population Studies Unit,Apicomplexan Molecular Physiology Section,0.0
Epidemiology and Population Studies Unit,Autoimmunity and Functional Genomics Section,0.0
Epidemiology and Population Studies Unit,B-Cell Immunology Section,0.0
Epidemiology and Population Studies Unit,B-Cell Molecular Immunology Section,0.0
Epidemiology and Population Studies Unit,Bacterial Physiology and Metabolism Unit,0.0
Epidemiology and Population Studies Unit,Barrier Immunity Section,0.0
Epidemiology and Population Studies Unit,Biological Imaging,0.0
Epidemiology and Population Studies Unit,Biology of Vector-Borne Viruses Section,0.0
Epidemiology and Population Studies Unit,Building 14B South,0.0
Epidemiology and Population Studies Unit,Building 33,0.0
Epidemiology and Population Studies Unit,Building 50,0.0
Epidemiology and Population Studies Unit,Building NIHAC/103,0.0
Epidemiology and Population Studies Unit,Buildings 4 and 10/11C127,0.0
Epidemiology and Population Studies Unit,Cell Signaling and Immunity Section,0.0
Epidemiology and Population Studies Unit,Cellular Biology Section,0.0
Epidemiology and Population Studies Unit,Cellular Immunology Section,0.0
Epidemiology and Population Studies Unit,Chemotaxis Signal Section,0.0
Epidemiology and Population Studies Unit,Chlamydial Diseases Section,0.0
Epidemiology and Population Studies Unit,Clinical Microbiome Unit (CMU),0.0
Epidemiology and Population Studies Unit,Clinical Pathophysiology Section,0.0
Epidemiology and Population Studies Unit,Clinical Research Section,0.0
Epidemiology and Population Studies Unit,Clinical and Molecular Retrovirology Section,0.0
Epidemiology and Population Studies Unit,Computational Biology Unit,0.0
Epidemiology and Population Studies Unit,Coxiella Pathogenesis Section,0.0
Epidemiology and Population Studies Unit,DNA Tumor Virus Section,0.0
Epidemiology and Population Studies Unit,Disease Modeling and Transmission Section,0.0
Epidemiology and Population Studies Unit,Emerging Respiratory Viruses Section,0.0
Epidemiology and Population Studies Unit,Emerging Virus Immunity Unit,0.0
Epithelial Therapeutics Unit,Allergy and Immunology Clinical Training Program,0.0
Epithelial Therapeutics Unit,Antibacterial Host Defense Unit,0.0
Epithelial Therapeutics Unit,Antibody Biology Unit,0.0
Epithelial Therapeutics Unit,Apicomplexan Molecular Physiology Section,0.0
Epithelial Therapeutics Unit,Autoimmunity and Functional Genomics Section,0.0
Epithelial Therapeutics Unit,B-Cell Immunology Section,0.0
Epithelial Therapeutics Unit,B-Cell Molecular Immunology Section,0.0
Epithelial Therapeutics Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Epithelial Therapeutics Unit,Bacterial Physiology and Metabolism Unit,0.0
Epithelial Therapeutics Unit,Barrier Immunity Section,0.0
Epithelial Therapeutics Unit,Biological Imaging,0.0
Epithelial Therapeutics Unit,Biology of Vector-Borne Viruses Section,0.0
Epithelial Therapeutics Unit,Building 14B South,0.0
Epithelial Therapeutics Unit,Building 33,0.0
Epithelial Therapeutics Unit,Building 50,0.0
Epithelial Therapeutics Unit,Building NIHAC/103,0.0
Epithelial Therapeutics Unit,Buildings 4 and 10/11C127,0.0
Epithelial Therapeutics Unit,Caliciviruses Section,0.0
Epithelial Therapeutics Unit,Cell Signaling and Immunity Section,0.0
Epithelial Therapeutics Unit,Cellular Biology Section,0.0
Epithelial Therapeutics Unit,Cellular Immunology Section,0.0
Epithelial Therapeutics Unit,Chemotaxis Signal Section,0.0
Epithelial Therapeutics Unit,Chlamydial Diseases Section,0.0
Epithelial Therapeutics Unit,Clinical Microbiome Unit (CMU),0.0
Epithelial Therapeutics Unit,Clinical Research Section,0.0
Epithelial Therapeutics Unit,Clinical and Molecular Retrovirology Section,0.0
Epithelial Therapeutics Unit,Computational Biology Unit,0.0
Epithelial Therapeutics Unit,Coxiella Pathogenesis Section,0.0
Epithelial Therapeutics Unit,DNA Tumor Virus Section,0.0
Epithelial Therapeutics Unit,Disease Modeling and Transmission Section,0.0
Epithelial Therapeutics Unit,Emerging Respiratory Viruses Section,0.0
Epithelial Therapeutics Unit,Emerging Virus Immunity Unit,0.0
Epithelial Therapeutics Unit,Epidemiology and Population Studies Unit,0.0
Flow Cytometry Section,Allergy and Immunology Clinical Training Program,0.0
Flow Cytometry Section,Antibacterial Host Defense Unit,0.0
Flow Cytometry Section,Antibody Biology Unit,0.0
Flow Cytometry Section,Apicomplexan Molecular Physiology Section,0.0
Flow Cytometry Section,Autoimmunity and Functional Genomics Section,0.0
Flow Cytometry Section,B-Cell Immunology Section,0.0
Flow Cytometry Section,B-Cell Molecular Immunology Section,0.0
Flow Cytometry Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Flow Cytometry Section,Bacterial Physiology and Metabolism Unit,0.0
Flow Cytometry Section,Barrier Immunity Section,0.0
Flow Cytometry Section,Biological Imaging,0.0
Flow Cytometry Section,Biology of Vector-Borne Viruses Section,0.0
Flow Cytometry Section,Building 14B South,0.0
Flow Cytometry Section,Building 33,0.0
Flow Cytometry Section,Building 50,0.0
Flow Cytometry Section,Building NIHAC/103,0.0
Flow Cytometry Section,Buildings 4 and 10/11C127,0.0
Flow Cytometry Section,Caliciviruses Section,0.0
Flow Cytometry Section,Cell Signaling and Immunity Section,0.0
Flow Cytometry Section,Cellular Biology Section,0.0
Flow Cytometry Section,Cellular Immunology Section,0.0
Flow Cytometry Section,Chemotaxis Signal Section,0.0
Flow Cytometry Section,Chlamydial Diseases Section,0.0
Flow Cytometry Section,Clinical Microbiome Unit (CMU),0.0
Flow Cytometry Section,Clinical Pathophysiology Section,0.0
Flow Cytometry Section,Clinical Research Section,0.0
Flow Cytometry Section,Clinical and Molecular Retrovirology Section,0.0
Flow Cytometry Section,Computational Biology Unit,0.0
Flow Cytometry Section,Coxiella Pathogenesis Section,0.0
Flow Cytometry Section,DNA Tumor Virus Section,0.0
Flow Cytometry Section,Disease Modeling and Transmission Section,0.0
Flow Cytometry Section,Emerging Respiratory Viruses Section,0.0
Flow Cytometry Section,Emerging Virus Immunity Unit,0.0
Flow Cytometry Section,Epidemiology and Population Studies Unit,0.0
Flow Cytometry Section,Epithelial Therapeutics Unit,0.0
Food Allergy Research Section,Allergy and Immunology Clinical Training Program,0.0
Food Allergy Research Section,Antibacterial Host Defense Unit,0.0
Food Allergy Research Section,Antibody Biology Unit,0.0
Food Allergy Research Section,Apicomplexan Molecular Physiology Section,0.0
Food Allergy Research Section,Autoimmunity and Functional Genomics Section,0.0
Food Allergy Research Section,B-Cell Immunology Section,0.0
Food Allergy Research Section,B-Cell Molecular Immunology Section,0.0
Food Allergy Research Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Food Allergy Research Section,Bacterial Physiology and Metabolism Unit,0.0
Food Allergy Research Section,Barrier Immunity Section,0.0
Food Allergy Research Section,Biological Imaging,0.0
Food Allergy Research Section,Biology of Vector-Borne Viruses Section,0.0
Food Allergy Research Section,Building 14B South,0.0
Food Allergy Research Section,Building 33,0.0
Food Allergy Research Section,Building 50,0.0
Food Allergy Research Section,Building NIHAC/103,0.0
Food Allergy Research Section,Buildings 4 and 10/11C127,0.0
Food Allergy Research Section,Caliciviruses Section,0.0
Food Allergy Research Section,Cell Signaling and Immunity Section,0.0
Food Allergy Research Section,Cellular Biology Section,0.0
Food Allergy Research Section,Cellular Immunology Section,0.0
Food Allergy Research Section,Chemotaxis Signal Section,0.0
Food Allergy Research Section,Chlamydial Diseases Section,0.0
Food Allergy Research Section,Clinical Microbiome Unit (CMU),0.0
Food Allergy Research Section,Clinical Pathophysiology Section,0.0
Food Allergy Research Section,Clinical Research Section,0.0
Food Allergy Research Section,Clinical and Molecular Retrovirology Section,0.0
Food Allergy Research Section,Computational Biology Unit,0.0
Food Allergy Research Section,Coxiella Pathogenesis Section,0.0
Food Allergy Research Section,DNA Tumor Virus Section,0.0
Food Allergy Research Section,Disease Modeling and Transmission Section,0.0
Food Allergy Research Section,Emerging Respiratory Viruses Section,0.0
Food Allergy Research Section,Emerging Virus Immunity Unit,0.0
Food Allergy Research Section,Epidemiology and Population Studies Unit,0.0
Food Allergy Research Section,Epithelial Therapeutics Unit,0.0
Food Allergy Research Section,Flow Cytometry Section,0.0
Functional Cellular Networks Section,Allergy and Immunology Clinical Training Program,0.0
Functional Cellular Networks Section,Antibacterial Host Defense Unit,0.0
Functional Cellular Networks Section,Antibody Biology Unit,0.0
Functional Cellular Networks Section,Apicomplexan Molecular Physiology Section,0.0
Functional Cellular Networks Section,Autoimmunity and Functional Genomics Section,0.0
Functional Cellular Networks Section,B-Cell Immunology Section,0.0
Functional Cellular Networks Section,B-Cell Molecular Immunology Section,0.0
Functional Cellular Networks Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Functional Cellular Networks Section,Bacterial Physiology and Metabolism Unit,0.0
Functional Cellular Networks Section,Barrier Immunity Section,0.0
Functional Cellular Networks Section,Biological Imaging,0.0
Functional Cellular Networks Section,Biology of Vector-Borne Viruses Section,0.0
Functional Cellular Networks Section,Building 14B South,0.0
Functional Cellular Networks Section,Building 33,0.0
Functional Cellular Networks Section,Building 50,0.0
Functional Cellular Networks Section,Building NIHAC/103,0.0
Functional Cellular Networks Section,Buildings 4 and 10/11C127,0.0
Functional Cellular Networks Section,Caliciviruses Section,0.0
Functional Cellular Networks Section,Cell Signaling and Immunity Section,0.0
Functional Cellular Networks Section,Cellular Biology Section,0.0
Functional Cellular Networks Section,Cellular Immunology Section,0.0
Functional Cellular Networks Section,Chemotaxis Signal Section,0.0
Functional Cellular Networks Section,Chlamydial Diseases Section,0.0
Functional Cellular Networks Section,Clinical Microbiome Unit (CMU),0.0
Functional Cellular Networks Section,Clinical Pathophysiology Section,0.0
Functional Cellular Networks Section,Clinical Research Section,0.0
Functional Cellular Networks Section,Clinical and Molecular Retrovirology Section,0.0
Functional Cellular Networks Section,Coxiella Pathogenesis Section,0.0
Functional Cellular Networks Section,DNA Tumor Virus Section,0.0
Functional Cellular Networks Section,Disease Modeling and Transmission Section,0.0
Functional Cellular Networks Section,Emerging Respiratory Viruses Section,0.0
Functional Cellular Networks Section,Emerging Virus Immunity Unit,0.0
Functional Cellular Networks Section,Epidemiology and Population Studies Unit,0.0
Functional Cellular Networks Section,Epithelial Therapeutics Unit,0.0
Functional Cellular Networks Section,Flow Cytometry Section,0.0
Functional Cellular Networks Section,Food Allergy Research Section,0.0
Fungal Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
Fungal Pathogenesis Section,Antibacterial Host Defense Unit,0.0
Fungal Pathogenesis Section,Antibody Biology Unit,0.0
Fungal Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
Fungal Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
Fungal Pathogenesis Section,B-Cell Immunology Section,0.0
Fungal Pathogenesis Section,B-Cell Molecular Immunology Section,0.0
Fungal Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Fungal Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
Fungal Pathogenesis Section,Barrier Immunity Section,0.0
Fungal Pathogenesis Section,Biological Imaging,0.0
Fungal Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.0
Fungal Pathogenesis Section,Building 14B South,0.0
Fungal Pathogenesis Section,Building 33,0.0
Fungal Pathogenesis Section,Building 50,0.0
Fungal Pathogenesis Section,Building NIHAC/103,0.0
Fungal Pathogenesis Section,Buildings 4 and 10/11C127,0.0
Fungal Pathogenesis Section,Caliciviruses Section,0.0
Fungal Pathogenesis Section,Cell Signaling and Immunity Section,0.0
Fungal Pathogenesis Section,Cellular Biology Section,0.0
Fungal Pathogenesis Section,Cellular Immunology Section,0.0
Fungal Pathogenesis Section,Chemotaxis Signal Section,0.0
Fungal Pathogenesis Section,Chlamydial Diseases Section,0.0
Fungal Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
Fungal Pathogenesis Section,Clinical Pathophysiology Section,0.0
Fungal Pathogenesis Section,Clinical Research Section,0.0
Fungal Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.0
Fungal Pathogenesis Section,Computational Biology Unit,0.0
Fungal Pathogenesis Section,Coxiella Pathogenesis Section,0.0
Fungal Pathogenesis Section,DNA Tumor Virus Section,0.0
Fungal Pathogenesis Section,Disease Modeling and Transmission Section,0.0
Fungal Pathogenesis Section,Emerging Virus Immunity Unit,0.0
Fungal Pathogenesis Section,Flow Cytometry Section,0.0
Fungal Pathogenesis Section,Food Allergy Research Section,0.0
Fungal Pathogenesis Section,Functional Cellular Networks Section,0.0
Gene Regulation Section,Allergy and Immunology Clinical Training Program,0.0
Gene Regulation Section,Antibacterial Host Defense Unit,0.0
Gene Regulation Section,Antibody Biology Unit,0.0
Gene Regulation Section,Apicomplexan Molecular Physiology Section,0.0
Gene Regulation Section,Autoimmunity and Functional Genomics Section,0.0
Gene Regulation Section,B-Cell Immunology Section,0.0
Gene Regulation Section,B-Cell Molecular Immunology Section,0.0
Gene Regulation Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Gene Regulation Section,Barrier Immunity Section,0.0
Gene Regulation Section,Biological Imaging,0.0
Gene Regulation Section,Biology of Vector-Borne Viruses Section,0.0
Gene Regulation Section,Building 14B South,0.0
Gene Regulation Section,Building 33,0.0
Gene Regulation Section,Building 50,0.0
Gene Regulation Section,Building NIHAC/103,0.0
Gene Regulation Section,Buildings 4 and 10/11C127,0.0
Gene Regulation Section,Caliciviruses Section,0.0
Gene Regulation Section,Cell Signaling and Immunity Section,0.0
Gene Regulation Section,Cellular Biology Section,0.0
Gene Regulation Section,Cellular Immunology Section,0.0
Gene Regulation Section,Chemotaxis Signal Section,0.0
Gene Regulation Section,Chlamydial Diseases Section,0.0
Gene Regulation Section,Clinical Microbiome Unit (CMU),0.0
Gene Regulation Section,Clinical Pathophysiology Section,0.0
Gene Regulation Section,Clinical Research Section,0.0
Gene Regulation Section,Clinical and Molecular Retrovirology Section,0.0
Gene Regulation Section,Computational Biology Unit,0.0
Gene Regulation Section,Coxiella Pathogenesis Section,0.0
Gene Regulation Section,DNA Tumor Virus Section,0.0
Gene Regulation Section,Disease Modeling and Transmission Section,0.0
Gene Regulation Section,Emerging Respiratory Viruses Section,0.0
Gene Regulation Section,Emerging Virus Immunity Unit,0.0
Gene Regulation Section,Epidemiology and Population Studies Unit,0.0
Gene Regulation Section,Epithelial Therapeutics Unit,0.0
Gene Regulation Section,Flow Cytometry Section,0.0
Gene Regulation Section,Food Allergy Research Section,0.0
Gene Regulation Section,Functional Cellular Networks Section,0.0
Gene Regulation Section,Fungal Pathogenesis Section,0.0
Genetic Engineering Section,Allergy and Immunology Clinical Training Program,0.0
Genetic Engineering Section,Antibacterial Host Defense Unit,0.0
Genetic Engineering Section,Antibody Biology Unit,0.0
Genetic Engineering Section,Apicomplexan Molecular Physiology Section,0.0
Genetic Engineering Section,Autoimmunity and Functional Genomics Section,0.0
Genetic Engineering Section,B-Cell Immunology Section,0.0
Genetic Engineering Section,B-Cell Molecular Immunology Section,0.0
Genetic Engineering Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Genetic Engineering Section,Bacterial Physiology and Metabolism Unit,0.0
Genetic Engineering Section,Barrier Immunity Section,0.0
Genetic Engineering Section,Biological Imaging,0.0
Genetic Engineering Section,Biology of Vector-Borne Viruses Section,0.0
Genetic Engineering Section,Building 14B South,0.0
Genetic Engineering Section,Building 33,0.0
Genetic Engineering Section,Building 50,0.0
Genetic Engineering Section,Building NIHAC/103,0.0
Genetic Engineering Section,Buildings 4 and 10/11C127,0.0
Genetic Engineering Section,Caliciviruses Section,0.0
Genetic Engineering Section,Cell Signaling and Immunity Section,0.0
Genetic Engineering Section,Cellular Biology Section,0.0
Genetic Engineering Section,Cellular Immunology Section,0.0
Genetic Engineering Section,Chemotaxis Signal Section,0.0
Genetic Engineering Section,Chlamydial Diseases Section,0.0
Genetic Engineering Section,Clinical Microbiome Unit (CMU),0.0
Genetic Engineering Section,Clinical Pathophysiology Section,0.0
Genetic Engineering Section,Clinical Research Section,0.0
Genetic Engineering Section,Clinical and Molecular Retrovirology Section,0.0
Genetic Engineering Section,Computational Biology Unit,0.0
Genetic Engineering Section,Coxiella Pathogenesis Section,0.0
Genetic Engineering Section,DNA Tumor Virus Section,0.0
Genetic Engineering Section,Disease Modeling and Transmission Section,0.0
Genetic Engineering Section,Emerging Virus Immunity Unit,0.0
Genetic Engineering Section,Epidemiology and Population Studies Unit,0.0
Genetic Engineering Section,Epithelial Therapeutics Unit,0.0
Genetic Engineering Section,Flow Cytometry Section,0.0
Genetic Engineering Section,Food Allergy Research Section,0.0
Genetic Engineering Section,Functional Cellular Networks Section,0.0
Genetic Engineering Section,Fungal Pathogenesis Section,0.0
Genetic Engineering Section,Gene Regulation Section,0.0
Genetic Immunotherapy Section,Allergy and Immunology Clinical Training Program,0.0
Genetic Immunotherapy Section,Antibacterial Host Defense Unit,0.0
Genetic Immunotherapy Section,Antibody Biology Unit,0.0
Genetic Immunotherapy Section,Apicomplexan Molecular Physiology Section,0.0
Genetic Immunotherapy Section,Autoimmunity and Functional Genomics Section,0.0
Genetic Immunotherapy Section,B-Cell Molecular Immunology Section,0.0
Genetic Immunotherapy Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Genetic Immunotherapy Section,Bacterial Physiology and Metabolism Unit,0.0
Genetic Immunotherapy Section,Barrier Immunity Section,0.0
Genetic Immunotherapy Section,Biological Imaging,0.0
Genetic Immunotherapy Section,Biology of Vector-Borne Viruses Section,0.0
Genetic Immunotherapy Section,Building 14B South,0.0
Genetic Immunotherapy Section,Building 33,0.0
Genetic Immunotherapy Section,Building 50,0.0
Genetic Immunotherapy Section,Building NIHAC/103,0.0
Genetic Immunotherapy Section,Buildings 4 and 10/11C127,0.0
Genetic Immunotherapy Section,Caliciviruses Section,0.0
Genetic Immunotherapy Section,Cell Signaling and Immunity Section,0.0
Genetic Immunotherapy Section,Cellular Biology Section,0.0
Genetic Immunotherapy Section,Cellular Immunology Section,0.0
Genetic Immunotherapy Section,Chemotaxis Signal Section,0.0
Genetic Immunotherapy Section,Chlamydial Diseases Section,0.0
Genetic Immunotherapy Section,Clinical Microbiome Unit (CMU),0.0
Genetic Immunotherapy Section,Clinical Research Section,0.0
Genetic Immunotherapy Section,Computational Biology Unit,0.0
Genetic Immunotherapy Section,Coxiella Pathogenesis Section,0.0
Genetic Immunotherapy Section,DNA Tumor Virus Section,0.0
Genetic Immunotherapy Section,Disease Modeling and Transmission Section,0.0
Genetic Immunotherapy Section,Emerging Respiratory Viruses Section,0.0
Genetic Immunotherapy Section,Emerging Virus Immunity Unit,0.0
Genetic Immunotherapy Section,Epidemiology and Population Studies Unit,0.0
Genetic Immunotherapy Section,Epithelial Therapeutics Unit,0.0
Genetic Immunotherapy Section,Flow Cytometry Section,0.0
Genetic Immunotherapy Section,Food Allergy Research Section,0.0
Genetic Immunotherapy Section,Functional Cellular Networks Section,0.0
Genetic Immunotherapy Section,Fungal Pathogenesis Section,0.0
Genetic Immunotherapy Section,Gene Regulation Section,0.0
Genetic Immunotherapy Section,Genetic Engineering Section,0.0
Genomic Technologies Section,Allergy and Immunology Clinical Training Program,0.0
Genomic Technologies Section,Antibody Biology Unit,0.0
Genomic Technologies Section,Apicomplexan Molecular Physiology Section,0.0
Genomic Technologies Section,B-Cell Immunology Section,0.0
Genomic Technologies Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Genomic Technologies Section,Bacterial Physiology and Metabolism Unit,0.0
Genomic Technologies Section,Barrier Immunity Section,0.0
Genomic Technologies Section,Biological Imaging,0.0
Genomic Technologies Section,Building 14B South,0.0
Genomic Technologies Section,Building 50,0.0
Genomic Technologies Section,Building NIHAC/103,0.0
Genomic Technologies Section,Buildings 4 and 10/11C127,0.0
Genomic Technologies Section,Caliciviruses Section,0.0
Genomic Technologies Section,Cell Signaling and Immunity Section,0.0
Genomic Technologies Section,Cellular Immunology Section,0.0
Genomic Technologies Section,Chemotaxis Signal Section,0.0
Genomic Technologies Section,Chlamydial Diseases Section,0.0
Genomic Technologies Section,Clinical Microbiome Unit (CMU),0.0
Genomic Technologies Section,Clinical Pathophysiology Section,0.0
Genomic Technologies Section,Clinical Research Section,0.0
Genomic Technologies Section,Computational Biology Unit,0.0
Genomic Technologies Section,Coxiella Pathogenesis Section,0.0
Genomic Technologies Section,DNA Tumor Virus Section,0.0
Genomic Technologies Section,Disease Modeling and Transmission Section,0.0
Genomic Technologies Section,Emerging Virus Immunity Unit,0.0
Genomic Technologies Section,Epidemiology and Population Studies Unit,0.0
Genomic Technologies Section,Flow Cytometry Section,0.0
Genomic Technologies Section,Food Allergy Research Section,0.0
Genomic Technologies Section,Functional Cellular Networks Section,0.0
Genomic Technologies Section,Gene Regulation Section,0.0
HIV Immunovirology Section,Allergy and Immunology Clinical Training Program,0.0
HIV Immunovirology Section,Antibacterial Host Defense Unit,0.0
HIV Immunovirology Section,Antibody Biology Unit,0.0
HIV Immunovirology Section,Apicomplexan Molecular Physiology Section,0.0
HIV Immunovirology Section,Autoimmunity and Functional Genomics Section,0.0
HIV Immunovirology Section,B-Cell Molecular Immunology Section,0.0
HIV Immunovirology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
HIV Immunovirology Section,Bacterial Physiology and Metabolism Unit,0.0
HIV Immunovirology Section,Biological Imaging,0.0
HIV Immunovirology Section,Biology of Vector-Borne Viruses Section,0.0
HIV Immunovirology Section,Building 14B South,0.0
HIV Immunovirology Section,Building 33,0.0
HIV Immunovirology Section,Building 50,0.0
HIV Immunovirology Section,Building NIHAC/103,0.0
HIV Immunovirology Section,Buildings 4 and 10/11C127,0.0
HIV Immunovirology Section,Caliciviruses Section,0.0
HIV Immunovirology Section,Cell Signaling and Immunity Section,0.0
HIV Immunovirology Section,Cellular Biology Section,0.0
HIV Immunovirology Section,Cellular Immunology Section,0.0
HIV Immunovirology Section,Chemotaxis Signal Section,0.0
HIV Immunovirology Section,Chlamydial Diseases Section,0.0
HIV Immunovirology Section,Clinical Microbiome Unit (CMU),0.0
HIV Immunovirology Section,Clinical Pathophysiology Section,0.0
HIV Immunovirology Section,Clinical and Molecular Retrovirology Section,0.0
HIV Immunovirology Section,Computational Biology Unit,0.0
HIV Immunovirology Section,Coxiella Pathogenesis Section,0.0
HIV Immunovirology Section,DNA Tumor Virus Section,0.0
HIV Immunovirology Section,Disease Modeling and Transmission Section,0.0
HIV Immunovirology Section,Emerging Respiratory Viruses Section,0.0
HIV Immunovirology Section,Emerging Virus Immunity Unit,0.0
HIV Immunovirology Section,Epidemiology and Population Studies Unit,0.0
HIV Immunovirology Section,Epithelial Therapeutics Unit,0.0
HIV Immunovirology Section,Flow Cytometry Section,0.0
HIV Immunovirology Section,Food Allergy Research Section,0.0
HIV Immunovirology Section,Functional Cellular Networks Section,0.0
HIV Immunovirology Section,Fungal Pathogenesis Section,0.0
HIV Immunovirology Section,Gene Regulation Section,0.0
HIV Immunovirology Section,Genetic Engineering Section,0.0
HIV Immunovirology Section,Genomic Technologies Section,0.0
HIV Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
HIV Pathogenesis Section,Antibacterial Host Defense Unit,0.0
HIV Pathogenesis Section,Antibody Biology Unit,0.0
HIV Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
HIV Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
HIV Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
HIV Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
HIV Pathogenesis Section,Biological Imaging,0.0
HIV Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.0
HIV Pathogenesis Section,Building 14B South,0.0
HIV Pathogenesis Section,Building 33,0.0
HIV Pathogenesis Section,Building 50,0.0
HIV Pathogenesis Section,Building NIHAC/103,0.0
HIV Pathogenesis Section,Buildings 4 and 10/11C127,0.0
HIV Pathogenesis Section,Caliciviruses Section,0.0
HIV Pathogenesis Section,Cell Signaling and Immunity Section,0.0
HIV Pathogenesis Section,Cellular Biology Section,0.0
HIV Pathogenesis Section,Chemotaxis Signal Section,0.0
HIV Pathogenesis Section,Chlamydial Diseases Section,0.0
HIV Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
HIV Pathogenesis Section,Clinical Pathophysiology Section,0.0
HIV Pathogenesis Section,Computational Biology Unit,0.0
HIV Pathogenesis Section,Coxiella Pathogenesis Section,0.0
HIV Pathogenesis Section,Disease Modeling and Transmission Section,0.0
HIV Pathogenesis Section,Emerging Virus Immunity Unit,0.0
HIV Pathogenesis Section,Epidemiology and Population Studies Unit,0.0
HIV Pathogenesis Section,Epithelial Therapeutics Unit,0.0
HIV Pathogenesis Section,Flow Cytometry Section,0.0
HIV Pathogenesis Section,Food Allergy Research Section,0.0
HIV Pathogenesis Section,Functional Cellular Networks Section,0.0
HIV Pathogenesis Section,Fungal Pathogenesis Section,0.0
HIV Pathogenesis Section,Gene Regulation Section,0.0
HIV Pathogenesis Section,Genetic Engineering Section,0.0
HIV Pathogenesis Section,Genetic Immunotherapy Section,0.0
HIV Pathogenesis Section,Genomic Technologies Section,0.0
HIV-Specific Immunity Section,Allergy and Immunology Clinical Training Program,0.0
HIV-Specific Immunity Section,Antibacterial Host Defense Unit,0.0
HIV-Specific Immunity Section,Antibody Biology Unit,0.0
HIV-Specific Immunity Section,Apicomplexan Molecular Physiology Section,0.0
HIV-Specific Immunity Section,Autoimmunity and Functional Genomics Section,0.0
HIV-Specific Immunity Section,B-Cell Molecular Immunology Section,0.0
HIV-Specific Immunity Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
HIV-Specific Immunity Section,Bacterial Physiology and Metabolism Unit,0.0
HIV-Specific Immunity Section,Biological Imaging,0.0
HIV-Specific Immunity Section,Biology of Vector-Borne Viruses Section,0.0
HIV-Specific Immunity Section,Building 14B South,0.0
HIV-Specific Immunity Section,Building 33,0.0
HIV-Specific Immunity Section,Building 50,0.0
HIV-Specific Immunity Section,Building NIHAC/103,0.0
HIV-Specific Immunity Section,Buildings 4 and 10/11C127,0.0
HIV-Specific Immunity Section,Caliciviruses Section,0.0
HIV-Specific Immunity Section,Cell Signaling and Immunity Section,0.0
HIV-Specific Immunity Section,Cellular Biology Section,0.0
HIV-Specific Immunity Section,Cellular Immunology Section,0.0
HIV-Specific Immunity Section,Chemotaxis Signal Section,0.0
HIV-Specific Immunity Section,Chlamydial Diseases Section,0.0
HIV-Specific Immunity Section,Clinical Microbiome Unit (CMU),0.0
HIV-Specific Immunity Section,Clinical Pathophysiology Section,0.0
HIV-Specific Immunity Section,Computational Biology Unit,0.0
HIV-Specific Immunity Section,Coxiella Pathogenesis Section,0.0
HIV-Specific Immunity Section,DNA Tumor Virus Section,0.0
HIV-Specific Immunity Section,Disease Modeling and Transmission Section,0.0
HIV-Specific Immunity Section,Emerging Respiratory Viruses Section,0.0
HIV-Specific Immunity Section,Emerging Virus Immunity Unit,0.0
HIV-Specific Immunity Section,Epidemiology and Population Studies Unit,0.0
HIV-Specific Immunity Section,Epithelial Therapeutics Unit,0.0
HIV-Specific Immunity Section,Flow Cytometry Section,0.0
HIV-Specific Immunity Section,Food Allergy Research Section,0.0
HIV-Specific Immunity Section,Functional Cellular Networks Section,0.0
HIV-Specific Immunity Section,Fungal Pathogenesis Section,0.0
HIV-Specific Immunity Section,Gene Regulation Section,0.0
HIV-Specific Immunity Section,Genetic Engineering Section,0.0
HIV-Specific Immunity Section,Genetic Immunotherapy Section,0.0
HIV-Specific Immunity Section,Genomic Technologies Section,0.0
Helminth Immunology Section,Antibacterial Host Defense Unit,0.0
Helminth Immunology Section,Antibody Biology Unit,0.0
Helminth Immunology Section,Apicomplexan Molecular Physiology Section,0.0
Helminth Immunology Section,Autoimmunity and Functional Genomics Section,0.0
Helminth Immunology Section,B-Cell Immunology Section,0.0
Helminth Immunology Section,B-Cell Molecular Immunology Section,0.0
Helminth Immunology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Helminth Immunology Section,Bacterial Physiology and Metabolism Unit,0.0
Helminth Immunology Section,Barrier Immunity Section,0.0
Helminth Immunology Section,Biological Imaging,0.0
Helminth Immunology Section,Biology of Vector-Borne Viruses Section,0.0
Helminth Immunology Section,Building 14B South,0.0
Helminth Immunology Section,Building 33,0.0
Helminth Immunology Section,Building 50,0.0
Helminth Immunology Section,Building NIHAC/103,0.0
Helminth Immunology Section,Buildings 4 and 10/11C127,0.0
Helminth Immunology Section,Caliciviruses Section,0.0
Helminth Immunology Section,Cell Signaling and Immunity Section,0.0
Helminth Immunology Section,Cellular Biology Section,0.0
Helminth Immunology Section,Cellular Immunology Section,0.0
Helminth Immunology Section,Chemotaxis Signal Section,0.0
Helminth Immunology Section,Chlamydial Diseases Section,0.0
Helminth Immunology Section,Clinical Microbiome Unit (CMU),0.0
Helminth Immunology Section,Clinical Pathophysiology Section,0.0
Helminth Immunology Section,Clinical Research Section,0.0
Helminth Immunology Section,Clinical and Molecular Retrovirology Section,0.0
Helminth Immunology Section,Computational Biology Unit,0.0
Helminth Immunology Section,Coxiella Pathogenesis Section,0.0
Helminth Immunology Section,DNA Tumor Virus Section,0.0
Helminth Immunology Section,Disease Modeling and Transmission Section,0.0
Helminth Immunology Section,Emerging Respiratory Viruses Section,0.0
Helminth Immunology Section,Emerging Virus Immunity Unit,0.0
Helminth Immunology Section,Epithelial Therapeutics Unit,0.0
Helminth Immunology Section,Flow Cytometry Section,0.0
Helminth Immunology Section,Food Allergy Research Section,0.0
Helminth Immunology Section,Functional Cellular Networks Section,0.0
Helminth Immunology Section,Fungal Pathogenesis Section,0.0
Helminth Immunology Section,Gene Regulation Section,0.0
Helminth Immunology Section,Genetic Engineering Section,0.0
Helminth Immunology Section,Genetic Immunotherapy Section,0.0
Helminth Immunology Section,HIV Immunovirology Section,0.0
Helminth Immunology Section,HIV-Specific Immunity Section,0.0
Hepatic Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
Hepatic Pathogenesis Section,Antibacterial Host Defense Unit,0.0
Hepatic Pathogenesis Section,Antibody Biology Unit,0.0
Hepatic Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
Hepatic Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
Hepatic Pathogenesis Section,B-Cell Immunology Section,0.0
Hepatic Pathogenesis Section,B-Cell Molecular Immunology Section,0.0
Hepatic Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Hepatic Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
Hepatic Pathogenesis Section,Barrier Immunity Section,0.0
Hepatic Pathogenesis Section,Biological Imaging,0.0
Hepatic Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.0
Hepatic Pathogenesis Section,Building 14B South,0.0
Hepatic Pathogenesis Section,Building 33,0.0
Hepatic Pathogenesis Section,Building 50,0.0
Hepatic Pathogenesis Section,Building NIHAC/103,0.0
Hepatic Pathogenesis Section,Buildings 4 and 10/11C127,0.0
Hepatic Pathogenesis Section,Caliciviruses Section,0.0
Hepatic Pathogenesis Section,Cell Signaling and Immunity Section,0.0
Hepatic Pathogenesis Section,Cellular Biology Section,0.0
Hepatic Pathogenesis Section,Cellular Immunology Section,0.0
Hepatic Pathogenesis Section,Chemotaxis Signal Section,0.0
Hepatic Pathogenesis Section,Chlamydial Diseases Section,0.0
Hepatic Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
Hepatic Pathogenesis Section,Clinical Pathophysiology Section,0.0
Hepatic Pathogenesis Section,Clinical Research Section,0.0
Hepatic Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.0
Hepatic Pathogenesis Section,Computational Biology Unit,0.0
Hepatic Pathogenesis Section,Coxiella Pathogenesis Section,0.0
Hepatic Pathogenesis Section,DNA Tumor Virus Section,0.0
Hepatic Pathogenesis Section,Disease Modeling and Transmission Section,0.0
Hepatic Pathogenesis Section,Emerging Respiratory Viruses Section,0.0
Hepatic Pathogenesis Section,Emerging Virus Immunity Unit,0.0
Hepatic Pathogenesis Section,Epidemiology and Population Studies Unit,0.0
Hepatic Pathogenesis Section,Epithelial Therapeutics Unit,0.0
Hepatic Pathogenesis Section,Flow Cytometry Section,0.0
Hepatic Pathogenesis Section,Food Allergy Research Section,0.0
Hepatic Pathogenesis Section,Functional Cellular Networks Section,0.0
Hepatic Pathogenesis Section,Fungal Pathogenesis Section,0.0
Hepatic Pathogenesis Section,Gene Regulation Section,0.0
Hepatic Pathogenesis Section,Genetic Engineering Section,0.0
Hepatic Pathogenesis Section,Genetic Immunotherapy Section,0.0
Hepatic Pathogenesis Section,Genomic Technologies Section,0.0
Hepatic Pathogenesis Section,HIV Immunovirology Section,0.0
Hepatic Pathogenesis Section,HIV Pathogenesis Section,0.0
Hepatic Pathogenesis Section,HIV-Specific Immunity Section,0.0
Hepatic Pathogenesis Section,Helminth Immunology Section,0.0
Host-Parasite Interactions Section,Allergy and Immunology Clinical Training Program,0.0
Host-Parasite Interactions Section,Antibacterial Host Defense Unit,0.0
Host-Parasite Interactions Section,Antibody Biology Unit,0.0
Host-Parasite Interactions Section,Apicomplexan Molecular Physiology Section,0.0
Host-Parasite Interactions Section,Autoimmunity and Functional Genomics Section,0.0
Host-Parasite Interactions Section,B-Cell Immunology Section,0.0
Host-Parasite Interactions Section,B-Cell Molecular Immunology Section,0.0
Host-Parasite Interactions Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Host-Parasite Interactions Section,Bacterial Physiology and Metabolism Unit,0.0
Host-Parasite Interactions Section,Barrier Immunity Section,0.0
Host-Parasite Interactions Section,Biological Imaging,0.0
Host-Parasite Interactions Section,Biology of Vector-Borne Viruses Section,0.0
Host-Parasite Interactions Section,Building 14B South,0.0
Host-Parasite Interactions Section,Building 33,0.0
Host-Parasite Interactions Section,Building 50,0.0
Host-Parasite Interactions Section,Building NIHAC/103,0.0
Host-Parasite Interactions Section,Buildings 4 and 10/11C127,0.0
Host-Parasite Interactions Section,Caliciviruses Section,0.0
Host-Parasite Interactions Section,Cell Signaling and Immunity Section,0.0
Host-Parasite Interactions Section,Cellular Biology Section,0.0
Host-Parasite Interactions Section,Cellular Immunology Section,0.0
Host-Parasite Interactions Section,Chemotaxis Signal Section,0.0
Host-Parasite Interactions Section,Clinical Microbiome Unit (CMU),0.0
Host-Parasite Interactions Section,Clinical Pathophysiology Section,0.0
Host-Parasite Interactions Section,Clinical Research Section,0.0
Host-Parasite Interactions Section,Clinical and Molecular Retrovirology Section,0.0
Host-Parasite Interactions Section,Computational Biology Unit,0.0
Host-Parasite Interactions Section,DNA Tumor Virus Section,0.0
Host-Parasite Interactions Section,Disease Modeling and Transmission Section,0.0
Host-Parasite Interactions Section,Emerging Respiratory Viruses Section,0.0
Host-Parasite Interactions Section,Emerging Virus Immunity Unit,0.0
Host-Parasite Interactions Section,Epidemiology and Population Studies Unit,0.0
Host-Parasite Interactions Section,Epithelial Therapeutics Unit,0.0
Host-Parasite Interactions Section,Flow Cytometry Section,0.0
Host-Parasite Interactions Section,Food Allergy Research Section,0.0
Host-Parasite Interactions Section,Functional Cellular Networks Section,0.0
Host-Parasite Interactions Section,Fungal Pathogenesis Section,0.0
Host-Parasite Interactions Section,Gene Regulation Section,0.0
Host-Parasite Interactions Section,Genetic Engineering Section,0.0
Host-Parasite Interactions Section,Genetic Immunotherapy Section,0.0
Host-Parasite Interactions Section,Genomic Technologies Section,0.0
Host-Parasite Interactions Section,HIV Immunovirology Section,0.0
Host-Parasite Interactions Section,HIV Pathogenesis Section,0.0
Host-Parasite Interactions Section,HIV-Specific Immunity Section,0.0
Host-Parasite Interactions Section,Helminth Immunology Section,0.0
Host-Parasite Interactions Section,Hepatic Pathogenesis Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Allergy and Immunology Clinical Training Program,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Antibacterial Host Defense Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Antibody Biology Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Apicomplexan Molecular Physiology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Autoimmunity and Functional Genomics Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,B-Cell Immunology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,B-Cell Molecular Immunology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Bacterial Physiology and Metabolism Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Barrier Immunity Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Biological Imaging,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Biology of Vector-Borne Viruses Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Building 14B South,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Building 33,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Building 50,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Building NIHAC/103,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Buildings 4 and 10/11C127,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Caliciviruses Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Cell Signaling and Immunity Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Cellular Biology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Cellular Immunology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Chemotaxis Signal Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Chlamydial Diseases Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Clinical Microbiome Unit (CMU),0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Clinical Pathophysiology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Clinical Research Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Clinical and Molecular Retrovirology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Computational Biology Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Coxiella Pathogenesis Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,DNA Tumor Virus Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Disease Modeling and Transmission Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Emerging Respiratory Viruses Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Emerging Virus Immunity Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Epidemiology and Population Studies Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Epithelial Therapeutics Unit,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Flow Cytometry Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Food Allergy Research Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Functional Cellular Networks Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Fungal Pathogenesis Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Gene Regulation Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Genetic Engineering Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Genetic Immunotherapy Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Genomic Technologies Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,HIV Immunovirology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,HIV Pathogenesis Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,HIV-Specific Immunity Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Helminth Immunology Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Hepatic Pathogenesis Section,0.0
Host-Pathogen Interactions and Structural Vaccinology Section,Host-Parasite Interactions Section,0.0
Human Eosinophil Section,Antibacterial Host Defense Unit,0.0
Human Eosinophil Section,Antibody Biology Unit,0.0
Human Eosinophil Section,Apicomplexan Molecular Physiology Section,0.0
Human Eosinophil Section,Autoimmunity and Functional Genomics Section,0.0
Human Eosinophil Section,B-Cell Immunology Section,0.0
Human Eosinophil Section,B-Cell Molecular Immunology Section,0.0
Human Eosinophil Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Human Eosinophil Section,Bacterial Physiology and Metabolism Unit,0.0
Human Eosinophil Section,Barrier Immunity Section,0.0
Human Eosinophil Section,Biological Imaging,0.0
Human Eosinophil Section,Biology of Vector-Borne Viruses Section,0.0
Human Eosinophil Section,Building 14B South,0.0
Human Eosinophil Section,Building 33,0.0
Human Eosinophil Section,Building 50,0.0
Human Eosinophil Section,Building NIHAC/103,0.0
Human Eosinophil Section,Buildings 4 and 10/11C127,0.0
Human Eosinophil Section,Caliciviruses Section,0.0
Human Eosinophil Section,Cell Signaling and Immunity Section,0.0
Human Eosinophil Section,Cellular Biology Section,0.0
Human Eosinophil Section,Cellular Immunology Section,0.0
Human Eosinophil Section,Chemotaxis Signal Section,0.0
Human Eosinophil Section,Chlamydial Diseases Section,0.0
Human Eosinophil Section,Clinical Microbiome Unit (CMU),0.0
Human Eosinophil Section,Clinical Pathophysiology Section,0.0
Human Eosinophil Section,Clinical Research Section,0.0
Human Eosinophil Section,Clinical and Molecular Retrovirology Section,0.0
Human Eosinophil Section,Computational Biology Unit,0.0
Human Eosinophil Section,Coxiella Pathogenesis Section,0.0
Human Eosinophil Section,DNA Tumor Virus Section,0.0
Human Eosinophil Section,Disease Modeling and Transmission Section,0.0
Human Eosinophil Section,Emerging Virus Immunity Unit,0.0
Human Eosinophil Section,Epithelial Therapeutics Unit,0.0
Human Eosinophil Section,Flow Cytometry Section,0.0
Human Eosinophil Section,Food Allergy Research Section,0.0
Human Eosinophil Section,Functional Cellular Networks Section,0.0
Human Eosinophil Section,Fungal Pathogenesis Section,0.0
Human Eosinophil Section,Gene Regulation Section,0.0
Human Eosinophil Section,Genetic Engineering Section,0.0
Human Eosinophil Section,Genetic Immunotherapy Section,0.0
Human Eosinophil Section,HIV Immunovirology Section,0.0
Human Eosinophil Section,HIV Pathogenesis Section,0.0
Human Eosinophil Section,HIV-Specific Immunity Section,0.0
Human Eosinophil Section,Hepatic Pathogenesis Section,0.0
Human Eosinophil Section,Host-Parasite Interactions Section,0.0
Human Eosinophil Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Human Immunological Diseases Section,Allergy and Immunology Clinical Training Program,0.0
Human Immunological Diseases Section,Antibacterial Host Defense Unit,0.0
Human Immunological Diseases Section,Antibody Biology Unit,0.0
Human Immunological Diseases Section,Apicomplexan Molecular Physiology Section,0.0
Human Immunological Diseases Section,Autoimmunity and Functional Genomics Section,0.0
Human Immunological Diseases Section,B-Cell Molecular Immunology Section,0.0
Human Immunological Diseases Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Human Immunological Diseases Section,Bacterial Physiology and Metabolism Unit,0.0
Human Immunological Diseases Section,Barrier Immunity Section,0.0
Human Immunological Diseases Section,Biological Imaging,0.0
Human Immunological Diseases Section,Biology of Vector-Borne Viruses Section,0.0
Human Immunological Diseases Section,Building 14B South,0.0
Human Immunological Diseases Section,Building 33,0.0
Human Immunological Diseases Section,Building 50,0.0
Human Immunological Diseases Section,Building NIHAC/103,0.0
Human Immunological Diseases Section,Buildings 4 and 10/11C127,0.0
Human Immunological Diseases Section,Caliciviruses Section,0.0
Human Immunological Diseases Section,Cell Signaling and Immunity Section,0.0
Human Immunological Diseases Section,Cellular Biology Section,0.0
Human Immunological Diseases Section,Cellular Immunology Section,0.0
Human Immunological Diseases Section,Chemotaxis Signal Section,0.0
Human Immunological Diseases Section,Chlamydial Diseases Section,0.0
Human Immunological Diseases Section,Clinical Microbiome Unit (CMU),0.0
Human Immunological Diseases Section,Clinical Pathophysiology Section,0.0
Human Immunological Diseases Section,Clinical Research Section,0.0
Human Immunological Diseases Section,Clinical and Molecular Retrovirology Section,0.0
Human Immunological Diseases Section,Computational Biology Unit,0.0
Human Immunological Diseases Section,Coxiella Pathogenesis Section,0.0
Human Immunological Diseases Section,DNA Tumor Virus Section,0.0
Human Immunological Diseases Section,Disease Modeling and Transmission Section,0.0
Human Immunological Diseases Section,Emerging Virus Immunity Unit,0.0
Human Immunological Diseases Section,Epidemiology and Population Studies Unit,0.0
Human Immunological Diseases Section,Epithelial Therapeutics Unit,0.0
Human Immunological Diseases Section,Flow Cytometry Section,0.0
Human Immunological Diseases Section,Functional Cellular Networks Section,0.0
Human Immunological Diseases Section,Fungal Pathogenesis Section,0.0
Human Immunological Diseases Section,Genetic Engineering Section,0.0
Human Immunological Diseases Section,Genetic Immunotherapy Section,0.0
Human Immunological Diseases Section,Genomic Technologies Section,0.0
Human Immunological Diseases Section,HIV Immunovirology Section,0.0
Human Immunological Diseases Section,HIV Pathogenesis Section,0.0
Human Immunological Diseases Section,HIV-Specific Immunity Section,0.0
Human Immunological Diseases Section,Helminth Immunology Section,0.0
Human Immunological Diseases Section,Hepatic Pathogenesis Section,0.0
Human Immunological Diseases Section,Host-Parasite Interactions Section,0.0
Human Immunological Diseases Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Human Immunological Diseases Section,Human Eosinophil Section,0.0
Immune Activation Section,Allergy and Immunology Clinical Training Program,0.0
Immune Activation Section,Antibacterial Host Defense Unit,0.0
Immune Activation Section,Antibody Biology Unit,0.0
Immune Activation Section,Apicomplexan Molecular Physiology Section,0.0
Immune Activation Section,Autoimmunity and Functional Genomics Section,0.0
Immune Activation Section,B-Cell Immunology Section,0.0
Immune Activation Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Immune Activation Section,Bacterial Physiology and Metabolism Unit,0.0
Immune Activation Section,Barrier Immunity Section,0.0
Immune Activation Section,Biological Imaging,0.0
Immune Activation Section,Biology of Vector-Borne Viruses Section,0.0
Immune Activation Section,Building 14B South,0.0
Immune Activation Section,Building 33,0.0
Immune Activation Section,Building 50,0.0
Immune Activation Section,Building NIHAC/103,0.0
Immune Activation Section,Buildings 4 and 10/11C127,0.0
Immune Activation Section,Caliciviruses Section,0.0
Immune Activation Section,Cell Signaling and Immunity Section,0.0
Immune Activation Section,Cellular Biology Section,0.0
Immune Activation Section,Cellular Immunology Section,0.0
Immune Activation Section,Chemotaxis Signal Section,0.0
Immune Activation Section,Chlamydial Diseases Section,0.0
Immune Activation Section,Clinical Microbiome Unit (CMU),0.0
Immune Activation Section,Clinical Pathophysiology Section,0.0
Immune Activation Section,Clinical and Molecular Retrovirology Section,0.0
Immune Activation Section,Computational Biology Unit,0.0
Immune Activation Section,Coxiella Pathogenesis Section,0.0
Immune Activation Section,Disease Modeling and Transmission Section,0.0
Immune Activation Section,Emerging Virus Immunity Unit,0.0
Immune Activation Section,Epidemiology and Population Studies Unit,0.0
Immune Activation Section,Epithelial Therapeutics Unit,0.0
Immune Activation Section,Flow Cytometry Section,0.0
Immune Activation Section,Food Allergy Research Section,0.0
Immune Activation Section,Functional Cellular Networks Section,0.0
Immune Activation Section,Gene Regulation Section,0.0
Immune Activation Section,Genetic Engineering Section,0.0
Immune Activation Section,Genomic Technologies Section,0.0
Immune Activation Section,HIV Immunovirology Section,0.0
Immune Activation Section,Helminth Immunology Section,0.0
Immune Activation Section,Hepatic Pathogenesis Section,0.0
Immune Activation Section,Host-Parasite Interactions Section,0.0
Immune Activation Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Immune Activation Section,Human Eosinophil Section,0.0
Immune Activation Section,Human Immunological Diseases Section,0.0
Immune Deficiency Genetics Section,Allergy and Immunology Clinical Training Program,0.0
Immune Deficiency Genetics Section,Antibacterial Host Defense Unit,0.0
Immune Deficiency Genetics Section,Antibody Biology Unit,0.0
Immune Deficiency Genetics Section,Apicomplexan Molecular Physiology Section,0.0
Immune Deficiency Genetics Section,Autoimmunity and Functional Genomics Section,0.0
Immune Deficiency Genetics Section,B-Cell Molecular Immunology Section,0.0
Immune Deficiency Genetics Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Immune Deficiency Genetics Section,Bacterial Physiology and Metabolism Unit,0.0
Immune Deficiency Genetics Section,Barrier Immunity Section,0.0
Immune Deficiency Genetics Section,Biological Imaging,0.0
Immune Deficiency Genetics Section,Biology of Vector-Borne Viruses Section,0.0
Immune Deficiency Genetics Section,Building 14B South,0.0
Immune Deficiency Genetics Section,Building 33,0.0
Immune Deficiency Genetics Section,Building 50,0.0
Immune Deficiency Genetics Section,Building NIHAC/103,0.0
Immune Deficiency Genetics Section,Buildings 4 and 10/11C127,0.0
Immune Deficiency Genetics Section,Caliciviruses Section,0.0
Immune Deficiency Genetics Section,Cellular Biology Section,0.0
Immune Deficiency Genetics Section,Cellular Immunology Section,0.0
Immune Deficiency Genetics Section,Chemotaxis Signal Section,0.0
Immune Deficiency Genetics Section,Chlamydial Diseases Section,0.0
Immune Deficiency Genetics Section,Clinical Microbiome Unit (CMU),0.0
Immune Deficiency Genetics Section,Clinical Pathophysiology Section,0.0
Immune Deficiency Genetics Section,Clinical Research Section,0.0
Immune Deficiency Genetics Section,Clinical and Molecular Retrovirology Section,0.0
Immune Deficiency Genetics Section,Computational Biology Unit,0.0
Immune Deficiency Genetics Section,Coxiella Pathogenesis Section,0.0
Immune Deficiency Genetics Section,DNA Tumor Virus Section,0.0
Immune Deficiency Genetics Section,Disease Modeling and Transmission Section,0.0
Immune Deficiency Genetics Section,Emerging Virus Immunity Unit,0.0
Immune Deficiency Genetics Section,Epidemiology and Population Studies Unit,0.0
Immune Deficiency Genetics Section,Epithelial Therapeutics Unit,0.0
Immune Deficiency Genetics Section,Flow Cytometry Section,0.0
Immune Deficiency Genetics Section,Food Allergy Research Section,0.0
Immune Deficiency Genetics Section,Functional Cellular Networks Section,0.0
Immune Deficiency Genetics Section,Fungal Pathogenesis Section,0.0
Immune Deficiency Genetics Section,Gene Regulation Section,0.0
Immune Deficiency Genetics Section,Genetic Engineering Section,0.0
Immune Deficiency Genetics Section,Genomic Technologies Section,0.0
Immune Deficiency Genetics Section,HIV Immunovirology Section,0.0
Immune Deficiency Genetics Section,HIV Pathogenesis Section,0.0
Immune Deficiency Genetics Section,HIV-Specific Immunity Section,0.0
Immune Deficiency Genetics Section,Helminth Immunology Section,0.0
Immune Deficiency Genetics Section,Hepatic Pathogenesis Section,0.0
Immune Deficiency Genetics Section,Host-Parasite Interactions Section,0.0
Immune Deficiency Genetics Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Immune Deficiency Genetics Section,Immune Activation Section,0.0
Immunity to Pulmonary Pathogens Section,Allergy and Immunology Clinical Training Program,0.0
Immunity to Pulmonary Pathogens Section,Antibacterial Host Defense Unit,0.0
Immunity to Pulmonary Pathogens Section,Antibody Biology Unit,0.0
Immunity to Pulmonary Pathogens Section,Apicomplexan Molecular Physiology Section,0.0
Immunity to Pulmonary Pathogens Section,Autoimmunity and Functional Genomics Section,0.0
Immunity to Pulmonary Pathogens Section,B-Cell Immunology Section,0.0
Immunity to Pulmonary Pathogens Section,B-Cell Molecular Immunology Section,0.0
Immunity to Pulmonary Pathogens Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Immunity to Pulmonary Pathogens Section,Bacterial Physiology and Metabolism Unit,0.0
Immunity to Pulmonary Pathogens Section,Barrier Immunity Section,0.0
Immunity to Pulmonary Pathogens Section,Biological Imaging,0.0
Immunity to Pulmonary Pathogens Section,Biology of Vector-Borne Viruses Section,0.0
Immunity to Pulmonary Pathogens Section,Building 14B South,0.0
Immunity to Pulmonary Pathogens Section,Building 33,0.0
Immunity to Pulmonary Pathogens Section,Building 50,0.0
Immunity to Pulmonary Pathogens Section,Building NIHAC/103,0.0
Immunity to Pulmonary Pathogens Section,Buildings 4 and 10/11C127,0.0
Immunity to Pulmonary Pathogens Section,Caliciviruses Section,0.0
Immunity to Pulmonary Pathogens Section,Cell Signaling and Immunity Section,0.0
Immunity to Pulmonary Pathogens Section,Cellular Biology Section,0.0
Immunity to Pulmonary Pathogens Section,Cellular Immunology Section,0.0
Immunity to Pulmonary Pathogens Section,Chemotaxis Signal Section,0.0
Immunity to Pulmonary Pathogens Section,Chlamydial Diseases Section,0.0
Immunity to Pulmonary Pathogens Section,Clinical Microbiome Unit (CMU),0.0
Immunity to Pulmonary Pathogens Section,Clinical Pathophysiology Section,0.0
Immunity to Pulmonary Pathogens Section,Clinical Research Section,0.0
Immunity to Pulmonary Pathogens Section,Clinical and Molecular Retrovirology Section,0.0
Immunity to Pulmonary Pathogens Section,Computational Biology Unit,0.0
Immunity to Pulmonary Pathogens Section,Coxiella Pathogenesis Section,0.0
Immunity to Pulmonary Pathogens Section,DNA Tumor Virus Section,0.0
Immunity to Pulmonary Pathogens Section,Emerging Respiratory Viruses Section,0.0
Immunity to Pulmonary Pathogens Section,Emerging Virus Immunity Unit,0.0
Immunity to Pulmonary Pathogens Section,Epidemiology and Population Studies Unit,0.0
Immunity to Pulmonary Pathogens Section,Epithelial Therapeutics Unit,0.0
Immunity to Pulmonary Pathogens Section,Flow Cytometry Section,0.0
Immunity to Pulmonary Pathogens Section,Food Allergy Research Section,0.0
Immunity to Pulmonary Pathogens Section,Functional Cellular Networks Section,0.0
Immunity to Pulmonary Pathogens Section,Fungal Pathogenesis Section,0.0
Immunity to Pulmonary Pathogens Section,Genetic Engineering Section,0.0
Immunity to Pulmonary Pathogens Section,Genetic Immunotherapy Section,0.0
Immunity to Pulmonary Pathogens Section,Genomic Technologies Section,0.0
Immunity to Pulmonary Pathogens Section,HIV Immunovirology Section,0.0
Immunity to Pulmonary Pathogens Section,HIV Pathogenesis Section,0.0
Immunity to Pulmonary Pathogens Section,HIV-Specific Immunity Section,0.0
Immunity to Pulmonary Pathogens Section,Helminth Immunology Section,0.0
Immunity to Pulmonary Pathogens Section,Hepatic Pathogenesis Section,0.0
Immunity to Pulmonary Pathogens Section,Host-Parasite Interactions Section,0.0
Immunity to Pulmonary Pathogens Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Immunity to Pulmonary Pathogens Section,Human Eosinophil Section,0.0
Immunity to Pulmonary Pathogens Section,Human Immunological Diseases Section,0.0
Immunity to Pulmonary Pathogens Section,Immune Activation Section,0.0
Immunity to Pulmonary Pathogens Section,Immune Deficiency Genetics Section,0.0
Immunobiology Section,Allergy and Immunology Clinical Training Program,0.0
Immunobiology Section,Antibacterial Host Defense Unit,0.0
Immunobiology Section,Antibody Biology Unit,0.0
Immunobiology Section,Apicomplexan Molecular Physiology Section,0.0
Immunobiology Section,Autoimmunity and Functional Genomics Section,0.0
Immunobiology Section,B-Cell Immunology Section,0.0
Immunobiology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Immunobiology Section,Bacterial Physiology and Metabolism Unit,0.0
Immunobiology Section,Barrier Immunity Section,0.0
Immunobiology Section,Biological Imaging,0.0
Immunobiology Section,Biology of Vector-Borne Viruses Section,0.0
Immunobiology Section,Building 14B South,0.0
Immunobiology Section,Building 50,0.0
Immunobiology Section,Building NIHAC/103,0.0
Immunobiology Section,Buildings 4 and 10/11C127,0.0
Immunobiology Section,Caliciviruses Section,0.0
Immunobiology Section,Cellular Biology Section,0.0
Immunobiology Section,Chemotaxis Signal Section,0.0
Immunobiology Section,Chlamydial Diseases Section,0.0
Immunobiology Section,Clinical Microbiome Unit (CMU),0.0
Immunobiology Section,Clinical Pathophysiology Section,0.0
Immunobiology Section,Clinical Research Section,0.0
Immunobiology Section,Clinical and Molecular Retrovirology Section,0.0
Immunobiology Section,Computational Biology Unit,0.0
Immunobiology Section,Coxiella Pathogenesis Section,0.0
Immunobiology Section,DNA Tumor Virus Section,0.0
Immunobiology Section,Disease Modeling and Transmission Section,0.0
Immunobiology Section,Emerging Respiratory Viruses Section,0.0
Immunobiology Section,Emerging Virus Immunity Unit,0.0
Immunobiology Section,Epidemiology and Population Studies Unit,0.0
Immunobiology Section,Epithelial Therapeutics Unit,0.0
Immunobiology Section,Flow Cytometry Section,0.0
Immunobiology Section,Functional Cellular Networks Section,0.0
Immunobiology Section,Fungal Pathogenesis Section,0.0
Immunobiology Section,Gene Regulation Section,0.0
Immunobiology Section,Genetic Engineering Section,0.0
Immunobiology Section,Genetic Immunotherapy Section,0.0
Immunobiology Section,HIV Immunovirology Section,0.0
Immunobiology Section,HIV-Specific Immunity Section,0.0
Immunobiology Section,Hepatic Pathogenesis Section,0.0
Immunobiology Section,Host-Parasite Interactions Section,0.0
Immunobiology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Immunobiology Section,Human Eosinophil Section,0.0
Immunobiology Section,Human Immunological Diseases Section,0.0
Immunobiology Section,Immune Activation Section,0.0
Immunobiology Section,Immune Deficiency Genetics Section,0.0
Immunobiology Section,Immunity to Pulmonary Pathogens Section,0.0
Immunobiology and Molecular Virology Unit,Allergy and Immunology Clinical Training Program,0.0
Immunobiology and Molecular Virology Unit,Antibacterial Host Defense Unit,0.0
Immunobiology and Molecular Virology Unit,Antibody Biology Unit,0.0
Immunobiology and Molecular Virology Unit,Apicomplexan Molecular Physiology Section,0.0
Immunobiology and Molecular Virology Unit,Autoimmunity and Functional Genomics Section,0.0
Immunobiology and Molecular Virology Unit,B-Cell Immunology Section,0.0
Immunobiology and Molecular Virology Unit,B-Cell Molecular Immunology Section,0.0
Immunobiology and Molecular Virology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Immunobiology and Molecular Virology Unit,Bacterial Physiology and Metabolism Unit,0.0
Immunobiology and Molecular Virology Unit,Barrier Immunity Section,0.0
Immunobiology and Molecular Virology Unit,Biological Imaging,0.0
Immunobiology and Molecular Virology Unit,Biology of Vector-Borne Viruses Section,0.0
Immunobiology and Molecular Virology Unit,Building 14B South,0.0
Immunobiology and Molecular Virology Unit,Building 33,0.0
Immunobiology and Molecular Virology Unit,Building 50,0.0
Immunobiology and Molecular Virology Unit,Building NIHAC/103,0.0
Immunobiology and Molecular Virology Unit,Buildings 4 and 10/11C127,0.0
Immunobiology and Molecular Virology Unit,Caliciviruses Section,0.0
Immunobiology and Molecular Virology Unit,Cell Signaling and Immunity Section,0.0
Immunobiology and Molecular Virology Unit,Cellular Biology Section,0.0
Immunobiology and Molecular Virology Unit,Cellular Immunology Section,0.0
Immunobiology and Molecular Virology Unit,Chemotaxis Signal Section,0.0
Immunobiology and Molecular Virology Unit,Chlamydial Diseases Section,0.0
Immunobiology and Molecular Virology Unit,Clinical Microbiome Unit (CMU),0.0
Immunobiology and Molecular Virology Unit,Clinical Pathophysiology Section,0.0
Immunobiology and Molecular Virology Unit,Clinical Research Section,0.0
Immunobiology and Molecular Virology Unit,Clinical and Molecular Retrovirology Section,0.0
Immunobiology and Molecular Virology Unit,Computational Biology Unit,0.0
Immunobiology and Molecular Virology Unit,Coxiella Pathogenesis Section,0.0
Immunobiology and Molecular Virology Unit,DNA Tumor Virus Section,0.0
Immunobiology and Molecular Virology Unit,Emerging Respiratory Viruses Section,0.0
Immunobiology and Molecular Virology Unit,Emerging Virus Immunity Unit,0.0
Immunobiology and Molecular Virology Unit,Epidemiology and Population Studies Unit,0.0
Immunobiology and Molecular Virology Unit,Epithelial Therapeutics Unit,0.0
Immunobiology and Molecular Virology Unit,Flow Cytometry Section,0.0
Immunobiology and Molecular Virology Unit,Food Allergy Research Section,0.0
Immunobiology and Molecular Virology Unit,Functional Cellular Networks Section,0.0
Immunobiology and Molecular Virology Unit,Fungal Pathogenesis Section,0.0
Immunobiology and Molecular Virology Unit,Gene Regulation Section,0.0
Immunobiology and Molecular Virology Unit,Genetic Engineering Section,0.0
Immunobiology and Molecular Virology Unit,Genetic Immunotherapy Section,0.0
Immunobiology and Molecular Virology Unit,Genomic Technologies Section,0.0
Immunobiology and Molecular Virology Unit,HIV Immunovirology Section,0.0
Immunobiology and Molecular Virology Unit,HIV Pathogenesis Section,0.0
Immunobiology and Molecular Virology Unit,HIV-Specific Immunity Section,0.0
Immunobiology and Molecular Virology Unit,Helminth Immunology Section,0.0
Immunobiology and Molecular Virology Unit,Hepatic Pathogenesis Section,0.0
Immunobiology and Molecular Virology Unit,Host-Parasite Interactions Section,0.0
Immunobiology and Molecular Virology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Immunobiology and Molecular Virology Unit,Human Eosinophil Section,0.0
Immunobiology and Molecular Virology Unit,Human Immunological Diseases Section,0.0
Immunobiology and Molecular Virology Unit,Immune Activation Section,0.0
Immunobiology and Molecular Virology Unit,Immune Deficiency Genetics Section,0.0
Immunobiology and Molecular Virology Unit,Immunity to Pulmonary Pathogens Section,0.0
Immunobiology and Molecular Virology Unit,Immunobiology Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Allergy and Immunology Clinical Training Program,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Antibacterial Host Defense Unit,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Antibody Biology Unit,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Apicomplexan Molecular Physiology Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Autoimmunity and Functional Genomics Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),B-Cell Molecular Immunology Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Bacterial Physiology and Metabolism Unit,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Biology of Vector-Borne Viruses Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Building 14B South,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Building 33,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Building 50,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Building NIHAC/103,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Buildings 4 and 10/11C127,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Cellular Biology Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Chemotaxis Signal Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Chlamydial Diseases Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Clinical Microbiome Unit (CMU),0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Clinical Research Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Clinical and Molecular Retrovirology Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Computational Biology Unit,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Coxiella Pathogenesis Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),DNA Tumor Virus Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Disease Modeling and Transmission Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Emerging Virus Immunity Unit,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Flow Cytometry Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Food Allergy Research Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Functional Cellular Networks Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Gene Regulation Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Genetic Engineering Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),HIV Immunovirology Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),HIV-Specific Immunity Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Hepatic Pathogenesis Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Host-Parasite Interactions Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Immune Activation Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Immunity to Pulmonary Pathogens Section,0.0
Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),Immunobiology and Molecular Virology Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Allergy and Immunology Clinical Training Program,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Antibacterial Host Defense Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Antibody Biology Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Apicomplexan Molecular Physiology Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Autoimmunity and Functional Genomics Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Bacterial Physiology and Metabolism Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Biological Imaging,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Building 14B South,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Building 33,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Building 50,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Building NIHAC/103,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Buildings 4 and 10/11C127,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Caliciviruses Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Cell Signaling and Immunity Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Cellular Biology Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Cellular Immunology Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Chemotaxis Signal Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Chlamydial Diseases Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Clinical Microbiome Unit (CMU),0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Computational Biology Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Coxiella Pathogenesis Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),DNA Tumor Virus Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Disease Modeling and Transmission Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Emerging Virus Immunity Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Epidemiology and Population Studies Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Epithelial Therapeutics Unit,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Flow Cytometry Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Food Allergy Research Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Functional Cellular Networks Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Fungal Pathogenesis Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Gene Regulation Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Genetic Engineering Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Genomic Technologies Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Hepatic Pathogenesis Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Host-Parasite Interactions Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Human Eosinophil Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Human Immunological Diseases Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Immune Activation Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Immune Deficiency Genetics Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Immunity to Pulmonary Pathogens Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Immunobiology Section,0.0
Immunopathogenesis Section (Laboratory of Immunoregulation),Immunobiology and Molecular Virology Unit,0.0
Infectious Disease Fellowship Training Program,Allergy and Immunology Clinical Training Program,0.0
Infectious Disease Fellowship Training Program,Antibacterial Host Defense Unit,0.0
Infectious Disease Fellowship Training Program,Antibody Biology Unit,0.0
Infectious Disease Fellowship Training Program,Apicomplexan Molecular Physiology Section,0.0
Infectious Disease Fellowship Training Program,Autoimmunity and Functional Genomics Section,0.0
Infectious Disease Fellowship Training Program,B-Cell Immunology Section,0.0
Infectious Disease Fellowship Training Program,B-Cell Molecular Immunology Section,0.0
Infectious Disease Fellowship Training Program,Bacterial Physiology and Metabolism Unit,0.0
Infectious Disease Fellowship Training Program,Barrier Immunity Section,0.0
Infectious Disease Fellowship Training Program,Biological Imaging,0.0
Infectious Disease Fellowship Training Program,Biology of Vector-Borne Viruses Section,0.0
Infectious Disease Fellowship Training Program,Building 14B South,0.0
Infectious Disease Fellowship Training Program,Building 33,0.0
Infectious Disease Fellowship Training Program,Building 50,0.0
Infectious Disease Fellowship Training Program,Building NIHAC/103,0.0
Infectious Disease Fellowship Training Program,Buildings 4 and 10/11C127,0.0
Infectious Disease Fellowship Training Program,Caliciviruses Section,0.0
Infectious Disease Fellowship Training Program,Cell Signaling and Immunity Section,0.0
Infectious Disease Fellowship Training Program,Cellular Biology Section,0.0
Infectious Disease Fellowship Training Program,Cellular Immunology Section,0.0
Infectious Disease Fellowship Training Program,Chemotaxis Signal Section,0.0
Infectious Disease Fellowship Training Program,Chlamydial Diseases Section,0.0
Infectious Disease Fellowship Training Program,Clinical Microbiome Unit (CMU),0.0
Infectious Disease Fellowship Training Program,Clinical Pathophysiology Section,0.0
Infectious Disease Fellowship Training Program,Computational Biology Unit,0.0
Infectious Disease Fellowship Training Program,Coxiella Pathogenesis Section,0.0
Infectious Disease Fellowship Training Program,DNA Tumor Virus Section,0.0
Infectious Disease Fellowship Training Program,Disease Modeling and Transmission Section,0.0
Infectious Disease Fellowship Training Program,Emerging Respiratory Viruses Section,0.0
Infectious Disease Fellowship Training Program,Emerging Virus Immunity Unit,0.0
Infectious Disease Fellowship Training Program,Epidemiology and Population Studies Unit,0.0
Infectious Disease Fellowship Training Program,Epithelial Therapeutics Unit,0.0
Infectious Disease Fellowship Training Program,Flow Cytometry Section,0.0
Infectious Disease Fellowship Training Program,Food Allergy Research Section,0.0
Infectious Disease Fellowship Training Program,Functional Cellular Networks Section,0.0
Infectious Disease Fellowship Training Program,Gene Regulation Section,0.0
Infectious Disease Fellowship Training Program,Genetic Engineering Section,0.0
Infectious Disease Fellowship Training Program,Genetic Immunotherapy Section,0.0
Infectious Disease Fellowship Training Program,HIV Immunovirology Section,0.0
Infectious Disease Fellowship Training Program,HIV-Specific Immunity Section,0.0
Infectious Disease Fellowship Training Program,Helminth Immunology Section,0.0
Infectious Disease Fellowship Training Program,Hepatic Pathogenesis Section,0.0
Infectious Disease Fellowship Training Program,Host-Parasite Interactions Section,0.0
Infectious Disease Fellowship Training Program,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Infectious Disease Fellowship Training Program,Human Eosinophil Section,0.0
Infectious Disease Fellowship Training Program,Human Immunological Diseases Section,0.0
Infectious Disease Fellowship Training Program,Immune Activation Section,0.0
Infectious Disease Fellowship Training Program,Immune Deficiency Genetics Section,0.0
Infectious Disease Fellowship Training Program,Immunity to Pulmonary Pathogens Section,0.0
Infectious Disease Fellowship Training Program,Immunobiology Section,0.0
Infectious Disease Fellowship Training Program,Immunobiology and Molecular Virology Unit,0.0
Infectious Disease Fellowship Training Program,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Infectious Disease Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
Infectious Disease Pathogenesis Section,Antibacterial Host Defense Unit,0.0
Infectious Disease Pathogenesis Section,Antibody Biology Unit,0.0
Infectious Disease Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
Infectious Disease Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
Infectious Disease Pathogenesis Section,B-Cell Immunology Section,0.0
Infectious Disease Pathogenesis Section,B-Cell Molecular Immunology Section,0.0
Infectious Disease Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Infectious Disease Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
Infectious Disease Pathogenesis Section,Barrier Immunity Section,0.0
Infectious Disease Pathogenesis Section,Biological Imaging,0.0
Infectious Disease Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.0
Infectious Disease Pathogenesis Section,Building 14B South,0.0
Infectious Disease Pathogenesis Section,Building 50,0.0
Infectious Disease Pathogenesis Section,Building NIHAC/103,0.0
Infectious Disease Pathogenesis Section,Buildings 4 and 10/11C127,0.0
Infectious Disease Pathogenesis Section,Caliciviruses Section,0.0
Infectious Disease Pathogenesis Section,Cell Signaling and Immunity Section,0.0
Infectious Disease Pathogenesis Section,Cellular Biology Section,0.0
Infectious Disease Pathogenesis Section,Cellular Immunology Section,0.0
Infectious Disease Pathogenesis Section,Chemotaxis Signal Section,0.0
Infectious Disease Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
Infectious Disease Pathogenesis Section,Clinical Research Section,0.0
Infectious Disease Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.0
Infectious Disease Pathogenesis Section,Computational Biology Unit,0.0
Infectious Disease Pathogenesis Section,Coxiella Pathogenesis Section,0.0
Infectious Disease Pathogenesis Section,DNA Tumor Virus Section,0.0
Infectious Disease Pathogenesis Section,Disease Modeling and Transmission Section,0.0
Infectious Disease Pathogenesis Section,Emerging Respiratory Viruses Section,0.0
Infectious Disease Pathogenesis Section,Emerging Virus Immunity Unit,0.0
Infectious Disease Pathogenesis Section,Epidemiology and Population Studies Unit,0.0
Infectious Disease Pathogenesis Section,Flow Cytometry Section,0.0
Infectious Disease Pathogenesis Section,Food Allergy Research Section,0.0
Infectious Disease Pathogenesis Section,Functional Cellular Networks Section,0.0
Infectious Disease Pathogenesis Section,Fungal Pathogenesis Section,0.0
Infectious Disease Pathogenesis Section,Gene Regulation Section,0.0
Infectious Disease Pathogenesis Section,Genetic Immunotherapy Section,0.0
Infectious Disease Pathogenesis Section,HIV Immunovirology Section,0.0
Infectious Disease Pathogenesis Section,HIV Pathogenesis Section,0.0
Infectious Disease Pathogenesis Section,HIV-Specific Immunity Section,0.0
Infectious Disease Pathogenesis Section,Helminth Immunology Section,0.0
Infectious Disease Pathogenesis Section,Host-Parasite Interactions Section,0.0
Infectious Disease Pathogenesis Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Infectious Disease Pathogenesis Section,Human Eosinophil Section,0.0
Infectious Disease Pathogenesis Section,Human Immunological Diseases Section,0.0
Infectious Disease Pathogenesis Section,Immune Activation Section,0.0
Infectious Disease Pathogenesis Section,Immune Deficiency Genetics Section,0.0
Infectious Disease Pathogenesis Section,Immunity to Pulmonary Pathogens Section,0.0
Infectious Disease Pathogenesis Section,Immunobiology and Molecular Virology Unit,0.0
Infectious Disease Pathogenesis Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Infectious Disease Pathogenesis Section,Infectious Disease Fellowship Training Program,0.0
Inflammation & Innate Immunity Unit,Allergy and Immunology Clinical Training Program,0.0
Inflammation & Innate Immunity Unit,Antibacterial Host Defense Unit,0.0
Inflammation & Innate Immunity Unit,Antibody Biology Unit,0.0
Inflammation & Innate Immunity Unit,Apicomplexan Molecular Physiology Section,0.0
Inflammation & Innate Immunity Unit,Autoimmunity and Functional Genomics Section,0.0
Inflammation & Innate Immunity Unit,B-Cell Immunology Section,0.0
Inflammation & Innate Immunity Unit,B-Cell Molecular Immunology Section,0.0
Inflammation & Innate Immunity Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Inflammation & Innate Immunity Unit,Bacterial Physiology and Metabolism Unit,0.0
Inflammation & Innate Immunity Unit,Barrier Immunity Section,0.0
Inflammation & Innate Immunity Unit,Biological Imaging,0.0
Inflammation & Innate Immunity Unit,Biology of Vector-Borne Viruses Section,0.0
Inflammation & Innate Immunity Unit,Building 14B South,0.0
Inflammation & Innate Immunity Unit,Building 33,0.0
Inflammation & Innate Immunity Unit,Building 50,0.0
Inflammation & Innate Immunity Unit,Building NIHAC/103,0.0
Inflammation & Innate Immunity Unit,Buildings 4 and 10/11C127,0.0
Inflammation & Innate Immunity Unit,Caliciviruses Section,0.0
Inflammation & Innate Immunity Unit,Cell Signaling and Immunity Section,0.0
Inflammation & Innate Immunity Unit,Cellular Biology Section,0.0
Inflammation & Innate Immunity Unit,Cellular Immunology Section,0.0
Inflammation & Innate Immunity Unit,Chemotaxis Signal Section,0.0
Inflammation & Innate Immunity Unit,Chlamydial Diseases Section,0.0
Inflammation & Innate Immunity Unit,Clinical Microbiome Unit (CMU),0.0
Inflammation & Innate Immunity Unit,Clinical Pathophysiology Section,0.0
Inflammation & Innate Immunity Unit,Clinical Research Section,0.0
Inflammation & Innate Immunity Unit,Clinical and Molecular Retrovirology Section,0.0
Inflammation & Innate Immunity Unit,Computational Biology Unit,0.0
Inflammation & Innate Immunity Unit,Coxiella Pathogenesis Section,0.0
Inflammation & Innate Immunity Unit,DNA Tumor Virus Section,0.0
Inflammation & Innate Immunity Unit,Disease Modeling and Transmission Section,0.0
Inflammation & Innate Immunity Unit,Emerging Respiratory Viruses Section,0.0
Inflammation & Innate Immunity Unit,Emerging Virus Immunity Unit,0.0
Inflammation & Innate Immunity Unit,Epidemiology and Population Studies Unit,0.0
Inflammation & Innate Immunity Unit,Epithelial Therapeutics Unit,0.0
Inflammation & Innate Immunity Unit,Flow Cytometry Section,0.0
Inflammation & Innate Immunity Unit,Food Allergy Research Section,0.0
Inflammation & Innate Immunity Unit,Functional Cellular Networks Section,0.0
Inflammation & Innate Immunity Unit,Gene Regulation Section,0.0
Inflammation & Innate Immunity Unit,Genetic Engineering Section,0.0
Inflammation & Innate Immunity Unit,Genetic Immunotherapy Section,0.0
Inflammation & Innate Immunity Unit,HIV Immunovirology Section,0.0
Inflammation & Innate Immunity Unit,HIV-Specific Immunity Section,0.0
Inflammation & Innate Immunity Unit,Hepatic Pathogenesis Section,0.0
Inflammation & Innate Immunity Unit,Host-Parasite Interactions Section,0.0
Inflammation & Innate Immunity Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Inflammation & Innate Immunity Unit,Human Eosinophil Section,0.0
Inflammation & Innate Immunity Unit,Human Immunological Diseases Section,0.0
Inflammation & Innate Immunity Unit,Immune Activation Section,0.0
Inflammation & Innate Immunity Unit,Immune Deficiency Genetics Section,0.0
Inflammation & Innate Immunity Unit,Immunity to Pulmonary Pathogens Section,0.0
Inflammation & Innate Immunity Unit,Immunobiology and Molecular Virology Unit,0.0
Inflammation & Innate Immunity Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Inflammation & Innate Immunity Unit,Infectious Disease Fellowship Training Program,0.0
Inflammation & Innate Immunity Unit,Infectious Disease Pathogenesis Section,0.0
Inflammation Biology Section,Allergy and Immunology Clinical Training Program,0.0
Inflammation Biology Section,Antibacterial Host Defense Unit,0.0
Inflammation Biology Section,Antibody Biology Unit,0.0
Inflammation Biology Section,Apicomplexan Molecular Physiology Section,0.0
Inflammation Biology Section,Autoimmunity and Functional Genomics Section,0.0
Inflammation Biology Section,B-Cell Immunology Section,0.0
Inflammation Biology Section,B-Cell Molecular Immunology Section,0.0
Inflammation Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Inflammation Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Inflammation Biology Section,Barrier Immunity Section,0.0
Inflammation Biology Section,Biological Imaging,0.0
Inflammation Biology Section,Biology of Vector-Borne Viruses Section,0.0
Inflammation Biology Section,Building 14B South,0.0
Inflammation Biology Section,Building 33,0.0
Inflammation Biology Section,Building 50,0.0
Inflammation Biology Section,Building NIHAC/103,0.0
Inflammation Biology Section,Buildings 4 and 10/11C127,0.0
Inflammation Biology Section,Caliciviruses Section,0.0
Inflammation Biology Section,Cell Signaling and Immunity Section,0.0
Inflammation Biology Section,Cellular Biology Section,0.0
Inflammation Biology Section,Cellular Immunology Section,0.0
Inflammation Biology Section,Chemotaxis Signal Section,0.0
Inflammation Biology Section,Chlamydial Diseases Section,0.0
Inflammation Biology Section,Clinical Microbiome Unit (CMU),0.0
Inflammation Biology Section,Clinical Pathophysiology Section,0.0
Inflammation Biology Section,Clinical Research Section,0.0
Inflammation Biology Section,Clinical and Molecular Retrovirology Section,0.0
Inflammation Biology Section,Computational Biology Unit,0.0
Inflammation Biology Section,Coxiella Pathogenesis Section,0.0
Inflammation Biology Section,DNA Tumor Virus Section,0.0
Inflammation Biology Section,Disease Modeling and Transmission Section,0.0
Inflammation Biology Section,Emerging Respiratory Viruses Section,0.0
Inflammation Biology Section,Emerging Virus Immunity Unit,0.0
Inflammation Biology Section,Epidemiology and Population Studies Unit,0.0
Inflammation Biology Section,Epithelial Therapeutics Unit,0.0
Inflammation Biology Section,Flow Cytometry Section,0.0
Inflammation Biology Section,Food Allergy Research Section,0.0
Inflammation Biology Section,Functional Cellular Networks Section,0.0
Inflammation Biology Section,Gene Regulation Section,0.0
Inflammation Biology Section,Genetic Engineering Section,0.0
Inflammation Biology Section,Genetic Immunotherapy Section,0.0
Inflammation Biology Section,HIV Immunovirology Section,0.0
Inflammation Biology Section,HIV Pathogenesis Section,0.0
Inflammation Biology Section,HIV-Specific Immunity Section,0.0
Inflammation Biology Section,Helminth Immunology Section,0.0
Inflammation Biology Section,Hepatic Pathogenesis Section,0.0
Inflammation Biology Section,Host-Parasite Interactions Section,0.0
Inflammation Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Inflammation Biology Section,Human Eosinophil Section,0.0
Inflammation Biology Section,Human Immunological Diseases Section,0.0
Inflammation Biology Section,Immune Deficiency Genetics Section,0.0
Inflammation Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Inflammation Biology Section,Immunobiology Section,0.0
Inflammation Biology Section,Immunobiology and Molecular Virology Unit,0.0
Inflammation Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Inflammation Biology Section,Infectious Disease Fellowship Training Program,0.0
Inflammation Biology Section,Infectious Disease Pathogenesis Section,0.0
Inflammation Biology Section,Inflammation & Innate Immunity Unit,0.0
Innate Immunity and Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
Innate Immunity and Pathogenesis Section,Antibacterial Host Defense Unit,0.0
Innate Immunity and Pathogenesis Section,Antibody Biology Unit,0.0
Innate Immunity and Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
Innate Immunity and Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
Innate Immunity and Pathogenesis Section,B-Cell Immunology Section,0.0
Innate Immunity and Pathogenesis Section,B-Cell Molecular Immunology Section,0.0
Innate Immunity and Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Innate Immunity and Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
Innate Immunity and Pathogenesis Section,Barrier Immunity Section,0.0
Innate Immunity and Pathogenesis Section,Biological Imaging,0.0
Innate Immunity and Pathogenesis Section,Building 14B South,0.0
Innate Immunity and Pathogenesis Section,Building 33,0.0
Innate Immunity and Pathogenesis Section,Building 50,0.0
Innate Immunity and Pathogenesis Section,Building NIHAC/103,0.0
Innate Immunity and Pathogenesis Section,Buildings 4 and 10/11C127,0.0
Innate Immunity and Pathogenesis Section,Caliciviruses Section,0.0
Innate Immunity and Pathogenesis Section,Cell Signaling and Immunity Section,0.0
Innate Immunity and Pathogenesis Section,Cellular Biology Section,0.0
Innate Immunity and Pathogenesis Section,Cellular Immunology Section,0.0
Innate Immunity and Pathogenesis Section,Chemotaxis Signal Section,0.0
Innate Immunity and Pathogenesis Section,Chlamydial Diseases Section,0.0
Innate Immunity and Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
Innate Immunity and Pathogenesis Section,Clinical Pathophysiology Section,0.0
Innate Immunity and Pathogenesis Section,Clinical Research Section,0.0
Innate Immunity and Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.0
Innate Immunity and Pathogenesis Section,Computational Biology Unit,0.0
Innate Immunity and Pathogenesis Section,Coxiella Pathogenesis Section,0.0
Innate Immunity and Pathogenesis Section,DNA Tumor Virus Section,0.0
Innate Immunity and Pathogenesis Section,Emerging Respiratory Viruses Section,0.0
Innate Immunity and Pathogenesis Section,Emerging Virus Immunity Unit,0.0
Innate Immunity and Pathogenesis Section,Epidemiology and Population Studies Unit,0.0
Innate Immunity and Pathogenesis Section,Epithelial Therapeutics Unit,0.0
Innate Immunity and Pathogenesis Section,Flow Cytometry Section,0.0
Innate Immunity and Pathogenesis Section,Food Allergy Research Section,0.0
Innate Immunity and Pathogenesis Section,Functional Cellular Networks Section,0.0
Innate Immunity and Pathogenesis Section,Fungal Pathogenesis Section,0.0
Innate Immunity and Pathogenesis Section,Gene Regulation Section,0.0
Innate Immunity and Pathogenesis Section,Genetic Engineering Section,0.0
Innate Immunity and Pathogenesis Section,Genetic Immunotherapy Section,0.0
Innate Immunity and Pathogenesis Section,HIV Immunovirology Section,0.0
Innate Immunity and Pathogenesis Section,HIV Pathogenesis Section,0.0
Innate Immunity and Pathogenesis Section,HIV-Specific Immunity Section,0.0
Innate Immunity and Pathogenesis Section,Helminth Immunology Section,0.0
Innate Immunity and Pathogenesis Section,Hepatic Pathogenesis Section,0.0
Innate Immunity and Pathogenesis Section,Host-Parasite Interactions Section,0.0
Innate Immunity and Pathogenesis Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Innate Immunity and Pathogenesis Section,Human Eosinophil Section,0.0
Innate Immunity and Pathogenesis Section,Human Immunological Diseases Section,0.0
Innate Immunity and Pathogenesis Section,Immune Activation Section,0.0
Innate Immunity and Pathogenesis Section,Immune Deficiency Genetics Section,0.0
Innate Immunity and Pathogenesis Section,Immunobiology Section,0.0
Innate Immunity and Pathogenesis Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Innate Immunity and Pathogenesis Section,Infectious Disease Fellowship Training Program,0.0
Innate Immunity and Pathogenesis Section,Infectious Disease Pathogenesis Section,0.0
Innate Immunity and Pathogenesis Section,Inflammation & Innate Immunity Unit,0.0
Innate Immunity and Pathogenesis Section,Inflammation Biology Section,0.0
Integrative Immunobiology Section,Allergy and Immunology Clinical Training Program,0.0
Integrative Immunobiology Section,Antibacterial Host Defense Unit,0.0
Integrative Immunobiology Section,Antibody Biology Unit,0.0
Integrative Immunobiology Section,Apicomplexan Molecular Physiology Section,0.0
Integrative Immunobiology Section,Autoimmunity and Functional Genomics Section,0.0
Integrative Immunobiology Section,B-Cell Immunology Section,0.0
Integrative Immunobiology Section,B-Cell Molecular Immunology Section,0.0
Integrative Immunobiology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Integrative Immunobiology Section,Bacterial Physiology and Metabolism Unit,0.0
Integrative Immunobiology Section,Barrier Immunity Section,0.0
Integrative Immunobiology Section,Biological Imaging,0.0
Integrative Immunobiology Section,Biology of Vector-Borne Viruses Section,0.0
Integrative Immunobiology Section,Building 14B South,0.0
Integrative Immunobiology Section,Building 33,0.0
Integrative Immunobiology Section,Building 50,0.0
Integrative Immunobiology Section,Building NIHAC/103,0.0
Integrative Immunobiology Section,Buildings 4 and 10/11C127,0.0
Integrative Immunobiology Section,Caliciviruses Section,0.0
Integrative Immunobiology Section,Cellular Biology Section,0.0
Integrative Immunobiology Section,Chemotaxis Signal Section,0.0
Integrative Immunobiology Section,Chlamydial Diseases Section,0.0
Integrative Immunobiology Section,Clinical Microbiome Unit (CMU),0.0
Integrative Immunobiology Section,Clinical Pathophysiology Section,0.0
Integrative Immunobiology Section,Clinical Research Section,0.0
Integrative Immunobiology Section,Clinical and Molecular Retrovirology Section,0.0
Integrative Immunobiology Section,Computational Biology Unit,0.0
Integrative Immunobiology Section,Coxiella Pathogenesis Section,0.0
Integrative Immunobiology Section,DNA Tumor Virus Section,0.0
Integrative Immunobiology Section,Disease Modeling and Transmission Section,0.0
Integrative Immunobiology Section,Emerging Respiratory Viruses Section,0.0
Integrative Immunobiology Section,Emerging Virus Immunity Unit,0.0
Integrative Immunobiology Section,Epidemiology and Population Studies Unit,0.0
Integrative Immunobiology Section,Epithelial Therapeutics Unit,0.0
Integrative Immunobiology Section,Flow Cytometry Section,0.0
Integrative Immunobiology Section,Food Allergy Research Section,0.0
Integrative Immunobiology Section,Functional Cellular Networks Section,0.0
Integrative Immunobiology Section,Fungal Pathogenesis Section,0.0
Integrative Immunobiology Section,Gene Regulation Section,0.0
Integrative Immunobiology Section,Genetic Engineering Section,0.0
Integrative Immunobiology Section,Genetic Immunotherapy Section,0.0
Integrative Immunobiology Section,Genomic Technologies Section,0.0
Integrative Immunobiology Section,HIV Immunovirology Section,0.0
Integrative Immunobiology Section,HIV Pathogenesis Section,0.0
Integrative Immunobiology Section,HIV-Specific Immunity Section,0.0
Integrative Immunobiology Section,Helminth Immunology Section,0.0
Integrative Immunobiology Section,Hepatic Pathogenesis Section,0.0
Integrative Immunobiology Section,Host-Parasite Interactions Section,0.0
Integrative Immunobiology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Integrative Immunobiology Section,Human Eosinophil Section,0.0
Integrative Immunobiology Section,Human Immunological Diseases Section,0.0
Integrative Immunobiology Section,Immune Activation Section,0.0
Integrative Immunobiology Section,Immune Deficiency Genetics Section,0.0
Integrative Immunobiology Section,Immunity to Pulmonary Pathogens Section,0.0
Integrative Immunobiology Section,Immunobiology and Molecular Virology Unit,0.0
Integrative Immunobiology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Integrative Immunobiology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Integrative Immunobiology Section,Infectious Disease Fellowship Training Program,0.0
Integrative Immunobiology Section,Infectious Disease Pathogenesis Section,0.0
Integrative Immunobiology Section,Inflammation & Innate Immunity Unit,0.0
Integrative Immunobiology Section,Inflammation Biology Section,0.0
Integrative Immunobiology Section,Innate Immunity and Pathogenesis Section,0.0
International HIV/STD Section,Allergy and Immunology Clinical Training Program,0.0
International HIV/STD Section,Antibacterial Host Defense Unit,0.0
International HIV/STD Section,Antibody Biology Unit,0.0
International HIV/STD Section,Apicomplexan Molecular Physiology Section,0.0
International HIV/STD Section,Autoimmunity and Functional Genomics Section,0.0
International HIV/STD Section,B-Cell Immunology Section,0.0
International HIV/STD Section,B-Cell Molecular Immunology Section,0.0
International HIV/STD Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
International HIV/STD Section,Bacterial Physiology and Metabolism Unit,0.0
International HIV/STD Section,Barrier Immunity Section,0.0
International HIV/STD Section,Biological Imaging,0.0
International HIV/STD Section,Biology of Vector-Borne Viruses Section,0.0
International HIV/STD Section,Building 14B South,0.0
International HIV/STD Section,Building 33,0.0
International HIV/STD Section,Building 50,0.0
International HIV/STD Section,Building NIHAC/103,0.0
International HIV/STD Section,Buildings 4 and 10/11C127,0.0
International HIV/STD Section,Caliciviruses Section,0.0
International HIV/STD Section,Cell Signaling and Immunity Section,0.0
International HIV/STD Section,Cellular Biology Section,0.0
International HIV/STD Section,Cellular Immunology Section,0.0
International HIV/STD Section,Chemotaxis Signal Section,0.0
International HIV/STD Section,Clinical Microbiome Unit (CMU),0.0
International HIV/STD Section,Clinical Pathophysiology Section,0.0
International HIV/STD Section,Clinical and Molecular Retrovirology Section,0.0
International HIV/STD Section,Computational Biology Unit,0.0
International HIV/STD Section,Coxiella Pathogenesis Section,0.0
International HIV/STD Section,DNA Tumor Virus Section,0.0
International HIV/STD Section,Disease Modeling and Transmission Section,0.0
International HIV/STD Section,Emerging Virus Immunity Unit,0.0
International HIV/STD Section,Epidemiology and Population Studies Unit,0.0
International HIV/STD Section,Epithelial Therapeutics Unit,0.0
International HIV/STD Section,Flow Cytometry Section,0.0
International HIV/STD Section,Food Allergy Research Section,0.0
International HIV/STD Section,Functional Cellular Networks Section,0.0
International HIV/STD Section,Fungal Pathogenesis Section,0.0
International HIV/STD Section,Gene Regulation Section,0.0
International HIV/STD Section,Genetic Engineering Section,0.0
International HIV/STD Section,Genetic Immunotherapy Section,0.0
International HIV/STD Section,Genomic Technologies Section,0.0
International HIV/STD Section,HIV Immunovirology Section,0.0
International HIV/STD Section,HIV Pathogenesis Section,0.0
International HIV/STD Section,HIV-Specific Immunity Section,0.0
International HIV/STD Section,Helminth Immunology Section,0.0
International HIV/STD Section,Hepatic Pathogenesis Section,0.0
International HIV/STD Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
International HIV/STD Section,Human Eosinophil Section,0.0
International HIV/STD Section,Human Immunological Diseases Section,0.0
International HIV/STD Section,Immune Activation Section,0.0
International HIV/STD Section,Immune Deficiency Genetics Section,0.0
International HIV/STD Section,Immunity to Pulmonary Pathogens Section,0.0
International HIV/STD Section,Immunobiology Section,0.0
International HIV/STD Section,Immunobiology and Molecular Virology Unit,0.0
International HIV/STD Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
International HIV/STD Section,Infectious Disease Fellowship Training Program,0.0
International HIV/STD Section,Infectious Disease Pathogenesis Section,0.0
International HIV/STD Section,Inflammation & Innate Immunity Unit,0.0
International HIV/STD Section,Inflammation Biology Section,0.0
International HIV/STD Section,Innate Immunity and Pathogenesis Section,0.0
International HIV/STD Section,Integrative Immunobiology Section,0.0
Intracellular Parasite Biology Section,Allergy and Immunology Clinical Training Program,0.0
Intracellular Parasite Biology Section,Antibacterial Host Defense Unit,0.0
Intracellular Parasite Biology Section,Antibody Biology Unit,0.0
Intracellular Parasite Biology Section,Apicomplexan Molecular Physiology Section,0.0
Intracellular Parasite Biology Section,Autoimmunity and Functional Genomics Section,0.0
Intracellular Parasite Biology Section,B-Cell Immunology Section,0.0
Intracellular Parasite Biology Section,B-Cell Molecular Immunology Section,0.0
Intracellular Parasite Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Intracellular Parasite Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Intracellular Parasite Biology Section,Barrier Immunity Section,0.0
Intracellular Parasite Biology Section,Biological Imaging,0.0
Intracellular Parasite Biology Section,Biology of Vector-Borne Viruses Section,0.0
Intracellular Parasite Biology Section,Building 14B South,0.0
Intracellular Parasite Biology Section,Building 33,0.0
Intracellular Parasite Biology Section,Building 50,0.0
Intracellular Parasite Biology Section,Building NIHAC/103,0.0
Intracellular Parasite Biology Section,Buildings 4 and 10/11C127,0.0
Intracellular Parasite Biology Section,Caliciviruses Section,0.0
Intracellular Parasite Biology Section,Cell Signaling and Immunity Section,0.0
Intracellular Parasite Biology Section,Cellular Biology Section,0.0
Intracellular Parasite Biology Section,Chemotaxis Signal Section,0.0
Intracellular Parasite Biology Section,Chlamydial Diseases Section,0.0
Intracellular Parasite Biology Section,Clinical Microbiome Unit (CMU),0.0
Intracellular Parasite Biology Section,Clinical Pathophysiology Section,0.0
Intracellular Parasite Biology Section,Clinical Research Section,0.0
Intracellular Parasite Biology Section,Clinical and Molecular Retrovirology Section,0.0
Intracellular Parasite Biology Section,Computational Biology Unit,0.0
Intracellular Parasite Biology Section,Coxiella Pathogenesis Section,0.0
Intracellular Parasite Biology Section,DNA Tumor Virus Section,0.0
Intracellular Parasite Biology Section,Disease Modeling and Transmission Section,0.0
Intracellular Parasite Biology Section,Emerging Respiratory Viruses Section,0.0
Intracellular Parasite Biology Section,Emerging Virus Immunity Unit,0.0
Intracellular Parasite Biology Section,Epidemiology and Population Studies Unit,0.0
Intracellular Parasite Biology Section,Epithelial Therapeutics Unit,0.0
Intracellular Parasite Biology Section,Flow Cytometry Section,0.0
Intracellular Parasite Biology Section,Food Allergy Research Section,0.0
Intracellular Parasite Biology Section,Functional Cellular Networks Section,0.0
Intracellular Parasite Biology Section,Fungal Pathogenesis Section,0.0
Intracellular Parasite Biology Section,Gene Regulation Section,0.0
Intracellular Parasite Biology Section,Genetic Engineering Section,0.0
Intracellular Parasite Biology Section,Genetic Immunotherapy Section,0.0
Intracellular Parasite Biology Section,Genomic Technologies Section,0.0
Intracellular Parasite Biology Section,HIV Immunovirology Section,0.0
Intracellular Parasite Biology Section,HIV Pathogenesis Section,0.0
Intracellular Parasite Biology Section,HIV-Specific Immunity Section,0.0
Intracellular Parasite Biology Section,Hepatic Pathogenesis Section,0.0
Intracellular Parasite Biology Section,Host-Parasite Interactions Section,0.0
Intracellular Parasite Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Intracellular Parasite Biology Section,Human Eosinophil Section,0.0
Intracellular Parasite Biology Section,Human Immunological Diseases Section,0.0
Intracellular Parasite Biology Section,Immune Activation Section,0.0
Intracellular Parasite Biology Section,Immune Deficiency Genetics Section,0.0
Intracellular Parasite Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Intracellular Parasite Biology Section,Immunobiology and Molecular Virology Unit,0.0
Intracellular Parasite Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Intracellular Parasite Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Intracellular Parasite Biology Section,Infectious Disease Fellowship Training Program,0.0
Intracellular Parasite Biology Section,Infectious Disease Pathogenesis Section,0.0
Intracellular Parasite Biology Section,Inflammation Biology Section,0.0
Intracellular Parasite Biology Section,Innate Immunity and Pathogenesis Section,0.0
Intracellular Parasite Biology Section,Integrative Immunobiology Section,0.0
Intracellular Parasite Biology Section,International HIV/STD Section,0.0
LID Clinical Studies Unit,Allergy and Immunology Clinical Training Program,0.0
LID Clinical Studies Unit,Antibacterial Host Defense Unit,0.0
LID Clinical Studies Unit,Antibody Biology Unit,0.0
LID Clinical Studies Unit,Apicomplexan Molecular Physiology Section,0.0
LID Clinical Studies Unit,Autoimmunity and Functional Genomics Section,0.0
LID Clinical Studies Unit,B-Cell Molecular Immunology Section,0.0
LID Clinical Studies Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
LID Clinical Studies Unit,Bacterial Physiology and Metabolism Unit,0.0
LID Clinical Studies Unit,Barrier Immunity Section,0.0
LID Clinical Studies Unit,Biological Imaging,0.0
LID Clinical Studies Unit,Biology of Vector-Borne Viruses Section,0.0
LID Clinical Studies Unit,Building 14B South,0.0
LID Clinical Studies Unit,Building 33,0.0
LID Clinical Studies Unit,Building 50,0.0
LID Clinical Studies Unit,Building NIHAC/103,0.0
LID Clinical Studies Unit,Buildings 4 and 10/11C127,0.0
LID Clinical Studies Unit,Caliciviruses Section,0.0
LID Clinical Studies Unit,Cell Signaling and Immunity Section,0.0
LID Clinical Studies Unit,Cellular Biology Section,0.0
LID Clinical Studies Unit,Cellular Immunology Section,0.0
LID Clinical Studies Unit,Chemotaxis Signal Section,0.0
LID Clinical Studies Unit,Chlamydial Diseases Section,0.0
LID Clinical Studies Unit,Clinical Microbiome Unit (CMU),0.0
LID Clinical Studies Unit,Clinical Pathophysiology Section,0.0
LID Clinical Studies Unit,Clinical and Molecular Retrovirology Section,0.0
LID Clinical Studies Unit,Computational Biology Unit,0.0
LID Clinical Studies Unit,Coxiella Pathogenesis Section,0.0
LID Clinical Studies Unit,DNA Tumor Virus Section,0.0
LID Clinical Studies Unit,Disease Modeling and Transmission Section,0.0
LID Clinical Studies Unit,Emerging Respiratory Viruses Section,0.0
LID Clinical Studies Unit,Emerging Virus Immunity Unit,0.0
LID Clinical Studies Unit,Epidemiology and Population Studies Unit,0.0
LID Clinical Studies Unit,Epithelial Therapeutics Unit,0.0
LID Clinical Studies Unit,Flow Cytometry Section,0.0
LID Clinical Studies Unit,Food Allergy Research Section,0.0
LID Clinical Studies Unit,Functional Cellular Networks Section,0.0
LID Clinical Studies Unit,Fungal Pathogenesis Section,0.0
LID Clinical Studies Unit,Gene Regulation Section,0.0
LID Clinical Studies Unit,Genetic Engineering Section,0.0
LID Clinical Studies Unit,Genetic Immunotherapy Section,0.0
LID Clinical Studies Unit,Genomic Technologies Section,0.0
LID Clinical Studies Unit,HIV Pathogenesis Section,0.0
LID Clinical Studies Unit,HIV-Specific Immunity Section,0.0
LID Clinical Studies Unit,Helminth Immunology Section,0.0
LID Clinical Studies Unit,Hepatic Pathogenesis Section,0.0
LID Clinical Studies Unit,Host-Parasite Interactions Section,0.0
LID Clinical Studies Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
LID Clinical Studies Unit,Human Eosinophil Section,0.0
LID Clinical Studies Unit,Human Immunological Diseases Section,0.0
LID Clinical Studies Unit,Immune Activation Section,0.0
LID Clinical Studies Unit,Immune Deficiency Genetics Section,0.0
LID Clinical Studies Unit,Immunity to Pulmonary Pathogens Section,0.0
LID Clinical Studies Unit,Immunobiology Section,0.0
LID Clinical Studies Unit,Immunobiology and Molecular Virology Unit,0.0
LID Clinical Studies Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
LID Clinical Studies Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
LID Clinical Studies Unit,Infectious Disease Fellowship Training Program,0.0
LID Clinical Studies Unit,Infectious Disease Pathogenesis Section,0.0
LID Clinical Studies Unit,Inflammation & Innate Immunity Unit,0.0
LID Clinical Studies Unit,Inflammation Biology Section,0.0
LID Clinical Studies Unit,Innate Immunity and Pathogenesis Section,0.0
LID Clinical Studies Unit,Integrative Immunobiology Section,0.0
LID Clinical Studies Unit,International HIV/STD Section,0.0
LID Clinical Studies Unit,Intracellular Parasite Biology Section,0.0
Lung and Vascular Inflammation Section,Allergy and Immunology Clinical Training Program,0.0
Lung and Vascular Inflammation Section,Antibacterial Host Defense Unit,0.0
Lung and Vascular Inflammation Section,Antibody Biology Unit,0.0
Lung and Vascular Inflammation Section,Apicomplexan Molecular Physiology Section,0.0
Lung and Vascular Inflammation Section,Autoimmunity and Functional Genomics Section,0.0
Lung and Vascular Inflammation Section,B-Cell Immunology Section,0.0
Lung and Vascular Inflammation Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Lung and Vascular Inflammation Section,Bacterial Physiology and Metabolism Unit,0.0
Lung and Vascular Inflammation Section,Barrier Immunity Section,0.0
Lung and Vascular Inflammation Section,Biological Imaging,0.0
Lung and Vascular Inflammation Section,Biology of Vector-Borne Viruses Section,0.0
Lung and Vascular Inflammation Section,Building 14B South,0.0
Lung and Vascular Inflammation Section,Building 33,0.0
Lung and Vascular Inflammation Section,Building 50,0.0
Lung and Vascular Inflammation Section,Building NIHAC/103,0.0
Lung and Vascular Inflammation Section,Buildings 4 and 10/11C127,0.0
Lung and Vascular Inflammation Section,Caliciviruses Section,0.0
Lung and Vascular Inflammation Section,Cell Signaling and Immunity Section,0.0
Lung and Vascular Inflammation Section,Cellular Biology Section,0.0
Lung and Vascular Inflammation Section,Cellular Immunology Section,0.0
Lung and Vascular Inflammation Section,Chemotaxis Signal Section,0.0
Lung and Vascular Inflammation Section,Chlamydial Diseases Section,0.0
Lung and Vascular Inflammation Section,Clinical Microbiome Unit (CMU),0.0
Lung and Vascular Inflammation Section,Clinical Research Section,0.0
Lung and Vascular Inflammation Section,Computational Biology Unit,0.0
Lung and Vascular Inflammation Section,Coxiella Pathogenesis Section,0.0
Lung and Vascular Inflammation Section,DNA Tumor Virus Section,0.0
Lung and Vascular Inflammation Section,Disease Modeling and Transmission Section,0.0
Lung and Vascular Inflammation Section,Emerging Respiratory Viruses Section,0.0
Lung and Vascular Inflammation Section,Emerging Virus Immunity Unit,0.0
Lung and Vascular Inflammation Section,Epidemiology and Population Studies Unit,0.0
Lung and Vascular Inflammation Section,Epithelial Therapeutics Unit,0.0
Lung and Vascular Inflammation Section,Flow Cytometry Section,0.0
Lung and Vascular Inflammation Section,Food Allergy Research Section,0.0
Lung and Vascular Inflammation Section,Functional Cellular Networks Section,0.0
Lung and Vascular Inflammation Section,Fungal Pathogenesis Section,0.0
Lung and Vascular Inflammation Section,Gene Regulation Section,0.0
Lung and Vascular Inflammation Section,Genetic Engineering Section,0.0
Lung and Vascular Inflammation Section,Genetic Immunotherapy Section,0.0
Lung and Vascular Inflammation Section,HIV Immunovirology Section,0.0
Lung and Vascular Inflammation Section,HIV Pathogenesis Section,0.0
Lung and Vascular Inflammation Section,HIV-Specific Immunity Section,0.0
Lung and Vascular Inflammation Section,Helminth Immunology Section,0.0
Lung and Vascular Inflammation Section,Hepatic Pathogenesis Section,0.0
Lung and Vascular Inflammation Section,Host-Parasite Interactions Section,0.0
Lung and Vascular Inflammation Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Lung and Vascular Inflammation Section,Human Eosinophil Section,0.0
Lung and Vascular Inflammation Section,Human Immunological Diseases Section,0.0
Lung and Vascular Inflammation Section,Immune Deficiency Genetics Section,0.0
Lung and Vascular Inflammation Section,Immunity to Pulmonary Pathogens Section,0.0
Lung and Vascular Inflammation Section,Immunobiology Section,0.0
Lung and Vascular Inflammation Section,Immunobiology and Molecular Virology Unit,0.0
Lung and Vascular Inflammation Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Lung and Vascular Inflammation Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Lung and Vascular Inflammation Section,Infectious Disease Fellowship Training Program,0.0
Lung and Vascular Inflammation Section,Infectious Disease Pathogenesis Section,0.0
Lung and Vascular Inflammation Section,Inflammation & Innate Immunity Unit,0.0
Lung and Vascular Inflammation Section,Inflammation Biology Section,0.0
Lung and Vascular Inflammation Section,Innate Immunity and Pathogenesis Section,0.0
Lung and Vascular Inflammation Section,Integrative Immunobiology Section,0.0
Lung and Vascular Inflammation Section,International HIV/STD Section,0.0
Lung and Vascular Inflammation Section,Intracellular Parasite Biology Section,0.0
Lung and Vascular Inflammation Section,LID Clinical Studies Unit,0.0
Lyme Disease Studies Unit,Allergy and Immunology Clinical Training Program,0.0
Lyme Disease Studies Unit,Antibacterial Host Defense Unit,0.0
Lyme Disease Studies Unit,Antibody Biology Unit,0.0
Lyme Disease Studies Unit,Apicomplexan Molecular Physiology Section,0.0
Lyme Disease Studies Unit,Autoimmunity and Functional Genomics Section,0.0
Lyme Disease Studies Unit,B-Cell Immunology Section,0.0
Lyme Disease Studies Unit,B-Cell Molecular Immunology Section,0.0
Lyme Disease Studies Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Lyme Disease Studies Unit,Bacterial Physiology and Metabolism Unit,0.0
Lyme Disease Studies Unit,Barrier Immunity Section,0.0
Lyme Disease Studies Unit,Biological Imaging,0.0
Lyme Disease Studies Unit,Biology of Vector-Borne Viruses Section,0.0
Lyme Disease Studies Unit,Building 14B South,0.0
Lyme Disease Studies Unit,Building 33,0.0
Lyme Disease Studies Unit,Building 50,0.0
Lyme Disease Studies Unit,Building NIHAC/103,0.0
Lyme Disease Studies Unit,Buildings 4 and 10/11C127,0.0
Lyme Disease Studies Unit,Caliciviruses Section,0.0
Lyme Disease Studies Unit,Cell Signaling and Immunity Section,0.0
Lyme Disease Studies Unit,Cellular Biology Section,0.0
Lyme Disease Studies Unit,Cellular Immunology Section,0.0
Lyme Disease Studies Unit,Chemotaxis Signal Section,0.0
Lyme Disease Studies Unit,Chlamydial Diseases Section,0.0
Lyme Disease Studies Unit,Clinical Microbiome Unit (CMU),0.0
Lyme Disease Studies Unit,Clinical Pathophysiology Section,0.0
Lyme Disease Studies Unit,Clinical Research Section,0.0
Lyme Disease Studies Unit,Clinical and Molecular Retrovirology Section,0.0
Lyme Disease Studies Unit,Computational Biology Unit,0.0
Lyme Disease Studies Unit,Coxiella Pathogenesis Section,0.0
Lyme Disease Studies Unit,DNA Tumor Virus Section,0.0
Lyme Disease Studies Unit,Disease Modeling and Transmission Section,0.0
Lyme Disease Studies Unit,Emerging Virus Immunity Unit,0.0
Lyme Disease Studies Unit,Epithelial Therapeutics Unit,0.0
Lyme Disease Studies Unit,Flow Cytometry Section,0.0
Lyme Disease Studies Unit,Food Allergy Research Section,0.0
Lyme Disease Studies Unit,Functional Cellular Networks Section,0.0
Lyme Disease Studies Unit,Fungal Pathogenesis Section,0.0
Lyme Disease Studies Unit,Gene Regulation Section,0.0
Lyme Disease Studies Unit,Genetic Engineering Section,0.0
Lyme Disease Studies Unit,Genetic Immunotherapy Section,0.0
Lyme Disease Studies Unit,Genomic Technologies Section,0.0
Lyme Disease Studies Unit,HIV Immunovirology Section,0.0
Lyme Disease Studies Unit,HIV Pathogenesis Section,0.0
Lyme Disease Studies Unit,HIV-Specific Immunity Section,0.0
Lyme Disease Studies Unit,Helminth Immunology Section,0.0
Lyme Disease Studies Unit,Hepatic Pathogenesis Section,0.0
Lyme Disease Studies Unit,Host-Parasite Interactions Section,0.0
Lyme Disease Studies Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Lyme Disease Studies Unit,Human Eosinophil Section,0.0
Lyme Disease Studies Unit,Human Immunological Diseases Section,0.0
Lyme Disease Studies Unit,Immune Activation Section,0.0
Lyme Disease Studies Unit,Immune Deficiency Genetics Section,0.0
Lyme Disease Studies Unit,Immunity to Pulmonary Pathogens Section,0.0
Lyme Disease Studies Unit,Immunobiology Section,0.0
Lyme Disease Studies Unit,Immunobiology and Molecular Virology Unit,0.0
Lyme Disease Studies Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Lyme Disease Studies Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Lyme Disease Studies Unit,Infectious Disease Fellowship Training Program,0.0
Lyme Disease Studies Unit,Infectious Disease Pathogenesis Section,0.0
Lyme Disease Studies Unit,Inflammation & Innate Immunity Unit,0.0
Lyme Disease Studies Unit,Inflammation Biology Section,0.0
Lyme Disease Studies Unit,Innate Immunity and Pathogenesis Section,0.0
Lyme Disease Studies Unit,Integrative Immunobiology Section,0.0
Lyme Disease Studies Unit,International HIV/STD Section,0.0
Lyme Disease Studies Unit,Intracellular Parasite Biology Section,0.0
Lyme Disease Studies Unit,LID Clinical Studies Unit,0.0
Lyme Disease Studies Unit,Lung and Vascular Inflammation Section,0.0
Lymphocyte Activation Section,Allergy and Immunology Clinical Training Program,0.0
Lymphocyte Activation Section,Antibacterial Host Defense Unit,0.0
Lymphocyte Activation Section,Antibody Biology Unit,0.0
Lymphocyte Activation Section,B-Cell Molecular Immunology Section,0.0
Lymphocyte Activation Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Lymphocyte Activation Section,Bacterial Physiology and Metabolism Unit,0.0
Lymphocyte Activation Section,Barrier Immunity Section,0.0
Lymphocyte Activation Section,Biological Imaging,0.0
Lymphocyte Activation Section,Biology of Vector-Borne Viruses Section,0.0
Lymphocyte Activation Section,Building 14B South,0.0
Lymphocyte Activation Section,Building 33,0.0
Lymphocyte Activation Section,Building 50,0.0
Lymphocyte Activation Section,Building NIHAC/103,0.0
Lymphocyte Activation Section,Buildings 4 and 10/11C127,0.0
Lymphocyte Activation Section,Caliciviruses Section,0.0
Lymphocyte Activation Section,Cell Signaling and Immunity Section,0.0
Lymphocyte Activation Section,Cellular Biology Section,0.0
Lymphocyte Activation Section,Chlamydial Diseases Section,0.0
Lymphocyte Activation Section,Clinical Microbiome Unit (CMU),0.0
Lymphocyte Activation Section,Clinical Pathophysiology Section,0.0
Lymphocyte Activation Section,Clinical Research Section,0.0
Lymphocyte Activation Section,Clinical and Molecular Retrovirology Section,0.0
Lymphocyte Activation Section,Computational Biology Unit,0.0
Lymphocyte Activation Section,Coxiella Pathogenesis Section,0.0
Lymphocyte Activation Section,DNA Tumor Virus Section,0.0
Lymphocyte Activation Section,Disease Modeling and Transmission Section,0.0
Lymphocyte Activation Section,Emerging Respiratory Viruses Section,0.0
Lymphocyte Activation Section,Emerging Virus Immunity Unit,0.0
Lymphocyte Activation Section,Epidemiology and Population Studies Unit,0.0
Lymphocyte Activation Section,Epithelial Therapeutics Unit,0.0
Lymphocyte Activation Section,Flow Cytometry Section,0.0
Lymphocyte Activation Section,Food Allergy Research Section,0.0
Lymphocyte Activation Section,Functional Cellular Networks Section,0.0
Lymphocyte Activation Section,Fungal Pathogenesis Section,0.0
Lymphocyte Activation Section,Gene Regulation Section,0.0
Lymphocyte Activation Section,Genetic Engineering Section,0.0
Lymphocyte Activation Section,Genetic Immunotherapy Section,0.0
Lymphocyte Activation Section,Genomic Technologies Section,0.0
Lymphocyte Activation Section,HIV Pathogenesis Section,0.0
Lymphocyte Activation Section,HIV-Specific Immunity Section,0.0
Lymphocyte Activation Section,Helminth Immunology Section,0.0
Lymphocyte Activation Section,Hepatic Pathogenesis Section,0.0
Lymphocyte Activation Section,Host-Parasite Interactions Section,0.0
Lymphocyte Activation Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Lymphocyte Activation Section,Human Eosinophil Section,0.0
Lymphocyte Activation Section,Human Immunological Diseases Section,0.0
Lymphocyte Activation Section,Immune Activation Section,0.0
Lymphocyte Activation Section,Immune Deficiency Genetics Section,0.0
Lymphocyte Activation Section,Immunity to Pulmonary Pathogens Section,0.0
Lymphocyte Activation Section,Immunobiology Section,0.0
Lymphocyte Activation Section,Immunobiology and Molecular Virology Unit,0.0
Lymphocyte Activation Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Lymphocyte Activation Section,Infectious Disease Fellowship Training Program,0.0
Lymphocyte Activation Section,Infectious Disease Pathogenesis Section,0.0
Lymphocyte Activation Section,Inflammation & Innate Immunity Unit,0.0
Lymphocyte Activation Section,Inflammation Biology Section,0.0
Lymphocyte Activation Section,Innate Immunity and Pathogenesis Section,0.0
Lymphocyte Activation Section,Integrative Immunobiology Section,0.0
Lymphocyte Activation Section,International HIV/STD Section,0.0
Lymphocyte Activation Section,Intracellular Parasite Biology Section,0.0
Lymphocyte Activation Section,LID Clinical Studies Unit,0.0
Lymphocyte Activation Section,Lung and Vascular Inflammation Section,0.0
Lymphocyte Activation Section,Lyme Disease Studies Unit,0.0
Lymphocyte Biology Section,Allergy and Immunology Clinical Training Program,0.0
Lymphocyte Biology Section,Antibacterial Host Defense Unit,0.0
Lymphocyte Biology Section,Antibody Biology Unit,0.0
Lymphocyte Biology Section,Apicomplexan Molecular Physiology Section,0.0
Lymphocyte Biology Section,Autoimmunity and Functional Genomics Section,0.0
Lymphocyte Biology Section,B-Cell Molecular Immunology Section,0.0
Lymphocyte Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Lymphocyte Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Lymphocyte Biology Section,Biological Imaging,0.0
Lymphocyte Biology Section,Biology of Vector-Borne Viruses Section,0.0
Lymphocyte Biology Section,Building 14B South,0.0
Lymphocyte Biology Section,Building 33,0.0
Lymphocyte Biology Section,Building 50,0.0
Lymphocyte Biology Section,Building NIHAC/103,0.0
Lymphocyte Biology Section,Buildings 4 and 10/11C127,0.0
Lymphocyte Biology Section,Caliciviruses Section,0.0
Lymphocyte Biology Section,Cellular Biology Section,0.0
Lymphocyte Biology Section,Chlamydial Diseases Section,0.0
Lymphocyte Biology Section,Clinical Microbiome Unit (CMU),0.0
Lymphocyte Biology Section,Clinical Pathophysiology Section,0.0
Lymphocyte Biology Section,Clinical Research Section,0.0
Lymphocyte Biology Section,Clinical and Molecular Retrovirology Section,0.0
Lymphocyte Biology Section,Coxiella Pathogenesis Section,0.0
Lymphocyte Biology Section,DNA Tumor Virus Section,0.0
Lymphocyte Biology Section,Disease Modeling and Transmission Section,0.0
Lymphocyte Biology Section,Emerging Respiratory Viruses Section,0.0
Lymphocyte Biology Section,Emerging Virus Immunity Unit,0.0
Lymphocyte Biology Section,Epidemiology and Population Studies Unit,0.0
Lymphocyte Biology Section,Epithelial Therapeutics Unit,0.0
Lymphocyte Biology Section,Flow Cytometry Section,0.0
Lymphocyte Biology Section,Food Allergy Research Section,0.0
Lymphocyte Biology Section,Fungal Pathogenesis Section,0.0
Lymphocyte Biology Section,Gene Regulation Section,0.0
Lymphocyte Biology Section,Genetic Engineering Section,0.0
Lymphocyte Biology Section,Genetic Immunotherapy Section,0.0
Lymphocyte Biology Section,Genomic Technologies Section,0.0
Lymphocyte Biology Section,HIV Immunovirology Section,0.0
Lymphocyte Biology Section,HIV Pathogenesis Section,0.0
Lymphocyte Biology Section,HIV-Specific Immunity Section,0.0
Lymphocyte Biology Section,Helminth Immunology Section,0.0
Lymphocyte Biology Section,Hepatic Pathogenesis Section,0.0
Lymphocyte Biology Section,Host-Parasite Interactions Section,0.0
Lymphocyte Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Lymphocyte Biology Section,Human Eosinophil Section,0.0
Lymphocyte Biology Section,Immune Activation Section,0.0
Lymphocyte Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Lymphocyte Biology Section,Immunobiology and Molecular Virology Unit,0.0
Lymphocyte Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Lymphocyte Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Lymphocyte Biology Section,Infectious Disease Fellowship Training Program,0.0
Lymphocyte Biology Section,Infectious Disease Pathogenesis Section,0.0
Lymphocyte Biology Section,Inflammation & Innate Immunity Unit,0.0
Lymphocyte Biology Section,Inflammation Biology Section,0.0
Lymphocyte Biology Section,Innate Immunity and Pathogenesis Section,0.0
Lymphocyte Biology Section,Integrative Immunobiology Section,0.0
Lymphocyte Biology Section,International HIV/STD Section,0.0
Lymphocyte Biology Section,LID Clinical Studies Unit,0.0
Lymphocyte Biology Section,Lung and Vascular Inflammation Section,0.0
Lymphocyte Biology Section,Lyme Disease Studies Unit,0.0
Lymphocyte Biology Section,Lymphocyte Activation Section,0.0
Malaria Cell Biology Section,Allergy and Immunology Clinical Training Program,0.0
Malaria Cell Biology Section,Antibacterial Host Defense Unit,0.0
Malaria Cell Biology Section,Antibody Biology Unit,0.0
Malaria Cell Biology Section,B-Cell Immunology Section,0.0
Malaria Cell Biology Section,B-Cell Molecular Immunology Section,0.0
Malaria Cell Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Malaria Cell Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Malaria Cell Biology Section,Barrier Immunity Section,0.0
Malaria Cell Biology Section,Biology of Vector-Borne Viruses Section,0.0
Malaria Cell Biology Section,Building 14B South,0.0
Malaria Cell Biology Section,Building 33,0.0
Malaria Cell Biology Section,Building 50,0.0
Malaria Cell Biology Section,Building NIHAC/103,0.0
Malaria Cell Biology Section,Buildings 4 and 10/11C127,0.0
Malaria Cell Biology Section,Caliciviruses Section,0.0
Malaria Cell Biology Section,Cell Signaling and Immunity Section,0.0
Malaria Cell Biology Section,Cellular Biology Section,0.0
Malaria Cell Biology Section,Cellular Immunology Section,0.0
Malaria Cell Biology Section,Chemotaxis Signal Section,0.0
Malaria Cell Biology Section,Chlamydial Diseases Section,0.0
Malaria Cell Biology Section,Clinical Microbiome Unit (CMU),0.0
Malaria Cell Biology Section,Clinical Pathophysiology Section,0.0
Malaria Cell Biology Section,Clinical Research Section,0.0
Malaria Cell Biology Section,Clinical and Molecular Retrovirology Section,0.0
Malaria Cell Biology Section,Computational Biology Unit,0.0
Malaria Cell Biology Section,Coxiella Pathogenesis Section,0.0
Malaria Cell Biology Section,DNA Tumor Virus Section,0.0
Malaria Cell Biology Section,Disease Modeling and Transmission Section,0.0
Malaria Cell Biology Section,Emerging Respiratory Viruses Section,0.0
Malaria Cell Biology Section,Emerging Virus Immunity Unit,0.0
Malaria Cell Biology Section,Epidemiology and Population Studies Unit,0.0
Malaria Cell Biology Section,Epithelial Therapeutics Unit,0.0
Malaria Cell Biology Section,Flow Cytometry Section,0.0
Malaria Cell Biology Section,Food Allergy Research Section,0.0
Malaria Cell Biology Section,Functional Cellular Networks Section,0.0
Malaria Cell Biology Section,Fungal Pathogenesis Section,0.0
Malaria Cell Biology Section,Gene Regulation Section,0.0
Malaria Cell Biology Section,Genetic Engineering Section,0.0
Malaria Cell Biology Section,Genetic Immunotherapy Section,0.0
Malaria Cell Biology Section,Genomic Technologies Section,0.0
Malaria Cell Biology Section,HIV Immunovirology Section,0.0
Malaria Cell Biology Section,HIV Pathogenesis Section,0.0
Malaria Cell Biology Section,HIV-Specific Immunity Section,0.0
Malaria Cell Biology Section,Helminth Immunology Section,0.0
Malaria Cell Biology Section,Hepatic Pathogenesis Section,0.0
Malaria Cell Biology Section,Host-Parasite Interactions Section,0.0
Malaria Cell Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Malaria Cell Biology Section,Human Immunological Diseases Section,0.0
Malaria Cell Biology Section,Immune Deficiency Genetics Section,0.0
Malaria Cell Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Malaria Cell Biology Section,Immunobiology Section,0.0
Malaria Cell Biology Section,Immunobiology and Molecular Virology Unit,0.0
Malaria Cell Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Malaria Cell Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Malaria Cell Biology Section,Infectious Disease Fellowship Training Program,0.0
Malaria Cell Biology Section,Infectious Disease Pathogenesis Section,0.0
Malaria Cell Biology Section,Inflammation & Innate Immunity Unit,0.0
Malaria Cell Biology Section,Inflammation Biology Section,0.0
Malaria Cell Biology Section,Innate Immunity and Pathogenesis Section,0.0
Malaria Cell Biology Section,Integrative Immunobiology Section,0.0
Malaria Cell Biology Section,International HIV/STD Section,0.0
Malaria Cell Biology Section,Intracellular Parasite Biology Section,0.0
Malaria Cell Biology Section,LID Clinical Studies Unit,0.0
Malaria Cell Biology Section,Lung and Vascular Inflammation Section,0.0
Malaria Cell Biology Section,Lyme Disease Studies Unit,0.0
Malaria Cell Biology Section,Lymphocyte Biology Section,0.0
Malaria Functional Genomics Section,Allergy and Immunology Clinical Training Program,0.0
Malaria Functional Genomics Section,Antibacterial Host Defense Unit,0.0
Malaria Functional Genomics Section,Antibody Biology Unit,0.0
Malaria Functional Genomics Section,B-Cell Immunology Section,0.0
Malaria Functional Genomics Section,B-Cell Molecular Immunology Section,0.0
Malaria Functional Genomics Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Malaria Functional Genomics Section,Bacterial Physiology and Metabolism Unit,0.0
Malaria Functional Genomics Section,Barrier Immunity Section,0.0
Malaria Functional Genomics Section,Biological Imaging,0.0
Malaria Functional Genomics Section,Biology of Vector-Borne Viruses Section,0.0
Malaria Functional Genomics Section,Building 14B South,0.0
Malaria Functional Genomics Section,Building 33,0.0
Malaria Functional Genomics Section,Building 50,0.0
Malaria Functional Genomics Section,Building NIHAC/103,0.0
Malaria Functional Genomics Section,Buildings 4 and 10/11C127,0.0
Malaria Functional Genomics Section,Caliciviruses Section,0.0
Malaria Functional Genomics Section,Cell Signaling and Immunity Section,0.0
Malaria Functional Genomics Section,Cellular Biology Section,0.0
Malaria Functional Genomics Section,Cellular Immunology Section,0.0
Malaria Functional Genomics Section,Chemotaxis Signal Section,0.0
Malaria Functional Genomics Section,Chlamydial Diseases Section,0.0
Malaria Functional Genomics Section,Clinical Microbiome Unit (CMU),0.0
Malaria Functional Genomics Section,Clinical Pathophysiology Section,0.0
Malaria Functional Genomics Section,Clinical Research Section,0.0
Malaria Functional Genomics Section,Clinical and Molecular Retrovirology Section,0.0
Malaria Functional Genomics Section,Computational Biology Unit,0.0
Malaria Functional Genomics Section,Coxiella Pathogenesis Section,0.0
Malaria Functional Genomics Section,DNA Tumor Virus Section,0.0
Malaria Functional Genomics Section,Disease Modeling and Transmission Section,0.0
Malaria Functional Genomics Section,Emerging Virus Immunity Unit,0.0
Malaria Functional Genomics Section,Epidemiology and Population Studies Unit,0.0
Malaria Functional Genomics Section,Epithelial Therapeutics Unit,0.0
Malaria Functional Genomics Section,Flow Cytometry Section,0.0
Malaria Functional Genomics Section,Food Allergy Research Section,0.0
Malaria Functional Genomics Section,Functional Cellular Networks Section,0.0
Malaria Functional Genomics Section,Fungal Pathogenesis Section,0.0
Malaria Functional Genomics Section,Gene Regulation Section,0.0
Malaria Functional Genomics Section,Genetic Engineering Section,0.0
Malaria Functional Genomics Section,Genetic Immunotherapy Section,0.0
Malaria Functional Genomics Section,HIV Immunovirology Section,0.0
Malaria Functional Genomics Section,HIV Pathogenesis Section,0.0
Malaria Functional Genomics Section,HIV-Specific Immunity Section,0.0
Malaria Functional Genomics Section,Hepatic Pathogenesis Section,0.0
Malaria Functional Genomics Section,Host-Parasite Interactions Section,0.0
Malaria Functional Genomics Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Malaria Functional Genomics Section,Human Immunological Diseases Section,0.0
Malaria Functional Genomics Section,Immune Activation Section,0.0
Malaria Functional Genomics Section,Immune Deficiency Genetics Section,0.0
Malaria Functional Genomics Section,Immunity to Pulmonary Pathogens Section,0.0
Malaria Functional Genomics Section,Immunobiology and Molecular Virology Unit,0.0
Malaria Functional Genomics Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Malaria Functional Genomics Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Malaria Functional Genomics Section,Infectious Disease Fellowship Training Program,0.0
Malaria Functional Genomics Section,Inflammation & Innate Immunity Unit,0.0
Malaria Functional Genomics Section,Inflammation Biology Section,0.0
Malaria Functional Genomics Section,Innate Immunity and Pathogenesis Section,0.0
Malaria Functional Genomics Section,Integrative Immunobiology Section,0.0
Malaria Functional Genomics Section,International HIV/STD Section,0.0
Malaria Functional Genomics Section,Intracellular Parasite Biology Section,0.0
Malaria Functional Genomics Section,LID Clinical Studies Unit,0.0
Malaria Functional Genomics Section,Lung and Vascular Inflammation Section,0.0
Malaria Functional Genomics Section,Lyme Disease Studies Unit,0.0
Malaria Functional Genomics Section,Lymphocyte Activation Section,0.0
Malaria Functional Genomics Section,Lymphocyte Biology Section,0.0
Malaria Genetics Section,Allergy and Immunology Clinical Training Program,0.0
Malaria Genetics Section,Antibacterial Host Defense Unit,0.0
Malaria Genetics Section,Antibody Biology Unit,0.0
Malaria Genetics Section,Autoimmunity and Functional Genomics Section,0.0
Malaria Genetics Section,B-Cell Immunology Section,0.0
Malaria Genetics Section,B-Cell Molecular Immunology Section,0.0
Malaria Genetics Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Malaria Genetics Section,Bacterial Physiology and Metabolism Unit,0.0
Malaria Genetics Section,Barrier Immunity Section,0.0
Malaria Genetics Section,Biology of Vector-Borne Viruses Section,0.0
Malaria Genetics Section,Building 14B South,0.0
Malaria Genetics Section,Building 33,0.0
Malaria Genetics Section,Building 50,0.0
Malaria Genetics Section,Building NIHAC/103,0.0
Malaria Genetics Section,Buildings 4 and 10/11C127,0.0
Malaria Genetics Section,Caliciviruses Section,0.0
Malaria Genetics Section,Cell Signaling and Immunity Section,0.0
Malaria Genetics Section,Cellular Biology Section,0.0
Malaria Genetics Section,Cellular Immunology Section,0.0
Malaria Genetics Section,Chemotaxis Signal Section,0.0
Malaria Genetics Section,Chlamydial Diseases Section,0.0
Malaria Genetics Section,Clinical Microbiome Unit (CMU),0.0
Malaria Genetics Section,Clinical Pathophysiology Section,0.0
Malaria Genetics Section,Clinical Research Section,0.0
Malaria Genetics Section,Clinical and Molecular Retrovirology Section,0.0
Malaria Genetics Section,Computational Biology Unit,0.0
Malaria Genetics Section,Coxiella Pathogenesis Section,0.0
Malaria Genetics Section,DNA Tumor Virus Section,0.0
Malaria Genetics Section,Disease Modeling and Transmission Section,0.0
Malaria Genetics Section,Emerging Respiratory Viruses Section,0.0
Malaria Genetics Section,Emerging Virus Immunity Unit,0.0
Malaria Genetics Section,Epidemiology and Population Studies Unit,0.0
Malaria Genetics Section,Epithelial Therapeutics Unit,0.0
Malaria Genetics Section,Flow Cytometry Section,0.0
Malaria Genetics Section,Food Allergy Research Section,0.0
Malaria Genetics Section,Functional Cellular Networks Section,0.0
Malaria Genetics Section,Fungal Pathogenesis Section,0.0
Malaria Genetics Section,Gene Regulation Section,0.0
Malaria Genetics Section,Genetic Engineering Section,0.0
Malaria Genetics Section,Genetic Immunotherapy Section,0.0
Malaria Genetics Section,Genomic Technologies Section,0.0
Malaria Genetics Section,HIV Immunovirology Section,0.0
Malaria Genetics Section,HIV Pathogenesis Section,0.0
Malaria Genetics Section,HIV-Specific Immunity Section,0.0
Malaria Genetics Section,Helminth Immunology Section,0.0
Malaria Genetics Section,Hepatic Pathogenesis Section,0.0
Malaria Genetics Section,Host-Parasite Interactions Section,0.0
Malaria Genetics Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Malaria Genetics Section,Human Eosinophil Section,0.0
Malaria Genetics Section,Human Immunological Diseases Section,0.0
Malaria Genetics Section,Immune Activation Section,0.0
Malaria Genetics Section,Immune Deficiency Genetics Section,0.0
Malaria Genetics Section,Immunity to Pulmonary Pathogens Section,0.0
Malaria Genetics Section,Immunobiology Section,0.0
Malaria Genetics Section,Immunobiology and Molecular Virology Unit,0.0
Malaria Genetics Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Malaria Genetics Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Malaria Genetics Section,Infectious Disease Fellowship Training Program,0.0
Malaria Genetics Section,Infectious Disease Pathogenesis Section,0.0
Malaria Genetics Section,Inflammation & Innate Immunity Unit,0.0
Malaria Genetics Section,Inflammation Biology Section,0.0
Malaria Genetics Section,Innate Immunity and Pathogenesis Section,0.0
Malaria Genetics Section,Integrative Immunobiology Section,0.0
Malaria Genetics Section,International HIV/STD Section,0.0
Malaria Genetics Section,Intracellular Parasite Biology Section,0.0
Malaria Genetics Section,LID Clinical Studies Unit,0.0
Malaria Genetics Section,Lung and Vascular Inflammation Section,0.0
Malaria Genetics Section,Lyme Disease Studies Unit,0.0
Malaria Genetics Section,Lymphocyte Activation Section,0.0
Malaria Genetics Section,Lymphocyte Biology Section,0.0
Malaria Immunology Section,Allergy and Immunology Clinical Training Program,0.0
Malaria Immunology Section,Antibacterial Host Defense Unit,0.0
Malaria Immunology Section,Antibody Biology Unit,0.0
Malaria Immunology Section,Apicomplexan Molecular Physiology Section,0.0
Malaria Immunology Section,B-Cell Immunology Section,0.0
Malaria Immunology Section,B-Cell Molecular Immunology Section,0.0
Malaria Immunology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Malaria Immunology Section,Bacterial Physiology and Metabolism Unit,0.0
Malaria Immunology Section,Barrier Immunity Section,0.0
Malaria Immunology Section,Biological Imaging,0.0
Malaria Immunology Section,Biology of Vector-Borne Viruses Section,0.0
Malaria Immunology Section,Building 14B South,0.0
Malaria Immunology Section,Building 33,0.0
Malaria Immunology Section,Building 50,0.0
Malaria Immunology Section,Building NIHAC/103,0.0
Malaria Immunology Section,Buildings 4 and 10/11C127,0.0
Malaria Immunology Section,Caliciviruses Section,0.0
Malaria Immunology Section,Cell Signaling and Immunity Section,0.0
Malaria Immunology Section,Cellular Biology Section,0.0
Malaria Immunology Section,Cellular Immunology Section,0.0
Malaria Immunology Section,Chemotaxis Signal Section,0.0
Malaria Immunology Section,Chlamydial Diseases Section,0.0
Malaria Immunology Section,Clinical Microbiome Unit (CMU),0.0
Malaria Immunology Section,Clinical Pathophysiology Section,0.0
Malaria Immunology Section,Clinical Research Section,0.0
Malaria Immunology Section,Clinical and Molecular Retrovirology Section,0.0
Malaria Immunology Section,Computational Biology Unit,0.0
Malaria Immunology Section,Coxiella Pathogenesis Section,0.0
Malaria Immunology Section,DNA Tumor Virus Section,0.0
Malaria Immunology Section,Disease Modeling and Transmission Section,0.0
Malaria Immunology Section,Emerging Virus Immunity Unit,0.0
Malaria Immunology Section,Epidemiology and Population Studies Unit,0.0
Malaria Immunology Section,Epithelial Therapeutics Unit,0.0
Malaria Immunology Section,Flow Cytometry Section,0.0
Malaria Immunology Section,Food Allergy Research Section,0.0
Malaria Immunology Section,Functional Cellular Networks Section,0.0
Malaria Immunology Section,Fungal Pathogenesis Section,0.0
Malaria Immunology Section,Gene Regulation Section,0.0
Malaria Immunology Section,Genetic Engineering Section,0.0
Malaria Immunology Section,Genetic Immunotherapy Section,0.0
Malaria Immunology Section,HIV Immunovirology Section,0.0
Malaria Immunology Section,HIV Pathogenesis Section,0.0
Malaria Immunology Section,HIV-Specific Immunity Section,0.0
Malaria Immunology Section,Helminth Immunology Section,0.0
Malaria Immunology Section,Hepatic Pathogenesis Section,0.0
Malaria Immunology Section,Host-Parasite Interactions Section,0.0
Malaria Immunology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Malaria Immunology Section,Human Eosinophil Section,0.0
Malaria Immunology Section,Human Immunological Diseases Section,0.0
Malaria Immunology Section,Immune Activation Section,0.0
Malaria Immunology Section,Immune Deficiency Genetics Section,0.0
Malaria Immunology Section,Immunity to Pulmonary Pathogens Section,0.0
Malaria Immunology Section,Immunobiology and Molecular Virology Unit,0.0
Malaria Immunology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Malaria Immunology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Malaria Immunology Section,Infectious Disease Fellowship Training Program,0.0
Malaria Immunology Section,Inflammation & Innate Immunity Unit,0.0
Malaria Immunology Section,Inflammation Biology Section,0.0
Malaria Immunology Section,Innate Immunity and Pathogenesis Section,0.0
Malaria Immunology Section,Integrative Immunobiology Section,0.0
Malaria Immunology Section,International HIV/STD Section,0.0
Malaria Immunology Section,LID Clinical Studies Unit,0.0
Malaria Immunology Section,Lung and Vascular Inflammation Section,0.0
Malaria Immunology Section,Lyme Disease Studies Unit,0.0
Malaria Immunology Section,Lymphocyte Biology Section,0.0
Malaria Infection Biology and Immunity Unit,Allergy and Immunology Clinical Training Program,0.0
Malaria Infection Biology and Immunity Unit,Antibacterial Host Defense Unit,0.0
Malaria Infection Biology and Immunity Unit,Autoimmunity and Functional Genomics Section,0.0
Malaria Infection Biology and Immunity Unit,B-Cell Molecular Immunology Section,0.0
Malaria Infection Biology and Immunity Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Malaria Infection Biology and Immunity Unit,Bacterial Physiology and Metabolism Unit,0.0
Malaria Infection Biology and Immunity Unit,Barrier Immunity Section,0.0
Malaria Infection Biology and Immunity Unit,Biological Imaging,0.0
Malaria Infection Biology and Immunity Unit,Biology of Vector-Borne Viruses Section,0.0
Malaria Infection Biology and Immunity Unit,Building 14B South,0.0
Malaria Infection Biology and Immunity Unit,Building 33,0.0
Malaria Infection Biology and Immunity Unit,Building 50,0.0
Malaria Infection Biology and Immunity Unit,Building NIHAC/103,0.0
Malaria Infection Biology and Immunity Unit,Buildings 4 and 10/11C127,0.0
Malaria Infection Biology and Immunity Unit,Caliciviruses Section,0.0
Malaria Infection Biology and Immunity Unit,Cell Signaling and Immunity Section,0.0
Malaria Infection Biology and Immunity Unit,Cellular Biology Section,0.0
Malaria Infection Biology and Immunity Unit,Cellular Immunology Section,0.0
Malaria Infection Biology and Immunity Unit,Chemotaxis Signal Section,0.0
Malaria Infection Biology and Immunity Unit,Chlamydial Diseases Section,0.0
Malaria Infection Biology and Immunity Unit,Clinical Microbiome Unit (CMU),0.0
Malaria Infection Biology and Immunity Unit,Clinical Pathophysiology Section,0.0
Malaria Infection Biology and Immunity Unit,Clinical Research Section,0.0
Malaria Infection Biology and Immunity Unit,Clinical and Molecular Retrovirology Section,0.0
Malaria Infection Biology and Immunity Unit,Computational Biology Unit,0.0
Malaria Infection Biology and Immunity Unit,Coxiella Pathogenesis Section,0.0
Malaria Infection Biology and Immunity Unit,DNA Tumor Virus Section,0.0
Malaria Infection Biology and Immunity Unit,Disease Modeling and Transmission Section,0.0
Malaria Infection Biology and Immunity Unit,Emerging Respiratory Viruses Section,0.0
Malaria Infection Biology and Immunity Unit,Emerging Virus Immunity Unit,0.0
Malaria Infection Biology and Immunity Unit,Epidemiology and Population Studies Unit,0.0
Malaria Infection Biology and Immunity Unit,Epithelial Therapeutics Unit,0.0
Malaria Infection Biology and Immunity Unit,Flow Cytometry Section,0.0
Malaria Infection Biology and Immunity Unit,Food Allergy Research Section,0.0
Malaria Infection Biology and Immunity Unit,Functional Cellular Networks Section,0.0
Malaria Infection Biology and Immunity Unit,Fungal Pathogenesis Section,0.0
Malaria Infection Biology and Immunity Unit,Gene Regulation Section,0.0
Malaria Infection Biology and Immunity Unit,Genetic Engineering Section,0.0
Malaria Infection Biology and Immunity Unit,Genetic Immunotherapy Section,0.0
Malaria Infection Biology and Immunity Unit,Genomic Technologies Section,0.0
Malaria Infection Biology and Immunity Unit,HIV Immunovirology Section,0.0
Malaria Infection Biology and Immunity Unit,HIV Pathogenesis Section,0.0
Malaria Infection Biology and Immunity Unit,HIV-Specific Immunity Section,0.0
Malaria Infection Biology and Immunity Unit,Hepatic Pathogenesis Section,0.0
Malaria Infection Biology and Immunity Unit,Host-Parasite Interactions Section,0.0
Malaria Infection Biology and Immunity Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Malaria Infection Biology and Immunity Unit,Human Eosinophil Section,0.0
Malaria Infection Biology and Immunity Unit,Human Immunological Diseases Section,0.0
Malaria Infection Biology and Immunity Unit,Immune Activation Section,0.0
Malaria Infection Biology and Immunity Unit,Immune Deficiency Genetics Section,0.0
Malaria Infection Biology and Immunity Unit,Immunity to Pulmonary Pathogens Section,0.0
Malaria Infection Biology and Immunity Unit,Immunobiology Section,0.0
Malaria Infection Biology and Immunity Unit,Immunobiology and Molecular Virology Unit,0.0
Malaria Infection Biology and Immunity Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Malaria Infection Biology and Immunity Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Malaria Infection Biology and Immunity Unit,Infectious Disease Fellowship Training Program,0.0
Malaria Infection Biology and Immunity Unit,Infectious Disease Pathogenesis Section,0.0
Malaria Infection Biology and Immunity Unit,Inflammation & Innate Immunity Unit,0.0
Malaria Infection Biology and Immunity Unit,Inflammation Biology Section,0.0
Malaria Infection Biology and Immunity Unit,Innate Immunity and Pathogenesis Section,0.0
Malaria Infection Biology and Immunity Unit,Integrative Immunobiology Section,0.0
Malaria Infection Biology and Immunity Unit,International HIV/STD Section,0.0
Malaria Infection Biology and Immunity Unit,Intracellular Parasite Biology Section,0.0
Malaria Infection Biology and Immunity Unit,LID Clinical Studies Unit,0.0
Malaria Infection Biology and Immunity Unit,Lung and Vascular Inflammation Section,0.0
Malaria Infection Biology and Immunity Unit,Lyme Disease Studies Unit,0.0
Malaria Infection Biology and Immunity Unit,Lymphocyte Biology Section,0.0
Malaria Infection Biology and Immunity Unit,Malaria Functional Genomics Section,0.0
Malaria Infection Biology and Immunity Unit,Malaria Genetics Section,0.0
Mast Cell Biology Section,Antibacterial Host Defense Unit,0.0
Mast Cell Biology Section,Antibody Biology Unit,0.0
Mast Cell Biology Section,Apicomplexan Molecular Physiology Section,0.0
Mast Cell Biology Section,B-Cell Molecular Immunology Section,0.0
Mast Cell Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Mast Cell Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Mast Cell Biology Section,Barrier Immunity Section,0.0
Mast Cell Biology Section,Biological Imaging,0.0
Mast Cell Biology Section,Biology of Vector-Borne Viruses Section,0.0
Mast Cell Biology Section,Building 14B South,0.0
Mast Cell Biology Section,Building 33,0.0
Mast Cell Biology Section,Building 50,0.0
Mast Cell Biology Section,Building NIHAC/103,0.0
Mast Cell Biology Section,Buildings 4 and 10/11C127,0.0
Mast Cell Biology Section,Caliciviruses Section,0.0
Mast Cell Biology Section,Cell Signaling and Immunity Section,0.0
Mast Cell Biology Section,Cellular Biology Section,0.0
Mast Cell Biology Section,Cellular Immunology Section,0.0
Mast Cell Biology Section,Chemotaxis Signal Section,0.0
Mast Cell Biology Section,Chlamydial Diseases Section,0.0
Mast Cell Biology Section,Clinical Microbiome Unit (CMU),0.0
Mast Cell Biology Section,Clinical Pathophysiology Section,0.0
Mast Cell Biology Section,Clinical Research Section,0.0
Mast Cell Biology Section,Clinical and Molecular Retrovirology Section,0.0
Mast Cell Biology Section,Computational Biology Unit,0.0
Mast Cell Biology Section,Coxiella Pathogenesis Section,0.0
Mast Cell Biology Section,DNA Tumor Virus Section,0.0
Mast Cell Biology Section,Disease Modeling and Transmission Section,0.0
Mast Cell Biology Section,Emerging Respiratory Viruses Section,0.0
Mast Cell Biology Section,Emerging Virus Immunity Unit,0.0
Mast Cell Biology Section,Epidemiology and Population Studies Unit,0.0
Mast Cell Biology Section,Flow Cytometry Section,0.0
Mast Cell Biology Section,Food Allergy Research Section,0.0
Mast Cell Biology Section,Functional Cellular Networks Section,0.0
Mast Cell Biology Section,Fungal Pathogenesis Section,0.0
Mast Cell Biology Section,Gene Regulation Section,0.0
Mast Cell Biology Section,Genetic Engineering Section,0.0
Mast Cell Biology Section,Genetic Immunotherapy Section,0.0
Mast Cell Biology Section,Genomic Technologies Section,0.0
Mast Cell Biology Section,HIV Immunovirology Section,0.0
Mast Cell Biology Section,HIV Pathogenesis Section,0.0
Mast Cell Biology Section,HIV-Specific Immunity Section,0.0
Mast Cell Biology Section,Hepatic Pathogenesis Section,0.0
Mast Cell Biology Section,Host-Parasite Interactions Section,0.0
Mast Cell Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Mast Cell Biology Section,Human Immunological Diseases Section,0.0
Mast Cell Biology Section,Immune Activation Section,0.0
Mast Cell Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Mast Cell Biology Section,Immunobiology Section,0.0
Mast Cell Biology Section,Immunobiology and Molecular Virology Unit,0.0
Mast Cell Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Mast Cell Biology Section,Infectious Disease Fellowship Training Program,0.0
Mast Cell Biology Section,Infectious Disease Pathogenesis Section,0.0
Mast Cell Biology Section,Inflammation & Innate Immunity Unit,0.0
Mast Cell Biology Section,Inflammation Biology Section,0.0
Mast Cell Biology Section,Innate Immunity and Pathogenesis Section,0.0
Mast Cell Biology Section,Integrative Immunobiology Section,0.0
Mast Cell Biology Section,International HIV/STD Section,0.0
Mast Cell Biology Section,Intracellular Parasite Biology Section,0.0
Mast Cell Biology Section,LID Clinical Studies Unit,0.0
Mast Cell Biology Section,Lung and Vascular Inflammation Section,0.0
Mast Cell Biology Section,Lyme Disease Studies Unit,0.0
Mast Cell Biology Section,Lymphocyte Activation Section,0.0
Mast Cell Biology Section,Lymphocyte Biology Section,0.0
Mast Cell Biology Section,Malaria Cell Biology Section,0.0
Mast Cell Biology Section,Malaria Functional Genomics Section,0.0
Mast Cell Biology Section,Malaria Genetics Section,0.0
Mast Cell Biology Section,Malaria Immunology Section,0.0
Mast Cell Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Medical Virology Section,Allergy and Immunology Clinical Training Program,0.0
Medical Virology Section,Antibacterial Host Defense Unit,0.0
Medical Virology Section,Antibody Biology Unit,0.0
Medical Virology Section,Apicomplexan Molecular Physiology Section,0.0
Medical Virology Section,B-Cell Immunology Section,0.0
Medical Virology Section,B-Cell Molecular Immunology Section,0.0
Medical Virology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Medical Virology Section,Bacterial Physiology and Metabolism Unit,0.0
Medical Virology Section,Biological Imaging,0.0
Medical Virology Section,Biology of Vector-Borne Viruses Section,0.0
Medical Virology Section,Building 14B South,0.0
Medical Virology Section,Building 33,0.0
Medical Virology Section,Building 50,0.0
Medical Virology Section,Building NIHAC/103,0.0
Medical Virology Section,Buildings 4 and 10/11C127,0.0
Medical Virology Section,Cellular Biology Section,0.0
Medical Virology Section,Cellular Immunology Section,0.0
Medical Virology Section,Chemotaxis Signal Section,0.0
Medical Virology Section,Chlamydial Diseases Section,0.0
Medical Virology Section,Clinical Microbiome Unit (CMU),0.0
Medical Virology Section,Clinical Pathophysiology Section,0.0
Medical Virology Section,Clinical Research Section,0.0
Medical Virology Section,Clinical and Molecular Retrovirology Section,0.0
Medical Virology Section,Computational Biology Unit,0.0
Medical Virology Section,Coxiella Pathogenesis Section,0.0
Medical Virology Section,DNA Tumor Virus Section,0.0
Medical Virology Section,Disease Modeling and Transmission Section,0.0
Medical Virology Section,Emerging Virus Immunity Unit,0.0
Medical Virology Section,Epidemiology and Population Studies Unit,0.0
Medical Virology Section,Epithelial Therapeutics Unit,0.0
Medical Virology Section,Flow Cytometry Section,0.0
Medical Virology Section,Food Allergy Research Section,0.0
Medical Virology Section,Functional Cellular Networks Section,0.0
Medical Virology Section,Gene Regulation Section,0.0
Medical Virology Section,Genetic Immunotherapy Section,0.0
Medical Virology Section,HIV Immunovirology Section,0.0
Medical Virology Section,HIV-Specific Immunity Section,0.0
Medical Virology Section,Helminth Immunology Section,0.0
Medical Virology Section,Hepatic Pathogenesis Section,0.0
Medical Virology Section,Host-Parasite Interactions Section,0.0
Medical Virology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Medical Virology Section,Immunity to Pulmonary Pathogens Section,0.0
Medical Virology Section,Immunobiology Section,0.0
Medical Virology Section,Immunobiology and Molecular Virology Unit,0.0
Medical Virology Section,Infectious Disease Fellowship Training Program,0.0
Medical Virology Section,Infectious Disease Pathogenesis Section,0.0
Medical Virology Section,Inflammation & Innate Immunity Unit,0.0
Medical Virology Section,Inflammation Biology Section,0.0
Medical Virology Section,Innate Immunity and Pathogenesis Section,0.0
Medical Virology Section,Integrative Immunobiology Section,0.0
Medical Virology Section,Intracellular Parasite Biology Section,0.0
Medical Virology Section,LID Clinical Studies Unit,0.0
Medical Virology Section,Lung and Vascular Inflammation Section,0.0
Medical Virology Section,Lymphocyte Activation Section,0.0
Medical Virology Section,Lymphocyte Biology Section,0.0
Medical Virology Section,Malaria Cell Biology Section,0.0
Medical Virology Section,Malaria Genetics Section,0.0
Medical Virology Section,Malaria Infection Biology and Immunity Unit,0.0
Medical Virology Section,Mast Cell Biology Section,0.0
Metaorganism Immunity Section,Allergy and Immunology Clinical Training Program,0.0
Metaorganism Immunity Section,Antibacterial Host Defense Unit,0.0
Metaorganism Immunity Section,Antibody Biology Unit,0.0
Metaorganism Immunity Section,Apicomplexan Molecular Physiology Section,0.0
Metaorganism Immunity Section,Autoimmunity and Functional Genomics Section,0.0
Metaorganism Immunity Section,B-Cell Immunology Section,0.0
Metaorganism Immunity Section,B-Cell Molecular Immunology Section,0.0
Metaorganism Immunity Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Metaorganism Immunity Section,Bacterial Physiology and Metabolism Unit,0.0
Metaorganism Immunity Section,Biological Imaging,0.0
Metaorganism Immunity Section,Biology of Vector-Borne Viruses Section,0.0
Metaorganism Immunity Section,Building 14B South,0.0
Metaorganism Immunity Section,Building 33,0.0
Metaorganism Immunity Section,Building 50,0.0
Metaorganism Immunity Section,Building NIHAC/103,0.0
Metaorganism Immunity Section,Buildings 4 and 10/11C127,0.0
Metaorganism Immunity Section,Caliciviruses Section,0.0
Metaorganism Immunity Section,Cellular Biology Section,0.0
Metaorganism Immunity Section,Chemotaxis Signal Section,0.0
Metaorganism Immunity Section,Chlamydial Diseases Section,0.0
Metaorganism Immunity Section,Clinical Microbiome Unit (CMU),0.0
Metaorganism Immunity Section,Clinical Pathophysiology Section,0.0
Metaorganism Immunity Section,Clinical Research Section,0.0
Metaorganism Immunity Section,Clinical and Molecular Retrovirology Section,0.0
Metaorganism Immunity Section,Computational Biology Unit,0.0
Metaorganism Immunity Section,Coxiella Pathogenesis Section,0.0
Metaorganism Immunity Section,DNA Tumor Virus Section,0.0
Metaorganism Immunity Section,Disease Modeling and Transmission Section,0.0
Metaorganism Immunity Section,Emerging Respiratory Viruses Section,0.0
Metaorganism Immunity Section,Emerging Virus Immunity Unit,0.0
Metaorganism Immunity Section,Epidemiology and Population Studies Unit,0.0
Metaorganism Immunity Section,Flow Cytometry Section,0.0
Metaorganism Immunity Section,Food Allergy Research Section,0.0
Metaorganism Immunity Section,Functional Cellular Networks Section,0.0
Metaorganism Immunity Section,Gene Regulation Section,0.0
Metaorganism Immunity Section,Genetic Engineering Section,0.0
Metaorganism Immunity Section,Genetic Immunotherapy Section,0.0
Metaorganism Immunity Section,Genomic Technologies Section,0.0
Metaorganism Immunity Section,HIV Immunovirology Section,0.0
Metaorganism Immunity Section,HIV-Specific Immunity Section,0.0
Metaorganism Immunity Section,Hepatic Pathogenesis Section,0.0
Metaorganism Immunity Section,Host-Parasite Interactions Section,0.0
Metaorganism Immunity Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Metaorganism Immunity Section,Human Eosinophil Section,0.0
Metaorganism Immunity Section,Human Immunological Diseases Section,0.0
Metaorganism Immunity Section,Immunity to Pulmonary Pathogens Section,0.0
Metaorganism Immunity Section,Immunobiology and Molecular Virology Unit,0.0
Metaorganism Immunity Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Metaorganism Immunity Section,Infectious Disease Fellowship Training Program,0.0
Metaorganism Immunity Section,Infectious Disease Pathogenesis Section,0.0
Metaorganism Immunity Section,Inflammation & Innate Immunity Unit,0.0
Metaorganism Immunity Section,Inflammation Biology Section,0.0
Metaorganism Immunity Section,Innate Immunity and Pathogenesis Section,0.0
Metaorganism Immunity Section,Integrative Immunobiology Section,0.0
Metaorganism Immunity Section,International HIV/STD Section,0.0
Metaorganism Immunity Section,LID Clinical Studies Unit,0.0
Metaorganism Immunity Section,Lung and Vascular Inflammation Section,0.0
Metaorganism Immunity Section,Lyme Disease Studies Unit,0.0
Metaorganism Immunity Section,Lymphocyte Activation Section,0.0
Metaorganism Immunity Section,Malaria Cell Biology Section,0.0
Metaorganism Immunity Section,Malaria Genetics Section,0.0
Metaorganism Immunity Section,Malaria Immunology Section,0.0
Metaorganism Immunity Section,Malaria Infection Biology and Immunity Unit,0.0
Metaorganism Immunity Section,Mast Cell Biology Section,0.0
Metaorganism Immunity Section,Medical Virology Section,0.0
Microbial Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
Microbial Pathogenesis Section,Antibacterial Host Defense Unit,0.0
Microbial Pathogenesis Section,Antibody Biology Unit,0.0
Microbial Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
Microbial Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
Microbial Pathogenesis Section,B-Cell Immunology Section,0.0
Microbial Pathogenesis Section,B-Cell Molecular Immunology Section,0.0
Microbial Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Microbial Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
Microbial Pathogenesis Section,Barrier Immunity Section,0.0
Microbial Pathogenesis Section,Biological Imaging,0.0
Microbial Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.0
Microbial Pathogenesis Section,Building 14B South,0.0
Microbial Pathogenesis Section,Building 33,0.0
Microbial Pathogenesis Section,Building 50,0.0
Microbial Pathogenesis Section,Building NIHAC/103,0.0
Microbial Pathogenesis Section,Buildings 4 and 10/11C127,0.0
Microbial Pathogenesis Section,Caliciviruses Section,0.0
Microbial Pathogenesis Section,Cell Signaling and Immunity Section,0.0
Microbial Pathogenesis Section,Cellular Biology Section,0.0
Microbial Pathogenesis Section,Cellular Immunology Section,0.0
Microbial Pathogenesis Section,Chemotaxis Signal Section,0.0
Microbial Pathogenesis Section,Chlamydial Diseases Section,0.0
Microbial Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
Microbial Pathogenesis Section,Clinical Pathophysiology Section,0.0
Microbial Pathogenesis Section,Clinical Research Section,0.0
Microbial Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.0
Microbial Pathogenesis Section,Computational Biology Unit,0.0
Microbial Pathogenesis Section,Coxiella Pathogenesis Section,0.0
Microbial Pathogenesis Section,DNA Tumor Virus Section,0.0
Microbial Pathogenesis Section,Disease Modeling and Transmission Section,0.0
Microbial Pathogenesis Section,Emerging Respiratory Viruses Section,0.0
Microbial Pathogenesis Section,Emerging Virus Immunity Unit,0.0
Microbial Pathogenesis Section,Epidemiology and Population Studies Unit,0.0
Microbial Pathogenesis Section,Epithelial Therapeutics Unit,0.0
Microbial Pathogenesis Section,Flow Cytometry Section,0.0
Microbial Pathogenesis Section,Food Allergy Research Section,0.0
Microbial Pathogenesis Section,Functional Cellular Networks Section,0.0
Microbial Pathogenesis Section,Fungal Pathogenesis Section,0.0
Microbial Pathogenesis Section,Gene Regulation Section,0.0
Microbial Pathogenesis Section,Genetic Engineering Section,0.0
Microbial Pathogenesis Section,Genomic Technologies Section,0.0
Microbial Pathogenesis Section,HIV Immunovirology Section,0.0
Microbial Pathogenesis Section,HIV-Specific Immunity Section,0.0
Microbial Pathogenesis Section,Hepatic Pathogenesis Section,0.0
Microbial Pathogenesis Section,Host-Parasite Interactions Section,0.0
Microbial Pathogenesis Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Microbial Pathogenesis Section,Human Eosinophil Section,0.0
Microbial Pathogenesis Section,Human Immunological Diseases Section,0.0
Microbial Pathogenesis Section,Immune Activation Section,0.0
Microbial Pathogenesis Section,Immune Deficiency Genetics Section,0.0
Microbial Pathogenesis Section,Immunity to Pulmonary Pathogens Section,0.0
Microbial Pathogenesis Section,Immunobiology and Molecular Virology Unit,0.0
Microbial Pathogenesis Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Microbial Pathogenesis Section,Infectious Disease Fellowship Training Program,0.0
Microbial Pathogenesis Section,Infectious Disease Pathogenesis Section,0.0
Microbial Pathogenesis Section,Inflammation Biology Section,0.0
Microbial Pathogenesis Section,Innate Immunity and Pathogenesis Section,0.0
Microbial Pathogenesis Section,Integrative Immunobiology Section,0.0
Microbial Pathogenesis Section,International HIV/STD Section,0.0
Microbial Pathogenesis Section,Intracellular Parasite Biology Section,0.0
Microbial Pathogenesis Section,LID Clinical Studies Unit,0.0
Microbial Pathogenesis Section,Lung and Vascular Inflammation Section,0.0
Microbial Pathogenesis Section,Lyme Disease Studies Unit,0.0
Microbial Pathogenesis Section,Lymphocyte Activation Section,0.0
Microbial Pathogenesis Section,Lymphocyte Biology Section,0.0
Microbial Pathogenesis Section,Malaria Cell Biology Section,0.0
Microbial Pathogenesis Section,Malaria Functional Genomics Section,0.0
Microbial Pathogenesis Section,Malaria Genetics Section,0.0
Microbial Pathogenesis Section,Malaria Immunology Section,0.0
Microbial Pathogenesis Section,Malaria Infection Biology and Immunity Unit,0.0
Microbial Pathogenesis Section,Mast Cell Biology Section,0.0
Microbial Pathogenesis Section,Medical Virology Section,0.0
Microbial Pathogenesis Section,Metaorganism Immunity Section,0.0
Molecular Biology Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Biology Section,Antibacterial Host Defense Unit,0.0
Molecular Biology Section,Antibody Biology Unit,0.0
Molecular Biology Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Biology Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Biology Section,B-Cell Immunology Section,0.0
Molecular Biology Section,B-Cell Molecular Immunology Section,0.0
Molecular Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Biology Section,Barrier Immunity Section,0.0
Molecular Biology Section,Biological Imaging,0.0
Molecular Biology Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Biology Section,Building 14B South,0.0
Molecular Biology Section,Building 33,0.0
Molecular Biology Section,Building 50,0.0
Molecular Biology Section,Building NIHAC/103,0.0
Molecular Biology Section,Buildings 4 and 10/11C127,0.0
Molecular Biology Section,Caliciviruses Section,0.0
Molecular Biology Section,Cell Signaling and Immunity Section,0.0
Molecular Biology Section,Cellular Biology Section,0.0
Molecular Biology Section,Chemotaxis Signal Section,0.0
Molecular Biology Section,Chlamydial Diseases Section,0.0
Molecular Biology Section,Clinical Microbiome Unit (CMU),0.0
Molecular Biology Section,Clinical Pathophysiology Section,0.0
Molecular Biology Section,Clinical Research Section,0.0
Molecular Biology Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Biology Section,Computational Biology Unit,0.0
Molecular Biology Section,Coxiella Pathogenesis Section,0.0
Molecular Biology Section,DNA Tumor Virus Section,0.0
Molecular Biology Section,Disease Modeling and Transmission Section,0.0
Molecular Biology Section,Emerging Respiratory Viruses Section,0.0
Molecular Biology Section,Emerging Virus Immunity Unit,0.0
Molecular Biology Section,Epidemiology and Population Studies Unit,0.0
Molecular Biology Section,Epithelial Therapeutics Unit,0.0
Molecular Biology Section,Flow Cytometry Section,0.0
Molecular Biology Section,Food Allergy Research Section,0.0
Molecular Biology Section,Functional Cellular Networks Section,0.0
Molecular Biology Section,Fungal Pathogenesis Section,0.0
Molecular Biology Section,Gene Regulation Section,0.0
Molecular Biology Section,Genetic Engineering Section,0.0
Molecular Biology Section,Genetic Immunotherapy Section,0.0
Molecular Biology Section,Genomic Technologies Section,0.0
Molecular Biology Section,HIV Immunovirology Section,0.0
Molecular Biology Section,HIV Pathogenesis Section,0.0
Molecular Biology Section,HIV-Specific Immunity Section,0.0
Molecular Biology Section,Helminth Immunology Section,0.0
Molecular Biology Section,Hepatic Pathogenesis Section,0.0
Molecular Biology Section,Host-Parasite Interactions Section,0.0
Molecular Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Biology Section,Human Eosinophil Section,0.0
Molecular Biology Section,Human Immunological Diseases Section,0.0
Molecular Biology Section,Immune Activation Section,0.0
Molecular Biology Section,Immune Deficiency Genetics Section,0.0
Molecular Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Biology Section,Immunobiology Section,0.0
Molecular Biology Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Biology Section,Infectious Disease Fellowship Training Program,0.0
Molecular Biology Section,Infectious Disease Pathogenesis Section,0.0
Molecular Biology Section,Inflammation & Innate Immunity Unit,0.0
Molecular Biology Section,Inflammation Biology Section,0.0
Molecular Biology Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Biology Section,Integrative Immunobiology Section,0.0
Molecular Biology Section,International HIV/STD Section,0.0
Molecular Biology Section,Intracellular Parasite Biology Section,0.0
Molecular Biology Section,LID Clinical Studies Unit,0.0
Molecular Biology Section,Lung and Vascular Inflammation Section,0.0
Molecular Biology Section,Lyme Disease Studies Unit,0.0
Molecular Biology Section,Lymphocyte Activation Section,0.0
Molecular Biology Section,Lymphocyte Biology Section,0.0
Molecular Biology Section,Malaria Cell Biology Section,0.0
Molecular Biology Section,Malaria Functional Genomics Section,0.0
Molecular Biology Section,Malaria Genetics Section,0.0
Molecular Biology Section,Malaria Immunology Section,0.0
Molecular Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Biology Section,Mast Cell Biology Section,0.0
Molecular Biology Section,Medical Virology Section,0.0
Molecular Biology Section,Metaorganism Immunity Section,0.0
Molecular Biology Section,Microbial Pathogenesis Section,0.0
Molecular Defenses Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Defenses Section,Antibacterial Host Defense Unit,0.0
Molecular Defenses Section,Antibody Biology Unit,0.0
Molecular Defenses Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Defenses Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Defenses Section,B-Cell Immunology Section,0.0
Molecular Defenses Section,B-Cell Molecular Immunology Section,0.0
Molecular Defenses Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Defenses Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Defenses Section,Barrier Immunity Section,0.0
Molecular Defenses Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Defenses Section,Building 14B South,0.0
Molecular Defenses Section,Building 33,0.0
Molecular Defenses Section,Building 50,0.0
Molecular Defenses Section,Building NIHAC/103,0.0
Molecular Defenses Section,Buildings 4 and 10/11C127,0.0
Molecular Defenses Section,Caliciviruses Section,0.0
Molecular Defenses Section,Cell Signaling and Immunity Section,0.0
Molecular Defenses Section,Cellular Biology Section,0.0
Molecular Defenses Section,Cellular Immunology Section,0.0
Molecular Defenses Section,Chemotaxis Signal Section,0.0
Molecular Defenses Section,Chlamydial Diseases Section,0.0
Molecular Defenses Section,Clinical Microbiome Unit (CMU),0.0
Molecular Defenses Section,Clinical Research Section,0.0
Molecular Defenses Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Defenses Section,Computational Biology Unit,0.0
Molecular Defenses Section,Coxiella Pathogenesis Section,0.0
Molecular Defenses Section,DNA Tumor Virus Section,0.0
Molecular Defenses Section,Disease Modeling and Transmission Section,0.0
Molecular Defenses Section,Emerging Respiratory Viruses Section,0.0
Molecular Defenses Section,Emerging Virus Immunity Unit,0.0
Molecular Defenses Section,Epidemiology and Population Studies Unit,0.0
Molecular Defenses Section,Epithelial Therapeutics Unit,0.0
Molecular Defenses Section,Flow Cytometry Section,0.0
Molecular Defenses Section,Food Allergy Research Section,0.0
Molecular Defenses Section,Functional Cellular Networks Section,0.0
Molecular Defenses Section,Gene Regulation Section,0.0
Molecular Defenses Section,Genetic Engineering Section,0.0
Molecular Defenses Section,HIV Immunovirology Section,0.0
Molecular Defenses Section,HIV Pathogenesis Section,0.0
Molecular Defenses Section,HIV-Specific Immunity Section,0.0
Molecular Defenses Section,Helminth Immunology Section,0.0
Molecular Defenses Section,Hepatic Pathogenesis Section,0.0
Molecular Defenses Section,Host-Parasite Interactions Section,0.0
Molecular Defenses Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Defenses Section,Human Eosinophil Section,0.0
Molecular Defenses Section,Human Immunological Diseases Section,0.0
Molecular Defenses Section,Immune Deficiency Genetics Section,0.0
Molecular Defenses Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Defenses Section,Immunobiology Section,0.0
Molecular Defenses Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Defenses Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Defenses Section,Infectious Disease Fellowship Training Program,0.0
Molecular Defenses Section,Infectious Disease Pathogenesis Section,0.0
Molecular Defenses Section,Inflammation & Innate Immunity Unit,0.0
Molecular Defenses Section,Inflammation Biology Section,0.0
Molecular Defenses Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Defenses Section,Integrative Immunobiology Section,0.0
Molecular Defenses Section,International HIV/STD Section,0.0
Molecular Defenses Section,Intracellular Parasite Biology Section,0.0
Molecular Defenses Section,LID Clinical Studies Unit,0.0
Molecular Defenses Section,Lung and Vascular Inflammation Section,0.0
Molecular Defenses Section,Lyme Disease Studies Unit,0.0
Molecular Defenses Section,Lymphocyte Biology Section,0.0
Molecular Defenses Section,Malaria Functional Genomics Section,0.0
Molecular Defenses Section,Malaria Genetics Section,0.0
Molecular Defenses Section,Malaria Immunology Section,0.0
Molecular Defenses Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Defenses Section,Mast Cell Biology Section,0.0
Molecular Defenses Section,Medical Virology Section,0.0
Molecular Defenses Section,Metaorganism Immunity Section,0.0
Molecular Defenses Section,Microbial Pathogenesis Section,0.0
Molecular Defenses Section,Molecular Biology Section,0.0
Molecular Development of the Immune System Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Development of the Immune System Section,Antibacterial Host Defense Unit,0.0
Molecular Development of the Immune System Section,Antibody Biology Unit,0.0
Molecular Development of the Immune System Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Development of the Immune System Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Development of the Immune System Section,B-Cell Molecular Immunology Section,0.0
Molecular Development of the Immune System Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Development of the Immune System Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Development of the Immune System Section,Barrier Immunity Section,0.0
Molecular Development of the Immune System Section,Biological Imaging,0.0
Molecular Development of the Immune System Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Development of the Immune System Section,Building 14B South,0.0
Molecular Development of the Immune System Section,Building 33,0.0
Molecular Development of the Immune System Section,Building 50,0.0
Molecular Development of the Immune System Section,Building NIHAC/103,0.0
Molecular Development of the Immune System Section,Buildings 4 and 10/11C127,0.0
Molecular Development of the Immune System Section,Caliciviruses Section,0.0
Molecular Development of the Immune System Section,Cellular Biology Section,0.0
Molecular Development of the Immune System Section,Cellular Immunology Section,0.0
Molecular Development of the Immune System Section,Chemotaxis Signal Section,0.0
Molecular Development of the Immune System Section,Chlamydial Diseases Section,0.0
Molecular Development of the Immune System Section,Clinical Microbiome Unit (CMU),0.0
Molecular Development of the Immune System Section,Clinical Pathophysiology Section,0.0
Molecular Development of the Immune System Section,Clinical Research Section,0.0
Molecular Development of the Immune System Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Development of the Immune System Section,Computational Biology Unit,0.0
Molecular Development of the Immune System Section,Coxiella Pathogenesis Section,0.0
Molecular Development of the Immune System Section,DNA Tumor Virus Section,0.0
Molecular Development of the Immune System Section,Disease Modeling and Transmission Section,0.0
Molecular Development of the Immune System Section,Emerging Virus Immunity Unit,0.0
Molecular Development of the Immune System Section,Epidemiology and Population Studies Unit,0.0
Molecular Development of the Immune System Section,Epithelial Therapeutics Unit,0.0
Molecular Development of the Immune System Section,Flow Cytometry Section,0.0
Molecular Development of the Immune System Section,Food Allergy Research Section,0.0
Molecular Development of the Immune System Section,Functional Cellular Networks Section,0.0
Molecular Development of the Immune System Section,Fungal Pathogenesis Section,0.0
Molecular Development of the Immune System Section,Gene Regulation Section,0.0
Molecular Development of the Immune System Section,Genetic Immunotherapy Section,0.0
Molecular Development of the Immune System Section,Genomic Technologies Section,0.0
Molecular Development of the Immune System Section,HIV Immunovirology Section,0.0
Molecular Development of the Immune System Section,HIV Pathogenesis Section,0.0
Molecular Development of the Immune System Section,HIV-Specific Immunity Section,0.0
Molecular Development of the Immune System Section,Helminth Immunology Section,0.0
Molecular Development of the Immune System Section,Hepatic Pathogenesis Section,0.0
Molecular Development of the Immune System Section,Host-Parasite Interactions Section,0.0
Molecular Development of the Immune System Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Development of the Immune System Section,Human Eosinophil Section,0.0
Molecular Development of the Immune System Section,Immune Activation Section,0.0
Molecular Development of the Immune System Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Development of the Immune System Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Development of the Immune System Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Development of the Immune System Section,Infectious Disease Fellowship Training Program,0.0
Molecular Development of the Immune System Section,Infectious Disease Pathogenesis Section,0.0
Molecular Development of the Immune System Section,Inflammation & Innate Immunity Unit,0.0
Molecular Development of the Immune System Section,Inflammation Biology Section,0.0
Molecular Development of the Immune System Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Development of the Immune System Section,Intracellular Parasite Biology Section,0.0
Molecular Development of the Immune System Section,LID Clinical Studies Unit,0.0
Molecular Development of the Immune System Section,Lung and Vascular Inflammation Section,0.0
Molecular Development of the Immune System Section,Lyme Disease Studies Unit,0.0
Molecular Development of the Immune System Section,Lymphocyte Activation Section,0.0
Molecular Development of the Immune System Section,Lymphocyte Biology Section,0.0
Molecular Development of the Immune System Section,Malaria Cell Biology Section,0.0
Molecular Development of the Immune System Section,Malaria Functional Genomics Section,0.0
Molecular Development of the Immune System Section,Malaria Genetics Section,0.0
Molecular Development of the Immune System Section,Malaria Immunology Section,0.0
Molecular Development of the Immune System Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Development of the Immune System Section,Mast Cell Biology Section,0.0
Molecular Development of the Immune System Section,Metaorganism Immunity Section,0.0
Molecular Development of the Immune System Section,Microbial Pathogenesis Section,0.0
Molecular Development of the Immune System Section,Molecular Biology Section,0.0
Molecular Development of the Immune System Section,Molecular Defenses Section,0.0
Molecular Entomology Unit,Allergy and Immunology Clinical Training Program,0.0
Molecular Entomology Unit,Antibacterial Host Defense Unit,0.0
Molecular Entomology Unit,Antibody Biology Unit,0.0
Molecular Entomology Unit,Apicomplexan Molecular Physiology Section,0.0
Molecular Entomology Unit,Autoimmunity and Functional Genomics Section,0.0
Molecular Entomology Unit,B-Cell Immunology Section,0.0
Molecular Entomology Unit,B-Cell Molecular Immunology Section,0.0
Molecular Entomology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Entomology Unit,Bacterial Physiology and Metabolism Unit,0.0
Molecular Entomology Unit,Barrier Immunity Section,0.0
Molecular Entomology Unit,Biological Imaging,0.0
Molecular Entomology Unit,Biology of Vector-Borne Viruses Section,0.0
Molecular Entomology Unit,Building 14B South,0.0
Molecular Entomology Unit,Building 33,0.0
Molecular Entomology Unit,Building 50,0.0
Molecular Entomology Unit,Building NIHAC/103,0.0
Molecular Entomology Unit,Buildings 4 and 10/11C127,0.0
Molecular Entomology Unit,Caliciviruses Section,0.0
Molecular Entomology Unit,Cell Signaling and Immunity Section,0.0
Molecular Entomology Unit,Cellular Biology Section,0.0
Molecular Entomology Unit,Cellular Immunology Section,0.0
Molecular Entomology Unit,Chemotaxis Signal Section,0.0
Molecular Entomology Unit,Chlamydial Diseases Section,0.0
Molecular Entomology Unit,Clinical Microbiome Unit (CMU),0.0
Molecular Entomology Unit,Clinical Pathophysiology Section,0.0
Molecular Entomology Unit,Clinical Research Section,0.0
Molecular Entomology Unit,Clinical and Molecular Retrovirology Section,0.0
Molecular Entomology Unit,Computational Biology Unit,0.0
Molecular Entomology Unit,Coxiella Pathogenesis Section,0.0
Molecular Entomology Unit,DNA Tumor Virus Section,0.0
Molecular Entomology Unit,Disease Modeling and Transmission Section,0.0
Molecular Entomology Unit,Emerging Respiratory Viruses Section,0.0
Molecular Entomology Unit,Emerging Virus Immunity Unit,0.0
Molecular Entomology Unit,Epidemiology and Population Studies Unit,0.0
Molecular Entomology Unit,Epithelial Therapeutics Unit,0.0
Molecular Entomology Unit,Flow Cytometry Section,0.0
Molecular Entomology Unit,Food Allergy Research Section,0.0
Molecular Entomology Unit,Functional Cellular Networks Section,0.0
Molecular Entomology Unit,Fungal Pathogenesis Section,0.0
Molecular Entomology Unit,Gene Regulation Section,0.0
Molecular Entomology Unit,Genetic Engineering Section,0.0
Molecular Entomology Unit,Genetic Immunotherapy Section,0.0
Molecular Entomology Unit,Genomic Technologies Section,0.0
Molecular Entomology Unit,HIV Immunovirology Section,0.0
Molecular Entomology Unit,HIV Pathogenesis Section,0.0
Molecular Entomology Unit,HIV-Specific Immunity Section,0.0
Molecular Entomology Unit,Helminth Immunology Section,0.0
Molecular Entomology Unit,Hepatic Pathogenesis Section,0.0
Molecular Entomology Unit,Host-Parasite Interactions Section,0.0
Molecular Entomology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Entomology Unit,Human Eosinophil Section,0.0
Molecular Entomology Unit,Human Immunological Diseases Section,0.0
Molecular Entomology Unit,Immune Activation Section,0.0
Molecular Entomology Unit,Immune Deficiency Genetics Section,0.0
Molecular Entomology Unit,Immunity to Pulmonary Pathogens Section,0.0
Molecular Entomology Unit,Immunobiology Section,0.0
Molecular Entomology Unit,Immunobiology and Molecular Virology Unit,0.0
Molecular Entomology Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Entomology Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Entomology Unit,Infectious Disease Fellowship Training Program,0.0
Molecular Entomology Unit,Inflammation & Innate Immunity Unit,0.0
Molecular Entomology Unit,Inflammation Biology Section,0.0
Molecular Entomology Unit,Innate Immunity and Pathogenesis Section,0.0
Molecular Entomology Unit,Integrative Immunobiology Section,0.0
Molecular Entomology Unit,International HIV/STD Section,0.0
Molecular Entomology Unit,Intracellular Parasite Biology Section,0.0
Molecular Entomology Unit,LID Clinical Studies Unit,0.0
Molecular Entomology Unit,Lung and Vascular Inflammation Section,0.0
Molecular Entomology Unit,Lyme Disease Studies Unit,0.0
Molecular Entomology Unit,Lymphocyte Activation Section,0.0
Molecular Entomology Unit,Lymphocyte Biology Section,0.0
Molecular Entomology Unit,Malaria Cell Biology Section,0.0
Molecular Entomology Unit,Malaria Functional Genomics Section,0.0
Molecular Entomology Unit,Malaria Genetics Section,0.0
Molecular Entomology Unit,Malaria Immunology Section,0.0
Molecular Entomology Unit,Malaria Infection Biology and Immunity Unit,0.0
Molecular Entomology Unit,Mast Cell Biology Section,0.0
Molecular Entomology Unit,Medical Virology Section,0.0
Molecular Entomology Unit,Metaorganism Immunity Section,0.0
Molecular Entomology Unit,Microbial Pathogenesis Section,0.0
Molecular Entomology Unit,Molecular Biology Section,0.0
Molecular Entomology Unit,Molecular Defenses Section,0.0
Molecular Entomology Unit,Molecular Development of the Immune System Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Allergy and Immunology Clinical Training Program,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Antibacterial Host Defense Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Antibody Biology Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Apicomplexan Molecular Physiology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Autoimmunity and Functional Genomics Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),B-Cell Immunology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),B-Cell Molecular Immunology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Bacterial Physiology and Metabolism Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Barrier Immunity Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Biological Imaging,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Biology of Vector-Borne Viruses Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Building 14B South,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Building 33,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Building 50,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Building NIHAC/103,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Buildings 4 and 10/11C127,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Caliciviruses Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Cell Signaling and Immunity Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Cellular Biology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Cellular Immunology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Chemotaxis Signal Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Chlamydial Diseases Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Clinical Microbiome Unit (CMU),0.0
Molecular Genetics Section (Laboratory of Bacteriology),Clinical Pathophysiology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Clinical Research Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Clinical and Molecular Retrovirology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Computational Biology Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Coxiella Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),DNA Tumor Virus Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Disease Modeling and Transmission Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Emerging Respiratory Viruses Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Emerging Virus Immunity Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Epidemiology and Population Studies Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Epithelial Therapeutics Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Flow Cytometry Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Food Allergy Research Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Functional Cellular Networks Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Fungal Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Genetic Engineering Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Genetic Immunotherapy Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Genomic Technologies Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),HIV Immunovirology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),HIV Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),HIV-Specific Immunity Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Helminth Immunology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Hepatic Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Host-Parasite Interactions Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Human Eosinophil Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Human Immunological Diseases Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Immune Activation Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Immune Deficiency Genetics Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Immunity to Pulmonary Pathogens Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Immunobiology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Immunobiology and Molecular Virology Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Genetics Section (Laboratory of Bacteriology),Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Genetics Section (Laboratory of Bacteriology),Infectious Disease Fellowship Training Program,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Infectious Disease Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Inflammation & Innate Immunity Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Inflammation Biology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Innate Immunity and Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Integrative Immunobiology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),International HIV/STD Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Intracellular Parasite Biology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),LID Clinical Studies Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Lung and Vascular Inflammation Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Lyme Disease Studies Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Lymphocyte Activation Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Lymphocyte Biology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Malaria Cell Biology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Malaria Functional Genomics Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Malaria Genetics Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Malaria Immunology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Malaria Infection Biology and Immunity Unit,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Mast Cell Biology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Medical Virology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Metaorganism Immunity Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Microbial Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Molecular Biology Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Molecular Defenses Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Molecular Development of the Immune System Section,0.0
Molecular Genetics Section (Laboratory of Bacteriology),Molecular Entomology Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Allergy and Immunology Clinical Training Program,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Antibacterial Host Defense Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Antibody Biology Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Apicomplexan Molecular Physiology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Autoimmunity and Functional Genomics Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),B-Cell Immunology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),B-Cell Molecular Immunology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Bacterial Physiology and Metabolism Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Barrier Immunity Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Biological Imaging,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Biology of Vector-Borne Viruses Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Building 14B South,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Building 33,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Building 50,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Building NIHAC/103,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Buildings 4 and 10/11C127,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Caliciviruses Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Cell Signaling and Immunity Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Cellular Immunology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Chemotaxis Signal Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Chlamydial Diseases Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Clinical Microbiome Unit (CMU),0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Clinical Pathophysiology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Clinical Research Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Clinical and Molecular Retrovirology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Computational Biology Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Coxiella Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Disease Modeling and Transmission Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Emerging Respiratory Viruses Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Emerging Virus Immunity Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Epidemiology and Population Studies Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Epithelial Therapeutics Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Flow Cytometry Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Food Allergy Research Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Functional Cellular Networks Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Fungal Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Gene Regulation Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Genetic Immunotherapy Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),HIV Immunovirology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),HIV Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),HIV-Specific Immunity Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Helminth Immunology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Hepatic Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Host-Parasite Interactions Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Human Eosinophil Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Human Immunological Diseases Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Immune Activation Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Immune Deficiency Genetics Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Immunity to Pulmonary Pathogens Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Immunobiology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Immunobiology and Molecular Virology Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Infectious Disease Fellowship Training Program,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Infectious Disease Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Inflammation & Innate Immunity Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Inflammation Biology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Innate Immunity and Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Integrative Immunobiology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),International HIV/STD Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Intracellular Parasite Biology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),LID Clinical Studies Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Lung and Vascular Inflammation Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Lyme Disease Studies Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Lymphocyte Activation Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Lymphocyte Biology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Malaria Cell Biology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Malaria Functional Genomics Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Malaria Genetics Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Malaria Immunology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Malaria Infection Biology and Immunity Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Mast Cell Biology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Medical Virology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Metaorganism Immunity Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Microbial Pathogenesis Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Molecular Biology Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Molecular Defenses Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Molecular Development of the Immune System Section,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Molecular Entomology Unit,0.0
Molecular Genetics Section (Laboratory of Viral Diseases),Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular HIV Host Interactions Section,Allergy and Immunology Clinical Training Program,0.0
Molecular HIV Host Interactions Section,Antibacterial Host Defense Unit,0.0
Molecular HIV Host Interactions Section,Antibody Biology Unit,0.0
Molecular HIV Host Interactions Section,Apicomplexan Molecular Physiology Section,0.0
Molecular HIV Host Interactions Section,Autoimmunity and Functional Genomics Section,0.0
Molecular HIV Host Interactions Section,B-Cell Immunology Section,0.0
Molecular HIV Host Interactions Section,B-Cell Molecular Immunology Section,0.0
Molecular HIV Host Interactions Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular HIV Host Interactions Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular HIV Host Interactions Section,Barrier Immunity Section,0.0
Molecular HIV Host Interactions Section,Biological Imaging,0.0
Molecular HIV Host Interactions Section,Biology of Vector-Borne Viruses Section,0.0
Molecular HIV Host Interactions Section,Building 14B South,0.0
Molecular HIV Host Interactions Section,Building 33,0.0
Molecular HIV Host Interactions Section,Building 50,0.0
Molecular HIV Host Interactions Section,Building NIHAC/103,0.0
Molecular HIV Host Interactions Section,Buildings 4 and 10/11C127,0.0
Molecular HIV Host Interactions Section,Caliciviruses Section,0.0
Molecular HIV Host Interactions Section,Cell Signaling and Immunity Section,0.0
Molecular HIV Host Interactions Section,Cellular Biology Section,0.0
Molecular HIV Host Interactions Section,Cellular Immunology Section,0.0
Molecular HIV Host Interactions Section,Chemotaxis Signal Section,0.0
Molecular HIV Host Interactions Section,Chlamydial Diseases Section,0.0
Molecular HIV Host Interactions Section,Clinical Microbiome Unit (CMU),0.0
Molecular HIV Host Interactions Section,Clinical Pathophysiology Section,0.0
Molecular HIV Host Interactions Section,Clinical Research Section,0.0
Molecular HIV Host Interactions Section,Clinical and Molecular Retrovirology Section,0.0
Molecular HIV Host Interactions Section,Computational Biology Unit,0.0
Molecular HIV Host Interactions Section,Coxiella Pathogenesis Section,0.0
Molecular HIV Host Interactions Section,DNA Tumor Virus Section,0.0
Molecular HIV Host Interactions Section,Disease Modeling and Transmission Section,0.0
Molecular HIV Host Interactions Section,Emerging Respiratory Viruses Section,0.0
Molecular HIV Host Interactions Section,Emerging Virus Immunity Unit,0.0
Molecular HIV Host Interactions Section,Epidemiology and Population Studies Unit,0.0
Molecular HIV Host Interactions Section,Epithelial Therapeutics Unit,0.0
Molecular HIV Host Interactions Section,Flow Cytometry Section,0.0
Molecular HIV Host Interactions Section,Food Allergy Research Section,0.0
Molecular HIV Host Interactions Section,Functional Cellular Networks Section,0.0
Molecular HIV Host Interactions Section,Fungal Pathogenesis Section,0.0
Molecular HIV Host Interactions Section,Gene Regulation Section,0.0
Molecular HIV Host Interactions Section,Genetic Engineering Section,0.0
Molecular HIV Host Interactions Section,Genetic Immunotherapy Section,0.0
Molecular HIV Host Interactions Section,Genomic Technologies Section,0.0
Molecular HIV Host Interactions Section,HIV Immunovirology Section,0.0
Molecular HIV Host Interactions Section,HIV Pathogenesis Section,0.0
Molecular HIV Host Interactions Section,HIV-Specific Immunity Section,0.0
Molecular HIV Host Interactions Section,Helminth Immunology Section,0.0
Molecular HIV Host Interactions Section,Hepatic Pathogenesis Section,0.0
Molecular HIV Host Interactions Section,Host-Parasite Interactions Section,0.0
Molecular HIV Host Interactions Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular HIV Host Interactions Section,Human Eosinophil Section,0.0
Molecular HIV Host Interactions Section,Human Immunological Diseases Section,0.0
Molecular HIV Host Interactions Section,Immune Activation Section,0.0
Molecular HIV Host Interactions Section,Immune Deficiency Genetics Section,0.0
Molecular HIV Host Interactions Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular HIV Host Interactions Section,Immunobiology Section,0.0
Molecular HIV Host Interactions Section,Immunobiology and Molecular Virology Unit,0.0
Molecular HIV Host Interactions Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular HIV Host Interactions Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular HIV Host Interactions Section,Infectious Disease Fellowship Training Program,0.0
Molecular HIV Host Interactions Section,Infectious Disease Pathogenesis Section,0.0
Molecular HIV Host Interactions Section,Inflammation & Innate Immunity Unit,0.0
Molecular HIV Host Interactions Section,Inflammation Biology Section,0.0
Molecular HIV Host Interactions Section,Innate Immunity and Pathogenesis Section,0.0
Molecular HIV Host Interactions Section,Integrative Immunobiology Section,0.0
Molecular HIV Host Interactions Section,Intracellular Parasite Biology Section,0.0
Molecular HIV Host Interactions Section,LID Clinical Studies Unit,0.0
Molecular HIV Host Interactions Section,Lung and Vascular Inflammation Section,0.0
Molecular HIV Host Interactions Section,Lyme Disease Studies Unit,0.0
Molecular HIV Host Interactions Section,Lymphocyte Activation Section,0.0
Molecular HIV Host Interactions Section,Lymphocyte Biology Section,0.0
Molecular HIV Host Interactions Section,Malaria Cell Biology Section,0.0
Molecular HIV Host Interactions Section,Malaria Functional Genomics Section,0.0
Molecular HIV Host Interactions Section,Malaria Genetics Section,0.0
Molecular HIV Host Interactions Section,Malaria Immunology Section,0.0
Molecular HIV Host Interactions Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular HIV Host Interactions Section,Mast Cell Biology Section,0.0
Molecular HIV Host Interactions Section,Medical Virology Section,0.0
Molecular HIV Host Interactions Section,Metaorganism Immunity Section,0.0
Molecular HIV Host Interactions Section,Microbial Pathogenesis Section,0.0
Molecular HIV Host Interactions Section,Molecular Biology Section,0.0
Molecular HIV Host Interactions Section,Molecular Defenses Section,0.0
Molecular HIV Host Interactions Section,Molecular Development of the Immune System Section,0.0
Molecular HIV Host Interactions Section,Molecular Entomology Unit,0.0
Molecular HIV Host Interactions Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular HIV Host Interactions Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Microbiology Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Microbiology Section,Antibacterial Host Defense Unit,0.0
Molecular Microbiology Section,Antibody Biology Unit,0.0
Molecular Microbiology Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Microbiology Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Microbiology Section,B-Cell Immunology Section,0.0
Molecular Microbiology Section,B-Cell Molecular Immunology Section,0.0
Molecular Microbiology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Microbiology Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Microbiology Section,Barrier Immunity Section,0.0
Molecular Microbiology Section,Biological Imaging,0.0
Molecular Microbiology Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Microbiology Section,Building 14B South,0.0
Molecular Microbiology Section,Building 33,0.0
Molecular Microbiology Section,Building 50,0.0
Molecular Microbiology Section,Building NIHAC/103,0.0
Molecular Microbiology Section,Buildings 4 and 10/11C127,0.0
Molecular Microbiology Section,Caliciviruses Section,0.0
Molecular Microbiology Section,Cell Signaling and Immunity Section,0.0
Molecular Microbiology Section,Cellular Biology Section,0.0
Molecular Microbiology Section,Cellular Immunology Section,0.0
Molecular Microbiology Section,Chemotaxis Signal Section,0.0
Molecular Microbiology Section,Chlamydial Diseases Section,0.0
Molecular Microbiology Section,Clinical Microbiome Unit (CMU),0.0
Molecular Microbiology Section,Clinical Research Section,0.0
Molecular Microbiology Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Microbiology Section,Computational Biology Unit,0.0
Molecular Microbiology Section,Coxiella Pathogenesis Section,0.0
Molecular Microbiology Section,DNA Tumor Virus Section,0.0
Molecular Microbiology Section,Disease Modeling and Transmission Section,0.0
Molecular Microbiology Section,Emerging Respiratory Viruses Section,0.0
Molecular Microbiology Section,Emerging Virus Immunity Unit,0.0
Molecular Microbiology Section,Epidemiology and Population Studies Unit,0.0
Molecular Microbiology Section,Epithelial Therapeutics Unit,0.0
Molecular Microbiology Section,Flow Cytometry Section,0.0
Molecular Microbiology Section,Food Allergy Research Section,0.0
Molecular Microbiology Section,Functional Cellular Networks Section,0.0
Molecular Microbiology Section,Gene Regulation Section,0.0
Molecular Microbiology Section,Genetic Engineering Section,0.0
Molecular Microbiology Section,Genetic Immunotherapy Section,0.0
Molecular Microbiology Section,Genomic Technologies Section,0.0
Molecular Microbiology Section,HIV Immunovirology Section,0.0
Molecular Microbiology Section,HIV Pathogenesis Section,0.0
Molecular Microbiology Section,HIV-Specific Immunity Section,0.0
Molecular Microbiology Section,Helminth Immunology Section,0.0
Molecular Microbiology Section,Hepatic Pathogenesis Section,0.0
Molecular Microbiology Section,Host-Parasite Interactions Section,0.0
Molecular Microbiology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Microbiology Section,Human Eosinophil Section,0.0
Molecular Microbiology Section,Human Immunological Diseases Section,0.0
Molecular Microbiology Section,Immune Activation Section,0.0
Molecular Microbiology Section,Immune Deficiency Genetics Section,0.0
Molecular Microbiology Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Microbiology Section,Immunobiology Section,0.0
Molecular Microbiology Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Microbiology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Microbiology Section,Infectious Disease Pathogenesis Section,0.0
Molecular Microbiology Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Microbiology Section,Integrative Immunobiology Section,0.0
Molecular Microbiology Section,International HIV/STD Section,0.0
Molecular Microbiology Section,LID Clinical Studies Unit,0.0
Molecular Microbiology Section,Lung and Vascular Inflammation Section,0.0
Molecular Microbiology Section,Lyme Disease Studies Unit,0.0
Molecular Microbiology Section,Lymphocyte Activation Section,0.0
Molecular Microbiology Section,Lymphocyte Biology Section,0.0
Molecular Microbiology Section,Malaria Cell Biology Section,0.0
Molecular Microbiology Section,Malaria Functional Genomics Section,0.0
Molecular Microbiology Section,Malaria Genetics Section,0.0
Molecular Microbiology Section,Malaria Immunology Section,0.0
Molecular Microbiology Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Microbiology Section,Mast Cell Biology Section,0.0
Molecular Microbiology Section,Medical Virology Section,0.0
Molecular Microbiology Section,Metaorganism Immunity Section,0.0
Molecular Microbiology Section,Microbial Pathogenesis Section,0.0
Molecular Microbiology Section,Molecular Biology Section,0.0
Molecular Microbiology Section,Molecular Defenses Section,0.0
Molecular Microbiology Section,Molecular Development of the Immune System Section,0.0
Molecular Microbiology Section,Molecular Entomology Unit,0.0
Molecular Microbiology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular Microbiology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Microbiology Section,Molecular HIV Host Interactions Section,0.0
Molecular Parasitology Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Parasitology Section,Antibacterial Host Defense Unit,0.0
Molecular Parasitology Section,Antibody Biology Unit,0.0
Molecular Parasitology Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Parasitology Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Parasitology Section,B-Cell Immunology Section,0.0
Molecular Parasitology Section,B-Cell Molecular Immunology Section,0.0
Molecular Parasitology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Parasitology Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Parasitology Section,Barrier Immunity Section,0.0
Molecular Parasitology Section,Biological Imaging,0.0
Molecular Parasitology Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Parasitology Section,Building 14B South,0.0
Molecular Parasitology Section,Building 33,0.0
Molecular Parasitology Section,Building 50,0.0
Molecular Parasitology Section,Building NIHAC/103,0.0
Molecular Parasitology Section,Buildings 4 and 10/11C127,0.0
Molecular Parasitology Section,Caliciviruses Section,0.0
Molecular Parasitology Section,Cellular Biology Section,0.0
Molecular Parasitology Section,Cellular Immunology Section,0.0
Molecular Parasitology Section,Chemotaxis Signal Section,0.0
Molecular Parasitology Section,Chlamydial Diseases Section,0.0
Molecular Parasitology Section,Clinical Microbiome Unit (CMU),0.0
Molecular Parasitology Section,Clinical Pathophysiology Section,0.0
Molecular Parasitology Section,Clinical Research Section,0.0
Molecular Parasitology Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Parasitology Section,Computational Biology Unit,0.0
Molecular Parasitology Section,Coxiella Pathogenesis Section,0.0
Molecular Parasitology Section,DNA Tumor Virus Section,0.0
Molecular Parasitology Section,Disease Modeling and Transmission Section,0.0
Molecular Parasitology Section,Emerging Respiratory Viruses Section,0.0
Molecular Parasitology Section,Emerging Virus Immunity Unit,0.0
Molecular Parasitology Section,Epidemiology and Population Studies Unit,0.0
Molecular Parasitology Section,Epithelial Therapeutics Unit,0.0
Molecular Parasitology Section,Flow Cytometry Section,0.0
Molecular Parasitology Section,Food Allergy Research Section,0.0
Molecular Parasitology Section,Functional Cellular Networks Section,0.0
Molecular Parasitology Section,Fungal Pathogenesis Section,0.0
Molecular Parasitology Section,Gene Regulation Section,0.0
Molecular Parasitology Section,Genetic Engineering Section,0.0
Molecular Parasitology Section,Genetic Immunotherapy Section,0.0
Molecular Parasitology Section,Genomic Technologies Section,0.0
Molecular Parasitology Section,HIV Immunovirology Section,0.0
Molecular Parasitology Section,HIV Pathogenesis Section,0.0
Molecular Parasitology Section,HIV-Specific Immunity Section,0.0
Molecular Parasitology Section,Helminth Immunology Section,0.0
Molecular Parasitology Section,Hepatic Pathogenesis Section,0.0
Molecular Parasitology Section,Host-Parasite Interactions Section,0.0
Molecular Parasitology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Parasitology Section,Human Eosinophil Section,0.0
Molecular Parasitology Section,Human Immunological Diseases Section,0.0
Molecular Parasitology Section,Immune Activation Section,0.0
Molecular Parasitology Section,Immune Deficiency Genetics Section,0.0
Molecular Parasitology Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Parasitology Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Parasitology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Parasitology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Parasitology Section,Infectious Disease Fellowship Training Program,0.0
Molecular Parasitology Section,Infectious Disease Pathogenesis Section,0.0
Molecular Parasitology Section,Inflammation Biology Section,0.0
Molecular Parasitology Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Parasitology Section,Integrative Immunobiology Section,0.0
Molecular Parasitology Section,International HIV/STD Section,0.0
Molecular Parasitology Section,LID Clinical Studies Unit,0.0
Molecular Parasitology Section,Lung and Vascular Inflammation Section,0.0
Molecular Parasitology Section,Lyme Disease Studies Unit,0.0
Molecular Parasitology Section,Lymphocyte Activation Section,0.0
Molecular Parasitology Section,Lymphocyte Biology Section,0.0
Molecular Parasitology Section,Malaria Functional Genomics Section,0.0
Molecular Parasitology Section,Malaria Genetics Section,0.0
Molecular Parasitology Section,Malaria Immunology Section,0.0
Molecular Parasitology Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Parasitology Section,Mast Cell Biology Section,0.0
Molecular Parasitology Section,Medical Virology Section,0.0
Molecular Parasitology Section,Molecular Biology Section,0.0
Molecular Parasitology Section,Molecular Defenses Section,0.0
Molecular Parasitology Section,Molecular Development of the Immune System Section,0.0
Molecular Parasitology Section,Molecular Entomology Unit,0.0
Molecular Parasitology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular Parasitology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Parasitology Section,Molecular HIV Host Interactions Section,0.0
Molecular Parasitology Section,Molecular Microbiology Section,0.0
Molecular Parasitology and Entomology Unit,Allergy and Immunology Clinical Training Program,0.0
Molecular Parasitology and Entomology Unit,Antibacterial Host Defense Unit,0.0
Molecular Parasitology and Entomology Unit,Antibody Biology Unit,0.0
Molecular Parasitology and Entomology Unit,Apicomplexan Molecular Physiology Section,0.0
Molecular Parasitology and Entomology Unit,Autoimmunity and Functional Genomics Section,0.0
Molecular Parasitology and Entomology Unit,B-Cell Immunology Section,0.0
Molecular Parasitology and Entomology Unit,B-Cell Molecular Immunology Section,0.0
Molecular Parasitology and Entomology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Parasitology and Entomology Unit,Bacterial Physiology and Metabolism Unit,0.0
Molecular Parasitology and Entomology Unit,Barrier Immunity Section,0.0
Molecular Parasitology and Entomology Unit,Biological Imaging,0.0
Molecular Parasitology and Entomology Unit,Biology of Vector-Borne Viruses Section,0.0
Molecular Parasitology and Entomology Unit,Building 14B South,0.0
Molecular Parasitology and Entomology Unit,Building 33,0.0
Molecular Parasitology and Entomology Unit,Building 50,0.0
Molecular Parasitology and Entomology Unit,Building NIHAC/103,0.0
Molecular Parasitology and Entomology Unit,Buildings 4 and 10/11C127,0.0
Molecular Parasitology and Entomology Unit,Caliciviruses Section,0.0
Molecular Parasitology and Entomology Unit,Cell Signaling and Immunity Section,0.0
Molecular Parasitology and Entomology Unit,Cellular Biology Section,0.0
Molecular Parasitology and Entomology Unit,Cellular Immunology Section,0.0
Molecular Parasitology and Entomology Unit,Chemotaxis Signal Section,0.0
Molecular Parasitology and Entomology Unit,Chlamydial Diseases Section,0.0
Molecular Parasitology and Entomology Unit,Clinical Microbiome Unit (CMU),0.0
Molecular Parasitology and Entomology Unit,Clinical Pathophysiology Section,0.0
Molecular Parasitology and Entomology Unit,Clinical Research Section,0.0
Molecular Parasitology and Entomology Unit,Clinical and Molecular Retrovirology Section,0.0
Molecular Parasitology and Entomology Unit,Computational Biology Unit,0.0
Molecular Parasitology and Entomology Unit,Coxiella Pathogenesis Section,0.0
Molecular Parasitology and Entomology Unit,DNA Tumor Virus Section,0.0
Molecular Parasitology and Entomology Unit,Disease Modeling and Transmission Section,0.0
Molecular Parasitology and Entomology Unit,Emerging Respiratory Viruses Section,0.0
Molecular Parasitology and Entomology Unit,Emerging Virus Immunity Unit,0.0
Molecular Parasitology and Entomology Unit,Epidemiology and Population Studies Unit,0.0
Molecular Parasitology and Entomology Unit,Epithelial Therapeutics Unit,0.0
Molecular Parasitology and Entomology Unit,Flow Cytometry Section,0.0
Molecular Parasitology and Entomology Unit,Food Allergy Research Section,0.0
Molecular Parasitology and Entomology Unit,Functional Cellular Networks Section,0.0
Molecular Parasitology and Entomology Unit,Fungal Pathogenesis Section,0.0
Molecular Parasitology and Entomology Unit,Gene Regulation Section,0.0
Molecular Parasitology and Entomology Unit,Genetic Engineering Section,0.0
Molecular Parasitology and Entomology Unit,Genetic Immunotherapy Section,0.0
Molecular Parasitology and Entomology Unit,Genomic Technologies Section,0.0
Molecular Parasitology and Entomology Unit,HIV Immunovirology Section,0.0
Molecular Parasitology and Entomology Unit,HIV Pathogenesis Section,0.0
Molecular Parasitology and Entomology Unit,HIV-Specific Immunity Section,0.0
Molecular Parasitology and Entomology Unit,Helminth Immunology Section,0.0
Molecular Parasitology and Entomology Unit,Hepatic Pathogenesis Section,0.0
Molecular Parasitology and Entomology Unit,Host-Parasite Interactions Section,0.0
Molecular Parasitology and Entomology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Parasitology and Entomology Unit,Human Eosinophil Section,0.0
Molecular Parasitology and Entomology Unit,Human Immunological Diseases Section,0.0
Molecular Parasitology and Entomology Unit,Immune Activation Section,0.0
Molecular Parasitology and Entomology Unit,Immune Deficiency Genetics Section,0.0
Molecular Parasitology and Entomology Unit,Immunity to Pulmonary Pathogens Section,0.0
Molecular Parasitology and Entomology Unit,Immunobiology Section,0.0
Molecular Parasitology and Entomology Unit,Immunobiology and Molecular Virology Unit,0.0
Molecular Parasitology and Entomology Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Parasitology and Entomology Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Parasitology and Entomology Unit,Infectious Disease Fellowship Training Program,0.0
Molecular Parasitology and Entomology Unit,Infectious Disease Pathogenesis Section,0.0
Molecular Parasitology and Entomology Unit,Inflammation & Innate Immunity Unit,0.0
Molecular Parasitology and Entomology Unit,Inflammation Biology Section,0.0
Molecular Parasitology and Entomology Unit,Innate Immunity and Pathogenesis Section,0.0
Molecular Parasitology and Entomology Unit,Integrative Immunobiology Section,0.0
Molecular Parasitology and Entomology Unit,International HIV/STD Section,0.0
Molecular Parasitology and Entomology Unit,Intracellular Parasite Biology Section,0.0
Molecular Parasitology and Entomology Unit,LID Clinical Studies Unit,0.0
Molecular Parasitology and Entomology Unit,Lung and Vascular Inflammation Section,0.0
Molecular Parasitology and Entomology Unit,Lyme Disease Studies Unit,0.0
Molecular Parasitology and Entomology Unit,Lymphocyte Activation Section,0.0
Molecular Parasitology and Entomology Unit,Lymphocyte Biology Section,0.0
Molecular Parasitology and Entomology Unit,Malaria Cell Biology Section,0.0
Molecular Parasitology and Entomology Unit,Malaria Functional Genomics Section,0.0
Molecular Parasitology and Entomology Unit,Malaria Genetics Section,0.0
Molecular Parasitology and Entomology Unit,Malaria Infection Biology and Immunity Unit,0.0
Molecular Parasitology and Entomology Unit,Mast Cell Biology Section,0.0
Molecular Parasitology and Entomology Unit,Medical Virology Section,0.0
Molecular Parasitology and Entomology Unit,Metaorganism Immunity Section,0.0
Molecular Parasitology and Entomology Unit,Microbial Pathogenesis Section,0.0
Molecular Parasitology and Entomology Unit,Molecular Biology Section,0.0
Molecular Parasitology and Entomology Unit,Molecular Defenses Section,0.0
Molecular Parasitology and Entomology Unit,Molecular Development of the Immune System Section,0.0
Molecular Parasitology and Entomology Unit,Molecular Entomology Unit,0.0
Molecular Parasitology and Entomology Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular Parasitology and Entomology Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Parasitology and Entomology Unit,Molecular HIV Host Interactions Section,0.0
Molecular Parasitology and Entomology Unit,Molecular Microbiology Section,0.0
Molecular Parasitology and Entomology Unit,Molecular Parasitology Section,0.0
Molecular Pathogenesis Unit,Allergy and Immunology Clinical Training Program,0.0
Molecular Pathogenesis Unit,Antibacterial Host Defense Unit,0.0
Molecular Pathogenesis Unit,Antibody Biology Unit,0.0
Molecular Pathogenesis Unit,Apicomplexan Molecular Physiology Section,0.0
Molecular Pathogenesis Unit,Autoimmunity and Functional Genomics Section,0.0
Molecular Pathogenesis Unit,B-Cell Immunology Section,0.0
Molecular Pathogenesis Unit,B-Cell Molecular Immunology Section,0.0
Molecular Pathogenesis Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Pathogenesis Unit,Bacterial Physiology and Metabolism Unit,0.0
Molecular Pathogenesis Unit,Barrier Immunity Section,0.0
Molecular Pathogenesis Unit,Biological Imaging,0.0
Molecular Pathogenesis Unit,Biology of Vector-Borne Viruses Section,0.0
Molecular Pathogenesis Unit,Building 14B South,0.0
Molecular Pathogenesis Unit,Building 33,0.0
Molecular Pathogenesis Unit,Building 50,0.0
Molecular Pathogenesis Unit,Building NIHAC/103,0.0
Molecular Pathogenesis Unit,Buildings 4 and 10/11C127,0.0
Molecular Pathogenesis Unit,Caliciviruses Section,0.0
Molecular Pathogenesis Unit,Cell Signaling and Immunity Section,0.0
Molecular Pathogenesis Unit,Cellular Biology Section,0.0
Molecular Pathogenesis Unit,Cellular Immunology Section,0.0
Molecular Pathogenesis Unit,Chemotaxis Signal Section,0.0
Molecular Pathogenesis Unit,Chlamydial Diseases Section,0.0
Molecular Pathogenesis Unit,Clinical Microbiome Unit (CMU),0.0
Molecular Pathogenesis Unit,Clinical Pathophysiology Section,0.0
Molecular Pathogenesis Unit,Clinical Research Section,0.0
Molecular Pathogenesis Unit,Clinical and Molecular Retrovirology Section,0.0
Molecular Pathogenesis Unit,Computational Biology Unit,0.0
Molecular Pathogenesis Unit,Coxiella Pathogenesis Section,0.0
Molecular Pathogenesis Unit,DNA Tumor Virus Section,0.0
Molecular Pathogenesis Unit,Emerging Respiratory Viruses Section,0.0
Molecular Pathogenesis Unit,Emerging Virus Immunity Unit,0.0
Molecular Pathogenesis Unit,Epidemiology and Population Studies Unit,0.0
Molecular Pathogenesis Unit,Epithelial Therapeutics Unit,0.0
Molecular Pathogenesis Unit,Flow Cytometry Section,0.0
Molecular Pathogenesis Unit,Food Allergy Research Section,0.0
Molecular Pathogenesis Unit,Functional Cellular Networks Section,0.0
Molecular Pathogenesis Unit,Fungal Pathogenesis Section,0.0
Molecular Pathogenesis Unit,Gene Regulation Section,0.0
Molecular Pathogenesis Unit,Genetic Engineering Section,0.0
Molecular Pathogenesis Unit,Genetic Immunotherapy Section,0.0
Molecular Pathogenesis Unit,Genomic Technologies Section,0.0
Molecular Pathogenesis Unit,HIV Immunovirology Section,0.0
Molecular Pathogenesis Unit,HIV Pathogenesis Section,0.0
Molecular Pathogenesis Unit,HIV-Specific Immunity Section,0.0
Molecular Pathogenesis Unit,Helminth Immunology Section,0.0
Molecular Pathogenesis Unit,Hepatic Pathogenesis Section,0.0
Molecular Pathogenesis Unit,Host-Parasite Interactions Section,0.0
Molecular Pathogenesis Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Pathogenesis Unit,Human Eosinophil Section,0.0
Molecular Pathogenesis Unit,Human Immunological Diseases Section,0.0
Molecular Pathogenesis Unit,Immune Activation Section,0.0
Molecular Pathogenesis Unit,Immune Deficiency Genetics Section,0.0
Molecular Pathogenesis Unit,Immunity to Pulmonary Pathogens Section,0.0
Molecular Pathogenesis Unit,Immunobiology Section,0.0
Molecular Pathogenesis Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Pathogenesis Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Pathogenesis Unit,Infectious Disease Fellowship Training Program,0.0
Molecular Pathogenesis Unit,Infectious Disease Pathogenesis Section,0.0
Molecular Pathogenesis Unit,Inflammation & Innate Immunity Unit,0.0
Molecular Pathogenesis Unit,Inflammation Biology Section,0.0
Molecular Pathogenesis Unit,Integrative Immunobiology Section,0.0
Molecular Pathogenesis Unit,International HIV/STD Section,0.0
Molecular Pathogenesis Unit,Intracellular Parasite Biology Section,0.0
Molecular Pathogenesis Unit,LID Clinical Studies Unit,0.0
Molecular Pathogenesis Unit,Lung and Vascular Inflammation Section,0.0
Molecular Pathogenesis Unit,Lyme Disease Studies Unit,0.0
Molecular Pathogenesis Unit,Lymphocyte Activation Section,0.0
Molecular Pathogenesis Unit,Lymphocyte Biology Section,0.0
Molecular Pathogenesis Unit,Malaria Cell Biology Section,0.0
Molecular Pathogenesis Unit,Malaria Functional Genomics Section,0.0
Molecular Pathogenesis Unit,Malaria Genetics Section,0.0
Molecular Pathogenesis Unit,Malaria Immunology Section,0.0
Molecular Pathogenesis Unit,Malaria Infection Biology and Immunity Unit,0.0
Molecular Pathogenesis Unit,Mast Cell Biology Section,0.0
Molecular Pathogenesis Unit,Medical Virology Section,0.0
Molecular Pathogenesis Unit,Metaorganism Immunity Section,0.0
Molecular Pathogenesis Unit,Microbial Pathogenesis Section,0.0
Molecular Pathogenesis Unit,Molecular Biology Section,0.0
Molecular Pathogenesis Unit,Molecular Defenses Section,0.0
Molecular Pathogenesis Unit,Molecular Development of the Immune System Section,0.0
Molecular Pathogenesis Unit,Molecular Entomology Unit,0.0
Molecular Pathogenesis Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular Pathogenesis Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Pathogenesis Unit,Molecular HIV Host Interactions Section,0.0
Molecular Pathogenesis Unit,Molecular Microbiology Section,0.0
Molecular Pathogenesis Unit,Molecular Parasitology Section,0.0
Molecular Pathogenesis Unit,Molecular Parasitology and Entomology Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Pathogenesis and Biomarkers Section,Antibacterial Host Defense Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Antibody Biology Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Pathogenesis and Biomarkers Section,B-Cell Immunology Section,0.0
Molecular Pathogenesis and Biomarkers Section,B-Cell Molecular Immunology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Barrier Immunity Section,0.0
Molecular Pathogenesis and Biomarkers Section,Biological Imaging,0.0
Molecular Pathogenesis and Biomarkers Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Pathogenesis and Biomarkers Section,Building 14B South,0.0
Molecular Pathogenesis and Biomarkers Section,Building 33,0.0
Molecular Pathogenesis and Biomarkers Section,Building 50,0.0
Molecular Pathogenesis and Biomarkers Section,Building NIHAC/103,0.0
Molecular Pathogenesis and Biomarkers Section,Buildings 4 and 10/11C127,0.0
Molecular Pathogenesis and Biomarkers Section,Caliciviruses Section,0.0
Molecular Pathogenesis and Biomarkers Section,Cell Signaling and Immunity Section,0.0
Molecular Pathogenesis and Biomarkers Section,Cellular Biology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Cellular Immunology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Chemotaxis Signal Section,0.0
Molecular Pathogenesis and Biomarkers Section,Chlamydial Diseases Section,0.0
Molecular Pathogenesis and Biomarkers Section,Clinical Microbiome Unit (CMU),0.0
Molecular Pathogenesis and Biomarkers Section,Clinical Pathophysiology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Clinical Research Section,0.0
Molecular Pathogenesis and Biomarkers Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Computational Biology Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Coxiella Pathogenesis Section,0.0
Molecular Pathogenesis and Biomarkers Section,DNA Tumor Virus Section,0.0
Molecular Pathogenesis and Biomarkers Section,Disease Modeling and Transmission Section,0.0
Molecular Pathogenesis and Biomarkers Section,Emerging Respiratory Viruses Section,0.0
Molecular Pathogenesis and Biomarkers Section,Emerging Virus Immunity Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Epithelial Therapeutics Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Flow Cytometry Section,0.0
Molecular Pathogenesis and Biomarkers Section,Food Allergy Research Section,0.0
Molecular Pathogenesis and Biomarkers Section,Functional Cellular Networks Section,0.0
Molecular Pathogenesis and Biomarkers Section,Fungal Pathogenesis Section,0.0
Molecular Pathogenesis and Biomarkers Section,Gene Regulation Section,0.0
Molecular Pathogenesis and Biomarkers Section,Genetic Engineering Section,0.0
Molecular Pathogenesis and Biomarkers Section,Genetic Immunotherapy Section,0.0
Molecular Pathogenesis and Biomarkers Section,Genomic Technologies Section,0.0
Molecular Pathogenesis and Biomarkers Section,HIV Immunovirology Section,0.0
Molecular Pathogenesis and Biomarkers Section,HIV Pathogenesis Section,0.0
Molecular Pathogenesis and Biomarkers Section,HIV-Specific Immunity Section,0.0
Molecular Pathogenesis and Biomarkers Section,Hepatic Pathogenesis Section,0.0
Molecular Pathogenesis and Biomarkers Section,Host-Parasite Interactions Section,0.0
Molecular Pathogenesis and Biomarkers Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Human Eosinophil Section,0.0
Molecular Pathogenesis and Biomarkers Section,Human Immunological Diseases Section,0.0
Molecular Pathogenesis and Biomarkers Section,Immune Activation Section,0.0
Molecular Pathogenesis and Biomarkers Section,Immune Deficiency Genetics Section,0.0
Molecular Pathogenesis and Biomarkers Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Pathogenesis and Biomarkers Section,Immunobiology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Pathogenesis and Biomarkers Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Pathogenesis and Biomarkers Section,Infectious Disease Fellowship Training Program,0.0
Molecular Pathogenesis and Biomarkers Section,Infectious Disease Pathogenesis Section,0.0
Molecular Pathogenesis and Biomarkers Section,Inflammation & Innate Immunity Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Inflammation Biology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Pathogenesis and Biomarkers Section,Integrative Immunobiology Section,0.0
Molecular Pathogenesis and Biomarkers Section,International HIV/STD Section,0.0
Molecular Pathogenesis and Biomarkers Section,Intracellular Parasite Biology Section,0.0
Molecular Pathogenesis and Biomarkers Section,LID Clinical Studies Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Lung and Vascular Inflammation Section,0.0
Molecular Pathogenesis and Biomarkers Section,Lyme Disease Studies Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Lymphocyte Activation Section,0.0
Molecular Pathogenesis and Biomarkers Section,Lymphocyte Biology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Malaria Functional Genomics Section,0.0
Molecular Pathogenesis and Biomarkers Section,Malaria Genetics Section,0.0
Molecular Pathogenesis and Biomarkers Section,Malaria Immunology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Mast Cell Biology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Medical Virology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Metaorganism Immunity Section,0.0
Molecular Pathogenesis and Biomarkers Section,Microbial Pathogenesis Section,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Biology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Defenses Section,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Development of the Immune System Section,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Entomology Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Pathogenesis and Biomarkers Section,Molecular HIV Host Interactions Section,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Microbiology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Parasitology Section,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Parasitology and Entomology Unit,0.0
Molecular Pathogenesis and Biomarkers Section,Molecular Pathogenesis Unit,0.0
Molecular Pathology Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Pathology Section,Antibacterial Host Defense Unit,0.0
Molecular Pathology Section,Antibody Biology Unit,0.0
Molecular Pathology Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Pathology Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Pathology Section,B-Cell Immunology Section,0.0
Molecular Pathology Section,B-Cell Molecular Immunology Section,0.0
Molecular Pathology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Pathology Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Pathology Section,Barrier Immunity Section,0.0
Molecular Pathology Section,Biological Imaging,0.0
Molecular Pathology Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Pathology Section,Building 14B South,0.0
Molecular Pathology Section,Building 33,0.0
Molecular Pathology Section,Building 50,0.0
Molecular Pathology Section,Building NIHAC/103,0.0
Molecular Pathology Section,Buildings 4 and 10/11C127,0.0
Molecular Pathology Section,Caliciviruses Section,0.0
Molecular Pathology Section,Cell Signaling and Immunity Section,0.0
Molecular Pathology Section,Cellular Biology Section,0.0
Molecular Pathology Section,Cellular Immunology Section,0.0
Molecular Pathology Section,Chemotaxis Signal Section,0.0
Molecular Pathology Section,Chlamydial Diseases Section,0.0
Molecular Pathology Section,Clinical Microbiome Unit (CMU),0.0
Molecular Pathology Section,Clinical Pathophysiology Section,0.0
Molecular Pathology Section,Clinical Research Section,0.0
Molecular Pathology Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Pathology Section,Computational Biology Unit,0.0
Molecular Pathology Section,Coxiella Pathogenesis Section,0.0
Molecular Pathology Section,DNA Tumor Virus Section,0.0
Molecular Pathology Section,Disease Modeling and Transmission Section,0.0
Molecular Pathology Section,Emerging Respiratory Viruses Section,0.0
Molecular Pathology Section,Emerging Virus Immunity Unit,0.0
Molecular Pathology Section,Epidemiology and Population Studies Unit,0.0
Molecular Pathology Section,Epithelial Therapeutics Unit,0.0
Molecular Pathology Section,Flow Cytometry Section,0.0
Molecular Pathology Section,Food Allergy Research Section,0.0
Molecular Pathology Section,Functional Cellular Networks Section,0.0
Molecular Pathology Section,Fungal Pathogenesis Section,0.0
Molecular Pathology Section,Gene Regulation Section,0.0
Molecular Pathology Section,Genetic Engineering Section,0.0
Molecular Pathology Section,Genetic Immunotherapy Section,0.0
Molecular Pathology Section,Genomic Technologies Section,0.0
Molecular Pathology Section,HIV Immunovirology Section,0.0
Molecular Pathology Section,HIV Pathogenesis Section,0.0
Molecular Pathology Section,HIV-Specific Immunity Section,0.0
Molecular Pathology Section,Helminth Immunology Section,0.0
Molecular Pathology Section,Hepatic Pathogenesis Section,0.0
Molecular Pathology Section,Host-Parasite Interactions Section,0.0
Molecular Pathology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Pathology Section,Human Eosinophil Section,0.0
Molecular Pathology Section,Human Immunological Diseases Section,0.0
Molecular Pathology Section,Immune Activation Section,0.0
Molecular Pathology Section,Immune Deficiency Genetics Section,0.0
Molecular Pathology Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Pathology Section,Immunobiology Section,0.0
Molecular Pathology Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Pathology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Pathology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Pathology Section,Infectious Disease Fellowship Training Program,0.0
Molecular Pathology Section,Infectious Disease Pathogenesis Section,0.0
Molecular Pathology Section,Inflammation & Innate Immunity Unit,0.0
Molecular Pathology Section,Inflammation Biology Section,0.0
Molecular Pathology Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Pathology Section,Integrative Immunobiology Section,0.0
Molecular Pathology Section,International HIV/STD Section,0.0
Molecular Pathology Section,Intracellular Parasite Biology Section,0.0
Molecular Pathology Section,LID Clinical Studies Unit,0.0
Molecular Pathology Section,Lung and Vascular Inflammation Section,0.0
Molecular Pathology Section,Lyme Disease Studies Unit,0.0
Molecular Pathology Section,Lymphocyte Activation Section,0.0
Molecular Pathology Section,Lymphocyte Biology Section,0.0
Molecular Pathology Section,Malaria Cell Biology Section,0.0
Molecular Pathology Section,Malaria Functional Genomics Section,0.0
Molecular Pathology Section,Malaria Genetics Section,0.0
Molecular Pathology Section,Malaria Immunology Section,0.0
Molecular Pathology Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Pathology Section,Mast Cell Biology Section,0.0
Molecular Pathology Section,Medical Virology Section,0.0
Molecular Pathology Section,Metaorganism Immunity Section,0.0
Molecular Pathology Section,Microbial Pathogenesis Section,0.0
Molecular Pathology Section,Molecular Biology Section,0.0
Molecular Pathology Section,Molecular Defenses Section,0.0
Molecular Pathology Section,Molecular Development of the Immune System Section,0.0
Molecular Pathology Section,Molecular Entomology Unit,0.0
Molecular Pathology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular Pathology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Pathology Section,Molecular HIV Host Interactions Section,0.0
Molecular Pathology Section,Molecular Microbiology Section,0.0
Molecular Pathology Section,Molecular Parasitology Section,0.0
Molecular Pathology Section,Molecular Parasitology and Entomology Unit,0.0
Molecular Pathology Section,Molecular Pathogenesis Unit,0.0
Molecular Pathology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Molecular Signaling Section,Allergy and Immunology Clinical Training Program,0.0
Molecular Signaling Section,Antibacterial Host Defense Unit,0.0
Molecular Signaling Section,Antibody Biology Unit,0.0
Molecular Signaling Section,Apicomplexan Molecular Physiology Section,0.0
Molecular Signaling Section,Autoimmunity and Functional Genomics Section,0.0
Molecular Signaling Section,B-Cell Immunology Section,0.0
Molecular Signaling Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular Signaling Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular Signaling Section,Barrier Immunity Section,0.0
Molecular Signaling Section,Biological Imaging,0.0
Molecular Signaling Section,Biology of Vector-Borne Viruses Section,0.0
Molecular Signaling Section,Building 14B South,0.0
Molecular Signaling Section,Building 33,0.0
Molecular Signaling Section,Building 50,0.0
Molecular Signaling Section,Building NIHAC/103,0.0
Molecular Signaling Section,Buildings 4 and 10/11C127,0.0
Molecular Signaling Section,Caliciviruses Section,0.0
Molecular Signaling Section,Cell Signaling and Immunity Section,0.0
Molecular Signaling Section,Cellular Biology Section,0.0
Molecular Signaling Section,Cellular Immunology Section,0.0
Molecular Signaling Section,Chemotaxis Signal Section,0.0
Molecular Signaling Section,Chlamydial Diseases Section,0.0
Molecular Signaling Section,Clinical Microbiome Unit (CMU),0.0
Molecular Signaling Section,Clinical Pathophysiology Section,0.0
Molecular Signaling Section,Clinical and Molecular Retrovirology Section,0.0
Molecular Signaling Section,Computational Biology Unit,0.0
Molecular Signaling Section,Coxiella Pathogenesis Section,0.0
Molecular Signaling Section,Disease Modeling and Transmission Section,0.0
Molecular Signaling Section,Emerging Virus Immunity Unit,0.0
Molecular Signaling Section,Epidemiology and Population Studies Unit,0.0
Molecular Signaling Section,Epithelial Therapeutics Unit,0.0
Molecular Signaling Section,Flow Cytometry Section,0.0
Molecular Signaling Section,Food Allergy Research Section,0.0
Molecular Signaling Section,Functional Cellular Networks Section,0.0
Molecular Signaling Section,Gene Regulation Section,0.0
Molecular Signaling Section,Genetic Engineering Section,0.0
Molecular Signaling Section,Genomic Technologies Section,0.0
Molecular Signaling Section,HIV Immunovirology Section,0.0
Molecular Signaling Section,Helminth Immunology Section,0.0
Molecular Signaling Section,Hepatic Pathogenesis Section,0.0
Molecular Signaling Section,Host-Parasite Interactions Section,0.0
Molecular Signaling Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular Signaling Section,Human Eosinophil Section,0.0
Molecular Signaling Section,Human Immunological Diseases Section,0.0
Molecular Signaling Section,Immune Deficiency Genetics Section,0.0
Molecular Signaling Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular Signaling Section,Immunobiology Section,0.0
Molecular Signaling Section,Immunobiology and Molecular Virology Unit,0.0
Molecular Signaling Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular Signaling Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular Signaling Section,Infectious Disease Fellowship Training Program,0.0
Molecular Signaling Section,Infectious Disease Pathogenesis Section,0.0
Molecular Signaling Section,Inflammation & Innate Immunity Unit,0.0
Molecular Signaling Section,Innate Immunity and Pathogenesis Section,0.0
Molecular Signaling Section,Integrative Immunobiology Section,0.0
Molecular Signaling Section,International HIV/STD Section,0.0
Molecular Signaling Section,Intracellular Parasite Biology Section,0.0
Molecular Signaling Section,LID Clinical Studies Unit,0.0
Molecular Signaling Section,Lyme Disease Studies Unit,0.0
Molecular Signaling Section,Lymphocyte Activation Section,0.0
Molecular Signaling Section,Lymphocyte Biology Section,0.0
Molecular Signaling Section,Malaria Functional Genomics Section,0.0
Molecular Signaling Section,Malaria Genetics Section,0.0
Molecular Signaling Section,Malaria Immunology Section,0.0
Molecular Signaling Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular Signaling Section,Mast Cell Biology Section,0.0
Molecular Signaling Section,Microbial Pathogenesis Section,0.0
Molecular Signaling Section,Molecular Biology Section,0.0
Molecular Signaling Section,Molecular Development of the Immune System Section,0.0
Molecular Signaling Section,Molecular Entomology Unit,0.0
Molecular Signaling Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular Signaling Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular Signaling Section,Molecular HIV Host Interactions Section,0.0
Molecular Signaling Section,Molecular Microbiology Section,0.0
Molecular Signaling Section,Molecular Parasitology Section,0.0
Molecular Signaling Section,Molecular Parasitology and Entomology Unit,0.0
Molecular Signaling Section,Molecular Pathogenesis Unit,0.0
Molecular Signaling Section,Molecular Pathogenesis and Biomarkers Section,0.0
Molecular Signaling Section,Molecular Pathology Section,0.0
Molecular and Cellular Immunology Section,Allergy and Immunology Clinical Training Program,0.0
Molecular and Cellular Immunology Section,Antibacterial Host Defense Unit,0.0
Molecular and Cellular Immunology Section,Antibody Biology Unit,0.0
Molecular and Cellular Immunology Section,Autoimmunity and Functional Genomics Section,0.0
Molecular and Cellular Immunology Section,B-Cell Molecular Immunology Section,0.0
Molecular and Cellular Immunology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular and Cellular Immunology Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular and Cellular Immunology Section,Barrier Immunity Section,0.0
Molecular and Cellular Immunology Section,Biological Imaging,0.0
Molecular and Cellular Immunology Section,Biology of Vector-Borne Viruses Section,0.0
Molecular and Cellular Immunology Section,Building 14B South,0.0
Molecular and Cellular Immunology Section,Building 33,0.0
Molecular and Cellular Immunology Section,Building 50,0.0
Molecular and Cellular Immunology Section,Building NIHAC/103,0.0
Molecular and Cellular Immunology Section,Buildings 4 and 10/11C127,0.0
Molecular and Cellular Immunology Section,Caliciviruses Section,0.0
Molecular and Cellular Immunology Section,Cell Signaling and Immunity Section,0.0
Molecular and Cellular Immunology Section,Cellular Biology Section,0.0
Molecular and Cellular Immunology Section,Cellular Immunology Section,0.0
Molecular and Cellular Immunology Section,Chlamydial Diseases Section,0.0
Molecular and Cellular Immunology Section,Clinical Microbiome Unit (CMU),0.0
Molecular and Cellular Immunology Section,Clinical Pathophysiology Section,0.0
Molecular and Cellular Immunology Section,Clinical Research Section,0.0
Molecular and Cellular Immunology Section,Clinical and Molecular Retrovirology Section,0.0
Molecular and Cellular Immunology Section,Computational Biology Unit,0.0
Molecular and Cellular Immunology Section,Coxiella Pathogenesis Section,0.0
Molecular and Cellular Immunology Section,DNA Tumor Virus Section,0.0
Molecular and Cellular Immunology Section,Disease Modeling and Transmission Section,0.0
Molecular and Cellular Immunology Section,Emerging Respiratory Viruses Section,0.0
Molecular and Cellular Immunology Section,Emerging Virus Immunity Unit,0.0
Molecular and Cellular Immunology Section,Epidemiology and Population Studies Unit,0.0
Molecular and Cellular Immunology Section,Epithelial Therapeutics Unit,0.0
Molecular and Cellular Immunology Section,Flow Cytometry Section,0.0
Molecular and Cellular Immunology Section,Functional Cellular Networks Section,0.0
Molecular and Cellular Immunology Section,Fungal Pathogenesis Section,0.0
Molecular and Cellular Immunology Section,Gene Regulation Section,0.0
Molecular and Cellular Immunology Section,Genetic Engineering Section,0.0
Molecular and Cellular Immunology Section,Genetic Immunotherapy Section,0.0
Molecular and Cellular Immunology Section,Genomic Technologies Section,0.0
Molecular and Cellular Immunology Section,HIV Immunovirology Section,0.0
Molecular and Cellular Immunology Section,HIV Pathogenesis Section,0.0
Molecular and Cellular Immunology Section,HIV-Specific Immunity Section,0.0
Molecular and Cellular Immunology Section,Helminth Immunology Section,0.0
Molecular and Cellular Immunology Section,Hepatic Pathogenesis Section,0.0
Molecular and Cellular Immunology Section,Host-Parasite Interactions Section,0.0
Molecular and Cellular Immunology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular and Cellular Immunology Section,Human Eosinophil Section,0.0
Molecular and Cellular Immunology Section,Human Immunological Diseases Section,0.0
Molecular and Cellular Immunology Section,Immune Activation Section,0.0
Molecular and Cellular Immunology Section,Immune Deficiency Genetics Section,0.0
Molecular and Cellular Immunology Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular and Cellular Immunology Section,Immunobiology Section,0.0
Molecular and Cellular Immunology Section,Immunobiology and Molecular Virology Unit,0.0
Molecular and Cellular Immunology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular and Cellular Immunology Section,Infectious Disease Fellowship Training Program,0.0
Molecular and Cellular Immunology Section,Infectious Disease Pathogenesis Section,0.0
Molecular and Cellular Immunology Section,Inflammation & Innate Immunity Unit,0.0
Molecular and Cellular Immunology Section,Inflammation Biology Section,0.0
Molecular and Cellular Immunology Section,Innate Immunity and Pathogenesis Section,0.0
Molecular and Cellular Immunology Section,Integrative Immunobiology Section,0.0
Molecular and Cellular Immunology Section,International HIV/STD Section,0.0
Molecular and Cellular Immunology Section,Intracellular Parasite Biology Section,0.0
Molecular and Cellular Immunology Section,LID Clinical Studies Unit,0.0
Molecular and Cellular Immunology Section,Lung and Vascular Inflammation Section,0.0
Molecular and Cellular Immunology Section,Lyme Disease Studies Unit,0.0
Molecular and Cellular Immunology Section,Lymphocyte Biology Section,0.0
Molecular and Cellular Immunology Section,Malaria Functional Genomics Section,0.0
Molecular and Cellular Immunology Section,Malaria Genetics Section,0.0
Molecular and Cellular Immunology Section,Malaria Immunology Section,0.0
Molecular and Cellular Immunology Section,Medical Virology Section,0.0
Molecular and Cellular Immunology Section,Metaorganism Immunity Section,0.0
Molecular and Cellular Immunology Section,Microbial Pathogenesis Section,0.0
Molecular and Cellular Immunology Section,Molecular Biology Section,0.0
Molecular and Cellular Immunology Section,Molecular Defenses Section,0.0
Molecular and Cellular Immunology Section,Molecular Development of the Immune System Section,0.0
Molecular and Cellular Immunology Section,Molecular Entomology Unit,0.0
Molecular and Cellular Immunology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular and Cellular Immunology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular and Cellular Immunology Section,Molecular HIV Host Interactions Section,0.0
Molecular and Cellular Immunology Section,Molecular Microbiology Section,0.0
Molecular and Cellular Immunology Section,Molecular Parasitology Section,0.0
Molecular and Cellular Immunology Section,Molecular Parasitology and Entomology Unit,0.0
Molecular and Cellular Immunology Section,Molecular Pathogenesis Unit,0.0
Molecular and Cellular Immunology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Molecular and Cellular Immunology Section,Molecular Pathology Section,0.0
Molecular and Cellular Immunology Section,Molecular Signaling Section,0.0
Molecular and Cellular Immunoregulation Section,Allergy and Immunology Clinical Training Program,0.0
Molecular and Cellular Immunoregulation Section,Antibacterial Host Defense Unit,0.0
Molecular and Cellular Immunoregulation Section,Antibody Biology Unit,0.0
Molecular and Cellular Immunoregulation Section,Apicomplexan Molecular Physiology Section,0.0
Molecular and Cellular Immunoregulation Section,Autoimmunity and Functional Genomics Section,0.0
Molecular and Cellular Immunoregulation Section,B-Cell Immunology Section,0.0
Molecular and Cellular Immunoregulation Section,B-Cell Molecular Immunology Section,0.0
Molecular and Cellular Immunoregulation Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Molecular and Cellular Immunoregulation Section,Bacterial Physiology and Metabolism Unit,0.0
Molecular and Cellular Immunoregulation Section,Barrier Immunity Section,0.0
Molecular and Cellular Immunoregulation Section,Biological Imaging,0.0
Molecular and Cellular Immunoregulation Section,Biology of Vector-Borne Viruses Section,0.0
Molecular and Cellular Immunoregulation Section,Building 14B South,0.0
Molecular and Cellular Immunoregulation Section,Building 33,0.0
Molecular and Cellular Immunoregulation Section,Building 50,0.0
Molecular and Cellular Immunoregulation Section,Building NIHAC/103,0.0
Molecular and Cellular Immunoregulation Section,Buildings 4 and 10/11C127,0.0
Molecular and Cellular Immunoregulation Section,Caliciviruses Section,0.0
Molecular and Cellular Immunoregulation Section,Cell Signaling and Immunity Section,0.0
Molecular and Cellular Immunoregulation Section,Cellular Biology Section,0.0
Molecular and Cellular Immunoregulation Section,Chemotaxis Signal Section,0.0
Molecular and Cellular Immunoregulation Section,Chlamydial Diseases Section,0.0
Molecular and Cellular Immunoregulation Section,Clinical Microbiome Unit (CMU),0.0
Molecular and Cellular Immunoregulation Section,Clinical Pathophysiology Section,0.0
Molecular and Cellular Immunoregulation Section,Clinical Research Section,0.0
Molecular and Cellular Immunoregulation Section,Clinical and Molecular Retrovirology Section,0.0
Molecular and Cellular Immunoregulation Section,Computational Biology Unit,0.0
Molecular and Cellular Immunoregulation Section,Coxiella Pathogenesis Section,0.0
Molecular and Cellular Immunoregulation Section,DNA Tumor Virus Section,0.0
Molecular and Cellular Immunoregulation Section,Disease Modeling and Transmission Section,0.0
Molecular and Cellular Immunoregulation Section,Emerging Respiratory Viruses Section,0.0
Molecular and Cellular Immunoregulation Section,Emerging Virus Immunity Unit,0.0
Molecular and Cellular Immunoregulation Section,Epidemiology and Population Studies Unit,0.0
Molecular and Cellular Immunoregulation Section,Epithelial Therapeutics Unit,0.0
Molecular and Cellular Immunoregulation Section,Flow Cytometry Section,0.0
Molecular and Cellular Immunoregulation Section,Food Allergy Research Section,0.0
Molecular and Cellular Immunoregulation Section,Functional Cellular Networks Section,0.0
Molecular and Cellular Immunoregulation Section,Fungal Pathogenesis Section,0.0
Molecular and Cellular Immunoregulation Section,Gene Regulation Section,0.0
Molecular and Cellular Immunoregulation Section,Genetic Engineering Section,0.0
Molecular and Cellular Immunoregulation Section,Genetic Immunotherapy Section,0.0
Molecular and Cellular Immunoregulation Section,Genomic Technologies Section,0.0
Molecular and Cellular Immunoregulation Section,HIV Immunovirology Section,0.0
Molecular and Cellular Immunoregulation Section,HIV Pathogenesis Section,0.0
Molecular and Cellular Immunoregulation Section,HIV-Specific Immunity Section,0.0
Molecular and Cellular Immunoregulation Section,Helminth Immunology Section,0.0
Molecular and Cellular Immunoregulation Section,Hepatic Pathogenesis Section,0.0
Molecular and Cellular Immunoregulation Section,Host-Parasite Interactions Section,0.0
Molecular and Cellular Immunoregulation Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Molecular and Cellular Immunoregulation Section,Human Eosinophil Section,0.0
Molecular and Cellular Immunoregulation Section,Human Immunological Diseases Section,0.0
Molecular and Cellular Immunoregulation Section,Immune Activation Section,0.0
Molecular and Cellular Immunoregulation Section,Immune Deficiency Genetics Section,0.0
Molecular and Cellular Immunoregulation Section,Immunity to Pulmonary Pathogens Section,0.0
Molecular and Cellular Immunoregulation Section,Immunobiology and Molecular Virology Unit,0.0
Molecular and Cellular Immunoregulation Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Molecular and Cellular Immunoregulation Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Molecular and Cellular Immunoregulation Section,Infectious Disease Fellowship Training Program,0.0
Molecular and Cellular Immunoregulation Section,Infectious Disease Pathogenesis Section,0.0
Molecular and Cellular Immunoregulation Section,Inflammation & Innate Immunity Unit,0.0
Molecular and Cellular Immunoregulation Section,Inflammation Biology Section,0.0
Molecular and Cellular Immunoregulation Section,Innate Immunity and Pathogenesis Section,0.0
Molecular and Cellular Immunoregulation Section,International HIV/STD Section,0.0
Molecular and Cellular Immunoregulation Section,Intracellular Parasite Biology Section,0.0
Molecular and Cellular Immunoregulation Section,LID Clinical Studies Unit,0.0
Molecular and Cellular Immunoregulation Section,Lung and Vascular Inflammation Section,0.0
Molecular and Cellular Immunoregulation Section,Lyme Disease Studies Unit,0.0
Molecular and Cellular Immunoregulation Section,Lymphocyte Activation Section,0.0
Molecular and Cellular Immunoregulation Section,Malaria Cell Biology Section,0.0
Molecular and Cellular Immunoregulation Section,Malaria Functional Genomics Section,0.0
Molecular and Cellular Immunoregulation Section,Malaria Genetics Section,0.0
Molecular and Cellular Immunoregulation Section,Malaria Immunology Section,0.0
Molecular and Cellular Immunoregulation Section,Malaria Infection Biology and Immunity Unit,0.0
Molecular and Cellular Immunoregulation Section,Mast Cell Biology Section,0.0
Molecular and Cellular Immunoregulation Section,Medical Virology Section,0.0
Molecular and Cellular Immunoregulation Section,Microbial Pathogenesis Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Biology Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Defenses Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Development of the Immune System Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Entomology Unit,0.0
Molecular and Cellular Immunoregulation Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Molecular and Cellular Immunoregulation Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Molecular and Cellular Immunoregulation Section,Molecular HIV Host Interactions Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Microbiology Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Parasitology Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Parasitology and Entomology Unit,0.0
Molecular and Cellular Immunoregulation Section,Molecular Pathogenesis Unit,0.0
Molecular and Cellular Immunoregulation Section,Molecular Pathogenesis and Biomarkers Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Pathology Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular Signaling Section,0.0
Molecular and Cellular Immunoregulation Section,Molecular and Cellular Immunology Section,0.0
Mosquito Immunity and Vector Competence Section,Allergy and Immunology Clinical Training Program,0.0
Mosquito Immunity and Vector Competence Section,Antibacterial Host Defense Unit,0.0
Mosquito Immunity and Vector Competence Section,Antibody Biology Unit,0.0
Mosquito Immunity and Vector Competence Section,Apicomplexan Molecular Physiology Section,0.0
Mosquito Immunity and Vector Competence Section,B-Cell Immunology Section,0.0
Mosquito Immunity and Vector Competence Section,B-Cell Molecular Immunology Section,0.0
Mosquito Immunity and Vector Competence Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Mosquito Immunity and Vector Competence Section,Bacterial Physiology and Metabolism Unit,0.0
Mosquito Immunity and Vector Competence Section,Barrier Immunity Section,0.0
Mosquito Immunity and Vector Competence Section,Biological Imaging,0.0
Mosquito Immunity and Vector Competence Section,Biology of Vector-Borne Viruses Section,0.0
Mosquito Immunity and Vector Competence Section,Building 14B South,0.0
Mosquito Immunity and Vector Competence Section,Building 33,0.0
Mosquito Immunity and Vector Competence Section,Building 50,0.0
Mosquito Immunity and Vector Competence Section,Building NIHAC/103,0.0
Mosquito Immunity and Vector Competence Section,Buildings 4 and 10/11C127,0.0
Mosquito Immunity and Vector Competence Section,Caliciviruses Section,0.0
Mosquito Immunity and Vector Competence Section,Cell Signaling and Immunity Section,0.0
Mosquito Immunity and Vector Competence Section,Cellular Biology Section,0.0
Mosquito Immunity and Vector Competence Section,Cellular Immunology Section,0.0
Mosquito Immunity and Vector Competence Section,Chemotaxis Signal Section,0.0
Mosquito Immunity and Vector Competence Section,Chlamydial Diseases Section,0.0
Mosquito Immunity and Vector Competence Section,Clinical Microbiome Unit (CMU),0.0
Mosquito Immunity and Vector Competence Section,Clinical Pathophysiology Section,0.0
Mosquito Immunity and Vector Competence Section,Clinical Research Section,0.0
Mosquito Immunity and Vector Competence Section,Clinical and Molecular Retrovirology Section,0.0
Mosquito Immunity and Vector Competence Section,Computational Biology Unit,0.0
Mosquito Immunity and Vector Competence Section,Coxiella Pathogenesis Section,0.0
Mosquito Immunity and Vector Competence Section,DNA Tumor Virus Section,0.0
Mosquito Immunity and Vector Competence Section,Disease Modeling and Transmission Section,0.0
Mosquito Immunity and Vector Competence Section,Emerging Respiratory Viruses Section,0.0
Mosquito Immunity and Vector Competence Section,Emerging Virus Immunity Unit,0.0
Mosquito Immunity and Vector Competence Section,Epidemiology and Population Studies Unit,0.0
Mosquito Immunity and Vector Competence Section,Epithelial Therapeutics Unit,0.0
Mosquito Immunity and Vector Competence Section,Flow Cytometry Section,0.0
Mosquito Immunity and Vector Competence Section,Food Allergy Research Section,0.0
Mosquito Immunity and Vector Competence Section,Functional Cellular Networks Section,0.0
Mosquito Immunity and Vector Competence Section,Fungal Pathogenesis Section,0.0
Mosquito Immunity and Vector Competence Section,Gene Regulation Section,0.0
Mosquito Immunity and Vector Competence Section,Genetic Engineering Section,0.0
Mosquito Immunity and Vector Competence Section,Genetic Immunotherapy Section,0.0
Mosquito Immunity and Vector Competence Section,Genomic Technologies Section,0.0
Mosquito Immunity and Vector Competence Section,HIV Immunovirology Section,0.0
Mosquito Immunity and Vector Competence Section,HIV Pathogenesis Section,0.0
Mosquito Immunity and Vector Competence Section,HIV-Specific Immunity Section,0.0
Mosquito Immunity and Vector Competence Section,Helminth Immunology Section,0.0
Mosquito Immunity and Vector Competence Section,Hepatic Pathogenesis Section,0.0
Mosquito Immunity and Vector Competence Section,Host-Parasite Interactions Section,0.0
Mosquito Immunity and Vector Competence Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Mosquito Immunity and Vector Competence Section,Human Eosinophil Section,0.0
Mosquito Immunity and Vector Competence Section,Human Immunological Diseases Section,0.0
Mosquito Immunity and Vector Competence Section,Immune Activation Section,0.0
Mosquito Immunity and Vector Competence Section,Immune Deficiency Genetics Section,0.0
Mosquito Immunity and Vector Competence Section,Immunity to Pulmonary Pathogens Section,0.0
Mosquito Immunity and Vector Competence Section,Immunobiology Section,0.0
Mosquito Immunity and Vector Competence Section,Immunobiology and Molecular Virology Unit,0.0
Mosquito Immunity and Vector Competence Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Mosquito Immunity and Vector Competence Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Mosquito Immunity and Vector Competence Section,Infectious Disease Fellowship Training Program,0.0
Mosquito Immunity and Vector Competence Section,Infectious Disease Pathogenesis Section,0.0
Mosquito Immunity and Vector Competence Section,Inflammation & Innate Immunity Unit,0.0
Mosquito Immunity and Vector Competence Section,Inflammation Biology Section,0.0
Mosquito Immunity and Vector Competence Section,Innate Immunity and Pathogenesis Section,0.0
Mosquito Immunity and Vector Competence Section,Integrative Immunobiology Section,0.0
Mosquito Immunity and Vector Competence Section,International HIV/STD Section,0.0
Mosquito Immunity and Vector Competence Section,LID Clinical Studies Unit,0.0
Mosquito Immunity and Vector Competence Section,Lung and Vascular Inflammation Section,0.0
Mosquito Immunity and Vector Competence Section,Lyme Disease Studies Unit,0.0
Mosquito Immunity and Vector Competence Section,Lymphocyte Biology Section,0.0
Mosquito Immunity and Vector Competence Section,Malaria Genetics Section,0.0
Mosquito Immunity and Vector Competence Section,Malaria Immunology Section,0.0
Mosquito Immunity and Vector Competence Section,Mast Cell Biology Section,0.0
Mosquito Immunity and Vector Competence Section,Medical Virology Section,0.0
Mosquito Immunity and Vector Competence Section,Metaorganism Immunity Section,0.0
Mosquito Immunity and Vector Competence Section,Microbial Pathogenesis Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Biology Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Defenses Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Development of the Immune System Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Mosquito Immunity and Vector Competence Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Mosquito Immunity and Vector Competence Section,Molecular HIV Host Interactions Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Microbiology Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Parasitology Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Parasitology and Entomology Unit,0.0
Mosquito Immunity and Vector Competence Section,Molecular Pathogenesis Unit,0.0
Mosquito Immunity and Vector Competence Section,Molecular Pathogenesis and Biomarkers Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Pathology Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular Signaling Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular and Cellular Immunology Section,0.0
Mosquito Immunity and Vector Competence Section,Molecular and Cellular Immunoregulation Section,0.0
Mucosal Immunity Section,Allergy and Immunology Clinical Training Program,0.0
Mucosal Immunity Section,Antibacterial Host Defense Unit,0.0
Mucosal Immunity Section,Antibody Biology Unit,0.0
Mucosal Immunity Section,Apicomplexan Molecular Physiology Section,0.0
Mucosal Immunity Section,Autoimmunity and Functional Genomics Section,0.0
Mucosal Immunity Section,B-Cell Immunology Section,0.0
Mucosal Immunity Section,B-Cell Molecular Immunology Section,0.0
Mucosal Immunity Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Mucosal Immunity Section,Bacterial Physiology and Metabolism Unit,0.0
Mucosal Immunity Section,Barrier Immunity Section,0.0
Mucosal Immunity Section,Biology of Vector-Borne Viruses Section,0.0
Mucosal Immunity Section,Building 14B South,0.0
Mucosal Immunity Section,Building 33,0.0
Mucosal Immunity Section,Building 50,0.0
Mucosal Immunity Section,Building NIHAC/103,0.0
Mucosal Immunity Section,Buildings 4 and 10/11C127,0.0
Mucosal Immunity Section,Caliciviruses Section,0.0
Mucosal Immunity Section,Cell Signaling and Immunity Section,0.0
Mucosal Immunity Section,Cellular Biology Section,0.0
Mucosal Immunity Section,Chemotaxis Signal Section,0.0
Mucosal Immunity Section,Chlamydial Diseases Section,0.0
Mucosal Immunity Section,Clinical Microbiome Unit (CMU),0.0
Mucosal Immunity Section,Clinical Pathophysiology Section,0.0
Mucosal Immunity Section,Clinical Research Section,0.0
Mucosal Immunity Section,Clinical and Molecular Retrovirology Section,0.0
Mucosal Immunity Section,Computational Biology Unit,0.0
Mucosal Immunity Section,Coxiella Pathogenesis Section,0.0
Mucosal Immunity Section,DNA Tumor Virus Section,0.0
Mucosal Immunity Section,Disease Modeling and Transmission Section,0.0
Mucosal Immunity Section,Emerging Respiratory Viruses Section,0.0
Mucosal Immunity Section,Emerging Virus Immunity Unit,0.0
Mucosal Immunity Section,Epidemiology and Population Studies Unit,0.0
Mucosal Immunity Section,Epithelial Therapeutics Unit,0.0
Mucosal Immunity Section,Flow Cytometry Section,0.0
Mucosal Immunity Section,Food Allergy Research Section,0.0
Mucosal Immunity Section,Functional Cellular Networks Section,0.0
Mucosal Immunity Section,Fungal Pathogenesis Section,0.0
Mucosal Immunity Section,Gene Regulation Section,0.0
Mucosal Immunity Section,Genetic Engineering Section,0.0
Mucosal Immunity Section,Genetic Immunotherapy Section,0.0
Mucosal Immunity Section,HIV Immunovirology Section,0.0
Mucosal Immunity Section,HIV Pathogenesis Section,0.0
Mucosal Immunity Section,HIV-Specific Immunity Section,0.0
Mucosal Immunity Section,Helminth Immunology Section,0.0
Mucosal Immunity Section,Hepatic Pathogenesis Section,0.0
Mucosal Immunity Section,Host-Parasite Interactions Section,0.0
Mucosal Immunity Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Mucosal Immunity Section,Human Eosinophil Section,0.0
Mucosal Immunity Section,Human Immunological Diseases Section,0.0
Mucosal Immunity Section,Immune Activation Section,0.0
Mucosal Immunity Section,Immune Deficiency Genetics Section,0.0
Mucosal Immunity Section,Immunity to Pulmonary Pathogens Section,0.0
Mucosal Immunity Section,Immunobiology Section,0.0
Mucosal Immunity Section,Immunobiology and Molecular Virology Unit,0.0
Mucosal Immunity Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Mucosal Immunity Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Mucosal Immunity Section,Infectious Disease Fellowship Training Program,0.0
Mucosal Immunity Section,Infectious Disease Pathogenesis Section,0.0
Mucosal Immunity Section,Inflammation & Innate Immunity Unit,0.0
Mucosal Immunity Section,Inflammation Biology Section,0.0
Mucosal Immunity Section,Innate Immunity and Pathogenesis Section,0.0
Mucosal Immunity Section,Integrative Immunobiology Section,0.0
Mucosal Immunity Section,International HIV/STD Section,0.0
Mucosal Immunity Section,Intracellular Parasite Biology Section,0.0
Mucosal Immunity Section,LID Clinical Studies Unit,0.0
Mucosal Immunity Section,Lung and Vascular Inflammation Section,0.0
Mucosal Immunity Section,Lyme Disease Studies Unit,0.0
Mucosal Immunity Section,Lymphocyte Activation Section,0.0
Mucosal Immunity Section,Lymphocyte Biology Section,0.0
Mucosal Immunity Section,Malaria Cell Biology Section,0.0
Mucosal Immunity Section,Malaria Functional Genomics Section,0.0
Mucosal Immunity Section,Malaria Genetics Section,0.0
Mucosal Immunity Section,Malaria Immunology Section,0.0
Mucosal Immunity Section,Malaria Infection Biology and Immunity Unit,0.0
Mucosal Immunity Section,Mast Cell Biology Section,0.0
Mucosal Immunity Section,Medical Virology Section,0.0
Mucosal Immunity Section,Microbial Pathogenesis Section,0.0
Mucosal Immunity Section,Molecular Biology Section,0.0
Mucosal Immunity Section,Molecular Defenses Section,0.0
Mucosal Immunity Section,Molecular Entomology Unit,0.0
Mucosal Immunity Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Mucosal Immunity Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Mucosal Immunity Section,Molecular HIV Host Interactions Section,0.0
Mucosal Immunity Section,Molecular Microbiology Section,0.0
Mucosal Immunity Section,Molecular Parasitology Section,0.0
Mucosal Immunity Section,Molecular Parasitology and Entomology Unit,0.0
Mucosal Immunity Section,Molecular Pathogenesis Unit,0.0
Mucosal Immunity Section,Molecular Pathogenesis and Biomarkers Section,0.0
Mucosal Immunity Section,Molecular Pathology Section,0.0
Mucosal Immunity Section,Molecular Signaling Section,0.0
Mucosal Immunity Section,Molecular and Cellular Immunology Section,0.0
Mucosal Immunity Section,Molecular and Cellular Immunoregulation Section,0.0
Mucosal Immunity Section,Mosquito Immunity and Vector Competence Section,0.0
Mucosal Immunobiology Section,Allergy and Immunology Clinical Training Program,0.0
Mucosal Immunobiology Section,Antibacterial Host Defense Unit,0.0
Mucosal Immunobiology Section,Antibody Biology Unit,0.0
Mucosal Immunobiology Section,Apicomplexan Molecular Physiology Section,0.0
Mucosal Immunobiology Section,Autoimmunity and Functional Genomics Section,0.0
Mucosal Immunobiology Section,B-Cell Immunology Section,0.0
Mucosal Immunobiology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Mucosal Immunobiology Section,Bacterial Physiology and Metabolism Unit,0.0
Mucosal Immunobiology Section,Barrier Immunity Section,0.0
Mucosal Immunobiology Section,Biology of Vector-Borne Viruses Section,0.0
Mucosal Immunobiology Section,Building 14B South,0.0
Mucosal Immunobiology Section,Building 33,0.0
Mucosal Immunobiology Section,Building 50,0.0
Mucosal Immunobiology Section,Building NIHAC/103,0.0
Mucosal Immunobiology Section,Buildings 4 and 10/11C127,0.0
Mucosal Immunobiology Section,Caliciviruses Section,0.0
Mucosal Immunobiology Section,Cell Signaling and Immunity Section,0.0
Mucosal Immunobiology Section,Cellular Immunology Section,0.0
Mucosal Immunobiology Section,Chemotaxis Signal Section,0.0
Mucosal Immunobiology Section,Chlamydial Diseases Section,0.0
Mucosal Immunobiology Section,Clinical Microbiome Unit (CMU),0.0
Mucosal Immunobiology Section,Clinical Pathophysiology Section,0.0
Mucosal Immunobiology Section,Clinical Research Section,0.0
Mucosal Immunobiology Section,Clinical and Molecular Retrovirology Section,0.0
Mucosal Immunobiology Section,Computational Biology Unit,0.0
Mucosal Immunobiology Section,Coxiella Pathogenesis Section,0.0
Mucosal Immunobiology Section,DNA Tumor Virus Section,0.0
Mucosal Immunobiology Section,Disease Modeling and Transmission Section,0.0
Mucosal Immunobiology Section,Emerging Respiratory Viruses Section,0.0
Mucosal Immunobiology Section,Emerging Virus Immunity Unit,0.0
Mucosal Immunobiology Section,Epidemiology and Population Studies Unit,0.0
Mucosal Immunobiology Section,Epithelial Therapeutics Unit,0.0
Mucosal Immunobiology Section,Flow Cytometry Section,0.0
Mucosal Immunobiology Section,Food Allergy Research Section,0.0
Mucosal Immunobiology Section,Functional Cellular Networks Section,0.0
Mucosal Immunobiology Section,Gene Regulation Section,0.0
Mucosal Immunobiology Section,Genetic Engineering Section,0.0
Mucosal Immunobiology Section,Genetic Immunotherapy Section,0.0
Mucosal Immunobiology Section,HIV Immunovirology Section,0.0
Mucosal Immunobiology Section,HIV Pathogenesis Section,0.0
Mucosal Immunobiology Section,HIV-Specific Immunity Section,0.0
Mucosal Immunobiology Section,Helminth Immunology Section,0.0
Mucosal Immunobiology Section,Hepatic Pathogenesis Section,0.0
Mucosal Immunobiology Section,Host-Parasite Interactions Section,0.0
Mucosal Immunobiology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Mucosal Immunobiology Section,Human Eosinophil Section,0.0
Mucosal Immunobiology Section,Human Immunological Diseases Section,0.0
Mucosal Immunobiology Section,Immune Deficiency Genetics Section,0.0
Mucosal Immunobiology Section,Immunity to Pulmonary Pathogens Section,0.0
Mucosal Immunobiology Section,Immunobiology and Molecular Virology Unit,0.0
Mucosal Immunobiology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Mucosal Immunobiology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Mucosal Immunobiology Section,Infectious Disease Fellowship Training Program,0.0
Mucosal Immunobiology Section,Infectious Disease Pathogenesis Section,0.0
Mucosal Immunobiology Section,Inflammation & Innate Immunity Unit,0.0
Mucosal Immunobiology Section,Innate Immunity and Pathogenesis Section,0.0
Mucosal Immunobiology Section,Integrative Immunobiology Section,0.0
Mucosal Immunobiology Section,International HIV/STD Section,0.0
Mucosal Immunobiology Section,Intracellular Parasite Biology Section,0.0
Mucosal Immunobiology Section,LID Clinical Studies Unit,0.0
Mucosal Immunobiology Section,Lung and Vascular Inflammation Section,0.0
Mucosal Immunobiology Section,Lyme Disease Studies Unit,0.0
Mucosal Immunobiology Section,Lymphocyte Activation Section,0.0
Mucosal Immunobiology Section,Lymphocyte Biology Section,0.0
Mucosal Immunobiology Section,Malaria Cell Biology Section,0.0
Mucosal Immunobiology Section,Malaria Functional Genomics Section,0.0
Mucosal Immunobiology Section,Malaria Genetics Section,0.0
Mucosal Immunobiology Section,Malaria Immunology Section,0.0
Mucosal Immunobiology Section,Malaria Infection Biology and Immunity Unit,0.0
Mucosal Immunobiology Section,Mast Cell Biology Section,0.0
Mucosal Immunobiology Section,Medical Virology Section,0.0
Mucosal Immunobiology Section,Metaorganism Immunity Section,0.0
Mucosal Immunobiology Section,Microbial Pathogenesis Section,0.0
Mucosal Immunobiology Section,Molecular Biology Section,0.0
Mucosal Immunobiology Section,Molecular Defenses Section,0.0
Mucosal Immunobiology Section,Molecular Development of the Immune System Section,0.0
Mucosal Immunobiology Section,Molecular Entomology Unit,0.0
Mucosal Immunobiology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Mucosal Immunobiology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Mucosal Immunobiology Section,Molecular HIV Host Interactions Section,0.0
Mucosal Immunobiology Section,Molecular Parasitology Section,0.0
Mucosal Immunobiology Section,Molecular Parasitology and Entomology Unit,0.0
Mucosal Immunobiology Section,Molecular Pathogenesis Unit,0.0
Mucosal Immunobiology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Mucosal Immunobiology Section,Molecular Pathology Section,0.0
Mucosal Immunobiology Section,Molecular and Cellular Immunology Section,0.0
Mucosal Immunobiology Section,Molecular and Cellular Immunoregulation Section,0.0
Mucosal Immunobiology Section,Mosquito Immunity and Vector Competence Section,0.0
Multiscale Systems Biology Section,Allergy and Immunology Clinical Training Program,0.0
Multiscale Systems Biology Section,Antibacterial Host Defense Unit,0.0
Multiscale Systems Biology Section,Antibody Biology Unit,0.0
Multiscale Systems Biology Section,Apicomplexan Molecular Physiology Section,0.0
Multiscale Systems Biology Section,Autoimmunity and Functional Genomics Section,0.0
Multiscale Systems Biology Section,B-Cell Molecular Immunology Section,0.0
Multiscale Systems Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Multiscale Systems Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Multiscale Systems Biology Section,Barrier Immunity Section,0.0
Multiscale Systems Biology Section,Biological Imaging,0.0
Multiscale Systems Biology Section,Biology of Vector-Borne Viruses Section,0.0
Multiscale Systems Biology Section,Building 14B South,0.0
Multiscale Systems Biology Section,Building 33,0.0
Multiscale Systems Biology Section,Building 50,0.0
Multiscale Systems Biology Section,Building NIHAC/103,0.0
Multiscale Systems Biology Section,Buildings 4 and 10/11C127,0.0
Multiscale Systems Biology Section,Caliciviruses Section,0.0
Multiscale Systems Biology Section,Cellular Biology Section,0.0
Multiscale Systems Biology Section,Cellular Immunology Section,0.0
Multiscale Systems Biology Section,Chemotaxis Signal Section,0.0
Multiscale Systems Biology Section,Chlamydial Diseases Section,0.0
Multiscale Systems Biology Section,Clinical Microbiome Unit (CMU),0.0
Multiscale Systems Biology Section,Clinical Pathophysiology Section,0.0
Multiscale Systems Biology Section,Clinical Research Section,0.0
Multiscale Systems Biology Section,Clinical and Molecular Retrovirology Section,0.0
Multiscale Systems Biology Section,Coxiella Pathogenesis Section,0.0
Multiscale Systems Biology Section,DNA Tumor Virus Section,0.0
Multiscale Systems Biology Section,Disease Modeling and Transmission Section,0.0
Multiscale Systems Biology Section,Emerging Respiratory Viruses Section,0.0
Multiscale Systems Biology Section,Emerging Virus Immunity Unit,0.0
Multiscale Systems Biology Section,Epidemiology and Population Studies Unit,0.0
Multiscale Systems Biology Section,Epithelial Therapeutics Unit,0.0
Multiscale Systems Biology Section,Flow Cytometry Section,0.0
Multiscale Systems Biology Section,Food Allergy Research Section,0.0
Multiscale Systems Biology Section,Functional Cellular Networks Section,0.0
Multiscale Systems Biology Section,Fungal Pathogenesis Section,0.0
Multiscale Systems Biology Section,Gene Regulation Section,0.0
Multiscale Systems Biology Section,Genetic Engineering Section,0.0
Multiscale Systems Biology Section,Genetic Immunotherapy Section,0.0
Multiscale Systems Biology Section,Genomic Technologies Section,0.0
Multiscale Systems Biology Section,HIV Pathogenesis Section,0.0
Multiscale Systems Biology Section,HIV-Specific Immunity Section,0.0
Multiscale Systems Biology Section,Helminth Immunology Section,0.0
Multiscale Systems Biology Section,Hepatic Pathogenesis Section,0.0
Multiscale Systems Biology Section,Host-Parasite Interactions Section,0.0
Multiscale Systems Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Multiscale Systems Biology Section,Human Eosinophil Section,0.0
Multiscale Systems Biology Section,Human Immunological Diseases Section,0.0
Multiscale Systems Biology Section,Immune Activation Section,0.0
Multiscale Systems Biology Section,Immune Deficiency Genetics Section,0.0
Multiscale Systems Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Multiscale Systems Biology Section,Immunobiology Section,0.0
Multiscale Systems Biology Section,Immunobiology and Molecular Virology Unit,0.0
Multiscale Systems Biology Section,Infectious Disease Fellowship Training Program,0.0
Multiscale Systems Biology Section,Infectious Disease Pathogenesis Section,0.0
Multiscale Systems Biology Section,Inflammation & Innate Immunity Unit,0.0
Multiscale Systems Biology Section,Inflammation Biology Section,0.0
Multiscale Systems Biology Section,Innate Immunity and Pathogenesis Section,0.0
Multiscale Systems Biology Section,Integrative Immunobiology Section,0.0
Multiscale Systems Biology Section,International HIV/STD Section,0.0
Multiscale Systems Biology Section,Intracellular Parasite Biology Section,0.0
Multiscale Systems Biology Section,LID Clinical Studies Unit,0.0
Multiscale Systems Biology Section,Lung and Vascular Inflammation Section,0.0
Multiscale Systems Biology Section,Lyme Disease Studies Unit,0.0
Multiscale Systems Biology Section,Lymphocyte Activation Section,0.0
Multiscale Systems Biology Section,Malaria Cell Biology Section,0.0
Multiscale Systems Biology Section,Malaria Functional Genomics Section,0.0
Multiscale Systems Biology Section,Malaria Genetics Section,0.0
Multiscale Systems Biology Section,Malaria Immunology Section,0.0
Multiscale Systems Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Multiscale Systems Biology Section,Mast Cell Biology Section,0.0
Multiscale Systems Biology Section,Medical Virology Section,0.0
Multiscale Systems Biology Section,Metaorganism Immunity Section,0.0
Multiscale Systems Biology Section,Microbial Pathogenesis Section,0.0
Multiscale Systems Biology Section,Molecular Biology Section,0.0
Multiscale Systems Biology Section,Molecular Defenses Section,0.0
Multiscale Systems Biology Section,Molecular Development of the Immune System Section,0.0
Multiscale Systems Biology Section,Molecular Entomology Unit,0.0
Multiscale Systems Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Multiscale Systems Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Multiscale Systems Biology Section,Molecular HIV Host Interactions Section,0.0
Multiscale Systems Biology Section,Molecular Microbiology Section,0.0
Multiscale Systems Biology Section,Molecular Parasitology Section,0.0
Multiscale Systems Biology Section,Molecular Parasitology and Entomology Unit,0.0
Multiscale Systems Biology Section,Molecular Pathogenesis Unit,0.0
Multiscale Systems Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Multiscale Systems Biology Section,Molecular Pathology Section,0.0
Multiscale Systems Biology Section,Molecular Signaling Section,0.0
Multiscale Systems Biology Section,Molecular and Cellular Immunology Section,0.0
Multiscale Systems Biology Section,Molecular and Cellular Immunoregulation Section,0.0
Multiscale Systems Biology Section,Mosquito Immunity and Vector Competence Section,0.0
Multiscale Systems Biology Section,Mucosal Immunity Section,0.0
Multiscale Systems Biology Section,Mucosal Immunobiology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Allergy and Immunology Clinical Training Program,0.0
NIAID International Center of Excellence in Research Cambodia,Antibacterial Host Defense Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Antibody Biology Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Apicomplexan Molecular Physiology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Autoimmunity and Functional Genomics Section,0.0
NIAID International Center of Excellence in Research Cambodia,B-Cell Immunology Section,0.0
NIAID International Center of Excellence in Research Cambodia,B-Cell Molecular Immunology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Bacterial Physiology and Metabolism Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Barrier Immunity Section,0.0
NIAID International Center of Excellence in Research Cambodia,Biological Imaging,0.0
NIAID International Center of Excellence in Research Cambodia,Biology of Vector-Borne Viruses Section,0.0
NIAID International Center of Excellence in Research Cambodia,Building 14B South,0.0
NIAID International Center of Excellence in Research Cambodia,Building 33,0.0
NIAID International Center of Excellence in Research Cambodia,Building 50,0.0
NIAID International Center of Excellence in Research Cambodia,Building NIHAC/103,0.0
NIAID International Center of Excellence in Research Cambodia,Buildings 4 and 10/11C127,0.0
NIAID International Center of Excellence in Research Cambodia,Caliciviruses Section,0.0
NIAID International Center of Excellence in Research Cambodia,Cell Signaling and Immunity Section,0.0
NIAID International Center of Excellence in Research Cambodia,Cellular Biology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Cellular Immunology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Chemotaxis Signal Section,0.0
NIAID International Center of Excellence in Research Cambodia,Chlamydial Diseases Section,0.0
NIAID International Center of Excellence in Research Cambodia,Clinical Microbiome Unit (CMU),0.0
NIAID International Center of Excellence in Research Cambodia,Clinical Pathophysiology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Clinical Research Section,0.0
NIAID International Center of Excellence in Research Cambodia,Clinical and Molecular Retrovirology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Computational Biology Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Coxiella Pathogenesis Section,0.0
NIAID International Center of Excellence in Research Cambodia,DNA Tumor Virus Section,0.0
NIAID International Center of Excellence in Research Cambodia,Disease Modeling and Transmission Section,0.0
NIAID International Center of Excellence in Research Cambodia,Emerging Respiratory Viruses Section,0.0
NIAID International Center of Excellence in Research Cambodia,Emerging Virus Immunity Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Epidemiology and Population Studies Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Epithelial Therapeutics Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Flow Cytometry Section,0.0
NIAID International Center of Excellence in Research Cambodia,Food Allergy Research Section,0.0
NIAID International Center of Excellence in Research Cambodia,Functional Cellular Networks Section,0.0
NIAID International Center of Excellence in Research Cambodia,Fungal Pathogenesis Section,0.0
NIAID International Center of Excellence in Research Cambodia,Gene Regulation Section,0.0
NIAID International Center of Excellence in Research Cambodia,Genetic Engineering Section,0.0
NIAID International Center of Excellence in Research Cambodia,Genetic Immunotherapy Section,0.0
NIAID International Center of Excellence in Research Cambodia,Genomic Technologies Section,0.0
NIAID International Center of Excellence in Research Cambodia,HIV Immunovirology Section,0.0
NIAID International Center of Excellence in Research Cambodia,HIV Pathogenesis Section,0.0
NIAID International Center of Excellence in Research Cambodia,HIV-Specific Immunity Section,0.0
NIAID International Center of Excellence in Research Cambodia,Helminth Immunology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Hepatic Pathogenesis Section,0.0
NIAID International Center of Excellence in Research Cambodia,Host-Parasite Interactions Section,0.0
NIAID International Center of Excellence in Research Cambodia,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Human Eosinophil Section,0.0
NIAID International Center of Excellence in Research Cambodia,Human Immunological Diseases Section,0.0
NIAID International Center of Excellence in Research Cambodia,Immune Activation Section,0.0
NIAID International Center of Excellence in Research Cambodia,Immune Deficiency Genetics Section,0.0
NIAID International Center of Excellence in Research Cambodia,Immunity to Pulmonary Pathogens Section,0.0
NIAID International Center of Excellence in Research Cambodia,Immunobiology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Immunobiology and Molecular Virology Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
NIAID International Center of Excellence in Research Cambodia,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
NIAID International Center of Excellence in Research Cambodia,Infectious Disease Fellowship Training Program,0.0
NIAID International Center of Excellence in Research Cambodia,Infectious Disease Pathogenesis Section,0.0
NIAID International Center of Excellence in Research Cambodia,Inflammation & Innate Immunity Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Inflammation Biology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Innate Immunity and Pathogenesis Section,0.0
NIAID International Center of Excellence in Research Cambodia,Integrative Immunobiology Section,0.0
NIAID International Center of Excellence in Research Cambodia,International HIV/STD Section,0.0
NIAID International Center of Excellence in Research Cambodia,Intracellular Parasite Biology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Lung and Vascular Inflammation Section,0.0
NIAID International Center of Excellence in Research Cambodia,Lyme Disease Studies Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Lymphocyte Activation Section,0.0
NIAID International Center of Excellence in Research Cambodia,Lymphocyte Biology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Malaria Cell Biology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Malaria Functional Genomics Section,0.0
NIAID International Center of Excellence in Research Cambodia,Malaria Immunology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Malaria Infection Biology and Immunity Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Mast Cell Biology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Medical Virology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Metaorganism Immunity Section,0.0
NIAID International Center of Excellence in Research Cambodia,Microbial Pathogenesis Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Biology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Defenses Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Development of the Immune System Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Entomology Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Genetics Section (Laboratory of Bacteriology),0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
NIAID International Center of Excellence in Research Cambodia,Molecular HIV Host Interactions Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Microbiology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Parasitology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Parasitology and Entomology Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Pathogenesis Unit,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Pathogenesis and Biomarkers Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Pathology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular Signaling Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular and Cellular Immunology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Molecular and Cellular Immunoregulation Section,0.0
NIAID International Center of Excellence in Research Cambodia,Mosquito Immunity and Vector Competence Section,0.0
NIAID International Center of Excellence in Research Cambodia,Mucosal Immunity Section,0.0
NIAID International Center of Excellence in Research Cambodia,Mucosal Immunobiology Section,0.0
NIAID International Center of Excellence in Research Cambodia,Multiscale Systems Biology Section,0.0
Neuroimmunological Diseases Section,Allergy and Immunology Clinical Training Program,0.0
Neuroimmunological Diseases Section,Antibacterial Host Defense Unit,0.0
Neuroimmunological Diseases Section,Antibody Biology Unit,0.0
Neuroimmunological Diseases Section,Apicomplexan Molecular Physiology Section,0.0
Neuroimmunological Diseases Section,Autoimmunity and Functional Genomics Section,0.0
Neuroimmunological Diseases Section,B-Cell Immunology Section,0.0
Neuroimmunological Diseases Section,B-Cell Molecular Immunology Section,0.0
Neuroimmunological Diseases Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Neuroimmunological Diseases Section,Bacterial Physiology and Metabolism Unit,0.0
Neuroimmunological Diseases Section,Barrier Immunity Section,0.0
Neuroimmunological Diseases Section,Biological Imaging,0.0
Neuroimmunological Diseases Section,Biology of Vector-Borne Viruses Section,0.0
Neuroimmunological Diseases Section,Building 14B South,0.0
Neuroimmunological Diseases Section,Building 33,0.0
Neuroimmunological Diseases Section,Building 50,0.0
Neuroimmunological Diseases Section,Building NIHAC/103,0.0
Neuroimmunological Diseases Section,Buildings 4 and 10/11C127,0.0
Neuroimmunological Diseases Section,Caliciviruses Section,0.0
Neuroimmunological Diseases Section,Cell Signaling and Immunity Section,0.0
Neuroimmunological Diseases Section,Cellular Biology Section,0.0
Neuroimmunological Diseases Section,Cellular Immunology Section,0.0
Neuroimmunological Diseases Section,Chemotaxis Signal Section,0.0
Neuroimmunological Diseases Section,Chlamydial Diseases Section,0.0
Neuroimmunological Diseases Section,Clinical Microbiome Unit (CMU),0.0
Neuroimmunological Diseases Section,Clinical Pathophysiology Section,0.0
Neuroimmunological Diseases Section,Clinical Research Section,0.0
Neuroimmunological Diseases Section,Clinical and Molecular Retrovirology Section,0.0
Neuroimmunological Diseases Section,Computational Biology Unit,0.0
Neuroimmunological Diseases Section,Coxiella Pathogenesis Section,0.0
Neuroimmunological Diseases Section,DNA Tumor Virus Section,0.0
Neuroimmunological Diseases Section,Disease Modeling and Transmission Section,0.0
Neuroimmunological Diseases Section,Emerging Respiratory Viruses Section,0.0
Neuroimmunological Diseases Section,Emerging Virus Immunity Unit,0.0
Neuroimmunological Diseases Section,Epidemiology and Population Studies Unit,0.0
Neuroimmunological Diseases Section,Epithelial Therapeutics Unit,0.0
Neuroimmunological Diseases Section,Flow Cytometry Section,0.0
Neuroimmunological Diseases Section,Food Allergy Research Section,0.0
Neuroimmunological Diseases Section,Functional Cellular Networks Section,0.0
Neuroimmunological Diseases Section,Fungal Pathogenesis Section,0.0
Neuroimmunological Diseases Section,Gene Regulation Section,0.0
Neuroimmunological Diseases Section,Genetic Engineering Section,0.0
Neuroimmunological Diseases Section,Genetic Immunotherapy Section,0.0
Neuroimmunological Diseases Section,Genomic Technologies Section,0.0
Neuroimmunological Diseases Section,HIV Immunovirology Section,0.0
Neuroimmunological Diseases Section,HIV Pathogenesis Section,0.0
Neuroimmunological Diseases Section,HIV-Specific Immunity Section,0.0
Neuroimmunological Diseases Section,Helminth Immunology Section,0.0
Neuroimmunological Diseases Section,Hepatic Pathogenesis Section,0.0
Neuroimmunological Diseases Section,Host-Parasite Interactions Section,0.0
Neuroimmunological Diseases Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Neuroimmunological Diseases Section,Human Eosinophil Section,0.0
Neuroimmunological Diseases Section,Human Immunological Diseases Section,0.0
Neuroimmunological Diseases Section,Immune Activation Section,0.0
Neuroimmunological Diseases Section,Immune Deficiency Genetics Section,0.0
Neuroimmunological Diseases Section,Immunity to Pulmonary Pathogens Section,0.0
Neuroimmunological Diseases Section,Immunobiology Section,0.0
Neuroimmunological Diseases Section,Immunobiology and Molecular Virology Unit,0.0
Neuroimmunological Diseases Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Neuroimmunological Diseases Section,Infectious Disease Pathogenesis Section,0.0
Neuroimmunological Diseases Section,Inflammation & Innate Immunity Unit,0.0
Neuroimmunological Diseases Section,Inflammation Biology Section,0.0
Neuroimmunological Diseases Section,Innate Immunity and Pathogenesis Section,0.0
Neuroimmunological Diseases Section,Integrative Immunobiology Section,0.0
Neuroimmunological Diseases Section,International HIV/STD Section,0.0
Neuroimmunological Diseases Section,Intracellular Parasite Biology Section,0.0
Neuroimmunological Diseases Section,LID Clinical Studies Unit,0.0
Neuroimmunological Diseases Section,Lung and Vascular Inflammation Section,0.0
Neuroimmunological Diseases Section,Lymphocyte Activation Section,0.0
Neuroimmunological Diseases Section,Lymphocyte Biology Section,0.0
Neuroimmunological Diseases Section,Malaria Cell Biology Section,0.0
Neuroimmunological Diseases Section,Malaria Functional Genomics Section,0.0
Neuroimmunological Diseases Section,Malaria Genetics Section,0.0
Neuroimmunological Diseases Section,Malaria Immunology Section,0.0
Neuroimmunological Diseases Section,Malaria Infection Biology and Immunity Unit,0.0
Neuroimmunological Diseases Section,Mast Cell Biology Section,0.0
Neuroimmunological Diseases Section,Medical Virology Section,0.0
Neuroimmunological Diseases Section,Metaorganism Immunity Section,0.0
Neuroimmunological Diseases Section,Microbial Pathogenesis Section,0.0
Neuroimmunological Diseases Section,Molecular Biology Section,0.0
Neuroimmunological Diseases Section,Molecular Defenses Section,0.0
Neuroimmunological Diseases Section,Molecular Development of the Immune System Section,0.0
Neuroimmunological Diseases Section,Molecular Entomology Unit,0.0
Neuroimmunological Diseases Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Neuroimmunological Diseases Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Neuroimmunological Diseases Section,Molecular HIV Host Interactions Section,0.0
Neuroimmunological Diseases Section,Molecular Microbiology Section,0.0
Neuroimmunological Diseases Section,Molecular Parasitology Section,0.0
Neuroimmunological Diseases Section,Molecular Parasitology and Entomology Unit,0.0
Neuroimmunological Diseases Section,Molecular Pathogenesis Unit,0.0
Neuroimmunological Diseases Section,Molecular Pathogenesis and Biomarkers Section,0.0
Neuroimmunological Diseases Section,Molecular Pathology Section,0.0
Neuroimmunological Diseases Section,Molecular Signaling Section,0.0
Neuroimmunological Diseases Section,Molecular and Cellular Immunology Section,0.0
Neuroimmunological Diseases Section,Molecular and Cellular Immunoregulation Section,0.0
Neuroimmunological Diseases Section,Mosquito Immunity and Vector Competence Section,0.0
Neuroimmunological Diseases Section,Mucosal Immunobiology Section,0.0
Neuroimmunological Diseases Section,Multiscale Systems Biology Section,0.0
Neuroimmunological Diseases Section,NIAID International Center of Excellence in Research Cambodia,0.0
Neuroimmunology Unit,Allergy and Immunology Clinical Training Program,0.0
Neuroimmunology Unit,Antibacterial Host Defense Unit,0.0
Neuroimmunology Unit,Antibody Biology Unit,0.0
Neuroimmunology Unit,Apicomplexan Molecular Physiology Section,0.0
Neuroimmunology Unit,Autoimmunity and Functional Genomics Section,0.0
Neuroimmunology Unit,B-Cell Immunology Section,0.0
Neuroimmunology Unit,B-Cell Molecular Immunology Section,0.0
Neuroimmunology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Neuroimmunology Unit,Bacterial Physiology and Metabolism Unit,0.0
Neuroimmunology Unit,Barrier Immunity Section,0.0
Neuroimmunology Unit,Biological Imaging,0.0
Neuroimmunology Unit,Biology of Vector-Borne Viruses Section,0.0
Neuroimmunology Unit,Building 14B South,0.0
Neuroimmunology Unit,Building 33,0.0
Neuroimmunology Unit,Building 50,0.0
Neuroimmunology Unit,Building NIHAC/103,0.0
Neuroimmunology Unit,Buildings 4 and 10/11C127,0.0
Neuroimmunology Unit,Caliciviruses Section,0.0
Neuroimmunology Unit,Cell Signaling and Immunity Section,0.0
Neuroimmunology Unit,Cellular Biology Section,0.0
Neuroimmunology Unit,Cellular Immunology Section,0.0
Neuroimmunology Unit,Chemotaxis Signal Section,0.0
Neuroimmunology Unit,Chlamydial Diseases Section,0.0
Neuroimmunology Unit,Clinical Microbiome Unit (CMU),0.0
Neuroimmunology Unit,Clinical Pathophysiology Section,0.0
Neuroimmunology Unit,Clinical Research Section,0.0
Neuroimmunology Unit,Clinical and Molecular Retrovirology Section,0.0
Neuroimmunology Unit,Computational Biology Unit,0.0
Neuroimmunology Unit,Coxiella Pathogenesis Section,0.0
Neuroimmunology Unit,DNA Tumor Virus Section,0.0
Neuroimmunology Unit,Disease Modeling and Transmission Section,0.0
Neuroimmunology Unit,Emerging Respiratory Viruses Section,0.0
Neuroimmunology Unit,Emerging Virus Immunity Unit,0.0
Neuroimmunology Unit,Epidemiology and Population Studies Unit,0.0
Neuroimmunology Unit,Epithelial Therapeutics Unit,0.0
Neuroimmunology Unit,Flow Cytometry Section,0.0
Neuroimmunology Unit,Food Allergy Research Section,0.0
Neuroimmunology Unit,Functional Cellular Networks Section,0.0
Neuroimmunology Unit,Fungal Pathogenesis Section,0.0
Neuroimmunology Unit,Gene Regulation Section,0.0
Neuroimmunology Unit,Genetic Engineering Section,0.0
Neuroimmunology Unit,Genetic Immunotherapy Section,0.0
Neuroimmunology Unit,Genomic Technologies Section,0.0
Neuroimmunology Unit,HIV Immunovirology Section,0.0
Neuroimmunology Unit,HIV Pathogenesis Section,0.0
Neuroimmunology Unit,HIV-Specific Immunity Section,0.0
Neuroimmunology Unit,Helminth Immunology Section,0.0
Neuroimmunology Unit,Hepatic Pathogenesis Section,0.0
Neuroimmunology Unit,Host-Parasite Interactions Section,0.0
Neuroimmunology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Neuroimmunology Unit,Human Eosinophil Section,0.0
Neuroimmunology Unit,Human Immunological Diseases Section,0.0
Neuroimmunology Unit,Immune Activation Section,0.0
Neuroimmunology Unit,Immune Deficiency Genetics Section,0.0
Neuroimmunology Unit,Immunity to Pulmonary Pathogens Section,0.0
Neuroimmunology Unit,Immunobiology Section,0.0
Neuroimmunology Unit,Immunobiology and Molecular Virology Unit,0.0
Neuroimmunology Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Neuroimmunology Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Neuroimmunology Unit,Infectious Disease Fellowship Training Program,0.0
Neuroimmunology Unit,Infectious Disease Pathogenesis Section,0.0
Neuroimmunology Unit,Inflammation & Innate Immunity Unit,0.0
Neuroimmunology Unit,Inflammation Biology Section,0.0
Neuroimmunology Unit,Integrative Immunobiology Section,0.0
Neuroimmunology Unit,International HIV/STD Section,0.0
Neuroimmunology Unit,Intracellular Parasite Biology Section,0.0
Neuroimmunology Unit,LID Clinical Studies Unit,0.0
Neuroimmunology Unit,Lung and Vascular Inflammation Section,0.0
Neuroimmunology Unit,Lyme Disease Studies Unit,0.0
Neuroimmunology Unit,Lymphocyte Activation Section,0.0
Neuroimmunology Unit,Lymphocyte Biology Section,0.0
Neuroimmunology Unit,Malaria Cell Biology Section,0.0
Neuroimmunology Unit,Malaria Functional Genomics Section,0.0
Neuroimmunology Unit,Malaria Genetics Section,0.0
Neuroimmunology Unit,Malaria Immunology Section,0.0
Neuroimmunology Unit,Malaria Infection Biology and Immunity Unit,0.0
Neuroimmunology Unit,Mast Cell Biology Section,0.0
Neuroimmunology Unit,Medical Virology Section,0.0
Neuroimmunology Unit,Metaorganism Immunity Section,0.0
Neuroimmunology Unit,Microbial Pathogenesis Section,0.0
Neuroimmunology Unit,Molecular Biology Section,0.0
Neuroimmunology Unit,Molecular Defenses Section,0.0
Neuroimmunology Unit,Molecular Development of the Immune System Section,0.0
Neuroimmunology Unit,Molecular Entomology Unit,0.0
Neuroimmunology Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Neuroimmunology Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Neuroimmunology Unit,Molecular HIV Host Interactions Section,0.0
Neuroimmunology Unit,Molecular Microbiology Section,0.0
Neuroimmunology Unit,Molecular Parasitology Section,0.0
Neuroimmunology Unit,Molecular Parasitology and Entomology Unit,0.0
Neuroimmunology Unit,Molecular Pathogenesis Unit,0.0
Neuroimmunology Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Neuroimmunology Unit,Molecular Pathology Section,0.0
Neuroimmunology Unit,Molecular Signaling Section,0.0
Neuroimmunology Unit,Molecular and Cellular Immunology Section,0.0
Neuroimmunology Unit,Molecular and Cellular Immunoregulation Section,0.0
Neuroimmunology Unit,Mosquito Immunity and Vector Competence Section,0.0
Neuroimmunology Unit,Mucosal Immunity Section,0.0
Neuroimmunology Unit,Mucosal Immunobiology Section,0.0
Neuroimmunology Unit,Multiscale Systems Biology Section,0.0
Neuroimmunology Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Neuroimmunology Unit,Neuroimmunological Diseases Section,0.0
Nonhuman Primate Virology Section,Allergy and Immunology Clinical Training Program,0.0
Nonhuman Primate Virology Section,Antibacterial Host Defense Unit,0.0
Nonhuman Primate Virology Section,Antibody Biology Unit,0.0
Nonhuman Primate Virology Section,Apicomplexan Molecular Physiology Section,0.0
Nonhuman Primate Virology Section,Autoimmunity and Functional Genomics Section,0.0
Nonhuman Primate Virology Section,B-Cell Immunology Section,0.0
Nonhuman Primate Virology Section,B-Cell Molecular Immunology Section,0.0
Nonhuman Primate Virology Section,Bacterial Physiology and Metabolism Unit,0.0
Nonhuman Primate Virology Section,Biological Imaging,0.0
Nonhuman Primate Virology Section,Biology of Vector-Borne Viruses Section,0.0
Nonhuman Primate Virology Section,Building 14B South,0.0
Nonhuman Primate Virology Section,Building 33,0.0
Nonhuman Primate Virology Section,Building 50,0.0
Nonhuman Primate Virology Section,Buildings 4 and 10/11C127,0.0
Nonhuman Primate Virology Section,Caliciviruses Section,0.0
Nonhuman Primate Virology Section,Cell Signaling and Immunity Section,0.0
Nonhuman Primate Virology Section,Cellular Biology Section,0.0
Nonhuman Primate Virology Section,Cellular Immunology Section,0.0
Nonhuman Primate Virology Section,Chemotaxis Signal Section,0.0
Nonhuman Primate Virology Section,Chlamydial Diseases Section,0.0
Nonhuman Primate Virology Section,Clinical Microbiome Unit (CMU),0.0
Nonhuman Primate Virology Section,Clinical Pathophysiology Section,0.0
Nonhuman Primate Virology Section,Clinical Research Section,0.0
Nonhuman Primate Virology Section,Computational Biology Unit,0.0
Nonhuman Primate Virology Section,Coxiella Pathogenesis Section,0.0
Nonhuman Primate Virology Section,DNA Tumor Virus Section,0.0
Nonhuman Primate Virology Section,Disease Modeling and Transmission Section,0.0
Nonhuman Primate Virology Section,Emerging Respiratory Viruses Section,0.0
Nonhuman Primate Virology Section,Emerging Virus Immunity Unit,0.0
Nonhuman Primate Virology Section,Epidemiology and Population Studies Unit,0.0
Nonhuman Primate Virology Section,Epithelial Therapeutics Unit,0.0
Nonhuman Primate Virology Section,Flow Cytometry Section,0.0
Nonhuman Primate Virology Section,Food Allergy Research Section,0.0
Nonhuman Primate Virology Section,Functional Cellular Networks Section,0.0
Nonhuman Primate Virology Section,Fungal Pathogenesis Section,0.0
Nonhuman Primate Virology Section,Gene Regulation Section,0.0
Nonhuman Primate Virology Section,Genetic Immunotherapy Section,0.0
Nonhuman Primate Virology Section,Genomic Technologies Section,0.0
Nonhuman Primate Virology Section,HIV Immunovirology Section,0.0
Nonhuman Primate Virology Section,HIV Pathogenesis Section,0.0
Nonhuman Primate Virology Section,Helminth Immunology Section,0.0
Nonhuman Primate Virology Section,Hepatic Pathogenesis Section,0.0
Nonhuman Primate Virology Section,Host-Parasite Interactions Section,0.0
Nonhuman Primate Virology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Nonhuman Primate Virology Section,Human Eosinophil Section,0.0
Nonhuman Primate Virology Section,Human Immunological Diseases Section,0.0
Nonhuman Primate Virology Section,Immune Activation Section,0.0
Nonhuman Primate Virology Section,Immune Deficiency Genetics Section,0.0
Nonhuman Primate Virology Section,Immunobiology Section,0.0
Nonhuman Primate Virology Section,Immunobiology and Molecular Virology Unit,0.0
Nonhuman Primate Virology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Nonhuman Primate Virology Section,Infectious Disease Fellowship Training Program,0.0
Nonhuman Primate Virology Section,Infectious Disease Pathogenesis Section,0.0
Nonhuman Primate Virology Section,Inflammation & Innate Immunity Unit,0.0
Nonhuman Primate Virology Section,Inflammation Biology Section,0.0
Nonhuman Primate Virology Section,Integrative Immunobiology Section,0.0
Nonhuman Primate Virology Section,International HIV/STD Section,0.0
Nonhuman Primate Virology Section,Intracellular Parasite Biology Section,0.0
Nonhuman Primate Virology Section,LID Clinical Studies Unit,0.0
Nonhuman Primate Virology Section,Lung and Vascular Inflammation Section,0.0
Nonhuman Primate Virology Section,Lyme Disease Studies Unit,0.0
Nonhuman Primate Virology Section,Lymphocyte Activation Section,0.0
Nonhuman Primate Virology Section,Lymphocyte Biology Section,0.0
Nonhuman Primate Virology Section,Malaria Cell Biology Section,0.0
Nonhuman Primate Virology Section,Malaria Functional Genomics Section,0.0
Nonhuman Primate Virology Section,Malaria Genetics Section,0.0
Nonhuman Primate Virology Section,Malaria Immunology Section,0.0
Nonhuman Primate Virology Section,Malaria Infection Biology and Immunity Unit,0.0
Nonhuman Primate Virology Section,Mast Cell Biology Section,0.0
Nonhuman Primate Virology Section,Medical Virology Section,0.0
Nonhuman Primate Virology Section,Microbial Pathogenesis Section,0.0
Nonhuman Primate Virology Section,Molecular Biology Section,0.0
Nonhuman Primate Virology Section,Molecular Defenses Section,0.0
Nonhuman Primate Virology Section,Molecular Development of the Immune System Section,0.0
Nonhuman Primate Virology Section,Molecular Entomology Unit,0.0
Nonhuman Primate Virology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Nonhuman Primate Virology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Nonhuman Primate Virology Section,Molecular HIV Host Interactions Section,0.0
Nonhuman Primate Virology Section,Molecular Microbiology Section,0.0
Nonhuman Primate Virology Section,Molecular Parasitology Section,0.0
Nonhuman Primate Virology Section,Molecular Parasitology and Entomology Unit,0.0
Nonhuman Primate Virology Section,Molecular Pathogenesis Unit,0.0
Nonhuman Primate Virology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Nonhuman Primate Virology Section,Molecular Pathology Section,0.0
Nonhuman Primate Virology Section,Molecular Signaling Section,0.0
Nonhuman Primate Virology Section,Molecular and Cellular Immunology Section,0.0
Nonhuman Primate Virology Section,Molecular and Cellular Immunoregulation Section,0.0
Nonhuman Primate Virology Section,Mosquito Immunity and Vector Competence Section,0.0
Nonhuman Primate Virology Section,Mucosal Immunity Section,0.0
Nonhuman Primate Virology Section,Mucosal Immunobiology Section,0.0
Nonhuman Primate Virology Section,Multiscale Systems Biology Section,0.0
Nonhuman Primate Virology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Nonhuman Primate Virology Section,Neuroimmunological Diseases Section,0.0
Nonhuman Primate Virology Section,Neuroimmunology Unit,0.0
Office of the Animal Program Director,Allergy and Immunology Clinical Training Program,0.0
Office of the Animal Program Director,Antibacterial Host Defense Unit,0.0
Office of the Animal Program Director,Antibody Biology Unit,0.0
Office of the Animal Program Director,Apicomplexan Molecular Physiology Section,0.0
Office of the Animal Program Director,Autoimmunity and Functional Genomics Section,0.0
Office of the Animal Program Director,B-Cell Immunology Section,0.0
Office of the Animal Program Director,B-Cell Molecular Immunology Section,0.0
Office of the Animal Program Director,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Office of the Animal Program Director,Bacterial Physiology and Metabolism Unit,0.0
Office of the Animal Program Director,Barrier Immunity Section,0.0
Office of the Animal Program Director,Biological Imaging,0.0
Office of the Animal Program Director,Biology of Vector-Borne Viruses Section,0.0
Office of the Animal Program Director,Building 14B South,0.0
Office of the Animal Program Director,Building 33,0.0
Office of the Animal Program Director,Building 50,0.0
Office of the Animal Program Director,Building NIHAC/103,0.0
Office of the Animal Program Director,Buildings 4 and 10/11C127,0.0
Office of the Animal Program Director,Caliciviruses Section,0.0
Office of the Animal Program Director,Cell Signaling and Immunity Section,0.0
Office of the Animal Program Director,Cellular Biology Section,0.0
Office of the Animal Program Director,Cellular Immunology Section,0.0
Office of the Animal Program Director,Chemotaxis Signal Section,0.0
Office of the Animal Program Director,Chlamydial Diseases Section,0.0
Office of the Animal Program Director,Clinical Microbiome Unit (CMU),0.0
Office of the Animal Program Director,Clinical Pathophysiology Section,0.0
Office of the Animal Program Director,Clinical Research Section,0.0
Office of the Animal Program Director,Clinical and Molecular Retrovirology Section,0.0
Office of the Animal Program Director,Computational Biology Unit,0.0
Office of the Animal Program Director,Coxiella Pathogenesis Section,0.0
Office of the Animal Program Director,DNA Tumor Virus Section,0.0
Office of the Animal Program Director,Disease Modeling and Transmission Section,0.0
Office of the Animal Program Director,Emerging Respiratory Viruses Section,0.0
Office of the Animal Program Director,Emerging Virus Immunity Unit,0.0
Office of the Animal Program Director,Epidemiology and Population Studies Unit,0.0
Office of the Animal Program Director,Epithelial Therapeutics Unit,0.0
Office of the Animal Program Director,Flow Cytometry Section,0.0
Office of the Animal Program Director,Food Allergy Research Section,0.0
Office of the Animal Program Director,Functional Cellular Networks Section,0.0
Office of the Animal Program Director,Fungal Pathogenesis Section,0.0
Office of the Animal Program Director,Gene Regulation Section,0.0
Office of the Animal Program Director,Genetic Immunotherapy Section,0.0
Office of the Animal Program Director,Genomic Technologies Section,0.0
Office of the Animal Program Director,HIV Immunovirology Section,0.0
Office of the Animal Program Director,HIV Pathogenesis Section,0.0
Office of the Animal Program Director,HIV-Specific Immunity Section,0.0
Office of the Animal Program Director,Helminth Immunology Section,0.0
Office of the Animal Program Director,Hepatic Pathogenesis Section,0.0
Office of the Animal Program Director,Host-Parasite Interactions Section,0.0
Office of the Animal Program Director,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Office of the Animal Program Director,Human Eosinophil Section,0.0
Office of the Animal Program Director,Human Immunological Diseases Section,0.0
Office of the Animal Program Director,Immune Activation Section,0.0
Office of the Animal Program Director,Immune Deficiency Genetics Section,0.0
Office of the Animal Program Director,Immunity to Pulmonary Pathogens Section,0.0
Office of the Animal Program Director,Immunobiology Section,0.0
Office of the Animal Program Director,Immunobiology and Molecular Virology Unit,0.0
Office of the Animal Program Director,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Office of the Animal Program Director,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Office of the Animal Program Director,Infectious Disease Fellowship Training Program,0.0
Office of the Animal Program Director,Infectious Disease Pathogenesis Section,0.0
Office of the Animal Program Director,Inflammation & Innate Immunity Unit,0.0
Office of the Animal Program Director,Inflammation Biology Section,0.0
Office of the Animal Program Director,Innate Immunity and Pathogenesis Section,0.0
Office of the Animal Program Director,Integrative Immunobiology Section,0.0
Office of the Animal Program Director,International HIV/STD Section,0.0
Office of the Animal Program Director,Intracellular Parasite Biology Section,0.0
Office of the Animal Program Director,LID Clinical Studies Unit,0.0
Office of the Animal Program Director,Lung and Vascular Inflammation Section,0.0
Office of the Animal Program Director,Lyme Disease Studies Unit,0.0
Office of the Animal Program Director,Lymphocyte Activation Section,0.0
Office of the Animal Program Director,Lymphocyte Biology Section,0.0
Office of the Animal Program Director,Malaria Cell Biology Section,0.0
Office of the Animal Program Director,Malaria Functional Genomics Section,0.0
Office of the Animal Program Director,Malaria Genetics Section,0.0
Office of the Animal Program Director,Malaria Immunology Section,0.0
Office of the Animal Program Director,Malaria Infection Biology and Immunity Unit,0.0
Office of the Animal Program Director,Mast Cell Biology Section,0.0
Office of the Animal Program Director,Medical Virology Section,0.0
Office of the Animal Program Director,Metaorganism Immunity Section,0.0
Office of the Animal Program Director,Microbial Pathogenesis Section,0.0
Office of the Animal Program Director,Molecular Biology Section,0.0
Office of the Animal Program Director,Molecular Defenses Section,0.0
Office of the Animal Program Director,Molecular Development of the Immune System Section,0.0
Office of the Animal Program Director,Molecular Entomology Unit,0.0
Office of the Animal Program Director,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Office of the Animal Program Director,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Office of the Animal Program Director,Molecular HIV Host Interactions Section,0.0
Office of the Animal Program Director,Molecular Microbiology Section,0.0
Office of the Animal Program Director,Molecular Parasitology Section,0.0
Office of the Animal Program Director,Molecular Parasitology and Entomology Unit,0.0
Office of the Animal Program Director,Molecular Pathogenesis Unit,0.0
Office of the Animal Program Director,Molecular Pathogenesis and Biomarkers Section,0.0
Office of the Animal Program Director,Molecular Pathology Section,0.0
Office of the Animal Program Director,Molecular Signaling Section,0.0
Office of the Animal Program Director,Molecular and Cellular Immunology Section,0.0
Office of the Animal Program Director,Molecular and Cellular Immunoregulation Section,0.0
Office of the Animal Program Director,Mosquito Immunity and Vector Competence Section,0.0
Office of the Animal Program Director,Mucosal Immunity Section,0.0
Office of the Animal Program Director,Mucosal Immunobiology Section,0.0
Office of the Animal Program Director,Multiscale Systems Biology Section,0.0
Office of the Animal Program Director,NIAID International Center of Excellence in Research Cambodia,0.0
Office of the Animal Program Director,Neuroimmunological Diseases Section,0.0
Office of the Animal Program Director,Neuroimmunology Unit,0.0
Office of the Animal Program Director,Nonhuman Primate Virology Section,0.0
Pathogen Molecular Genetics Section,Allergy and Immunology Clinical Training Program,0.0
Pathogen Molecular Genetics Section,Antibacterial Host Defense Unit,0.0
Pathogen Molecular Genetics Section,Antibody Biology Unit,0.0
Pathogen Molecular Genetics Section,Apicomplexan Molecular Physiology Section,0.0
Pathogen Molecular Genetics Section,Autoimmunity and Functional Genomics Section,0.0
Pathogen Molecular Genetics Section,B-Cell Immunology Section,0.0
Pathogen Molecular Genetics Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Pathogen Molecular Genetics Section,Bacterial Physiology and Metabolism Unit,0.0
Pathogen Molecular Genetics Section,Barrier Immunity Section,0.0
Pathogen Molecular Genetics Section,Biological Imaging,0.0
Pathogen Molecular Genetics Section,Biology of Vector-Borne Viruses Section,0.0
Pathogen Molecular Genetics Section,Building 14B South,0.0
Pathogen Molecular Genetics Section,Building 33,0.0
Pathogen Molecular Genetics Section,Building 50,0.0
Pathogen Molecular Genetics Section,Building NIHAC/103,0.0
Pathogen Molecular Genetics Section,Buildings 4 and 10/11C127,0.0
Pathogen Molecular Genetics Section,Caliciviruses Section,0.0
Pathogen Molecular Genetics Section,Cell Signaling and Immunity Section,0.0
Pathogen Molecular Genetics Section,Cellular Biology Section,0.0
Pathogen Molecular Genetics Section,Cellular Immunology Section,0.0
Pathogen Molecular Genetics Section,Chemotaxis Signal Section,0.0
Pathogen Molecular Genetics Section,Chlamydial Diseases Section,0.0
Pathogen Molecular Genetics Section,Clinical Microbiome Unit (CMU),0.0
Pathogen Molecular Genetics Section,Clinical Pathophysiology Section,0.0
Pathogen Molecular Genetics Section,Clinical Research Section,0.0
Pathogen Molecular Genetics Section,Clinical and Molecular Retrovirology Section,0.0
Pathogen Molecular Genetics Section,Computational Biology Unit,0.0
Pathogen Molecular Genetics Section,Coxiella Pathogenesis Section,0.0
Pathogen Molecular Genetics Section,DNA Tumor Virus Section,0.0
Pathogen Molecular Genetics Section,Emerging Respiratory Viruses Section,0.0
Pathogen Molecular Genetics Section,Emerging Virus Immunity Unit,0.0
Pathogen Molecular Genetics Section,Epidemiology and Population Studies Unit,0.0
Pathogen Molecular Genetics Section,Epithelial Therapeutics Unit,0.0
Pathogen Molecular Genetics Section,Flow Cytometry Section,0.0
Pathogen Molecular Genetics Section,Food Allergy Research Section,0.0
Pathogen Molecular Genetics Section,Functional Cellular Networks Section,0.0
Pathogen Molecular Genetics Section,Fungal Pathogenesis Section,0.0
Pathogen Molecular Genetics Section,Gene Regulation Section,0.0
Pathogen Molecular Genetics Section,Genetic Engineering Section,0.0
Pathogen Molecular Genetics Section,Genetic Immunotherapy Section,0.0
Pathogen Molecular Genetics Section,Genomic Technologies Section,0.0
Pathogen Molecular Genetics Section,HIV Immunovirology Section,0.0
Pathogen Molecular Genetics Section,HIV Pathogenesis Section,0.0
Pathogen Molecular Genetics Section,HIV-Specific Immunity Section,0.0
Pathogen Molecular Genetics Section,Helminth Immunology Section,0.0
Pathogen Molecular Genetics Section,Hepatic Pathogenesis Section,0.0
Pathogen Molecular Genetics Section,Host-Parasite Interactions Section,0.0
Pathogen Molecular Genetics Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Pathogen Molecular Genetics Section,Human Eosinophil Section,0.0
Pathogen Molecular Genetics Section,Human Immunological Diseases Section,0.0
Pathogen Molecular Genetics Section,Immune Activation Section,0.0
Pathogen Molecular Genetics Section,Immune Deficiency Genetics Section,0.0
Pathogen Molecular Genetics Section,Immunity to Pulmonary Pathogens Section,0.0
Pathogen Molecular Genetics Section,Immunobiology Section,0.0
Pathogen Molecular Genetics Section,Immunobiology and Molecular Virology Unit,0.0
Pathogen Molecular Genetics Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Pathogen Molecular Genetics Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Pathogen Molecular Genetics Section,Infectious Disease Fellowship Training Program,0.0
Pathogen Molecular Genetics Section,Infectious Disease Pathogenesis Section,0.0
Pathogen Molecular Genetics Section,Inflammation & Innate Immunity Unit,0.0
Pathogen Molecular Genetics Section,Inflammation Biology Section,0.0
Pathogen Molecular Genetics Section,Innate Immunity and Pathogenesis Section,0.0
Pathogen Molecular Genetics Section,Integrative Immunobiology Section,0.0
Pathogen Molecular Genetics Section,International HIV/STD Section,0.0
Pathogen Molecular Genetics Section,Intracellular Parasite Biology Section,0.0
Pathogen Molecular Genetics Section,LID Clinical Studies Unit,0.0
Pathogen Molecular Genetics Section,Lung and Vascular Inflammation Section,0.0
Pathogen Molecular Genetics Section,Lyme Disease Studies Unit,0.0
Pathogen Molecular Genetics Section,Lymphocyte Activation Section,0.0
Pathogen Molecular Genetics Section,Lymphocyte Biology Section,0.0
Pathogen Molecular Genetics Section,Malaria Cell Biology Section,0.0
Pathogen Molecular Genetics Section,Malaria Functional Genomics Section,0.0
Pathogen Molecular Genetics Section,Malaria Genetics Section,0.0
Pathogen Molecular Genetics Section,Malaria Immunology Section,0.0
Pathogen Molecular Genetics Section,Malaria Infection Biology and Immunity Unit,0.0
Pathogen Molecular Genetics Section,Mast Cell Biology Section,0.0
Pathogen Molecular Genetics Section,Medical Virology Section,0.0
Pathogen Molecular Genetics Section,Metaorganism Immunity Section,0.0
Pathogen Molecular Genetics Section,Microbial Pathogenesis Section,0.0
Pathogen Molecular Genetics Section,Molecular Biology Section,0.0
Pathogen Molecular Genetics Section,Molecular Defenses Section,0.0
Pathogen Molecular Genetics Section,Molecular Development of the Immune System Section,0.0
Pathogen Molecular Genetics Section,Molecular Entomology Unit,0.0
Pathogen Molecular Genetics Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Pathogen Molecular Genetics Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Pathogen Molecular Genetics Section,Molecular HIV Host Interactions Section,0.0
Pathogen Molecular Genetics Section,Molecular Microbiology Section,0.0
Pathogen Molecular Genetics Section,Molecular Parasitology Section,0.0
Pathogen Molecular Genetics Section,Molecular Parasitology and Entomology Unit,0.0
Pathogen Molecular Genetics Section,Molecular Pathogenesis Unit,0.0
Pathogen Molecular Genetics Section,Molecular Pathogenesis and Biomarkers Section,0.0
Pathogen Molecular Genetics Section,Molecular Pathology Section,0.0
Pathogen Molecular Genetics Section,Molecular Signaling Section,0.0
Pathogen Molecular Genetics Section,Molecular and Cellular Immunology Section,0.0
Pathogen Molecular Genetics Section,Molecular and Cellular Immunoregulation Section,0.0
Pathogen Molecular Genetics Section,Mosquito Immunity and Vector Competence Section,0.0
Pathogen Molecular Genetics Section,Mucosal Immunity Section,0.0
Pathogen Molecular Genetics Section,Mucosal Immunobiology Section,0.0
Pathogen Molecular Genetics Section,Multiscale Systems Biology Section,0.0
Pathogen Molecular Genetics Section,NIAID International Center of Excellence in Research Cambodia,0.0
Pathogen Molecular Genetics Section,Neuroimmunological Diseases Section,0.0
Pathogen Molecular Genetics Section,Neuroimmunology Unit,0.0
Pathogen Molecular Genetics Section,Nonhuman Primate Virology Section,0.0
Pathogen Molecular Genetics Section,Office of the Animal Program Director,0.0
Pathogen-Host Cell Biology Section,Allergy and Immunology Clinical Training Program,0.0
Pathogen-Host Cell Biology Section,Antibacterial Host Defense Unit,0.0
Pathogen-Host Cell Biology Section,Antibody Biology Unit,0.0
Pathogen-Host Cell Biology Section,Apicomplexan Molecular Physiology Section,0.0
Pathogen-Host Cell Biology Section,Autoimmunity and Functional Genomics Section,0.0
Pathogen-Host Cell Biology Section,B-Cell Immunology Section,0.0
Pathogen-Host Cell Biology Section,B-Cell Molecular Immunology Section,0.0
Pathogen-Host Cell Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Pathogen-Host Cell Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Pathogen-Host Cell Biology Section,Barrier Immunity Section,0.0
Pathogen-Host Cell Biology Section,Biological Imaging,0.0
Pathogen-Host Cell Biology Section,Biology of Vector-Borne Viruses Section,0.0
Pathogen-Host Cell Biology Section,Building 14B South,0.0
Pathogen-Host Cell Biology Section,Building 33,0.0
Pathogen-Host Cell Biology Section,Building 50,0.0
Pathogen-Host Cell Biology Section,Building NIHAC/103,0.0
Pathogen-Host Cell Biology Section,Buildings 4 and 10/11C127,0.0
Pathogen-Host Cell Biology Section,Caliciviruses Section,0.0
Pathogen-Host Cell Biology Section,Cell Signaling and Immunity Section,0.0
Pathogen-Host Cell Biology Section,Cellular Biology Section,0.0
Pathogen-Host Cell Biology Section,Cellular Immunology Section,0.0
Pathogen-Host Cell Biology Section,Chemotaxis Signal Section,0.0
Pathogen-Host Cell Biology Section,Chlamydial Diseases Section,0.0
Pathogen-Host Cell Biology Section,Clinical Microbiome Unit (CMU),0.0
Pathogen-Host Cell Biology Section,Clinical Research Section,0.0
Pathogen-Host Cell Biology Section,Clinical and Molecular Retrovirology Section,0.0
Pathogen-Host Cell Biology Section,Computational Biology Unit,0.0
Pathogen-Host Cell Biology Section,DNA Tumor Virus Section,0.0
Pathogen-Host Cell Biology Section,Emerging Respiratory Viruses Section,0.0
Pathogen-Host Cell Biology Section,Emerging Virus Immunity Unit,0.0
Pathogen-Host Cell Biology Section,Epidemiology and Population Studies Unit,0.0
Pathogen-Host Cell Biology Section,Epithelial Therapeutics Unit,0.0
Pathogen-Host Cell Biology Section,Flow Cytometry Section,0.0
Pathogen-Host Cell Biology Section,Food Allergy Research Section,0.0
Pathogen-Host Cell Biology Section,Functional Cellular Networks Section,0.0
Pathogen-Host Cell Biology Section,Fungal Pathogenesis Section,0.0
Pathogen-Host Cell Biology Section,Gene Regulation Section,0.0
Pathogen-Host Cell Biology Section,Genetic Engineering Section,0.0
Pathogen-Host Cell Biology Section,Genomic Technologies Section,0.0
Pathogen-Host Cell Biology Section,HIV Immunovirology Section,0.0
Pathogen-Host Cell Biology Section,HIV Pathogenesis Section,0.0
Pathogen-Host Cell Biology Section,HIV-Specific Immunity Section,0.0
Pathogen-Host Cell Biology Section,Helminth Immunology Section,0.0
Pathogen-Host Cell Biology Section,Hepatic Pathogenesis Section,0.0
Pathogen-Host Cell Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Pathogen-Host Cell Biology Section,Human Eosinophil Section,0.0
Pathogen-Host Cell Biology Section,Human Immunological Diseases Section,0.0
Pathogen-Host Cell Biology Section,Immune Activation Section,0.0
Pathogen-Host Cell Biology Section,Immune Deficiency Genetics Section,0.0
Pathogen-Host Cell Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Pathogen-Host Cell Biology Section,Immunobiology Section,0.0
Pathogen-Host Cell Biology Section,Immunobiology and Molecular Virology Unit,0.0
Pathogen-Host Cell Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Pathogen-Host Cell Biology Section,Infectious Disease Fellowship Training Program,0.0
Pathogen-Host Cell Biology Section,Infectious Disease Pathogenesis Section,0.0
Pathogen-Host Cell Biology Section,Inflammation & Innate Immunity Unit,0.0
Pathogen-Host Cell Biology Section,Inflammation Biology Section,0.0
Pathogen-Host Cell Biology Section,Innate Immunity and Pathogenesis Section,0.0
Pathogen-Host Cell Biology Section,Integrative Immunobiology Section,0.0
Pathogen-Host Cell Biology Section,International HIV/STD Section,0.0
Pathogen-Host Cell Biology Section,Intracellular Parasite Biology Section,0.0
Pathogen-Host Cell Biology Section,LID Clinical Studies Unit,0.0
Pathogen-Host Cell Biology Section,Lung and Vascular Inflammation Section,0.0
Pathogen-Host Cell Biology Section,Lyme Disease Studies Unit,0.0
Pathogen-Host Cell Biology Section,Lymphocyte Activation Section,0.0
Pathogen-Host Cell Biology Section,Lymphocyte Biology Section,0.0
Pathogen-Host Cell Biology Section,Malaria Cell Biology Section,0.0
Pathogen-Host Cell Biology Section,Malaria Functional Genomics Section,0.0
Pathogen-Host Cell Biology Section,Malaria Genetics Section,0.0
Pathogen-Host Cell Biology Section,Malaria Immunology Section,0.0
Pathogen-Host Cell Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Pathogen-Host Cell Biology Section,Medical Virology Section,0.0
Pathogen-Host Cell Biology Section,Metaorganism Immunity Section,0.0
Pathogen-Host Cell Biology Section,Microbial Pathogenesis Section,0.0
Pathogen-Host Cell Biology Section,Molecular Biology Section,0.0
Pathogen-Host Cell Biology Section,Molecular Defenses Section,0.0
Pathogen-Host Cell Biology Section,Molecular Development of the Immune System Section,0.0
Pathogen-Host Cell Biology Section,Molecular Entomology Unit,0.0
Pathogen-Host Cell Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Pathogen-Host Cell Biology Section,Molecular HIV Host Interactions Section,0.0
Pathogen-Host Cell Biology Section,Molecular Microbiology Section,0.0
Pathogen-Host Cell Biology Section,Molecular Parasitology Section,0.0
Pathogen-Host Cell Biology Section,Molecular Parasitology and Entomology Unit,0.0
Pathogen-Host Cell Biology Section,Molecular Pathogenesis Unit,0.0
Pathogen-Host Cell Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Pathogen-Host Cell Biology Section,Molecular Pathology Section,0.0
Pathogen-Host Cell Biology Section,Molecular Signaling Section,0.0
Pathogen-Host Cell Biology Section,Molecular and Cellular Immunology Section,0.0
Pathogen-Host Cell Biology Section,Molecular and Cellular Immunoregulation Section,0.0
Pathogen-Host Cell Biology Section,Mosquito Immunity and Vector Competence Section,0.0
Pathogen-Host Cell Biology Section,Mucosal Immunity Section,0.0
Pathogen-Host Cell Biology Section,Mucosal Immunobiology Section,0.0
Pathogen-Host Cell Biology Section,Multiscale Systems Biology Section,0.0
Pathogen-Host Cell Biology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Pathogen-Host Cell Biology Section,Neuroimmunological Diseases Section,0.0
Pathogen-Host Cell Biology Section,Neuroimmunology Unit,0.0
Pathogen-Host Cell Biology Section,Nonhuman Primate Virology Section,0.0
Pathogen-Host Cell Biology Section,Office of the Animal Program Director,0.0
Pathogenesis and Immunity Section,Allergy and Immunology Clinical Training Program,0.0
Pathogenesis and Immunity Section,Antibacterial Host Defense Unit,0.0
Pathogenesis and Immunity Section,Antibody Biology Unit,0.0
Pathogenesis and Immunity Section,Autoimmunity and Functional Genomics Section,0.0
Pathogenesis and Immunity Section,B-Cell Immunology Section,0.0
Pathogenesis and Immunity Section,B-Cell Molecular Immunology Section,0.0
Pathogenesis and Immunity Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Pathogenesis and Immunity Section,Bacterial Physiology and Metabolism Unit,0.0
Pathogenesis and Immunity Section,Barrier Immunity Section,0.0
Pathogenesis and Immunity Section,Biological Imaging,0.0
Pathogenesis and Immunity Section,Biology of Vector-Borne Viruses Section,0.0
Pathogenesis and Immunity Section,Building 14B South,0.0
Pathogenesis and Immunity Section,Building 33,0.0
Pathogenesis and Immunity Section,Building 50,0.0
Pathogenesis and Immunity Section,Building NIHAC/103,0.0
Pathogenesis and Immunity Section,Buildings 4 and 10/11C127,0.0
Pathogenesis and Immunity Section,Caliciviruses Section,0.0
Pathogenesis and Immunity Section,Cell Signaling and Immunity Section,0.0
Pathogenesis and Immunity Section,Cellular Biology Section,0.0
Pathogenesis and Immunity Section,Cellular Immunology Section,0.0
Pathogenesis and Immunity Section,Chemotaxis Signal Section,0.0
Pathogenesis and Immunity Section,Chlamydial Diseases Section,0.0
Pathogenesis and Immunity Section,Clinical Microbiome Unit (CMU),0.0
Pathogenesis and Immunity Section,Clinical Pathophysiology Section,0.0
Pathogenesis and Immunity Section,Clinical Research Section,0.0
Pathogenesis and Immunity Section,Clinical and Molecular Retrovirology Section,0.0
Pathogenesis and Immunity Section,Computational Biology Unit,0.0
Pathogenesis and Immunity Section,Coxiella Pathogenesis Section,0.0
Pathogenesis and Immunity Section,DNA Tumor Virus Section,0.0
Pathogenesis and Immunity Section,Emerging Respiratory Viruses Section,0.0
Pathogenesis and Immunity Section,Emerging Virus Immunity Unit,0.0
Pathogenesis and Immunity Section,Epithelial Therapeutics Unit,0.0
Pathogenesis and Immunity Section,Flow Cytometry Section,0.0
Pathogenesis and Immunity Section,Food Allergy Research Section,0.0
Pathogenesis and Immunity Section,Functional Cellular Networks Section,0.0
Pathogenesis and Immunity Section,Fungal Pathogenesis Section,0.0
Pathogenesis and Immunity Section,Gene Regulation Section,0.0
Pathogenesis and Immunity Section,Genetic Engineering Section,0.0
Pathogenesis and Immunity Section,Genetic Immunotherapy Section,0.0
Pathogenesis and Immunity Section,Genomic Technologies Section,0.0
Pathogenesis and Immunity Section,HIV Immunovirology Section,0.0
Pathogenesis and Immunity Section,HIV Pathogenesis Section,0.0
Pathogenesis and Immunity Section,HIV-Specific Immunity Section,0.0
Pathogenesis and Immunity Section,Hepatic Pathogenesis Section,0.0
Pathogenesis and Immunity Section,Host-Parasite Interactions Section,0.0
Pathogenesis and Immunity Section,Human Eosinophil Section,0.0
Pathogenesis and Immunity Section,Human Immunological Diseases Section,0.0
Pathogenesis and Immunity Section,Immune Activation Section,0.0
Pathogenesis and Immunity Section,Immune Deficiency Genetics Section,0.0
Pathogenesis and Immunity Section,Immunity to Pulmonary Pathogens Section,0.0
Pathogenesis and Immunity Section,Immunobiology and Molecular Virology Unit,0.0
Pathogenesis and Immunity Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Pathogenesis and Immunity Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Pathogenesis and Immunity Section,Infectious Disease Fellowship Training Program,0.0
Pathogenesis and Immunity Section,Infectious Disease Pathogenesis Section,0.0
Pathogenesis and Immunity Section,Inflammation & Innate Immunity Unit,0.0
Pathogenesis and Immunity Section,Inflammation Biology Section,0.0
Pathogenesis and Immunity Section,Innate Immunity and Pathogenesis Section,0.0
Pathogenesis and Immunity Section,Integrative Immunobiology Section,0.0
Pathogenesis and Immunity Section,Intracellular Parasite Biology Section,0.0
Pathogenesis and Immunity Section,LID Clinical Studies Unit,0.0
Pathogenesis and Immunity Section,Lung and Vascular Inflammation Section,0.0
Pathogenesis and Immunity Section,Lyme Disease Studies Unit,0.0
Pathogenesis and Immunity Section,Malaria Functional Genomics Section,0.0
Pathogenesis and Immunity Section,Malaria Genetics Section,0.0
Pathogenesis and Immunity Section,Mast Cell Biology Section,0.0
Pathogenesis and Immunity Section,Medical Virology Section,0.0
Pathogenesis and Immunity Section,Metaorganism Immunity Section,0.0
Pathogenesis and Immunity Section,Microbial Pathogenesis Section,0.0
Pathogenesis and Immunity Section,Molecular Biology Section,0.0
Pathogenesis and Immunity Section,Molecular Defenses Section,0.0
Pathogenesis and Immunity Section,Molecular Development of the Immune System Section,0.0
Pathogenesis and Immunity Section,Molecular Entomology Unit,0.0
Pathogenesis and Immunity Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Pathogenesis and Immunity Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Pathogenesis and Immunity Section,Molecular HIV Host Interactions Section,0.0
Pathogenesis and Immunity Section,Molecular Microbiology Section,0.0
Pathogenesis and Immunity Section,Molecular Parasitology Section,0.0
Pathogenesis and Immunity Section,Molecular Parasitology and Entomology Unit,0.0
Pathogenesis and Immunity Section,Molecular Pathology Section,0.0
Pathogenesis and Immunity Section,Molecular Signaling Section,0.0
Pathogenesis and Immunity Section,Molecular and Cellular Immunoregulation Section,0.0
Pathogenesis and Immunity Section,Mucosal Immunity Section,0.0
Pathogenesis and Immunity Section,Mucosal Immunobiology Section,0.0
Pathogenesis and Immunity Section,Multiscale Systems Biology Section,0.0
Pathogenesis and Immunity Section,NIAID International Center of Excellence in Research Cambodia,0.0
Pathogenesis and Immunity Section,Neuroimmunological Diseases Section,0.0
Pathogenesis and Immunity Section,Neuroimmunology Unit,0.0
Pathogenesis and Immunity Section,Nonhuman Primate Virology Section,0.0
Pathogenesis and Immunity Section,Office of the Animal Program Director,0.0
Pathogenesis and Immunity Section,Pathogen Molecular Genetics Section,0.0
Pathogenesis and Immunity Section,Pathogen-Host Cell Biology Section,0.0
Pathology Core,Allergy and Immunology Clinical Training Program,0.0
Pathology Core,Antibacterial Host Defense Unit,0.0
Pathology Core,Antibody Biology Unit,0.0
Pathology Core,Apicomplexan Molecular Physiology Section,0.0
Pathology Core,B-Cell Immunology Section,0.0
Pathology Core,B-Cell Molecular Immunology Section,0.0
Pathology Core,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Pathology Core,Bacterial Physiology and Metabolism Unit,0.0
Pathology Core,Barrier Immunity Section,0.0
Pathology Core,Biological Imaging,0.0
Pathology Core,Biology of Vector-Borne Viruses Section,0.0
Pathology Core,Building 14B South,0.0
Pathology Core,Building 33,0.0
Pathology Core,Building 50,0.0
Pathology Core,Building NIHAC/103,0.0
Pathology Core,Buildings 4 and 10/11C127,0.0
Pathology Core,Caliciviruses Section,0.0
Pathology Core,Cellular Biology Section,0.0
Pathology Core,Cellular Immunology Section,0.0
Pathology Core,Chemotaxis Signal Section,0.0
Pathology Core,Chlamydial Diseases Section,0.0
Pathology Core,Clinical Microbiome Unit (CMU),0.0
Pathology Core,Clinical Pathophysiology Section,0.0
Pathology Core,Clinical Research Section,0.0
Pathology Core,Clinical and Molecular Retrovirology Section,0.0
Pathology Core,Computational Biology Unit,0.0
Pathology Core,Coxiella Pathogenesis Section,0.0
Pathology Core,DNA Tumor Virus Section,0.0
Pathology Core,Disease Modeling and Transmission Section,0.0
Pathology Core,Emerging Respiratory Viruses Section,0.0
Pathology Core,Emerging Virus Immunity Unit,0.0
Pathology Core,Epidemiology and Population Studies Unit,0.0
Pathology Core,Epithelial Therapeutics Unit,0.0
Pathology Core,Flow Cytometry Section,0.0
Pathology Core,Food Allergy Research Section,0.0
Pathology Core,Functional Cellular Networks Section,0.0
Pathology Core,Fungal Pathogenesis Section,0.0
Pathology Core,Gene Regulation Section,0.0
Pathology Core,Genetic Engineering Section,0.0
Pathology Core,Genetic Immunotherapy Section,0.0
Pathology Core,HIV Immunovirology Section,0.0
Pathology Core,HIV Pathogenesis Section,0.0
Pathology Core,HIV-Specific Immunity Section,0.0
Pathology Core,Helminth Immunology Section,0.0
Pathology Core,Hepatic Pathogenesis Section,0.0
Pathology Core,Host-Parasite Interactions Section,0.0
Pathology Core,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Pathology Core,Human Eosinophil Section,0.0
Pathology Core,Human Immunological Diseases Section,0.0
Pathology Core,Immune Activation Section,0.0
Pathology Core,Immune Deficiency Genetics Section,0.0
Pathology Core,Immunity to Pulmonary Pathogens Section,0.0
Pathology Core,Immunobiology and Molecular Virology Unit,0.0
Pathology Core,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Pathology Core,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Pathology Core,Infectious Disease Fellowship Training Program,0.0
Pathology Core,Infectious Disease Pathogenesis Section,0.0
Pathology Core,Inflammation & Innate Immunity Unit,0.0
Pathology Core,Inflammation Biology Section,0.0
Pathology Core,Innate Immunity and Pathogenesis Section,0.0
Pathology Core,Integrative Immunobiology Section,0.0
Pathology Core,International HIV/STD Section,0.0
Pathology Core,Intracellular Parasite Biology Section,0.0
Pathology Core,LID Clinical Studies Unit,0.0
Pathology Core,Lung and Vascular Inflammation Section,0.0
Pathology Core,Lyme Disease Studies Unit,0.0
Pathology Core,Lymphocyte Biology Section,0.0
Pathology Core,Malaria Genetics Section,0.0
Pathology Core,Malaria Infection Biology and Immunity Unit,0.0
Pathology Core,Mast Cell Biology Section,0.0
Pathology Core,Medical Virology Section,0.0
Pathology Core,Metaorganism Immunity Section,0.0
Pathology Core,Microbial Pathogenesis Section,0.0
Pathology Core,Molecular Development of the Immune System Section,0.0
Pathology Core,Molecular Entomology Unit,0.0
Pathology Core,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Pathology Core,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Pathology Core,Molecular HIV Host Interactions Section,0.0
Pathology Core,Molecular Microbiology Section,0.0
Pathology Core,Molecular Parasitology Section,0.0
Pathology Core,Molecular Parasitology and Entomology Unit,0.0
Pathology Core,Molecular Pathogenesis Unit,0.0
Pathology Core,Molecular Pathogenesis and Biomarkers Section,0.0
Pathology Core,Molecular Signaling Section,0.0
Pathology Core,Molecular and Cellular Immunology Section,0.0
Pathology Core,Molecular and Cellular Immunoregulation Section,0.0
Pathology Core,Mosquito Immunity and Vector Competence Section,0.0
Pathology Core,Mucosal Immunity Section,0.0
Pathology Core,Mucosal Immunobiology Section,0.0
Pathology Core,Multiscale Systems Biology Section,0.0
Pathology Core,NIAID International Center of Excellence in Research Cambodia,0.0
Pathology Core,Neuroimmunological Diseases Section,0.0
Pathology Core,Neuroimmunology Unit,0.0
Pathology Core,Nonhuman Primate Virology Section,0.0
Pathology Core,Office of the Animal Program Director,0.0
Pathology Core,Pathogen Molecular Genetics Section,0.0
Pathology Core,Pathogen-Host Cell Biology Section,0.0
Physiology Unit,Allergy and Immunology Clinical Training Program,0.0
Physiology Unit,Antibacterial Host Defense Unit,0.0
Physiology Unit,Antibody Biology Unit,0.0
Physiology Unit,Apicomplexan Molecular Physiology Section,0.0
Physiology Unit,Autoimmunity and Functional Genomics Section,0.0
Physiology Unit,B-Cell Immunology Section,0.0
Physiology Unit,B-Cell Molecular Immunology Section,0.0
Physiology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Physiology Unit,Bacterial Physiology and Metabolism Unit,0.0
Physiology Unit,Barrier Immunity Section,0.0
Physiology Unit,Biological Imaging,0.0
Physiology Unit,Biology of Vector-Borne Viruses Section,0.0
Physiology Unit,Building 14B South,0.0
Physiology Unit,Building 33,0.0
Physiology Unit,Building 50,0.0
Physiology Unit,Building NIHAC/103,0.0
Physiology Unit,Buildings 4 and 10/11C127,0.0
Physiology Unit,Caliciviruses Section,0.0
Physiology Unit,Cell Signaling and Immunity Section,0.0
Physiology Unit,Cellular Biology Section,0.0
Physiology Unit,Cellular Immunology Section,0.0
Physiology Unit,Chemotaxis Signal Section,0.0
Physiology Unit,Chlamydial Diseases Section,0.0
Physiology Unit,Clinical Microbiome Unit (CMU),0.0
Physiology Unit,Clinical Pathophysiology Section,0.0
Physiology Unit,Clinical Research Section,0.0
Physiology Unit,Clinical and Molecular Retrovirology Section,0.0
Physiology Unit,Computational Biology Unit,0.0
Physiology Unit,Coxiella Pathogenesis Section,0.0
Physiology Unit,DNA Tumor Virus Section,0.0
Physiology Unit,Disease Modeling and Transmission Section,0.0
Physiology Unit,Emerging Respiratory Viruses Section,0.0
Physiology Unit,Emerging Virus Immunity Unit,0.0
Physiology Unit,Epidemiology and Population Studies Unit,0.0
Physiology Unit,Epithelial Therapeutics Unit,0.0
Physiology Unit,Flow Cytometry Section,0.0
Physiology Unit,Food Allergy Research Section,0.0
Physiology Unit,Functional Cellular Networks Section,0.0
Physiology Unit,Fungal Pathogenesis Section,0.0
Physiology Unit,Gene Regulation Section,0.0
Physiology Unit,Genetic Engineering Section,0.0
Physiology Unit,Genetic Immunotherapy Section,0.0
Physiology Unit,Genomic Technologies Section,0.0
Physiology Unit,HIV Immunovirology Section,0.0
Physiology Unit,HIV Pathogenesis Section,0.0
Physiology Unit,HIV-Specific Immunity Section,0.0
Physiology Unit,Helminth Immunology Section,0.0
Physiology Unit,Hepatic Pathogenesis Section,0.0
Physiology Unit,Host-Parasite Interactions Section,0.0
Physiology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Physiology Unit,Human Eosinophil Section,0.0
Physiology Unit,Human Immunological Diseases Section,0.0
Physiology Unit,Immune Activation Section,0.0
Physiology Unit,Immune Deficiency Genetics Section,0.0
Physiology Unit,Immunity to Pulmonary Pathogens Section,0.0
Physiology Unit,Immunobiology Section,0.0
Physiology Unit,Immunobiology and Molecular Virology Unit,0.0
Physiology Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Physiology Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Physiology Unit,Infectious Disease Fellowship Training Program,0.0
Physiology Unit,Infectious Disease Pathogenesis Section,0.0
Physiology Unit,Inflammation & Innate Immunity Unit,0.0
Physiology Unit,Inflammation Biology Section,0.0
Physiology Unit,Innate Immunity and Pathogenesis Section,0.0
Physiology Unit,Integrative Immunobiology Section,0.0
Physiology Unit,International HIV/STD Section,0.0
Physiology Unit,Intracellular Parasite Biology Section,0.0
Physiology Unit,LID Clinical Studies Unit,0.0
Physiology Unit,Lung and Vascular Inflammation Section,0.0
Physiology Unit,Lyme Disease Studies Unit,0.0
Physiology Unit,Lymphocyte Biology Section,0.0
Physiology Unit,Malaria Infection Biology and Immunity Unit,0.0
Physiology Unit,Mast Cell Biology Section,0.0
Physiology Unit,Medical Virology Section,0.0
Physiology Unit,Metaorganism Immunity Section,0.0
Physiology Unit,Microbial Pathogenesis Section,0.0
Physiology Unit,Molecular Biology Section,0.0
Physiology Unit,Molecular Defenses Section,0.0
Physiology Unit,Molecular Development of the Immune System Section,0.0
Physiology Unit,Molecular Entomology Unit,0.0
Physiology Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Physiology Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Physiology Unit,Molecular HIV Host Interactions Section,0.0
Physiology Unit,Molecular Microbiology Section,0.0
Physiology Unit,Molecular Parasitology Section,0.0
Physiology Unit,Molecular Parasitology and Entomology Unit,0.0
Physiology Unit,Molecular Pathogenesis Unit,0.0
Physiology Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Physiology Unit,Molecular Pathology Section,0.0
Physiology Unit,Molecular Signaling Section,0.0
Physiology Unit,Molecular and Cellular Immunology Section,0.0
Physiology Unit,Molecular and Cellular Immunoregulation Section,0.0
Physiology Unit,Mosquito Immunity and Vector Competence Section,0.0
Physiology Unit,Mucosal Immunity Section,0.0
Physiology Unit,Mucosal Immunobiology Section,0.0
Physiology Unit,Multiscale Systems Biology Section,0.0
Physiology Unit,Neuroimmunological Diseases Section,0.0
Physiology Unit,Neuroimmunology Unit,0.0
Physiology Unit,Nonhuman Primate Virology Section,0.0
Physiology Unit,Office of the Animal Program Director,0.0
Physiology Unit,Pathogen Molecular Genetics Section,0.0
Physiology Unit,Pathogen-Host Cell Biology Section,0.0
Physiology Unit,Pathogenesis and Immunity Section,0.0
Plague Section,Allergy and Immunology Clinical Training Program,0.0
Plague Section,Antibacterial Host Defense Unit,0.0
Plague Section,Antibody Biology Unit,0.0
Plague Section,Apicomplexan Molecular Physiology Section,0.0
Plague Section,Autoimmunity and Functional Genomics Section,0.0
Plague Section,B-Cell Immunology Section,0.0
Plague Section,B-Cell Molecular Immunology Section,0.0
Plague Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Plague Section,Bacterial Physiology and Metabolism Unit,0.0
Plague Section,Barrier Immunity Section,0.0
Plague Section,Biological Imaging,0.0
Plague Section,Biology of Vector-Borne Viruses Section,0.0
Plague Section,Building 14B South,0.0
Plague Section,Building 33,0.0
Plague Section,Building 50,0.0
Plague Section,Building NIHAC/103,0.0
Plague Section,Buildings 4 and 10/11C127,0.0
Plague Section,Caliciviruses Section,0.0
Plague Section,Cell Signaling and Immunity Section,0.0
Plague Section,Cellular Biology Section,0.0
Plague Section,Cellular Immunology Section,0.0
Plague Section,Chemotaxis Signal Section,0.0
Plague Section,Chlamydial Diseases Section,0.0
Plague Section,Clinical Microbiome Unit (CMU),0.0
Plague Section,Clinical Pathophysiology Section,0.0
Plague Section,Clinical Research Section,0.0
Plague Section,Clinical and Molecular Retrovirology Section,0.0
Plague Section,Computational Biology Unit,0.0
Plague Section,Coxiella Pathogenesis Section,0.0
Plague Section,DNA Tumor Virus Section,0.0
Plague Section,Disease Modeling and Transmission Section,0.0
Plague Section,Emerging Respiratory Viruses Section,0.0
Plague Section,Emerging Virus Immunity Unit,0.0
Plague Section,Epidemiology and Population Studies Unit,0.0
Plague Section,Epithelial Therapeutics Unit,0.0
Plague Section,Flow Cytometry Section,0.0
Plague Section,Food Allergy Research Section,0.0
Plague Section,Functional Cellular Networks Section,0.0
Plague Section,Fungal Pathogenesis Section,0.0
Plague Section,Genetic Engineering Section,0.0
Plague Section,Genetic Immunotherapy Section,0.0
Plague Section,Genomic Technologies Section,0.0
Plague Section,HIV Immunovirology Section,0.0
Plague Section,HIV Pathogenesis Section,0.0
Plague Section,HIV-Specific Immunity Section,0.0
Plague Section,Helminth Immunology Section,0.0
Plague Section,Hepatic Pathogenesis Section,0.0
Plague Section,Host-Parasite Interactions Section,0.0
Plague Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Plague Section,Human Eosinophil Section,0.0
Plague Section,Human Immunological Diseases Section,0.0
Plague Section,Immune Activation Section,0.0
Plague Section,Immune Deficiency Genetics Section,0.0
Plague Section,Immunobiology Section,0.0
Plague Section,Immunobiology and Molecular Virology Unit,0.0
Plague Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Plague Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Plague Section,Infectious Disease Fellowship Training Program,0.0
Plague Section,Infectious Disease Pathogenesis Section,0.0
Plague Section,Inflammation & Innate Immunity Unit,0.0
Plague Section,Inflammation Biology Section,0.0
Plague Section,Innate Immunity and Pathogenesis Section,0.0
Plague Section,Integrative Immunobiology Section,0.0
Plague Section,International HIV/STD Section,0.0
Plague Section,Intracellular Parasite Biology Section,0.0
Plague Section,LID Clinical Studies Unit,0.0
Plague Section,Lung and Vascular Inflammation Section,0.0
Plague Section,Lyme Disease Studies Unit,0.0
Plague Section,Lymphocyte Activation Section,0.0
Plague Section,Lymphocyte Biology Section,0.0
Plague Section,Malaria Cell Biology Section,0.0
Plague Section,Malaria Functional Genomics Section,0.0
Plague Section,Malaria Genetics Section,0.0
Plague Section,Malaria Immunology Section,0.0
Plague Section,Malaria Infection Biology and Immunity Unit,0.0
Plague Section,Mast Cell Biology Section,0.0
Plague Section,Medical Virology Section,0.0
Plague Section,Metaorganism Immunity Section,0.0
Plague Section,Microbial Pathogenesis Section,0.0
Plague Section,Molecular Biology Section,0.0
Plague Section,Molecular Defenses Section,0.0
Plague Section,Molecular Development of the Immune System Section,0.0
Plague Section,Molecular Entomology Unit,0.0
Plague Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Plague Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Plague Section,Molecular HIV Host Interactions Section,0.0
Plague Section,Molecular Microbiology Section,0.0
Plague Section,Molecular Parasitology Section,0.0
Plague Section,Molecular Parasitology and Entomology Unit,0.0
Plague Section,Molecular Pathogenesis Unit,0.0
Plague Section,Molecular Pathogenesis and Biomarkers Section,0.0
Plague Section,Molecular Pathology Section,0.0
Plague Section,Molecular Signaling Section,0.0
Plague Section,Molecular and Cellular Immunology Section,0.0
Plague Section,Molecular and Cellular Immunoregulation Section,0.0
Plague Section,Mosquito Immunity and Vector Competence Section,0.0
Plague Section,Mucosal Immunity Section,0.0
Plague Section,Mucosal Immunobiology Section,0.0
Plague Section,Multiscale Systems Biology Section,0.0
Plague Section,NIAID International Center of Excellence in Research Cambodia,0.0
Plague Section,Neuroimmunological Diseases Section,0.0
Plague Section,Neuroimmunology Unit,0.0
Plague Section,Nonhuman Primate Virology Section,0.0
Plague Section,Office of the Animal Program Director,0.0
Plague Section,Pathogen Molecular Genetics Section,0.0
Plague Section,Pathogenesis and Immunity Section,0.0
Plague Section,Pathology Core,0.0
Plague Section,Physiology Unit,0.0
Primary Immune Deficiency Clinic,Allergy and Immunology Clinical Training Program,0.0
Primary Immune Deficiency Clinic,Antibacterial Host Defense Unit,0.0
Primary Immune Deficiency Clinic,Antibody Biology Unit,0.0
Primary Immune Deficiency Clinic,Apicomplexan Molecular Physiology Section,0.0
Primary Immune Deficiency Clinic,Autoimmunity and Functional Genomics Section,0.0
Primary Immune Deficiency Clinic,B-Cell Immunology Section,0.0
Primary Immune Deficiency Clinic,B-Cell Molecular Immunology Section,0.0
Primary Immune Deficiency Clinic,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Primary Immune Deficiency Clinic,Bacterial Physiology and Metabolism Unit,0.0
Primary Immune Deficiency Clinic,Barrier Immunity Section,0.0
Primary Immune Deficiency Clinic,Biological Imaging,0.0
Primary Immune Deficiency Clinic,Biology of Vector-Borne Viruses Section,0.0
Primary Immune Deficiency Clinic,Building 14B South,0.0
Primary Immune Deficiency Clinic,Building 33,0.0
Primary Immune Deficiency Clinic,Building 50,0.0
Primary Immune Deficiency Clinic,Building NIHAC/103,0.0
Primary Immune Deficiency Clinic,Buildings 4 and 10/11C127,0.0
Primary Immune Deficiency Clinic,Caliciviruses Section,0.0
Primary Immune Deficiency Clinic,Cellular Biology Section,0.0
Primary Immune Deficiency Clinic,Cellular Immunology Section,0.0
Primary Immune Deficiency Clinic,Chemotaxis Signal Section,0.0
Primary Immune Deficiency Clinic,Chlamydial Diseases Section,0.0
Primary Immune Deficiency Clinic,Clinical Microbiome Unit (CMU),0.0
Primary Immune Deficiency Clinic,Clinical Pathophysiology Section,0.0
Primary Immune Deficiency Clinic,Clinical Research Section,0.0
Primary Immune Deficiency Clinic,Clinical and Molecular Retrovirology Section,0.0
Primary Immune Deficiency Clinic,Computational Biology Unit,0.0
Primary Immune Deficiency Clinic,Coxiella Pathogenesis Section,0.0
Primary Immune Deficiency Clinic,DNA Tumor Virus Section,0.0
Primary Immune Deficiency Clinic,Disease Modeling and Transmission Section,0.0
Primary Immune Deficiency Clinic,Emerging Virus Immunity Unit,0.0
Primary Immune Deficiency Clinic,Epidemiology and Population Studies Unit,0.0
Primary Immune Deficiency Clinic,Epithelial Therapeutics Unit,0.0
Primary Immune Deficiency Clinic,Flow Cytometry Section,0.0
Primary Immune Deficiency Clinic,Food Allergy Research Section,0.0
Primary Immune Deficiency Clinic,Functional Cellular Networks Section,0.0
Primary Immune Deficiency Clinic,Gene Regulation Section,0.0
Primary Immune Deficiency Clinic,Genetic Engineering Section,0.0
Primary Immune Deficiency Clinic,Genetic Immunotherapy Section,0.0
Primary Immune Deficiency Clinic,Genomic Technologies Section,0.0
Primary Immune Deficiency Clinic,HIV Immunovirology Section,0.0
Primary Immune Deficiency Clinic,HIV Pathogenesis Section,0.0
Primary Immune Deficiency Clinic,HIV-Specific Immunity Section,0.0
Primary Immune Deficiency Clinic,Helminth Immunology Section,0.0
Primary Immune Deficiency Clinic,Hepatic Pathogenesis Section,0.0
Primary Immune Deficiency Clinic,Host-Parasite Interactions Section,0.0
Primary Immune Deficiency Clinic,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Primary Immune Deficiency Clinic,Immune Activation Section,0.0
Primary Immune Deficiency Clinic,Immunity to Pulmonary Pathogens Section,0.0
Primary Immune Deficiency Clinic,Immunobiology Section,0.0
Primary Immune Deficiency Clinic,Immunobiology and Molecular Virology Unit,0.0
Primary Immune Deficiency Clinic,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Primary Immune Deficiency Clinic,Infectious Disease Fellowship Training Program,0.0
Primary Immune Deficiency Clinic,Infectious Disease Pathogenesis Section,0.0
Primary Immune Deficiency Clinic,Inflammation & Innate Immunity Unit,0.0
Primary Immune Deficiency Clinic,Inflammation Biology Section,0.0
Primary Immune Deficiency Clinic,Innate Immunity and Pathogenesis Section,0.0
Primary Immune Deficiency Clinic,Integrative Immunobiology Section,0.0
Primary Immune Deficiency Clinic,International HIV/STD Section,0.0
Primary Immune Deficiency Clinic,Intracellular Parasite Biology Section,0.0
Primary Immune Deficiency Clinic,LID Clinical Studies Unit,0.0
Primary Immune Deficiency Clinic,Lung and Vascular Inflammation Section,0.0
Primary Immune Deficiency Clinic,Lymphocyte Activation Section,0.0
Primary Immune Deficiency Clinic,Lymphocyte Biology Section,0.0
Primary Immune Deficiency Clinic,Malaria Cell Biology Section,0.0
Primary Immune Deficiency Clinic,Malaria Functional Genomics Section,0.0
Primary Immune Deficiency Clinic,Malaria Genetics Section,0.0
Primary Immune Deficiency Clinic,Malaria Immunology Section,0.0
Primary Immune Deficiency Clinic,Malaria Infection Biology and Immunity Unit,0.0
Primary Immune Deficiency Clinic,Metaorganism Immunity Section,0.0
Primary Immune Deficiency Clinic,Microbial Pathogenesis Section,0.0
Primary Immune Deficiency Clinic,Molecular Biology Section,0.0
Primary Immune Deficiency Clinic,Molecular Entomology Unit,0.0
Primary Immune Deficiency Clinic,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Primary Immune Deficiency Clinic,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Primary Immune Deficiency Clinic,Molecular HIV Host Interactions Section,0.0
Primary Immune Deficiency Clinic,Molecular Microbiology Section,0.0
Primary Immune Deficiency Clinic,Molecular Parasitology Section,0.0
Primary Immune Deficiency Clinic,Molecular Parasitology and Entomology Unit,0.0
Primary Immune Deficiency Clinic,Molecular Pathogenesis Unit,0.0
Primary Immune Deficiency Clinic,Molecular Pathogenesis and Biomarkers Section,0.0
Primary Immune Deficiency Clinic,Molecular Pathology Section,0.0
Primary Immune Deficiency Clinic,Molecular Signaling Section,0.0
Primary Immune Deficiency Clinic,Molecular and Cellular Immunology Section,0.0
Primary Immune Deficiency Clinic,Molecular and Cellular Immunoregulation Section,0.0
Primary Immune Deficiency Clinic,Mosquito Immunity and Vector Competence Section,0.0
Primary Immune Deficiency Clinic,Mucosal Immunity Section,0.0
Primary Immune Deficiency Clinic,Mucosal Immunobiology Section,0.0
Primary Immune Deficiency Clinic,Multiscale Systems Biology Section,0.0
Primary Immune Deficiency Clinic,NIAID International Center of Excellence in Research Cambodia,0.0
Primary Immune Deficiency Clinic,Neuroimmunological Diseases Section,0.0
Primary Immune Deficiency Clinic,Neuroimmunology Unit,0.0
Primary Immune Deficiency Clinic,Nonhuman Primate Virology Section,0.0
Primary Immune Deficiency Clinic,Office of the Animal Program Director,0.0
Primary Immune Deficiency Clinic,Pathogen Molecular Genetics Section,0.0
Primary Immune Deficiency Clinic,Pathogen-Host Cell Biology Section,0.0
Primary Immune Deficiency Clinic,Pathogenesis and Immunity Section,0.0
Primary Immune Deficiency Clinic,Pathology Core,0.0
Primary Immune Deficiency Clinic,Physiology Unit,0.0
Primary Immune Deficiency Clinic,Plague Section,0.0
Prion Cell Biology Unit,Allergy and Immunology Clinical Training Program,0.0
Prion Cell Biology Unit,Antibacterial Host Defense Unit,0.0
Prion Cell Biology Unit,Antibody Biology Unit,0.0
Prion Cell Biology Unit,Apicomplexan Molecular Physiology Section,0.0
Prion Cell Biology Unit,Autoimmunity and Functional Genomics Section,0.0
Prion Cell Biology Unit,B-Cell Immunology Section,0.0
Prion Cell Biology Unit,B-Cell Molecular Immunology Section,0.0
Prion Cell Biology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Prion Cell Biology Unit,Bacterial Physiology and Metabolism Unit,0.0
Prion Cell Biology Unit,Barrier Immunity Section,0.0
Prion Cell Biology Unit,Biological Imaging,0.0
Prion Cell Biology Unit,Biology of Vector-Borne Viruses Section,0.0
Prion Cell Biology Unit,Building 14B South,0.0
Prion Cell Biology Unit,Building 33,0.0
Prion Cell Biology Unit,Building 50,0.0
Prion Cell Biology Unit,Building NIHAC/103,0.0
Prion Cell Biology Unit,Buildings 4 and 10/11C127,0.0
Prion Cell Biology Unit,Caliciviruses Section,0.0
Prion Cell Biology Unit,Cell Signaling and Immunity Section,0.0
Prion Cell Biology Unit,Cellular Biology Section,0.0
Prion Cell Biology Unit,Cellular Immunology Section,0.0
Prion Cell Biology Unit,Chemotaxis Signal Section,0.0
Prion Cell Biology Unit,Chlamydial Diseases Section,0.0
Prion Cell Biology Unit,Clinical Microbiome Unit (CMU),0.0
Prion Cell Biology Unit,Clinical Pathophysiology Section,0.0
Prion Cell Biology Unit,Clinical Research Section,0.0
Prion Cell Biology Unit,Clinical and Molecular Retrovirology Section,0.0
Prion Cell Biology Unit,Computational Biology Unit,0.0
Prion Cell Biology Unit,Coxiella Pathogenesis Section,0.0
Prion Cell Biology Unit,DNA Tumor Virus Section,0.0
Prion Cell Biology Unit,Disease Modeling and Transmission Section,0.0
Prion Cell Biology Unit,Emerging Respiratory Viruses Section,0.0
Prion Cell Biology Unit,Emerging Virus Immunity Unit,0.0
Prion Cell Biology Unit,Epidemiology and Population Studies Unit,0.0
Prion Cell Biology Unit,Epithelial Therapeutics Unit,0.0
Prion Cell Biology Unit,Flow Cytometry Section,0.0
Prion Cell Biology Unit,Food Allergy Research Section,0.0
Prion Cell Biology Unit,Functional Cellular Networks Section,0.0
Prion Cell Biology Unit,Fungal Pathogenesis Section,0.0
Prion Cell Biology Unit,Gene Regulation Section,0.0
Prion Cell Biology Unit,Genetic Engineering Section,0.0
Prion Cell Biology Unit,Genetic Immunotherapy Section,0.0
Prion Cell Biology Unit,Genomic Technologies Section,0.0
Prion Cell Biology Unit,HIV Immunovirology Section,0.0
Prion Cell Biology Unit,HIV Pathogenesis Section,0.0
Prion Cell Biology Unit,HIV-Specific Immunity Section,0.0
Prion Cell Biology Unit,Helminth Immunology Section,0.0
Prion Cell Biology Unit,Hepatic Pathogenesis Section,0.0
Prion Cell Biology Unit,Host-Parasite Interactions Section,0.0
Prion Cell Biology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Prion Cell Biology Unit,Human Eosinophil Section,0.0
Prion Cell Biology Unit,Human Immunological Diseases Section,0.0
Prion Cell Biology Unit,Immune Activation Section,0.0
Prion Cell Biology Unit,Immune Deficiency Genetics Section,0.0
Prion Cell Biology Unit,Immunity to Pulmonary Pathogens Section,0.0
Prion Cell Biology Unit,Immunobiology Section,0.0
Prion Cell Biology Unit,Immunobiology and Molecular Virology Unit,0.0
Prion Cell Biology Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Prion Cell Biology Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Prion Cell Biology Unit,Infectious Disease Fellowship Training Program,0.0
Prion Cell Biology Unit,Infectious Disease Pathogenesis Section,0.0
Prion Cell Biology Unit,Inflammation & Innate Immunity Unit,0.0
Prion Cell Biology Unit,Inflammation Biology Section,0.0
Prion Cell Biology Unit,Innate Immunity and Pathogenesis Section,0.0
Prion Cell Biology Unit,Integrative Immunobiology Section,0.0
Prion Cell Biology Unit,International HIV/STD Section,0.0
Prion Cell Biology Unit,Intracellular Parasite Biology Section,0.0
Prion Cell Biology Unit,LID Clinical Studies Unit,0.0
Prion Cell Biology Unit,Lung and Vascular Inflammation Section,0.0
Prion Cell Biology Unit,Lyme Disease Studies Unit,0.0
Prion Cell Biology Unit,Lymphocyte Activation Section,0.0
Prion Cell Biology Unit,Lymphocyte Biology Section,0.0
Prion Cell Biology Unit,Malaria Cell Biology Section,0.0
Prion Cell Biology Unit,Malaria Functional Genomics Section,0.0
Prion Cell Biology Unit,Malaria Genetics Section,0.0
Prion Cell Biology Unit,Malaria Immunology Section,0.0
Prion Cell Biology Unit,Malaria Infection Biology and Immunity Unit,0.0
Prion Cell Biology Unit,Mast Cell Biology Section,0.0
Prion Cell Biology Unit,Medical Virology Section,0.0
Prion Cell Biology Unit,Metaorganism Immunity Section,0.0
Prion Cell Biology Unit,Microbial Pathogenesis Section,0.0
Prion Cell Biology Unit,Molecular Biology Section,0.0
Prion Cell Biology Unit,Molecular Defenses Section,0.0
Prion Cell Biology Unit,Molecular Development of the Immune System Section,0.0
Prion Cell Biology Unit,Molecular Entomology Unit,0.0
Prion Cell Biology Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Prion Cell Biology Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Prion Cell Biology Unit,Molecular HIV Host Interactions Section,0.0
Prion Cell Biology Unit,Molecular Microbiology Section,0.0
Prion Cell Biology Unit,Molecular Parasitology Section,0.0
Prion Cell Biology Unit,Molecular Parasitology and Entomology Unit,0.0
Prion Cell Biology Unit,Molecular Pathogenesis Unit,0.0
Prion Cell Biology Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Prion Cell Biology Unit,Molecular Pathology Section,0.0
Prion Cell Biology Unit,Molecular Signaling Section,0.0
Prion Cell Biology Unit,Molecular and Cellular Immunology Section,0.0
Prion Cell Biology Unit,Molecular and Cellular Immunoregulation Section,0.0
Prion Cell Biology Unit,Mosquito Immunity and Vector Competence Section,0.0
Prion Cell Biology Unit,Mucosal Immunity Section,0.0
Prion Cell Biology Unit,Mucosal Immunobiology Section,0.0
Prion Cell Biology Unit,Multiscale Systems Biology Section,0.0
Prion Cell Biology Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Prion Cell Biology Unit,Neuroimmunological Diseases Section,0.0
Prion Cell Biology Unit,Neuroimmunology Unit,0.0
Prion Cell Biology Unit,Nonhuman Primate Virology Section,0.0
Prion Cell Biology Unit,Office of the Animal Program Director,0.0
Prion Cell Biology Unit,Pathogen Molecular Genetics Section,0.0
Prion Cell Biology Unit,Pathogen-Host Cell Biology Section,0.0
Prion Cell Biology Unit,Pathogenesis and Immunity Section,0.0
Prion Cell Biology Unit,Pathology Core,0.0
Prion Cell Biology Unit,Physiology Unit,0.0
Prion Cell Biology Unit,Plague Section,0.0
Prion Cell Biology Unit,Primary Immune Deficiency Clinic,0.0
Protein Chemistry Section,Allergy and Immunology Clinical Training Program,0.0
Protein Chemistry Section,Antibacterial Host Defense Unit,0.0
Protein Chemistry Section,Antibody Biology Unit,0.0
Protein Chemistry Section,Apicomplexan Molecular Physiology Section,0.0
Protein Chemistry Section,Autoimmunity and Functional Genomics Section,0.0
Protein Chemistry Section,B-Cell Immunology Section,0.0
Protein Chemistry Section,B-Cell Molecular Immunology Section,0.0
Protein Chemistry Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Protein Chemistry Section,Bacterial Physiology and Metabolism Unit,0.0
Protein Chemistry Section,Barrier Immunity Section,0.0
Protein Chemistry Section,Biological Imaging,0.0
Protein Chemistry Section,Biology of Vector-Borne Viruses Section,0.0
Protein Chemistry Section,Building 14B South,0.0
Protein Chemistry Section,Building 33,0.0
Protein Chemistry Section,Building 50,0.0
Protein Chemistry Section,Building NIHAC/103,0.0
Protein Chemistry Section,Buildings 4 and 10/11C127,0.0
Protein Chemistry Section,Caliciviruses Section,0.0
Protein Chemistry Section,Cell Signaling and Immunity Section,0.0
Protein Chemistry Section,Cellular Biology Section,0.0
Protein Chemistry Section,Cellular Immunology Section,0.0
Protein Chemistry Section,Chemotaxis Signal Section,0.0
Protein Chemistry Section,Chlamydial Diseases Section,0.0
Protein Chemistry Section,Clinical Microbiome Unit (CMU),0.0
Protein Chemistry Section,Clinical Pathophysiology Section,0.0
Protein Chemistry Section,Clinical Research Section,0.0
Protein Chemistry Section,Clinical and Molecular Retrovirology Section,0.0
Protein Chemistry Section,Computational Biology Unit,0.0
Protein Chemistry Section,Coxiella Pathogenesis Section,0.0
Protein Chemistry Section,DNA Tumor Virus Section,0.0
Protein Chemistry Section,Disease Modeling and Transmission Section,0.0
Protein Chemistry Section,Emerging Respiratory Viruses Section,0.0
Protein Chemistry Section,Emerging Virus Immunity Unit,0.0
Protein Chemistry Section,Epidemiology and Population Studies Unit,0.0
Protein Chemistry Section,Epithelial Therapeutics Unit,0.0
Protein Chemistry Section,Flow Cytometry Section,0.0
Protein Chemistry Section,Food Allergy Research Section,0.0
Protein Chemistry Section,Functional Cellular Networks Section,0.0
Protein Chemistry Section,Fungal Pathogenesis Section,0.0
Protein Chemistry Section,Gene Regulation Section,0.0
Protein Chemistry Section,Genetic Immunotherapy Section,0.0
Protein Chemistry Section,Genomic Technologies Section,0.0
Protein Chemistry Section,HIV Immunovirology Section,0.0
Protein Chemistry Section,HIV Pathogenesis Section,0.0
Protein Chemistry Section,HIV-Specific Immunity Section,0.0
Protein Chemistry Section,Helminth Immunology Section,0.0
Protein Chemistry Section,Hepatic Pathogenesis Section,0.0
Protein Chemistry Section,Host-Parasite Interactions Section,0.0
Protein Chemistry Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Protein Chemistry Section,Human Eosinophil Section,0.0
Protein Chemistry Section,Human Immunological Diseases Section,0.0
Protein Chemistry Section,Immune Activation Section,0.0
Protein Chemistry Section,Immune Deficiency Genetics Section,0.0
Protein Chemistry Section,Immunity to Pulmonary Pathogens Section,0.0
Protein Chemistry Section,Immunobiology Section,0.0
Protein Chemistry Section,Immunobiology and Molecular Virology Unit,0.0
Protein Chemistry Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Protein Chemistry Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Protein Chemistry Section,Infectious Disease Fellowship Training Program,0.0
Protein Chemistry Section,Infectious Disease Pathogenesis Section,0.0
Protein Chemistry Section,Inflammation & Innate Immunity Unit,0.0
Protein Chemistry Section,Inflammation Biology Section,0.0
Protein Chemistry Section,Innate Immunity and Pathogenesis Section,0.0
Protein Chemistry Section,Integrative Immunobiology Section,0.0
Protein Chemistry Section,International HIV/STD Section,0.0
Protein Chemistry Section,Intracellular Parasite Biology Section,0.0
Protein Chemistry Section,LID Clinical Studies Unit,0.0
Protein Chemistry Section,Lung and Vascular Inflammation Section,0.0
Protein Chemistry Section,Lyme Disease Studies Unit,0.0
Protein Chemistry Section,Lymphocyte Activation Section,0.0
Protein Chemistry Section,Lymphocyte Biology Section,0.0
Protein Chemistry Section,Malaria Cell Biology Section,0.0
Protein Chemistry Section,Malaria Functional Genomics Section,0.0
Protein Chemistry Section,Malaria Genetics Section,0.0
Protein Chemistry Section,Malaria Immunology Section,0.0
Protein Chemistry Section,Malaria Infection Biology and Immunity Unit,0.0
Protein Chemistry Section,Mast Cell Biology Section,0.0
Protein Chemistry Section,Medical Virology Section,0.0
Protein Chemistry Section,Metaorganism Immunity Section,0.0
Protein Chemistry Section,Microbial Pathogenesis Section,0.0
Protein Chemistry Section,Molecular Biology Section,0.0
Protein Chemistry Section,Molecular Defenses Section,0.0
Protein Chemistry Section,Molecular Development of the Immune System Section,0.0
Protein Chemistry Section,Molecular Entomology Unit,0.0
Protein Chemistry Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Protein Chemistry Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Protein Chemistry Section,Molecular HIV Host Interactions Section,0.0
Protein Chemistry Section,Molecular Microbiology Section,0.0
Protein Chemistry Section,Molecular Parasitology Section,0.0
Protein Chemistry Section,Molecular Parasitology and Entomology Unit,0.0
Protein Chemistry Section,Molecular Pathogenesis Unit,0.0
Protein Chemistry Section,Molecular Pathogenesis and Biomarkers Section,0.0
Protein Chemistry Section,Molecular Pathology Section,0.0
Protein Chemistry Section,Molecular Signaling Section,0.0
Protein Chemistry Section,Molecular and Cellular Immunology Section,0.0
Protein Chemistry Section,Molecular and Cellular Immunoregulation Section,0.0
Protein Chemistry Section,Mosquito Immunity and Vector Competence Section,0.0
Protein Chemistry Section,Mucosal Immunity Section,0.0
Protein Chemistry Section,Mucosal Immunobiology Section,0.0
Protein Chemistry Section,Multiscale Systems Biology Section,0.0
Protein Chemistry Section,NIAID International Center of Excellence in Research Cambodia,0.0
Protein Chemistry Section,Neuroimmunological Diseases Section,0.0
Protein Chemistry Section,Neuroimmunology Unit,0.0
Protein Chemistry Section,Nonhuman Primate Virology Section,0.0
Protein Chemistry Section,Office of the Animal Program Director,0.0
Protein Chemistry Section,Pathogen Molecular Genetics Section,0.0
Protein Chemistry Section,Pathology Core,0.0
Protein Chemistry Section,Physiology Unit,0.0
Protein Chemistry Section,Plague Section,0.0
Protein Chemistry Section,Primary Immune Deficiency Clinic,0.0
Protein Chemistry Section,Prion Cell Biology Unit,0.0
Quantitative Virology and Evolution Unit,Allergy and Immunology Clinical Training Program,0.0
Quantitative Virology and Evolution Unit,Antibacterial Host Defense Unit,0.0
Quantitative Virology and Evolution Unit,Antibody Biology Unit,0.0
Quantitative Virology and Evolution Unit,Apicomplexan Molecular Physiology Section,0.0
Quantitative Virology and Evolution Unit,Autoimmunity and Functional Genomics Section,0.0
Quantitative Virology and Evolution Unit,B-Cell Immunology Section,0.0
Quantitative Virology and Evolution Unit,B-Cell Molecular Immunology Section,0.0
Quantitative Virology and Evolution Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Quantitative Virology and Evolution Unit,Bacterial Physiology and Metabolism Unit,0.0
Quantitative Virology and Evolution Unit,Barrier Immunity Section,0.0
Quantitative Virology and Evolution Unit,Biological Imaging,0.0
Quantitative Virology and Evolution Unit,Biology of Vector-Borne Viruses Section,0.0
Quantitative Virology and Evolution Unit,Building 14B South,0.0
Quantitative Virology and Evolution Unit,Building 33,0.0
Quantitative Virology and Evolution Unit,Building 50,0.0
Quantitative Virology and Evolution Unit,Building NIHAC/103,0.0
Quantitative Virology and Evolution Unit,Buildings 4 and 10/11C127,0.0
Quantitative Virology and Evolution Unit,Caliciviruses Section,0.0
Quantitative Virology and Evolution Unit,Cell Signaling and Immunity Section,0.0
Quantitative Virology and Evolution Unit,Cellular Biology Section,0.0
Quantitative Virology and Evolution Unit,Cellular Immunology Section,0.0
Quantitative Virology and Evolution Unit,Chemotaxis Signal Section,0.0
Quantitative Virology and Evolution Unit,Chlamydial Diseases Section,0.0
Quantitative Virology and Evolution Unit,Clinical Microbiome Unit (CMU),0.0
Quantitative Virology and Evolution Unit,Clinical Pathophysiology Section,0.0
Quantitative Virology and Evolution Unit,Clinical Research Section,0.0
Quantitative Virology and Evolution Unit,Clinical and Molecular Retrovirology Section,0.0
Quantitative Virology and Evolution Unit,Computational Biology Unit,0.0
Quantitative Virology and Evolution Unit,Coxiella Pathogenesis Section,0.0
Quantitative Virology and Evolution Unit,DNA Tumor Virus Section,0.0
Quantitative Virology and Evolution Unit,Disease Modeling and Transmission Section,0.0
Quantitative Virology and Evolution Unit,Emerging Respiratory Viruses Section,0.0
Quantitative Virology and Evolution Unit,Emerging Virus Immunity Unit,0.0
Quantitative Virology and Evolution Unit,Epidemiology and Population Studies Unit,0.0
Quantitative Virology and Evolution Unit,Epithelial Therapeutics Unit,0.0
Quantitative Virology and Evolution Unit,Flow Cytometry Section,0.0
Quantitative Virology and Evolution Unit,Food Allergy Research Section,0.0
Quantitative Virology and Evolution Unit,Functional Cellular Networks Section,0.0
Quantitative Virology and Evolution Unit,Fungal Pathogenesis Section,0.0
Quantitative Virology and Evolution Unit,Gene Regulation Section,0.0
Quantitative Virology and Evolution Unit,Genetic Engineering Section,0.0
Quantitative Virology and Evolution Unit,Genetic Immunotherapy Section,0.0
Quantitative Virology and Evolution Unit,Genomic Technologies Section,0.0
Quantitative Virology and Evolution Unit,HIV Immunovirology Section,0.0
Quantitative Virology and Evolution Unit,HIV Pathogenesis Section,0.0
Quantitative Virology and Evolution Unit,HIV-Specific Immunity Section,0.0
Quantitative Virology and Evolution Unit,Helminth Immunology Section,0.0
Quantitative Virology and Evolution Unit,Hepatic Pathogenesis Section,0.0
Quantitative Virology and Evolution Unit,Host-Parasite Interactions Section,0.0
Quantitative Virology and Evolution Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Quantitative Virology and Evolution Unit,Human Eosinophil Section,0.0
Quantitative Virology and Evolution Unit,Human Immunological Diseases Section,0.0
Quantitative Virology and Evolution Unit,Immune Activation Section,0.0
Quantitative Virology and Evolution Unit,Immune Deficiency Genetics Section,0.0
Quantitative Virology and Evolution Unit,Immunity to Pulmonary Pathogens Section,0.0
Quantitative Virology and Evolution Unit,Immunobiology Section,0.0
Quantitative Virology and Evolution Unit,Immunobiology and Molecular Virology Unit,0.0
Quantitative Virology and Evolution Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Quantitative Virology and Evolution Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Quantitative Virology and Evolution Unit,Infectious Disease Fellowship Training Program,0.0
Quantitative Virology and Evolution Unit,Infectious Disease Pathogenesis Section,0.0
Quantitative Virology and Evolution Unit,Inflammation & Innate Immunity Unit,0.0
Quantitative Virology and Evolution Unit,Inflammation Biology Section,0.0
Quantitative Virology and Evolution Unit,Innate Immunity and Pathogenesis Section,0.0
Quantitative Virology and Evolution Unit,Integrative Immunobiology Section,0.0
Quantitative Virology and Evolution Unit,International HIV/STD Section,0.0
Quantitative Virology and Evolution Unit,Intracellular Parasite Biology Section,0.0
Quantitative Virology and Evolution Unit,LID Clinical Studies Unit,0.0
Quantitative Virology and Evolution Unit,Lung and Vascular Inflammation Section,0.0
Quantitative Virology and Evolution Unit,Lyme Disease Studies Unit,0.0
Quantitative Virology and Evolution Unit,Lymphocyte Activation Section,0.0
Quantitative Virology and Evolution Unit,Lymphocyte Biology Section,0.0
Quantitative Virology and Evolution Unit,Malaria Cell Biology Section,0.0
Quantitative Virology and Evolution Unit,Malaria Functional Genomics Section,0.0
Quantitative Virology and Evolution Unit,Malaria Genetics Section,0.0
Quantitative Virology and Evolution Unit,Malaria Immunology Section,0.0
Quantitative Virology and Evolution Unit,Malaria Infection Biology and Immunity Unit,0.0
Quantitative Virology and Evolution Unit,Mast Cell Biology Section,0.0
Quantitative Virology and Evolution Unit,Medical Virology Section,0.0
Quantitative Virology and Evolution Unit,Metaorganism Immunity Section,0.0
Quantitative Virology and Evolution Unit,Microbial Pathogenesis Section,0.0
Quantitative Virology and Evolution Unit,Molecular Biology Section,0.0
Quantitative Virology and Evolution Unit,Molecular Defenses Section,0.0
Quantitative Virology and Evolution Unit,Molecular Development of the Immune System Section,0.0
Quantitative Virology and Evolution Unit,Molecular Entomology Unit,0.0
Quantitative Virology and Evolution Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Quantitative Virology and Evolution Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Quantitative Virology and Evolution Unit,Molecular HIV Host Interactions Section,0.0
Quantitative Virology and Evolution Unit,Molecular Microbiology Section,0.0
Quantitative Virology and Evolution Unit,Molecular Parasitology Section,0.0
Quantitative Virology and Evolution Unit,Molecular Parasitology and Entomology Unit,0.0
Quantitative Virology and Evolution Unit,Molecular Pathogenesis Unit,0.0
Quantitative Virology and Evolution Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Quantitative Virology and Evolution Unit,Molecular Pathology Section,0.0
Quantitative Virology and Evolution Unit,Molecular Signaling Section,0.0
Quantitative Virology and Evolution Unit,Molecular and Cellular Immunology Section,0.0
Quantitative Virology and Evolution Unit,Molecular and Cellular Immunoregulation Section,0.0
Quantitative Virology and Evolution Unit,Mosquito Immunity and Vector Competence Section,0.0
Quantitative Virology and Evolution Unit,Mucosal Immunity Section,0.0
Quantitative Virology and Evolution Unit,Mucosal Immunobiology Section,0.0
Quantitative Virology and Evolution Unit,Multiscale Systems Biology Section,0.0
Quantitative Virology and Evolution Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Quantitative Virology and Evolution Unit,Neuroimmunological Diseases Section,0.0
Quantitative Virology and Evolution Unit,Neuroimmunology Unit,0.0
Quantitative Virology and Evolution Unit,Nonhuman Primate Virology Section,0.0
Quantitative Virology and Evolution Unit,Office of the Animal Program Director,0.0
Quantitative Virology and Evolution Unit,Pathogen Molecular Genetics Section,0.0
Quantitative Virology and Evolution Unit,Pathogen-Host Cell Biology Section,0.0
Quantitative Virology and Evolution Unit,Pathogenesis and Immunity Section,0.0
Quantitative Virology and Evolution Unit,Pathology Core,0.0
Quantitative Virology and Evolution Unit,Physiology Unit,0.0
Quantitative Virology and Evolution Unit,Plague Section,0.0
Quantitative Virology and Evolution Unit,Primary Immune Deficiency Clinic,0.0
Quantitative Virology and Evolution Unit,Prion Cell Biology Unit,0.0
Quantitative Virology and Evolution Unit,Protein Chemistry Section,0.0
RML Flow Cytometry Unit,Allergy and Immunology Clinical Training Program,0.0
RML Flow Cytometry Unit,Antibacterial Host Defense Unit,0.0
RML Flow Cytometry Unit,Antibody Biology Unit,0.0
RML Flow Cytometry Unit,Apicomplexan Molecular Physiology Section,0.0
RML Flow Cytometry Unit,Autoimmunity and Functional Genomics Section,0.0
RML Flow Cytometry Unit,B-Cell Immunology Section,0.0
RML Flow Cytometry Unit,B-Cell Molecular Immunology Section,0.0
RML Flow Cytometry Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
RML Flow Cytometry Unit,Bacterial Physiology and Metabolism Unit,0.0
RML Flow Cytometry Unit,Barrier Immunity Section,0.0
RML Flow Cytometry Unit,Biological Imaging,0.0
RML Flow Cytometry Unit,Building 14B South,0.0
RML Flow Cytometry Unit,Building 33,0.0
RML Flow Cytometry Unit,Building 50,0.0
RML Flow Cytometry Unit,Building NIHAC/103,0.0
RML Flow Cytometry Unit,Buildings 4 and 10/11C127,0.0
RML Flow Cytometry Unit,Cell Signaling and Immunity Section,0.0
RML Flow Cytometry Unit,Cellular Biology Section,0.0
RML Flow Cytometry Unit,Cellular Immunology Section,0.0
RML Flow Cytometry Unit,Chemotaxis Signal Section,0.0
RML Flow Cytometry Unit,Clinical Microbiome Unit (CMU),0.0
RML Flow Cytometry Unit,Clinical Pathophysiology Section,0.0
RML Flow Cytometry Unit,Clinical Research Section,0.0
RML Flow Cytometry Unit,Clinical and Molecular Retrovirology Section,0.0
RML Flow Cytometry Unit,Computational Biology Unit,0.0
RML Flow Cytometry Unit,Coxiella Pathogenesis Section,0.0
RML Flow Cytometry Unit,DNA Tumor Virus Section,0.0
RML Flow Cytometry Unit,Emerging Respiratory Viruses Section,0.0
RML Flow Cytometry Unit,Emerging Virus Immunity Unit,0.0
RML Flow Cytometry Unit,Epidemiology and Population Studies Unit,0.0
RML Flow Cytometry Unit,Epithelial Therapeutics Unit,0.0
RML Flow Cytometry Unit,Flow Cytometry Section,0.0
RML Flow Cytometry Unit,Food Allergy Research Section,0.0
RML Flow Cytometry Unit,Functional Cellular Networks Section,0.0
RML Flow Cytometry Unit,Fungal Pathogenesis Section,0.0
RML Flow Cytometry Unit,Gene Regulation Section,0.0
RML Flow Cytometry Unit,Genetic Engineering Section,0.0
RML Flow Cytometry Unit,Genetic Immunotherapy Section,0.0
RML Flow Cytometry Unit,Genomic Technologies Section,0.0
RML Flow Cytometry Unit,HIV Immunovirology Section,0.0
RML Flow Cytometry Unit,HIV Pathogenesis Section,0.0
RML Flow Cytometry Unit,HIV-Specific Immunity Section,0.0
RML Flow Cytometry Unit,Helminth Immunology Section,0.0
RML Flow Cytometry Unit,Hepatic Pathogenesis Section,0.0
RML Flow Cytometry Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
RML Flow Cytometry Unit,Human Eosinophil Section,0.0
RML Flow Cytometry Unit,Human Immunological Diseases Section,0.0
RML Flow Cytometry Unit,Immune Activation Section,0.0
RML Flow Cytometry Unit,Immune Deficiency Genetics Section,0.0
RML Flow Cytometry Unit,Immunity to Pulmonary Pathogens Section,0.0
RML Flow Cytometry Unit,Immunobiology Section,0.0
RML Flow Cytometry Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
RML Flow Cytometry Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
RML Flow Cytometry Unit,Infectious Disease Fellowship Training Program,0.0
RML Flow Cytometry Unit,Infectious Disease Pathogenesis Section,0.0
RML Flow Cytometry Unit,Inflammation & Innate Immunity Unit,0.0
RML Flow Cytometry Unit,Inflammation Biology Section,0.0
RML Flow Cytometry Unit,Integrative Immunobiology Section,0.0
RML Flow Cytometry Unit,International HIV/STD Section,0.0
RML Flow Cytometry Unit,Intracellular Parasite Biology Section,0.0
RML Flow Cytometry Unit,LID Clinical Studies Unit,0.0
RML Flow Cytometry Unit,Lung and Vascular Inflammation Section,0.0
RML Flow Cytometry Unit,Lyme Disease Studies Unit,0.0
RML Flow Cytometry Unit,Lymphocyte Activation Section,0.0
RML Flow Cytometry Unit,Lymphocyte Biology Section,0.0
RML Flow Cytometry Unit,Malaria Cell Biology Section,0.0
RML Flow Cytometry Unit,Malaria Functional Genomics Section,0.0
RML Flow Cytometry Unit,Malaria Genetics Section,0.0
RML Flow Cytometry Unit,Malaria Immunology Section,0.0
RML Flow Cytometry Unit,Malaria Infection Biology and Immunity Unit,0.0
RML Flow Cytometry Unit,Mast Cell Biology Section,0.0
RML Flow Cytometry Unit,Medical Virology Section,0.0
RML Flow Cytometry Unit,Metaorganism Immunity Section,0.0
RML Flow Cytometry Unit,Microbial Pathogenesis Section,0.0
RML Flow Cytometry Unit,Molecular Biology Section,0.0
RML Flow Cytometry Unit,Molecular Defenses Section,0.0
RML Flow Cytometry Unit,Molecular Development of the Immune System Section,0.0
RML Flow Cytometry Unit,Molecular Entomology Unit,0.0
RML Flow Cytometry Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
RML Flow Cytometry Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
RML Flow Cytometry Unit,Molecular HIV Host Interactions Section,0.0
RML Flow Cytometry Unit,Molecular Microbiology Section,0.0
RML Flow Cytometry Unit,Molecular Parasitology Section,0.0
RML Flow Cytometry Unit,Molecular Parasitology and Entomology Unit,0.0
RML Flow Cytometry Unit,Molecular Pathogenesis Unit,0.0
RML Flow Cytometry Unit,Molecular Pathogenesis and Biomarkers Section,0.0
RML Flow Cytometry Unit,Molecular Pathology Section,0.0
RML Flow Cytometry Unit,Molecular Signaling Section,0.0
RML Flow Cytometry Unit,Molecular and Cellular Immunology Section,0.0
RML Flow Cytometry Unit,Molecular and Cellular Immunoregulation Section,0.0
RML Flow Cytometry Unit,Mosquito Immunity and Vector Competence Section,0.0
RML Flow Cytometry Unit,Mucosal Immunity Section,0.0
RML Flow Cytometry Unit,Mucosal Immunobiology Section,0.0
RML Flow Cytometry Unit,Multiscale Systems Biology Section,0.0
RML Flow Cytometry Unit,NIAID International Center of Excellence in Research Cambodia,0.0
RML Flow Cytometry Unit,Neuroimmunological Diseases Section,0.0
RML Flow Cytometry Unit,Nonhuman Primate Virology Section,0.0
RML Flow Cytometry Unit,Office of the Animal Program Director,0.0
RML Flow Cytometry Unit,Pathogenesis and Immunity Section,0.0
RML Flow Cytometry Unit,Pathology Core,0.0
RML Flow Cytometry Unit,Physiology Unit,0.0
RML Flow Cytometry Unit,Primary Immune Deficiency Clinic,0.0
RML Flow Cytometry Unit,Prion Cell Biology Unit,0.0
RML Flow Cytometry Unit,Protein Chemistry Section,0.0
RML Flow Cytometry Unit,Quantitative Virology and Evolution Unit,0.0
RML Genomics Unit,Allergy and Immunology Clinical Training Program,0.0
RML Genomics Unit,Antibacterial Host Defense Unit,0.0
RML Genomics Unit,Antibody Biology Unit,0.0
RML Genomics Unit,Apicomplexan Molecular Physiology Section,0.0
RML Genomics Unit,Autoimmunity and Functional Genomics Section,0.0
RML Genomics Unit,B-Cell Immunology Section,0.0
RML Genomics Unit,B-Cell Molecular Immunology Section,0.0
RML Genomics Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
RML Genomics Unit,Bacterial Physiology and Metabolism Unit,0.0
RML Genomics Unit,Barrier Immunity Section,0.0
RML Genomics Unit,Biological Imaging,0.0
RML Genomics Unit,Building 14B South,0.0
RML Genomics Unit,Building 33,0.0
RML Genomics Unit,Building 50,0.0
RML Genomics Unit,Building NIHAC/103,0.0
RML Genomics Unit,Buildings 4 and 10/11C127,0.0
RML Genomics Unit,Cell Signaling and Immunity Section,0.0
RML Genomics Unit,Cellular Biology Section,0.0
RML Genomics Unit,Chemotaxis Signal Section,0.0
RML Genomics Unit,Clinical Microbiome Unit (CMU),0.0
RML Genomics Unit,Clinical Pathophysiology Section,0.0
RML Genomics Unit,Clinical Research Section,0.0
RML Genomics Unit,Clinical and Molecular Retrovirology Section,0.0
RML Genomics Unit,Computational Biology Unit,0.0
RML Genomics Unit,DNA Tumor Virus Section,0.0
RML Genomics Unit,Emerging Virus Immunity Unit,0.0
RML Genomics Unit,Epidemiology and Population Studies Unit,0.0
RML Genomics Unit,Epithelial Therapeutics Unit,0.0
RML Genomics Unit,Flow Cytometry Section,0.0
RML Genomics Unit,Food Allergy Research Section,0.0
RML Genomics Unit,Functional Cellular Networks Section,0.0
RML Genomics Unit,Fungal Pathogenesis Section,0.0
RML Genomics Unit,Gene Regulation Section,0.0
RML Genomics Unit,Genomic Technologies Section,0.0
RML Genomics Unit,HIV Immunovirology Section,0.0
RML Genomics Unit,HIV-Specific Immunity Section,0.0
RML Genomics Unit,Helminth Immunology Section,0.0
RML Genomics Unit,Hepatic Pathogenesis Section,0.0
RML Genomics Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
RML Genomics Unit,Human Eosinophil Section,0.0
RML Genomics Unit,Human Immunological Diseases Section,0.0
RML Genomics Unit,Immune Deficiency Genetics Section,0.0
RML Genomics Unit,Immunobiology Section,0.0
RML Genomics Unit,Immunobiology and Molecular Virology Unit,0.0
RML Genomics Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
RML Genomics Unit,Infectious Disease Fellowship Training Program,0.0
RML Genomics Unit,Infectious Disease Pathogenesis Section,0.0
RML Genomics Unit,Inflammation & Innate Immunity Unit,0.0
RML Genomics Unit,Inflammation Biology Section,0.0
RML Genomics Unit,Innate Immunity and Pathogenesis Section,0.0
RML Genomics Unit,Integrative Immunobiology Section,0.0
RML Genomics Unit,Intracellular Parasite Biology Section,0.0
RML Genomics Unit,LID Clinical Studies Unit,0.0
RML Genomics Unit,Lung and Vascular Inflammation Section,0.0
RML Genomics Unit,Lyme Disease Studies Unit,0.0
RML Genomics Unit,Lymphocyte Activation Section,0.0
RML Genomics Unit,Lymphocyte Biology Section,0.0
RML Genomics Unit,Malaria Functional Genomics Section,0.0
RML Genomics Unit,Malaria Genetics Section,0.0
RML Genomics Unit,Malaria Immunology Section,0.0
RML Genomics Unit,Malaria Infection Biology and Immunity Unit,0.0
RML Genomics Unit,Mast Cell Biology Section,0.0
RML Genomics Unit,Molecular Biology Section,0.0
RML Genomics Unit,Molecular Defenses Section,0.0
RML Genomics Unit,Molecular Development of the Immune System Section,0.0
RML Genomics Unit,Molecular Entomology Unit,0.0
RML Genomics Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
RML Genomics Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
RML Genomics Unit,Molecular HIV Host Interactions Section,0.0
RML Genomics Unit,Molecular Microbiology Section,0.0
RML Genomics Unit,Molecular Parasitology Section,0.0
RML Genomics Unit,Molecular Parasitology and Entomology Unit,0.0
RML Genomics Unit,Molecular Pathogenesis Unit,0.0
RML Genomics Unit,Molecular Pathogenesis and Biomarkers Section,0.0
RML Genomics Unit,Molecular Pathology Section,0.0
RML Genomics Unit,Molecular and Cellular Immunology Section,0.0
RML Genomics Unit,Mosquito Immunity and Vector Competence Section,0.0
RML Genomics Unit,Mucosal Immunity Section,0.0
RML Genomics Unit,Mucosal Immunobiology Section,0.0
RML Genomics Unit,Multiscale Systems Biology Section,0.0
RML Genomics Unit,NIAID International Center of Excellence in Research Cambodia,0.0
RML Genomics Unit,Neuroimmunological Diseases Section,0.0
RML Genomics Unit,Neuroimmunology Unit,0.0
RML Genomics Unit,Nonhuman Primate Virology Section,0.0
RML Genomics Unit,Office of the Animal Program Director,0.0
RML Genomics Unit,Pathogenesis and Immunity Section,0.0
RML Genomics Unit,Pathology Core,0.0
RML Genomics Unit,Physiology Unit,0.0
RML Genomics Unit,Plague Section,0.0
RML Genomics Unit,Primary Immune Deficiency Clinic,0.0
RML Genomics Unit,Prion Cell Biology Unit,0.0
RML Genomics Unit,Protein Chemistry Section,0.0
RML Genomics Unit,Quantitative Virology and Evolution Unit,0.0
RML Genomics Unit,RML Flow Cytometry Unit,0.0
RML Microscopy Unit,Allergy and Immunology Clinical Training Program,0.0
RML Microscopy Unit,Antibacterial Host Defense Unit,0.0
RML Microscopy Unit,Antibody Biology Unit,0.0
RML Microscopy Unit,Autoimmunity and Functional Genomics Section,0.0
RML Microscopy Unit,B-Cell Molecular Immunology Section,0.0
RML Microscopy Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
RML Microscopy Unit,Bacterial Physiology and Metabolism Unit,0.0
RML Microscopy Unit,Barrier Immunity Section,0.0
RML Microscopy Unit,Biological Imaging,0.0
RML Microscopy Unit,Building 14B South,0.0
RML Microscopy Unit,Building 33,0.0
RML Microscopy Unit,Building 50,0.0
RML Microscopy Unit,Building NIHAC/103,0.0
RML Microscopy Unit,Buildings 4 and 10/11C127,0.0
RML Microscopy Unit,Caliciviruses Section,0.0
RML Microscopy Unit,Cell Signaling and Immunity Section,0.0
RML Microscopy Unit,Cellular Biology Section,0.0
RML Microscopy Unit,Cellular Immunology Section,0.0
RML Microscopy Unit,Chemotaxis Signal Section,0.0
RML Microscopy Unit,Clinical Microbiome Unit (CMU),0.0
RML Microscopy Unit,Clinical Pathophysiology Section,0.0
RML Microscopy Unit,Clinical Research Section,0.0
RML Microscopy Unit,Clinical and Molecular Retrovirology Section,0.0
RML Microscopy Unit,Computational Biology Unit,0.0
RML Microscopy Unit,DNA Tumor Virus Section,0.0
RML Microscopy Unit,Emerging Virus Immunity Unit,0.0
RML Microscopy Unit,Epidemiology and Population Studies Unit,0.0
RML Microscopy Unit,Epithelial Therapeutics Unit,0.0
RML Microscopy Unit,Flow Cytometry Section,0.0
RML Microscopy Unit,Functional Cellular Networks Section,0.0
RML Microscopy Unit,Fungal Pathogenesis Section,0.0
RML Microscopy Unit,Gene Regulation Section,0.0
RML Microscopy Unit,Genetic Immunotherapy Section,0.0
RML Microscopy Unit,Genomic Technologies Section,0.0
RML Microscopy Unit,HIV Pathogenesis Section,0.0
RML Microscopy Unit,HIV-Specific Immunity Section,0.0
RML Microscopy Unit,Helminth Immunology Section,0.0
RML Microscopy Unit,Hepatic Pathogenesis Section,0.0
RML Microscopy Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
RML Microscopy Unit,Human Eosinophil Section,0.0
RML Microscopy Unit,Human Immunological Diseases Section,0.0
RML Microscopy Unit,Immune Activation Section,0.0
RML Microscopy Unit,Immune Deficiency Genetics Section,0.0
RML Microscopy Unit,Immunobiology Section,0.0
RML Microscopy Unit,Immunobiology and Molecular Virology Unit,0.0
RML Microscopy Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
RML Microscopy Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
RML Microscopy Unit,Infectious Disease Fellowship Training Program,0.0
RML Microscopy Unit,Infectious Disease Pathogenesis Section,0.0
RML Microscopy Unit,Inflammation & Innate Immunity Unit,0.0
RML Microscopy Unit,Inflammation Biology Section,0.0
RML Microscopy Unit,Innate Immunity and Pathogenesis Section,0.0
RML Microscopy Unit,Integrative Immunobiology Section,0.0
RML Microscopy Unit,International HIV/STD Section,0.0
RML Microscopy Unit,Intracellular Parasite Biology Section,0.0
RML Microscopy Unit,LID Clinical Studies Unit,0.0
RML Microscopy Unit,Lyme Disease Studies Unit,0.0
RML Microscopy Unit,Lymphocyte Activation Section,0.0
RML Microscopy Unit,Lymphocyte Biology Section,0.0
RML Microscopy Unit,Malaria Functional Genomics Section,0.0
RML Microscopy Unit,Malaria Genetics Section,0.0
RML Microscopy Unit,Malaria Immunology Section,0.0
RML Microscopy Unit,Malaria Infection Biology and Immunity Unit,0.0
RML Microscopy Unit,Metaorganism Immunity Section,0.0
RML Microscopy Unit,Molecular Biology Section,0.0
RML Microscopy Unit,Molecular Defenses Section,0.0
RML Microscopy Unit,Molecular Development of the Immune System Section,0.0
RML Microscopy Unit,Molecular Entomology Unit,0.0
RML Microscopy Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
RML Microscopy Unit,Molecular HIV Host Interactions Section,0.0
RML Microscopy Unit,Molecular Parasitology Section,0.0
RML Microscopy Unit,Molecular Parasitology and Entomology Unit,0.0
RML Microscopy Unit,Molecular Pathogenesis and Biomarkers Section,0.0
RML Microscopy Unit,Molecular Pathology Section,0.0
RML Microscopy Unit,Molecular Signaling Section,0.0
RML Microscopy Unit,Molecular and Cellular Immunology Section,0.0
RML Microscopy Unit,Molecular and Cellular Immunoregulation Section,0.0
RML Microscopy Unit,Mucosal Immunity Section,0.0
RML Microscopy Unit,Mucosal Immunobiology Section,0.0
RML Microscopy Unit,Multiscale Systems Biology Section,0.0
RML Microscopy Unit,NIAID International Center of Excellence in Research Cambodia,0.0
RML Microscopy Unit,Neuroimmunological Diseases Section,0.0
RML Microscopy Unit,Neuroimmunology Unit,0.0
RML Microscopy Unit,Nonhuman Primate Virology Section,0.0
RML Microscopy Unit,Office of the Animal Program Director,0.0
RML Microscopy Unit,Pathology Core,0.0
RML Microscopy Unit,Physiology Unit,0.0
RML Microscopy Unit,Primary Immune Deficiency Clinic,0.0
RML Microscopy Unit,Prion Cell Biology Unit,0.0
RML Microscopy Unit,Protein Chemistry Section,0.0
RML Microscopy Unit,Quantitative Virology and Evolution Unit,0.0
RNA Viruses Section,Allergy and Immunology Clinical Training Program,0.0
RNA Viruses Section,Antibacterial Host Defense Unit,0.0
RNA Viruses Section,Antibody Biology Unit,0.0
RNA Viruses Section,Apicomplexan Molecular Physiology Section,0.0
RNA Viruses Section,Autoimmunity and Functional Genomics Section,0.0
RNA Viruses Section,B-Cell Immunology Section,0.0
RNA Viruses Section,B-Cell Molecular Immunology Section,0.0
RNA Viruses Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
RNA Viruses Section,Bacterial Physiology and Metabolism Unit,0.0
RNA Viruses Section,Barrier Immunity Section,0.0
RNA Viruses Section,Biological Imaging,0.0
RNA Viruses Section,Biology of Vector-Borne Viruses Section,0.0
RNA Viruses Section,Building 14B South,0.0
RNA Viruses Section,Building 33,0.0
RNA Viruses Section,Building 50,0.0
RNA Viruses Section,Buildings 4 and 10/11C127,0.0
RNA Viruses Section,Caliciviruses Section,0.0
RNA Viruses Section,Cell Signaling and Immunity Section,0.0
RNA Viruses Section,Cellular Biology Section,0.0
RNA Viruses Section,Cellular Immunology Section,0.0
RNA Viruses Section,Chemotaxis Signal Section,0.0
RNA Viruses Section,Chlamydial Diseases Section,0.0
RNA Viruses Section,Clinical Microbiome Unit (CMU),0.0
RNA Viruses Section,Clinical Pathophysiology Section,0.0
RNA Viruses Section,Clinical Research Section,0.0
RNA Viruses Section,Clinical and Molecular Retrovirology Section,0.0
RNA Viruses Section,Computational Biology Unit,0.0
RNA Viruses Section,Coxiella Pathogenesis Section,0.0
RNA Viruses Section,DNA Tumor Virus Section,0.0
RNA Viruses Section,Disease Modeling and Transmission Section,0.0
RNA Viruses Section,Emerging Respiratory Viruses Section,0.0
RNA Viruses Section,Emerging Virus Immunity Unit,0.0
RNA Viruses Section,Epidemiology and Population Studies Unit,0.0
RNA Viruses Section,Epithelial Therapeutics Unit,0.0
RNA Viruses Section,Flow Cytometry Section,0.0
RNA Viruses Section,Food Allergy Research Section,0.0
RNA Viruses Section,Functional Cellular Networks Section,0.0
RNA Viruses Section,Fungal Pathogenesis Section,0.0
RNA Viruses Section,Gene Regulation Section,0.0
RNA Viruses Section,Genetic Engineering Section,0.0
RNA Viruses Section,Genetic Immunotherapy Section,0.0
RNA Viruses Section,Genomic Technologies Section,0.0
RNA Viruses Section,HIV Immunovirology Section,0.0
RNA Viruses Section,HIV Pathogenesis Section,0.0
RNA Viruses Section,HIV-Specific Immunity Section,0.0
RNA Viruses Section,Helminth Immunology Section,0.0
RNA Viruses Section,Hepatic Pathogenesis Section,0.0
RNA Viruses Section,Host-Parasite Interactions Section,0.0
RNA Viruses Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
RNA Viruses Section,Human Eosinophil Section,0.0
RNA Viruses Section,Human Immunological Diseases Section,0.0
RNA Viruses Section,Immune Activation Section,0.0
RNA Viruses Section,Immune Deficiency Genetics Section,0.0
RNA Viruses Section,Immunity to Pulmonary Pathogens Section,0.0
RNA Viruses Section,Immunobiology Section,0.0
RNA Viruses Section,Immunobiology and Molecular Virology Unit,0.0
RNA Viruses Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
RNA Viruses Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
RNA Viruses Section,Infectious Disease Fellowship Training Program,0.0
RNA Viruses Section,Infectious Disease Pathogenesis Section,0.0
RNA Viruses Section,Inflammation & Innate Immunity Unit,0.0
RNA Viruses Section,Inflammation Biology Section,0.0
RNA Viruses Section,Innate Immunity and Pathogenesis Section,0.0
RNA Viruses Section,Integrative Immunobiology Section,0.0
RNA Viruses Section,International HIV/STD Section,0.0
RNA Viruses Section,Intracellular Parasite Biology Section,0.0
RNA Viruses Section,LID Clinical Studies Unit,0.0
RNA Viruses Section,Lung and Vascular Inflammation Section,0.0
RNA Viruses Section,Lyme Disease Studies Unit,0.0
RNA Viruses Section,Lymphocyte Activation Section,0.0
RNA Viruses Section,Lymphocyte Biology Section,0.0
RNA Viruses Section,Malaria Cell Biology Section,0.0
RNA Viruses Section,Malaria Functional Genomics Section,0.0
RNA Viruses Section,Malaria Genetics Section,0.0
RNA Viruses Section,Malaria Immunology Section,0.0
RNA Viruses Section,Malaria Infection Biology and Immunity Unit,0.0
RNA Viruses Section,Mast Cell Biology Section,0.0
RNA Viruses Section,Medical Virology Section,0.0
RNA Viruses Section,Metaorganism Immunity Section,0.0
RNA Viruses Section,Microbial Pathogenesis Section,0.0
RNA Viruses Section,Molecular Biology Section,0.0
RNA Viruses Section,Molecular Defenses Section,0.0
RNA Viruses Section,Molecular Entomology Unit,0.0
RNA Viruses Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
RNA Viruses Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
RNA Viruses Section,Molecular HIV Host Interactions Section,0.0
RNA Viruses Section,Molecular Microbiology Section,0.0
RNA Viruses Section,Molecular Parasitology Section,0.0
RNA Viruses Section,Molecular Parasitology and Entomology Unit,0.0
RNA Viruses Section,Molecular Pathogenesis Unit,0.0
RNA Viruses Section,Molecular Pathogenesis and Biomarkers Section,0.0
RNA Viruses Section,Molecular Pathology Section,0.0
RNA Viruses Section,Molecular Signaling Section,0.0
RNA Viruses Section,Molecular and Cellular Immunology Section,0.0
RNA Viruses Section,Molecular and Cellular Immunoregulation Section,0.0
RNA Viruses Section,Mosquito Immunity and Vector Competence Section,0.0
RNA Viruses Section,Mucosal Immunity Section,0.0
RNA Viruses Section,Mucosal Immunobiology Section,0.0
RNA Viruses Section,Multiscale Systems Biology Section,0.0
RNA Viruses Section,NIAID International Center of Excellence in Research Cambodia,0.0
RNA Viruses Section,Neuroimmunological Diseases Section,0.0
RNA Viruses Section,Neuroimmunology Unit,0.0
RNA Viruses Section,Nonhuman Primate Virology Section,0.0
RNA Viruses Section,Office of the Animal Program Director,0.0
RNA Viruses Section,Pathogen Molecular Genetics Section,0.0
RNA Viruses Section,Pathogen-Host Cell Biology Section,0.0
RNA Viruses Section,Pathogenesis and Immunity Section,0.0
RNA Viruses Section,Pathology Core,0.0
RNA Viruses Section,Physiology Unit,0.0
RNA Viruses Section,Plague Section,0.0
RNA Viruses Section,Primary Immune Deficiency Clinic,0.0
RNA Viruses Section,Prion Cell Biology Unit,0.0
RNA Viruses Section,Protein Chemistry Section,0.0
RNA Viruses Section,Quantitative Virology and Evolution Unit,0.0
RNA Viruses Section,RML Flow Cytometry Unit,0.0
Research Technology Branch,Allergy and Immunology Clinical Training Program,0.0
Research Technology Branch,Antibacterial Host Defense Unit,0.0
Research Technology Branch,Antibody Biology Unit,0.0
Research Technology Branch,Apicomplexan Molecular Physiology Section,0.0
Research Technology Branch,Autoimmunity and Functional Genomics Section,0.0
Research Technology Branch,B-Cell Immunology Section,0.0
Research Technology Branch,B-Cell Molecular Immunology Section,0.0
Research Technology Branch,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Research Technology Branch,Bacterial Physiology and Metabolism Unit,0.0
Research Technology Branch,Barrier Immunity Section,0.0
Research Technology Branch,Biological Imaging,0.0
Research Technology Branch,Biology of Vector-Borne Viruses Section,0.0
Research Technology Branch,Building 14B South,0.0
Research Technology Branch,Building 33,0.0
Research Technology Branch,Building 50,0.0
Research Technology Branch,Building NIHAC/103,0.0
Research Technology Branch,Buildings 4 and 10/11C127,0.0
Research Technology Branch,Caliciviruses Section,0.0
Research Technology Branch,Cell Signaling and Immunity Section,0.0
Research Technology Branch,Cellular Biology Section,0.0
Research Technology Branch,Cellular Immunology Section,0.0
Research Technology Branch,Chemotaxis Signal Section,0.0
Research Technology Branch,Chlamydial Diseases Section,0.0
Research Technology Branch,Clinical Microbiome Unit (CMU),0.0
Research Technology Branch,Clinical Pathophysiology Section,0.0
Research Technology Branch,Clinical Research Section,0.0
Research Technology Branch,Clinical and Molecular Retrovirology Section,0.0
Research Technology Branch,Computational Biology Unit,0.0
Research Technology Branch,Coxiella Pathogenesis Section,0.0
Research Technology Branch,DNA Tumor Virus Section,0.0
Research Technology Branch,Disease Modeling and Transmission Section,0.0
Research Technology Branch,Emerging Respiratory Viruses Section,0.0
Research Technology Branch,Emerging Virus Immunity Unit,0.0
Research Technology Branch,Epidemiology and Population Studies Unit,0.0
Research Technology Branch,Epithelial Therapeutics Unit,0.0
Research Technology Branch,Flow Cytometry Section,0.0
Research Technology Branch,Food Allergy Research Section,0.0
Research Technology Branch,Functional Cellular Networks Section,0.0
Research Technology Branch,Fungal Pathogenesis Section,0.0
Research Technology Branch,Gene Regulation Section,0.0
Research Technology Branch,Genetic Engineering Section,0.0
Research Technology Branch,Genetic Immunotherapy Section,0.0
Research Technology Branch,Genomic Technologies Section,0.0
Research Technology Branch,HIV Immunovirology Section,0.0
Research Technology Branch,HIV Pathogenesis Section,0.0
Research Technology Branch,HIV-Specific Immunity Section,0.0
Research Technology Branch,Helminth Immunology Section,0.0
Research Technology Branch,Hepatic Pathogenesis Section,0.0
Research Technology Branch,Host-Parasite Interactions Section,0.0
Research Technology Branch,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Research Technology Branch,Human Eosinophil Section,0.0
Research Technology Branch,Human Immunological Diseases Section,0.0
Research Technology Branch,Immune Activation Section,0.0
Research Technology Branch,Immune Deficiency Genetics Section,0.0
Research Technology Branch,Immunity to Pulmonary Pathogens Section,0.0
Research Technology Branch,Immunobiology Section,0.0
Research Technology Branch,Immunobiology and Molecular Virology Unit,0.0
Research Technology Branch,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Research Technology Branch,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Research Technology Branch,Infectious Disease Fellowship Training Program,0.0
Research Technology Branch,Infectious Disease Pathogenesis Section,0.0
Research Technology Branch,Inflammation & Innate Immunity Unit,0.0
Research Technology Branch,Inflammation Biology Section,0.0
Research Technology Branch,Innate Immunity and Pathogenesis Section,0.0
Research Technology Branch,Integrative Immunobiology Section,0.0
Research Technology Branch,International HIV/STD Section,0.0
Research Technology Branch,Intracellular Parasite Biology Section,0.0
Research Technology Branch,LID Clinical Studies Unit,0.0
Research Technology Branch,Lung and Vascular Inflammation Section,0.0
Research Technology Branch,Lyme Disease Studies Unit,0.0
Research Technology Branch,Lymphocyte Activation Section,0.0
Research Technology Branch,Lymphocyte Biology Section,0.0
Research Technology Branch,Malaria Cell Biology Section,0.0
Research Technology Branch,Malaria Functional Genomics Section,0.0
Research Technology Branch,Malaria Genetics Section,0.0
Research Technology Branch,Malaria Immunology Section,0.0
Research Technology Branch,Malaria Infection Biology and Immunity Unit,0.0
Research Technology Branch,Mast Cell Biology Section,0.0
Research Technology Branch,Medical Virology Section,0.0
Research Technology Branch,Metaorganism Immunity Section,0.0
Research Technology Branch,Microbial Pathogenesis Section,0.0
Research Technology Branch,Molecular Biology Section,0.0
Research Technology Branch,Molecular Defenses Section,0.0
Research Technology Branch,Molecular Development of the Immune System Section,0.0
Research Technology Branch,Molecular Entomology Unit,0.0
Research Technology Branch,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Research Technology Branch,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Research Technology Branch,Molecular HIV Host Interactions Section,0.0
Research Technology Branch,Molecular Microbiology Section,0.0
Research Technology Branch,Molecular Parasitology Section,0.0
Research Technology Branch,Molecular Parasitology and Entomology Unit,0.0
Research Technology Branch,Molecular Pathogenesis Unit,0.0
Research Technology Branch,Molecular Pathogenesis and Biomarkers Section,0.0
Research Technology Branch,Molecular Pathology Section,0.0
Research Technology Branch,Molecular Signaling Section,0.0
Research Technology Branch,Molecular and Cellular Immunology Section,0.0
Research Technology Branch,Molecular and Cellular Immunoregulation Section,0.0
Research Technology Branch,Mosquito Immunity and Vector Competence Section,0.0
Research Technology Branch,Mucosal Immunity Section,0.0
Research Technology Branch,Mucosal Immunobiology Section,0.0
Research Technology Branch,Multiscale Systems Biology Section,0.0
Research Technology Branch,NIAID International Center of Excellence in Research Cambodia,0.0
Research Technology Branch,Neuroimmunological Diseases Section,0.0
Research Technology Branch,Neuroimmunology Unit,0.0
Research Technology Branch,Nonhuman Primate Virology Section,0.0
Research Technology Branch,Office of the Animal Program Director,0.0
Research Technology Branch,Pathogen Molecular Genetics Section,0.0
Research Technology Branch,Pathogen-Host Cell Biology Section,0.0
Research Technology Branch,Pathogenesis and Immunity Section,0.0
Research Technology Branch,Pathology Core,0.0
Research Technology Branch,Physiology Unit,0.0
Research Technology Branch,Plague Section,0.0
Research Technology Branch,Primary Immune Deficiency Clinic,0.0
Research Technology Branch,Prion Cell Biology Unit,0.0
Research Technology Branch,Protein Chemistry Section,0.0
Research Technology Branch,Quantitative Virology and Evolution Unit,0.0
Research Technology Branch,RML Flow Cytometry Unit,0.0
Research Technology Branch,RML Genomics Unit,0.0
Research Technology Branch,RML Microscopy Unit,0.0
Research Technology Branch,RNA Viruses Section,0.0
Retroviral Immunology Section,Allergy and Immunology Clinical Training Program,0.0
Retroviral Immunology Section,Antibacterial Host Defense Unit,0.0
Retroviral Immunology Section,Antibody Biology Unit,0.0
Retroviral Immunology Section,Apicomplexan Molecular Physiology Section,0.0
Retroviral Immunology Section,Autoimmunity and Functional Genomics Section,0.0
Retroviral Immunology Section,B-Cell Immunology Section,0.0
Retroviral Immunology Section,B-Cell Molecular Immunology Section,0.0
Retroviral Immunology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Retroviral Immunology Section,Bacterial Physiology and Metabolism Unit,0.0
Retroviral Immunology Section,Barrier Immunity Section,0.0
Retroviral Immunology Section,Biological Imaging,0.0
Retroviral Immunology Section,Biology of Vector-Borne Viruses Section,0.0
Retroviral Immunology Section,Building 14B South,0.0
Retroviral Immunology Section,Building 33,0.0
Retroviral Immunology Section,Building 50,0.0
Retroviral Immunology Section,Building NIHAC/103,0.0
Retroviral Immunology Section,Buildings 4 and 10/11C127,0.0
Retroviral Immunology Section,Cell Signaling and Immunity Section,0.0
Retroviral Immunology Section,Cellular Biology Section,0.0
Retroviral Immunology Section,Cellular Immunology Section,0.0
Retroviral Immunology Section,Chemotaxis Signal Section,0.0
Retroviral Immunology Section,Chlamydial Diseases Section,0.0
Retroviral Immunology Section,Clinical Microbiome Unit (CMU),0.0
Retroviral Immunology Section,Clinical Pathophysiology Section,0.0
Retroviral Immunology Section,Clinical Research Section,0.0
Retroviral Immunology Section,Clinical and Molecular Retrovirology Section,0.0
Retroviral Immunology Section,Computational Biology Unit,0.0
Retroviral Immunology Section,Coxiella Pathogenesis Section,0.0
Retroviral Immunology Section,DNA Tumor Virus Section,0.0
Retroviral Immunology Section,Emerging Respiratory Viruses Section,0.0
Retroviral Immunology Section,Emerging Virus Immunity Unit,0.0
Retroviral Immunology Section,Epidemiology and Population Studies Unit,0.0
Retroviral Immunology Section,Epithelial Therapeutics Unit,0.0
Retroviral Immunology Section,Flow Cytometry Section,0.0
Retroviral Immunology Section,Food Allergy Research Section,0.0
Retroviral Immunology Section,Functional Cellular Networks Section,0.0
Retroviral Immunology Section,Fungal Pathogenesis Section,0.0
Retroviral Immunology Section,Gene Regulation Section,0.0
Retroviral Immunology Section,Genetic Engineering Section,0.0
Retroviral Immunology Section,Genetic Immunotherapy Section,0.0
Retroviral Immunology Section,Genomic Technologies Section,0.0
Retroviral Immunology Section,HIV Immunovirology Section,0.0
Retroviral Immunology Section,HIV Pathogenesis Section,0.0
Retroviral Immunology Section,HIV-Specific Immunity Section,0.0
Retroviral Immunology Section,Helminth Immunology Section,0.0
Retroviral Immunology Section,Hepatic Pathogenesis Section,0.0
Retroviral Immunology Section,Host-Parasite Interactions Section,0.0
Retroviral Immunology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Retroviral Immunology Section,Human Eosinophil Section,0.0
Retroviral Immunology Section,Human Immunological Diseases Section,0.0
Retroviral Immunology Section,Immune Activation Section,0.0
Retroviral Immunology Section,Immune Deficiency Genetics Section,0.0
Retroviral Immunology Section,Immunity to Pulmonary Pathogens Section,0.0
Retroviral Immunology Section,Immunobiology Section,0.0
Retroviral Immunology Section,Immunobiology and Molecular Virology Unit,0.0
Retroviral Immunology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Retroviral Immunology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Retroviral Immunology Section,Infectious Disease Fellowship Training Program,0.0
Retroviral Immunology Section,Infectious Disease Pathogenesis Section,0.0
Retroviral Immunology Section,Inflammation & Innate Immunity Unit,0.0
Retroviral Immunology Section,Inflammation Biology Section,0.0
Retroviral Immunology Section,Integrative Immunobiology Section,0.0
Retroviral Immunology Section,International HIV/STD Section,0.0
Retroviral Immunology Section,Intracellular Parasite Biology Section,0.0
Retroviral Immunology Section,LID Clinical Studies Unit,0.0
Retroviral Immunology Section,Lung and Vascular Inflammation Section,0.0
Retroviral Immunology Section,Lyme Disease Studies Unit,0.0
Retroviral Immunology Section,Lymphocyte Activation Section,0.0
Retroviral Immunology Section,Lymphocyte Biology Section,0.0
Retroviral Immunology Section,Malaria Cell Biology Section,0.0
Retroviral Immunology Section,Malaria Functional Genomics Section,0.0
Retroviral Immunology Section,Malaria Genetics Section,0.0
Retroviral Immunology Section,Malaria Immunology Section,0.0
Retroviral Immunology Section,Malaria Infection Biology and Immunity Unit,0.0
Retroviral Immunology Section,Mast Cell Biology Section,0.0
Retroviral Immunology Section,Medical Virology Section,0.0
Retroviral Immunology Section,Metaorganism Immunity Section,0.0
Retroviral Immunology Section,Microbial Pathogenesis Section,0.0
Retroviral Immunology Section,Molecular Biology Section,0.0
Retroviral Immunology Section,Molecular Defenses Section,0.0
Retroviral Immunology Section,Molecular Development of the Immune System Section,0.0
Retroviral Immunology Section,Molecular Entomology Unit,0.0
Retroviral Immunology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Retroviral Immunology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Retroviral Immunology Section,Molecular HIV Host Interactions Section,0.0
Retroviral Immunology Section,Molecular Microbiology Section,0.0
Retroviral Immunology Section,Molecular Parasitology Section,0.0
Retroviral Immunology Section,Molecular Parasitology and Entomology Unit,0.0
Retroviral Immunology Section,Molecular Pathogenesis Unit,0.0
Retroviral Immunology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Retroviral Immunology Section,Molecular Pathology Section,0.0
Retroviral Immunology Section,Molecular Signaling Section,0.0
Retroviral Immunology Section,Molecular and Cellular Immunology Section,0.0
Retroviral Immunology Section,Molecular and Cellular Immunoregulation Section,0.0
Retroviral Immunology Section,Mosquito Immunity and Vector Competence Section,0.0
Retroviral Immunology Section,Mucosal Immunity Section,0.0
Retroviral Immunology Section,Mucosal Immunobiology Section,0.0
Retroviral Immunology Section,Multiscale Systems Biology Section,0.0
Retroviral Immunology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Retroviral Immunology Section,Neuroimmunological Diseases Section,0.0
Retroviral Immunology Section,Nonhuman Primate Virology Section,0.0
Retroviral Immunology Section,Office of the Animal Program Director,0.0
Retroviral Immunology Section,Pathogen Molecular Genetics Section,0.0
Retroviral Immunology Section,Pathogen-Host Cell Biology Section,0.0
Retroviral Immunology Section,Pathogenesis and Immunity Section,0.0
Retroviral Immunology Section,Pathology Core,0.0
Retroviral Immunology Section,Physiology Unit,0.0
Retroviral Immunology Section,Plague Section,0.0
Retroviral Immunology Section,Primary Immune Deficiency Clinic,0.0
Retroviral Immunology Section,Prion Cell Biology Unit,0.0
Retroviral Immunology Section,Protein Chemistry Section,0.0
Retroviral Immunology Section,Quantitative Virology and Evolution Unit,0.0
Retroviral Immunology Section,RML Genomics Unit,0.0
Retroviral Immunology Section,RML Microscopy Unit,0.0
Retroviral Immunology Section,RNA Viruses Section,0.0
Retroviral Immunology Section,Research Technology Branch,0.0
Salmonella-Host Cell Interactions Section,Allergy and Immunology Clinical Training Program,0.0
Salmonella-Host Cell Interactions Section,Antibacterial Host Defense Unit,0.0
Salmonella-Host Cell Interactions Section,Antibody Biology Unit,0.0
Salmonella-Host Cell Interactions Section,Apicomplexan Molecular Physiology Section,0.0
Salmonella-Host Cell Interactions Section,Autoimmunity and Functional Genomics Section,0.0
Salmonella-Host Cell Interactions Section,B-Cell Immunology Section,0.0
Salmonella-Host Cell Interactions Section,B-Cell Molecular Immunology Section,0.0
Salmonella-Host Cell Interactions Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Salmonella-Host Cell Interactions Section,Bacterial Physiology and Metabolism Unit,0.0
Salmonella-Host Cell Interactions Section,Barrier Immunity Section,0.0
Salmonella-Host Cell Interactions Section,Biological Imaging,0.0
Salmonella-Host Cell Interactions Section,Biology of Vector-Borne Viruses Section,0.0
Salmonella-Host Cell Interactions Section,Building 14B South,0.0
Salmonella-Host Cell Interactions Section,Building 33,0.0
Salmonella-Host Cell Interactions Section,Building 50,0.0
Salmonella-Host Cell Interactions Section,Building NIHAC/103,0.0
Salmonella-Host Cell Interactions Section,Buildings 4 and 10/11C127,0.0
Salmonella-Host Cell Interactions Section,Caliciviruses Section,0.0
Salmonella-Host Cell Interactions Section,Cell Signaling and Immunity Section,0.0
Salmonella-Host Cell Interactions Section,Cellular Biology Section,0.0
Salmonella-Host Cell Interactions Section,Cellular Immunology Section,0.0
Salmonella-Host Cell Interactions Section,Chemotaxis Signal Section,0.0
Salmonella-Host Cell Interactions Section,Clinical Microbiome Unit (CMU),0.0
Salmonella-Host Cell Interactions Section,Clinical Pathophysiology Section,0.0
Salmonella-Host Cell Interactions Section,Clinical Research Section,0.0
Salmonella-Host Cell Interactions Section,Clinical and Molecular Retrovirology Section,0.0
Salmonella-Host Cell Interactions Section,Computational Biology Unit,0.0
Salmonella-Host Cell Interactions Section,DNA Tumor Virus Section,0.0
Salmonella-Host Cell Interactions Section,Emerging Respiratory Viruses Section,0.0
Salmonella-Host Cell Interactions Section,Emerging Virus Immunity Unit,0.0
Salmonella-Host Cell Interactions Section,Epidemiology and Population Studies Unit,0.0
Salmonella-Host Cell Interactions Section,Epithelial Therapeutics Unit,0.0
Salmonella-Host Cell Interactions Section,Flow Cytometry Section,0.0
Salmonella-Host Cell Interactions Section,Food Allergy Research Section,0.0
Salmonella-Host Cell Interactions Section,Functional Cellular Networks Section,0.0
Salmonella-Host Cell Interactions Section,Fungal Pathogenesis Section,0.0
Salmonella-Host Cell Interactions Section,Gene Regulation Section,0.0
Salmonella-Host Cell Interactions Section,Genetic Engineering Section,0.0
Salmonella-Host Cell Interactions Section,Genetic Immunotherapy Section,0.0
Salmonella-Host Cell Interactions Section,Genomic Technologies Section,0.0
Salmonella-Host Cell Interactions Section,HIV Immunovirology Section,0.0
Salmonella-Host Cell Interactions Section,HIV Pathogenesis Section,0.0
Salmonella-Host Cell Interactions Section,HIV-Specific Immunity Section,0.0
Salmonella-Host Cell Interactions Section,Helminth Immunology Section,0.0
Salmonella-Host Cell Interactions Section,Hepatic Pathogenesis Section,0.0
Salmonella-Host Cell Interactions Section,Host-Parasite Interactions Section,0.0
Salmonella-Host Cell Interactions Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Salmonella-Host Cell Interactions Section,Human Eosinophil Section,0.0
Salmonella-Host Cell Interactions Section,Human Immunological Diseases Section,0.0
Salmonella-Host Cell Interactions Section,Immune Activation Section,0.0
Salmonella-Host Cell Interactions Section,Immune Deficiency Genetics Section,0.0
Salmonella-Host Cell Interactions Section,Immunity to Pulmonary Pathogens Section,0.0
Salmonella-Host Cell Interactions Section,Immunobiology Section,0.0
Salmonella-Host Cell Interactions Section,Immunobiology and Molecular Virology Unit,0.0
Salmonella-Host Cell Interactions Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Salmonella-Host Cell Interactions Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Salmonella-Host Cell Interactions Section,Infectious Disease Fellowship Training Program,0.0
Salmonella-Host Cell Interactions Section,Infectious Disease Pathogenesis Section,0.0
Salmonella-Host Cell Interactions Section,Inflammation & Innate Immunity Unit,0.0
Salmonella-Host Cell Interactions Section,Inflammation Biology Section,0.0
Salmonella-Host Cell Interactions Section,Innate Immunity and Pathogenesis Section,0.0
Salmonella-Host Cell Interactions Section,Integrative Immunobiology Section,0.0
Salmonella-Host Cell Interactions Section,International HIV/STD Section,0.0
Salmonella-Host Cell Interactions Section,Intracellular Parasite Biology Section,0.0
Salmonella-Host Cell Interactions Section,LID Clinical Studies Unit,0.0
Salmonella-Host Cell Interactions Section,Lung and Vascular Inflammation Section,0.0
Salmonella-Host Cell Interactions Section,Lyme Disease Studies Unit,0.0
Salmonella-Host Cell Interactions Section,Lymphocyte Activation Section,0.0
Salmonella-Host Cell Interactions Section,Lymphocyte Biology Section,0.0
Salmonella-Host Cell Interactions Section,Malaria Cell Biology Section,0.0
Salmonella-Host Cell Interactions Section,Malaria Functional Genomics Section,0.0
Salmonella-Host Cell Interactions Section,Malaria Genetics Section,0.0
Salmonella-Host Cell Interactions Section,Malaria Immunology Section,0.0
Salmonella-Host Cell Interactions Section,Malaria Infection Biology and Immunity Unit,0.0
Salmonella-Host Cell Interactions Section,Mast Cell Biology Section,0.0
Salmonella-Host Cell Interactions Section,Medical Virology Section,0.0
Salmonella-Host Cell Interactions Section,Metaorganism Immunity Section,0.0
Salmonella-Host Cell Interactions Section,Microbial Pathogenesis Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Biology Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Defenses Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Development of the Immune System Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Entomology Unit,0.0
Salmonella-Host Cell Interactions Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Salmonella-Host Cell Interactions Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Salmonella-Host Cell Interactions Section,Molecular HIV Host Interactions Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Microbiology Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Parasitology Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Parasitology and Entomology Unit,0.0
Salmonella-Host Cell Interactions Section,Molecular Pathogenesis Unit,0.0
Salmonella-Host Cell Interactions Section,Molecular Pathogenesis and Biomarkers Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Pathology Section,0.0
Salmonella-Host Cell Interactions Section,Molecular Signaling Section,0.0
Salmonella-Host Cell Interactions Section,Molecular and Cellular Immunology Section,0.0
Salmonella-Host Cell Interactions Section,Molecular and Cellular Immunoregulation Section,0.0
Salmonella-Host Cell Interactions Section,Mosquito Immunity and Vector Competence Section,0.0
Salmonella-Host Cell Interactions Section,Mucosal Immunity Section,0.0
Salmonella-Host Cell Interactions Section,Mucosal Immunobiology Section,0.0
Salmonella-Host Cell Interactions Section,Multiscale Systems Biology Section,0.0
Salmonella-Host Cell Interactions Section,NIAID International Center of Excellence in Research Cambodia,0.0
Salmonella-Host Cell Interactions Section,Neuroimmunological Diseases Section,0.0
Salmonella-Host Cell Interactions Section,Nonhuman Primate Virology Section,0.0
Salmonella-Host Cell Interactions Section,Office of the Animal Program Director,0.0
Salmonella-Host Cell Interactions Section,Pathogen Molecular Genetics Section,0.0
Salmonella-Host Cell Interactions Section,Pathogenesis and Immunity Section,0.0
Salmonella-Host Cell Interactions Section,Pathology Core,0.0
Salmonella-Host Cell Interactions Section,Physiology Unit,0.0
Salmonella-Host Cell Interactions Section,Primary Immune Deficiency Clinic,0.0
Salmonella-Host Cell Interactions Section,Prion Cell Biology Unit,0.0
Salmonella-Host Cell Interactions Section,Protein Chemistry Section,0.0
Salmonella-Host Cell Interactions Section,Quantitative Virology and Evolution Unit,0.0
Salmonella-Host Cell Interactions Section,RML Genomics Unit,0.0
Salmonella-Host Cell Interactions Section,RNA Viruses Section,0.0
Salmonella-Host Cell Interactions Section,Research Technology Branch,0.0
Salmonella-Host Cell Interactions Section,Retroviral Immunology Section,0.0
Scientist Emerita,Allergy and Immunology Clinical Training Program,0.0
Scientist Emerita,Antibacterial Host Defense Unit,0.0
Scientist Emerita,Antibody Biology Unit,0.0
Scientist Emerita,Apicomplexan Molecular Physiology Section,0.0
Scientist Emerita,Autoimmunity and Functional Genomics Section,0.0
Scientist Emerita,B-Cell Immunology Section,0.0
Scientist Emerita,B-Cell Molecular Immunology Section,0.0
Scientist Emerita,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Scientist Emerita,Bacterial Physiology and Metabolism Unit,0.0
Scientist Emerita,Barrier Immunity Section,0.0
Scientist Emerita,Biological Imaging,0.0
Scientist Emerita,Biology of Vector-Borne Viruses Section,0.0
Scientist Emerita,Building 14B South,0.0
Scientist Emerita,Building 33,0.0
Scientist Emerita,Building 50,0.0
Scientist Emerita,Building NIHAC/103,0.0
Scientist Emerita,Buildings 4 and 10/11C127,0.0
Scientist Emerita,Caliciviruses Section,0.0
Scientist Emerita,Cell Signaling and Immunity Section,0.0
Scientist Emerita,Cellular Biology Section,0.0
Scientist Emerita,Cellular Immunology Section,0.0
Scientist Emerita,Chemotaxis Signal Section,0.0
Scientist Emerita,Chlamydial Diseases Section,0.0
Scientist Emerita,Clinical Microbiome Unit (CMU),0.0
Scientist Emerita,Clinical Pathophysiology Section,0.0
Scientist Emerita,Clinical Research Section,0.0
Scientist Emerita,Clinical and Molecular Retrovirology Section,0.0
Scientist Emerita,Computational Biology Unit,0.0
Scientist Emerita,Coxiella Pathogenesis Section,0.0
Scientist Emerita,DNA Tumor Virus Section,0.0
Scientist Emerita,Disease Modeling and Transmission Section,0.0
Scientist Emerita,Emerging Respiratory Viruses Section,0.0
Scientist Emerita,Emerging Virus Immunity Unit,0.0
Scientist Emerita,Epidemiology and Population Studies Unit,0.0
Scientist Emerita,Epithelial Therapeutics Unit,0.0
Scientist Emerita,Flow Cytometry Section,0.0
Scientist Emerita,Food Allergy Research Section,0.0
Scientist Emerita,Functional Cellular Networks Section,0.0
Scientist Emerita,Fungal Pathogenesis Section,0.0
Scientist Emerita,Gene Regulation Section,0.0
Scientist Emerita,Genetic Engineering Section,0.0
Scientist Emerita,Genetic Immunotherapy Section,0.0
Scientist Emerita,Genomic Technologies Section,0.0
Scientist Emerita,HIV Immunovirology Section,0.0
Scientist Emerita,HIV Pathogenesis Section,0.0
Scientist Emerita,HIV-Specific Immunity Section,0.0
Scientist Emerita,Helminth Immunology Section,0.0
Scientist Emerita,Hepatic Pathogenesis Section,0.0
Scientist Emerita,Host-Parasite Interactions Section,0.0
Scientist Emerita,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Scientist Emerita,Human Eosinophil Section,0.0
Scientist Emerita,Human Immunological Diseases Section,0.0
Scientist Emerita,Immune Activation Section,0.0
Scientist Emerita,Immune Deficiency Genetics Section,0.0
Scientist Emerita,Immunity to Pulmonary Pathogens Section,0.0
Scientist Emerita,Immunobiology Section,0.0
Scientist Emerita,Immunobiology and Molecular Virology Unit,0.0
Scientist Emerita,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Scientist Emerita,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Scientist Emerita,Infectious Disease Fellowship Training Program,0.0
Scientist Emerita,Infectious Disease Pathogenesis Section,0.0
Scientist Emerita,Inflammation & Innate Immunity Unit,0.0
Scientist Emerita,Inflammation Biology Section,0.0
Scientist Emerita,Innate Immunity and Pathogenesis Section,0.0
Scientist Emerita,Integrative Immunobiology Section,0.0
Scientist Emerita,International HIV/STD Section,0.0
Scientist Emerita,Intracellular Parasite Biology Section,0.0
Scientist Emerita,LID Clinical Studies Unit,0.0
Scientist Emerita,Lung and Vascular Inflammation Section,0.0
Scientist Emerita,Lyme Disease Studies Unit,0.0
Scientist Emerita,Lymphocyte Activation Section,0.0
Scientist Emerita,Lymphocyte Biology Section,0.0
Scientist Emerita,Malaria Cell Biology Section,0.0
Scientist Emerita,Malaria Functional Genomics Section,0.0
Scientist Emerita,Malaria Genetics Section,0.0
Scientist Emerita,Malaria Immunology Section,0.0
Scientist Emerita,Malaria Infection Biology and Immunity Unit,0.0
Scientist Emerita,Medical Virology Section,0.0
Scientist Emerita,Metaorganism Immunity Section,0.0
Scientist Emerita,Microbial Pathogenesis Section,0.0
Scientist Emerita,Molecular Biology Section,0.0
Scientist Emerita,Molecular Defenses Section,0.0
Scientist Emerita,Molecular Development of the Immune System Section,0.0
Scientist Emerita,Molecular Entomology Unit,0.0
Scientist Emerita,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Scientist Emerita,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Scientist Emerita,Molecular HIV Host Interactions Section,0.0
Scientist Emerita,Molecular Microbiology Section,0.0
Scientist Emerita,Molecular Parasitology Section,0.0
Scientist Emerita,Molecular Parasitology and Entomology Unit,0.0
Scientist Emerita,Molecular Pathogenesis Unit,0.0
Scientist Emerita,Molecular Pathogenesis and Biomarkers Section,0.0
Scientist Emerita,Molecular Pathology Section,0.0
Scientist Emerita,Molecular Signaling Section,0.0
Scientist Emerita,Molecular and Cellular Immunology Section,0.0
Scientist Emerita,Molecular and Cellular Immunoregulation Section,0.0
Scientist Emerita,Mosquito Immunity and Vector Competence Section,0.0
Scientist Emerita,Mucosal Immunity Section,0.0
Scientist Emerita,Mucosal Immunobiology Section,0.0
Scientist Emerita,Multiscale Systems Biology Section,0.0
Scientist Emerita,NIAID International Center of Excellence in Research Cambodia,0.0
Scientist Emerita,Neuroimmunological Diseases Section,0.0
Scientist Emerita,Neuroimmunology Unit,0.0
Scientist Emerita,Nonhuman Primate Virology Section,0.0
Scientist Emerita,Office of the Animal Program Director,0.0
Scientist Emerita,Pathogen Molecular Genetics Section,0.0
Scientist Emerita,Pathogen-Host Cell Biology Section,0.0
Scientist Emerita,Pathogenesis and Immunity Section,0.0
Scientist Emerita,Pathology Core,0.0
Scientist Emerita,Physiology Unit,0.0
Scientist Emerita,Plague Section,0.0
Scientist Emerita,Primary Immune Deficiency Clinic,0.0
Scientist Emerita,Prion Cell Biology Unit,0.0
Scientist Emerita,Protein Chemistry Section,0.0
Scientist Emerita,Quantitative Virology and Evolution Unit,0.0
Scientist Emerita,RML Flow Cytometry Unit,0.0
Scientist Emerita,RML Genomics Unit,0.0
Scientist Emerita,RML Microscopy Unit,0.0
Scientist Emerita,RNA Viruses Section,0.0
Scientist Emerita,Research Technology Branch,0.0
Scientist Emerita,Retroviral Immunology Section,0.0
Scientist Emerita,Salmonella-Host Cell Interactions Section,0.0
Signaling Systems Section,Allergy and Immunology Clinical Training Program,0.0
Signaling Systems Section,Antibacterial Host Defense Unit,0.0
Signaling Systems Section,Antibody Biology Unit,0.0
Signaling Systems Section,Apicomplexan Molecular Physiology Section,0.0
Signaling Systems Section,Autoimmunity and Functional Genomics Section,0.0
Signaling Systems Section,B-Cell Immunology Section,0.0
Signaling Systems Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Signaling Systems Section,Bacterial Physiology and Metabolism Unit,0.0
Signaling Systems Section,Biological Imaging,0.0
Signaling Systems Section,Biology of Vector-Borne Viruses Section,0.0
Signaling Systems Section,Building 14B South,0.0
Signaling Systems Section,Building 33,0.0
Signaling Systems Section,Building 50,0.0
Signaling Systems Section,Building NIHAC/103,0.0
Signaling Systems Section,Buildings 4 and 10/11C127,0.0
Signaling Systems Section,Caliciviruses Section,0.0
Signaling Systems Section,Cell Signaling and Immunity Section,0.0
Signaling Systems Section,Cellular Biology Section,0.0
Signaling Systems Section,Cellular Immunology Section,0.0
Signaling Systems Section,Chemotaxis Signal Section,0.0
Signaling Systems Section,Chlamydial Diseases Section,0.0
Signaling Systems Section,Clinical Microbiome Unit (CMU),0.0
Signaling Systems Section,Clinical Pathophysiology Section,0.0
Signaling Systems Section,Clinical Research Section,0.0
Signaling Systems Section,Clinical and Molecular Retrovirology Section,0.0
Signaling Systems Section,Coxiella Pathogenesis Section,0.0
Signaling Systems Section,DNA Tumor Virus Section,0.0
Signaling Systems Section,Disease Modeling and Transmission Section,0.0
Signaling Systems Section,Emerging Respiratory Viruses Section,0.0
Signaling Systems Section,Emerging Virus Immunity Unit,0.0
Signaling Systems Section,Epidemiology and Population Studies Unit,0.0
Signaling Systems Section,Epithelial Therapeutics Unit,0.0
Signaling Systems Section,Flow Cytometry Section,0.0
Signaling Systems Section,Food Allergy Research Section,0.0
Signaling Systems Section,Fungal Pathogenesis Section,0.0
Signaling Systems Section,Gene Regulation Section,0.0
Signaling Systems Section,Genetic Engineering Section,0.0
Signaling Systems Section,Genetic Immunotherapy Section,0.0
Signaling Systems Section,Genomic Technologies Section,0.0
Signaling Systems Section,HIV Immunovirology Section,0.0
Signaling Systems Section,HIV Pathogenesis Section,0.0
Signaling Systems Section,HIV-Specific Immunity Section,0.0
Signaling Systems Section,Helminth Immunology Section,0.0
Signaling Systems Section,Hepatic Pathogenesis Section,0.0
Signaling Systems Section,Host-Parasite Interactions Section,0.0
Signaling Systems Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Signaling Systems Section,Human Eosinophil Section,0.0
Signaling Systems Section,Human Immunological Diseases Section,0.0
Signaling Systems Section,Immune Activation Section,0.0
Signaling Systems Section,Immune Deficiency Genetics Section,0.0
Signaling Systems Section,Immunity to Pulmonary Pathogens Section,0.0
Signaling Systems Section,Immunobiology Section,0.0
Signaling Systems Section,Immunobiology and Molecular Virology Unit,0.0
Signaling Systems Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Signaling Systems Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Signaling Systems Section,Infectious Disease Fellowship Training Program,0.0
Signaling Systems Section,Infectious Disease Pathogenesis Section,0.0
Signaling Systems Section,Inflammation & Innate Immunity Unit,0.0
Signaling Systems Section,Inflammation Biology Section,0.0
Signaling Systems Section,Innate Immunity and Pathogenesis Section,0.0
Signaling Systems Section,Integrative Immunobiology Section,0.0
Signaling Systems Section,International HIV/STD Section,0.0
Signaling Systems Section,Intracellular Parasite Biology Section,0.0
Signaling Systems Section,LID Clinical Studies Unit,0.0
Signaling Systems Section,Lung and Vascular Inflammation Section,0.0
Signaling Systems Section,Lyme Disease Studies Unit,0.0
Signaling Systems Section,Lymphocyte Activation Section,0.0
Signaling Systems Section,Malaria Cell Biology Section,0.0
Signaling Systems Section,Malaria Functional Genomics Section,0.0
Signaling Systems Section,Malaria Genetics Section,0.0
Signaling Systems Section,Malaria Immunology Section,0.0
Signaling Systems Section,Malaria Infection Biology and Immunity Unit,0.0
Signaling Systems Section,Mast Cell Biology Section,0.0
Signaling Systems Section,Medical Virology Section,0.0
Signaling Systems Section,Microbial Pathogenesis Section,0.0
Signaling Systems Section,Molecular Biology Section,0.0
Signaling Systems Section,Molecular Defenses Section,0.0
Signaling Systems Section,Molecular Development of the Immune System Section,0.0
Signaling Systems Section,Molecular Entomology Unit,0.0
Signaling Systems Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Signaling Systems Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Signaling Systems Section,Molecular HIV Host Interactions Section,0.0
Signaling Systems Section,Molecular Microbiology Section,0.0
Signaling Systems Section,Molecular Parasitology Section,0.0
Signaling Systems Section,Molecular Parasitology and Entomology Unit,0.0
Signaling Systems Section,Molecular Pathogenesis Unit,0.0
Signaling Systems Section,Molecular Pathogenesis and Biomarkers Section,0.0
Signaling Systems Section,Molecular Pathology Section,0.0
Signaling Systems Section,Molecular Signaling Section,0.0
Signaling Systems Section,Molecular and Cellular Immunology Section,0.0
Signaling Systems Section,Molecular and Cellular Immunoregulation Section,0.0
Signaling Systems Section,Mosquito Immunity and Vector Competence Section,0.0
Signaling Systems Section,Mucosal Immunity Section,0.0
Signaling Systems Section,Mucosal Immunobiology Section,0.0
Signaling Systems Section,NIAID International Center of Excellence in Research Cambodia,0.0
Signaling Systems Section,Neuroimmunological Diseases Section,0.0
Signaling Systems Section,Neuroimmunology Unit,0.0
Signaling Systems Section,Nonhuman Primate Virology Section,0.0
Signaling Systems Section,Office of the Animal Program Director,0.0
Signaling Systems Section,Pathogen-Host Cell Biology Section,0.0
Signaling Systems Section,Pathogenesis and Immunity Section,0.0
Signaling Systems Section,Pathology Core,0.0
Signaling Systems Section,Physiology Unit,0.0
Signaling Systems Section,Plague Section,0.0
Signaling Systems Section,Primary Immune Deficiency Clinic,0.0
Signaling Systems Section,Prion Cell Biology Unit,0.0
Signaling Systems Section,Protein Chemistry Section,0.0
Signaling Systems Section,Quantitative Virology and Evolution Unit,0.0
Signaling Systems Section,RML Flow Cytometry Unit,0.0
Signaling Systems Section,RML Genomics Unit,0.0
Signaling Systems Section,RML Microscopy Unit,0.0
Signaling Systems Section,RNA Viruses Section,0.0
Signaling Systems Section,Research Technology Branch,0.0
Signaling Systems Section,Retroviral Immunology Section,0.0
Signaling Systems Section,Salmonella-Host Cell Interactions Section,0.0
Signaling Systems Section,Scientist Emerita,0.0
Structural Biology Section,Allergy and Immunology Clinical Training Program,0.0
Structural Biology Section,Antibacterial Host Defense Unit,0.0
Structural Biology Section,Antibody Biology Unit,0.0
Structural Biology Section,Apicomplexan Molecular Physiology Section,0.0
Structural Biology Section,Autoimmunity and Functional Genomics Section,0.0
Structural Biology Section,B-Cell Immunology Section,0.0
Structural Biology Section,B-Cell Molecular Immunology Section,0.0
Structural Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Structural Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Structural Biology Section,Barrier Immunity Section,0.0
Structural Biology Section,Biological Imaging,0.0
Structural Biology Section,Biology of Vector-Borne Viruses Section,0.0
Structural Biology Section,Building 14B South,0.0
Structural Biology Section,Building 33,0.0
Structural Biology Section,Building 50,0.0
Structural Biology Section,Building NIHAC/103,0.0
Structural Biology Section,Buildings 4 and 10/11C127,0.0
Structural Biology Section,Caliciviruses Section,0.0
Structural Biology Section,Cell Signaling and Immunity Section,0.0
Structural Biology Section,Cellular Biology Section,0.0
Structural Biology Section,Cellular Immunology Section,0.0
Structural Biology Section,Chemotaxis Signal Section,0.0
Structural Biology Section,Chlamydial Diseases Section,0.0
Structural Biology Section,Clinical Microbiome Unit (CMU),0.0
Structural Biology Section,Clinical Pathophysiology Section,0.0
Structural Biology Section,Clinical Research Section,0.0
Structural Biology Section,Clinical and Molecular Retrovirology Section,0.0
Structural Biology Section,Computational Biology Unit,0.0
Structural Biology Section,Coxiella Pathogenesis Section,0.0
Structural Biology Section,DNA Tumor Virus Section,0.0
Structural Biology Section,Disease Modeling and Transmission Section,0.0
Structural Biology Section,Emerging Respiratory Viruses Section,0.0
Structural Biology Section,Emerging Virus Immunity Unit,0.0
Structural Biology Section,Epidemiology and Population Studies Unit,0.0
Structural Biology Section,Epithelial Therapeutics Unit,0.0
Structural Biology Section,Flow Cytometry Section,0.0
Structural Biology Section,Food Allergy Research Section,0.0
Structural Biology Section,Functional Cellular Networks Section,0.0
Structural Biology Section,Fungal Pathogenesis Section,0.0
Structural Biology Section,Gene Regulation Section,0.0
Structural Biology Section,Genetic Immunotherapy Section,0.0
Structural Biology Section,Genomic Technologies Section,0.0
Structural Biology Section,HIV Immunovirology Section,0.0
Structural Biology Section,HIV Pathogenesis Section,0.0
Structural Biology Section,HIV-Specific Immunity Section,0.0
Structural Biology Section,Hepatic Pathogenesis Section,0.0
Structural Biology Section,Host-Parasite Interactions Section,0.0
Structural Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Structural Biology Section,Human Eosinophil Section,0.0
Structural Biology Section,Human Immunological Diseases Section,0.0
Structural Biology Section,Immune Deficiency Genetics Section,0.0
Structural Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Structural Biology Section,Immunobiology Section,0.0
Structural Biology Section,Immunobiology and Molecular Virology Unit,0.0
Structural Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Structural Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Structural Biology Section,Infectious Disease Fellowship Training Program,0.0
Structural Biology Section,Infectious Disease Pathogenesis Section,0.0
Structural Biology Section,Inflammation & Innate Immunity Unit,0.0
Structural Biology Section,Inflammation Biology Section,0.0
Structural Biology Section,Innate Immunity and Pathogenesis Section,0.0
Structural Biology Section,Integrative Immunobiology Section,0.0
Structural Biology Section,International HIV/STD Section,0.0
Structural Biology Section,Intracellular Parasite Biology Section,0.0
Structural Biology Section,LID Clinical Studies Unit,0.0
Structural Biology Section,Lung and Vascular Inflammation Section,0.0
Structural Biology Section,Lyme Disease Studies Unit,0.0
Structural Biology Section,Lymphocyte Activation Section,0.0
Structural Biology Section,Lymphocyte Biology Section,0.0
Structural Biology Section,Malaria Functional Genomics Section,0.0
Structural Biology Section,Malaria Genetics Section,0.0
Structural Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Structural Biology Section,Mast Cell Biology Section,0.0
Structural Biology Section,Medical Virology Section,0.0
Structural Biology Section,Metaorganism Immunity Section,0.0
Structural Biology Section,Molecular Biology Section,0.0
Structural Biology Section,Molecular Defenses Section,0.0
Structural Biology Section,Molecular Development of the Immune System Section,0.0
Structural Biology Section,Molecular Entomology Unit,0.0
Structural Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Structural Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Structural Biology Section,Molecular HIV Host Interactions Section,0.0
Structural Biology Section,Molecular Microbiology Section,0.0
Structural Biology Section,Molecular Parasitology Section,0.0
Structural Biology Section,Molecular Parasitology and Entomology Unit,0.0
Structural Biology Section,Molecular Pathogenesis Unit,0.0
Structural Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Structural Biology Section,Molecular Pathology Section,0.0
Structural Biology Section,Molecular and Cellular Immunology Section,0.0
Structural Biology Section,Molecular and Cellular Immunoregulation Section,0.0
Structural Biology Section,Mosquito Immunity and Vector Competence Section,0.0
Structural Biology Section,Mucosal Immunity Section,0.0
Structural Biology Section,Mucosal Immunobiology Section,0.0
Structural Biology Section,Multiscale Systems Biology Section,0.0
Structural Biology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Structural Biology Section,Neuroimmunological Diseases Section,0.0
Structural Biology Section,Neuroimmunology Unit,0.0
Structural Biology Section,Nonhuman Primate Virology Section,0.0
Structural Biology Section,Office of the Animal Program Director,0.0
Structural Biology Section,Pathogen Molecular Genetics Section,0.0
Structural Biology Section,Pathogen-Host Cell Biology Section,0.0
Structural Biology Section,Pathogenesis and Immunity Section,0.0
Structural Biology Section,Pathology Core,0.0
Structural Biology Section,Physiology Unit,0.0
Structural Biology Section,Plague Section,0.0
Structural Biology Section,Primary Immune Deficiency Clinic,0.0
Structural Biology Section,Prion Cell Biology Unit,0.0
Structural Biology Section,Protein Chemistry Section,0.0
Structural Biology Section,Quantitative Virology and Evolution Unit,0.0
Structural Biology Section,RML Flow Cytometry Unit,0.0
Structural Biology Section,RML Genomics Unit,0.0
Structural Biology Section,RML Microscopy Unit,0.0
Structural Biology Section,RNA Viruses Section,0.0
Structural Biology Section,Research Technology Branch,0.0
Structural Biology Section,Retroviral Immunology Section,0.0
Structural Biology Section,Salmonella-Host Cell Interactions Section,0.0
Structural Biology Section,Scientist Emerita,0.0
Structural Biology Section,Signaling Systems Section,0.0
Structural Immunology Section,Allergy and Immunology Clinical Training Program,0.0
Structural Immunology Section,Antibacterial Host Defense Unit,0.0
Structural Immunology Section,Antibody Biology Unit,0.0
Structural Immunology Section,Apicomplexan Molecular Physiology Section,0.0
Structural Immunology Section,Autoimmunity and Functional Genomics Section,0.0
Structural Immunology Section,B-Cell Molecular Immunology Section,0.0
Structural Immunology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Structural Immunology Section,Bacterial Physiology and Metabolism Unit,0.0
Structural Immunology Section,Barrier Immunity Section,0.0
Structural Immunology Section,Biological Imaging,0.0
Structural Immunology Section,Biology of Vector-Borne Viruses Section,0.0
Structural Immunology Section,Building 14B South,0.0
Structural Immunology Section,Building 33,0.0
Structural Immunology Section,Building 50,0.0
Structural Immunology Section,Building NIHAC/103,0.0
Structural Immunology Section,Buildings 4 and 10/11C127,0.0
Structural Immunology Section,Caliciviruses Section,0.0
Structural Immunology Section,Cell Signaling and Immunity Section,0.0
Structural Immunology Section,Cellular Biology Section,0.0
Structural Immunology Section,Chemotaxis Signal Section,0.0
Structural Immunology Section,Chlamydial Diseases Section,0.0
Structural Immunology Section,Clinical Microbiome Unit (CMU),0.0
Structural Immunology Section,Clinical Pathophysiology Section,0.0
Structural Immunology Section,Clinical Research Section,0.0
Structural Immunology Section,Clinical and Molecular Retrovirology Section,0.0
Structural Immunology Section,Computational Biology Unit,0.0
Structural Immunology Section,Coxiella Pathogenesis Section,0.0
Structural Immunology Section,DNA Tumor Virus Section,0.0
Structural Immunology Section,Disease Modeling and Transmission Section,0.0
Structural Immunology Section,Emerging Respiratory Viruses Section,0.0
Structural Immunology Section,Emerging Virus Immunity Unit,0.0
Structural Immunology Section,Epidemiology and Population Studies Unit,0.0
Structural Immunology Section,Epithelial Therapeutics Unit,0.0
Structural Immunology Section,Flow Cytometry Section,0.0
Structural Immunology Section,Food Allergy Research Section,0.0
Structural Immunology Section,Functional Cellular Networks Section,0.0
Structural Immunology Section,Fungal Pathogenesis Section,0.0
Structural Immunology Section,Gene Regulation Section,0.0
Structural Immunology Section,Genetic Engineering Section,0.0
Structural Immunology Section,Genetic Immunotherapy Section,0.0
Structural Immunology Section,Genomic Technologies Section,0.0
Structural Immunology Section,HIV Pathogenesis Section,0.0
Structural Immunology Section,HIV-Specific Immunity Section,0.0
Structural Immunology Section,Helminth Immunology Section,0.0
Structural Immunology Section,Hepatic Pathogenesis Section,0.0
Structural Immunology Section,Host-Parasite Interactions Section,0.0
Structural Immunology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Structural Immunology Section,Human Eosinophil Section,0.0
Structural Immunology Section,Human Immunological Diseases Section,0.0
Structural Immunology Section,Immune Activation Section,0.0
Structural Immunology Section,Immune Deficiency Genetics Section,0.0
Structural Immunology Section,Immunity to Pulmonary Pathogens Section,0.0
Structural Immunology Section,Immunobiology Section,0.0
Structural Immunology Section,Immunobiology and Molecular Virology Unit,0.0
Structural Immunology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Structural Immunology Section,Infectious Disease Fellowship Training Program,0.0
Structural Immunology Section,Infectious Disease Pathogenesis Section,0.0
Structural Immunology Section,Inflammation & Innate Immunity Unit,0.0
Structural Immunology Section,Inflammation Biology Section,0.0
Structural Immunology Section,Innate Immunity and Pathogenesis Section,0.0
Structural Immunology Section,Integrative Immunobiology Section,0.0
Structural Immunology Section,International HIV/STD Section,0.0
Structural Immunology Section,Intracellular Parasite Biology Section,0.0
Structural Immunology Section,Lung and Vascular Inflammation Section,0.0
Structural Immunology Section,Lyme Disease Studies Unit,0.0
Structural Immunology Section,Lymphocyte Biology Section,0.0
Structural Immunology Section,Malaria Cell Biology Section,0.0
Structural Immunology Section,Malaria Functional Genomics Section,0.0
Structural Immunology Section,Malaria Immunology Section,0.0
Structural Immunology Section,Malaria Infection Biology and Immunity Unit,0.0
Structural Immunology Section,Mast Cell Biology Section,0.0
Structural Immunology Section,Medical Virology Section,0.0
Structural Immunology Section,Metaorganism Immunity Section,0.0
Structural Immunology Section,Microbial Pathogenesis Section,0.0
Structural Immunology Section,Molecular Biology Section,0.0
Structural Immunology Section,Molecular Defenses Section,0.0
Structural Immunology Section,Molecular Development of the Immune System Section,0.0
Structural Immunology Section,Molecular Entomology Unit,0.0
Structural Immunology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Structural Immunology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Structural Immunology Section,Molecular HIV Host Interactions Section,0.0
Structural Immunology Section,Molecular Microbiology Section,0.0
Structural Immunology Section,Molecular Parasitology Section,0.0
Structural Immunology Section,Molecular Parasitology and Entomology Unit,0.0
Structural Immunology Section,Molecular Pathogenesis Unit,0.0
Structural Immunology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Structural Immunology Section,Molecular Pathology Section,0.0
Structural Immunology Section,Molecular Signaling Section,0.0
Structural Immunology Section,Molecular and Cellular Immunoregulation Section,0.0
Structural Immunology Section,Mosquito Immunity and Vector Competence Section,0.0
Structural Immunology Section,Mucosal Immunity Section,0.0
Structural Immunology Section,Mucosal Immunobiology Section,0.0
Structural Immunology Section,Multiscale Systems Biology Section,0.0
Structural Immunology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Structural Immunology Section,Neuroimmunological Diseases Section,0.0
Structural Immunology Section,Neuroimmunology Unit,0.0
Structural Immunology Section,Nonhuman Primate Virology Section,0.0
Structural Immunology Section,Office of the Animal Program Director,0.0
Structural Immunology Section,Pathogen Molecular Genetics Section,0.0
Structural Immunology Section,Pathogen-Host Cell Biology Section,0.0
Structural Immunology Section,Pathogenesis and Immunity Section,0.0
Structural Immunology Section,Pathology Core,0.0
Structural Immunology Section,Physiology Unit,0.0
Structural Immunology Section,Plague Section,0.0
Structural Immunology Section,Primary Immune Deficiency Clinic,0.0
Structural Immunology Section,Prion Cell Biology Unit,0.0
Structural Immunology Section,Protein Chemistry Section,0.0
Structural Immunology Section,Quantitative Virology and Evolution Unit,0.0
Structural Immunology Section,RML Flow Cytometry Unit,0.0
Structural Immunology Section,RML Microscopy Unit,0.0
Structural Immunology Section,RNA Viruses Section,0.0
Structural Immunology Section,Research Technology Branch,0.0
Structural Immunology Section,Retroviral Immunology Section,0.0
Structural Immunology Section,Salmonella-Host Cell Interactions Section,0.0
Structural Immunology Section,Scientist Emerita,0.0
Structural Immunology Section,Signaling Systems Section,0.0
Structural Immunology Section,Structural Biology Section,0.0
Structural Informatics Unit,Allergy and Immunology Clinical Training Program,0.0
Structural Informatics Unit,Antibacterial Host Defense Unit,0.0
Structural Informatics Unit,Antibody Biology Unit,0.0
Structural Informatics Unit,Apicomplexan Molecular Physiology Section,0.0
Structural Informatics Unit,Autoimmunity and Functional Genomics Section,0.0
Structural Informatics Unit,B-Cell Immunology Section,0.0
Structural Informatics Unit,B-Cell Molecular Immunology Section,0.0
Structural Informatics Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Structural Informatics Unit,Bacterial Physiology and Metabolism Unit,0.0
Structural Informatics Unit,Barrier Immunity Section,0.0
Structural Informatics Unit,Biological Imaging,0.0
Structural Informatics Unit,Biology of Vector-Borne Viruses Section,0.0
Structural Informatics Unit,Building 14B South,0.0
Structural Informatics Unit,Building 33,0.0
Structural Informatics Unit,Building 50,0.0
Structural Informatics Unit,Building NIHAC/103,0.0
Structural Informatics Unit,Buildings 4 and 10/11C127,0.0
Structural Informatics Unit,Caliciviruses Section,0.0
Structural Informatics Unit,Cell Signaling and Immunity Section,0.0
Structural Informatics Unit,Cellular Immunology Section,0.0
Structural Informatics Unit,Chemotaxis Signal Section,0.0
Structural Informatics Unit,Chlamydial Diseases Section,0.0
Structural Informatics Unit,Clinical Microbiome Unit (CMU),0.0
Structural Informatics Unit,Clinical Pathophysiology Section,0.0
Structural Informatics Unit,Clinical Research Section,0.0
Structural Informatics Unit,Clinical and Molecular Retrovirology Section,0.0
Structural Informatics Unit,Computational Biology Unit,0.0
Structural Informatics Unit,Coxiella Pathogenesis Section,0.0
Structural Informatics Unit,DNA Tumor Virus Section,0.0
Structural Informatics Unit,Disease Modeling and Transmission Section,0.0
Structural Informatics Unit,Emerging Respiratory Viruses Section,0.0
Structural Informatics Unit,Emerging Virus Immunity Unit,0.0
Structural Informatics Unit,Epidemiology and Population Studies Unit,0.0
Structural Informatics Unit,Epithelial Therapeutics Unit,0.0
Structural Informatics Unit,Flow Cytometry Section,0.0
Structural Informatics Unit,Food Allergy Research Section,0.0
Structural Informatics Unit,Functional Cellular Networks Section,0.0
Structural Informatics Unit,Fungal Pathogenesis Section,0.0
Structural Informatics Unit,Gene Regulation Section,0.0
Structural Informatics Unit,Genetic Engineering Section,0.0
Structural Informatics Unit,Genetic Immunotherapy Section,0.0
Structural Informatics Unit,Genomic Technologies Section,0.0
Structural Informatics Unit,HIV Immunovirology Section,0.0
Structural Informatics Unit,HIV Pathogenesis Section,0.0
Structural Informatics Unit,HIV-Specific Immunity Section,0.0
Structural Informatics Unit,Helminth Immunology Section,0.0
Structural Informatics Unit,Hepatic Pathogenesis Section,0.0
Structural Informatics Unit,Host-Parasite Interactions Section,0.0
Structural Informatics Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Structural Informatics Unit,Human Eosinophil Section,0.0
Structural Informatics Unit,Human Immunological Diseases Section,0.0
Structural Informatics Unit,Immune Activation Section,0.0
Structural Informatics Unit,Immune Deficiency Genetics Section,0.0
Structural Informatics Unit,Immunity to Pulmonary Pathogens Section,0.0
Structural Informatics Unit,Immunobiology Section,0.0
Structural Informatics Unit,Immunobiology and Molecular Virology Unit,0.0
Structural Informatics Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Structural Informatics Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Structural Informatics Unit,Infectious Disease Fellowship Training Program,0.0
Structural Informatics Unit,Infectious Disease Pathogenesis Section,0.0
Structural Informatics Unit,Inflammation & Innate Immunity Unit,0.0
Structural Informatics Unit,Inflammation Biology Section,0.0
Structural Informatics Unit,Innate Immunity and Pathogenesis Section,0.0
Structural Informatics Unit,Integrative Immunobiology Section,0.0
Structural Informatics Unit,International HIV/STD Section,0.0
Structural Informatics Unit,Intracellular Parasite Biology Section,0.0
Structural Informatics Unit,LID Clinical Studies Unit,0.0
Structural Informatics Unit,Lung and Vascular Inflammation Section,0.0
Structural Informatics Unit,Lyme Disease Studies Unit,0.0
Structural Informatics Unit,Lymphocyte Activation Section,0.0
Structural Informatics Unit,Lymphocyte Biology Section,0.0
Structural Informatics Unit,Malaria Cell Biology Section,0.0
Structural Informatics Unit,Malaria Functional Genomics Section,0.0
Structural Informatics Unit,Malaria Genetics Section,0.0
Structural Informatics Unit,Malaria Immunology Section,0.0
Structural Informatics Unit,Malaria Infection Biology and Immunity Unit,0.0
Structural Informatics Unit,Mast Cell Biology Section,0.0
Structural Informatics Unit,Medical Virology Section,0.0
Structural Informatics Unit,Metaorganism Immunity Section,0.0
Structural Informatics Unit,Microbial Pathogenesis Section,0.0
Structural Informatics Unit,Molecular Biology Section,0.0
Structural Informatics Unit,Molecular Defenses Section,0.0
Structural Informatics Unit,Molecular Development of the Immune System Section,0.0
Structural Informatics Unit,Molecular Entomology Unit,0.0
Structural Informatics Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Structural Informatics Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Structural Informatics Unit,Molecular HIV Host Interactions Section,0.0
Structural Informatics Unit,Molecular Microbiology Section,0.0
Structural Informatics Unit,Molecular Parasitology Section,0.0
Structural Informatics Unit,Molecular Parasitology and Entomology Unit,0.0
Structural Informatics Unit,Molecular Pathogenesis Unit,0.0
Structural Informatics Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Structural Informatics Unit,Molecular Pathology Section,0.0
Structural Informatics Unit,Molecular Signaling Section,0.0
Structural Informatics Unit,Molecular and Cellular Immunology Section,0.0
Structural Informatics Unit,Molecular and Cellular Immunoregulation Section,0.0
Structural Informatics Unit,Mosquito Immunity and Vector Competence Section,0.0
Structural Informatics Unit,Mucosal Immunity Section,0.0
Structural Informatics Unit,Mucosal Immunobiology Section,0.0
Structural Informatics Unit,Multiscale Systems Biology Section,0.0
Structural Informatics Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Structural Informatics Unit,Neuroimmunological Diseases Section,0.0
Structural Informatics Unit,Neuroimmunology Unit,0.0
Structural Informatics Unit,Nonhuman Primate Virology Section,0.0
Structural Informatics Unit,Office of the Animal Program Director,0.0
Structural Informatics Unit,Pathogen Molecular Genetics Section,0.0
Structural Informatics Unit,Pathogen-Host Cell Biology Section,0.0
Structural Informatics Unit,Pathogenesis and Immunity Section,0.0
Structural Informatics Unit,Pathology Core,0.0
Structural Informatics Unit,Physiology Unit,0.0
Structural Informatics Unit,Plague Section,0.0
Structural Informatics Unit,Primary Immune Deficiency Clinic,0.0
Structural Informatics Unit,Prion Cell Biology Unit,0.0
Structural Informatics Unit,Protein Chemistry Section,0.0
Structural Informatics Unit,Quantitative Virology and Evolution Unit,0.0
Structural Informatics Unit,RML Flow Cytometry Unit,0.0
Structural Informatics Unit,RML Genomics Unit,0.0
Structural Informatics Unit,RML Microscopy Unit,0.0
Structural Informatics Unit,RNA Viruses Section,0.0
Structural Informatics Unit,Research Technology Branch,0.0
Structural Informatics Unit,Retroviral Immunology Section,0.0
Structural Informatics Unit,Salmonella-Host Cell Interactions Section,0.0
Structural Informatics Unit,Scientist Emerita,0.0
Structural Informatics Unit,Signaling Systems Section,0.0
Structural Informatics Unit,Structural Biology Section,0.0
Structural Informatics Unit,Structural Immunology Section,0.0
Structural Virology Section,Allergy and Immunology Clinical Training Program,0.0
Structural Virology Section,Antibacterial Host Defense Unit,0.0
Structural Virology Section,Antibody Biology Unit,0.0
Structural Virology Section,Apicomplexan Molecular Physiology Section,0.0
Structural Virology Section,Autoimmunity and Functional Genomics Section,0.0
Structural Virology Section,B-Cell Immunology Section,0.0
Structural Virology Section,B-Cell Molecular Immunology Section,0.0
Structural Virology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Structural Virology Section,Bacterial Physiology and Metabolism Unit,0.0
Structural Virology Section,Barrier Immunity Section,0.0
Structural Virology Section,Biological Imaging,0.0
Structural Virology Section,Biology of Vector-Borne Viruses Section,0.0
Structural Virology Section,Building 14B South,0.0
Structural Virology Section,Building 33,0.0
Structural Virology Section,Building 50,0.0
Structural Virology Section,Building NIHAC/103,0.0
Structural Virology Section,Buildings 4 and 10/11C127,0.0
Structural Virology Section,Caliciviruses Section,0.0
Structural Virology Section,Cell Signaling and Immunity Section,0.0
Structural Virology Section,Cellular Biology Section,0.0
Structural Virology Section,Cellular Immunology Section,0.0
Structural Virology Section,Chemotaxis Signal Section,0.0
Structural Virology Section,Chlamydial Diseases Section,0.0
Structural Virology Section,Clinical Microbiome Unit (CMU),0.0
Structural Virology Section,Clinical Pathophysiology Section,0.0
Structural Virology Section,Clinical Research Section,0.0
Structural Virology Section,Clinical and Molecular Retrovirology Section,0.0
Structural Virology Section,Computational Biology Unit,0.0
Structural Virology Section,Coxiella Pathogenesis Section,0.0
Structural Virology Section,DNA Tumor Virus Section,0.0
Structural Virology Section,Disease Modeling and Transmission Section,0.0
Structural Virology Section,Emerging Respiratory Viruses Section,0.0
Structural Virology Section,Emerging Virus Immunity Unit,0.0
Structural Virology Section,Epidemiology and Population Studies Unit,0.0
Structural Virology Section,Epithelial Therapeutics Unit,0.0
Structural Virology Section,Flow Cytometry Section,0.0
Structural Virology Section,Food Allergy Research Section,0.0
Structural Virology Section,Functional Cellular Networks Section,0.0
Structural Virology Section,Fungal Pathogenesis Section,0.0
Structural Virology Section,Gene Regulation Section,0.0
Structural Virology Section,Genetic Engineering Section,0.0
Structural Virology Section,Genetic Immunotherapy Section,0.0
Structural Virology Section,Genomic Technologies Section,0.0
Structural Virology Section,HIV Immunovirology Section,0.0
Structural Virology Section,HIV Pathogenesis Section,0.0
Structural Virology Section,HIV-Specific Immunity Section,0.0
Structural Virology Section,Helminth Immunology Section,0.0
Structural Virology Section,Hepatic Pathogenesis Section,0.0
Structural Virology Section,Host-Parasite Interactions Section,0.0
Structural Virology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Structural Virology Section,Human Eosinophil Section,0.0
Structural Virology Section,Human Immunological Diseases Section,0.0
Structural Virology Section,Immune Activation Section,0.0
Structural Virology Section,Immune Deficiency Genetics Section,0.0
Structural Virology Section,Immunity to Pulmonary Pathogens Section,0.0
Structural Virology Section,Immunobiology Section,0.0
Structural Virology Section,Immunobiology and Molecular Virology Unit,0.0
Structural Virology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Structural Virology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Structural Virology Section,Infectious Disease Fellowship Training Program,0.0
Structural Virology Section,Infectious Disease Pathogenesis Section,0.0
Structural Virology Section,Inflammation & Innate Immunity Unit,0.0
Structural Virology Section,Inflammation Biology Section,0.0
Structural Virology Section,Innate Immunity and Pathogenesis Section,0.0
Structural Virology Section,Integrative Immunobiology Section,0.0
Structural Virology Section,International HIV/STD Section,0.0
Structural Virology Section,Intracellular Parasite Biology Section,0.0
Structural Virology Section,LID Clinical Studies Unit,0.0
Structural Virology Section,Lung and Vascular Inflammation Section,0.0
Structural Virology Section,Lyme Disease Studies Unit,0.0
Structural Virology Section,Lymphocyte Activation Section,0.0
Structural Virology Section,Lymphocyte Biology Section,0.0
Structural Virology Section,Malaria Cell Biology Section,0.0
Structural Virology Section,Malaria Functional Genomics Section,0.0
Structural Virology Section,Malaria Genetics Section,0.0
Structural Virology Section,Malaria Immunology Section,0.0
Structural Virology Section,Malaria Infection Biology and Immunity Unit,0.0
Structural Virology Section,Mast Cell Biology Section,0.0
Structural Virology Section,Medical Virology Section,0.0
Structural Virology Section,Metaorganism Immunity Section,0.0
Structural Virology Section,Microbial Pathogenesis Section,0.0
Structural Virology Section,Molecular Biology Section,0.0
Structural Virology Section,Molecular Defenses Section,0.0
Structural Virology Section,Molecular Development of the Immune System Section,0.0
Structural Virology Section,Molecular Entomology Unit,0.0
Structural Virology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Structural Virology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Structural Virology Section,Molecular HIV Host Interactions Section,0.0
Structural Virology Section,Molecular Microbiology Section,0.0
Structural Virology Section,Molecular Parasitology Section,0.0
Structural Virology Section,Molecular Parasitology and Entomology Unit,0.0
Structural Virology Section,Molecular Pathogenesis Unit,0.0
Structural Virology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Structural Virology Section,Molecular Pathology Section,0.0
Structural Virology Section,Molecular Signaling Section,0.0
Structural Virology Section,Molecular and Cellular Immunology Section,0.0
Structural Virology Section,Molecular and Cellular Immunoregulation Section,0.0
Structural Virology Section,Mosquito Immunity and Vector Competence Section,0.0
Structural Virology Section,Mucosal Immunity Section,0.0
Structural Virology Section,Mucosal Immunobiology Section,0.0
Structural Virology Section,Multiscale Systems Biology Section,0.0
Structural Virology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Structural Virology Section,Neuroimmunological Diseases Section,0.0
Structural Virology Section,Neuroimmunology Unit,0.0
Structural Virology Section,Nonhuman Primate Virology Section,0.0
Structural Virology Section,Office of the Animal Program Director,0.0
Structural Virology Section,Pathogen Molecular Genetics Section,0.0
Structural Virology Section,Pathogen-Host Cell Biology Section,0.0
Structural Virology Section,Pathogenesis and Immunity Section,0.0
Structural Virology Section,Pathology Core,0.0
Structural Virology Section,Physiology Unit,0.0
Structural Virology Section,Plague Section,0.0
Structural Virology Section,Primary Immune Deficiency Clinic,0.0
Structural Virology Section,Prion Cell Biology Unit,0.0
Structural Virology Section,Protein Chemistry Section,0.0
Structural Virology Section,Quantitative Virology and Evolution Unit,0.0
Structural Virology Section,RML Flow Cytometry Unit,0.0
Structural Virology Section,RML Genomics Unit,0.0
Structural Virology Section,RML Microscopy Unit,0.0
Structural Virology Section,RNA Viruses Section,0.0
Structural Virology Section,Research Technology Branch,0.0
Structural Virology Section,Retroviral Immunology Section,0.0
Structural Virology Section,Salmonella-Host Cell Interactions Section,0.0
Structural Virology Section,Scientist Emerita,0.0
Structural Virology Section,Signaling Systems Section,0.0
Structural Virology Section,Structural Biology Section,0.0
Structural Virology Section,Structural Immunology Section,0.0
Structural Virology Section,Structural Informatics Unit,0.0
Systems Genomics Section,Allergy and Immunology Clinical Training Program,0.0
Systems Genomics Section,Antibacterial Host Defense Unit,0.0
Systems Genomics Section,Antibody Biology Unit,0.0
Systems Genomics Section,Apicomplexan Molecular Physiology Section,0.0
Systems Genomics Section,Autoimmunity and Functional Genomics Section,0.0
Systems Genomics Section,B-Cell Immunology Section,0.0
Systems Genomics Section,B-Cell Molecular Immunology Section,0.0
Systems Genomics Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Systems Genomics Section,Bacterial Physiology and Metabolism Unit,0.0
Systems Genomics Section,Barrier Immunity Section,0.0
Systems Genomics Section,Biological Imaging,0.0
Systems Genomics Section,Biology of Vector-Borne Viruses Section,0.0
Systems Genomics Section,Building 14B South,0.0
Systems Genomics Section,Building 33,0.0
Systems Genomics Section,Building 50,0.0
Systems Genomics Section,Building NIHAC/103,0.0
Systems Genomics Section,Buildings 4 and 10/11C127,0.0
Systems Genomics Section,Caliciviruses Section,0.0
Systems Genomics Section,Cell Signaling and Immunity Section,0.0
Systems Genomics Section,Cellular Biology Section,0.0
Systems Genomics Section,Cellular Immunology Section,0.0
Systems Genomics Section,Chemotaxis Signal Section,0.0
Systems Genomics Section,Chlamydial Diseases Section,0.0
Systems Genomics Section,Clinical Microbiome Unit (CMU),0.0
Systems Genomics Section,Clinical Pathophysiology Section,0.0
Systems Genomics Section,Clinical and Molecular Retrovirology Section,0.0
Systems Genomics Section,Computational Biology Unit,0.0
Systems Genomics Section,Coxiella Pathogenesis Section,0.0
Systems Genomics Section,DNA Tumor Virus Section,0.0
Systems Genomics Section,Disease Modeling and Transmission Section,0.0
Systems Genomics Section,Emerging Respiratory Viruses Section,0.0
Systems Genomics Section,Emerging Virus Immunity Unit,0.0
Systems Genomics Section,Epidemiology and Population Studies Unit,0.0
Systems Genomics Section,Epithelial Therapeutics Unit,0.0
Systems Genomics Section,Flow Cytometry Section,0.0
Systems Genomics Section,Food Allergy Research Section,0.0
Systems Genomics Section,Functional Cellular Networks Section,0.0
Systems Genomics Section,Fungal Pathogenesis Section,0.0
Systems Genomics Section,Gene Regulation Section,0.0
Systems Genomics Section,Genetic Engineering Section,0.0
Systems Genomics Section,Genetic Immunotherapy Section,0.0
Systems Genomics Section,Genomic Technologies Section,0.0
Systems Genomics Section,HIV Immunovirology Section,0.0
Systems Genomics Section,HIV Pathogenesis Section,0.0
Systems Genomics Section,HIV-Specific Immunity Section,0.0
Systems Genomics Section,Hepatic Pathogenesis Section,0.0
Systems Genomics Section,Host-Parasite Interactions Section,0.0
Systems Genomics Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Systems Genomics Section,Human Eosinophil Section,0.0
Systems Genomics Section,Human Immunological Diseases Section,0.0
Systems Genomics Section,Immune Activation Section,0.0
Systems Genomics Section,Immune Deficiency Genetics Section,0.0
Systems Genomics Section,Immunity to Pulmonary Pathogens Section,0.0
Systems Genomics Section,Immunobiology Section,0.0
Systems Genomics Section,Immunobiology and Molecular Virology Unit,0.0
Systems Genomics Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Systems Genomics Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Systems Genomics Section,Infectious Disease Fellowship Training Program,0.0
Systems Genomics Section,Infectious Disease Pathogenesis Section,0.0
Systems Genomics Section,Inflammation & Innate Immunity Unit,0.0
Systems Genomics Section,Inflammation Biology Section,0.0
Systems Genomics Section,Innate Immunity and Pathogenesis Section,0.0
Systems Genomics Section,Integrative Immunobiology Section,0.0
Systems Genomics Section,International HIV/STD Section,0.0
Systems Genomics Section,Intracellular Parasite Biology Section,0.0
Systems Genomics Section,LID Clinical Studies Unit,0.0
Systems Genomics Section,Lung and Vascular Inflammation Section,0.0
Systems Genomics Section,Lyme Disease Studies Unit,0.0
Systems Genomics Section,Lymphocyte Activation Section,0.0
Systems Genomics Section,Lymphocyte Biology Section,0.0
Systems Genomics Section,Malaria Cell Biology Section,0.0
Systems Genomics Section,Malaria Functional Genomics Section,0.0
Systems Genomics Section,Malaria Genetics Section,0.0
Systems Genomics Section,Malaria Immunology Section,0.0
Systems Genomics Section,Malaria Infection Biology and Immunity Unit,0.0
Systems Genomics Section,Mast Cell Biology Section,0.0
Systems Genomics Section,Medical Virology Section,0.0
Systems Genomics Section,Metaorganism Immunity Section,0.0
Systems Genomics Section,Microbial Pathogenesis Section,0.0
Systems Genomics Section,Molecular Biology Section,0.0
Systems Genomics Section,Molecular Defenses Section,0.0
Systems Genomics Section,Molecular Development of the Immune System Section,0.0
Systems Genomics Section,Molecular Entomology Unit,0.0
Systems Genomics Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Systems Genomics Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Systems Genomics Section,Molecular HIV Host Interactions Section,0.0
Systems Genomics Section,Molecular Microbiology Section,0.0
Systems Genomics Section,Molecular Parasitology Section,0.0
Systems Genomics Section,Molecular Parasitology and Entomology Unit,0.0
Systems Genomics Section,Molecular Pathogenesis Unit,0.0
Systems Genomics Section,Molecular Pathogenesis and Biomarkers Section,0.0
Systems Genomics Section,Molecular Pathology Section,0.0
Systems Genomics Section,Molecular Signaling Section,0.0
Systems Genomics Section,Molecular and Cellular Immunology Section,0.0
Systems Genomics Section,Molecular and Cellular Immunoregulation Section,0.0
Systems Genomics Section,Mosquito Immunity and Vector Competence Section,0.0
Systems Genomics Section,Mucosal Immunity Section,0.0
Systems Genomics Section,Mucosal Immunobiology Section,0.0
Systems Genomics Section,Multiscale Systems Biology Section,0.0
Systems Genomics Section,NIAID International Center of Excellence in Research Cambodia,0.0
Systems Genomics Section,Neuroimmunological Diseases Section,0.0
Systems Genomics Section,Neuroimmunology Unit,0.0
Systems Genomics Section,Nonhuman Primate Virology Section,0.0
Systems Genomics Section,Office of the Animal Program Director,0.0
Systems Genomics Section,Pathogen Molecular Genetics Section,0.0
Systems Genomics Section,Pathogen-Host Cell Biology Section,0.0
Systems Genomics Section,Pathogenesis and Immunity Section,0.0
Systems Genomics Section,Pathology Core,0.0
Systems Genomics Section,Physiology Unit,0.0
Systems Genomics Section,Plague Section,0.0
Systems Genomics Section,Primary Immune Deficiency Clinic,0.0
Systems Genomics Section,Prion Cell Biology Unit,0.0
Systems Genomics Section,Protein Chemistry Section,0.0
Systems Genomics Section,Quantitative Virology and Evolution Unit,0.0
Systems Genomics Section,RML Flow Cytometry Unit,0.0
Systems Genomics Section,RML Genomics Unit,0.0
Systems Genomics Section,RML Microscopy Unit,0.0
Systems Genomics Section,Research Technology Branch,0.0
Systems Genomics Section,Retroviral Immunology Section,0.0
Systems Genomics Section,Salmonella-Host Cell Interactions Section,0.0
Systems Genomics Section,Scientist Emerita,0.0
Systems Genomics Section,Signaling Systems Section,0.0
Systems Genomics Section,Structural Biology Section,0.0
Systems Genomics Section,Structural Immunology Section,0.0
Systems Genomics Section,Structural Informatics Unit,0.0
Systems Genomics Section,Structural Virology Section,0.0
T-Cell Tolerance and Memory Section,Allergy and Immunology Clinical Training Program,0.0
T-Cell Tolerance and Memory Section,Antibacterial Host Defense Unit,0.0
T-Cell Tolerance and Memory Section,Antibody Biology Unit,0.0
T-Cell Tolerance and Memory Section,Apicomplexan Molecular Physiology Section,0.0
T-Cell Tolerance and Memory Section,Autoimmunity and Functional Genomics Section,0.0
T-Cell Tolerance and Memory Section,B-Cell Immunology Section,0.0
T-Cell Tolerance and Memory Section,B-Cell Molecular Immunology Section,0.0
T-Cell Tolerance and Memory Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
T-Cell Tolerance and Memory Section,Bacterial Physiology and Metabolism Unit,0.0
T-Cell Tolerance and Memory Section,Barrier Immunity Section,0.0
T-Cell Tolerance and Memory Section,Biological Imaging,0.0
T-Cell Tolerance and Memory Section,Biology of Vector-Borne Viruses Section,0.0
T-Cell Tolerance and Memory Section,Building 14B South,0.0
T-Cell Tolerance and Memory Section,Building 33,0.0
T-Cell Tolerance and Memory Section,Building 50,0.0
T-Cell Tolerance and Memory Section,Building NIHAC/103,0.0
T-Cell Tolerance and Memory Section,Buildings 4 and 10/11C127,0.0
T-Cell Tolerance and Memory Section,Caliciviruses Section,0.0
T-Cell Tolerance and Memory Section,Cell Signaling and Immunity Section,0.0
T-Cell Tolerance and Memory Section,Cellular Biology Section,0.0
T-Cell Tolerance and Memory Section,Cellular Immunology Section,0.0
T-Cell Tolerance and Memory Section,Chemotaxis Signal Section,0.0
T-Cell Tolerance and Memory Section,Chlamydial Diseases Section,0.0
T-Cell Tolerance and Memory Section,Clinical Microbiome Unit (CMU),0.0
T-Cell Tolerance and Memory Section,Clinical Pathophysiology Section,0.0
T-Cell Tolerance and Memory Section,Clinical Research Section,0.0
T-Cell Tolerance and Memory Section,Clinical and Molecular Retrovirology Section,0.0
T-Cell Tolerance and Memory Section,Computational Biology Unit,0.0
T-Cell Tolerance and Memory Section,Coxiella Pathogenesis Section,0.0
T-Cell Tolerance and Memory Section,DNA Tumor Virus Section,0.0
T-Cell Tolerance and Memory Section,Disease Modeling and Transmission Section,0.0
T-Cell Tolerance and Memory Section,Emerging Respiratory Viruses Section,0.0
T-Cell Tolerance and Memory Section,Emerging Virus Immunity Unit,0.0
T-Cell Tolerance and Memory Section,Epidemiology and Population Studies Unit,0.0
T-Cell Tolerance and Memory Section,Epithelial Therapeutics Unit,0.0
T-Cell Tolerance and Memory Section,Flow Cytometry Section,0.0
T-Cell Tolerance and Memory Section,Food Allergy Research Section,0.0
T-Cell Tolerance and Memory Section,Functional Cellular Networks Section,0.0
T-Cell Tolerance and Memory Section,Fungal Pathogenesis Section,0.0
T-Cell Tolerance and Memory Section,Gene Regulation Section,0.0
T-Cell Tolerance and Memory Section,Genetic Engineering Section,0.0
T-Cell Tolerance and Memory Section,Genetic Immunotherapy Section,0.0
T-Cell Tolerance and Memory Section,Genomic Technologies Section,0.0
T-Cell Tolerance and Memory Section,HIV Immunovirology Section,0.0
T-Cell Tolerance and Memory Section,HIV Pathogenesis Section,0.0
T-Cell Tolerance and Memory Section,HIV-Specific Immunity Section,0.0
T-Cell Tolerance and Memory Section,Helminth Immunology Section,0.0
T-Cell Tolerance and Memory Section,Hepatic Pathogenesis Section,0.0
T-Cell Tolerance and Memory Section,Host-Parasite Interactions Section,0.0
T-Cell Tolerance and Memory Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
T-Cell Tolerance and Memory Section,Human Eosinophil Section,0.0
T-Cell Tolerance and Memory Section,Human Immunological Diseases Section,0.0
T-Cell Tolerance and Memory Section,Immune Activation Section,0.0
T-Cell Tolerance and Memory Section,Immune Deficiency Genetics Section,0.0
T-Cell Tolerance and Memory Section,Immunity to Pulmonary Pathogens Section,0.0
T-Cell Tolerance and Memory Section,Immunobiology Section,0.0
T-Cell Tolerance and Memory Section,Immunobiology and Molecular Virology Unit,0.0
T-Cell Tolerance and Memory Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
T-Cell Tolerance and Memory Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
T-Cell Tolerance and Memory Section,Infectious Disease Fellowship Training Program,0.0
T-Cell Tolerance and Memory Section,Infectious Disease Pathogenesis Section,0.0
T-Cell Tolerance and Memory Section,Inflammation & Innate Immunity Unit,0.0
T-Cell Tolerance and Memory Section,Inflammation Biology Section,0.0
T-Cell Tolerance and Memory Section,Innate Immunity and Pathogenesis Section,0.0
T-Cell Tolerance and Memory Section,Integrative Immunobiology Section,0.0
T-Cell Tolerance and Memory Section,International HIV/STD Section,0.0
T-Cell Tolerance and Memory Section,Intracellular Parasite Biology Section,0.0
T-Cell Tolerance and Memory Section,LID Clinical Studies Unit,0.0
T-Cell Tolerance and Memory Section,Lung and Vascular Inflammation Section,0.0
T-Cell Tolerance and Memory Section,Lyme Disease Studies Unit,0.0
T-Cell Tolerance and Memory Section,Lymphocyte Activation Section,0.0
T-Cell Tolerance and Memory Section,Lymphocyte Biology Section,0.0
T-Cell Tolerance and Memory Section,Malaria Cell Biology Section,0.0
T-Cell Tolerance and Memory Section,Malaria Functional Genomics Section,0.0
T-Cell Tolerance and Memory Section,Malaria Genetics Section,0.0
T-Cell Tolerance and Memory Section,Malaria Immunology Section,0.0
T-Cell Tolerance and Memory Section,Mast Cell Biology Section,0.0
T-Cell Tolerance and Memory Section,Medical Virology Section,0.0
T-Cell Tolerance and Memory Section,Metaorganism Immunity Section,0.0
T-Cell Tolerance and Memory Section,Microbial Pathogenesis Section,0.0
T-Cell Tolerance and Memory Section,Molecular Biology Section,0.0
T-Cell Tolerance and Memory Section,Molecular Defenses Section,0.0
T-Cell Tolerance and Memory Section,Molecular Development of the Immune System Section,0.0
T-Cell Tolerance and Memory Section,Molecular Entomology Unit,0.0
T-Cell Tolerance and Memory Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
T-Cell Tolerance and Memory Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
T-Cell Tolerance and Memory Section,Molecular HIV Host Interactions Section,0.0
T-Cell Tolerance and Memory Section,Molecular Microbiology Section,0.0
T-Cell Tolerance and Memory Section,Molecular Parasitology Section,0.0
T-Cell Tolerance and Memory Section,Molecular Parasitology and Entomology Unit,0.0
T-Cell Tolerance and Memory Section,Molecular Pathogenesis Unit,0.0
T-Cell Tolerance and Memory Section,Molecular Pathogenesis and Biomarkers Section,0.0
T-Cell Tolerance and Memory Section,Molecular Pathology Section,0.0
T-Cell Tolerance and Memory Section,Molecular Signaling Section,0.0
T-Cell Tolerance and Memory Section,Molecular and Cellular Immunology Section,0.0
T-Cell Tolerance and Memory Section,Molecular and Cellular Immunoregulation Section,0.0
T-Cell Tolerance and Memory Section,Mosquito Immunity and Vector Competence Section,0.0
T-Cell Tolerance and Memory Section,Mucosal Immunity Section,0.0
T-Cell Tolerance and Memory Section,Mucosal Immunobiology Section,0.0
T-Cell Tolerance and Memory Section,Multiscale Systems Biology Section,0.0
T-Cell Tolerance and Memory Section,NIAID International Center of Excellence in Research Cambodia,0.0
T-Cell Tolerance and Memory Section,Neuroimmunological Diseases Section,0.0
T-Cell Tolerance and Memory Section,Neuroimmunology Unit,0.0
T-Cell Tolerance and Memory Section,Nonhuman Primate Virology Section,0.0
T-Cell Tolerance and Memory Section,Office of the Animal Program Director,0.0
T-Cell Tolerance and Memory Section,Pathogen Molecular Genetics Section,0.0
T-Cell Tolerance and Memory Section,Pathogen-Host Cell Biology Section,0.0
T-Cell Tolerance and Memory Section,Pathogenesis and Immunity Section,0.0
T-Cell Tolerance and Memory Section,Pathology Core,0.0
T-Cell Tolerance and Memory Section,Physiology Unit,0.0
T-Cell Tolerance and Memory Section,Plague Section,0.0
T-Cell Tolerance and Memory Section,Primary Immune Deficiency Clinic,0.0
T-Cell Tolerance and Memory Section,Prion Cell Biology Unit,0.0
T-Cell Tolerance and Memory Section,Protein Chemistry Section,0.0
T-Cell Tolerance and Memory Section,Quantitative Virology and Evolution Unit,0.0
T-Cell Tolerance and Memory Section,RML Flow Cytometry Unit,0.0
T-Cell Tolerance and Memory Section,RML Genomics Unit,0.0
T-Cell Tolerance and Memory Section,RML Microscopy Unit,0.0
T-Cell Tolerance and Memory Section,RNA Viruses Section,0.0
T-Cell Tolerance and Memory Section,Research Technology Branch,0.0
T-Cell Tolerance and Memory Section,Retroviral Immunology Section,0.0
T-Cell Tolerance and Memory Section,Salmonella-Host Cell Interactions Section,0.0
T-Cell Tolerance and Memory Section,Scientist Emerita,0.0
T-Cell Tolerance and Memory Section,Signaling Systems Section,0.0
T-Cell Tolerance and Memory Section,Structural Biology Section,0.0
T-Cell Tolerance and Memory Section,Structural Informatics Unit,0.0
T-Cell Tolerance and Memory Section,Structural Virology Section,0.0
T-Cell Tolerance and Memory Section,Systems Genomics Section,0.0
T-Lymphocyte Biology Section,Allergy and Immunology Clinical Training Program,0.0
T-Lymphocyte Biology Section,Antibacterial Host Defense Unit,0.0
T-Lymphocyte Biology Section,Antibody Biology Unit,0.0
T-Lymphocyte Biology Section,Apicomplexan Molecular Physiology Section,0.0
T-Lymphocyte Biology Section,Autoimmunity and Functional Genomics Section,0.0
T-Lymphocyte Biology Section,B-Cell Immunology Section,0.0
T-Lymphocyte Biology Section,B-Cell Molecular Immunology Section,0.0
T-Lymphocyte Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
T-Lymphocyte Biology Section,Bacterial Physiology and Metabolism Unit,0.0
T-Lymphocyte Biology Section,Barrier Immunity Section,0.0
T-Lymphocyte Biology Section,Biological Imaging,0.0
T-Lymphocyte Biology Section,Biology of Vector-Borne Viruses Section,0.0
T-Lymphocyte Biology Section,Building 14B South,0.0
T-Lymphocyte Biology Section,Building 50,0.0
T-Lymphocyte Biology Section,Building NIHAC/103,0.0
T-Lymphocyte Biology Section,Buildings 4 and 10/11C127,0.0
T-Lymphocyte Biology Section,Caliciviruses Section,0.0
T-Lymphocyte Biology Section,Cell Signaling and Immunity Section,0.0
T-Lymphocyte Biology Section,Cellular Biology Section,0.0
T-Lymphocyte Biology Section,Cellular Immunology Section,0.0
T-Lymphocyte Biology Section,Chemotaxis Signal Section,0.0
T-Lymphocyte Biology Section,Chlamydial Diseases Section,0.0
T-Lymphocyte Biology Section,Clinical Microbiome Unit (CMU),0.0
T-Lymphocyte Biology Section,Clinical Pathophysiology Section,0.0
T-Lymphocyte Biology Section,Clinical Research Section,0.0
T-Lymphocyte Biology Section,Clinical and Molecular Retrovirology Section,0.0
T-Lymphocyte Biology Section,Computational Biology Unit,0.0
T-Lymphocyte Biology Section,Coxiella Pathogenesis Section,0.0
T-Lymphocyte Biology Section,DNA Tumor Virus Section,0.0
T-Lymphocyte Biology Section,Disease Modeling and Transmission Section,0.0
T-Lymphocyte Biology Section,Emerging Respiratory Viruses Section,0.0
T-Lymphocyte Biology Section,Emerging Virus Immunity Unit,0.0
T-Lymphocyte Biology Section,Epithelial Therapeutics Unit,0.0
T-Lymphocyte Biology Section,Flow Cytometry Section,0.0
T-Lymphocyte Biology Section,Food Allergy Research Section,0.0
T-Lymphocyte Biology Section,Functional Cellular Networks Section,0.0
T-Lymphocyte Biology Section,Gene Regulation Section,0.0
T-Lymphocyte Biology Section,Genetic Engineering Section,0.0
T-Lymphocyte Biology Section,Genetic Immunotherapy Section,0.0
T-Lymphocyte Biology Section,HIV Immunovirology Section,0.0
T-Lymphocyte Biology Section,HIV-Specific Immunity Section,0.0
T-Lymphocyte Biology Section,Hepatic Pathogenesis Section,0.0
T-Lymphocyte Biology Section,Host-Parasite Interactions Section,0.0
T-Lymphocyte Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
T-Lymphocyte Biology Section,Human Eosinophil Section,0.0
T-Lymphocyte Biology Section,Human Immunological Diseases Section,0.0
T-Lymphocyte Biology Section,Immune Activation Section,0.0
T-Lymphocyte Biology Section,Immune Deficiency Genetics Section,0.0
T-Lymphocyte Biology Section,Immunity to Pulmonary Pathogens Section,0.0
T-Lymphocyte Biology Section,Immunobiology and Molecular Virology Unit,0.0
T-Lymphocyte Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
T-Lymphocyte Biology Section,Infectious Disease Fellowship Training Program,0.0
T-Lymphocyte Biology Section,Inflammation Biology Section,0.0
T-Lymphocyte Biology Section,Innate Immunity and Pathogenesis Section,0.0
T-Lymphocyte Biology Section,Integrative Immunobiology Section,0.0
T-Lymphocyte Biology Section,International HIV/STD Section,0.0
T-Lymphocyte Biology Section,Intracellular Parasite Biology Section,0.0
T-Lymphocyte Biology Section,LID Clinical Studies Unit,0.0
T-Lymphocyte Biology Section,Lung and Vascular Inflammation Section,0.0
T-Lymphocyte Biology Section,Lyme Disease Studies Unit,0.0
T-Lymphocyte Biology Section,Lymphocyte Activation Section,0.0
T-Lymphocyte Biology Section,Lymphocyte Biology Section,0.0
T-Lymphocyte Biology Section,Malaria Cell Biology Section,0.0
T-Lymphocyte Biology Section,Malaria Functional Genomics Section,0.0
T-Lymphocyte Biology Section,Malaria Genetics Section,0.0
T-Lymphocyte Biology Section,Malaria Immunology Section,0.0
T-Lymphocyte Biology Section,Malaria Infection Biology and Immunity Unit,0.0
T-Lymphocyte Biology Section,Mast Cell Biology Section,0.0
T-Lymphocyte Biology Section,Medical Virology Section,0.0
T-Lymphocyte Biology Section,Metaorganism Immunity Section,0.0
T-Lymphocyte Biology Section,Molecular Biology Section,0.0
T-Lymphocyte Biology Section,Molecular Defenses Section,0.0
T-Lymphocyte Biology Section,Molecular Development of the Immune System Section,0.0
T-Lymphocyte Biology Section,Molecular Entomology Unit,0.0
T-Lymphocyte Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
T-Lymphocyte Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
T-Lymphocyte Biology Section,Molecular HIV Host Interactions Section,0.0
T-Lymphocyte Biology Section,Molecular Parasitology and Entomology Unit,0.0
T-Lymphocyte Biology Section,Molecular Pathogenesis Unit,0.0
T-Lymphocyte Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
T-Lymphocyte Biology Section,Molecular Pathology Section,0.0
T-Lymphocyte Biology Section,Molecular Signaling Section,0.0
T-Lymphocyte Biology Section,Molecular and Cellular Immunology Section,0.0
T-Lymphocyte Biology Section,Mosquito Immunity and Vector Competence Section,0.0
T-Lymphocyte Biology Section,Mucosal Immunity Section,0.0
T-Lymphocyte Biology Section,Mucosal Immunobiology Section,0.0
T-Lymphocyte Biology Section,Multiscale Systems Biology Section,0.0
T-Lymphocyte Biology Section,NIAID International Center of Excellence in Research Cambodia,0.0
T-Lymphocyte Biology Section,Neuroimmunological Diseases Section,0.0
T-Lymphocyte Biology Section,Neuroimmunology Unit,0.0
T-Lymphocyte Biology Section,Nonhuman Primate Virology Section,0.0
T-Lymphocyte Biology Section,Office of the Animal Program Director,0.0
T-Lymphocyte Biology Section,Pathogen Molecular Genetics Section,0.0
T-Lymphocyte Biology Section,Pathogen-Host Cell Biology Section,0.0
T-Lymphocyte Biology Section,Pathogenesis and Immunity Section,0.0
T-Lymphocyte Biology Section,Pathology Core,0.0
T-Lymphocyte Biology Section,Physiology Unit,0.0
T-Lymphocyte Biology Section,Plague Section,0.0
T-Lymphocyte Biology Section,Primary Immune Deficiency Clinic,0.0
T-Lymphocyte Biology Section,Prion Cell Biology Unit,0.0
T-Lymphocyte Biology Section,Protein Chemistry Section,0.0
T-Lymphocyte Biology Section,Quantitative Virology and Evolution Unit,0.0
T-Lymphocyte Biology Section,RML Flow Cytometry Unit,0.0
T-Lymphocyte Biology Section,RML Genomics Unit,0.0
T-Lymphocyte Biology Section,RML Microscopy Unit,0.0
T-Lymphocyte Biology Section,RNA Viruses Section,0.0
T-Lymphocyte Biology Section,Research Technology Branch,0.0
T-Lymphocyte Biology Section,Retroviral Immunology Section,0.0
T-Lymphocyte Biology Section,Salmonella-Host Cell Interactions Section,0.0
T-Lymphocyte Biology Section,Scientist Emerita,0.0
T-Lymphocyte Biology Section,Signaling Systems Section,0.0
T-Lymphocyte Biology Section,Structural Biology Section,0.0
T-Lymphocyte Biology Section,Structural Immunology Section,0.0
T-Lymphocyte Biology Section,Structural Informatics Unit,0.0
T-Lymphocyte Biology Section,Structural Virology Section,0.0
T-Lymphocyte Biology Section,Systems Genomics Section,0.0
T-Lymphocyte Biology Section,T-Cell Tolerance and Memory Section,0.0
TSE/Prion Biochemistry Section,Allergy and Immunology Clinical Training Program,0.0
TSE/Prion Biochemistry Section,Antibacterial Host Defense Unit,0.0
TSE/Prion Biochemistry Section,Antibody Biology Unit,0.0
TSE/Prion Biochemistry Section,Apicomplexan Molecular Physiology Section,0.0
TSE/Prion Biochemistry Section,Autoimmunity and Functional Genomics Section,0.0
TSE/Prion Biochemistry Section,B-Cell Immunology Section,0.0
TSE/Prion Biochemistry Section,B-Cell Molecular Immunology Section,0.0
TSE/Prion Biochemistry Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
TSE/Prion Biochemistry Section,Bacterial Physiology and Metabolism Unit,0.0
TSE/Prion Biochemistry Section,Barrier Immunity Section,0.0
TSE/Prion Biochemistry Section,Biological Imaging,0.0
TSE/Prion Biochemistry Section,Building 14B South,0.0
TSE/Prion Biochemistry Section,Building 33,0.0
TSE/Prion Biochemistry Section,Building 50,0.0
TSE/Prion Biochemistry Section,Building NIHAC/103,0.0
TSE/Prion Biochemistry Section,Buildings 4 and 10/11C127,0.0
TSE/Prion Biochemistry Section,Caliciviruses Section,0.0
TSE/Prion Biochemistry Section,Cell Signaling and Immunity Section,0.0
TSE/Prion Biochemistry Section,Cellular Biology Section,0.0
TSE/Prion Biochemistry Section,Cellular Immunology Section,0.0
TSE/Prion Biochemistry Section,Chemotaxis Signal Section,0.0
TSE/Prion Biochemistry Section,Chlamydial Diseases Section,0.0
TSE/Prion Biochemistry Section,Clinical Microbiome Unit (CMU),0.0
TSE/Prion Biochemistry Section,Clinical Pathophysiology Section,0.0
TSE/Prion Biochemistry Section,Clinical Research Section,0.0
TSE/Prion Biochemistry Section,Clinical and Molecular Retrovirology Section,0.0
TSE/Prion Biochemistry Section,Computational Biology Unit,0.0
TSE/Prion Biochemistry Section,Coxiella Pathogenesis Section,0.0
TSE/Prion Biochemistry Section,DNA Tumor Virus Section,0.0
TSE/Prion Biochemistry Section,Disease Modeling and Transmission Section,0.0
TSE/Prion Biochemistry Section,Emerging Respiratory Viruses Section,0.0
TSE/Prion Biochemistry Section,Emerging Virus Immunity Unit,0.0
TSE/Prion Biochemistry Section,Epidemiology and Population Studies Unit,0.0
TSE/Prion Biochemistry Section,Epithelial Therapeutics Unit,0.0
TSE/Prion Biochemistry Section,Flow Cytometry Section,0.0
TSE/Prion Biochemistry Section,Food Allergy Research Section,0.0
TSE/Prion Biochemistry Section,Functional Cellular Networks Section,0.0
TSE/Prion Biochemistry Section,Fungal Pathogenesis Section,0.0
TSE/Prion Biochemistry Section,Gene Regulation Section,0.0
TSE/Prion Biochemistry Section,Genetic Engineering Section,0.0
TSE/Prion Biochemistry Section,Genetic Immunotherapy Section,0.0
TSE/Prion Biochemistry Section,Genomic Technologies Section,0.0
TSE/Prion Biochemistry Section,HIV Immunovirology Section,0.0
TSE/Prion Biochemistry Section,HIV Pathogenesis Section,0.0
TSE/Prion Biochemistry Section,HIV-Specific Immunity Section,0.0
TSE/Prion Biochemistry Section,Helminth Immunology Section,0.0
TSE/Prion Biochemistry Section,Hepatic Pathogenesis Section,0.0
TSE/Prion Biochemistry Section,Host-Parasite Interactions Section,0.0
TSE/Prion Biochemistry Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
TSE/Prion Biochemistry Section,Human Eosinophil Section,0.0
TSE/Prion Biochemistry Section,Human Immunological Diseases Section,0.0
TSE/Prion Biochemistry Section,Immune Activation Section,0.0
TSE/Prion Biochemistry Section,Immune Deficiency Genetics Section,0.0
TSE/Prion Biochemistry Section,Immunity to Pulmonary Pathogens Section,0.0
TSE/Prion Biochemistry Section,Immunobiology Section,0.0
TSE/Prion Biochemistry Section,Immunobiology and Molecular Virology Unit,0.0
TSE/Prion Biochemistry Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
TSE/Prion Biochemistry Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
TSE/Prion Biochemistry Section,Infectious Disease Fellowship Training Program,0.0
TSE/Prion Biochemistry Section,Infectious Disease Pathogenesis Section,0.0
TSE/Prion Biochemistry Section,Inflammation & Innate Immunity Unit,0.0
TSE/Prion Biochemistry Section,Inflammation Biology Section,0.0
TSE/Prion Biochemistry Section,Innate Immunity and Pathogenesis Section,0.0
TSE/Prion Biochemistry Section,Integrative Immunobiology Section,0.0
TSE/Prion Biochemistry Section,International HIV/STD Section,0.0
TSE/Prion Biochemistry Section,Intracellular Parasite Biology Section,0.0
TSE/Prion Biochemistry Section,LID Clinical Studies Unit,0.0
TSE/Prion Biochemistry Section,Lung and Vascular Inflammation Section,0.0
TSE/Prion Biochemistry Section,Lyme Disease Studies Unit,0.0
TSE/Prion Biochemistry Section,Lymphocyte Activation Section,0.0
TSE/Prion Biochemistry Section,Lymphocyte Biology Section,0.0
TSE/Prion Biochemistry Section,Malaria Cell Biology Section,0.0
TSE/Prion Biochemistry Section,Malaria Functional Genomics Section,0.0
TSE/Prion Biochemistry Section,Malaria Genetics Section,0.0
TSE/Prion Biochemistry Section,Malaria Immunology Section,0.0
TSE/Prion Biochemistry Section,Malaria Infection Biology and Immunity Unit,0.0
TSE/Prion Biochemistry Section,Mast Cell Biology Section,0.0
TSE/Prion Biochemistry Section,Medical Virology Section,0.0
TSE/Prion Biochemistry Section,Metaorganism Immunity Section,0.0
TSE/Prion Biochemistry Section,Microbial Pathogenesis Section,0.0
TSE/Prion Biochemistry Section,Molecular Biology Section,0.0
TSE/Prion Biochemistry Section,Molecular Defenses Section,0.0
TSE/Prion Biochemistry Section,Molecular Development of the Immune System Section,0.0
TSE/Prion Biochemistry Section,Molecular Entomology Unit,0.0
TSE/Prion Biochemistry Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
TSE/Prion Biochemistry Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
TSE/Prion Biochemistry Section,Molecular HIV Host Interactions Section,0.0
TSE/Prion Biochemistry Section,Molecular Microbiology Section,0.0
TSE/Prion Biochemistry Section,Molecular Parasitology Section,0.0
TSE/Prion Biochemistry Section,Molecular Parasitology and Entomology Unit,0.0
TSE/Prion Biochemistry Section,Molecular Pathogenesis Unit,0.0
TSE/Prion Biochemistry Section,Molecular Pathogenesis and Biomarkers Section,0.0
TSE/Prion Biochemistry Section,Molecular Pathology Section,0.0
TSE/Prion Biochemistry Section,Molecular Signaling Section,0.0
TSE/Prion Biochemistry Section,Molecular and Cellular Immunology Section,0.0
TSE/Prion Biochemistry Section,Molecular and Cellular Immunoregulation Section,0.0
TSE/Prion Biochemistry Section,Mosquito Immunity and Vector Competence Section,0.0
TSE/Prion Biochemistry Section,Mucosal Immunity Section,0.0
TSE/Prion Biochemistry Section,Mucosal Immunobiology Section,0.0
TSE/Prion Biochemistry Section,Multiscale Systems Biology Section,0.0
TSE/Prion Biochemistry Section,NIAID International Center of Excellence in Research Cambodia,0.0
TSE/Prion Biochemistry Section,Neuroimmunological Diseases Section,0.0
TSE/Prion Biochemistry Section,Nonhuman Primate Virology Section,0.0
TSE/Prion Biochemistry Section,Office of the Animal Program Director,0.0
TSE/Prion Biochemistry Section,Pathogen Molecular Genetics Section,0.0
TSE/Prion Biochemistry Section,Pathogen-Host Cell Biology Section,0.0
TSE/Prion Biochemistry Section,Pathogenesis and Immunity Section,0.0
TSE/Prion Biochemistry Section,Pathology Core,0.0
TSE/Prion Biochemistry Section,Physiology Unit,0.0
TSE/Prion Biochemistry Section,Plague Section,0.0
TSE/Prion Biochemistry Section,Primary Immune Deficiency Clinic,0.0
TSE/Prion Biochemistry Section,Prion Cell Biology Unit,0.0
TSE/Prion Biochemistry Section,Protein Chemistry Section,0.0
TSE/Prion Biochemistry Section,Quantitative Virology and Evolution Unit,0.0
TSE/Prion Biochemistry Section,RML Microscopy Unit,0.0
TSE/Prion Biochemistry Section,RNA Viruses Section,0.0
TSE/Prion Biochemistry Section,Research Technology Branch,0.0
TSE/Prion Biochemistry Section,Retroviral Immunology Section,0.0
TSE/Prion Biochemistry Section,Scientist Emerita,0.0
TSE/Prion Biochemistry Section,Signaling Systems Section,0.0
TSE/Prion Biochemistry Section,Structural Biology Section,0.0
TSE/Prion Biochemistry Section,Structural Immunology Section,0.0
TSE/Prion Biochemistry Section,Structural Informatics Unit,0.0
TSE/Prion Biochemistry Section,Structural Virology Section,0.0
TSE/Prion Biochemistry Section,Systems Genomics Section,0.0
TSE/Prion Biochemistry Section,T-Cell Tolerance and Memory Section,0.0
TSE/Prion Biochemistry Section,T-Lymphocyte Biology Section,0.0
TSE/Prion Molecular Biology Section,Allergy and Immunology Clinical Training Program,0.0
TSE/Prion Molecular Biology Section,Antibacterial Host Defense Unit,0.0
TSE/Prion Molecular Biology Section,Antibody Biology Unit,0.0
TSE/Prion Molecular Biology Section,Apicomplexan Molecular Physiology Section,0.0
TSE/Prion Molecular Biology Section,Autoimmunity and Functional Genomics Section,0.0
TSE/Prion Molecular Biology Section,B-Cell Immunology Section,0.0
TSE/Prion Molecular Biology Section,B-Cell Molecular Immunology Section,0.0
TSE/Prion Molecular Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
TSE/Prion Molecular Biology Section,Bacterial Physiology and Metabolism Unit,0.0
TSE/Prion Molecular Biology Section,Barrier Immunity Section,0.0
TSE/Prion Molecular Biology Section,Biological Imaging,0.0
TSE/Prion Molecular Biology Section,Biology of Vector-Borne Viruses Section,0.0
TSE/Prion Molecular Biology Section,Building 14B South,0.0
TSE/Prion Molecular Biology Section,Building 33,0.0
TSE/Prion Molecular Biology Section,Building 50,0.0
TSE/Prion Molecular Biology Section,Building NIHAC/103,0.0
TSE/Prion Molecular Biology Section,Buildings 4 and 10/11C127,0.0
TSE/Prion Molecular Biology Section,Caliciviruses Section,0.0
TSE/Prion Molecular Biology Section,Cell Signaling and Immunity Section,0.0
TSE/Prion Molecular Biology Section,Cellular Biology Section,0.0
TSE/Prion Molecular Biology Section,Cellular Immunology Section,0.0
TSE/Prion Molecular Biology Section,Chemotaxis Signal Section,0.0
TSE/Prion Molecular Biology Section,Chlamydial Diseases Section,0.0
TSE/Prion Molecular Biology Section,Clinical Microbiome Unit (CMU),0.0
TSE/Prion Molecular Biology Section,Clinical Pathophysiology Section,0.0
TSE/Prion Molecular Biology Section,Clinical Research Section,0.0
TSE/Prion Molecular Biology Section,Clinical and Molecular Retrovirology Section,0.0
TSE/Prion Molecular Biology Section,Computational Biology Unit,0.0
TSE/Prion Molecular Biology Section,Coxiella Pathogenesis Section,0.0
TSE/Prion Molecular Biology Section,DNA Tumor Virus Section,0.0
TSE/Prion Molecular Biology Section,Disease Modeling and Transmission Section,0.0
TSE/Prion Molecular Biology Section,Emerging Respiratory Viruses Section,0.0
TSE/Prion Molecular Biology Section,Emerging Virus Immunity Unit,0.0
TSE/Prion Molecular Biology Section,Epidemiology and Population Studies Unit,0.0
TSE/Prion Molecular Biology Section,Epithelial Therapeutics Unit,0.0
TSE/Prion Molecular Biology Section,Flow Cytometry Section,0.0
TSE/Prion Molecular Biology Section,Food Allergy Research Section,0.0
TSE/Prion Molecular Biology Section,Functional Cellular Networks Section,0.0
TSE/Prion Molecular Biology Section,Fungal Pathogenesis Section,0.0
TSE/Prion Molecular Biology Section,Gene Regulation Section,0.0
TSE/Prion Molecular Biology Section,Genetic Engineering Section,0.0
TSE/Prion Molecular Biology Section,Genetic Immunotherapy Section,0.0
TSE/Prion Molecular Biology Section,Genomic Technologies Section,0.0
TSE/Prion Molecular Biology Section,HIV Immunovirology Section,0.0
TSE/Prion Molecular Biology Section,HIV Pathogenesis Section,0.0
TSE/Prion Molecular Biology Section,HIV-Specific Immunity Section,0.0
TSE/Prion Molecular Biology Section,Helminth Immunology Section,0.0
TSE/Prion Molecular Biology Section,Hepatic Pathogenesis Section,0.0
TSE/Prion Molecular Biology Section,Host-Parasite Interactions Section,0.0
TSE/Prion Molecular Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
TSE/Prion Molecular Biology Section,Human Eosinophil Section,0.0
TSE/Prion Molecular Biology Section,Human Immunological Diseases Section,0.0
TSE/Prion Molecular Biology Section,Immune Activation Section,0.0
TSE/Prion Molecular Biology Section,Immune Deficiency Genetics Section,0.0
TSE/Prion Molecular Biology Section,Immunity to Pulmonary Pathogens Section,0.0
TSE/Prion Molecular Biology Section,Immunobiology Section,0.0
TSE/Prion Molecular Biology Section,Immunobiology and Molecular Virology Unit,0.0
TSE/Prion Molecular Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
TSE/Prion Molecular Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
TSE/Prion Molecular Biology Section,Infectious Disease Fellowship Training Program,0.0
TSE/Prion Molecular Biology Section,Infectious Disease Pathogenesis Section,0.0
TSE/Prion Molecular Biology Section,Inflammation & Innate Immunity Unit,0.0
TSE/Prion Molecular Biology Section,Inflammation Biology Section,0.0
TSE/Prion Molecular Biology Section,Innate Immunity and Pathogenesis Section,0.0
TSE/Prion Molecular Biology Section,Integrative Immunobiology Section,0.0
TSE/Prion Molecular Biology Section,International HIV/STD Section,0.0
TSE/Prion Molecular Biology Section,Intracellular Parasite Biology Section,0.0
TSE/Prion Molecular Biology Section,LID Clinical Studies Unit,0.0
TSE/Prion Molecular Biology Section,Lung and Vascular Inflammation Section,0.0
TSE/Prion Molecular Biology Section,Lyme Disease Studies Unit,0.0
TSE/Prion Molecular Biology Section,Lymphocyte Activation Section,0.0
TSE/Prion Molecular Biology Section,Lymphocyte Biology Section,0.0
TSE/Prion Molecular Biology Section,Malaria Cell Biology Section,0.0
TSE/Prion Molecular Biology Section,Malaria Functional Genomics Section,0.0
TSE/Prion Molecular Biology Section,Malaria Genetics Section,0.0
TSE/Prion Molecular Biology Section,Malaria Immunology Section,0.0
TSE/Prion Molecular Biology Section,Malaria Infection Biology and Immunity Unit,0.0
TSE/Prion Molecular Biology Section,Mast Cell Biology Section,0.0
TSE/Prion Molecular Biology Section,Medical Virology Section,0.0
TSE/Prion Molecular Biology Section,Metaorganism Immunity Section,0.0
TSE/Prion Molecular Biology Section,Microbial Pathogenesis Section,0.0
TSE/Prion Molecular Biology Section,Molecular Biology Section,0.0
TSE/Prion Molecular Biology Section,Molecular Defenses Section,0.0
TSE/Prion Molecular Biology Section,Molecular Development of the Immune System Section,0.0
TSE/Prion Molecular Biology Section,Molecular Entomology Unit,0.0
TSE/Prion Molecular Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
TSE/Prion Molecular Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
TSE/Prion Molecular Biology Section,Molecular HIV Host Interactions Section,0.0
TSE/Prion Molecular Biology Section,Molecular Microbiology Section,0.0
TSE/Prion Molecular Biology Section,Molecular Parasitology Section,0.0
TSE/Prion Molecular Biology Section,Molecular Parasitology and Entomology Unit,0.0
TSE/Prion Molecular Biology Section,Molecular Pathogenesis Unit,0.0
TSE/Prion Molecular Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
TSE/Prion Molecular Biology Section,Molecular Pathology Section,0.0
TSE/Prion Molecular Biology Section,Molecular Signaling Section,0.0
TSE/Prion Molecular Biology Section,Molecular and Cellular Immunology Section,0.0
TSE/Prion Molecular Biology Section,Molecular and Cellular Immunoregulation Section,0.0
TSE/Prion Molecular Biology Section,Mosquito Immunity and Vector Competence Section,0.0
TSE/Prion Molecular Biology Section,Mucosal Immunity Section,0.0
TSE/Prion Molecular Biology Section,Mucosal Immunobiology Section,0.0
TSE/Prion Molecular Biology Section,Multiscale Systems Biology Section,0.0
TSE/Prion Molecular Biology Section,NIAID International Center of Excellence in Research Cambodia,0.0
TSE/Prion Molecular Biology Section,Neuroimmunological Diseases Section,0.0
TSE/Prion Molecular Biology Section,Neuroimmunology Unit,0.0
TSE/Prion Molecular Biology Section,Nonhuman Primate Virology Section,0.0
TSE/Prion Molecular Biology Section,Office of the Animal Program Director,0.0
TSE/Prion Molecular Biology Section,Pathogen Molecular Genetics Section,0.0
TSE/Prion Molecular Biology Section,Pathogen-Host Cell Biology Section,0.0
TSE/Prion Molecular Biology Section,Pathogenesis and Immunity Section,0.0
TSE/Prion Molecular Biology Section,Pathology Core,0.0
TSE/Prion Molecular Biology Section,Physiology Unit,0.0
TSE/Prion Molecular Biology Section,Plague Section,0.0
TSE/Prion Molecular Biology Section,Primary Immune Deficiency Clinic,0.0
TSE/Prion Molecular Biology Section,Prion Cell Biology Unit,0.0
TSE/Prion Molecular Biology Section,Protein Chemistry Section,0.0
TSE/Prion Molecular Biology Section,Quantitative Virology and Evolution Unit,0.0
TSE/Prion Molecular Biology Section,RML Flow Cytometry Unit,0.0
TSE/Prion Molecular Biology Section,RML Genomics Unit,0.0
TSE/Prion Molecular Biology Section,RNA Viruses Section,0.0
TSE/Prion Molecular Biology Section,Research Technology Branch,0.0
TSE/Prion Molecular Biology Section,Salmonella-Host Cell Interactions Section,0.0
TSE/Prion Molecular Biology Section,Scientist Emerita,0.0
TSE/Prion Molecular Biology Section,Signaling Systems Section,0.0
TSE/Prion Molecular Biology Section,Structural Biology Section,0.0
TSE/Prion Molecular Biology Section,Structural Immunology Section,0.0
TSE/Prion Molecular Biology Section,Structural Informatics Unit,0.0
TSE/Prion Molecular Biology Section,Structural Virology Section,0.0
TSE/Prion Molecular Biology Section,Systems Genomics Section,0.0
TSE/Prion Molecular Biology Section,T-Cell Tolerance and Memory Section,0.0
TSE/Prion Molecular Biology Section,T-Lymphocyte Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Allergy and Immunology Clinical Training Program,0.0
TSE/Prion and Retroviral Pathogenesis Section,Antibacterial Host Defense Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Antibody Biology Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Apicomplexan Molecular Physiology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Autoimmunity and Functional Genomics Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,B-Cell Immunology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,B-Cell Molecular Immunology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Bacterial Physiology and Metabolism Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Barrier Immunity Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Biological Imaging,0.0
TSE/Prion and Retroviral Pathogenesis Section,Biology of Vector-Borne Viruses Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Building 14B South,0.0
TSE/Prion and Retroviral Pathogenesis Section,Building 33,0.0
TSE/Prion and Retroviral Pathogenesis Section,Building 50,0.0
TSE/Prion and Retroviral Pathogenesis Section,Building NIHAC/103,0.0
TSE/Prion and Retroviral Pathogenesis Section,Buildings 4 and 10/11C127,0.0
TSE/Prion and Retroviral Pathogenesis Section,Caliciviruses Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Cell Signaling and Immunity Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Cellular Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Cellular Immunology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Chemotaxis Signal Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Chlamydial Diseases Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Clinical Microbiome Unit (CMU),0.0
TSE/Prion and Retroviral Pathogenesis Section,Clinical Pathophysiology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Clinical Research Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Clinical and Molecular Retrovirology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Computational Biology Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Coxiella Pathogenesis Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,DNA Tumor Virus Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Disease Modeling and Transmission Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Emerging Respiratory Viruses Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Emerging Virus Immunity Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Epidemiology and Population Studies Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Epithelial Therapeutics Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Flow Cytometry Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Food Allergy Research Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Functional Cellular Networks Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Fungal Pathogenesis Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Gene Regulation Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Genetic Engineering Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Genetic Immunotherapy Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Genomic Technologies Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,HIV Pathogenesis Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,HIV-Specific Immunity Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Helminth Immunology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Hepatic Pathogenesis Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Host-Parasite Interactions Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Human Eosinophil Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Human Immunological Diseases Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Immune Activation Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Immune Deficiency Genetics Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Immunity to Pulmonary Pathogens Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Immunobiology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Immunobiology and Molecular Virology Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
TSE/Prion and Retroviral Pathogenesis Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
TSE/Prion and Retroviral Pathogenesis Section,Infectious Disease Fellowship Training Program,0.0
TSE/Prion and Retroviral Pathogenesis Section,Infectious Disease Pathogenesis Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Inflammation & Innate Immunity Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Inflammation Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Innate Immunity and Pathogenesis Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Integrative Immunobiology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,International HIV/STD Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Intracellular Parasite Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,LID Clinical Studies Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Lung and Vascular Inflammation Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Lyme Disease Studies Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Lymphocyte Activation Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Lymphocyte Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Malaria Cell Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Malaria Functional Genomics Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Malaria Genetics Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Malaria Immunology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Malaria Infection Biology and Immunity Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Mast Cell Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Medical Virology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Metaorganism Immunity Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Microbial Pathogenesis Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Defenses Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Development of the Immune System Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Entomology Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular HIV Host Interactions Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Microbiology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Parasitology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Parasitology and Entomology Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Pathogenesis Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Pathogenesis and Biomarkers Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Pathology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular Signaling Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular and Cellular Immunology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Molecular and Cellular Immunoregulation Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Mosquito Immunity and Vector Competence Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Mucosal Immunity Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Mucosal Immunobiology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Multiscale Systems Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,NIAID International Center of Excellence in Research Cambodia,0.0
TSE/Prion and Retroviral Pathogenesis Section,Neuroimmunological Diseases Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Nonhuman Primate Virology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Office of the Animal Program Director,0.0
TSE/Prion and Retroviral Pathogenesis Section,Pathogen Molecular Genetics Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Pathogen-Host Cell Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Pathogenesis and Immunity Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Pathology Core,0.0
TSE/Prion and Retroviral Pathogenesis Section,Physiology Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Plague Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Primary Immune Deficiency Clinic,0.0
TSE/Prion and Retroviral Pathogenesis Section,Prion Cell Biology Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Protein Chemistry Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Quantitative Virology and Evolution Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,RML Flow Cytometry Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,RML Genomics Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,RML Microscopy Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,RNA Viruses Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Research Technology Branch,0.0
TSE/Prion and Retroviral Pathogenesis Section,Salmonella-Host Cell Interactions Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Scientist Emerita,0.0
TSE/Prion and Retroviral Pathogenesis Section,Signaling Systems Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Structural Biology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Structural Immunology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Structural Informatics Unit,0.0
TSE/Prion and Retroviral Pathogenesis Section,Structural Virology Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,Systems Genomics Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,T-Cell Tolerance and Memory Section,0.0
TSE/Prion and Retroviral Pathogenesis Section,T-Lymphocyte Biology Section,0.0
Tick-Pathogen Transmission Unit,Allergy and Immunology Clinical Training Program,0.0
Tick-Pathogen Transmission Unit,Antibacterial Host Defense Unit,0.0
Tick-Pathogen Transmission Unit,Antibody Biology Unit,0.0
Tick-Pathogen Transmission Unit,Apicomplexan Molecular Physiology Section,0.0
Tick-Pathogen Transmission Unit,Autoimmunity and Functional Genomics Section,0.0
Tick-Pathogen Transmission Unit,B-Cell Immunology Section,0.0
Tick-Pathogen Transmission Unit,B-Cell Molecular Immunology Section,0.0
Tick-Pathogen Transmission Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Tick-Pathogen Transmission Unit,Bacterial Physiology and Metabolism Unit,0.0
Tick-Pathogen Transmission Unit,Barrier Immunity Section,0.0
Tick-Pathogen Transmission Unit,Biological Imaging,0.0
Tick-Pathogen Transmission Unit,Biology of Vector-Borne Viruses Section,0.0
Tick-Pathogen Transmission Unit,Building 14B South,0.0
Tick-Pathogen Transmission Unit,Building 33,0.0
Tick-Pathogen Transmission Unit,Building 50,0.0
Tick-Pathogen Transmission Unit,Building NIHAC/103,0.0
Tick-Pathogen Transmission Unit,Buildings 4 and 10/11C127,0.0
Tick-Pathogen Transmission Unit,Caliciviruses Section,0.0
Tick-Pathogen Transmission Unit,Cell Signaling and Immunity Section,0.0
Tick-Pathogen Transmission Unit,Cellular Biology Section,0.0
Tick-Pathogen Transmission Unit,Cellular Immunology Section,0.0
Tick-Pathogen Transmission Unit,Chemotaxis Signal Section,0.0
Tick-Pathogen Transmission Unit,Chlamydial Diseases Section,0.0
Tick-Pathogen Transmission Unit,Clinical Microbiome Unit (CMU),0.0
Tick-Pathogen Transmission Unit,Clinical Pathophysiology Section,0.0
Tick-Pathogen Transmission Unit,Clinical Research Section,0.0
Tick-Pathogen Transmission Unit,Clinical and Molecular Retrovirology Section,0.0
Tick-Pathogen Transmission Unit,Computational Biology Unit,0.0
Tick-Pathogen Transmission Unit,Coxiella Pathogenesis Section,0.0
Tick-Pathogen Transmission Unit,DNA Tumor Virus Section,0.0
Tick-Pathogen Transmission Unit,Disease Modeling and Transmission Section,0.0
Tick-Pathogen Transmission Unit,Emerging Respiratory Viruses Section,0.0
Tick-Pathogen Transmission Unit,Emerging Virus Immunity Unit,0.0
Tick-Pathogen Transmission Unit,Epidemiology and Population Studies Unit,0.0
Tick-Pathogen Transmission Unit,Epithelial Therapeutics Unit,0.0
Tick-Pathogen Transmission Unit,Flow Cytometry Section,0.0
Tick-Pathogen Transmission Unit,Food Allergy Research Section,0.0
Tick-Pathogen Transmission Unit,Functional Cellular Networks Section,0.0
Tick-Pathogen Transmission Unit,Fungal Pathogenesis Section,0.0
Tick-Pathogen Transmission Unit,Gene Regulation Section,0.0
Tick-Pathogen Transmission Unit,Genetic Engineering Section,0.0
Tick-Pathogen Transmission Unit,Genetic Immunotherapy Section,0.0
Tick-Pathogen Transmission Unit,Genomic Technologies Section,0.0
Tick-Pathogen Transmission Unit,HIV Immunovirology Section,0.0
Tick-Pathogen Transmission Unit,HIV Pathogenesis Section,0.0
Tick-Pathogen Transmission Unit,HIV-Specific Immunity Section,0.0
Tick-Pathogen Transmission Unit,Helminth Immunology Section,0.0
Tick-Pathogen Transmission Unit,Hepatic Pathogenesis Section,0.0
Tick-Pathogen Transmission Unit,Host-Parasite Interactions Section,0.0
Tick-Pathogen Transmission Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Tick-Pathogen Transmission Unit,Human Eosinophil Section,0.0
Tick-Pathogen Transmission Unit,Human Immunological Diseases Section,0.0
Tick-Pathogen Transmission Unit,Immune Activation Section,0.0
Tick-Pathogen Transmission Unit,Immune Deficiency Genetics Section,0.0
Tick-Pathogen Transmission Unit,Immunity to Pulmonary Pathogens Section,0.0
Tick-Pathogen Transmission Unit,Immunobiology Section,0.0
Tick-Pathogen Transmission Unit,Immunobiology and Molecular Virology Unit,0.0
Tick-Pathogen Transmission Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Tick-Pathogen Transmission Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Tick-Pathogen Transmission Unit,Infectious Disease Fellowship Training Program,0.0
Tick-Pathogen Transmission Unit,Infectious Disease Pathogenesis Section,0.0
Tick-Pathogen Transmission Unit,Inflammation & Innate Immunity Unit,0.0
Tick-Pathogen Transmission Unit,Inflammation Biology Section,0.0
Tick-Pathogen Transmission Unit,Innate Immunity and Pathogenesis Section,0.0
Tick-Pathogen Transmission Unit,Integrative Immunobiology Section,0.0
Tick-Pathogen Transmission Unit,International HIV/STD Section,0.0
Tick-Pathogen Transmission Unit,Intracellular Parasite Biology Section,0.0
Tick-Pathogen Transmission Unit,LID Clinical Studies Unit,0.0
Tick-Pathogen Transmission Unit,Lung and Vascular Inflammation Section,0.0
Tick-Pathogen Transmission Unit,Lyme Disease Studies Unit,0.0
Tick-Pathogen Transmission Unit,Lymphocyte Activation Section,0.0
Tick-Pathogen Transmission Unit,Lymphocyte Biology Section,0.0
Tick-Pathogen Transmission Unit,Malaria Cell Biology Section,0.0
Tick-Pathogen Transmission Unit,Malaria Functional Genomics Section,0.0
Tick-Pathogen Transmission Unit,Malaria Genetics Section,0.0
Tick-Pathogen Transmission Unit,Malaria Immunology Section,0.0
Tick-Pathogen Transmission Unit,Malaria Infection Biology and Immunity Unit,0.0
Tick-Pathogen Transmission Unit,Mast Cell Biology Section,0.0
Tick-Pathogen Transmission Unit,Medical Virology Section,0.0
Tick-Pathogen Transmission Unit,Metaorganism Immunity Section,0.0
Tick-Pathogen Transmission Unit,Microbial Pathogenesis Section,0.0
Tick-Pathogen Transmission Unit,Molecular Biology Section,0.0
Tick-Pathogen Transmission Unit,Molecular Defenses Section,0.0
Tick-Pathogen Transmission Unit,Molecular Development of the Immune System Section,0.0
Tick-Pathogen Transmission Unit,Molecular Entomology Unit,0.0
Tick-Pathogen Transmission Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Tick-Pathogen Transmission Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Tick-Pathogen Transmission Unit,Molecular HIV Host Interactions Section,0.0
Tick-Pathogen Transmission Unit,Molecular Microbiology Section,0.0
Tick-Pathogen Transmission Unit,Molecular Parasitology Section,0.0
Tick-Pathogen Transmission Unit,Molecular Parasitology and Entomology Unit,0.0
Tick-Pathogen Transmission Unit,Molecular Pathogenesis Unit,0.0
Tick-Pathogen Transmission Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Tick-Pathogen Transmission Unit,Molecular Pathology Section,0.0
Tick-Pathogen Transmission Unit,Molecular Signaling Section,0.0
Tick-Pathogen Transmission Unit,Molecular and Cellular Immunology Section,0.0
Tick-Pathogen Transmission Unit,Molecular and Cellular Immunoregulation Section,0.0
Tick-Pathogen Transmission Unit,Mosquito Immunity and Vector Competence Section,0.0
Tick-Pathogen Transmission Unit,Mucosal Immunity Section,0.0
Tick-Pathogen Transmission Unit,Mucosal Immunobiology Section,0.0
Tick-Pathogen Transmission Unit,Multiscale Systems Biology Section,0.0
Tick-Pathogen Transmission Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Tick-Pathogen Transmission Unit,Neuroimmunological Diseases Section,0.0
Tick-Pathogen Transmission Unit,Neuroimmunology Unit,0.0
Tick-Pathogen Transmission Unit,Nonhuman Primate Virology Section,0.0
Tick-Pathogen Transmission Unit,Office of the Animal Program Director,0.0
Tick-Pathogen Transmission Unit,Pathogen Molecular Genetics Section,0.0
Tick-Pathogen Transmission Unit,Pathogen-Host Cell Biology Section,0.0
Tick-Pathogen Transmission Unit,Pathogenesis and Immunity Section,0.0
Tick-Pathogen Transmission Unit,Pathology Core,0.0
Tick-Pathogen Transmission Unit,Physiology Unit,0.0
Tick-Pathogen Transmission Unit,Plague Section,0.0
Tick-Pathogen Transmission Unit,Primary Immune Deficiency Clinic,0.0
Tick-Pathogen Transmission Unit,Prion Cell Biology Unit,0.0
Tick-Pathogen Transmission Unit,Protein Chemistry Section,0.0
Tick-Pathogen Transmission Unit,Quantitative Virology and Evolution Unit,0.0
Tick-Pathogen Transmission Unit,RML Flow Cytometry Unit,0.0
Tick-Pathogen Transmission Unit,RML Genomics Unit,0.0
Tick-Pathogen Transmission Unit,RML Microscopy Unit,0.0
Tick-Pathogen Transmission Unit,RNA Viruses Section,0.0
Tick-Pathogen Transmission Unit,Research Technology Branch,0.0
Tick-Pathogen Transmission Unit,Retroviral Immunology Section,0.0
Tick-Pathogen Transmission Unit,Salmonella-Host Cell Interactions Section,0.0
Tick-Pathogen Transmission Unit,Scientist Emerita,0.0
Tick-Pathogen Transmission Unit,Signaling Systems Section,0.0
Tick-Pathogen Transmission Unit,Structural Biology Section,0.0
Tick-Pathogen Transmission Unit,Structural Immunology Section,0.0
Tick-Pathogen Transmission Unit,Structural Informatics Unit,0.0
Tick-Pathogen Transmission Unit,Structural Virology Section,0.0
Tick-Pathogen Transmission Unit,Systems Genomics Section,0.0
Tick-Pathogen Transmission Unit,T-Cell Tolerance and Memory Section,0.0
Tick-Pathogen Transmission Unit,T-Lymphocyte Biology Section,0.0
Tick-Pathogen Transmission Unit,TSE/Prion Biochemistry Section,0.0
Tick-Pathogen Transmission Unit,TSE/Prion Molecular Biology Section,0.0
Tick-Pathogen Transmission Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,Allergy and Immunology Clinical Training Program,0.0
Translational Allergic Immunopathology Unit,Antibacterial Host Defense Unit,0.0
Translational Allergic Immunopathology Unit,Antibody Biology Unit,0.0
Translational Allergic Immunopathology Unit,Apicomplexan Molecular Physiology Section,0.0
Translational Allergic Immunopathology Unit,Autoimmunity and Functional Genomics Section,0.0
Translational Allergic Immunopathology Unit,B-Cell Immunology Section,0.0
Translational Allergic Immunopathology Unit,B-Cell Molecular Immunology Section,0.0
Translational Allergic Immunopathology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Translational Allergic Immunopathology Unit,Bacterial Physiology and Metabolism Unit,0.0
Translational Allergic Immunopathology Unit,Barrier Immunity Section,0.0
Translational Allergic Immunopathology Unit,Biological Imaging,0.0
Translational Allergic Immunopathology Unit,Biology of Vector-Borne Viruses Section,0.0
Translational Allergic Immunopathology Unit,Building 14B South,0.0
Translational Allergic Immunopathology Unit,Building 33,0.0
Translational Allergic Immunopathology Unit,Building 50,0.0
Translational Allergic Immunopathology Unit,Building NIHAC/103,0.0
Translational Allergic Immunopathology Unit,Buildings 4 and 10/11C127,0.0
Translational Allergic Immunopathology Unit,Caliciviruses Section,0.0
Translational Allergic Immunopathology Unit,Cell Signaling and Immunity Section,0.0
Translational Allergic Immunopathology Unit,Cellular Biology Section,0.0
Translational Allergic Immunopathology Unit,Cellular Immunology Section,0.0
Translational Allergic Immunopathology Unit,Chemotaxis Signal Section,0.0
Translational Allergic Immunopathology Unit,Chlamydial Diseases Section,0.0
Translational Allergic Immunopathology Unit,Clinical Microbiome Unit (CMU),0.0
Translational Allergic Immunopathology Unit,Clinical Pathophysiology Section,0.0
Translational Allergic Immunopathology Unit,Clinical Research Section,0.0
Translational Allergic Immunopathology Unit,Clinical and Molecular Retrovirology Section,0.0
Translational Allergic Immunopathology Unit,Computational Biology Unit,0.0
Translational Allergic Immunopathology Unit,Coxiella Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,DNA Tumor Virus Section,0.0
Translational Allergic Immunopathology Unit,Disease Modeling and Transmission Section,0.0
Translational Allergic Immunopathology Unit,Emerging Respiratory Viruses Section,0.0
Translational Allergic Immunopathology Unit,Emerging Virus Immunity Unit,0.0
Translational Allergic Immunopathology Unit,Epidemiology and Population Studies Unit,0.0
Translational Allergic Immunopathology Unit,Epithelial Therapeutics Unit,0.0
Translational Allergic Immunopathology Unit,Flow Cytometry Section,0.0
Translational Allergic Immunopathology Unit,Functional Cellular Networks Section,0.0
Translational Allergic Immunopathology Unit,Gene Regulation Section,0.0
Translational Allergic Immunopathology Unit,Genetic Engineering Section,0.0
Translational Allergic Immunopathology Unit,Genetic Immunotherapy Section,0.0
Translational Allergic Immunopathology Unit,Genomic Technologies Section,0.0
Translational Allergic Immunopathology Unit,HIV Immunovirology Section,0.0
Translational Allergic Immunopathology Unit,HIV Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,HIV-Specific Immunity Section,0.0
Translational Allergic Immunopathology Unit,Helminth Immunology Section,0.0
Translational Allergic Immunopathology Unit,Hepatic Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,Host-Parasite Interactions Section,0.0
Translational Allergic Immunopathology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Translational Allergic Immunopathology Unit,Human Eosinophil Section,0.0
Translational Allergic Immunopathology Unit,Immune Activation Section,0.0
Translational Allergic Immunopathology Unit,Immune Deficiency Genetics Section,0.0
Translational Allergic Immunopathology Unit,Immunity to Pulmonary Pathogens Section,0.0
Translational Allergic Immunopathology Unit,Immunobiology Section,0.0
Translational Allergic Immunopathology Unit,Immunobiology and Molecular Virology Unit,0.0
Translational Allergic Immunopathology Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Translational Allergic Immunopathology Unit,Infectious Disease Fellowship Training Program,0.0
Translational Allergic Immunopathology Unit,Infectious Disease Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,Inflammation & Innate Immunity Unit,0.0
Translational Allergic Immunopathology Unit,Inflammation Biology Section,0.0
Translational Allergic Immunopathology Unit,Innate Immunity and Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,Integrative Immunobiology Section,0.0
Translational Allergic Immunopathology Unit,International HIV/STD Section,0.0
Translational Allergic Immunopathology Unit,Intracellular Parasite Biology Section,0.0
Translational Allergic Immunopathology Unit,LID Clinical Studies Unit,0.0
Translational Allergic Immunopathology Unit,Lyme Disease Studies Unit,0.0
Translational Allergic Immunopathology Unit,Lymphocyte Activation Section,0.0
Translational Allergic Immunopathology Unit,Lymphocyte Biology Section,0.0
Translational Allergic Immunopathology Unit,Malaria Cell Biology Section,0.0
Translational Allergic Immunopathology Unit,Malaria Functional Genomics Section,0.0
Translational Allergic Immunopathology Unit,Malaria Genetics Section,0.0
Translational Allergic Immunopathology Unit,Malaria Immunology Section,0.0
Translational Allergic Immunopathology Unit,Malaria Infection Biology and Immunity Unit,0.0
Translational Allergic Immunopathology Unit,Medical Virology Section,0.0
Translational Allergic Immunopathology Unit,Metaorganism Immunity Section,0.0
Translational Allergic Immunopathology Unit,Microbial Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,Molecular Biology Section,0.0
Translational Allergic Immunopathology Unit,Molecular Defenses Section,0.0
Translational Allergic Immunopathology Unit,Molecular Development of the Immune System Section,0.0
Translational Allergic Immunopathology Unit,Molecular Entomology Unit,0.0
Translational Allergic Immunopathology Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Translational Allergic Immunopathology Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Translational Allergic Immunopathology Unit,Molecular HIV Host Interactions Section,0.0
Translational Allergic Immunopathology Unit,Molecular Microbiology Section,0.0
Translational Allergic Immunopathology Unit,Molecular Parasitology Section,0.0
Translational Allergic Immunopathology Unit,Molecular Parasitology and Entomology Unit,0.0
Translational Allergic Immunopathology Unit,Molecular Pathogenesis Unit,0.0
Translational Allergic Immunopathology Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Translational Allergic Immunopathology Unit,Molecular Pathology Section,0.0
Translational Allergic Immunopathology Unit,Molecular Signaling Section,0.0
Translational Allergic Immunopathology Unit,Molecular and Cellular Immunology Section,0.0
Translational Allergic Immunopathology Unit,Molecular and Cellular Immunoregulation Section,0.0
Translational Allergic Immunopathology Unit,Mosquito Immunity and Vector Competence Section,0.0
Translational Allergic Immunopathology Unit,Mucosal Immunity Section,0.0
Translational Allergic Immunopathology Unit,Mucosal Immunobiology Section,0.0
Translational Allergic Immunopathology Unit,Multiscale Systems Biology Section,0.0
Translational Allergic Immunopathology Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Translational Allergic Immunopathology Unit,Neuroimmunological Diseases Section,0.0
Translational Allergic Immunopathology Unit,Neuroimmunology Unit,0.0
Translational Allergic Immunopathology Unit,Nonhuman Primate Virology Section,0.0
Translational Allergic Immunopathology Unit,Office of the Animal Program Director,0.0
Translational Allergic Immunopathology Unit,Pathogen Molecular Genetics Section,0.0
Translational Allergic Immunopathology Unit,Pathogen-Host Cell Biology Section,0.0
Translational Allergic Immunopathology Unit,Pathogenesis and Immunity Section,0.0
Translational Allergic Immunopathology Unit,Pathology Core,0.0
Translational Allergic Immunopathology Unit,Physiology Unit,0.0
Translational Allergic Immunopathology Unit,Plague Section,0.0
Translational Allergic Immunopathology Unit,Prion Cell Biology Unit,0.0
Translational Allergic Immunopathology Unit,Protein Chemistry Section,0.0
Translational Allergic Immunopathology Unit,Quantitative Virology and Evolution Unit,0.0
Translational Allergic Immunopathology Unit,RML Flow Cytometry Unit,0.0
Translational Allergic Immunopathology Unit,RML Genomics Unit,0.0
Translational Allergic Immunopathology Unit,RML Microscopy Unit,0.0
Translational Allergic Immunopathology Unit,RNA Viruses Section,0.0
Translational Allergic Immunopathology Unit,Research Technology Branch,0.0
Translational Allergic Immunopathology Unit,Retroviral Immunology Section,0.0
Translational Allergic Immunopathology Unit,Salmonella-Host Cell Interactions Section,0.0
Translational Allergic Immunopathology Unit,Scientist Emerita,0.0
Translational Allergic Immunopathology Unit,Signaling Systems Section,0.0
Translational Allergic Immunopathology Unit,Structural Biology Section,0.0
Translational Allergic Immunopathology Unit,Structural Immunology Section,0.0
Translational Allergic Immunopathology Unit,Structural Informatics Unit,0.0
Translational Allergic Immunopathology Unit,Structural Virology Section,0.0
Translational Allergic Immunopathology Unit,Systems Genomics Section,0.0
Translational Allergic Immunopathology Unit,T-Cell Tolerance and Memory Section,0.0
Translational Allergic Immunopathology Unit,TSE/Prion Biochemistry Section,0.0
Translational Allergic Immunopathology Unit,TSE/Prion Molecular Biology Section,0.0
Translational Allergic Immunopathology Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Translational Allergic Immunopathology Unit,Tick-Pathogen Transmission Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Allergy and Immunology Clinical Training Program,0.0
Translational Autoinflammatory Disease Studies Unit,Antibacterial Host Defense Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Antibody Biology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Apicomplexan Molecular Physiology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Autoimmunity and Functional Genomics Section,0.0
Translational Autoinflammatory Disease Studies Unit,B-Cell Molecular Immunology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Bacterial Physiology and Metabolism Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Barrier Immunity Section,0.0
Translational Autoinflammatory Disease Studies Unit,Biological Imaging,0.0
Translational Autoinflammatory Disease Studies Unit,Biology of Vector-Borne Viruses Section,0.0
Translational Autoinflammatory Disease Studies Unit,Building 14B South,0.0
Translational Autoinflammatory Disease Studies Unit,Building 33,0.0
Translational Autoinflammatory Disease Studies Unit,Building 50,0.0
Translational Autoinflammatory Disease Studies Unit,Building NIHAC/103,0.0
Translational Autoinflammatory Disease Studies Unit,Buildings 4 and 10/11C127,0.0
Translational Autoinflammatory Disease Studies Unit,Caliciviruses Section,0.0
Translational Autoinflammatory Disease Studies Unit,Cell Signaling and Immunity Section,0.0
Translational Autoinflammatory Disease Studies Unit,Cellular Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Chemotaxis Signal Section,0.0
Translational Autoinflammatory Disease Studies Unit,Chlamydial Diseases Section,0.0
Translational Autoinflammatory Disease Studies Unit,Clinical Microbiome Unit (CMU),0.0
Translational Autoinflammatory Disease Studies Unit,Clinical Pathophysiology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Clinical Research Section,0.0
Translational Autoinflammatory Disease Studies Unit,Clinical and Molecular Retrovirology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Computational Biology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Coxiella Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,Disease Modeling and Transmission Section,0.0
Translational Autoinflammatory Disease Studies Unit,Emerging Virus Immunity Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Epidemiology and Population Studies Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Epithelial Therapeutics Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Flow Cytometry Section,0.0
Translational Autoinflammatory Disease Studies Unit,Food Allergy Research Section,0.0
Translational Autoinflammatory Disease Studies Unit,Functional Cellular Networks Section,0.0
Translational Autoinflammatory Disease Studies Unit,Fungal Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,Gene Regulation Section,0.0
Translational Autoinflammatory Disease Studies Unit,Genetic Engineering Section,0.0
Translational Autoinflammatory Disease Studies Unit,Genetic Immunotherapy Section,0.0
Translational Autoinflammatory Disease Studies Unit,Genomic Technologies Section,0.0
Translational Autoinflammatory Disease Studies Unit,HIV Immunovirology Section,0.0
Translational Autoinflammatory Disease Studies Unit,HIV Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,HIV-Specific Immunity Section,0.0
Translational Autoinflammatory Disease Studies Unit,Helminth Immunology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Hepatic Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,Host-Parasite Interactions Section,0.0
Translational Autoinflammatory Disease Studies Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Human Eosinophil Section,0.0
Translational Autoinflammatory Disease Studies Unit,Human Immunological Diseases Section,0.0
Translational Autoinflammatory Disease Studies Unit,Immune Activation Section,0.0
Translational Autoinflammatory Disease Studies Unit,Immune Deficiency Genetics Section,0.0
Translational Autoinflammatory Disease Studies Unit,Immunity to Pulmonary Pathogens Section,0.0
Translational Autoinflammatory Disease Studies Unit,Immunobiology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Immunobiology and Molecular Virology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Translational Autoinflammatory Disease Studies Unit,Infectious Disease Fellowship Training Program,0.0
Translational Autoinflammatory Disease Studies Unit,Infectious Disease Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,Inflammation & Innate Immunity Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Inflammation Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Innate Immunity and Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,Integrative Immunobiology Section,0.0
Translational Autoinflammatory Disease Studies Unit,International HIV/STD Section,0.0
Translational Autoinflammatory Disease Studies Unit,Intracellular Parasite Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,LID Clinical Studies Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Lung and Vascular Inflammation Section,0.0
Translational Autoinflammatory Disease Studies Unit,Lymphocyte Activation Section,0.0
Translational Autoinflammatory Disease Studies Unit,Malaria Cell Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Malaria Functional Genomics Section,0.0
Translational Autoinflammatory Disease Studies Unit,Malaria Genetics Section,0.0
Translational Autoinflammatory Disease Studies Unit,Malaria Immunology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Malaria Infection Biology and Immunity Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Metaorganism Immunity Section,0.0
Translational Autoinflammatory Disease Studies Unit,Microbial Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Defenses Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Development of the Immune System Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Entomology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Translational Autoinflammatory Disease Studies Unit,Molecular HIV Host Interactions Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Microbiology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Parasitology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Parasitology and Entomology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Pathogenesis Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Pathology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular Signaling Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular and Cellular Immunology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Molecular and Cellular Immunoregulation Section,0.0
Translational Autoinflammatory Disease Studies Unit,Mosquito Immunity and Vector Competence Section,0.0
Translational Autoinflammatory Disease Studies Unit,Mucosal Immunity Section,0.0
Translational Autoinflammatory Disease Studies Unit,Mucosal Immunobiology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Multiscale Systems Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Translational Autoinflammatory Disease Studies Unit,Neuroimmunology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Nonhuman Primate Virology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Office of the Animal Program Director,0.0
Translational Autoinflammatory Disease Studies Unit,Pathogen Molecular Genetics Section,0.0
Translational Autoinflammatory Disease Studies Unit,Pathogen-Host Cell Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Pathogenesis and Immunity Section,0.0
Translational Autoinflammatory Disease Studies Unit,Pathology Core,0.0
Translational Autoinflammatory Disease Studies Unit,Physiology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Plague Section,0.0
Translational Autoinflammatory Disease Studies Unit,Primary Immune Deficiency Clinic,0.0
Translational Autoinflammatory Disease Studies Unit,Prion Cell Biology Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Protein Chemistry Section,0.0
Translational Autoinflammatory Disease Studies Unit,Quantitative Virology and Evolution Unit,0.0
Translational Autoinflammatory Disease Studies Unit,RML Flow Cytometry Unit,0.0
Translational Autoinflammatory Disease Studies Unit,RML Genomics Unit,0.0
Translational Autoinflammatory Disease Studies Unit,RML Microscopy Unit,0.0
Translational Autoinflammatory Disease Studies Unit,RNA Viruses Section,0.0
Translational Autoinflammatory Disease Studies Unit,Research Technology Branch,0.0
Translational Autoinflammatory Disease Studies Unit,Retroviral Immunology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Salmonella-Host Cell Interactions Section,0.0
Translational Autoinflammatory Disease Studies Unit,Scientist Emerita,0.0
Translational Autoinflammatory Disease Studies Unit,Signaling Systems Section,0.0
Translational Autoinflammatory Disease Studies Unit,Structural Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Structural Immunology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Structural Informatics Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Structural Virology Section,0.0
Translational Autoinflammatory Disease Studies Unit,Systems Genomics Section,0.0
Translational Autoinflammatory Disease Studies Unit,T-Cell Tolerance and Memory Section,0.0
Translational Autoinflammatory Disease Studies Unit,T-Lymphocyte Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,TSE/Prion Biochemistry Section,0.0
Translational Autoinflammatory Disease Studies Unit,TSE/Prion Molecular Biology Section,0.0
Translational Autoinflammatory Disease Studies Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Translational Autoinflammatory Disease Studies Unit,Tick-Pathogen Transmission Unit,0.0
Translational Autoinflammatory Disease Studies Unit,Translational Allergic Immunopathology Unit,0.0
Translational Immunobiology Unit,Allergy and Immunology Clinical Training Program,0.0
Translational Immunobiology Unit,Antibacterial Host Defense Unit,0.0
Translational Immunobiology Unit,Antibody Biology Unit,0.0
Translational Immunobiology Unit,Apicomplexan Molecular Physiology Section,0.0
Translational Immunobiology Unit,Autoimmunity and Functional Genomics Section,0.0
Translational Immunobiology Unit,B-Cell Immunology Section,0.0
Translational Immunobiology Unit,B-Cell Molecular Immunology Section,0.0
Translational Immunobiology Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Translational Immunobiology Unit,Bacterial Physiology and Metabolism Unit,0.0
Translational Immunobiology Unit,Barrier Immunity Section,0.0
Translational Immunobiology Unit,Biological Imaging,0.0
Translational Immunobiology Unit,Biology of Vector-Borne Viruses Section,0.0
Translational Immunobiology Unit,Building 14B South,0.0
Translational Immunobiology Unit,Building 33,0.0
Translational Immunobiology Unit,Building 50,0.0
Translational Immunobiology Unit,Building NIHAC/103,0.0
Translational Immunobiology Unit,Buildings 4 and 10/11C127,0.0
Translational Immunobiology Unit,Caliciviruses Section,0.0
Translational Immunobiology Unit,Cell Signaling and Immunity Section,0.0
Translational Immunobiology Unit,Cellular Biology Section,0.0
Translational Immunobiology Unit,Cellular Immunology Section,0.0
Translational Immunobiology Unit,Chemotaxis Signal Section,0.0
Translational Immunobiology Unit,Chlamydial Diseases Section,0.0
Translational Immunobiology Unit,Clinical Microbiome Unit (CMU),0.0
Translational Immunobiology Unit,Clinical Pathophysiology Section,0.0
Translational Immunobiology Unit,Clinical Research Section,0.0
Translational Immunobiology Unit,Clinical and Molecular Retrovirology Section,0.0
Translational Immunobiology Unit,Computational Biology Unit,0.0
Translational Immunobiology Unit,Coxiella Pathogenesis Section,0.0
Translational Immunobiology Unit,DNA Tumor Virus Section,0.0
Translational Immunobiology Unit,Disease Modeling and Transmission Section,0.0
Translational Immunobiology Unit,Emerging Respiratory Viruses Section,0.0
Translational Immunobiology Unit,Emerging Virus Immunity Unit,0.0
Translational Immunobiology Unit,Epidemiology and Population Studies Unit,0.0
Translational Immunobiology Unit,Epithelial Therapeutics Unit,0.0
Translational Immunobiology Unit,Flow Cytometry Section,0.0
Translational Immunobiology Unit,Food Allergy Research Section,0.0
Translational Immunobiology Unit,Functional Cellular Networks Section,0.0
Translational Immunobiology Unit,Fungal Pathogenesis Section,0.0
Translational Immunobiology Unit,Gene Regulation Section,0.0
Translational Immunobiology Unit,Genetic Engineering Section,0.0
Translational Immunobiology Unit,Genetic Immunotherapy Section,0.0
Translational Immunobiology Unit,Genomic Technologies Section,0.0
Translational Immunobiology Unit,HIV Immunovirology Section,0.0
Translational Immunobiology Unit,HIV Pathogenesis Section,0.0
Translational Immunobiology Unit,Helminth Immunology Section,0.0
Translational Immunobiology Unit,Hepatic Pathogenesis Section,0.0
Translational Immunobiology Unit,Host-Parasite Interactions Section,0.0
Translational Immunobiology Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Translational Immunobiology Unit,Human Eosinophil Section,0.0
Translational Immunobiology Unit,Human Immunological Diseases Section,0.0
Translational Immunobiology Unit,Immune Activation Section,0.0
Translational Immunobiology Unit,Immune Deficiency Genetics Section,0.0
Translational Immunobiology Unit,Immunity to Pulmonary Pathogens Section,0.0
Translational Immunobiology Unit,Immunobiology Section,0.0
Translational Immunobiology Unit,Immunobiology and Molecular Virology Unit,0.0
Translational Immunobiology Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Translational Immunobiology Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Translational Immunobiology Unit,Infectious Disease Fellowship Training Program,0.0
Translational Immunobiology Unit,Infectious Disease Pathogenesis Section,0.0
Translational Immunobiology Unit,Inflammation & Innate Immunity Unit,0.0
Translational Immunobiology Unit,Inflammation Biology Section,0.0
Translational Immunobiology Unit,Innate Immunity and Pathogenesis Section,0.0
Translational Immunobiology Unit,Integrative Immunobiology Section,0.0
Translational Immunobiology Unit,International HIV/STD Section,0.0
Translational Immunobiology Unit,Intracellular Parasite Biology Section,0.0
Translational Immunobiology Unit,LID Clinical Studies Unit,0.0
Translational Immunobiology Unit,Lung and Vascular Inflammation Section,0.0
Translational Immunobiology Unit,Lyme Disease Studies Unit,0.0
Translational Immunobiology Unit,Lymphocyte Activation Section,0.0
Translational Immunobiology Unit,Lymphocyte Biology Section,0.0
Translational Immunobiology Unit,Malaria Cell Biology Section,0.0
Translational Immunobiology Unit,Malaria Functional Genomics Section,0.0
Translational Immunobiology Unit,Malaria Genetics Section,0.0
Translational Immunobiology Unit,Malaria Immunology Section,0.0
Translational Immunobiology Unit,Malaria Infection Biology and Immunity Unit,0.0
Translational Immunobiology Unit,Mast Cell Biology Section,0.0
Translational Immunobiology Unit,Medical Virology Section,0.0
Translational Immunobiology Unit,Metaorganism Immunity Section,0.0
Translational Immunobiology Unit,Microbial Pathogenesis Section,0.0
Translational Immunobiology Unit,Molecular Biology Section,0.0
Translational Immunobiology Unit,Molecular Defenses Section,0.0
Translational Immunobiology Unit,Molecular Development of the Immune System Section,0.0
Translational Immunobiology Unit,Molecular Entomology Unit,0.0
Translational Immunobiology Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Translational Immunobiology Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Translational Immunobiology Unit,Molecular HIV Host Interactions Section,0.0
Translational Immunobiology Unit,Molecular Microbiology Section,0.0
Translational Immunobiology Unit,Molecular Parasitology Section,0.0
Translational Immunobiology Unit,Molecular Parasitology and Entomology Unit,0.0
Translational Immunobiology Unit,Molecular Pathogenesis Unit,0.0
Translational Immunobiology Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Translational Immunobiology Unit,Molecular Pathology Section,0.0
Translational Immunobiology Unit,Molecular Signaling Section,0.0
Translational Immunobiology Unit,Molecular and Cellular Immunology Section,0.0
Translational Immunobiology Unit,Molecular and Cellular Immunoregulation Section,0.0
Translational Immunobiology Unit,Mosquito Immunity and Vector Competence Section,0.0
Translational Immunobiology Unit,Mucosal Immunity Section,0.0
Translational Immunobiology Unit,Mucosal Immunobiology Section,0.0
Translational Immunobiology Unit,Multiscale Systems Biology Section,0.0
Translational Immunobiology Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Translational Immunobiology Unit,Neuroimmunological Diseases Section,0.0
Translational Immunobiology Unit,Neuroimmunology Unit,0.0
Translational Immunobiology Unit,Nonhuman Primate Virology Section,0.0
Translational Immunobiology Unit,Office of the Animal Program Director,0.0
Translational Immunobiology Unit,Pathogen Molecular Genetics Section,0.0
Translational Immunobiology Unit,Pathogen-Host Cell Biology Section,0.0
Translational Immunobiology Unit,Pathogenesis and Immunity Section,0.0
Translational Immunobiology Unit,Pathology Core,0.0
Translational Immunobiology Unit,Physiology Unit,0.0
Translational Immunobiology Unit,Plague Section,0.0
Translational Immunobiology Unit,Primary Immune Deficiency Clinic,0.0
Translational Immunobiology Unit,Prion Cell Biology Unit,0.0
Translational Immunobiology Unit,Protein Chemistry Section,0.0
Translational Immunobiology Unit,Quantitative Virology and Evolution Unit,0.0
Translational Immunobiology Unit,RML Flow Cytometry Unit,0.0
Translational Immunobiology Unit,RML Genomics Unit,0.0
Translational Immunobiology Unit,RML Microscopy Unit,0.0
Translational Immunobiology Unit,RNA Viruses Section,0.0
Translational Immunobiology Unit,Research Technology Branch,0.0
Translational Immunobiology Unit,Retroviral Immunology Section,0.0
Translational Immunobiology Unit,Salmonella-Host Cell Interactions Section,0.0
Translational Immunobiology Unit,Scientist Emerita,0.0
Translational Immunobiology Unit,Signaling Systems Section,0.0
Translational Immunobiology Unit,Structural Biology Section,0.0
Translational Immunobiology Unit,Structural Immunology Section,0.0
Translational Immunobiology Unit,Structural Informatics Unit,0.0
Translational Immunobiology Unit,Structural Virology Section,0.0
Translational Immunobiology Unit,Systems Genomics Section,0.0
Translational Immunobiology Unit,T-Cell Tolerance and Memory Section,0.0
Translational Immunobiology Unit,T-Lymphocyte Biology Section,0.0
Translational Immunobiology Unit,TSE/Prion Biochemistry Section,0.0
Translational Immunobiology Unit,TSE/Prion Molecular Biology Section,0.0
Translational Immunobiology Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Translational Immunobiology Unit,Tick-Pathogen Transmission Unit,0.0
Translational Immunobiology Unit,Translational Allergic Immunopathology Unit,0.0
Translational Immunobiology Unit,Translational Autoinflammatory Disease Studies Unit,0.0
Translational Mycology Section,Allergy and Immunology Clinical Training Program,0.0
Translational Mycology Section,Antibacterial Host Defense Unit,0.0
Translational Mycology Section,Antibody Biology Unit,0.0
Translational Mycology Section,Apicomplexan Molecular Physiology Section,0.0
Translational Mycology Section,Autoimmunity and Functional Genomics Section,0.0
Translational Mycology Section,B-Cell Immunology Section,0.0
Translational Mycology Section,Bacterial Physiology and Metabolism Unit,0.0
Translational Mycology Section,Barrier Immunity Section,0.0
Translational Mycology Section,Biological Imaging,0.0
Translational Mycology Section,Biology of Vector-Borne Viruses Section,0.0
Translational Mycology Section,Building 14B South,0.0
Translational Mycology Section,Building 33,0.0
Translational Mycology Section,Building 50,0.0
Translational Mycology Section,Building NIHAC/103,0.0
Translational Mycology Section,Buildings 4 and 10/11C127,0.0
Translational Mycology Section,Caliciviruses Section,0.0
Translational Mycology Section,Cell Signaling and Immunity Section,0.0
Translational Mycology Section,Cellular Biology Section,0.0
Translational Mycology Section,Cellular Immunology Section,0.0
Translational Mycology Section,Chemotaxis Signal Section,0.0
Translational Mycology Section,Chlamydial Diseases Section,0.0
Translational Mycology Section,Clinical Microbiome Unit (CMU),0.0
Translational Mycology Section,Clinical Pathophysiology Section,0.0
Translational Mycology Section,Clinical Research Section,0.0
Translational Mycology Section,Clinical and Molecular Retrovirology Section,0.0
Translational Mycology Section,Computational Biology Unit,0.0
Translational Mycology Section,Coxiella Pathogenesis Section,0.0
Translational Mycology Section,DNA Tumor Virus Section,0.0
Translational Mycology Section,Disease Modeling and Transmission Section,0.0
Translational Mycology Section,Emerging Respiratory Viruses Section,0.0
Translational Mycology Section,Emerging Virus Immunity Unit,0.0
Translational Mycology Section,Epithelial Therapeutics Unit,0.0
Translational Mycology Section,Flow Cytometry Section,0.0
Translational Mycology Section,Food Allergy Research Section,0.0
Translational Mycology Section,Functional Cellular Networks Section,0.0
Translational Mycology Section,Gene Regulation Section,0.0
Translational Mycology Section,Genetic Engineering Section,0.0
Translational Mycology Section,Genetic Immunotherapy Section,0.0
Translational Mycology Section,HIV Immunovirology Section,0.0
Translational Mycology Section,HIV-Specific Immunity Section,0.0
Translational Mycology Section,Helminth Immunology Section,0.0
Translational Mycology Section,Hepatic Pathogenesis Section,0.0
Translational Mycology Section,Host-Parasite Interactions Section,0.0
Translational Mycology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Translational Mycology Section,Human Eosinophil Section,0.0
Translational Mycology Section,Human Immunological Diseases Section,0.0
Translational Mycology Section,Immune Activation Section,0.0
Translational Mycology Section,Immune Deficiency Genetics Section,0.0
Translational Mycology Section,Immunity to Pulmonary Pathogens Section,0.0
Translational Mycology Section,Immunobiology Section,0.0
Translational Mycology Section,Immunobiology and Molecular Virology Unit,0.0
Translational Mycology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Translational Mycology Section,Infectious Disease Pathogenesis Section,0.0
Translational Mycology Section,Inflammation & Innate Immunity Unit,0.0
Translational Mycology Section,Inflammation Biology Section,0.0
Translational Mycology Section,Innate Immunity and Pathogenesis Section,0.0
Translational Mycology Section,Integrative Immunobiology Section,0.0
Translational Mycology Section,International HIV/STD Section,0.0
Translational Mycology Section,Intracellular Parasite Biology Section,0.0
Translational Mycology Section,LID Clinical Studies Unit,0.0
Translational Mycology Section,Lung and Vascular Inflammation Section,0.0
Translational Mycology Section,Lymphocyte Activation Section,0.0
Translational Mycology Section,Lymphocyte Biology Section,0.0
Translational Mycology Section,Malaria Cell Biology Section,0.0
Translational Mycology Section,Malaria Functional Genomics Section,0.0
Translational Mycology Section,Malaria Genetics Section,0.0
Translational Mycology Section,Malaria Immunology Section,0.0
Translational Mycology Section,Malaria Infection Biology and Immunity Unit,0.0
Translational Mycology Section,Mast Cell Biology Section,0.0
Translational Mycology Section,Medical Virology Section,0.0
Translational Mycology Section,Metaorganism Immunity Section,0.0
Translational Mycology Section,Microbial Pathogenesis Section,0.0
Translational Mycology Section,Molecular Biology Section,0.0
Translational Mycology Section,Molecular Defenses Section,0.0
Translational Mycology Section,Molecular Development of the Immune System Section,0.0
Translational Mycology Section,Molecular Entomology Unit,0.0
Translational Mycology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Translational Mycology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Translational Mycology Section,Molecular HIV Host Interactions Section,0.0
Translational Mycology Section,Molecular Parasitology and Entomology Unit,0.0
Translational Mycology Section,Molecular Pathogenesis Unit,0.0
Translational Mycology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Translational Mycology Section,Molecular Pathology Section,0.0
Translational Mycology Section,Molecular Signaling Section,0.0
Translational Mycology Section,Molecular and Cellular Immunology Section,0.0
Translational Mycology Section,Molecular and Cellular Immunoregulation Section,0.0
Translational Mycology Section,Mosquito Immunity and Vector Competence Section,0.0
Translational Mycology Section,Mucosal Immunity Section,0.0
Translational Mycology Section,Mucosal Immunobiology Section,0.0
Translational Mycology Section,Multiscale Systems Biology Section,0.0
Translational Mycology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Translational Mycology Section,Neuroimmunology Unit,0.0
Translational Mycology Section,Nonhuman Primate Virology Section,0.0
Translational Mycology Section,Office of the Animal Program Director,0.0
Translational Mycology Section,Pathogen-Host Cell Biology Section,0.0
Translational Mycology Section,Pathogenesis and Immunity Section,0.0
Translational Mycology Section,Pathology Core,0.0
Translational Mycology Section,Physiology Unit,0.0
Translational Mycology Section,Plague Section,0.0
Translational Mycology Section,Primary Immune Deficiency Clinic,0.0
Translational Mycology Section,Prion Cell Biology Unit,0.0
Translational Mycology Section,Protein Chemistry Section,0.0
Translational Mycology Section,Quantitative Virology and Evolution Unit,0.0
Translational Mycology Section,RML Flow Cytometry Unit,0.0
Translational Mycology Section,RML Genomics Unit,0.0
Translational Mycology Section,RML Microscopy Unit,0.0
Translational Mycology Section,RNA Viruses Section,0.0
Translational Mycology Section,Research Technology Branch,0.0
Translational Mycology Section,Retroviral Immunology Section,0.0
Translational Mycology Section,Salmonella-Host Cell Interactions Section,0.0
Translational Mycology Section,Scientist Emerita,0.0
Translational Mycology Section,Structural Biology Section,0.0
Translational Mycology Section,Structural Immunology Section,0.0
Translational Mycology Section,Structural Informatics Unit,0.0
Translational Mycology Section,Structural Virology Section,0.0
Translational Mycology Section,Systems Genomics Section,0.0
Translational Mycology Section,T-Cell Tolerance and Memory Section,0.0
Translational Mycology Section,T-Lymphocyte Biology Section,0.0
Translational Mycology Section,TSE/Prion Biochemistry Section,0.0
Translational Mycology Section,TSE/Prion Molecular Biology Section,0.0
Translational Mycology Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Translational Mycology Section,Tick-Pathogen Transmission Unit,0.0
Translational Mycology Section,Translational Allergic Immunopathology Unit,0.0
Translational Mycology Section,Translational Immunobiology Unit,0.0
Transplant Infectious Diseases Consult Service,Allergy and Immunology Clinical Training Program,0.0
Transplant Infectious Diseases Consult Service,Antibacterial Host Defense Unit,0.0
Transplant Infectious Diseases Consult Service,Antibody Biology Unit,0.0
Transplant Infectious Diseases Consult Service,Apicomplexan Molecular Physiology Section,0.0
Transplant Infectious Diseases Consult Service,Autoimmunity and Functional Genomics Section,0.0
Transplant Infectious Diseases Consult Service,B-Cell Immunology Section,0.0
Transplant Infectious Diseases Consult Service,B-Cell Molecular Immunology Section,0.0
Transplant Infectious Diseases Consult Service,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Transplant Infectious Diseases Consult Service,Bacterial Physiology and Metabolism Unit,0.0
Transplant Infectious Diseases Consult Service,Barrier Immunity Section,0.0
Transplant Infectious Diseases Consult Service,Biological Imaging,0.0
Transplant Infectious Diseases Consult Service,Biology of Vector-Borne Viruses Section,0.0
Transplant Infectious Diseases Consult Service,Building 14B South,0.0
Transplant Infectious Diseases Consult Service,Building 33,0.0
Transplant Infectious Diseases Consult Service,Building 50,0.0
Transplant Infectious Diseases Consult Service,Building NIHAC/103,0.0
Transplant Infectious Diseases Consult Service,Buildings 4 and 10/11C127,0.0
Transplant Infectious Diseases Consult Service,Caliciviruses Section,0.0
Transplant Infectious Diseases Consult Service,Cell Signaling and Immunity Section,0.0
Transplant Infectious Diseases Consult Service,Cellular Biology Section,0.0
Transplant Infectious Diseases Consult Service,Cellular Immunology Section,0.0
Transplant Infectious Diseases Consult Service,Chemotaxis Signal Section,0.0
Transplant Infectious Diseases Consult Service,Chlamydial Diseases Section,0.0
Transplant Infectious Diseases Consult Service,Clinical Microbiome Unit (CMU),0.0
Transplant Infectious Diseases Consult Service,Clinical Pathophysiology Section,0.0
Transplant Infectious Diseases Consult Service,Clinical Research Section,0.0
Transplant Infectious Diseases Consult Service,Clinical and Molecular Retrovirology Section,0.0
Transplant Infectious Diseases Consult Service,Computational Biology Unit,0.0
Transplant Infectious Diseases Consult Service,Coxiella Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,DNA Tumor Virus Section,0.0
Transplant Infectious Diseases Consult Service,Disease Modeling and Transmission Section,0.0
Transplant Infectious Diseases Consult Service,Emerging Respiratory Viruses Section,0.0
Transplant Infectious Diseases Consult Service,Emerging Virus Immunity Unit,0.0
Transplant Infectious Diseases Consult Service,Epidemiology and Population Studies Unit,0.0
Transplant Infectious Diseases Consult Service,Epithelial Therapeutics Unit,0.0
Transplant Infectious Diseases Consult Service,Flow Cytometry Section,0.0
Transplant Infectious Diseases Consult Service,Food Allergy Research Section,0.0
Transplant Infectious Diseases Consult Service,Functional Cellular Networks Section,0.0
Transplant Infectious Diseases Consult Service,Fungal Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,Gene Regulation Section,0.0
Transplant Infectious Diseases Consult Service,Genetic Engineering Section,0.0
Transplant Infectious Diseases Consult Service,Genetic Immunotherapy Section,0.0
Transplant Infectious Diseases Consult Service,Genomic Technologies Section,0.0
Transplant Infectious Diseases Consult Service,HIV Immunovirology Section,0.0
Transplant Infectious Diseases Consult Service,HIV Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,HIV-Specific Immunity Section,0.0
Transplant Infectious Diseases Consult Service,Helminth Immunology Section,0.0
Transplant Infectious Diseases Consult Service,Hepatic Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,Host-Parasite Interactions Section,0.0
Transplant Infectious Diseases Consult Service,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Transplant Infectious Diseases Consult Service,Human Eosinophil Section,0.0
Transplant Infectious Diseases Consult Service,Immune Activation Section,0.0
Transplant Infectious Diseases Consult Service,Immune Deficiency Genetics Section,0.0
Transplant Infectious Diseases Consult Service,Immunity to Pulmonary Pathogens Section,0.0
Transplant Infectious Diseases Consult Service,Immunobiology Section,0.0
Transplant Infectious Diseases Consult Service,Immunobiology and Molecular Virology Unit,0.0
Transplant Infectious Diseases Consult Service,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Transplant Infectious Diseases Consult Service,Infectious Disease Fellowship Training Program,0.0
Transplant Infectious Diseases Consult Service,Infectious Disease Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,Inflammation & Innate Immunity Unit,0.0
Transplant Infectious Diseases Consult Service,Inflammation Biology Section,0.0
Transplant Infectious Diseases Consult Service,Innate Immunity and Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,Integrative Immunobiology Section,0.0
Transplant Infectious Diseases Consult Service,International HIV/STD Section,0.0
Transplant Infectious Diseases Consult Service,Intracellular Parasite Biology Section,0.0
Transplant Infectious Diseases Consult Service,LID Clinical Studies Unit,0.0
Transplant Infectious Diseases Consult Service,Lung and Vascular Inflammation Section,0.0
Transplant Infectious Diseases Consult Service,Lyme Disease Studies Unit,0.0
Transplant Infectious Diseases Consult Service,Lymphocyte Activation Section,0.0
Transplant Infectious Diseases Consult Service,Lymphocyte Biology Section,0.0
Transplant Infectious Diseases Consult Service,Malaria Cell Biology Section,0.0
Transplant Infectious Diseases Consult Service,Malaria Functional Genomics Section,0.0
Transplant Infectious Diseases Consult Service,Malaria Genetics Section,0.0
Transplant Infectious Diseases Consult Service,Malaria Immunology Section,0.0
Transplant Infectious Diseases Consult Service,Malaria Infection Biology and Immunity Unit,0.0
Transplant Infectious Diseases Consult Service,Mast Cell Biology Section,0.0
Transplant Infectious Diseases Consult Service,Medical Virology Section,0.0
Transplant Infectious Diseases Consult Service,Metaorganism Immunity Section,0.0
Transplant Infectious Diseases Consult Service,Microbial Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Biology Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Defenses Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Development of the Immune System Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Entomology Unit,0.0
Transplant Infectious Diseases Consult Service,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Transplant Infectious Diseases Consult Service,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Transplant Infectious Diseases Consult Service,Molecular HIV Host Interactions Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Microbiology Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Parasitology Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Parasitology and Entomology Unit,0.0
Transplant Infectious Diseases Consult Service,Molecular Pathogenesis Unit,0.0
Transplant Infectious Diseases Consult Service,Molecular Pathogenesis and Biomarkers Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Pathology Section,0.0
Transplant Infectious Diseases Consult Service,Molecular Signaling Section,0.0
Transplant Infectious Diseases Consult Service,Molecular and Cellular Immunology Section,0.0
Transplant Infectious Diseases Consult Service,Molecular and Cellular Immunoregulation Section,0.0
Transplant Infectious Diseases Consult Service,Mosquito Immunity and Vector Competence Section,0.0
Transplant Infectious Diseases Consult Service,Mucosal Immunity Section,0.0
Transplant Infectious Diseases Consult Service,Mucosal Immunobiology Section,0.0
Transplant Infectious Diseases Consult Service,Multiscale Systems Biology Section,0.0
Transplant Infectious Diseases Consult Service,NIAID International Center of Excellence in Research Cambodia,0.0
Transplant Infectious Diseases Consult Service,Neuroimmunological Diseases Section,0.0
Transplant Infectious Diseases Consult Service,Neuroimmunology Unit,0.0
Transplant Infectious Diseases Consult Service,Nonhuman Primate Virology Section,0.0
Transplant Infectious Diseases Consult Service,Office of the Animal Program Director,0.0
Transplant Infectious Diseases Consult Service,Pathogen Molecular Genetics Section,0.0
Transplant Infectious Diseases Consult Service,Pathogen-Host Cell Biology Section,0.0
Transplant Infectious Diseases Consult Service,Pathogenesis and Immunity Section,0.0
Transplant Infectious Diseases Consult Service,Pathology Core,0.0
Transplant Infectious Diseases Consult Service,Physiology Unit,0.0
Transplant Infectious Diseases Consult Service,Plague Section,0.0
Transplant Infectious Diseases Consult Service,Primary Immune Deficiency Clinic,0.0
Transplant Infectious Diseases Consult Service,Prion Cell Biology Unit,0.0
Transplant Infectious Diseases Consult Service,Protein Chemistry Section,0.0
Transplant Infectious Diseases Consult Service,Quantitative Virology and Evolution Unit,0.0
Transplant Infectious Diseases Consult Service,RML Flow Cytometry Unit,0.0
Transplant Infectious Diseases Consult Service,RML Genomics Unit,0.0
Transplant Infectious Diseases Consult Service,RML Microscopy Unit,0.0
Transplant Infectious Diseases Consult Service,RNA Viruses Section,0.0
Transplant Infectious Diseases Consult Service,Research Technology Branch,0.0
Transplant Infectious Diseases Consult Service,Retroviral Immunology Section,0.0
Transplant Infectious Diseases Consult Service,Salmonella-Host Cell Interactions Section,0.0
Transplant Infectious Diseases Consult Service,Scientist Emerita,0.0
Transplant Infectious Diseases Consult Service,Signaling Systems Section,0.0
Transplant Infectious Diseases Consult Service,Structural Biology Section,0.0
Transplant Infectious Diseases Consult Service,Structural Immunology Section,0.0
Transplant Infectious Diseases Consult Service,Structural Informatics Unit,0.0
Transplant Infectious Diseases Consult Service,Structural Virology Section,0.0
Transplant Infectious Diseases Consult Service,Systems Genomics Section,0.0
Transplant Infectious Diseases Consult Service,T-Cell Tolerance and Memory Section,0.0
Transplant Infectious Diseases Consult Service,T-Lymphocyte Biology Section,0.0
Transplant Infectious Diseases Consult Service,TSE/Prion Biochemistry Section,0.0
Transplant Infectious Diseases Consult Service,TSE/Prion Molecular Biology Section,0.0
Transplant Infectious Diseases Consult Service,TSE/Prion and Retroviral Pathogenesis Section,0.0
Transplant Infectious Diseases Consult Service,Tick-Pathogen Transmission Unit,0.0
Transplant Infectious Diseases Consult Service,Translational Allergic Immunopathology Unit,0.0
Transplant Infectious Diseases Consult Service,Translational Autoinflammatory Disease Studies Unit,0.0
Transplant Infectious Diseases Consult Service,Translational Immunobiology Unit,0.0
Transplant Infectious Diseases Consult Service,Translational Mycology Section,0.0
Tuberculosis Research Section,Allergy and Immunology Clinical Training Program,0.0
Tuberculosis Research Section,Antibacterial Host Defense Unit,0.0
Tuberculosis Research Section,Antibody Biology Unit,0.0
Tuberculosis Research Section,Apicomplexan Molecular Physiology Section,0.0
Tuberculosis Research Section,Autoimmunity and Functional Genomics Section,0.0
Tuberculosis Research Section,B-Cell Immunology Section,0.0
Tuberculosis Research Section,B-Cell Molecular Immunology Section,0.0
Tuberculosis Research Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Tuberculosis Research Section,Bacterial Physiology and Metabolism Unit,0.0
Tuberculosis Research Section,Barrier Immunity Section,0.0
Tuberculosis Research Section,Biological Imaging,0.0
Tuberculosis Research Section,Biology of Vector-Borne Viruses Section,0.0
Tuberculosis Research Section,Building 14B South,0.0
Tuberculosis Research Section,Building 50,0.0
Tuberculosis Research Section,Building NIHAC/103,0.0
Tuberculosis Research Section,Buildings 4 and 10/11C127,0.0
Tuberculosis Research Section,Caliciviruses Section,0.0
Tuberculosis Research Section,Cell Signaling and Immunity Section,0.0
Tuberculosis Research Section,Cellular Biology Section,0.0
Tuberculosis Research Section,Cellular Immunology Section,0.0
Tuberculosis Research Section,Chemotaxis Signal Section,0.0
Tuberculosis Research Section,Chlamydial Diseases Section,0.0
Tuberculosis Research Section,Clinical Microbiome Unit (CMU),0.0
Tuberculosis Research Section,Clinical Pathophysiology Section,0.0
Tuberculosis Research Section,Clinical Research Section,0.0
Tuberculosis Research Section,Clinical and Molecular Retrovirology Section,0.0
Tuberculosis Research Section,Computational Biology Unit,0.0
Tuberculosis Research Section,Coxiella Pathogenesis Section,0.0
Tuberculosis Research Section,DNA Tumor Virus Section,0.0
Tuberculosis Research Section,Disease Modeling and Transmission Section,0.0
Tuberculosis Research Section,Emerging Respiratory Viruses Section,0.0
Tuberculosis Research Section,Emerging Virus Immunity Unit,0.0
Tuberculosis Research Section,Epithelial Therapeutics Unit,0.0
Tuberculosis Research Section,Flow Cytometry Section,0.0
Tuberculosis Research Section,Food Allergy Research Section,0.0
Tuberculosis Research Section,Functional Cellular Networks Section,0.0
Tuberculosis Research Section,Fungal Pathogenesis Section,0.0
Tuberculosis Research Section,Gene Regulation Section,0.0
Tuberculosis Research Section,Genetic Engineering Section,0.0
Tuberculosis Research Section,Genetic Immunotherapy Section,0.0
Tuberculosis Research Section,HIV Immunovirology Section,0.0
Tuberculosis Research Section,HIV Pathogenesis Section,0.0
Tuberculosis Research Section,HIV-Specific Immunity Section,0.0
Tuberculosis Research Section,Helminth Immunology Section,0.0
Tuberculosis Research Section,Hepatic Pathogenesis Section,0.0
Tuberculosis Research Section,Host-Parasite Interactions Section,0.0
Tuberculosis Research Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Tuberculosis Research Section,Human Eosinophil Section,0.0
Tuberculosis Research Section,Human Immunological Diseases Section,0.0
Tuberculosis Research Section,Immune Activation Section,0.0
Tuberculosis Research Section,Immune Deficiency Genetics Section,0.0
Tuberculosis Research Section,Immunity to Pulmonary Pathogens Section,0.0
Tuberculosis Research Section,Immunobiology and Molecular Virology Unit,0.0
Tuberculosis Research Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Tuberculosis Research Section,Infectious Disease Fellowship Training Program,0.0
Tuberculosis Research Section,Inflammation Biology Section,0.0
Tuberculosis Research Section,Innate Immunity and Pathogenesis Section,0.0
Tuberculosis Research Section,Integrative Immunobiology Section,0.0
Tuberculosis Research Section,International HIV/STD Section,0.0
Tuberculosis Research Section,Intracellular Parasite Biology Section,0.0
Tuberculosis Research Section,LID Clinical Studies Unit,0.0
Tuberculosis Research Section,Lung and Vascular Inflammation Section,0.0
Tuberculosis Research Section,Lyme Disease Studies Unit,0.0
Tuberculosis Research Section,Lymphocyte Activation Section,0.0
Tuberculosis Research Section,Lymphocyte Biology Section,0.0
Tuberculosis Research Section,Malaria Cell Biology Section,0.0
Tuberculosis Research Section,Malaria Functional Genomics Section,0.0
Tuberculosis Research Section,Malaria Genetics Section,0.0
Tuberculosis Research Section,Malaria Immunology Section,0.0
Tuberculosis Research Section,Malaria Infection Biology and Immunity Unit,0.0
Tuberculosis Research Section,Mast Cell Biology Section,0.0
Tuberculosis Research Section,Medical Virology Section,0.0
Tuberculosis Research Section,Metaorganism Immunity Section,0.0
Tuberculosis Research Section,Microbial Pathogenesis Section,0.0
Tuberculosis Research Section,Molecular Biology Section,0.0
Tuberculosis Research Section,Molecular Defenses Section,0.0
Tuberculosis Research Section,Molecular Development of the Immune System Section,0.0
Tuberculosis Research Section,Molecular Entomology Unit,0.0
Tuberculosis Research Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Tuberculosis Research Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Tuberculosis Research Section,Molecular HIV Host Interactions Section,0.0
Tuberculosis Research Section,Molecular Microbiology Section,0.0
Tuberculosis Research Section,Molecular Parasitology Section,0.0
Tuberculosis Research Section,Molecular Parasitology and Entomology Unit,0.0
Tuberculosis Research Section,Molecular Pathogenesis Unit,0.0
Tuberculosis Research Section,Molecular Pathogenesis and Biomarkers Section,0.0
Tuberculosis Research Section,Molecular Pathology Section,0.0
Tuberculosis Research Section,Molecular Signaling Section,0.0
Tuberculosis Research Section,Molecular and Cellular Immunology Section,0.0
Tuberculosis Research Section,Molecular and Cellular Immunoregulation Section,0.0
Tuberculosis Research Section,Mosquito Immunity and Vector Competence Section,0.0
Tuberculosis Research Section,Mucosal Immunity Section,0.0
Tuberculosis Research Section,Mucosal Immunobiology Section,0.0
Tuberculosis Research Section,Multiscale Systems Biology Section,0.0
Tuberculosis Research Section,NIAID International Center of Excellence in Research Cambodia,0.0
Tuberculosis Research Section,Neuroimmunological Diseases Section,0.0
Tuberculosis Research Section,Neuroimmunology Unit,0.0
Tuberculosis Research Section,Nonhuman Primate Virology Section,0.0
Tuberculosis Research Section,Office of the Animal Program Director,0.0
Tuberculosis Research Section,Pathogen Molecular Genetics Section,0.0
Tuberculosis Research Section,Pathogen-Host Cell Biology Section,0.0
Tuberculosis Research Section,Pathogenesis and Immunity Section,0.0
Tuberculosis Research Section,Pathology Core,0.0
Tuberculosis Research Section,Physiology Unit,0.0
Tuberculosis Research Section,Plague Section,0.0
Tuberculosis Research Section,Primary Immune Deficiency Clinic,0.0
Tuberculosis Research Section,Prion Cell Biology Unit,0.0
Tuberculosis Research Section,Protein Chemistry Section,0.0
Tuberculosis Research Section,Quantitative Virology and Evolution Unit,0.0
Tuberculosis Research Section,RML Flow Cytometry Unit,0.0
Tuberculosis Research Section,RML Genomics Unit,0.0
Tuberculosis Research Section,RNA Viruses Section,0.0
Tuberculosis Research Section,Research Technology Branch,0.0
Tuberculosis Research Section,Retroviral Immunology Section,0.0
Tuberculosis Research Section,Salmonella-Host Cell Interactions Section,0.0
Tuberculosis Research Section,Scientist Emerita,0.0
Tuberculosis Research Section,Signaling Systems Section,0.0
Tuberculosis Research Section,Structural Immunology Section,0.0
Tuberculosis Research Section,Structural Informatics Unit,0.0
Tuberculosis Research Section,Structural Virology Section,0.0
Tuberculosis Research Section,Systems Genomics Section,0.0
Tuberculosis Research Section,T-Cell Tolerance and Memory Section,0.0
Tuberculosis Research Section,TSE/Prion Biochemistry Section,0.0
Tuberculosis Research Section,TSE/Prion Molecular Biology Section,0.0
Tuberculosis Research Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Tuberculosis Research Section,Tick-Pathogen Transmission Unit,0.0
Tuberculosis Research Section,Translational Allergic Immunopathology Unit,0.0
Tuberculosis Research Section,Translational Autoinflammatory Disease Studies Unit,0.0
Tuberculosis Research Section,Translational Immunobiology Unit,0.0
Tuberculosis Research Section,Translational Mycology Section,0.0
Tuberculosis Research Section,Transplant Infectious Diseases Consult Service,0.0
Twinbrook III,Allergy and Immunology Clinical Training Program,0.0
Twinbrook III,Antibacterial Host Defense Unit,0.0
Twinbrook III,Antibody Biology Unit,0.0
Twinbrook III,Apicomplexan Molecular Physiology Section,0.0
Twinbrook III,Autoimmunity and Functional Genomics Section,0.0
Twinbrook III,B-Cell Immunology Section,0.0
Twinbrook III,B-Cell Molecular Immunology Section,0.0
Twinbrook III,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Twinbrook III,Bacterial Physiology and Metabolism Unit,0.0
Twinbrook III,Barrier Immunity Section,0.0
Twinbrook III,Biological Imaging,0.0
Twinbrook III,Biology of Vector-Borne Viruses Section,0.0
Twinbrook III,Building 14B South,0.0
Twinbrook III,Building 33,0.0
Twinbrook III,Building 50,0.0
Twinbrook III,Buildings 4 and 10/11C127,0.0
Twinbrook III,Caliciviruses Section,0.0
Twinbrook III,Cell Signaling and Immunity Section,0.0
Twinbrook III,Cellular Biology Section,0.0
Twinbrook III,Cellular Immunology Section,0.0
Twinbrook III,Chemotaxis Signal Section,0.0
Twinbrook III,Chlamydial Diseases Section,0.0
Twinbrook III,Clinical Microbiome Unit (CMU),0.0
Twinbrook III,Clinical Pathophysiology Section,0.0
Twinbrook III,Clinical Research Section,0.0
Twinbrook III,Clinical and Molecular Retrovirology Section,0.0
Twinbrook III,Computational Biology Unit,0.0
Twinbrook III,Coxiella Pathogenesis Section,0.0
Twinbrook III,DNA Tumor Virus Section,0.0
Twinbrook III,Disease Modeling and Transmission Section,0.0
Twinbrook III,Emerging Respiratory Viruses Section,0.0
Twinbrook III,Emerging Virus Immunity Unit,0.0
Twinbrook III,Epidemiology and Population Studies Unit,0.0
Twinbrook III,Epithelial Therapeutics Unit,0.0
Twinbrook III,Flow Cytometry Section,0.0
Twinbrook III,Food Allergy Research Section,0.0
Twinbrook III,Functional Cellular Networks Section,0.0
Twinbrook III,Fungal Pathogenesis Section,0.0
Twinbrook III,Gene Regulation Section,0.0
Twinbrook III,Genetic Engineering Section,0.0
Twinbrook III,Genetic Immunotherapy Section,0.0
Twinbrook III,Genomic Technologies Section,0.0
Twinbrook III,HIV Immunovirology Section,0.0
Twinbrook III,HIV Pathogenesis Section,0.0
Twinbrook III,HIV-Specific Immunity Section,0.0
Twinbrook III,Helminth Immunology Section,0.0
Twinbrook III,Hepatic Pathogenesis Section,0.0
Twinbrook III,Host-Parasite Interactions Section,0.0
Twinbrook III,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Twinbrook III,Human Eosinophil Section,0.0
Twinbrook III,Human Immunological Diseases Section,0.0
Twinbrook III,Immune Activation Section,0.0
Twinbrook III,Immune Deficiency Genetics Section,0.0
Twinbrook III,Immunity to Pulmonary Pathogens Section,0.0
Twinbrook III,Immunobiology Section,0.0
Twinbrook III,Immunobiology and Molecular Virology Unit,0.0
Twinbrook III,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Twinbrook III,Infectious Disease Fellowship Training Program,0.0
Twinbrook III,Infectious Disease Pathogenesis Section,0.0
Twinbrook III,Inflammation & Innate Immunity Unit,0.0
Twinbrook III,Inflammation Biology Section,0.0
Twinbrook III,Innate Immunity and Pathogenesis Section,0.0
Twinbrook III,Integrative Immunobiology Section,0.0
Twinbrook III,International HIV/STD Section,0.0
Twinbrook III,Intracellular Parasite Biology Section,0.0
Twinbrook III,LID Clinical Studies Unit,0.0
Twinbrook III,Lung and Vascular Inflammation Section,0.0
Twinbrook III,Lyme Disease Studies Unit,0.0
Twinbrook III,Lymphocyte Activation Section,0.0
Twinbrook III,Lymphocyte Biology Section,0.0
Twinbrook III,Malaria Cell Biology Section,0.0
Twinbrook III,Malaria Functional Genomics Section,0.0
Twinbrook III,Malaria Genetics Section,0.0
Twinbrook III,Malaria Immunology Section,0.0
Twinbrook III,Malaria Infection Biology and Immunity Unit,0.0
Twinbrook III,Mast Cell Biology Section,0.0
Twinbrook III,Medical Virology Section,0.0
Twinbrook III,Metaorganism Immunity Section,0.0
Twinbrook III,Microbial Pathogenesis Section,0.0
Twinbrook III,Molecular Biology Section,0.0
Twinbrook III,Molecular Defenses Section,0.0
Twinbrook III,Molecular Development of the Immune System Section,0.0
Twinbrook III,Molecular Entomology Unit,0.0
Twinbrook III,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Twinbrook III,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Twinbrook III,Molecular HIV Host Interactions Section,0.0
Twinbrook III,Molecular Microbiology Section,0.0
Twinbrook III,Molecular Parasitology Section,0.0
Twinbrook III,Molecular Parasitology and Entomology Unit,0.0
Twinbrook III,Molecular Pathogenesis Unit,0.0
Twinbrook III,Molecular Pathogenesis and Biomarkers Section,0.0
Twinbrook III,Molecular Pathology Section,0.0
Twinbrook III,Molecular Signaling Section,0.0
Twinbrook III,Molecular and Cellular Immunology Section,0.0
Twinbrook III,Molecular and Cellular Immunoregulation Section,0.0
Twinbrook III,Mosquito Immunity and Vector Competence Section,0.0
Twinbrook III,Mucosal Immunity Section,0.0
Twinbrook III,Mucosal Immunobiology Section,0.0
Twinbrook III,Multiscale Systems Biology Section,0.0
Twinbrook III,NIAID International Center of Excellence in Research Cambodia,0.0
Twinbrook III,Neuroimmunological Diseases Section,0.0
Twinbrook III,Neuroimmunology Unit,0.0
Twinbrook III,Nonhuman Primate Virology Section,0.0
Twinbrook III,Office of the Animal Program Director,0.0
Twinbrook III,Pathogen Molecular Genetics Section,0.0
Twinbrook III,Pathogen-Host Cell Biology Section,0.0
Twinbrook III,Pathogenesis and Immunity Section,0.0
Twinbrook III,Pathology Core,0.0
Twinbrook III,Physiology Unit,0.0
Twinbrook III,Plague Section,0.0
Twinbrook III,Primary Immune Deficiency Clinic,0.0
Twinbrook III,Prion Cell Biology Unit,0.0
Twinbrook III,Protein Chemistry Section,0.0
Twinbrook III,Quantitative Virology and Evolution Unit,0.0
Twinbrook III,RML Flow Cytometry Unit,0.0
Twinbrook III,RML Genomics Unit,0.0
Twinbrook III,RML Microscopy Unit,0.0
Twinbrook III,RNA Viruses Section,0.0
Twinbrook III,Research Technology Branch,0.0
Twinbrook III,Retroviral Immunology Section,0.0
Twinbrook III,Salmonella-Host Cell Interactions Section,0.0
Twinbrook III,Scientist Emerita,0.0
Twinbrook III,Signaling Systems Section,0.0
Twinbrook III,Structural Biology Section,0.0
Twinbrook III,Structural Immunology Section,0.0
Twinbrook III,Structural Informatics Unit,0.0
Twinbrook III,Structural Virology Section,0.0
Twinbrook III,Systems Genomics Section,0.0
Twinbrook III,T-Cell Tolerance and Memory Section,0.0
Twinbrook III,T-Lymphocyte Biology Section,0.0
Twinbrook III,TSE/Prion Biochemistry Section,0.0
Twinbrook III,TSE/Prion Molecular Biology Section,0.0
Twinbrook III,TSE/Prion and Retroviral Pathogenesis Section,0.0
Twinbrook III,Tick-Pathogen Transmission Unit,0.0
Twinbrook III,Translational Allergic Immunopathology Unit,0.0
Twinbrook III,Translational Autoinflammatory Disease Studies Unit,0.0
Twinbrook III,Translational Immunobiology Unit,0.0
Twinbrook III,Translational Mycology Section,0.0
Twinbrook III,Transplant Infectious Diseases Consult Service,0.0
Twinbrook III,Tuberculosis Research Section,0.0
Twinbrook Imaging Facility,Allergy and Immunology Clinical Training Program,0.0
Twinbrook Imaging Facility,Antibacterial Host Defense Unit,0.0
Twinbrook Imaging Facility,Antibody Biology Unit,0.0
Twinbrook Imaging Facility,Autoimmunity and Functional Genomics Section,0.0
Twinbrook Imaging Facility,B-Cell Immunology Section,0.0
Twinbrook Imaging Facility,B-Cell Molecular Immunology Section,0.0
Twinbrook Imaging Facility,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Twinbrook Imaging Facility,Bacterial Physiology and Metabolism Unit,0.0
Twinbrook Imaging Facility,Barrier Immunity Section,0.0
Twinbrook Imaging Facility,Biological Imaging,0.0
Twinbrook Imaging Facility,Biology of Vector-Borne Viruses Section,0.0
Twinbrook Imaging Facility,Building 14B South,0.0
Twinbrook Imaging Facility,Building 33,0.0
Twinbrook Imaging Facility,Building 50,0.0
Twinbrook Imaging Facility,Building NIHAC/103,0.0
Twinbrook Imaging Facility,Buildings 4 and 10/11C127,0.0
Twinbrook Imaging Facility,Caliciviruses Section,0.0
Twinbrook Imaging Facility,Cell Signaling and Immunity Section,0.0
Twinbrook Imaging Facility,Cellular Biology Section,0.0
Twinbrook Imaging Facility,Cellular Immunology Section,0.0
Twinbrook Imaging Facility,Chlamydial Diseases Section,0.0
Twinbrook Imaging Facility,Clinical Microbiome Unit (CMU),0.0
Twinbrook Imaging Facility,Clinical Pathophysiology Section,0.0
Twinbrook Imaging Facility,Clinical Research Section,0.0
Twinbrook Imaging Facility,Clinical and Molecular Retrovirology Section,0.0
Twinbrook Imaging Facility,Coxiella Pathogenesis Section,0.0
Twinbrook Imaging Facility,DNA Tumor Virus Section,0.0
Twinbrook Imaging Facility,Disease Modeling and Transmission Section,0.0
Twinbrook Imaging Facility,Emerging Respiratory Viruses Section,0.0
Twinbrook Imaging Facility,Emerging Virus Immunity Unit,0.0
Twinbrook Imaging Facility,Epidemiology and Population Studies Unit,0.0
Twinbrook Imaging Facility,Epithelial Therapeutics Unit,0.0
Twinbrook Imaging Facility,Flow Cytometry Section,0.0
Twinbrook Imaging Facility,Functional Cellular Networks Section,0.0
Twinbrook Imaging Facility,Fungal Pathogenesis Section,0.0
Twinbrook Imaging Facility,Gene Regulation Section,0.0
Twinbrook Imaging Facility,Genetic Engineering Section,0.0
Twinbrook Imaging Facility,Genetic Immunotherapy Section,0.0
Twinbrook Imaging Facility,Genomic Technologies Section,0.0
Twinbrook Imaging Facility,HIV Immunovirology Section,0.0
Twinbrook Imaging Facility,HIV Pathogenesis Section,0.0
Twinbrook Imaging Facility,HIV-Specific Immunity Section,0.0
Twinbrook Imaging Facility,Helminth Immunology Section,0.0
Twinbrook Imaging Facility,Hepatic Pathogenesis Section,0.0
Twinbrook Imaging Facility,Host-Parasite Interactions Section,0.0
Twinbrook Imaging Facility,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Twinbrook Imaging Facility,Human Eosinophil Section,0.0
Twinbrook Imaging Facility,Human Immunological Diseases Section,0.0
Twinbrook Imaging Facility,Immune Activation Section,0.0
Twinbrook Imaging Facility,Immune Deficiency Genetics Section,0.0
Twinbrook Imaging Facility,Immunity to Pulmonary Pathogens Section,0.0
Twinbrook Imaging Facility,Immunobiology Section,0.0
Twinbrook Imaging Facility,Immunobiology and Molecular Virology Unit,0.0
Twinbrook Imaging Facility,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Twinbrook Imaging Facility,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Twinbrook Imaging Facility,Infectious Disease Fellowship Training Program,0.0
Twinbrook Imaging Facility,Infectious Disease Pathogenesis Section,0.0
Twinbrook Imaging Facility,Inflammation & Innate Immunity Unit,0.0
Twinbrook Imaging Facility,Inflammation Biology Section,0.0
Twinbrook Imaging Facility,Innate Immunity and Pathogenesis Section,0.0
Twinbrook Imaging Facility,Integrative Immunobiology Section,0.0
Twinbrook Imaging Facility,International HIV/STD Section,0.0
Twinbrook Imaging Facility,Intracellular Parasite Biology Section,0.0
Twinbrook Imaging Facility,LID Clinical Studies Unit,0.0
Twinbrook Imaging Facility,Lung and Vascular Inflammation Section,0.0
Twinbrook Imaging Facility,Lyme Disease Studies Unit,0.0
Twinbrook Imaging Facility,Lymphocyte Biology Section,0.0
Twinbrook Imaging Facility,Malaria Functional Genomics Section,0.0
Twinbrook Imaging Facility,Malaria Immunology Section,0.0
Twinbrook Imaging Facility,Mast Cell Biology Section,0.0
Twinbrook Imaging Facility,Medical Virology Section,0.0
Twinbrook Imaging Facility,Metaorganism Immunity Section,0.0
Twinbrook Imaging Facility,Microbial Pathogenesis Section,0.0
Twinbrook Imaging Facility,Molecular Biology Section,0.0
Twinbrook Imaging Facility,Molecular Defenses Section,0.0
Twinbrook Imaging Facility,Molecular Development of the Immune System Section,0.0
Twinbrook Imaging Facility,Molecular Entomology Unit,0.0
Twinbrook Imaging Facility,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Twinbrook Imaging Facility,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Twinbrook Imaging Facility,Molecular HIV Host Interactions Section,0.0
Twinbrook Imaging Facility,Molecular Microbiology Section,0.0
Twinbrook Imaging Facility,Molecular Parasitology Section,0.0
Twinbrook Imaging Facility,Molecular Parasitology and Entomology Unit,0.0
Twinbrook Imaging Facility,Molecular Pathogenesis Unit,0.0
Twinbrook Imaging Facility,Molecular Pathogenesis and Biomarkers Section,0.0
Twinbrook Imaging Facility,Molecular Pathology Section,0.0
Twinbrook Imaging Facility,Molecular Signaling Section,0.0
Twinbrook Imaging Facility,Molecular and Cellular Immunoregulation Section,0.0
Twinbrook Imaging Facility,Mosquito Immunity and Vector Competence Section,0.0
Twinbrook Imaging Facility,Mucosal Immunity Section,0.0
Twinbrook Imaging Facility,Mucosal Immunobiology Section,0.0
Twinbrook Imaging Facility,Multiscale Systems Biology Section,0.0
Twinbrook Imaging Facility,NIAID International Center of Excellence in Research Cambodia,0.0
Twinbrook Imaging Facility,Neuroimmunological Diseases Section,0.0
Twinbrook Imaging Facility,Neuroimmunology Unit,0.0
Twinbrook Imaging Facility,Nonhuman Primate Virology Section,0.0
Twinbrook Imaging Facility,Office of the Animal Program Director,0.0
Twinbrook Imaging Facility,Pathogen Molecular Genetics Section,0.0
Twinbrook Imaging Facility,Pathogen-Host Cell Biology Section,0.0
Twinbrook Imaging Facility,Pathology Core,0.0
Twinbrook Imaging Facility,Physiology Unit,0.0
Twinbrook Imaging Facility,Plague Section,0.0
Twinbrook Imaging Facility,Primary Immune Deficiency Clinic,0.0
Twinbrook Imaging Facility,Prion Cell Biology Unit,0.0
Twinbrook Imaging Facility,Protein Chemistry Section,0.0
Twinbrook Imaging Facility,Quantitative Virology and Evolution Unit,0.0
Twinbrook Imaging Facility,RML Flow Cytometry Unit,0.0
Twinbrook Imaging Facility,RML Genomics Unit,0.0
Twinbrook Imaging Facility,RML Microscopy Unit,0.0
Twinbrook Imaging Facility,RNA Viruses Section,0.0
Twinbrook Imaging Facility,Research Technology Branch,0.0
Twinbrook Imaging Facility,Retroviral Immunology Section,0.0
Twinbrook Imaging Facility,Salmonella-Host Cell Interactions Section,0.0
Twinbrook Imaging Facility,Scientist Emerita,0.0
Twinbrook Imaging Facility,Signaling Systems Section,0.0
Twinbrook Imaging Facility,Structural Biology Section,0.0
Twinbrook Imaging Facility,Structural Immunology Section,0.0
Twinbrook Imaging Facility,Structural Informatics Unit,0.0
Twinbrook Imaging Facility,Structural Virology Section,0.0
Twinbrook Imaging Facility,Systems Genomics Section,0.0
Twinbrook Imaging Facility,T-Cell Tolerance and Memory Section,0.0
Twinbrook Imaging Facility,T-Lymphocyte Biology Section,0.0
Twinbrook Imaging Facility,TSE/Prion Biochemistry Section,0.0
Twinbrook Imaging Facility,TSE/Prion Molecular Biology Section,0.0
Twinbrook Imaging Facility,TSE/Prion and Retroviral Pathogenesis Section,0.0
Twinbrook Imaging Facility,Tick-Pathogen Transmission Unit,0.0
Twinbrook Imaging Facility,Translational Allergic Immunopathology Unit,0.0
Twinbrook Imaging Facility,Translational Autoinflammatory Disease Studies Unit,0.0
Twinbrook Imaging Facility,Translational Immunobiology Unit,0.0
Twinbrook Imaging Facility,Translational Mycology Section,0.0
Twinbrook Imaging Facility,Transplant Infectious Diseases Consult Service,0.0
Twinbrook Imaging Facility,Tuberculosis Research Section,0.0
Twinbrook Imaging Facility,Twinbrook III,0.0
Type 2 Immunity Section,Allergy and Immunology Clinical Training Program,0.0
Type 2 Immunity Section,Antibacterial Host Defense Unit,0.0
Type 2 Immunity Section,Antibody Biology Unit,0.0
Type 2 Immunity Section,Apicomplexan Molecular Physiology Section,0.0
Type 2 Immunity Section,Autoimmunity and Functional Genomics Section,0.0
Type 2 Immunity Section,B-Cell Immunology Section,0.0
Type 2 Immunity Section,B-Cell Molecular Immunology Section,0.0
Type 2 Immunity Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Type 2 Immunity Section,Bacterial Physiology and Metabolism Unit,0.0
Type 2 Immunity Section,Biological Imaging,0.0
Type 2 Immunity Section,Biology of Vector-Borne Viruses Section,0.0
Type 2 Immunity Section,Building 14B South,0.0
Type 2 Immunity Section,Building 33,0.0
Type 2 Immunity Section,Building 50,0.0
Type 2 Immunity Section,Building NIHAC/103,0.0
Type 2 Immunity Section,Buildings 4 and 10/11C127,0.0
Type 2 Immunity Section,Caliciviruses Section,0.0
Type 2 Immunity Section,Cell Signaling and Immunity Section,0.0
Type 2 Immunity Section,Cellular Biology Section,0.0
Type 2 Immunity Section,Cellular Immunology Section,0.0
Type 2 Immunity Section,Chemotaxis Signal Section,0.0
Type 2 Immunity Section,Chlamydial Diseases Section,0.0
Type 2 Immunity Section,Clinical Microbiome Unit (CMU),0.0
Type 2 Immunity Section,Clinical Pathophysiology Section,0.0
Type 2 Immunity Section,Clinical Research Section,0.0
Type 2 Immunity Section,Clinical and Molecular Retrovirology Section,0.0
Type 2 Immunity Section,Computational Biology Unit,0.0
Type 2 Immunity Section,Coxiella Pathogenesis Section,0.0
Type 2 Immunity Section,DNA Tumor Virus Section,0.0
Type 2 Immunity Section,Disease Modeling and Transmission Section,0.0
Type 2 Immunity Section,Emerging Respiratory Viruses Section,0.0
Type 2 Immunity Section,Emerging Virus Immunity Unit,0.0
Type 2 Immunity Section,Epidemiology and Population Studies Unit,0.0
Type 2 Immunity Section,Epithelial Therapeutics Unit,0.0
Type 2 Immunity Section,Flow Cytometry Section,0.0
Type 2 Immunity Section,Food Allergy Research Section,0.0
Type 2 Immunity Section,Functional Cellular Networks Section,0.0
Type 2 Immunity Section,Fungal Pathogenesis Section,0.0
Type 2 Immunity Section,Gene Regulation Section,0.0
Type 2 Immunity Section,Genetic Engineering Section,0.0
Type 2 Immunity Section,Genetic Immunotherapy Section,0.0
Type 2 Immunity Section,Genomic Technologies Section,0.0
Type 2 Immunity Section,HIV Immunovirology Section,0.0
Type 2 Immunity Section,HIV Pathogenesis Section,0.0
Type 2 Immunity Section,HIV-Specific Immunity Section,0.0
Type 2 Immunity Section,Helminth Immunology Section,0.0
Type 2 Immunity Section,Hepatic Pathogenesis Section,0.0
Type 2 Immunity Section,Host-Parasite Interactions Section,0.0
Type 2 Immunity Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Type 2 Immunity Section,Human Eosinophil Section,0.0
Type 2 Immunity Section,Human Immunological Diseases Section,0.0
Type 2 Immunity Section,Immune Activation Section,0.0
Type 2 Immunity Section,Immune Deficiency Genetics Section,0.0
Type 2 Immunity Section,Immunity to Pulmonary Pathogens Section,0.0
Type 2 Immunity Section,Immunobiology Section,0.0
Type 2 Immunity Section,Immunobiology and Molecular Virology Unit,0.0
Type 2 Immunity Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Type 2 Immunity Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Type 2 Immunity Section,Infectious Disease Fellowship Training Program,0.0
Type 2 Immunity Section,Infectious Disease Pathogenesis Section,0.0
Type 2 Immunity Section,Inflammation & Innate Immunity Unit,0.0
Type 2 Immunity Section,Inflammation Biology Section,0.0
Type 2 Immunity Section,Innate Immunity and Pathogenesis Section,0.0
Type 2 Immunity Section,Integrative Immunobiology Section,0.0
Type 2 Immunity Section,International HIV/STD Section,0.0
Type 2 Immunity Section,Intracellular Parasite Biology Section,0.0
Type 2 Immunity Section,LID Clinical Studies Unit,0.0
Type 2 Immunity Section,Lung and Vascular Inflammation Section,0.0
Type 2 Immunity Section,Lyme Disease Studies Unit,0.0
Type 2 Immunity Section,Lymphocyte Activation Section,0.0
Type 2 Immunity Section,Lymphocyte Biology Section,0.0
Type 2 Immunity Section,Malaria Cell Biology Section,0.0
Type 2 Immunity Section,Malaria Functional Genomics Section,0.0
Type 2 Immunity Section,Malaria Genetics Section,0.0
Type 2 Immunity Section,Malaria Immunology Section,0.0
Type 2 Immunity Section,Mast Cell Biology Section,0.0
Type 2 Immunity Section,Medical Virology Section,0.0
Type 2 Immunity Section,Metaorganism Immunity Section,0.0
Type 2 Immunity Section,Microbial Pathogenesis Section,0.0
Type 2 Immunity Section,Molecular Biology Section,0.0
Type 2 Immunity Section,Molecular Defenses Section,0.0
Type 2 Immunity Section,Molecular Development of the Immune System Section,0.0
Type 2 Immunity Section,Molecular Entomology Unit,0.0
Type 2 Immunity Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Type 2 Immunity Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Type 2 Immunity Section,Molecular HIV Host Interactions Section,0.0
Type 2 Immunity Section,Molecular Microbiology Section,0.0
Type 2 Immunity Section,Molecular Parasitology Section,0.0
Type 2 Immunity Section,Molecular Parasitology and Entomology Unit,0.0
Type 2 Immunity Section,Molecular Pathogenesis Unit,0.0
Type 2 Immunity Section,Molecular Pathogenesis and Biomarkers Section,0.0
Type 2 Immunity Section,Molecular Pathology Section,0.0
Type 2 Immunity Section,Molecular Signaling Section,0.0
Type 2 Immunity Section,Molecular and Cellular Immunology Section,0.0
Type 2 Immunity Section,Molecular and Cellular Immunoregulation Section,0.0
Type 2 Immunity Section,Mosquito Immunity and Vector Competence Section,0.0
Type 2 Immunity Section,Mucosal Immunity Section,0.0
Type 2 Immunity Section,Mucosal Immunobiology Section,0.0
Type 2 Immunity Section,Multiscale Systems Biology Section,0.0
Type 2 Immunity Section,NIAID International Center of Excellence in Research Cambodia,0.0
Type 2 Immunity Section,Neuroimmunological Diseases Section,0.0
Type 2 Immunity Section,Neuroimmunology Unit,0.0
Type 2 Immunity Section,Nonhuman Primate Virology Section,0.0
Type 2 Immunity Section,Office of the Animal Program Director,0.0
Type 2 Immunity Section,Pathogen Molecular Genetics Section,0.0
Type 2 Immunity Section,Pathogen-Host Cell Biology Section,0.0
Type 2 Immunity Section,Pathogenesis and Immunity Section,0.0
Type 2 Immunity Section,Pathology Core,0.0
Type 2 Immunity Section,Physiology Unit,0.0
Type 2 Immunity Section,Plague Section,0.0
Type 2 Immunity Section,Primary Immune Deficiency Clinic,0.0
Type 2 Immunity Section,Prion Cell Biology Unit,0.0
Type 2 Immunity Section,Protein Chemistry Section,0.0
Type 2 Immunity Section,Quantitative Virology and Evolution Unit,0.0
Type 2 Immunity Section,RML Flow Cytometry Unit,0.0
Type 2 Immunity Section,RML Genomics Unit,0.0
Type 2 Immunity Section,RML Microscopy Unit,0.0
Type 2 Immunity Section,RNA Viruses Section,0.0
Type 2 Immunity Section,Research Technology Branch,0.0
Type 2 Immunity Section,Retroviral Immunology Section,0.0
Type 2 Immunity Section,Salmonella-Host Cell Interactions Section,0.0
Type 2 Immunity Section,Scientist Emerita,0.0
Type 2 Immunity Section,Signaling Systems Section,0.0
Type 2 Immunity Section,Structural Biology Section,0.0
Type 2 Immunity Section,Structural Immunology Section,0.0
Type 2 Immunity Section,Structural Informatics Unit,0.0
Type 2 Immunity Section,Structural Virology Section,0.0
Type 2 Immunity Section,Systems Genomics Section,0.0
Type 2 Immunity Section,T-Cell Tolerance and Memory Section,0.0
Type 2 Immunity Section,T-Lymphocyte Biology Section,0.0
Type 2 Immunity Section,TSE/Prion Biochemistry Section,0.0
Type 2 Immunity Section,TSE/Prion Molecular Biology Section,0.0
Type 2 Immunity Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Type 2 Immunity Section,Tick-Pathogen Transmission Unit,0.0
Type 2 Immunity Section,Translational Allergic Immunopathology Unit,0.0
Type 2 Immunity Section,Translational Autoinflammatory Disease Studies Unit,0.0
Type 2 Immunity Section,Translational Immunobiology Unit,0.0
Type 2 Immunity Section,Translational Mycology Section,0.0
Type 2 Immunity Section,Transplant Infectious Diseases Consult Service,0.0
Type 2 Immunity Section,Tuberculosis Research Section,0.0
Type 2 Immunity Section,Twinbrook III,0.0
Type 2 Immunity Section,Twinbrook Imaging Facility,0.0
Vaccine Development Unit,Allergy and Immunology Clinical Training Program,0.0
Vaccine Development Unit,Antibacterial Host Defense Unit,0.0
Vaccine Development Unit,Antibody Biology Unit,0.0
Vaccine Development Unit,Autoimmunity and Functional Genomics Section,0.0
Vaccine Development Unit,B-Cell Immunology Section,0.0
Vaccine Development Unit,B-Cell Molecular Immunology Section,0.0
Vaccine Development Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Vaccine Development Unit,Bacterial Physiology and Metabolism Unit,0.0
Vaccine Development Unit,Barrier Immunity Section,0.0
Vaccine Development Unit,Biological Imaging,0.0
Vaccine Development Unit,Biology of Vector-Borne Viruses Section,0.0
Vaccine Development Unit,Building 14B South,0.0
Vaccine Development Unit,Building 33,0.0
Vaccine Development Unit,Building 50,0.0
Vaccine Development Unit,Building NIHAC/103,0.0
Vaccine Development Unit,Buildings 4 and 10/11C127,0.0
Vaccine Development Unit,Caliciviruses Section,0.0
Vaccine Development Unit,Cell Signaling and Immunity Section,0.0
Vaccine Development Unit,Cellular Biology Section,0.0
Vaccine Development Unit,Cellular Immunology Section,0.0
Vaccine Development Unit,Chemotaxis Signal Section,0.0
Vaccine Development Unit,Chlamydial Diseases Section,0.0
Vaccine Development Unit,Clinical Microbiome Unit (CMU),0.0
Vaccine Development Unit,Clinical Pathophysiology Section,0.0
Vaccine Development Unit,Clinical Research Section,0.0
Vaccine Development Unit,Clinical and Molecular Retrovirology Section,0.0
Vaccine Development Unit,Computational Biology Unit,0.0
Vaccine Development Unit,Coxiella Pathogenesis Section,0.0
Vaccine Development Unit,DNA Tumor Virus Section,0.0
Vaccine Development Unit,Emerging Respiratory Viruses Section,0.0
Vaccine Development Unit,Emerging Virus Immunity Unit,0.0
Vaccine Development Unit,Epithelial Therapeutics Unit,0.0
Vaccine Development Unit,Flow Cytometry Section,0.0
Vaccine Development Unit,Food Allergy Research Section,0.0
Vaccine Development Unit,Functional Cellular Networks Section,0.0
Vaccine Development Unit,Fungal Pathogenesis Section,0.0
Vaccine Development Unit,Gene Regulation Section,0.0
Vaccine Development Unit,Genetic Engineering Section,0.0
Vaccine Development Unit,Genetic Immunotherapy Section,0.0
Vaccine Development Unit,Genomic Technologies Section,0.0
Vaccine Development Unit,HIV Immunovirology Section,0.0
Vaccine Development Unit,HIV Pathogenesis Section,0.0
Vaccine Development Unit,HIV-Specific Immunity Section,0.0
Vaccine Development Unit,Hepatic Pathogenesis Section,0.0
Vaccine Development Unit,Host-Parasite Interactions Section,0.0
Vaccine Development Unit,Human Eosinophil Section,0.0
Vaccine Development Unit,Human Immunological Diseases Section,0.0
Vaccine Development Unit,Immune Activation Section,0.0
Vaccine Development Unit,Immune Deficiency Genetics Section,0.0
Vaccine Development Unit,Immunity to Pulmonary Pathogens Section,0.0
Vaccine Development Unit,Immunobiology and Molecular Virology Unit,0.0
Vaccine Development Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Vaccine Development Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Vaccine Development Unit,Infectious Disease Fellowship Training Program,0.0
Vaccine Development Unit,Infectious Disease Pathogenesis Section,0.0
Vaccine Development Unit,Inflammation & Innate Immunity Unit,0.0
Vaccine Development Unit,Inflammation Biology Section,0.0
Vaccine Development Unit,Innate Immunity and Pathogenesis Section,0.0
Vaccine Development Unit,Integrative Immunobiology Section,0.0
Vaccine Development Unit,Intracellular Parasite Biology Section,0.0
Vaccine Development Unit,LID Clinical Studies Unit,0.0
Vaccine Development Unit,Lung and Vascular Inflammation Section,0.0
Vaccine Development Unit,Lyme Disease Studies Unit,0.0
Vaccine Development Unit,Malaria Functional Genomics Section,0.0
Vaccine Development Unit,Malaria Genetics Section,0.0
Vaccine Development Unit,Mast Cell Biology Section,0.0
Vaccine Development Unit,Medical Virology Section,0.0
Vaccine Development Unit,Metaorganism Immunity Section,0.0
Vaccine Development Unit,Microbial Pathogenesis Section,0.0
Vaccine Development Unit,Molecular Biology Section,0.0
Vaccine Development Unit,Molecular Defenses Section,0.0
Vaccine Development Unit,Molecular Development of the Immune System Section,0.0
Vaccine Development Unit,Molecular Entomology Unit,0.0
Vaccine Development Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Vaccine Development Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Vaccine Development Unit,Molecular HIV Host Interactions Section,0.0
Vaccine Development Unit,Molecular Microbiology Section,0.0
Vaccine Development Unit,Molecular Parasitology Section,0.0
Vaccine Development Unit,Molecular Parasitology and Entomology Unit,0.0
Vaccine Development Unit,Molecular Pathology Section,0.0
Vaccine Development Unit,Molecular Signaling Section,0.0
Vaccine Development Unit,Molecular and Cellular Immunoregulation Section,0.0
Vaccine Development Unit,Mucosal Immunity Section,0.0
Vaccine Development Unit,Mucosal Immunobiology Section,0.0
Vaccine Development Unit,Multiscale Systems Biology Section,0.0
Vaccine Development Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Vaccine Development Unit,Neuroimmunological Diseases Section,0.0
Vaccine Development Unit,Neuroimmunology Unit,0.0
Vaccine Development Unit,Nonhuman Primate Virology Section,0.0
Vaccine Development Unit,Office of the Animal Program Director,0.0
Vaccine Development Unit,Pathogen Molecular Genetics Section,0.0
Vaccine Development Unit,Pathogen-Host Cell Biology Section,0.0
Vaccine Development Unit,Physiology Unit,0.0
Vaccine Development Unit,Plague Section,0.0
Vaccine Development Unit,Primary Immune Deficiency Clinic,0.0
Vaccine Development Unit,Prion Cell Biology Unit,0.0
Vaccine Development Unit,Quantitative Virology and Evolution Unit,0.0
Vaccine Development Unit,RML Flow Cytometry Unit,0.0
Vaccine Development Unit,RML Genomics Unit,0.0
Vaccine Development Unit,RNA Viruses Section,0.0
Vaccine Development Unit,Research Technology Branch,0.0
Vaccine Development Unit,Retroviral Immunology Section,0.0
Vaccine Development Unit,Salmonella-Host Cell Interactions Section,0.0
Vaccine Development Unit,Scientist Emerita,0.0
Vaccine Development Unit,Signaling Systems Section,0.0
Vaccine Development Unit,Structural Biology Section,0.0
Vaccine Development Unit,Structural Immunology Section,0.0
Vaccine Development Unit,Structural Informatics Unit,0.0
Vaccine Development Unit,Structural Virology Section,0.0
Vaccine Development Unit,Systems Genomics Section,0.0
Vaccine Development Unit,T-Cell Tolerance and Memory Section,0.0
Vaccine Development Unit,T-Lymphocyte Biology Section,0.0
Vaccine Development Unit,TSE/Prion Biochemistry Section,0.0
Vaccine Development Unit,TSE/Prion Molecular Biology Section,0.0
Vaccine Development Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Vaccine Development Unit,Tick-Pathogen Transmission Unit,0.0
Vaccine Development Unit,Translational Allergic Immunopathology Unit,0.0
Vaccine Development Unit,Translational Autoinflammatory Disease Studies Unit,0.0
Vaccine Development Unit,Translational Immunobiology Unit,0.0
Vaccine Development Unit,Translational Mycology Section,0.0
Vaccine Development Unit,Transplant Infectious Diseases Consult Service,0.0
Vaccine Development Unit,Tuberculosis Research Section,0.0
Vaccine Development Unit,Twinbrook III,0.0
Vaccine Development Unit,Type 2 Immunity Section,0.0
Vector Biology Section,Allergy and Immunology Clinical Training Program,0.0
Vector Biology Section,Antibacterial Host Defense Unit,0.0
Vector Biology Section,Antibody Biology Unit,0.0
Vector Biology Section,Autoimmunity and Functional Genomics Section,0.0
Vector Biology Section,B-Cell Immunology Section,0.0
Vector Biology Section,B-Cell Molecular Immunology Section,0.0
Vector Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Vector Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Vector Biology Section,Barrier Immunity Section,0.0
Vector Biology Section,Biological Imaging,0.0
Vector Biology Section,Building 14B South,0.0
Vector Biology Section,Building 33,0.0
Vector Biology Section,Building 50,0.0
Vector Biology Section,Building NIHAC/103,0.0
Vector Biology Section,Buildings 4 and 10/11C127,0.0
Vector Biology Section,Caliciviruses Section,0.0
Vector Biology Section,Cell Signaling and Immunity Section,0.0
Vector Biology Section,Cellular Biology Section,0.0
Vector Biology Section,Cellular Immunology Section,0.0
Vector Biology Section,Chemotaxis Signal Section,0.0
Vector Biology Section,Chlamydial Diseases Section,0.0
Vector Biology Section,Clinical Microbiome Unit (CMU),0.0
Vector Biology Section,Clinical Pathophysiology Section,0.0
Vector Biology Section,Clinical Research Section,0.0
Vector Biology Section,Clinical and Molecular Retrovirology Section,0.0
Vector Biology Section,Computational Biology Unit,0.0
Vector Biology Section,Coxiella Pathogenesis Section,0.0
Vector Biology Section,DNA Tumor Virus Section,0.0
Vector Biology Section,Disease Modeling and Transmission Section,0.0
Vector Biology Section,Emerging Respiratory Viruses Section,0.0
Vector Biology Section,Emerging Virus Immunity Unit,0.0
Vector Biology Section,Epidemiology and Population Studies Unit,0.0
Vector Biology Section,Epithelial Therapeutics Unit,0.0
Vector Biology Section,Flow Cytometry Section,0.0
Vector Biology Section,Food Allergy Research Section,0.0
Vector Biology Section,Functional Cellular Networks Section,0.0
Vector Biology Section,Fungal Pathogenesis Section,0.0
Vector Biology Section,Gene Regulation Section,0.0
Vector Biology Section,Genetic Engineering Section,0.0
Vector Biology Section,Genetic Immunotherapy Section,0.0
Vector Biology Section,HIV Immunovirology Section,0.0
Vector Biology Section,HIV Pathogenesis Section,0.0
Vector Biology Section,HIV-Specific Immunity Section,0.0
Vector Biology Section,Hepatic Pathogenesis Section,0.0
Vector Biology Section,Host-Parasite Interactions Section,0.0
Vector Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Vector Biology Section,Human Eosinophil Section,0.0
Vector Biology Section,Human Immunological Diseases Section,0.0
Vector Biology Section,Immune Activation Section,0.0
Vector Biology Section,Immune Deficiency Genetics Section,0.0
Vector Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Vector Biology Section,Immunobiology and Molecular Virology Unit,0.0
Vector Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Vector Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Vector Biology Section,Infectious Disease Fellowship Training Program,0.0
Vector Biology Section,Inflammation & Innate Immunity Unit,0.0
Vector Biology Section,Inflammation Biology Section,0.0
Vector Biology Section,Integrative Immunobiology Section,0.0
Vector Biology Section,International HIV/STD Section,0.0
Vector Biology Section,LID Clinical Studies Unit,0.0
Vector Biology Section,Lung and Vascular Inflammation Section,0.0
Vector Biology Section,Lyme Disease Studies Unit,0.0
Vector Biology Section,Lymphocyte Biology Section,0.0
Vector Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Vector Biology Section,Mast Cell Biology Section,0.0
Vector Biology Section,Medical Virology Section,0.0
Vector Biology Section,Microbial Pathogenesis Section,0.0
Vector Biology Section,Molecular Biology Section,0.0
Vector Biology Section,Molecular Defenses Section,0.0
Vector Biology Section,Molecular Development of the Immune System Section,0.0
Vector Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Vector Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Vector Biology Section,Molecular HIV Host Interactions Section,0.0
Vector Biology Section,Molecular Microbiology Section,0.0
Vector Biology Section,Molecular Parasitology Section,0.0
Vector Biology Section,Molecular Parasitology and Entomology Unit,0.0
Vector Biology Section,Molecular Pathogenesis Unit,0.0
Vector Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Vector Biology Section,Molecular Pathology Section,0.0
Vector Biology Section,Molecular Signaling Section,0.0
Vector Biology Section,Molecular and Cellular Immunology Section,0.0
Vector Biology Section,Molecular and Cellular Immunoregulation Section,0.0
Vector Biology Section,Mucosal Immunity Section,0.0
Vector Biology Section,Mucosal Immunobiology Section,0.0
Vector Biology Section,Multiscale Systems Biology Section,0.0
Vector Biology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Vector Biology Section,Neuroimmunological Diseases Section,0.0
Vector Biology Section,Neuroimmunology Unit,0.0
Vector Biology Section,Nonhuman Primate Virology Section,0.0
Vector Biology Section,Office of the Animal Program Director,0.0
Vector Biology Section,Pathogen Molecular Genetics Section,0.0
Vector Biology Section,Pathogen-Host Cell Biology Section,0.0
Vector Biology Section,Pathogenesis and Immunity Section,0.0
Vector Biology Section,Primary Immune Deficiency Clinic,0.0
Vector Biology Section,Prion Cell Biology Unit,0.0
Vector Biology Section,Protein Chemistry Section,0.0
Vector Biology Section,Quantitative Virology and Evolution Unit,0.0
Vector Biology Section,RML Flow Cytometry Unit,0.0
Vector Biology Section,RML Genomics Unit,0.0
Vector Biology Section,RML Microscopy Unit,0.0
Vector Biology Section,RNA Viruses Section,0.0
Vector Biology Section,Research Technology Branch,0.0
Vector Biology Section,Retroviral Immunology Section,0.0
Vector Biology Section,Salmonella-Host Cell Interactions Section,0.0
Vector Biology Section,Scientist Emerita,0.0
Vector Biology Section,Signaling Systems Section,0.0
Vector Biology Section,Structural Biology Section,0.0
Vector Biology Section,Structural Immunology Section,0.0
Vector Biology Section,Structural Informatics Unit,0.0
Vector Biology Section,Structural Virology Section,0.0
Vector Biology Section,T-Cell Tolerance and Memory Section,0.0
Vector Biology Section,T-Lymphocyte Biology Section,0.0
Vector Biology Section,TSE/Prion Biochemistry Section,0.0
Vector Biology Section,TSE/Prion Molecular Biology Section,0.0
Vector Biology Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Vector Biology Section,Tick-Pathogen Transmission Unit,0.0
Vector Biology Section,Translational Allergic Immunopathology Unit,0.0
Vector Biology Section,Translational Autoinflammatory Disease Studies Unit,0.0
Vector Biology Section,Translational Immunobiology Unit,0.0
Vector Biology Section,Translational Mycology Section,0.0
Vector Biology Section,Transplant Infectious Diseases Consult Service,0.0
Vector Biology Section,Tuberculosis Research Section,0.0
Vector Biology Section,Twinbrook III,0.0
Vector Biology Section,Type 2 Immunity Section,0.0
Vector Biology Section,Vaccine Development Unit,0.0
Vector Molecular Biology Section,Allergy and Immunology Clinical Training Program,0.0
Vector Molecular Biology Section,Antibacterial Host Defense Unit,0.0
Vector Molecular Biology Section,Antibody Biology Unit,0.0
Vector Molecular Biology Section,Apicomplexan Molecular Physiology Section,0.0
Vector Molecular Biology Section,Autoimmunity and Functional Genomics Section,0.0
Vector Molecular Biology Section,B-Cell Immunology Section,0.0
Vector Molecular Biology Section,B-Cell Molecular Immunology Section,0.0
Vector Molecular Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Vector Molecular Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Vector Molecular Biology Section,Barrier Immunity Section,0.0
Vector Molecular Biology Section,Biological Imaging,0.0
Vector Molecular Biology Section,Building 14B South,0.0
Vector Molecular Biology Section,Building 33,0.0
Vector Molecular Biology Section,Building 50,0.0
Vector Molecular Biology Section,Building NIHAC/103,0.0
Vector Molecular Biology Section,Buildings 4 and 10/11C127,0.0
Vector Molecular Biology Section,Caliciviruses Section,0.0
Vector Molecular Biology Section,Cell Signaling and Immunity Section,0.0
Vector Molecular Biology Section,Cellular Biology Section,0.0
Vector Molecular Biology Section,Cellular Immunology Section,0.0
Vector Molecular Biology Section,Chemotaxis Signal Section,0.0
Vector Molecular Biology Section,Chlamydial Diseases Section,0.0
Vector Molecular Biology Section,Clinical Microbiome Unit (CMU),0.0
Vector Molecular Biology Section,Clinical Pathophysiology Section,0.0
Vector Molecular Biology Section,Clinical Research Section,0.0
Vector Molecular Biology Section,Clinical and Molecular Retrovirology Section,0.0
Vector Molecular Biology Section,Computational Biology Unit,0.0
Vector Molecular Biology Section,Coxiella Pathogenesis Section,0.0
Vector Molecular Biology Section,DNA Tumor Virus Section,0.0
Vector Molecular Biology Section,Disease Modeling and Transmission Section,0.0
Vector Molecular Biology Section,Emerging Respiratory Viruses Section,0.0
Vector Molecular Biology Section,Emerging Virus Immunity Unit,0.0
Vector Molecular Biology Section,Epidemiology and Population Studies Unit,0.0
Vector Molecular Biology Section,Epithelial Therapeutics Unit,0.0
Vector Molecular Biology Section,Flow Cytometry Section,0.0
Vector Molecular Biology Section,Food Allergy Research Section,0.0
Vector Molecular Biology Section,Functional Cellular Networks Section,0.0
Vector Molecular Biology Section,Fungal Pathogenesis Section,0.0
Vector Molecular Biology Section,Gene Regulation Section,0.0
Vector Molecular Biology Section,Genetic Engineering Section,0.0
Vector Molecular Biology Section,Genetic Immunotherapy Section,0.0
Vector Molecular Biology Section,HIV Immunovirology Section,0.0
Vector Molecular Biology Section,HIV Pathogenesis Section,0.0
Vector Molecular Biology Section,HIV-Specific Immunity Section,0.0
Vector Molecular Biology Section,Hepatic Pathogenesis Section,0.0
Vector Molecular Biology Section,Host-Parasite Interactions Section,0.0
Vector Molecular Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Vector Molecular Biology Section,Human Eosinophil Section,0.0
Vector Molecular Biology Section,Human Immunological Diseases Section,0.0
Vector Molecular Biology Section,Immune Activation Section,0.0
Vector Molecular Biology Section,Immune Deficiency Genetics Section,0.0
Vector Molecular Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Vector Molecular Biology Section,Immunobiology and Molecular Virology Unit,0.0
Vector Molecular Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Vector Molecular Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Vector Molecular Biology Section,Infectious Disease Fellowship Training Program,0.0
Vector Molecular Biology Section,Inflammation & Innate Immunity Unit,0.0
Vector Molecular Biology Section,Inflammation Biology Section,0.0
Vector Molecular Biology Section,Integrative Immunobiology Section,0.0
Vector Molecular Biology Section,International HIV/STD Section,0.0
Vector Molecular Biology Section,Lung and Vascular Inflammation Section,0.0
Vector Molecular Biology Section,Lyme Disease Studies Unit,0.0
Vector Molecular Biology Section,Lymphocyte Activation Section,0.0
Vector Molecular Biology Section,Malaria Cell Biology Section,0.0
Vector Molecular Biology Section,Malaria Immunology Section,0.0
Vector Molecular Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Vector Molecular Biology Section,Mast Cell Biology Section,0.0
Vector Molecular Biology Section,Medical Virology Section,0.0
Vector Molecular Biology Section,Microbial Pathogenesis Section,0.0
Vector Molecular Biology Section,Molecular Biology Section,0.0
Vector Molecular Biology Section,Molecular Defenses Section,0.0
Vector Molecular Biology Section,Molecular Development of the Immune System Section,0.0
Vector Molecular Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Vector Molecular Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Vector Molecular Biology Section,Molecular HIV Host Interactions Section,0.0
Vector Molecular Biology Section,Molecular Microbiology Section,0.0
Vector Molecular Biology Section,Molecular Parasitology Section,0.0
Vector Molecular Biology Section,Molecular Parasitology and Entomology Unit,0.0
Vector Molecular Biology Section,Molecular Pathogenesis Unit,0.0
Vector Molecular Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Vector Molecular Biology Section,Molecular Pathology Section,0.0
Vector Molecular Biology Section,Molecular Signaling Section,0.0
Vector Molecular Biology Section,Molecular and Cellular Immunology Section,0.0
Vector Molecular Biology Section,Molecular and Cellular Immunoregulation Section,0.0
Vector Molecular Biology Section,Mucosal Immunity Section,0.0
Vector Molecular Biology Section,Mucosal Immunobiology Section,0.0
Vector Molecular Biology Section,Multiscale Systems Biology Section,0.0
Vector Molecular Biology Section,Neuroimmunological Diseases Section,0.0
Vector Molecular Biology Section,Neuroimmunology Unit,0.0
Vector Molecular Biology Section,Nonhuman Primate Virology Section,0.0
Vector Molecular Biology Section,Office of the Animal Program Director,0.0
Vector Molecular Biology Section,Pathogen Molecular Genetics Section,0.0
Vector Molecular Biology Section,Pathogen-Host Cell Biology Section,0.0
Vector Molecular Biology Section,Pathogenesis and Immunity Section,0.0
Vector Molecular Biology Section,Pathology Core,0.0
Vector Molecular Biology Section,Plague Section,0.0
Vector Molecular Biology Section,Primary Immune Deficiency Clinic,0.0
Vector Molecular Biology Section,Prion Cell Biology Unit,0.0
Vector Molecular Biology Section,Protein Chemistry Section,0.0
Vector Molecular Biology Section,Quantitative Virology and Evolution Unit,0.0
Vector Molecular Biology Section,RML Flow Cytometry Unit,0.0
Vector Molecular Biology Section,RML Genomics Unit,0.0
Vector Molecular Biology Section,RML Microscopy Unit,0.0
Vector Molecular Biology Section,RNA Viruses Section,0.0
Vector Molecular Biology Section,Research Technology Branch,0.0
Vector Molecular Biology Section,Retroviral Immunology Section,0.0
Vector Molecular Biology Section,Salmonella-Host Cell Interactions Section,0.0
Vector Molecular Biology Section,Scientist Emerita,0.0
Vector Molecular Biology Section,Signaling Systems Section,0.0
Vector Molecular Biology Section,Structural Biology Section,0.0
Vector Molecular Biology Section,Structural Immunology Section,0.0
Vector Molecular Biology Section,Structural Informatics Unit,0.0
Vector Molecular Biology Section,Structural Virology Section,0.0
Vector Molecular Biology Section,Systems Genomics Section,0.0
Vector Molecular Biology Section,T-Cell Tolerance and Memory Section,0.0
Vector Molecular Biology Section,T-Lymphocyte Biology Section,0.0
Vector Molecular Biology Section,TSE/Prion Biochemistry Section,0.0
Vector Molecular Biology Section,TSE/Prion Molecular Biology Section,0.0
Vector Molecular Biology Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Vector Molecular Biology Section,Tick-Pathogen Transmission Unit,0.0
Vector Molecular Biology Section,Translational Allergic Immunopathology Unit,0.0
Vector Molecular Biology Section,Translational Autoinflammatory Disease Studies Unit,0.0
Vector Molecular Biology Section,Translational Immunobiology Unit,0.0
Vector Molecular Biology Section,Translational Mycology Section,0.0
Vector Molecular Biology Section,Transplant Infectious Diseases Consult Service,0.0
Vector Molecular Biology Section,Tuberculosis Research Section,0.0
Vector Molecular Biology Section,Twinbrook III,0.0
Vector Molecular Biology Section,Twinbrook Imaging Facility,0.0
Vector Molecular Biology Section,Type 2 Immunity Section,0.0
Vector Molecular Biology Section,Vaccine Development Unit,0.0
Vector-Pathogen-Host Interaction Unit,Allergy and Immunology Clinical Training Program,0.0
Vector-Pathogen-Host Interaction Unit,Antibacterial Host Defense Unit,0.0
Vector-Pathogen-Host Interaction Unit,Antibody Biology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Apicomplexan Molecular Physiology Section,0.0
Vector-Pathogen-Host Interaction Unit,Autoimmunity and Functional Genomics Section,0.0
Vector-Pathogen-Host Interaction Unit,B-Cell Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,B-Cell Molecular Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Vector-Pathogen-Host Interaction Unit,Bacterial Physiology and Metabolism Unit,0.0
Vector-Pathogen-Host Interaction Unit,Barrier Immunity Section,0.0
Vector-Pathogen-Host Interaction Unit,Biological Imaging,0.0
Vector-Pathogen-Host Interaction Unit,Biology of Vector-Borne Viruses Section,0.0
Vector-Pathogen-Host Interaction Unit,Building 14B South,0.0
Vector-Pathogen-Host Interaction Unit,Building 33,0.0
Vector-Pathogen-Host Interaction Unit,Building 50,0.0
Vector-Pathogen-Host Interaction Unit,Building NIHAC/103,0.0
Vector-Pathogen-Host Interaction Unit,Buildings 4 and 10/11C127,0.0
Vector-Pathogen-Host Interaction Unit,Caliciviruses Section,0.0
Vector-Pathogen-Host Interaction Unit,Cell Signaling and Immunity Section,0.0
Vector-Pathogen-Host Interaction Unit,Cellular Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Cellular Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,Chemotaxis Signal Section,0.0
Vector-Pathogen-Host Interaction Unit,Chlamydial Diseases Section,0.0
Vector-Pathogen-Host Interaction Unit,Clinical Microbiome Unit (CMU),0.0
Vector-Pathogen-Host Interaction Unit,Clinical Pathophysiology Section,0.0
Vector-Pathogen-Host Interaction Unit,Clinical Research Section,0.0
Vector-Pathogen-Host Interaction Unit,Clinical and Molecular Retrovirology Section,0.0
Vector-Pathogen-Host Interaction Unit,Computational Biology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Coxiella Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,DNA Tumor Virus Section,0.0
Vector-Pathogen-Host Interaction Unit,Disease Modeling and Transmission Section,0.0
Vector-Pathogen-Host Interaction Unit,Emerging Respiratory Viruses Section,0.0
Vector-Pathogen-Host Interaction Unit,Emerging Virus Immunity Unit,0.0
Vector-Pathogen-Host Interaction Unit,Epidemiology and Population Studies Unit,0.0
Vector-Pathogen-Host Interaction Unit,Epithelial Therapeutics Unit,0.0
Vector-Pathogen-Host Interaction Unit,Flow Cytometry Section,0.0
Vector-Pathogen-Host Interaction Unit,Food Allergy Research Section,0.0
Vector-Pathogen-Host Interaction Unit,Functional Cellular Networks Section,0.0
Vector-Pathogen-Host Interaction Unit,Fungal Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,Gene Regulation Section,0.0
Vector-Pathogen-Host Interaction Unit,Genetic Engineering Section,0.0
Vector-Pathogen-Host Interaction Unit,Genetic Immunotherapy Section,0.0
Vector-Pathogen-Host Interaction Unit,Genomic Technologies Section,0.0
Vector-Pathogen-Host Interaction Unit,HIV Immunovirology Section,0.0
Vector-Pathogen-Host Interaction Unit,HIV Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,HIV-Specific Immunity Section,0.0
Vector-Pathogen-Host Interaction Unit,Helminth Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,Hepatic Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,Host-Parasite Interactions Section,0.0
Vector-Pathogen-Host Interaction Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Vector-Pathogen-Host Interaction Unit,Human Eosinophil Section,0.0
Vector-Pathogen-Host Interaction Unit,Human Immunological Diseases Section,0.0
Vector-Pathogen-Host Interaction Unit,Immune Activation Section,0.0
Vector-Pathogen-Host Interaction Unit,Immune Deficiency Genetics Section,0.0
Vector-Pathogen-Host Interaction Unit,Immunity to Pulmonary Pathogens Section,0.0
Vector-Pathogen-Host Interaction Unit,Immunobiology Section,0.0
Vector-Pathogen-Host Interaction Unit,Immunobiology and Molecular Virology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Vector-Pathogen-Host Interaction Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Vector-Pathogen-Host Interaction Unit,Infectious Disease Fellowship Training Program,0.0
Vector-Pathogen-Host Interaction Unit,Infectious Disease Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,Inflammation & Innate Immunity Unit,0.0
Vector-Pathogen-Host Interaction Unit,Inflammation Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Innate Immunity and Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,Integrative Immunobiology Section,0.0
Vector-Pathogen-Host Interaction Unit,International HIV/STD Section,0.0
Vector-Pathogen-Host Interaction Unit,Intracellular Parasite Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,LID Clinical Studies Unit,0.0
Vector-Pathogen-Host Interaction Unit,Lung and Vascular Inflammation Section,0.0
Vector-Pathogen-Host Interaction Unit,Lyme Disease Studies Unit,0.0
Vector-Pathogen-Host Interaction Unit,Lymphocyte Activation Section,0.0
Vector-Pathogen-Host Interaction Unit,Lymphocyte Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Malaria Cell Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Malaria Functional Genomics Section,0.0
Vector-Pathogen-Host Interaction Unit,Malaria Genetics Section,0.0
Vector-Pathogen-Host Interaction Unit,Malaria Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,Malaria Infection Biology and Immunity Unit,0.0
Vector-Pathogen-Host Interaction Unit,Mast Cell Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Medical Virology Section,0.0
Vector-Pathogen-Host Interaction Unit,Metaorganism Immunity Section,0.0
Vector-Pathogen-Host Interaction Unit,Microbial Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Defenses Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Development of the Immune System Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Entomology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Vector-Pathogen-Host Interaction Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Vector-Pathogen-Host Interaction Unit,Molecular HIV Host Interactions Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Microbiology Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Parasitology Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Parasitology and Entomology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Pathogenesis Unit,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Pathology Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular Signaling Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular and Cellular Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,Molecular and Cellular Immunoregulation Section,0.0
Vector-Pathogen-Host Interaction Unit,Mosquito Immunity and Vector Competence Section,0.0
Vector-Pathogen-Host Interaction Unit,Mucosal Immunity Section,0.0
Vector-Pathogen-Host Interaction Unit,Mucosal Immunobiology Section,0.0
Vector-Pathogen-Host Interaction Unit,Multiscale Systems Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Vector-Pathogen-Host Interaction Unit,Neuroimmunological Diseases Section,0.0
Vector-Pathogen-Host Interaction Unit,Neuroimmunology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Nonhuman Primate Virology Section,0.0
Vector-Pathogen-Host Interaction Unit,Office of the Animal Program Director,0.0
Vector-Pathogen-Host Interaction Unit,Pathogen Molecular Genetics Section,0.0
Vector-Pathogen-Host Interaction Unit,Pathogen-Host Cell Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Pathogenesis and Immunity Section,0.0
Vector-Pathogen-Host Interaction Unit,Pathology Core,0.0
Vector-Pathogen-Host Interaction Unit,Physiology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Plague Section,0.0
Vector-Pathogen-Host Interaction Unit,Primary Immune Deficiency Clinic,0.0
Vector-Pathogen-Host Interaction Unit,Prion Cell Biology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Protein Chemistry Section,0.0
Vector-Pathogen-Host Interaction Unit,Quantitative Virology and Evolution Unit,0.0
Vector-Pathogen-Host Interaction Unit,RML Flow Cytometry Unit,0.0
Vector-Pathogen-Host Interaction Unit,RML Genomics Unit,0.0
Vector-Pathogen-Host Interaction Unit,RML Microscopy Unit,0.0
Vector-Pathogen-Host Interaction Unit,RNA Viruses Section,0.0
Vector-Pathogen-Host Interaction Unit,Research Technology Branch,0.0
Vector-Pathogen-Host Interaction Unit,Retroviral Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,Salmonella-Host Cell Interactions Section,0.0
Vector-Pathogen-Host Interaction Unit,Scientist Emerita,0.0
Vector-Pathogen-Host Interaction Unit,Signaling Systems Section,0.0
Vector-Pathogen-Host Interaction Unit,Structural Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Structural Immunology Section,0.0
Vector-Pathogen-Host Interaction Unit,Structural Informatics Unit,0.0
Vector-Pathogen-Host Interaction Unit,Structural Virology Section,0.0
Vector-Pathogen-Host Interaction Unit,Systems Genomics Section,0.0
Vector-Pathogen-Host Interaction Unit,T-Cell Tolerance and Memory Section,0.0
Vector-Pathogen-Host Interaction Unit,T-Lymphocyte Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,TSE/Prion Biochemistry Section,0.0
Vector-Pathogen-Host Interaction Unit,TSE/Prion Molecular Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Vector-Pathogen-Host Interaction Unit,Tick-Pathogen Transmission Unit,0.0
Vector-Pathogen-Host Interaction Unit,Translational Allergic Immunopathology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Translational Autoinflammatory Disease Studies Unit,0.0
Vector-Pathogen-Host Interaction Unit,Translational Immunobiology Unit,0.0
Vector-Pathogen-Host Interaction Unit,Translational Mycology Section,0.0
Vector-Pathogen-Host Interaction Unit,Transplant Infectious Diseases Consult Service,0.0
Vector-Pathogen-Host Interaction Unit,Tuberculosis Research Section,0.0
Vector-Pathogen-Host Interaction Unit,Twinbrook III,0.0
Vector-Pathogen-Host Interaction Unit,Twinbrook Imaging Facility,0.0
Vector-Pathogen-Host Interaction Unit,Type 2 Immunity Section,0.0
Vector-Pathogen-Host Interaction Unit,Vaccine Development Unit,0.0
Vector-Pathogen-Host Interaction Unit,Vector Biology Section,0.0
Vector-Pathogen-Host Interaction Unit,Vector Molecular Biology Section,0.0
Viral Biochemistry Section,Allergy and Immunology Clinical Training Program,0.0
Viral Biochemistry Section,Antibacterial Host Defense Unit,0.0
Viral Biochemistry Section,Antibody Biology Unit,0.0
Viral Biochemistry Section,Apicomplexan Molecular Physiology Section,0.0
Viral Biochemistry Section,Autoimmunity and Functional Genomics Section,0.0
Viral Biochemistry Section,B-Cell Immunology Section,0.0
Viral Biochemistry Section,B-Cell Molecular Immunology Section,0.0
Viral Biochemistry Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Biochemistry Section,Bacterial Physiology and Metabolism Unit,0.0
Viral Biochemistry Section,Biological Imaging,0.0
Viral Biochemistry Section,Biology of Vector-Borne Viruses Section,0.0
Viral Biochemistry Section,Building 14B South,0.0
Viral Biochemistry Section,Building 33,0.0
Viral Biochemistry Section,Building 50,0.0
Viral Biochemistry Section,Building NIHAC/103,0.0
Viral Biochemistry Section,Buildings 4 and 10/11C127,0.0
Viral Biochemistry Section,Caliciviruses Section,0.0
Viral Biochemistry Section,Cell Signaling and Immunity Section,0.0
Viral Biochemistry Section,Cellular Biology Section,0.0
Viral Biochemistry Section,Cellular Immunology Section,0.0
Viral Biochemistry Section,Chemotaxis Signal Section,0.0
Viral Biochemistry Section,Chlamydial Diseases Section,0.0
Viral Biochemistry Section,Clinical Microbiome Unit (CMU),0.0
Viral Biochemistry Section,Clinical Pathophysiology Section,0.0
Viral Biochemistry Section,Clinical Research Section,0.0
Viral Biochemistry Section,Clinical and Molecular Retrovirology Section,0.0
Viral Biochemistry Section,Computational Biology Unit,0.0
Viral Biochemistry Section,Coxiella Pathogenesis Section,0.0
Viral Biochemistry Section,DNA Tumor Virus Section,0.0
Viral Biochemistry Section,Disease Modeling and Transmission Section,0.0
Viral Biochemistry Section,Emerging Respiratory Viruses Section,0.0
Viral Biochemistry Section,Emerging Virus Immunity Unit,0.0
Viral Biochemistry Section,Epidemiology and Population Studies Unit,0.0
Viral Biochemistry Section,Epithelial Therapeutics Unit,0.0
Viral Biochemistry Section,Flow Cytometry Section,0.0
Viral Biochemistry Section,Food Allergy Research Section,0.0
Viral Biochemistry Section,Functional Cellular Networks Section,0.0
Viral Biochemistry Section,Fungal Pathogenesis Section,0.0
Viral Biochemistry Section,Gene Regulation Section,0.0
Viral Biochemistry Section,Genetic Engineering Section,0.0
Viral Biochemistry Section,Genetic Immunotherapy Section,0.0
Viral Biochemistry Section,Genomic Technologies Section,0.0
Viral Biochemistry Section,HIV Immunovirology Section,0.0
Viral Biochemistry Section,HIV Pathogenesis Section,0.0
Viral Biochemistry Section,HIV-Specific Immunity Section,0.0
Viral Biochemistry Section,Helminth Immunology Section,0.0
Viral Biochemistry Section,Hepatic Pathogenesis Section,0.0
Viral Biochemistry Section,Host-Parasite Interactions Section,0.0
Viral Biochemistry Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Biochemistry Section,Human Eosinophil Section,0.0
Viral Biochemistry Section,Human Immunological Diseases Section,0.0
Viral Biochemistry Section,Immune Activation Section,0.0
Viral Biochemistry Section,Immune Deficiency Genetics Section,0.0
Viral Biochemistry Section,Immunity to Pulmonary Pathogens Section,0.0
Viral Biochemistry Section,Immunobiology Section,0.0
Viral Biochemistry Section,Immunobiology and Molecular Virology Unit,0.0
Viral Biochemistry Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Biochemistry Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Biochemistry Section,Infectious Disease Fellowship Training Program,0.0
Viral Biochemistry Section,Infectious Disease Pathogenesis Section,0.0
Viral Biochemistry Section,Inflammation & Innate Immunity Unit,0.0
Viral Biochemistry Section,Inflammation Biology Section,0.0
Viral Biochemistry Section,Innate Immunity and Pathogenesis Section,0.0
Viral Biochemistry Section,Integrative Immunobiology Section,0.0
Viral Biochemistry Section,International HIV/STD Section,0.0
Viral Biochemistry Section,Intracellular Parasite Biology Section,0.0
Viral Biochemistry Section,LID Clinical Studies Unit,0.0
Viral Biochemistry Section,Lung and Vascular Inflammation Section,0.0
Viral Biochemistry Section,Lyme Disease Studies Unit,0.0
Viral Biochemistry Section,Lymphocyte Activation Section,0.0
Viral Biochemistry Section,Lymphocyte Biology Section,0.0
Viral Biochemistry Section,Malaria Cell Biology Section,0.0
Viral Biochemistry Section,Malaria Functional Genomics Section,0.0
Viral Biochemistry Section,Malaria Genetics Section,0.0
Viral Biochemistry Section,Malaria Immunology Section,0.0
Viral Biochemistry Section,Malaria Infection Biology and Immunity Unit,0.0
Viral Biochemistry Section,Mast Cell Biology Section,0.0
Viral Biochemistry Section,Medical Virology Section,0.0
Viral Biochemistry Section,Metaorganism Immunity Section,0.0
Viral Biochemistry Section,Microbial Pathogenesis Section,0.0
Viral Biochemistry Section,Molecular Biology Section,0.0
Viral Biochemistry Section,Molecular Defenses Section,0.0
Viral Biochemistry Section,Molecular Development of the Immune System Section,0.0
Viral Biochemistry Section,Molecular Entomology Unit,0.0
Viral Biochemistry Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Biochemistry Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Biochemistry Section,Molecular HIV Host Interactions Section,0.0
Viral Biochemistry Section,Molecular Microbiology Section,0.0
Viral Biochemistry Section,Molecular Parasitology Section,0.0
Viral Biochemistry Section,Molecular Parasitology and Entomology Unit,0.0
Viral Biochemistry Section,Molecular Pathogenesis Unit,0.0
Viral Biochemistry Section,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Biochemistry Section,Molecular Pathology Section,0.0
Viral Biochemistry Section,Molecular Signaling Section,0.0
Viral Biochemistry Section,Molecular and Cellular Immunology Section,0.0
Viral Biochemistry Section,Molecular and Cellular Immunoregulation Section,0.0
Viral Biochemistry Section,Mosquito Immunity and Vector Competence Section,0.0
Viral Biochemistry Section,Mucosal Immunity Section,0.0
Viral Biochemistry Section,Mucosal Immunobiology Section,0.0
Viral Biochemistry Section,Multiscale Systems Biology Section,0.0
Viral Biochemistry Section,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Biochemistry Section,Neuroimmunological Diseases Section,0.0
Viral Biochemistry Section,Neuroimmunology Unit,0.0
Viral Biochemistry Section,Office of the Animal Program Director,0.0
Viral Biochemistry Section,Pathogen Molecular Genetics Section,0.0
Viral Biochemistry Section,Pathogen-Host Cell Biology Section,0.0
Viral Biochemistry Section,Pathogenesis and Immunity Section,0.0
Viral Biochemistry Section,Pathology Core,0.0
Viral Biochemistry Section,Physiology Unit,0.0
Viral Biochemistry Section,Plague Section,0.0
Viral Biochemistry Section,Primary Immune Deficiency Clinic,0.0
Viral Biochemistry Section,Prion Cell Biology Unit,0.0
Viral Biochemistry Section,Protein Chemistry Section,0.0
Viral Biochemistry Section,Quantitative Virology and Evolution Unit,0.0
Viral Biochemistry Section,RML Flow Cytometry Unit,0.0
Viral Biochemistry Section,RML Genomics Unit,0.0
Viral Biochemistry Section,RML Microscopy Unit,0.0
Viral Biochemistry Section,RNA Viruses Section,0.0
Viral Biochemistry Section,Research Technology Branch,0.0
Viral Biochemistry Section,Retroviral Immunology Section,0.0
Viral Biochemistry Section,Salmonella-Host Cell Interactions Section,0.0
Viral Biochemistry Section,Scientist Emerita,0.0
Viral Biochemistry Section,Signaling Systems Section,0.0
Viral Biochemistry Section,Structural Biology Section,0.0
Viral Biochemistry Section,Structural Immunology Section,0.0
Viral Biochemistry Section,Structural Informatics Unit,0.0
Viral Biochemistry Section,Structural Virology Section,0.0
Viral Biochemistry Section,Systems Genomics Section,0.0
Viral Biochemistry Section,T-Cell Tolerance and Memory Section,0.0
Viral Biochemistry Section,T-Lymphocyte Biology Section,0.0
Viral Biochemistry Section,TSE/Prion Biochemistry Section,0.0
Viral Biochemistry Section,TSE/Prion Molecular Biology Section,0.0
Viral Biochemistry Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Biochemistry Section,Tick-Pathogen Transmission Unit,0.0
Viral Biochemistry Section,Translational Allergic Immunopathology Unit,0.0
Viral Biochemistry Section,Translational Autoinflammatory Disease Studies Unit,0.0
Viral Biochemistry Section,Translational Immunobiology Unit,0.0
Viral Biochemistry Section,Translational Mycology Section,0.0
Viral Biochemistry Section,Transplant Infectious Diseases Consult Service,0.0
Viral Biochemistry Section,Tuberculosis Research Section,0.0
Viral Biochemistry Section,Twinbrook III,0.0
Viral Biochemistry Section,Twinbrook Imaging Facility,0.0
Viral Biochemistry Section,Type 2 Immunity Section,0.0
Viral Biochemistry Section,Vaccine Development Unit,0.0
Viral Biochemistry Section,Vector Biology Section,0.0
Viral Biochemistry Section,Vector Molecular Biology Section,0.0
Viral Biochemistry Section,Vector-Pathogen-Host Interaction Unit,0.0
Viral Biology Section,Allergy and Immunology Clinical Training Program,0.0
Viral Biology Section,Antibacterial Host Defense Unit,0.0
Viral Biology Section,Antibody Biology Unit,0.0
Viral Biology Section,Apicomplexan Molecular Physiology Section,0.0
Viral Biology Section,Autoimmunity and Functional Genomics Section,0.0
Viral Biology Section,B-Cell Immunology Section,0.0
Viral Biology Section,B-Cell Molecular Immunology Section,0.0
Viral Biology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Biology Section,Bacterial Physiology and Metabolism Unit,0.0
Viral Biology Section,Barrier Immunity Section,0.0
Viral Biology Section,Biological Imaging,0.0
Viral Biology Section,Biology of Vector-Borne Viruses Section,0.0
Viral Biology Section,Building 14B South,0.0
Viral Biology Section,Building 33,0.0
Viral Biology Section,Building 50,0.0
Viral Biology Section,Building NIHAC/103,0.0
Viral Biology Section,Buildings 4 and 10/11C127,0.0
Viral Biology Section,Caliciviruses Section,0.0
Viral Biology Section,Cell Signaling and Immunity Section,0.0
Viral Biology Section,Cellular Biology Section,0.0
Viral Biology Section,Cellular Immunology Section,0.0
Viral Biology Section,Chemotaxis Signal Section,0.0
Viral Biology Section,Chlamydial Diseases Section,0.0
Viral Biology Section,Clinical Microbiome Unit (CMU),0.0
Viral Biology Section,Clinical Pathophysiology Section,0.0
Viral Biology Section,Clinical Research Section,0.0
Viral Biology Section,Clinical and Molecular Retrovirology Section,0.0
Viral Biology Section,Computational Biology Unit,0.0
Viral Biology Section,Coxiella Pathogenesis Section,0.0
Viral Biology Section,DNA Tumor Virus Section,0.0
Viral Biology Section,Disease Modeling and Transmission Section,0.0
Viral Biology Section,Emerging Virus Immunity Unit,0.0
Viral Biology Section,Epidemiology and Population Studies Unit,0.0
Viral Biology Section,Epithelial Therapeutics Unit,0.0
Viral Biology Section,Flow Cytometry Section,0.0
Viral Biology Section,Food Allergy Research Section,0.0
Viral Biology Section,Functional Cellular Networks Section,0.0
Viral Biology Section,Fungal Pathogenesis Section,0.0
Viral Biology Section,Gene Regulation Section,0.0
Viral Biology Section,Genetic Engineering Section,0.0
Viral Biology Section,Genetic Immunotherapy Section,0.0
Viral Biology Section,Genomic Technologies Section,0.0
Viral Biology Section,HIV Immunovirology Section,0.0
Viral Biology Section,HIV Pathogenesis Section,0.0
Viral Biology Section,HIV-Specific Immunity Section,0.0
Viral Biology Section,Helminth Immunology Section,0.0
Viral Biology Section,Hepatic Pathogenesis Section,0.0
Viral Biology Section,Host-Parasite Interactions Section,0.0
Viral Biology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Biology Section,Human Eosinophil Section,0.0
Viral Biology Section,Human Immunological Diseases Section,0.0
Viral Biology Section,Immune Activation Section,0.0
Viral Biology Section,Immune Deficiency Genetics Section,0.0
Viral Biology Section,Immunity to Pulmonary Pathogens Section,0.0
Viral Biology Section,Immunobiology Section,0.0
Viral Biology Section,Immunobiology and Molecular Virology Unit,0.0
Viral Biology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Biology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Biology Section,Infectious Disease Fellowship Training Program,0.0
Viral Biology Section,Infectious Disease Pathogenesis Section,0.0
Viral Biology Section,Inflammation & Innate Immunity Unit,0.0
Viral Biology Section,Inflammation Biology Section,0.0
Viral Biology Section,Innate Immunity and Pathogenesis Section,0.0
Viral Biology Section,Integrative Immunobiology Section,0.0
Viral Biology Section,International HIV/STD Section,0.0
Viral Biology Section,Intracellular Parasite Biology Section,0.0
Viral Biology Section,LID Clinical Studies Unit,0.0
Viral Biology Section,Lung and Vascular Inflammation Section,0.0
Viral Biology Section,Lyme Disease Studies Unit,0.0
Viral Biology Section,Lymphocyte Activation Section,0.0
Viral Biology Section,Lymphocyte Biology Section,0.0
Viral Biology Section,Malaria Cell Biology Section,0.0
Viral Biology Section,Malaria Functional Genomics Section,0.0
Viral Biology Section,Malaria Genetics Section,0.0
Viral Biology Section,Malaria Immunology Section,0.0
Viral Biology Section,Malaria Infection Biology and Immunity Unit,0.0
Viral Biology Section,Mast Cell Biology Section,0.0
Viral Biology Section,Metaorganism Immunity Section,0.0
Viral Biology Section,Microbial Pathogenesis Section,0.0
Viral Biology Section,Molecular Biology Section,0.0
Viral Biology Section,Molecular Defenses Section,0.0
Viral Biology Section,Molecular Development of the Immune System Section,0.0
Viral Biology Section,Molecular Entomology Unit,0.0
Viral Biology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Biology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Biology Section,Molecular HIV Host Interactions Section,0.0
Viral Biology Section,Molecular Microbiology Section,0.0
Viral Biology Section,Molecular Parasitology Section,0.0
Viral Biology Section,Molecular Parasitology and Entomology Unit,0.0
Viral Biology Section,Molecular Pathogenesis Unit,0.0
Viral Biology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Biology Section,Molecular Pathology Section,0.0
Viral Biology Section,Molecular Signaling Section,0.0
Viral Biology Section,Molecular and Cellular Immunology Section,0.0
Viral Biology Section,Molecular and Cellular Immunoregulation Section,0.0
Viral Biology Section,Mosquito Immunity and Vector Competence Section,0.0
Viral Biology Section,Mucosal Immunity Section,0.0
Viral Biology Section,Mucosal Immunobiology Section,0.0
Viral Biology Section,Multiscale Systems Biology Section,0.0
Viral Biology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Biology Section,Neuroimmunological Diseases Section,0.0
Viral Biology Section,Neuroimmunology Unit,0.0
Viral Biology Section,Nonhuman Primate Virology Section,0.0
Viral Biology Section,Office of the Animal Program Director,0.0
Viral Biology Section,Pathogen Molecular Genetics Section,0.0
Viral Biology Section,Pathogen-Host Cell Biology Section,0.0
Viral Biology Section,Pathogenesis and Immunity Section,0.0
Viral Biology Section,Pathology Core,0.0
Viral Biology Section,Physiology Unit,0.0
Viral Biology Section,Plague Section,0.0
Viral Biology Section,Primary Immune Deficiency Clinic,0.0
Viral Biology Section,Prion Cell Biology Unit,0.0
Viral Biology Section,Protein Chemistry Section,0.0
Viral Biology Section,Quantitative Virology and Evolution Unit,0.0
Viral Biology Section,RML Flow Cytometry Unit,0.0
Viral Biology Section,RML Genomics Unit,0.0
Viral Biology Section,RML Microscopy Unit,0.0
Viral Biology Section,RNA Viruses Section,0.0
Viral Biology Section,Research Technology Branch,0.0
Viral Biology Section,Retroviral Immunology Section,0.0
Viral Biology Section,Salmonella-Host Cell Interactions Section,0.0
Viral Biology Section,Scientist Emerita,0.0
Viral Biology Section,Signaling Systems Section,0.0
Viral Biology Section,Structural Biology Section,0.0
Viral Biology Section,Structural Immunology Section,0.0
Viral Biology Section,Structural Informatics Unit,0.0
Viral Biology Section,Structural Virology Section,0.0
Viral Biology Section,Systems Genomics Section,0.0
Viral Biology Section,T-Cell Tolerance and Memory Section,0.0
Viral Biology Section,T-Lymphocyte Biology Section,0.0
Viral Biology Section,TSE/Prion Biochemistry Section,0.0
Viral Biology Section,TSE/Prion Molecular Biology Section,0.0
Viral Biology Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Biology Section,Tick-Pathogen Transmission Unit,0.0
Viral Biology Section,Translational Allergic Immunopathology Unit,0.0
Viral Biology Section,Translational Immunobiology Unit,0.0
Viral Biology Section,Translational Mycology Section,0.0
Viral Biology Section,Transplant Infectious Diseases Consult Service,0.0
Viral Biology Section,Tuberculosis Research Section,0.0
Viral Biology Section,Twinbrook III,0.0
Viral Biology Section,Twinbrook Imaging Facility,0.0
Viral Biology Section,Type 2 Immunity Section,0.0
Viral Biology Section,Vaccine Development Unit,0.0
Viral Biology Section,Vector Biology Section,0.0
Viral Biology Section,Vector Molecular Biology Section,0.0
Viral Biology Section,Vector-Pathogen-Host Interaction Unit,0.0
Viral Budding Unit,Allergy and Immunology Clinical Training Program,0.0
Viral Budding Unit,Antibacterial Host Defense Unit,0.0
Viral Budding Unit,Antibody Biology Unit,0.0
Viral Budding Unit,Apicomplexan Molecular Physiology Section,0.0
Viral Budding Unit,Autoimmunity and Functional Genomics Section,0.0
Viral Budding Unit,B-Cell Immunology Section,0.0
Viral Budding Unit,B-Cell Molecular Immunology Section,0.0
Viral Budding Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Budding Unit,Bacterial Physiology and Metabolism Unit,0.0
Viral Budding Unit,Barrier Immunity Section,0.0
Viral Budding Unit,Biological Imaging,0.0
Viral Budding Unit,Biology of Vector-Borne Viruses Section,0.0
Viral Budding Unit,Building 14B South,0.0
Viral Budding Unit,Building 33,0.0
Viral Budding Unit,Building 50,0.0
Viral Budding Unit,Building NIHAC/103,0.0
Viral Budding Unit,Buildings 4 and 10/11C127,0.0
Viral Budding Unit,Caliciviruses Section,0.0
Viral Budding Unit,Cell Signaling and Immunity Section,0.0
Viral Budding Unit,Cellular Biology Section,0.0
Viral Budding Unit,Cellular Immunology Section,0.0
Viral Budding Unit,Chemotaxis Signal Section,0.0
Viral Budding Unit,Chlamydial Diseases Section,0.0
Viral Budding Unit,Clinical Microbiome Unit (CMU),0.0
Viral Budding Unit,Clinical Pathophysiology Section,0.0
Viral Budding Unit,Clinical Research Section,0.0
Viral Budding Unit,Clinical and Molecular Retrovirology Section,0.0
Viral Budding Unit,Computational Biology Unit,0.0
Viral Budding Unit,Coxiella Pathogenesis Section,0.0
Viral Budding Unit,DNA Tumor Virus Section,0.0
Viral Budding Unit,Disease Modeling and Transmission Section,0.0
Viral Budding Unit,Emerging Respiratory Viruses Section,0.0
Viral Budding Unit,Emerging Virus Immunity Unit,0.0
Viral Budding Unit,Epidemiology and Population Studies Unit,0.0
Viral Budding Unit,Epithelial Therapeutics Unit,0.0
Viral Budding Unit,Flow Cytometry Section,0.0
Viral Budding Unit,Food Allergy Research Section,0.0
Viral Budding Unit,Functional Cellular Networks Section,0.0
Viral Budding Unit,Fungal Pathogenesis Section,0.0
Viral Budding Unit,Gene Regulation Section,0.0
Viral Budding Unit,Genetic Engineering Section,0.0
Viral Budding Unit,Genetic Immunotherapy Section,0.0
Viral Budding Unit,Genomic Technologies Section,0.0
Viral Budding Unit,HIV Immunovirology Section,0.0
Viral Budding Unit,HIV Pathogenesis Section,0.0
Viral Budding Unit,HIV-Specific Immunity Section,0.0
Viral Budding Unit,Helminth Immunology Section,0.0
Viral Budding Unit,Hepatic Pathogenesis Section,0.0
Viral Budding Unit,Host-Parasite Interactions Section,0.0
Viral Budding Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Budding Unit,Human Eosinophil Section,0.0
Viral Budding Unit,Human Immunological Diseases Section,0.0
Viral Budding Unit,Immune Activation Section,0.0
Viral Budding Unit,Immune Deficiency Genetics Section,0.0
Viral Budding Unit,Immunobiology Section,0.0
Viral Budding Unit,Immunobiology and Molecular Virology Unit,0.0
Viral Budding Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Budding Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Budding Unit,Infectious Disease Fellowship Training Program,0.0
Viral Budding Unit,Infectious Disease Pathogenesis Section,0.0
Viral Budding Unit,Inflammation & Innate Immunity Unit,0.0
Viral Budding Unit,Inflammation Biology Section,0.0
Viral Budding Unit,Integrative Immunobiology Section,0.0
Viral Budding Unit,International HIV/STD Section,0.0
Viral Budding Unit,Intracellular Parasite Biology Section,0.0
Viral Budding Unit,LID Clinical Studies Unit,0.0
Viral Budding Unit,Lung and Vascular Inflammation Section,0.0
Viral Budding Unit,Lyme Disease Studies Unit,0.0
Viral Budding Unit,Lymphocyte Activation Section,0.0
Viral Budding Unit,Lymphocyte Biology Section,0.0
Viral Budding Unit,Malaria Cell Biology Section,0.0
Viral Budding Unit,Malaria Functional Genomics Section,0.0
Viral Budding Unit,Malaria Genetics Section,0.0
Viral Budding Unit,Malaria Immunology Section,0.0
Viral Budding Unit,Malaria Infection Biology and Immunity Unit,0.0
Viral Budding Unit,Mast Cell Biology Section,0.0
Viral Budding Unit,Medical Virology Section,0.0
Viral Budding Unit,Metaorganism Immunity Section,0.0
Viral Budding Unit,Microbial Pathogenesis Section,0.0
Viral Budding Unit,Molecular Biology Section,0.0
Viral Budding Unit,Molecular Defenses Section,0.0
Viral Budding Unit,Molecular Development of the Immune System Section,0.0
Viral Budding Unit,Molecular Entomology Unit,0.0
Viral Budding Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Budding Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Budding Unit,Molecular HIV Host Interactions Section,0.0
Viral Budding Unit,Molecular Microbiology Section,0.0
Viral Budding Unit,Molecular Parasitology Section,0.0
Viral Budding Unit,Molecular Parasitology and Entomology Unit,0.0
Viral Budding Unit,Molecular Pathogenesis Unit,0.0
Viral Budding Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Budding Unit,Molecular Pathology Section,0.0
Viral Budding Unit,Molecular Signaling Section,0.0
Viral Budding Unit,Molecular and Cellular Immunology Section,0.0
Viral Budding Unit,Molecular and Cellular Immunoregulation Section,0.0
Viral Budding Unit,Mosquito Immunity and Vector Competence Section,0.0
Viral Budding Unit,Mucosal Immunity Section,0.0
Viral Budding Unit,Mucosal Immunobiology Section,0.0
Viral Budding Unit,Multiscale Systems Biology Section,0.0
Viral Budding Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Budding Unit,Neuroimmunological Diseases Section,0.0
Viral Budding Unit,Neuroimmunology Unit,0.0
Viral Budding Unit,Office of the Animal Program Director,0.0
Viral Budding Unit,Pathogen Molecular Genetics Section,0.0
Viral Budding Unit,Pathogen-Host Cell Biology Section,0.0
Viral Budding Unit,Pathogenesis and Immunity Section,0.0
Viral Budding Unit,Pathology Core,0.0
Viral Budding Unit,Physiology Unit,0.0
Viral Budding Unit,Plague Section,0.0
Viral Budding Unit,Primary Immune Deficiency Clinic,0.0
Viral Budding Unit,Prion Cell Biology Unit,0.0
Viral Budding Unit,Protein Chemistry Section,0.0
Viral Budding Unit,Quantitative Virology and Evolution Unit,0.0
Viral Budding Unit,RML Flow Cytometry Unit,0.0
Viral Budding Unit,RML Genomics Unit,0.0
Viral Budding Unit,RML Microscopy Unit,0.0
Viral Budding Unit,RNA Viruses Section,0.0
Viral Budding Unit,Research Technology Branch,0.0
Viral Budding Unit,Retroviral Immunology Section,0.0
Viral Budding Unit,Salmonella-Host Cell Interactions Section,0.0
Viral Budding Unit,Scientist Emerita,0.0
Viral Budding Unit,Signaling Systems Section,0.0
Viral Budding Unit,Structural Biology Section,0.0
Viral Budding Unit,Structural Immunology Section,0.0
Viral Budding Unit,Structural Informatics Unit,0.0
Viral Budding Unit,Structural Virology Section,0.0
Viral Budding Unit,Systems Genomics Section,0.0
Viral Budding Unit,T-Cell Tolerance and Memory Section,0.0
Viral Budding Unit,T-Lymphocyte Biology Section,0.0
Viral Budding Unit,TSE/Prion Biochemistry Section,0.0
Viral Budding Unit,TSE/Prion Molecular Biology Section,0.0
Viral Budding Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Budding Unit,Tick-Pathogen Transmission Unit,0.0
Viral Budding Unit,Translational Allergic Immunopathology Unit,0.0
Viral Budding Unit,Translational Autoinflammatory Disease Studies Unit,0.0
Viral Budding Unit,Translational Immunobiology Unit,0.0
Viral Budding Unit,Translational Mycology Section,0.0
Viral Budding Unit,Transplant Infectious Diseases Consult Service,0.0
Viral Budding Unit,Tuberculosis Research Section,0.0
Viral Budding Unit,Twinbrook III,0.0
Viral Budding Unit,Twinbrook Imaging Facility,0.0
Viral Budding Unit,Type 2 Immunity Section,0.0
Viral Budding Unit,Vaccine Development Unit,0.0
Viral Budding Unit,Vector Biology Section,0.0
Viral Budding Unit,Vector Molecular Biology Section,0.0
Viral Budding Unit,Vector-Pathogen-Host Interaction Unit,0.0
Viral Budding Unit,Viral Biology Section,0.0
Viral Epidemiology and Immunity Unit,Allergy and Immunology Clinical Training Program,0.0
Viral Epidemiology and Immunity Unit,Antibacterial Host Defense Unit,0.0
Viral Epidemiology and Immunity Unit,Antibody Biology Unit,0.0
Viral Epidemiology and Immunity Unit,Apicomplexan Molecular Physiology Section,0.0
Viral Epidemiology and Immunity Unit,Autoimmunity and Functional Genomics Section,0.0
Viral Epidemiology and Immunity Unit,B-Cell Immunology Section,0.0
Viral Epidemiology and Immunity Unit,B-Cell Molecular Immunology Section,0.0
Viral Epidemiology and Immunity Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Epidemiology and Immunity Unit,Bacterial Physiology and Metabolism Unit,0.0
Viral Epidemiology and Immunity Unit,Barrier Immunity Section,0.0
Viral Epidemiology and Immunity Unit,Biological Imaging,0.0
Viral Epidemiology and Immunity Unit,Biology of Vector-Borne Viruses Section,0.0
Viral Epidemiology and Immunity Unit,Building 14B South,0.0
Viral Epidemiology and Immunity Unit,Building 33,0.0
Viral Epidemiology and Immunity Unit,Building 50,0.0
Viral Epidemiology and Immunity Unit,Building NIHAC/103,0.0
Viral Epidemiology and Immunity Unit,Buildings 4 and 10/11C127,0.0
Viral Epidemiology and Immunity Unit,Caliciviruses Section,0.0
Viral Epidemiology and Immunity Unit,Cell Signaling and Immunity Section,0.0
Viral Epidemiology and Immunity Unit,Cellular Biology Section,0.0
Viral Epidemiology and Immunity Unit,Cellular Immunology Section,0.0
Viral Epidemiology and Immunity Unit,Chemotaxis Signal Section,0.0
Viral Epidemiology and Immunity Unit,Chlamydial Diseases Section,0.0
Viral Epidemiology and Immunity Unit,Clinical Microbiome Unit (CMU),0.0
Viral Epidemiology and Immunity Unit,Clinical Pathophysiology Section,0.0
Viral Epidemiology and Immunity Unit,Clinical Research Section,0.0
Viral Epidemiology and Immunity Unit,Clinical and Molecular Retrovirology Section,0.0
Viral Epidemiology and Immunity Unit,Computational Biology Unit,0.0
Viral Epidemiology and Immunity Unit,Coxiella Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,DNA Tumor Virus Section,0.0
Viral Epidemiology and Immunity Unit,Disease Modeling and Transmission Section,0.0
Viral Epidemiology and Immunity Unit,Emerging Respiratory Viruses Section,0.0
Viral Epidemiology and Immunity Unit,Emerging Virus Immunity Unit,0.0
Viral Epidemiology and Immunity Unit,Epidemiology and Population Studies Unit,0.0
Viral Epidemiology and Immunity Unit,Epithelial Therapeutics Unit,0.0
Viral Epidemiology and Immunity Unit,Flow Cytometry Section,0.0
Viral Epidemiology and Immunity Unit,Food Allergy Research Section,0.0
Viral Epidemiology and Immunity Unit,Functional Cellular Networks Section,0.0
Viral Epidemiology and Immunity Unit,Fungal Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,Gene Regulation Section,0.0
Viral Epidemiology and Immunity Unit,Genetic Engineering Section,0.0
Viral Epidemiology and Immunity Unit,Genetic Immunotherapy Section,0.0
Viral Epidemiology and Immunity Unit,Genomic Technologies Section,0.0
Viral Epidemiology and Immunity Unit,HIV Immunovirology Section,0.0
Viral Epidemiology and Immunity Unit,HIV Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,HIV-Specific Immunity Section,0.0
Viral Epidemiology and Immunity Unit,Helminth Immunology Section,0.0
Viral Epidemiology and Immunity Unit,Hepatic Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,Host-Parasite Interactions Section,0.0
Viral Epidemiology and Immunity Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Epidemiology and Immunity Unit,Human Eosinophil Section,0.0
Viral Epidemiology and Immunity Unit,Human Immunological Diseases Section,0.0
Viral Epidemiology and Immunity Unit,Immune Activation Section,0.0
Viral Epidemiology and Immunity Unit,Immune Deficiency Genetics Section,0.0
Viral Epidemiology and Immunity Unit,Immunity to Pulmonary Pathogens Section,0.0
Viral Epidemiology and Immunity Unit,Immunobiology Section,0.0
Viral Epidemiology and Immunity Unit,Immunobiology and Molecular Virology Unit,0.0
Viral Epidemiology and Immunity Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Epidemiology and Immunity Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Epidemiology and Immunity Unit,Infectious Disease Fellowship Training Program,0.0
Viral Epidemiology and Immunity Unit,Infectious Disease Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,Inflammation & Innate Immunity Unit,0.0
Viral Epidemiology and Immunity Unit,Inflammation Biology Section,0.0
Viral Epidemiology and Immunity Unit,Innate Immunity and Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,Integrative Immunobiology Section,0.0
Viral Epidemiology and Immunity Unit,International HIV/STD Section,0.0
Viral Epidemiology and Immunity Unit,Intracellular Parasite Biology Section,0.0
Viral Epidemiology and Immunity Unit,LID Clinical Studies Unit,0.0
Viral Epidemiology and Immunity Unit,Lung and Vascular Inflammation Section,0.0
Viral Epidemiology and Immunity Unit,Lyme Disease Studies Unit,0.0
Viral Epidemiology and Immunity Unit,Lymphocyte Activation Section,0.0
Viral Epidemiology and Immunity Unit,Lymphocyte Biology Section,0.0
Viral Epidemiology and Immunity Unit,Malaria Cell Biology Section,0.0
Viral Epidemiology and Immunity Unit,Malaria Functional Genomics Section,0.0
Viral Epidemiology and Immunity Unit,Malaria Genetics Section,0.0
Viral Epidemiology and Immunity Unit,Malaria Immunology Section,0.0
Viral Epidemiology and Immunity Unit,Malaria Infection Biology and Immunity Unit,0.0
Viral Epidemiology and Immunity Unit,Mast Cell Biology Section,0.0
Viral Epidemiology and Immunity Unit,Medical Virology Section,0.0
Viral Epidemiology and Immunity Unit,Metaorganism Immunity Section,0.0
Viral Epidemiology and Immunity Unit,Microbial Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Biology Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Defenses Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Development of the Immune System Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Entomology Unit,0.0
Viral Epidemiology and Immunity Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Epidemiology and Immunity Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Epidemiology and Immunity Unit,Molecular HIV Host Interactions Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Microbiology Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Parasitology Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Parasitology and Entomology Unit,0.0
Viral Epidemiology and Immunity Unit,Molecular Pathogenesis Unit,0.0
Viral Epidemiology and Immunity Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Pathology Section,0.0
Viral Epidemiology and Immunity Unit,Molecular Signaling Section,0.0
Viral Epidemiology and Immunity Unit,Molecular and Cellular Immunology Section,0.0
Viral Epidemiology and Immunity Unit,Molecular and Cellular Immunoregulation Section,0.0
Viral Epidemiology and Immunity Unit,Mosquito Immunity and Vector Competence Section,0.0
Viral Epidemiology and Immunity Unit,Mucosal Immunity Section,0.0
Viral Epidemiology and Immunity Unit,Mucosal Immunobiology Section,0.0
Viral Epidemiology and Immunity Unit,Multiscale Systems Biology Section,0.0
Viral Epidemiology and Immunity Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Epidemiology and Immunity Unit,Neuroimmunological Diseases Section,0.0
Viral Epidemiology and Immunity Unit,Neuroimmunology Unit,0.0
Viral Epidemiology and Immunity Unit,Nonhuman Primate Virology Section,0.0
Viral Epidemiology and Immunity Unit,Office of the Animal Program Director,0.0
Viral Epidemiology and Immunity Unit,Pathogen Molecular Genetics Section,0.0
Viral Epidemiology and Immunity Unit,Pathogen-Host Cell Biology Section,0.0
Viral Epidemiology and Immunity Unit,Pathogenesis and Immunity Section,0.0
Viral Epidemiology and Immunity Unit,Pathology Core,0.0
Viral Epidemiology and Immunity Unit,Physiology Unit,0.0
Viral Epidemiology and Immunity Unit,Plague Section,0.0
Viral Epidemiology and Immunity Unit,Primary Immune Deficiency Clinic,0.0
Viral Epidemiology and Immunity Unit,Prion Cell Biology Unit,0.0
Viral Epidemiology and Immunity Unit,Protein Chemistry Section,0.0
Viral Epidemiology and Immunity Unit,Quantitative Virology and Evolution Unit,0.0
Viral Epidemiology and Immunity Unit,RML Flow Cytometry Unit,0.0
Viral Epidemiology and Immunity Unit,RML Genomics Unit,0.0
Viral Epidemiology and Immunity Unit,RML Microscopy Unit,0.0
Viral Epidemiology and Immunity Unit,RNA Viruses Section,0.0
Viral Epidemiology and Immunity Unit,Research Technology Branch,0.0
Viral Epidemiology and Immunity Unit,Retroviral Immunology Section,0.0
Viral Epidemiology and Immunity Unit,Salmonella-Host Cell Interactions Section,0.0
Viral Epidemiology and Immunity Unit,Scientist Emerita,0.0
Viral Epidemiology and Immunity Unit,Signaling Systems Section,0.0
Viral Epidemiology and Immunity Unit,Structural Biology Section,0.0
Viral Epidemiology and Immunity Unit,Structural Immunology Section,0.0
Viral Epidemiology and Immunity Unit,Structural Informatics Unit,0.0
Viral Epidemiology and Immunity Unit,Structural Virology Section,0.0
Viral Epidemiology and Immunity Unit,Systems Genomics Section,0.0
Viral Epidemiology and Immunity Unit,T-Cell Tolerance and Memory Section,0.0
Viral Epidemiology and Immunity Unit,T-Lymphocyte Biology Section,0.0
Viral Epidemiology and Immunity Unit,TSE/Prion Biochemistry Section,0.0
Viral Epidemiology and Immunity Unit,TSE/Prion Molecular Biology Section,0.0
Viral Epidemiology and Immunity Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Epidemiology and Immunity Unit,Tick-Pathogen Transmission Unit,0.0
Viral Epidemiology and Immunity Unit,Translational Allergic Immunopathology Unit,0.0
Viral Epidemiology and Immunity Unit,Translational Autoinflammatory Disease Studies Unit,0.0
Viral Epidemiology and Immunity Unit,Translational Immunobiology Unit,0.0
Viral Epidemiology and Immunity Unit,Translational Mycology Section,0.0
Viral Epidemiology and Immunity Unit,Transplant Infectious Diseases Consult Service,0.0
Viral Epidemiology and Immunity Unit,Tuberculosis Research Section,0.0
Viral Epidemiology and Immunity Unit,Twinbrook III,0.0
Viral Epidemiology and Immunity Unit,Twinbrook Imaging Facility,0.0
Viral Epidemiology and Immunity Unit,Type 2 Immunity Section,0.0
Viral Epidemiology and Immunity Unit,Vaccine Development Unit,0.0
Viral Epidemiology and Immunity Unit,Vector Biology Section,0.0
Viral Epidemiology and Immunity Unit,Vector Molecular Biology Section,0.0
Viral Epidemiology and Immunity Unit,Vector-Pathogen-Host Interaction Unit,0.0
Viral Epidemiology and Immunity Unit,Viral Biochemistry Section,0.0
Viral Epidemiology and Immunity Unit,Viral Biology Section,0.0
Viral Epidemiology and Immunity Unit,Viral Budding Unit,0.0
Viral Immunity and Pathogenesis Unit,Allergy and Immunology Clinical Training Program,0.0
Viral Immunity and Pathogenesis Unit,Antibacterial Host Defense Unit,0.0
Viral Immunity and Pathogenesis Unit,Antibody Biology Unit,0.0
Viral Immunity and Pathogenesis Unit,Apicomplexan Molecular Physiology Section,0.0
Viral Immunity and Pathogenesis Unit,Autoimmunity and Functional Genomics Section,0.0
Viral Immunity and Pathogenesis Unit,B-Cell Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,B-Cell Molecular Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Immunity and Pathogenesis Unit,Bacterial Physiology and Metabolism Unit,0.0
Viral Immunity and Pathogenesis Unit,Biology of Vector-Borne Viruses Section,0.0
Viral Immunity and Pathogenesis Unit,Building 14B South,0.0
Viral Immunity and Pathogenesis Unit,Building 33,0.0
Viral Immunity and Pathogenesis Unit,Building 50,0.0
Viral Immunity and Pathogenesis Unit,Building NIHAC/103,0.0
Viral Immunity and Pathogenesis Unit,Buildings 4 and 10/11C127,0.0
Viral Immunity and Pathogenesis Unit,Caliciviruses Section,0.0
Viral Immunity and Pathogenesis Unit,Cell Signaling and Immunity Section,0.0
Viral Immunity and Pathogenesis Unit,Cellular Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,Chemotaxis Signal Section,0.0
Viral Immunity and Pathogenesis Unit,Chlamydial Diseases Section,0.0
Viral Immunity and Pathogenesis Unit,Clinical Microbiome Unit (CMU),0.0
Viral Immunity and Pathogenesis Unit,Clinical Pathophysiology Section,0.0
Viral Immunity and Pathogenesis Unit,Clinical Research Section,0.0
Viral Immunity and Pathogenesis Unit,Clinical and Molecular Retrovirology Section,0.0
Viral Immunity and Pathogenesis Unit,Computational Biology Unit,0.0
Viral Immunity and Pathogenesis Unit,Coxiella Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,DNA Tumor Virus Section,0.0
Viral Immunity and Pathogenesis Unit,Disease Modeling and Transmission Section,0.0
Viral Immunity and Pathogenesis Unit,Emerging Respiratory Viruses Section,0.0
Viral Immunity and Pathogenesis Unit,Emerging Virus Immunity Unit,0.0
Viral Immunity and Pathogenesis Unit,Epidemiology and Population Studies Unit,0.0
Viral Immunity and Pathogenesis Unit,Epithelial Therapeutics Unit,0.0
Viral Immunity and Pathogenesis Unit,Flow Cytometry Section,0.0
Viral Immunity and Pathogenesis Unit,Food Allergy Research Section,0.0
Viral Immunity and Pathogenesis Unit,Functional Cellular Networks Section,0.0
Viral Immunity and Pathogenesis Unit,Fungal Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,Gene Regulation Section,0.0
Viral Immunity and Pathogenesis Unit,Genetic Engineering Section,0.0
Viral Immunity and Pathogenesis Unit,Genetic Immunotherapy Section,0.0
Viral Immunity and Pathogenesis Unit,HIV Immunovirology Section,0.0
Viral Immunity and Pathogenesis Unit,HIV Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,HIV-Specific Immunity Section,0.0
Viral Immunity and Pathogenesis Unit,Helminth Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,Hepatic Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,Host-Parasite Interactions Section,0.0
Viral Immunity and Pathogenesis Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Immunity and Pathogenesis Unit,Human Eosinophil Section,0.0
Viral Immunity and Pathogenesis Unit,Human Immunological Diseases Section,0.0
Viral Immunity and Pathogenesis Unit,Immune Activation Section,0.0
Viral Immunity and Pathogenesis Unit,Immune Deficiency Genetics Section,0.0
Viral Immunity and Pathogenesis Unit,Immunity to Pulmonary Pathogens Section,0.0
Viral Immunity and Pathogenesis Unit,Immunobiology Section,0.0
Viral Immunity and Pathogenesis Unit,Immunobiology and Molecular Virology Unit,0.0
Viral Immunity and Pathogenesis Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Immunity and Pathogenesis Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Immunity and Pathogenesis Unit,Infectious Disease Fellowship Training Program,0.0
Viral Immunity and Pathogenesis Unit,Infectious Disease Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,Inflammation & Innate Immunity Unit,0.0
Viral Immunity and Pathogenesis Unit,Inflammation Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Innate Immunity and Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,Integrative Immunobiology Section,0.0
Viral Immunity and Pathogenesis Unit,International HIV/STD Section,0.0
Viral Immunity and Pathogenesis Unit,Intracellular Parasite Biology Section,0.0
Viral Immunity and Pathogenesis Unit,LID Clinical Studies Unit,0.0
Viral Immunity and Pathogenesis Unit,Lung and Vascular Inflammation Section,0.0
Viral Immunity and Pathogenesis Unit,Lyme Disease Studies Unit,0.0
Viral Immunity and Pathogenesis Unit,Lymphocyte Activation Section,0.0
Viral Immunity and Pathogenesis Unit,Lymphocyte Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Malaria Cell Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Malaria Functional Genomics Section,0.0
Viral Immunity and Pathogenesis Unit,Malaria Genetics Section,0.0
Viral Immunity and Pathogenesis Unit,Malaria Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,Malaria Infection Biology and Immunity Unit,0.0
Viral Immunity and Pathogenesis Unit,Mast Cell Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Medical Virology Section,0.0
Viral Immunity and Pathogenesis Unit,Microbial Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Defenses Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Development of the Immune System Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Entomology Unit,0.0
Viral Immunity and Pathogenesis Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Immunity and Pathogenesis Unit,Molecular HIV Host Interactions Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Microbiology Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Parasitology Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Parasitology and Entomology Unit,0.0
Viral Immunity and Pathogenesis Unit,Molecular Pathogenesis Unit,0.0
Viral Immunity and Pathogenesis Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Pathology Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular Signaling Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular and Cellular Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,Molecular and Cellular Immunoregulation Section,0.0
Viral Immunity and Pathogenesis Unit,Mosquito Immunity and Vector Competence Section,0.0
Viral Immunity and Pathogenesis Unit,Mucosal Immunity Section,0.0
Viral Immunity and Pathogenesis Unit,Mucosal Immunobiology Section,0.0
Viral Immunity and Pathogenesis Unit,Multiscale Systems Biology Section,0.0
Viral Immunity and Pathogenesis Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Immunity and Pathogenesis Unit,Neuroimmunological Diseases Section,0.0
Viral Immunity and Pathogenesis Unit,Neuroimmunology Unit,0.0
Viral Immunity and Pathogenesis Unit,Nonhuman Primate Virology Section,0.0
Viral Immunity and Pathogenesis Unit,Office of the Animal Program Director,0.0
Viral Immunity and Pathogenesis Unit,Pathogen Molecular Genetics Section,0.0
Viral Immunity and Pathogenesis Unit,Pathogen-Host Cell Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Pathogenesis and Immunity Section,0.0
Viral Immunity and Pathogenesis Unit,Pathology Core,0.0
Viral Immunity and Pathogenesis Unit,Physiology Unit,0.0
Viral Immunity and Pathogenesis Unit,Plague Section,0.0
Viral Immunity and Pathogenesis Unit,Primary Immune Deficiency Clinic,0.0
Viral Immunity and Pathogenesis Unit,Prion Cell Biology Unit,0.0
Viral Immunity and Pathogenesis Unit,Protein Chemistry Section,0.0
Viral Immunity and Pathogenesis Unit,Quantitative Virology and Evolution Unit,0.0
Viral Immunity and Pathogenesis Unit,RML Flow Cytometry Unit,0.0
Viral Immunity and Pathogenesis Unit,RML Genomics Unit,0.0
Viral Immunity and Pathogenesis Unit,RML Microscopy Unit,0.0
Viral Immunity and Pathogenesis Unit,RNA Viruses Section,0.0
Viral Immunity and Pathogenesis Unit,Research Technology Branch,0.0
Viral Immunity and Pathogenesis Unit,Retroviral Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,Salmonella-Host Cell Interactions Section,0.0
Viral Immunity and Pathogenesis Unit,Scientist Emerita,0.0
Viral Immunity and Pathogenesis Unit,Signaling Systems Section,0.0
Viral Immunity and Pathogenesis Unit,Structural Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Structural Immunology Section,0.0
Viral Immunity and Pathogenesis Unit,Structural Informatics Unit,0.0
Viral Immunity and Pathogenesis Unit,Structural Virology Section,0.0
Viral Immunity and Pathogenesis Unit,Systems Genomics Section,0.0
Viral Immunity and Pathogenesis Unit,T-Cell Tolerance and Memory Section,0.0
Viral Immunity and Pathogenesis Unit,T-Lymphocyte Biology Section,0.0
Viral Immunity and Pathogenesis Unit,TSE/Prion Biochemistry Section,0.0
Viral Immunity and Pathogenesis Unit,TSE/Prion Molecular Biology Section,0.0
Viral Immunity and Pathogenesis Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Immunity and Pathogenesis Unit,Tick-Pathogen Transmission Unit,0.0
Viral Immunity and Pathogenesis Unit,Translational Allergic Immunopathology Unit,0.0
Viral Immunity and Pathogenesis Unit,Translational Autoinflammatory Disease Studies Unit,0.0
Viral Immunity and Pathogenesis Unit,Translational Immunobiology Unit,0.0
Viral Immunity and Pathogenesis Unit,Translational Mycology Section,0.0
Viral Immunity and Pathogenesis Unit,Transplant Infectious Diseases Consult Service,0.0
Viral Immunity and Pathogenesis Unit,Tuberculosis Research Section,0.0
Viral Immunity and Pathogenesis Unit,Twinbrook III,0.0
Viral Immunity and Pathogenesis Unit,Twinbrook Imaging Facility,0.0
Viral Immunity and Pathogenesis Unit,Type 2 Immunity Section,0.0
Viral Immunity and Pathogenesis Unit,Vaccine Development Unit,0.0
Viral Immunity and Pathogenesis Unit,Vector Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Vector Molecular Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Vector-Pathogen-Host Interaction Unit,0.0
Viral Immunity and Pathogenesis Unit,Viral Biochemistry Section,0.0
Viral Immunity and Pathogenesis Unit,Viral Biology Section,0.0
Viral Immunity and Pathogenesis Unit,Viral Budding Unit,0.0
Viral Immunity and Pathogenesis Unit,Viral Epidemiology and Immunity Unit,0.0
Viral Immunology Section,Allergy and Immunology Clinical Training Program,0.0
Viral Immunology Section,Antibacterial Host Defense Unit,0.0
Viral Immunology Section,Antibody Biology Unit,0.0
Viral Immunology Section,Apicomplexan Molecular Physiology Section,0.0
Viral Immunology Section,Autoimmunity and Functional Genomics Section,0.0
Viral Immunology Section,B-Cell Immunology Section,0.0
Viral Immunology Section,B-Cell Molecular Immunology Section,0.0
Viral Immunology Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Immunology Section,Bacterial Physiology and Metabolism Unit,0.0
Viral Immunology Section,Barrier Immunity Section,0.0
Viral Immunology Section,Biology of Vector-Borne Viruses Section,0.0
Viral Immunology Section,Building 14B South,0.0
Viral Immunology Section,Building 33,0.0
Viral Immunology Section,Building 50,0.0
Viral Immunology Section,Building NIHAC/103,0.0
Viral Immunology Section,Buildings 4 and 10/11C127,0.0
Viral Immunology Section,Caliciviruses Section,0.0
Viral Immunology Section,Cell Signaling and Immunity Section,0.0
Viral Immunology Section,Cellular Immunology Section,0.0
Viral Immunology Section,Chemotaxis Signal Section,0.0
Viral Immunology Section,Chlamydial Diseases Section,0.0
Viral Immunology Section,Clinical Microbiome Unit (CMU),0.0
Viral Immunology Section,Clinical Pathophysiology Section,0.0
Viral Immunology Section,Clinical Research Section,0.0
Viral Immunology Section,Clinical and Molecular Retrovirology Section,0.0
Viral Immunology Section,Computational Biology Unit,0.0
Viral Immunology Section,Coxiella Pathogenesis Section,0.0
Viral Immunology Section,DNA Tumor Virus Section,0.0
Viral Immunology Section,Disease Modeling and Transmission Section,0.0
Viral Immunology Section,Emerging Respiratory Viruses Section,0.0
Viral Immunology Section,Emerging Virus Immunity Unit,0.0
Viral Immunology Section,Epidemiology and Population Studies Unit,0.0
Viral Immunology Section,Epithelial Therapeutics Unit,0.0
Viral Immunology Section,Flow Cytometry Section,0.0
Viral Immunology Section,Food Allergy Research Section,0.0
Viral Immunology Section,Functional Cellular Networks Section,0.0
Viral Immunology Section,Fungal Pathogenesis Section,0.0
Viral Immunology Section,Gene Regulation Section,0.0
Viral Immunology Section,Genetic Engineering Section,0.0
Viral Immunology Section,Genetic Immunotherapy Section,0.0
Viral Immunology Section,Genomic Technologies Section,0.0
Viral Immunology Section,HIV Immunovirology Section,0.0
Viral Immunology Section,HIV Pathogenesis Section,0.0
Viral Immunology Section,HIV-Specific Immunity Section,0.0
Viral Immunology Section,Helminth Immunology Section,0.0
Viral Immunology Section,Hepatic Pathogenesis Section,0.0
Viral Immunology Section,Host-Parasite Interactions Section,0.0
Viral Immunology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Immunology Section,Human Eosinophil Section,0.0
Viral Immunology Section,Human Immunological Diseases Section,0.0
Viral Immunology Section,Immune Activation Section,0.0
Viral Immunology Section,Immune Deficiency Genetics Section,0.0
Viral Immunology Section,Immunity to Pulmonary Pathogens Section,0.0
Viral Immunology Section,Immunobiology Section,0.0
Viral Immunology Section,Immunobiology and Molecular Virology Unit,0.0
Viral Immunology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Immunology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Immunology Section,Infectious Disease Fellowship Training Program,0.0
Viral Immunology Section,Infectious Disease Pathogenesis Section,0.0
Viral Immunology Section,Inflammation & Innate Immunity Unit,0.0
Viral Immunology Section,Inflammation Biology Section,0.0
Viral Immunology Section,Innate Immunity and Pathogenesis Section,0.0
Viral Immunology Section,Integrative Immunobiology Section,0.0
Viral Immunology Section,International HIV/STD Section,0.0
Viral Immunology Section,Intracellular Parasite Biology Section,0.0
Viral Immunology Section,LID Clinical Studies Unit,0.0
Viral Immunology Section,Lung and Vascular Inflammation Section,0.0
Viral Immunology Section,Lyme Disease Studies Unit,0.0
Viral Immunology Section,Lymphocyte Activation Section,0.0
Viral Immunology Section,Lymphocyte Biology Section,0.0
Viral Immunology Section,Malaria Cell Biology Section,0.0
Viral Immunology Section,Malaria Functional Genomics Section,0.0
Viral Immunology Section,Malaria Genetics Section,0.0
Viral Immunology Section,Malaria Immunology Section,0.0
Viral Immunology Section,Malaria Infection Biology and Immunity Unit,0.0
Viral Immunology Section,Mast Cell Biology Section,0.0
Viral Immunology Section,Medical Virology Section,0.0
Viral Immunology Section,Metaorganism Immunity Section,0.0
Viral Immunology Section,Microbial Pathogenesis Section,0.0
Viral Immunology Section,Molecular Biology Section,0.0
Viral Immunology Section,Molecular Defenses Section,0.0
Viral Immunology Section,Molecular Development of the Immune System Section,0.0
Viral Immunology Section,Molecular Entomology Unit,0.0
Viral Immunology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Immunology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Immunology Section,Molecular HIV Host Interactions Section,0.0
Viral Immunology Section,Molecular Microbiology Section,0.0
Viral Immunology Section,Molecular Parasitology Section,0.0
Viral Immunology Section,Molecular Parasitology and Entomology Unit,0.0
Viral Immunology Section,Molecular Pathogenesis Unit,0.0
Viral Immunology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Immunology Section,Molecular Pathology Section,0.0
Viral Immunology Section,Molecular Signaling Section,0.0
Viral Immunology Section,Molecular and Cellular Immunology Section,0.0
Viral Immunology Section,Molecular and Cellular Immunoregulation Section,0.0
Viral Immunology Section,Mosquito Immunity and Vector Competence Section,0.0
Viral Immunology Section,Mucosal Immunity Section,0.0
Viral Immunology Section,Multiscale Systems Biology Section,0.0
Viral Immunology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Immunology Section,Neuroimmunological Diseases Section,0.0
Viral Immunology Section,Neuroimmunology Unit,0.0
Viral Immunology Section,Nonhuman Primate Virology Section,0.0
Viral Immunology Section,Office of the Animal Program Director,0.0
Viral Immunology Section,Pathogen Molecular Genetics Section,0.0
Viral Immunology Section,Pathogen-Host Cell Biology Section,0.0
Viral Immunology Section,Pathogenesis and Immunity Section,0.0
Viral Immunology Section,Pathology Core,0.0
Viral Immunology Section,Physiology Unit,0.0
Viral Immunology Section,Plague Section,0.0
Viral Immunology Section,Primary Immune Deficiency Clinic,0.0
Viral Immunology Section,Prion Cell Biology Unit,0.0
Viral Immunology Section,Protein Chemistry Section,0.0
Viral Immunology Section,Quantitative Virology and Evolution Unit,0.0
Viral Immunology Section,RML Flow Cytometry Unit,0.0
Viral Immunology Section,RML Genomics Unit,0.0
Viral Immunology Section,RML Microscopy Unit,0.0
Viral Immunology Section,RNA Viruses Section,0.0
Viral Immunology Section,Research Technology Branch,0.0
Viral Immunology Section,Retroviral Immunology Section,0.0
Viral Immunology Section,Salmonella-Host Cell Interactions Section,0.0
Viral Immunology Section,Scientist Emerita,0.0
Viral Immunology Section,Signaling Systems Section,0.0
Viral Immunology Section,Structural Biology Section,0.0
Viral Immunology Section,Structural Immunology Section,0.0
Viral Immunology Section,Structural Informatics Unit,0.0
Viral Immunology Section,Structural Virology Section,0.0
Viral Immunology Section,Systems Genomics Section,0.0
Viral Immunology Section,T-Cell Tolerance and Memory Section,0.0
Viral Immunology Section,T-Lymphocyte Biology Section,0.0
Viral Immunology Section,TSE/Prion Biochemistry Section,0.0
Viral Immunology Section,TSE/Prion Molecular Biology Section,0.0
Viral Immunology Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Immunology Section,Tick-Pathogen Transmission Unit,0.0
Viral Immunology Section,Translational Allergic Immunopathology Unit,0.0
Viral Immunology Section,Translational Autoinflammatory Disease Studies Unit,0.0
Viral Immunology Section,Translational Immunobiology Unit,0.0
Viral Immunology Section,Translational Mycology Section,0.0
Viral Immunology Section,Transplant Infectious Diseases Consult Service,0.0
Viral Immunology Section,Tuberculosis Research Section,0.0
Viral Immunology Section,Twinbrook III,0.0
Viral Immunology Section,Twinbrook Imaging Facility,0.0
Viral Immunology Section,Type 2 Immunity Section,0.0
Viral Immunology Section,Vaccine Development Unit,0.0
Viral Immunology Section,Vector Biology Section,0.0
Viral Immunology Section,Vector Molecular Biology Section,0.0
Viral Immunology Section,Vector-Pathogen-Host Interaction Unit,0.0
Viral Immunology Section,Viral Biochemistry Section,0.0
Viral Immunology Section,Viral Biology Section,0.0
Viral Immunology Section,Viral Budding Unit,0.0
Viral Immunology Section,Viral Epidemiology and Immunity Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Allergy and Immunology Clinical Training Program,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Antibacterial Host Defense Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Antibody Biology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Apicomplexan Molecular Physiology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Autoimmunity and Functional Genomics Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Bacterial Physiology and Metabolism Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Barrier Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Biological Imaging,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Biology of Vector-Borne Viruses Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Building 14B South,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Building 33,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Building 50,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Building NIHAC/103,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Buildings 4 and 10/11C127,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Caliciviruses Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Cell Signaling and Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Cellular Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Cellular Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Chemotaxis Signal Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Chlamydial Diseases Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Clinical Microbiome Unit (CMU),0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Clinical Pathophysiology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Clinical Research Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Clinical and Molecular Retrovirology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Computational Biology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Coxiella Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),DNA Tumor Virus Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Disease Modeling and Transmission Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Emerging Respiratory Viruses Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Emerging Virus Immunity Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Epidemiology and Population Studies Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Epithelial Therapeutics Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Flow Cytometry Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Food Allergy Research Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Functional Cellular Networks Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Fungal Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Gene Regulation Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Genetic Engineering Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Genetic Immunotherapy Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Genomic Technologies Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Helminth Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Host-Parasite Interactions Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Human Eosinophil Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Human Immunological Diseases Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Immune Activation Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Immune Deficiency Genetics Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Immunity to Pulmonary Pathogens Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Immunobiology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Immunobiology and Molecular Virology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Infectious Disease Fellowship Training Program,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Infectious Disease Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Inflammation & Innate Immunity Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Inflammation Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Innate Immunity and Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Integrative Immunobiology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),International HIV/STD Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Intracellular Parasite Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Lung and Vascular Inflammation Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Lyme Disease Studies Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Lymphocyte Activation Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Lymphocyte Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Malaria Cell Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Malaria Functional Genomics Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Malaria Genetics Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Malaria Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Malaria Infection Biology and Immunity Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Mast Cell Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Medical Virology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Metaorganism Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Microbial Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Defenses Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Development of the Immune System Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Entomology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular HIV Host Interactions Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Microbiology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Parasitology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Parasitology and Entomology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Pathogenesis Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Pathogenesis and Biomarkers Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Pathology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular Signaling Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular and Cellular Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Molecular and Cellular Immunoregulation Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Mosquito Immunity and Vector Competence Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Mucosal Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Mucosal Immunobiology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Multiscale Systems Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),NIAID International Center of Excellence in Research Cambodia,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Neuroimmunological Diseases Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Neuroimmunology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Office of the Animal Program Director,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Pathogen Molecular Genetics Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Pathogen-Host Cell Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Pathogenesis and Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Pathology Core,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Physiology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Plague Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Primary Immune Deficiency Clinic,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Prion Cell Biology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Protein Chemistry Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Quantitative Virology and Evolution Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),RML Flow Cytometry Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),RML Genomics Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),RML Microscopy Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),RNA Viruses Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Research Technology Branch,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Retroviral Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Salmonella-Host Cell Interactions Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Scientist Emerita,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Signaling Systems Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Structural Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Structural Informatics Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Structural Virology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Systems Genomics Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),T-Cell Tolerance and Memory Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),T-Lymphocyte Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),TSE/Prion Biochemistry Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),TSE/Prion Molecular Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Tick-Pathogen Transmission Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Translational Allergic Immunopathology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Translational Autoinflammatory Disease Studies Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Translational Immunobiology Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Translational Mycology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Transplant Infectious Diseases Consult Service,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Tuberculosis Research Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Twinbrook III,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Twinbrook Imaging Facility,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Type 2 Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Vaccine Development Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Vector Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Vector Molecular Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Vector-Pathogen-Host Interaction Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Viral Biochemistry Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Viral Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Viral Budding Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Viral Epidemiology and Immunity Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Viral Immunity and Pathogenesis Unit,0.0
Viral Pathogenesis Section (Laboratory of Immunoregulation),Viral Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Allergy and Immunology Clinical Training Program,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Antibacterial Host Defense Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Antibody Biology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Apicomplexan Molecular Physiology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Autoimmunity and Functional Genomics Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),B-Cell Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),B-Cell Molecular Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Bacterial Physiology and Metabolism Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Barrier Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Biological Imaging,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Biology of Vector-Borne Viruses Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Building 14B South,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Building 33,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Building 50,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Building NIHAC/103,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Buildings 4 and 10/11C127,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Caliciviruses Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Cell Signaling and Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Cellular Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Chemotaxis Signal Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Chlamydial Diseases Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Clinical Microbiome Unit (CMU),0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Clinical Pathophysiology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Clinical Research Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Clinical and Molecular Retrovirology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Computational Biology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Coxiella Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),DNA Tumor Virus Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Epidemiology and Population Studies Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Epithelial Therapeutics Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Flow Cytometry Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Food Allergy Research Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Functional Cellular Networks Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Fungal Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Gene Regulation Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Genetic Engineering Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Genetic Immunotherapy Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),HIV Immunovirology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),HIV Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),HIV-Specific Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Helminth Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Hepatic Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Host-Parasite Interactions Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Human Eosinophil Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Human Immunological Diseases Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Immune Activation Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Immune Deficiency Genetics Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Immunity to Pulmonary Pathogens Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Immunobiology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Infectious Disease Fellowship Training Program,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Infectious Disease Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Inflammation & Innate Immunity Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Inflammation Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Innate Immunity and Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Integrative Immunobiology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Intracellular Parasite Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),LID Clinical Studies Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Lung and Vascular Inflammation Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Lyme Disease Studies Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Lymphocyte Activation Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Lymphocyte Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Malaria Cell Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Malaria Functional Genomics Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Malaria Genetics Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Malaria Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Malaria Infection Biology and Immunity Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Mast Cell Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Metaorganism Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Microbial Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Defenses Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Development of the Immune System Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Entomology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular HIV Host Interactions Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Microbiology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Parasitology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Parasitology and Entomology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Pathogenesis Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Pathogenesis and Biomarkers Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Pathology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular Signaling Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular and Cellular Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Molecular and Cellular Immunoregulation Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Mosquito Immunity and Vector Competence Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Mucosal Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Mucosal Immunobiology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Multiscale Systems Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),NIAID International Center of Excellence in Research Cambodia,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Neuroimmunological Diseases Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Neuroimmunology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Nonhuman Primate Virology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Office of the Animal Program Director,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Pathogen Molecular Genetics Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Pathogen-Host Cell Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Pathogenesis and Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Pathology Core,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Physiology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Plague Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Primary Immune Deficiency Clinic,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Prion Cell Biology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Protein Chemistry Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Quantitative Virology and Evolution Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),RML Flow Cytometry Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),RML Genomics Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),RML Microscopy Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),RNA Viruses Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Research Technology Branch,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Retroviral Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Salmonella-Host Cell Interactions Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Scientist Emerita,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Signaling Systems Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Structural Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Structural Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Structural Virology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Systems Genomics Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),T-Cell Tolerance and Memory Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),T-Lymphocyte Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),TSE/Prion Biochemistry Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),TSE/Prion Molecular Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Tick-Pathogen Transmission Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Translational Allergic Immunopathology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Translational Autoinflammatory Disease Studies Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Translational Immunobiology Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Translational Mycology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Transplant Infectious Diseases Consult Service,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Tuberculosis Research Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Twinbrook III,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Twinbrook Imaging Facility,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Type 2 Immunity Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Vaccine Development Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Vector Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Vector Molecular Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Vector-Pathogen-Host Interaction Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Viral Biochemistry Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Viral Biology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Viral Budding Unit,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Viral Immunology Section,0.0
Viral Pathogenesis Section (Laboratory of Viral Diseases),Viral Pathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Pathogenesis and Evolution Section,Allergy and Immunology Clinical Training Program,0.0
Viral Pathogenesis and Evolution Section,Antibacterial Host Defense Unit,0.0
Viral Pathogenesis and Evolution Section,Antibody Biology Unit,0.0
Viral Pathogenesis and Evolution Section,Apicomplexan Molecular Physiology Section,0.0
Viral Pathogenesis and Evolution Section,Autoimmunity and Functional Genomics Section,0.0
Viral Pathogenesis and Evolution Section,B-Cell Immunology Section,0.0
Viral Pathogenesis and Evolution Section,B-Cell Molecular Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Pathogenesis and Evolution Section,Bacterial Physiology and Metabolism Unit,0.0
Viral Pathogenesis and Evolution Section,Barrier Immunity Section,0.0
Viral Pathogenesis and Evolution Section,Biological Imaging,0.0
Viral Pathogenesis and Evolution Section,Biology of Vector-Borne Viruses Section,0.0
Viral Pathogenesis and Evolution Section,Building 14B South,0.0
Viral Pathogenesis and Evolution Section,Building 33,0.0
Viral Pathogenesis and Evolution Section,Building 50,0.0
Viral Pathogenesis and Evolution Section,Building NIHAC/103,0.0
Viral Pathogenesis and Evolution Section,Buildings 4 and 10/11C127,0.0
Viral Pathogenesis and Evolution Section,Caliciviruses Section,0.0
Viral Pathogenesis and Evolution Section,Cell Signaling and Immunity Section,0.0
Viral Pathogenesis and Evolution Section,Cellular Biology Section,0.0
Viral Pathogenesis and Evolution Section,Cellular Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Chemotaxis Signal Section,0.0
Viral Pathogenesis and Evolution Section,Chlamydial Diseases Section,0.0
Viral Pathogenesis and Evolution Section,Clinical Microbiome Unit (CMU),0.0
Viral Pathogenesis and Evolution Section,Clinical Pathophysiology Section,0.0
Viral Pathogenesis and Evolution Section,Clinical and Molecular Retrovirology Section,0.0
Viral Pathogenesis and Evolution Section,Computational Biology Unit,0.0
Viral Pathogenesis and Evolution Section,Coxiella Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,DNA Tumor Virus Section,0.0
Viral Pathogenesis and Evolution Section,Emerging Respiratory Viruses Section,0.0
Viral Pathogenesis and Evolution Section,Emerging Virus Immunity Unit,0.0
Viral Pathogenesis and Evolution Section,Epidemiology and Population Studies Unit,0.0
Viral Pathogenesis and Evolution Section,Epithelial Therapeutics Unit,0.0
Viral Pathogenesis and Evolution Section,Flow Cytometry Section,0.0
Viral Pathogenesis and Evolution Section,Food Allergy Research Section,0.0
Viral Pathogenesis and Evolution Section,Functional Cellular Networks Section,0.0
Viral Pathogenesis and Evolution Section,Fungal Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,Gene Regulation Section,0.0
Viral Pathogenesis and Evolution Section,Genetic Engineering Section,0.0
Viral Pathogenesis and Evolution Section,Genetic Immunotherapy Section,0.0
Viral Pathogenesis and Evolution Section,Genomic Technologies Section,0.0
Viral Pathogenesis and Evolution Section,HIV Immunovirology Section,0.0
Viral Pathogenesis and Evolution Section,HIV Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,HIV-Specific Immunity Section,0.0
Viral Pathogenesis and Evolution Section,Helminth Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Hepatic Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,Host-Parasite Interactions Section,0.0
Viral Pathogenesis and Evolution Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Pathogenesis and Evolution Section,Human Eosinophil Section,0.0
Viral Pathogenesis and Evolution Section,Human Immunological Diseases Section,0.0
Viral Pathogenesis and Evolution Section,Immune Activation Section,0.0
Viral Pathogenesis and Evolution Section,Immune Deficiency Genetics Section,0.0
Viral Pathogenesis and Evolution Section,Immunity to Pulmonary Pathogens Section,0.0
Viral Pathogenesis and Evolution Section,Immunobiology Section,0.0
Viral Pathogenesis and Evolution Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Pathogenesis and Evolution Section,Infectious Disease Fellowship Training Program,0.0
Viral Pathogenesis and Evolution Section,Infectious Disease Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,Inflammation & Innate Immunity Unit,0.0
Viral Pathogenesis and Evolution Section,Inflammation Biology Section,0.0
Viral Pathogenesis and Evolution Section,Innate Immunity and Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,Integrative Immunobiology Section,0.0
Viral Pathogenesis and Evolution Section,International HIV/STD Section,0.0
Viral Pathogenesis and Evolution Section,Intracellular Parasite Biology Section,0.0
Viral Pathogenesis and Evolution Section,Lung and Vascular Inflammation Section,0.0
Viral Pathogenesis and Evolution Section,Lyme Disease Studies Unit,0.0
Viral Pathogenesis and Evolution Section,Lymphocyte Activation Section,0.0
Viral Pathogenesis and Evolution Section,Lymphocyte Biology Section,0.0
Viral Pathogenesis and Evolution Section,Malaria Cell Biology Section,0.0
Viral Pathogenesis and Evolution Section,Malaria Functional Genomics Section,0.0
Viral Pathogenesis and Evolution Section,Malaria Genetics Section,0.0
Viral Pathogenesis and Evolution Section,Malaria Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Malaria Infection Biology and Immunity Unit,0.0
Viral Pathogenesis and Evolution Section,Mast Cell Biology Section,0.0
Viral Pathogenesis and Evolution Section,Medical Virology Section,0.0
Viral Pathogenesis and Evolution Section,Metaorganism Immunity Section,0.0
Viral Pathogenesis and Evolution Section,Microbial Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Biology Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Defenses Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Development of the Immune System Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Entomology Unit,0.0
Viral Pathogenesis and Evolution Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Pathogenesis and Evolution Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Pathogenesis and Evolution Section,Molecular HIV Host Interactions Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Microbiology Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Parasitology Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Parasitology and Entomology Unit,0.0
Viral Pathogenesis and Evolution Section,Molecular Pathogenesis Unit,0.0
Viral Pathogenesis and Evolution Section,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Pathology Section,0.0
Viral Pathogenesis and Evolution Section,Molecular Signaling Section,0.0
Viral Pathogenesis and Evolution Section,Molecular and Cellular Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Molecular and Cellular Immunoregulation Section,0.0
Viral Pathogenesis and Evolution Section,Mosquito Immunity and Vector Competence Section,0.0
Viral Pathogenesis and Evolution Section,Mucosal Immunity Section,0.0
Viral Pathogenesis and Evolution Section,Mucosal Immunobiology Section,0.0
Viral Pathogenesis and Evolution Section,Multiscale Systems Biology Section,0.0
Viral Pathogenesis and Evolution Section,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Pathogenesis and Evolution Section,Neuroimmunological Diseases Section,0.0
Viral Pathogenesis and Evolution Section,Neuroimmunology Unit,0.0
Viral Pathogenesis and Evolution Section,Nonhuman Primate Virology Section,0.0
Viral Pathogenesis and Evolution Section,Office of the Animal Program Director,0.0
Viral Pathogenesis and Evolution Section,Pathogenesis and Immunity Section,0.0
Viral Pathogenesis and Evolution Section,Pathology Core,0.0
Viral Pathogenesis and Evolution Section,Physiology Unit,0.0
Viral Pathogenesis and Evolution Section,Plague Section,0.0
Viral Pathogenesis and Evolution Section,Primary Immune Deficiency Clinic,0.0
Viral Pathogenesis and Evolution Section,Prion Cell Biology Unit,0.0
Viral Pathogenesis and Evolution Section,Protein Chemistry Section,0.0
Viral Pathogenesis and Evolution Section,Quantitative Virology and Evolution Unit,0.0
Viral Pathogenesis and Evolution Section,RML Flow Cytometry Unit,0.0
Viral Pathogenesis and Evolution Section,RML Genomics Unit,0.0
Viral Pathogenesis and Evolution Section,RML Microscopy Unit,0.0
Viral Pathogenesis and Evolution Section,RNA Viruses Section,0.0
Viral Pathogenesis and Evolution Section,Research Technology Branch,0.0
Viral Pathogenesis and Evolution Section,Retroviral Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Scientist Emerita,0.0
Viral Pathogenesis and Evolution Section,Signaling Systems Section,0.0
Viral Pathogenesis and Evolution Section,Structural Biology Section,0.0
Viral Pathogenesis and Evolution Section,Structural Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Structural Informatics Unit,0.0
Viral Pathogenesis and Evolution Section,Structural Virology Section,0.0
Viral Pathogenesis and Evolution Section,T-Cell Tolerance and Memory Section,0.0
Viral Pathogenesis and Evolution Section,T-Lymphocyte Biology Section,0.0
Viral Pathogenesis and Evolution Section,TSE/Prion Biochemistry Section,0.0
Viral Pathogenesis and Evolution Section,TSE/Prion Molecular Biology Section,0.0
Viral Pathogenesis and Evolution Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Pathogenesis and Evolution Section,Tick-Pathogen Transmission Unit,0.0
Viral Pathogenesis and Evolution Section,Translational Allergic Immunopathology Unit,0.0
Viral Pathogenesis and Evolution Section,Translational Autoinflammatory Disease Studies Unit,0.0
Viral Pathogenesis and Evolution Section,Translational Immunobiology Unit,0.0
Viral Pathogenesis and Evolution Section,Translational Mycology Section,0.0
Viral Pathogenesis and Evolution Section,Transplant Infectious Diseases Consult Service,0.0
Viral Pathogenesis and Evolution Section,Tuberculosis Research Section,0.0
Viral Pathogenesis and Evolution Section,Twinbrook III,0.0
Viral Pathogenesis and Evolution Section,Twinbrook Imaging Facility,0.0
Viral Pathogenesis and Evolution Section,Type 2 Immunity Section,0.0
Viral Pathogenesis and Evolution Section,Vaccine Development Unit,0.0
Viral Pathogenesis and Evolution Section,Vector Biology Section,0.0
Viral Pathogenesis and Evolution Section,Vector Molecular Biology Section,0.0
Viral Pathogenesis and Evolution Section,Vector-Pathogen-Host Interaction Unit,0.0
Viral Pathogenesis and Evolution Section,Viral Biochemistry Section,0.0
Viral Pathogenesis and Evolution Section,Viral Biology Section,0.0
Viral Pathogenesis and Evolution Section,Viral Budding Unit,0.0
Viral Pathogenesis and Evolution Section,Viral Epidemiology and Immunity Unit,0.0
Viral Pathogenesis and Evolution Section,Viral Immunity and Pathogenesis Unit,0.0
Viral Pathogenesis and Evolution Section,Viral Immunology Section,0.0
Viral Pathogenesis and Evolution Section,Viral Pathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Pathogenesis and Evolution Section,Viral Pathogenesis Section (Laboratory of Viral Diseases),0.0
Viral Pathogenesis and Vaccine Section,Allergy and Immunology Clinical Training Program,0.0
Viral Pathogenesis and Vaccine Section,Antibacterial Host Defense Unit,0.0
Viral Pathogenesis and Vaccine Section,Antibody Biology Unit,0.0
Viral Pathogenesis and Vaccine Section,Apicomplexan Molecular Physiology Section,0.0
Viral Pathogenesis and Vaccine Section,Autoimmunity and Functional Genomics Section,0.0
Viral Pathogenesis and Vaccine Section,B-Cell Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,B-Cell Molecular Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Viral Pathogenesis and Vaccine Section,Bacterial Physiology and Metabolism Unit,0.0
Viral Pathogenesis and Vaccine Section,Barrier Immunity Section,0.0
Viral Pathogenesis and Vaccine Section,Biological Imaging,0.0
Viral Pathogenesis and Vaccine Section,Biology of Vector-Borne Viruses Section,0.0
Viral Pathogenesis and Vaccine Section,Building 14B South,0.0
Viral Pathogenesis and Vaccine Section,Building 33,0.0
Viral Pathogenesis and Vaccine Section,Building 50,0.0
Viral Pathogenesis and Vaccine Section,Building NIHAC/103,0.0
Viral Pathogenesis and Vaccine Section,Buildings 4 and 10/11C127,0.0
Viral Pathogenesis and Vaccine Section,Caliciviruses Section,0.0
Viral Pathogenesis and Vaccine Section,Cell Signaling and Immunity Section,0.0
Viral Pathogenesis and Vaccine Section,Cellular Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Cellular Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Chemotaxis Signal Section,0.0
Viral Pathogenesis and Vaccine Section,Chlamydial Diseases Section,0.0
Viral Pathogenesis and Vaccine Section,Clinical Microbiome Unit (CMU),0.0
Viral Pathogenesis and Vaccine Section,Clinical Pathophysiology Section,0.0
Viral Pathogenesis and Vaccine Section,Clinical Research Section,0.0
Viral Pathogenesis and Vaccine Section,Computational Biology Unit,0.0
Viral Pathogenesis and Vaccine Section,Coxiella Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,DNA Tumor Virus Section,0.0
Viral Pathogenesis and Vaccine Section,Disease Modeling and Transmission Section,0.0
Viral Pathogenesis and Vaccine Section,Emerging Respiratory Viruses Section,0.0
Viral Pathogenesis and Vaccine Section,Emerging Virus Immunity Unit,0.0
Viral Pathogenesis and Vaccine Section,Epidemiology and Population Studies Unit,0.0
Viral Pathogenesis and Vaccine Section,Epithelial Therapeutics Unit,0.0
Viral Pathogenesis and Vaccine Section,Flow Cytometry Section,0.0
Viral Pathogenesis and Vaccine Section,Food Allergy Research Section,0.0
Viral Pathogenesis and Vaccine Section,Functional Cellular Networks Section,0.0
Viral Pathogenesis and Vaccine Section,Fungal Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,Gene Regulation Section,0.0
Viral Pathogenesis and Vaccine Section,Genetic Engineering Section,0.0
Viral Pathogenesis and Vaccine Section,Genetic Immunotherapy Section,0.0
Viral Pathogenesis and Vaccine Section,Genomic Technologies Section,0.0
Viral Pathogenesis and Vaccine Section,HIV Immunovirology Section,0.0
Viral Pathogenesis and Vaccine Section,HIV Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,Helminth Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Hepatic Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,Host-Parasite Interactions Section,0.0
Viral Pathogenesis and Vaccine Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Viral Pathogenesis and Vaccine Section,Human Eosinophil Section,0.0
Viral Pathogenesis and Vaccine Section,Human Immunological Diseases Section,0.0
Viral Pathogenesis and Vaccine Section,Immune Activation Section,0.0
Viral Pathogenesis and Vaccine Section,Immune Deficiency Genetics Section,0.0
Viral Pathogenesis and Vaccine Section,Immunity to Pulmonary Pathogens Section,0.0
Viral Pathogenesis and Vaccine Section,Immunobiology Section,0.0
Viral Pathogenesis and Vaccine Section,Immunobiology and Molecular Virology Unit,0.0
Viral Pathogenesis and Vaccine Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Viral Pathogenesis and Vaccine Section,Infectious Disease Fellowship Training Program,0.0
Viral Pathogenesis and Vaccine Section,Infectious Disease Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,Inflammation & Innate Immunity Unit,0.0
Viral Pathogenesis and Vaccine Section,Inflammation Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Innate Immunity and Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,Integrative Immunobiology Section,0.0
Viral Pathogenesis and Vaccine Section,International HIV/STD Section,0.0
Viral Pathogenesis and Vaccine Section,Intracellular Parasite Biology Section,0.0
Viral Pathogenesis and Vaccine Section,LID Clinical Studies Unit,0.0
Viral Pathogenesis and Vaccine Section,Lung and Vascular Inflammation Section,0.0
Viral Pathogenesis and Vaccine Section,Lyme Disease Studies Unit,0.0
Viral Pathogenesis and Vaccine Section,Lymphocyte Activation Section,0.0
Viral Pathogenesis and Vaccine Section,Lymphocyte Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Malaria Cell Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Malaria Functional Genomics Section,0.0
Viral Pathogenesis and Vaccine Section,Malaria Genetics Section,0.0
Viral Pathogenesis and Vaccine Section,Malaria Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Malaria Infection Biology and Immunity Unit,0.0
Viral Pathogenesis and Vaccine Section,Mast Cell Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Medical Virology Section,0.0
Viral Pathogenesis and Vaccine Section,Metaorganism Immunity Section,0.0
Viral Pathogenesis and Vaccine Section,Microbial Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Defenses Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Development of the Immune System Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Entomology Unit,0.0
Viral Pathogenesis and Vaccine Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Viral Pathogenesis and Vaccine Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Viral Pathogenesis and Vaccine Section,Molecular HIV Host Interactions Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Microbiology Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Parasitology Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Parasitology and Entomology Unit,0.0
Viral Pathogenesis and Vaccine Section,Molecular Pathogenesis Unit,0.0
Viral Pathogenesis and Vaccine Section,Molecular Pathogenesis and Biomarkers Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Pathology Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular Signaling Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular and Cellular Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Molecular and Cellular Immunoregulation Section,0.0
Viral Pathogenesis and Vaccine Section,Mosquito Immunity and Vector Competence Section,0.0
Viral Pathogenesis and Vaccine Section,Mucosal Immunity Section,0.0
Viral Pathogenesis and Vaccine Section,Mucosal Immunobiology Section,0.0
Viral Pathogenesis and Vaccine Section,Multiscale Systems Biology Section,0.0
Viral Pathogenesis and Vaccine Section,NIAID International Center of Excellence in Research Cambodia,0.0
Viral Pathogenesis and Vaccine Section,Neuroimmunological Diseases Section,0.0
Viral Pathogenesis and Vaccine Section,Neuroimmunology Unit,0.0
Viral Pathogenesis and Vaccine Section,Office of the Animal Program Director,0.0
Viral Pathogenesis and Vaccine Section,Pathogen Molecular Genetics Section,0.0
Viral Pathogenesis and Vaccine Section,Pathogen-Host Cell Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Pathogenesis and Immunity Section,0.0
Viral Pathogenesis and Vaccine Section,Pathology Core,0.0
Viral Pathogenesis and Vaccine Section,Physiology Unit,0.0
Viral Pathogenesis and Vaccine Section,Plague Section,0.0
Viral Pathogenesis and Vaccine Section,Primary Immune Deficiency Clinic,0.0
Viral Pathogenesis and Vaccine Section,Prion Cell Biology Unit,0.0
Viral Pathogenesis and Vaccine Section,Protein Chemistry Section,0.0
Viral Pathogenesis and Vaccine Section,Quantitative Virology and Evolution Unit,0.0
Viral Pathogenesis and Vaccine Section,RML Flow Cytometry Unit,0.0
Viral Pathogenesis and Vaccine Section,RML Genomics Unit,0.0
Viral Pathogenesis and Vaccine Section,RML Microscopy Unit,0.0
Viral Pathogenesis and Vaccine Section,RNA Viruses Section,0.0
Viral Pathogenesis and Vaccine Section,Research Technology Branch,0.0
Viral Pathogenesis and Vaccine Section,Retroviral Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Salmonella-Host Cell Interactions Section,0.0
Viral Pathogenesis and Vaccine Section,Scientist Emerita,0.0
Viral Pathogenesis and Vaccine Section,Signaling Systems Section,0.0
Viral Pathogenesis and Vaccine Section,Structural Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Structural Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Structural Informatics Unit,0.0
Viral Pathogenesis and Vaccine Section,Structural Virology Section,0.0
Viral Pathogenesis and Vaccine Section,Systems Genomics Section,0.0
Viral Pathogenesis and Vaccine Section,T-Cell Tolerance and Memory Section,0.0
Viral Pathogenesis and Vaccine Section,T-Lymphocyte Biology Section,0.0
Viral Pathogenesis and Vaccine Section,TSE/Prion Biochemistry Section,0.0
Viral Pathogenesis and Vaccine Section,TSE/Prion Molecular Biology Section,0.0
Viral Pathogenesis and Vaccine Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Viral Pathogenesis and Vaccine Section,Tick-Pathogen Transmission Unit,0.0
Viral Pathogenesis and Vaccine Section,Translational Allergic Immunopathology Unit,0.0
Viral Pathogenesis and Vaccine Section,Translational Autoinflammatory Disease Studies Unit,0.0
Viral Pathogenesis and Vaccine Section,Translational Immunobiology Unit,0.0
Viral Pathogenesis and Vaccine Section,Translational Mycology Section,0.0
Viral Pathogenesis and Vaccine Section,Transplant Infectious Diseases Consult Service,0.0
Viral Pathogenesis and Vaccine Section,Tuberculosis Research Section,0.0
Viral Pathogenesis and Vaccine Section,Twinbrook III,0.0
Viral Pathogenesis and Vaccine Section,Twinbrook Imaging Facility,0.0
Viral Pathogenesis and Vaccine Section,Type 2 Immunity Section,0.0
Viral Pathogenesis and Vaccine Section,Vaccine Development Unit,0.0
Viral Pathogenesis and Vaccine Section,Vector Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Vector Molecular Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Vector-Pathogen-Host Interaction Unit,0.0
Viral Pathogenesis and Vaccine Section,Viral Biochemistry Section,0.0
Viral Pathogenesis and Vaccine Section,Viral Biology Section,0.0
Viral Pathogenesis and Vaccine Section,Viral Budding Unit,0.0
Viral Pathogenesis and Vaccine Section,Viral Epidemiology and Immunity Unit,0.0
Viral Pathogenesis and Vaccine Section,Viral Immunity and Pathogenesis Unit,0.0
Viral Pathogenesis and Vaccine Section,Viral Immunology Section,0.0
Viral Pathogenesis and Vaccine Section,Viral Pathogenesis Section (Laboratory of Immunoregulation),0.0
Viral Pathogenesis and Vaccine Section,Viral Pathogenesis Section (Laboratory of Viral Diseases),0.0
Viral Pathogenesis and Vaccine Section,Viral Pathogenesis and Evolution Section,0.0
Virus Ecology Section,Allergy and Immunology Clinical Training Program,0.0
Virus Ecology Section,Antibacterial Host Defense Unit,0.0
Virus Ecology Section,Antibody Biology Unit,0.0
Virus Ecology Section,Apicomplexan Molecular Physiology Section,0.0
Virus Ecology Section,Autoimmunity and Functional Genomics Section,0.0
Virus Ecology Section,B-Cell Immunology Section,0.0
Virus Ecology Section,B-Cell Molecular Immunology Section,0.0
Virus Ecology Section,Bacterial Physiology and Metabolism Unit,0.0
Virus Ecology Section,Barrier Immunity Section,0.0
Virus Ecology Section,Biological Imaging,0.0
Virus Ecology Section,Biology of Vector-Borne Viruses Section,0.0
Virus Ecology Section,Building 14B South,0.0
Virus Ecology Section,Building 33,0.0
Virus Ecology Section,Building 50,0.0
Virus Ecology Section,Building NIHAC/103,0.0
Virus Ecology Section,Buildings 4 and 10/11C127,0.0
Virus Ecology Section,Caliciviruses Section,0.0
Virus Ecology Section,Cell Signaling and Immunity Section,0.0
Virus Ecology Section,Cellular Biology Section,0.0
Virus Ecology Section,Cellular Immunology Section,0.0
Virus Ecology Section,Chemotaxis Signal Section,0.0
Virus Ecology Section,Chlamydial Diseases Section,0.0
Virus Ecology Section,Clinical Microbiome Unit (CMU),0.0
Virus Ecology Section,Clinical Pathophysiology Section,0.0
Virus Ecology Section,Clinical Research Section,0.0
Virus Ecology Section,Clinical and Molecular Retrovirology Section,0.0
Virus Ecology Section,Computational Biology Unit,0.0
Virus Ecology Section,Coxiella Pathogenesis Section,0.0
Virus Ecology Section,DNA Tumor Virus Section,0.0
Virus Ecology Section,Emerging Respiratory Viruses Section,0.0
Virus Ecology Section,Emerging Virus Immunity Unit,0.0
Virus Ecology Section,Epidemiology and Population Studies Unit,0.0
Virus Ecology Section,Epithelial Therapeutics Unit,0.0
Virus Ecology Section,Flow Cytometry Section,0.0
Virus Ecology Section,Food Allergy Research Section,0.0
Virus Ecology Section,Functional Cellular Networks Section,0.0
Virus Ecology Section,Fungal Pathogenesis Section,0.0
Virus Ecology Section,Gene Regulation Section,0.0
Virus Ecology Section,Genetic Engineering Section,0.0
Virus Ecology Section,Genetic Immunotherapy Section,0.0
Virus Ecology Section,Genomic Technologies Section,0.0
Virus Ecology Section,HIV Immunovirology Section,0.0
Virus Ecology Section,HIV Pathogenesis Section,0.0
Virus Ecology Section,HIV-Specific Immunity Section,0.0
Virus Ecology Section,Helminth Immunology Section,0.0
Virus Ecology Section,Hepatic Pathogenesis Section,0.0
Virus Ecology Section,Host-Parasite Interactions Section,0.0
Virus Ecology Section,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Virus Ecology Section,Human Eosinophil Section,0.0
Virus Ecology Section,Human Immunological Diseases Section,0.0
Virus Ecology Section,Immune Activation Section,0.0
Virus Ecology Section,Immune Deficiency Genetics Section,0.0
Virus Ecology Section,Immunity to Pulmonary Pathogens Section,0.0
Virus Ecology Section,Immunobiology Section,0.0
Virus Ecology Section,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Virus Ecology Section,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Virus Ecology Section,Infectious Disease Fellowship Training Program,0.0
Virus Ecology Section,Infectious Disease Pathogenesis Section,0.0
Virus Ecology Section,Inflammation & Innate Immunity Unit,0.0
Virus Ecology Section,Inflammation Biology Section,0.0
Virus Ecology Section,Integrative Immunobiology Section,0.0
Virus Ecology Section,International HIV/STD Section,0.0
Virus Ecology Section,Intracellular Parasite Biology Section,0.0
Virus Ecology Section,LID Clinical Studies Unit,0.0
Virus Ecology Section,Lung and Vascular Inflammation Section,0.0
Virus Ecology Section,Lyme Disease Studies Unit,0.0
Virus Ecology Section,Lymphocyte Activation Section,0.0
Virus Ecology Section,Lymphocyte Biology Section,0.0
Virus Ecology Section,Malaria Cell Biology Section,0.0
Virus Ecology Section,Malaria Functional Genomics Section,0.0
Virus Ecology Section,Malaria Genetics Section,0.0
Virus Ecology Section,Malaria Immunology Section,0.0
Virus Ecology Section,Malaria Infection Biology and Immunity Unit,0.0
Virus Ecology Section,Mast Cell Biology Section,0.0
Virus Ecology Section,Medical Virology Section,0.0
Virus Ecology Section,Metaorganism Immunity Section,0.0
Virus Ecology Section,Microbial Pathogenesis Section,0.0
Virus Ecology Section,Molecular Biology Section,0.0
Virus Ecology Section,Molecular Defenses Section,0.0
Virus Ecology Section,Molecular Development of the Immune System Section,0.0
Virus Ecology Section,Molecular Entomology Unit,0.0
Virus Ecology Section,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Virus Ecology Section,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Virus Ecology Section,Molecular HIV Host Interactions Section,0.0
Virus Ecology Section,Molecular Microbiology Section,0.0
Virus Ecology Section,Molecular Parasitology Section,0.0
Virus Ecology Section,Molecular Parasitology and Entomology Unit,0.0
Virus Ecology Section,Molecular Pathogenesis and Biomarkers Section,0.0
Virus Ecology Section,Molecular Pathology Section,0.0
Virus Ecology Section,Molecular Signaling Section,0.0
Virus Ecology Section,Molecular and Cellular Immunology Section,0.0
Virus Ecology Section,Molecular and Cellular Immunoregulation Section,0.0
Virus Ecology Section,Mosquito Immunity and Vector Competence Section,0.0
Virus Ecology Section,Mucosal Immunity Section,0.0
Virus Ecology Section,Mucosal Immunobiology Section,0.0
Virus Ecology Section,Multiscale Systems Biology Section,0.0
Virus Ecology Section,NIAID International Center of Excellence in Research Cambodia,0.0
Virus Ecology Section,Neuroimmunological Diseases Section,0.0
Virus Ecology Section,Neuroimmunology Unit,0.0
Virus Ecology Section,Nonhuman Primate Virology Section,0.0
Virus Ecology Section,Office of the Animal Program Director,0.0
Virus Ecology Section,Pathogen Molecular Genetics Section,0.0
Virus Ecology Section,Pathogen-Host Cell Biology Section,0.0
Virus Ecology Section,Pathogenesis and Immunity Section,0.0
Virus Ecology Section,Pathology Core,0.0
Virus Ecology Section,Physiology Unit,0.0
Virus Ecology Section,Plague Section,0.0
Virus Ecology Section,Primary Immune Deficiency Clinic,0.0
Virus Ecology Section,Prion Cell Biology Unit,0.0
Virus Ecology Section,Protein Chemistry Section,0.0
Virus Ecology Section,Quantitative Virology and Evolution Unit,0.0
Virus Ecology Section,RML Genomics Unit,0.0
Virus Ecology Section,RNA Viruses Section,0.0
Virus Ecology Section,Research Technology Branch,0.0
Virus Ecology Section,Retroviral Immunology Section,0.0
Virus Ecology Section,Salmonella-Host Cell Interactions Section,0.0
Virus Ecology Section,Scientist Emerita,0.0
Virus Ecology Section,Signaling Systems Section,0.0
Virus Ecology Section,Structural Biology Section,0.0
Virus Ecology Section,Structural Immunology Section,0.0
Virus Ecology Section,Structural Informatics Unit,0.0
Virus Ecology Section,Structural Virology Section,0.0
Virus Ecology Section,Systems Genomics Section,0.0
Virus Ecology Section,T-Cell Tolerance and Memory Section,0.0
Virus Ecology Section,T-Lymphocyte Biology Section,0.0
Virus Ecology Section,TSE/Prion Biochemistry Section,0.0
Virus Ecology Section,TSE/Prion Molecular Biology Section,0.0
Virus Ecology Section,TSE/Prion and Retroviral Pathogenesis Section,0.0
Virus Ecology Section,Tick-Pathogen Transmission Unit,0.0
Virus Ecology Section,Translational Allergic Immunopathology Unit,0.0
Virus Ecology Section,Translational Autoinflammatory Disease Studies Unit,0.0
Virus Ecology Section,Translational Immunobiology Unit,0.0
Virus Ecology Section,Translational Mycology Section,0.0
Virus Ecology Section,Transplant Infectious Diseases Consult Service,0.0
Virus Ecology Section,Tuberculosis Research Section,0.0
Virus Ecology Section,Twinbrook III,0.0
Virus Ecology Section,Twinbrook Imaging Facility,0.0
Virus Ecology Section,Type 2 Immunity Section,0.0
Virus Ecology Section,Vaccine Development Unit,0.0
Virus Ecology Section,Vector Biology Section,0.0
Virus Ecology Section,Vector Molecular Biology Section,0.0
Virus Ecology Section,Vector-Pathogen-Host Interaction Unit,0.0
Virus Ecology Section,Viral Biochemistry Section,0.0
Virus Ecology Section,Viral Biology Section,0.0
Virus Ecology Section,Viral Budding Unit,0.0
Virus Ecology Section,Viral Epidemiology and Immunity Unit,0.0
Virus Ecology Section,Viral Immunity and Pathogenesis Unit,0.0
Virus Ecology Section,Viral Immunology Section,0.0
Virus Ecology Section,Viral Pathogenesis Section (Laboratory of Immunoregulation),0.0
Virus Ecology Section,Viral Pathogenesis Section (Laboratory of Viral Diseases),0.0
Virus Ecology Section,Viral Pathogenesis and Evolution Section,0.0
Virus Ecology Section,Viral Pathogenesis and Vaccine Section,0.0
Visual and Medical Arts Unit,Allergy and Immunology Clinical Training Program,0.0
Visual and Medical Arts Unit,Antibacterial Host Defense Unit,0.0
Visual and Medical Arts Unit,Antibody Biology Unit,0.0
Visual and Medical Arts Unit,Apicomplexan Molecular Physiology Section,0.0
Visual and Medical Arts Unit,Autoimmunity and Functional Genomics Section,0.0
Visual and Medical Arts Unit,B-Cell Immunology Section,0.0
Visual and Medical Arts Unit,B-Cell Molecular Immunology Section,0.0
Visual and Medical Arts Unit,Bacterial Pathogenesis and Antimicrobial Resistance Unit,0.0
Visual and Medical Arts Unit,Bacterial Physiology and Metabolism Unit,0.0
Visual and Medical Arts Unit,Barrier Immunity Section,0.0
Visual and Medical Arts Unit,Biological Imaging,0.0
Visual and Medical Arts Unit,Biology of Vector-Borne Viruses Section,0.0
Visual and Medical Arts Unit,Building 14B South,0.0
Visual and Medical Arts Unit,Building 33,0.0
Visual and Medical Arts Unit,Building 50,0.0
Visual and Medical Arts Unit,Building NIHAC/103,0.0
Visual and Medical Arts Unit,Buildings 4 and 10/11C127,0.0
Visual and Medical Arts Unit,Caliciviruses Section,0.0
Visual and Medical Arts Unit,Cell Signaling and Immunity Section,0.0
Visual and Medical Arts Unit,Cellular Biology Section,0.0
Visual and Medical Arts Unit,Cellular Immunology Section,0.0
Visual and Medical Arts Unit,Chemotaxis Signal Section,0.0
Visual and Medical Arts Unit,Chlamydial Diseases Section,0.0
Visual and Medical Arts Unit,Clinical Microbiome Unit (CMU),0.0
Visual and Medical Arts Unit,Clinical Pathophysiology Section,0.0
Visual and Medical Arts Unit,Clinical Research Section,0.0
Visual and Medical Arts Unit,Clinical and Molecular Retrovirology Section,0.0
Visual and Medical Arts Unit,Computational Biology Unit,0.0
Visual and Medical Arts Unit,Coxiella Pathogenesis Section,0.0
Visual and Medical Arts Unit,DNA Tumor Virus Section,0.0
Visual and Medical Arts Unit,Emerging Respiratory Viruses Section,0.0
Visual and Medical Arts Unit,Emerging Virus Immunity Unit,0.0
Visual and Medical Arts Unit,Epidemiology and Population Studies Unit,0.0
Visual and Medical Arts Unit,Epithelial Therapeutics Unit,0.0
Visual and Medical Arts Unit,Flow Cytometry Section,0.0
Visual and Medical Arts Unit,Food Allergy Research Section,0.0
Visual and Medical Arts Unit,Functional Cellular Networks Section,0.0
Visual and Medical Arts Unit,Fungal Pathogenesis Section,0.0
Visual and Medical Arts Unit,Gene Regulation Section,0.0
Visual and Medical Arts Unit,Genetic Engineering Section,0.0
Visual and Medical Arts Unit,Genetic Immunotherapy Section,0.0
Visual and Medical Arts Unit,Genomic Technologies Section,0.0
Visual and Medical Arts Unit,HIV Immunovirology Section,0.0
Visual and Medical Arts Unit,HIV Pathogenesis Section,0.0
Visual and Medical Arts Unit,HIV-Specific Immunity Section,0.0
Visual and Medical Arts Unit,Helminth Immunology Section,0.0
Visual and Medical Arts Unit,Hepatic Pathogenesis Section,0.0
Visual and Medical Arts Unit,Host-Parasite Interactions Section,0.0
Visual and Medical Arts Unit,Host-Pathogen Interactions and Structural Vaccinology Section,0.0
Visual and Medical Arts Unit,Human Eosinophil Section,0.0
Visual and Medical Arts Unit,Human Immunological Diseases Section,0.0
Visual and Medical Arts Unit,Immune Activation Section,0.0
Visual and Medical Arts Unit,Immune Deficiency Genetics Section,0.0
Visual and Medical Arts Unit,Immunity to Pulmonary Pathogens Section,0.0
Visual and Medical Arts Unit,Immunobiology Section,0.0
Visual and Medical Arts Unit,Immunobiology and Molecular Virology Unit,0.0
Visual and Medical Arts Unit,Immunopathogenesis Section (Laboratory of Clinical Immunology and Microbiology),0.0
Visual and Medical Arts Unit,Immunopathogenesis Section (Laboratory of Immunoregulation),0.0
Visual and Medical Arts Unit,Infectious Disease Fellowship Training Program,0.0
Visual and Medical Arts Unit,Infectious Disease Pathogenesis Section,0.0
Visual and Medical Arts Unit,Inflammation & Innate Immunity Unit,0.0
Visual and Medical Arts Unit,Inflammation Biology Section,0.0
Visual and Medical Arts Unit,Innate Immunity and Pathogenesis Section,0.0
Visual and Medical Arts Unit,Integrative Immunobiology Section,0.0
Visual and Medical Arts Unit,International HIV/STD Section,0.0
Visual and Medical Arts Unit,Intracellular Parasite Biology Section,0.0
Visual and Medical Arts Unit,LID Clinical Studies Unit,0.0
Visual and Medical Arts Unit,Lung and Vascular Inflammation Section,0.0
Visual and Medical Arts Unit,Lyme Disease Studies Unit,0.0
Visual and Medical Arts Unit,Lymphocyte Activation Section,0.0
Visual and Medical Arts Unit,Lymphocyte Biology Section,0.0
Visual and Medical Arts Unit,Malaria Cell Biology Section,0.0
Visual and Medical Arts Unit,Malaria Functional Genomics Section,0.0
Visual and Medical Arts Unit,Malaria Genetics Section,0.0
Visual and Medical Arts Unit,Malaria Immunology Section,0.0
Visual and Medical Arts Unit,Malaria Infection Biology and Immunity Unit,0.0
Visual and Medical Arts Unit,Mast Cell Biology Section,0.0
Visual and Medical Arts Unit,Medical Virology Section,0.0
Visual and Medical Arts Unit,Metaorganism Immunity Section,0.0
Visual and Medical Arts Unit,Microbial Pathogenesis Section,0.0
Visual and Medical Arts Unit,Molecular Biology Section,0.0
Visual and Medical Arts Unit,Molecular Defenses Section,0.0
Visual and Medical Arts Unit,Molecular Development of the Immune System Section,0.0
Visual and Medical Arts Unit,Molecular Entomology Unit,0.0
Visual and Medical Arts Unit,Molecular Genetics Section (Laboratory of Bacteriology),0.0
Visual and Medical Arts Unit,Molecular Genetics Section (Laboratory of Viral Diseases),0.0
Visual and Medical Arts Unit,Molecular HIV Host Interactions Section,0.0
Visual and Medical Arts Unit,Molecular Microbiology Section,0.0
Visual and Medical Arts Unit,Molecular Parasitology Section,0.0
Visual and Medical Arts Unit,Molecular Parasitology and Entomology Unit,0.0
Visual and Medical Arts Unit,Molecular Pathogenesis Unit,0.0
Visual and Medical Arts Unit,Molecular Pathogenesis and Biomarkers Section,0.0
Visual and Medical Arts Unit,Molecular Pathology Section,0.0
Visual and Medical Arts Unit,Molecular Signaling Section,0.0
Visual and Medical Arts Unit,Molecular and Cellular Immunology Section,0.0
Visual and Medical Arts Unit,Molecular and Cellular Immunoregulation Section,0.0
Visual and Medical Arts Unit,Mosquito Immunity and Vector Competence Section,0.0
Visual and Medical Arts Unit,Mucosal Immunity Section,0.0
Visual and Medical Arts Unit,Mucosal Immunobiology Section,0.0
Visual and Medical Arts Unit,Multiscale Systems Biology Section,0.0
Visual and Medical Arts Unit,NIAID International Center of Excellence in Research Cambodia,0.0
Visual and Medical Arts Unit,Neuroimmunological Diseases Section,0.0
Visual and Medical Arts Unit,Neuroimmunology Unit,0.0
Visual and Medical Arts Unit,Nonhuman Primate Virology Section,0.0
Visual and Medical Arts Unit,Office of the Animal Program Director,0.0
Visual and Medical Arts Unit,Pathogen Molecular Genetics Section,0.0
Visual and Medical Arts Unit,Pathogen-Host Cell Biology Section,0.0
Visual and Medical Arts Unit,Pathogenesis and Immunity Section,0.0
Visual and Medical Arts Unit,Pathology Core,0.0
Visual and Medical Arts Unit,Physiology Unit,0.0
Visual and Medical Arts Unit,Plague Section,0.0
Visual and Medical Arts Unit,Primary Immune Deficiency Clinic,0.0
Visual and Medical Arts Unit,Prion Cell Biology Unit,0.0
Visual and Medical Arts Unit,Protein Chemistry Section,0.0
Visual and Medical Arts Unit,Quantitative Virology and Evolution Unit,0.0
Visual and Medical Arts Unit,RML Flow Cytometry Unit,0.0
Visual and Medical Arts Unit,RML Genomics Unit,0.0
Visual and Medical Arts Unit,RML Microscopy Unit,0.0
Visual and Medical Arts Unit,RNA Viruses Section,0.0
Visual and Medical Arts Unit,Research Technology Branch,0.0
Visual and Medical Arts Unit,Retroviral Immunology Section,0.0
Visual and Medical Arts Unit,Salmonella-Host Cell Interactions Section,0.0
Visual and Medical Arts Unit,Scientist Emerita,0.0
Visual and Medical Arts Unit,Signaling Systems Section,0.0
Visual and Medical Arts Unit,Structural Biology Section,0.0
Visual and Medical Arts Unit,Structural Immunology Section,0.0
Visual and Medical Arts Unit,Structural Informatics Unit,0.0
Visual and Medical Arts Unit,Structural Virology Section,0.0
Visual and Medical Arts Unit,Systems Genomics Section,0.0
Visual and Medical Arts Unit,T-Cell Tolerance and Memory Section,0.0
Visual and Medical Arts Unit,T-Lymphocyte Biology Section,0.0
Visual and Medical Arts Unit,TSE/Prion Biochemistry Section,0.0
Visual and Medical Arts Unit,TSE/Prion Molecular Biology Section,0.0
Visual and Medical Arts Unit,TSE/Prion and Retroviral Pathogenesis Section,0.0
Visual and Medical Arts Unit,Tick-Pathogen Transmission Unit,0.0
Visual and Medical Arts Unit,Translational Allergic Immunopathology Unit,0.0
Visual and Medical Arts Unit,Translational Autoinflammatory Disease Studies Unit,0.0
Visual and Medical Arts Unit,Translational Immunobiology Unit,0.0
Visual and Medical Arts Unit,Translational Mycology Section,0.0
Visual and Medical Arts Unit,Transplant Infectious Diseases Consult Service,0.0
Visual and Medical Arts Unit,Tuberculosis Research Section,0.0
Visual and Medical Arts Unit,Twinbrook III,0.0
Visual and Medical Arts Unit,Twinbrook Imaging Facility,0.0
Visual and Medical Arts Unit,Type 2 Immunity Section,0.0
Visual and Medical Arts Unit,Vaccine Development Unit,0.0
Visual and Medical Arts Unit,Vector Biology Section,0.0
Visual and Medical Arts Unit,Vector Molecular Biology Section,0.0
Visual and Medical Arts Unit,Vector-Pathogen-Host Interaction Unit,0.0
Visual and Medical Arts Unit,Viral Biochemistry Section,0.0
Visual and Medical Arts Unit,Viral Biology Section,0.0
Visual and Medical Arts Unit,Viral Budding Unit,0.0
Visual and Medical Arts Unit,Viral Epidemiology and Immunity Unit,0.0
Visual and Medical Arts Unit,Viral Immunity and Pathogenesis Unit,0.0
Visual and Medical Arts Unit,Viral Immunology Section,0.0
Visual and Medical Arts Unit,Viral Pathogenesis Section (Laboratory of Immunoregulation),0.0
Visual and Medical Arts Unit,Viral Pathogenesis Section (Laboratory of Viral Diseases),0.0
Visual and Medical Arts Unit,Viral Pathogenesis and Evolution Section,0.0
Visual and Medical Arts Unit,Viral Pathogenesis and Vaccine Section,0.0
Visual and Medical Arts Unit,Virus Ecology Section,0.0